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ABSTRACT 
Advances in breast cancer detection and oncology treatment modalities have 
prolonged the survival time for the cancer population, which is officially the largest 
group of cancer survivors among women in the western world, including South 
Africa (Brem & Kumar, 2011; Fisher, Dolbeault, Sultan & Bredart, 2014; Herbst, 
2011; Reyes-Gibby, et al., 2012). In the light of shocking statistics and ever rising 
numbers of cancer, especially breast cancer, the time is ripe for further research in 
the domain of psycho-oncology and has motivated the researcher, due to her 
interest and involvement in breast cancer, to make this her field of research. 
Despite the need for a bio-psycho-social approach when treating cancer patients 
there is little literature available on the psychological interventions in South Africa 
where the majority of research studies previously conducted in South Africa have 
generally focused on the bio-medical aspects of cancer (Albrecht, 2009; Venter, 
2014). To comprehend the paradigm of psycho-oncology, which is the backbone 
of this study, a theoretical framework was attained from Engel’s humanistic or 
psychological model (caring) and Pasteur’s biomedical model (curing) (Borrel-
Carrio, Suchman,  & Epstein, 2004). 
The primary aim of this study was to explore the lived experiences of breast 
cancer patients concerning their diagnosis, treatment and survivorship and unique 
needs for psycho-oncological interventions through their own “voices”. The 
research was conducted within a qualitative framework with a case study method 
of inquiry employing open-ended style interviews and psychotherapeutic sessions 
with five purposely sampled breast cancer patients. Two qualitative questionnaires 
were also used for triangulation purposes. Transcripts of all the therapeutic 
sessions were analysed using interpretive analysis where categories and themes 
were developed and described in full. Findings indicated that in spite the extensive 
proof that breast cancer causes numerous sexual and psychological complications 
during active treatment and afterwards, patients still feel that they have no 
“platform” to express their emotions and sexual issues within the oncology 
framework, or that there is enough and sufficient assistance to attend to their 
needs.    
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The researcher hopes that this study will make a valuable contribution to research 
in the field of psycho-oncology in South Africa and to indicate new realities of the 
chronicity of breast cancer and treatment complications that demand 
psychotherapeutic interventions in cancer care and that the study will initiate new 
ways of understanding the role of psychology and the psychologist in the medical 
world of cancer. The researcher hopes that by offering an understanding of 
participants’ unique experiences of this process, practitioners will have insight 
when working therapeutically with this population and empower them to have a 
quality of life, even within the boundaries of their illness.   
Keywords: breast cancer, treatment modalities, multidisciplinary teams, 
chemotherapy, radiation therapy, hormonal therapy, chronicity, remission, 
oncology team, biological-, psychological and sexual side-effects, psycho-
oncology, IPOS, Psycho-oncologic interventions, cognitive-behavioural therapy 
and sex therapy.   
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CHAPTER I:  
INTRODUCTION 
1.1  OVERVIEW AND STATISTICS 
Breast cancer is a major health risk for all women throughout the world including 
South Africa. According to the National Cancer Registry (2010) breast cancer is 
the number one malignancy amongst women of all races with a lifetime risk of 1 in 
26 with approximately 5% being younger than 35 years of age (Brem & Kumar, 
2011; Reyes-Gibby, Anderson & Morrow, 2012; Travado & Reis, 2013; Van Oers 
& Schlebusch, 2013; Wong-Kim & Bloom, 2005). Because of advances in breast 
cancer detection and treatment modalities in the last decade, there is a noticeably 
prolonged survival time for this population with survivorship after 5 years for early 
localized breast cancer being above 96%.  There is an 82% survival rate for at 
least 10 years for all women diagnosed with breast cancer.  These statistics make 
breast cancer survivors officially the largest group of cancer survivors among 
women in the western world (Fiszer, Dolbeault, Sultan, & Bredart, 2014; Herbst, 
2011; Reyes-Gibby, Anderson, Morrow, Shete & Hassan, 2012; Vorobiof, Sitas & 
Vorobiof, 2001).  
The U.S. Census Bureau has predicted that over the next 50 years the number of 
cancer survivors will escalate at a larger rate than the incidence of cancer itself 
(Ries et al., 2008; Naus, Ishler, Parrot & Kovacs, 2009) and while these rising 
numbers should be celebrated, it also causes patients to live longer with possible 
pathological conditions resulting from the disease (Dean, 2008; Nekolaichuk, 
Turner, Collie & Cumming, 2012). This survivorship of the breast cancer 
population implies the necessity to concentrate on the unique needs of the breast 
cancer patient and survivor which is multifaceted and requires a shift from the 
biological, acute care model to a multidimensional chronic care model with a 
wellness component (Miles, 2009; Venter, 2014). It is the vision of the 
International Psycho-Oncology Society (IPOS) that all cancer patients and their 
families throughout the world should receive optimal psycho-social care at all 
stages of the disease and survivorship, pleading urgency with the behavioural and 
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social scientists to initiate and develop a psycho-social intervention plan as part of 
a holistic multidisciplinary quality care for cancer patients (Breibart, Bultz, Dunn, 
Grassi & Watson, 2013).    
1.2  BREAST CANCER AS THE MAIN SUBJECT OF THIS STUDY  
Although the incidence of survival of all types of cancers has grown noticeably in 
recent years (from 56% to 62%), breast cancer has become the most predominant 
cancer for women of all ages and races in the Western world with the highest 
survival rate and the second highest cause of death (Brem & Kumar, 2011; Reyes-
Gibby et al., 2012; Nekolaichuk, Turner, Collie, & Cumming, 2012; Wong & Bloom, 
2005). Because of the high incidence of breast cancer in South Africa and the 
anticipated increase in breast cancer survivors over the next few decades, this 
particular cancer population has become a field of interest and research within 
health related quality of life aspects.   This field necessitates the critical need to 
find creative strategies to assist this population to adapt successfully to their 
cancer reality (Fiszer et al., 2014; Greeff, 2008; Hummel, van Lankveld, 
Oldenburg, Hahn, Broomans, & Aaronson, 2015). 
The diagnosis of any form of cancer can have a distressing impact on the 
psychological and sexual welfare of the patient.  Going through the traumatic 
process of a cancer diagnosis, with an often sequential lengthy and tiring 
treatment process, can be biologically and psychologically exhaustive for the 
patient and her family (Carpenter, Andersen, Fowler & Maxwell, 2009; Katz, 
2005). Although all cancers can cause psycho-pathology such as depression, 
anxiety and sexual dysfunction, it is evident that women with breast cancer and 
gynaecologic cancers have a higher risk of developing depression or other mood 
disorders and sexual dysfunctions compared to other cancers. The main reason 
for this tendency is hormonal changes due to their postmenopausal or oestrogen 
deficiency state, causing certain symptoms to remain long after the end of 
treatment which make those women good candidates for psychotherapy 
(Juraskova, Butow, Bonner, Robertson, & Sharpe, 2013; Phaendler, Wenzel, 
Mechanic & Penner, 2015). A recent study done by Fiszer and colleagues, (2014) 
has confirmed this point by demonstrating that one in three patients who attended 
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counselling were women with breast cancer, as opposed to counselling for 
patients with colorectal, lung or prostate cancers who attended less counselling. 
Comparing breast cancer with related cancers such as gynaecologic cancers, 
prostate and testicular cancers, shows clear resemblances in symptoms, 
treatments, side-effects and chronicity, as well as influences on the patient’s 
quality of life. Another resemblance between these cancers and breast cancer is 
the lack of existing research and specific intervention guidelines and open 
communication between patients and treating practitioners concerning their 
emotional and sexual experiences and needs.   
Working as a private clinical psychologist predominantly in a hospital environment, 
I am challenged on a daily basis by the different kinds of physical illnesses that 
affect the psychological and sexual dimensions of the patient. For the last 25 
years I have worked closely with oncology patients, especially breast cancer 
patients, hence my interest in the dynamics of this illness. The emotional and 
sexual experiences of the breast cancer patient during her cancer journey and her 
needs and expectations related to psychotherapeutic interventions are the focus of 
this study. As the researcher and therapist of this study, I hope that by 
understanding the dynamics of breast cancer in terms of the illness and 
interventions, the information gained would be relevant to other cancer patients in 
similar situations. There are such a large number of chronic physical diseases, 
including cancer, which have psychological sequelae and demand psychological 
interventions that it will be impossible to cover all the conditions and their 
treatments in this study, therefore breast cancer and breast cancer interventions 
will be the topic under discussion.   
1.3  PHASES OF BREAST CANCER 
Breast cancer can be classified into three phases or periods according to 
Anderson (1992) and Mullan (1985) and which will be referred to often in this 
study. The first phase is the acute or active phase, beginning with the actual 
diagnosis of the cancer, continuing through the whole treatment procedure which 
usually includes surgery, chemotherapy, radiation therapy and hormonal therapy 
(Garcia et al., 2007). The second phase is the extended phase which is 
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immediately post-treatment and begins when the patient goes into remission or 
has completed the treatment. This phase can include extended treatment time, for 
instance, hormonal treatment that can continue for five years after the active 
treatment or other more chronic interventions when the patient is already in 
remission. Phase three, the permanent phase, is the remission phase, where 
there are no signs or symptoms of the breast cancer. Mullan (1995) himself a 
survivor of cancer, explains the phases of breast cancer through a more 
psychological and practical lens, describing it as living “with” cancer, living 
“through” cancer and living “beyond” cancer, but also acknowledges the fact that 
this process is unique for each cancer patient and the passage from one stage to 
the next may not always be clearly outlined. Some authors also use the term “re-
entry phase survivorship”, which can be defined as the time from treatment 
completion through 12 to 18 months, while long-term survivors of breast cancer 
can be defined as being beyond that point (Mulan, 1984; Stanton, 2012). For Park 
and colleagues (2009) being a cancer survivor represents living after a diagnosis 
of cancer regardless of whether he or she is still busy with the treatment or how 
long a person has been alive. Apart from this (more academic) classification, most 
people experience cancer in two stages, the active or acute phase of treatment 
and the survivor phase.       
1.4  THE DIFFERENCE BETWEEN THE TERM BREAST CANCER 
PATIENT AND BREAST CANCER SURVIVOR   
Different terminology may be used for the cancer population by both the patient 
and the oncology team. To differentiate between the terminology of ‘patient’ and 
‘survivor’ in this paper, the term cancer patient is seen as an identity which is 
common and appropriate during active and acute cancer treatment, while cancer 
survivor is the identity more applicable after treatment in the extended phase 
(Harwood & Sparks, 2003; Park, Zlateva, & Blank, 2009). Although the researcher 
uses the term “patient” during the entire study when describing the five 
participants, it refers more to the status of being actively busy with a 
psychotherapeutic process than to that of a cancer patient or survivor. In terms of 
describing the person in the literature, the researcher prefers the terminology 
“cancer patient” during the active cancer treatment (Harwood & Sparks, 2003; 
Park et al., 2009) and “cancer survivor” in the post treatment period which is 
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separated from the timespan encapsulating diagnosis and treatment (Twombly, 
2004).   
1.5  THE CHRONICITY OF BREAST CANCER SURVIVORSHIP 
The progress and advances in the oncology discipline over the last 15 years have 
led to the reality that cancer is no longer seen as a death sentence since people 
with cancer are living longer and their cancer may be managed as a chronic 
illness (Greeff, 2008; McCorkle, Ercolano, Lazenby, 2011; Naus, Ishler, Parrot & 
Kovacs, 2009). Breast cancer as a chronic illness challenges old school theories 
that the oncologist’s work is completed after treatment and requires of patients 
and their families to acknowledge their own participation in the management of 
their illness, emphasising the need for both providers and patients to recognise 
that cancer care is a long term process, extending beyond the active treatment 
phase (McCorkie, et al., 2011). In the framework of chronicity, breast cancer 
survivors often report that they were un-informed and unprepared for the complex 
rehabilitation process and persistent symptoms of depression or anxiety or other 
belated side-effects after the end of their treatment (Brem & Kumar, 2011; 
Burgess, Cornelius, Love, Graham, Richards, & Ramirez, 2005; Dolbeault et al., 
2009; Reyes-Gibby et al., 2012). 
One of the biggest causes of the chronic status of breast cancer is the continuity 
and severity of the adverse effects of cytotoxic drugs (chemotherapy) and 
hormonal therapy, which affects patients both psychologically and biologically 
(Clark, 2010; Fallowfield & Jenkins, 2015). Chronicity as a status quo “instigates” 
its own pathology, for example, anticipation anxiety, which is a dominant type of 
anxiety within the cancer population.  Anticipation anxiety has to do with fear and 
anxiety regarding permanent follow-up appointments with oncologists and regular 
cancer tests and results to confirm the cancer status and also the fear of 
recurrence and imminent death (Berger, Mitchell, Jacobson & Pirl, 2015; Lim, 
Devi, & Ang, 2011). It is a difficult transition for the cancer patient to move from an 
acute and active cancer patient to “beyond” the treatment stage and if not 
acknowledged by the oncology team, the cancer survivor, because of a lack of 
preparation for the re-entry phase, can find herself in a state of limbo without the 
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necessary skills to learn to live with the chronicity of cancer (Anderson, 1992; 
Mullan, 1985; Stanton, 2012).   
The adjustment to breast cancer survivorship is a complex and lifelong process 
demanding recognition from the oncology team and the need of certain skills 
through a psychotherapy process (Naus, Ishler, Parrott, & Kovacs, 2009; Venter, 
2014). This chronicity and often permanency of cancer-related side-effects have 
led to more interest and research regarding the quality of life of the cancer patient 
and to the balance thereof with improvements in longevity of life (Clark, 2010).   
1.6  BREAST CANCER AS A TRAUMATIC EVENT 
The very information of being diagnosed with cancer is bound to traumatise the 
patient and family. It causes a wide range of unanticipated psycho-social problems 
during the long and tiresome process of cancer treatment. In most cases the 
diagnosis will rapidly be followed by hospitalisation and surgical intervention, 
chemotherapy and radiation therapy which are often outside the person’s previous 
experience and can lead to confusion, acute anxiety, fears and even depressive 
manifestation (Kovac, Petrovic, Nedeljkovic, Kojic & Tomic, 2014). Meier (2010) 
described a cancer diagnosis as one of the most stressful and traumatic medical 
diagnoses and that the emotional impact of this diagnosis and the subsequent 
treatment and chronicity can be extremely overwhelming with effects on the 
patient’s physical, psycho-social and spiritual well-being which could compromise 
their short and long-term quality of life (Vahdaninia, Omidvari, & Montazeri, 2010). 
According to statistics at least one in three people with cancer will experience 
substantial and noteworthy emotional and psychological distress during their 
illness trajectory (Nekolaichuk et al., 2011).    
1.7  BREAST CANCER AND PSYCHOLOGICAL DISTRESS 
Recent studies have shown that the prevalence of psychological distress among 
breast cancer patients is particularly high and that this population is at risk of 
developing more severe mood disorders such as depression and/or anxiety, which 
are also the two most common psychiatric disorders in this population (Dolbeault 
et al., 2009; Lueboonthavatchai, 2007; Navari, Brenner, & Wilson, 2008; 
Vahdaninia et al., 2010). Depression and anxiety are known to have an influence 
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on the outcome of cancer treatment and even mortality, as well as on the quality of 
life of the breast cancer patient, therefore early detection and treatment of these is 
of value both for the patient and the clinician (Endicott, 1984; Hill et al., 2010; 
Meier, 2010; Mello, Tan, Armstrong, Schwartz, & Hornik, 2013; Vahdaninia et al., 
2010). 
1.7.1  Breast cancer and psychological distress 
 Major depression   
Depression in particular has a strong and complex relationship with cancer. 
Cancer patients experience depression as feelings of sadness and hopelessness, 
feelings of worthlessness and inappropriate guilt, sleep disturbance and loss of 
appetite, psychomotor retardation, withdrawal from social activities and 
heightened expectancy of pain that integrate with the criteria of major depression 
according to the Diagnostic and Statistical Manual of Mental Disorders-5R 
(American Psychiatric Association, 2000; Nekolaichuk et al., 2012; Mello et al., 
2013; Reyes-Gibby et al., 2012). It is important for the oncology team, especially 
the psychologist, to understand that all of this symptoms could be related to either 
the cancer self or the treatments, such as surgery, chemotherapy, hormone 
treatment or to depression (Dean, 2008; Gregorio, Jimenez, Rodriguez, & Borda-
Mas, 2013; Vahdaninia, 2010). Due to the overlapping of the somatic symptoms 
the diagnosis of depression can be overseen or difficult to make which often leads 
to the under diagnosis and treatment of depression, complicating the treatment 
and outcome of the cancer (Lueboonthavatchai, 2007).  
Although there is a high prevalence of depression in cancer patients in general, it 
was found that women with breast cancer have an even higher risk to develop 
symptoms of depression because of a premature-menopausal, postmenopausal or 
oestrogen deficiency state due to their specific cancer treatment. This should 
make the oncology team more “alert” to their patients and their emotional status 
(Berger et al., 2015; Gandubert et al., 2009; Navari, Brenner & Wilson, 2008; 
Reyes-Gibby et al., 2012).     
 Anxiety and anticipation anxiety 
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Taking into consideration that a cancer diagnosis confronts a person with his/her 
own mortality, anxiety is often a psychological reality for the cancer patient (Lim, 
Devi, & Ang, 2011). Feelings of anxiety after a cancer diagnosis are not 
necessarily abnormal, for the threat of cancer is to some degree a realistic threat, 
and must be understood and regarded in this light. However without managing the 
“normal” anxiety, it may become maladaptive, incapacitating a person’s 
functioning (Brem & Kumar, 2011; Dolbeault et al., 2009; Lim et al., 2011; Spiegel 
& Rodrigues, 2008; Stark, Kiely, Smith, Velikova, House, & Selby, 2002). To 
distinguish between “normal” anxiety and pathological anxiety with regards to the 
breast cancer patient, the Diagnostic and Statistical Manual of Mental Disorders’ 
diagnostic classification requires that the following core anxiety symptoms must be 
present:  
 The experience of anxiety must be disproportionate to the level of threat. 
 The anxiety symptoms are persistent or deteriorate without treatment and 
interfere with normal functioning (Stark et al., 2002; van Oers & 
Schlebusch, 2013).   
To give a more general description to a General Anxiety Disorder (GAD): it is 
characterized by persistent, excessive and unrealistic worry about everyday things 
and includes worrying beyond a person’s control where they expect the worst 
even if there is no apparent reason for concern. Anxiety symptoms that a person 
can experience are: motor tension (trembling, muscle tension and soreness, 
restlessness), autonomic hyperactivity (shortness of breath, palpitations, sweating, 
dry mouth, dizziness, nausea or other abdominal distress, flushes, frequent 
urination and trouble swallowing) and vigilance (feeling on edge, exaggerated 
startle response, difficulty concentrating and irritability) (American Psychiatric 
Association, 2000).     
Both chemotherapy and radiation therapy are associated with high levels of 
anxiety and it was found that anxiety is the highest before the first application of 
chemotherapy and radiation, mediated by age and trait anxiety (Berger et al; 2015; 
Lim et al., 2011; Lin & Yee, 2011; Lueboonthavatchai, 2007; Sariah & Zainal, 
2010; Travado & Reis, 2013; Vahdaninia et al., 2010). Because prolonged anxiety 
can have immunosuppressive effects on the patient, compromising treatment 
9 
 
outcome and mortality, healthcare professionals should pay greater attention to 
identify signs of anxiety in patients and design interventions to help alleviate it as 
early as possible (Shejila et al., 2014; Stark et al., 2002). Anticipation fear and 
anxiety prior to breast surgery and follow-up examinations and their results are 
also related to high levels of anxiety (Berger et al., 2015; Travado & Reis, 2013; 
Van Oers & Schlebusch, 2013; Vahdaninia et al., 2010). Given the anticipated 
increase in the number of breast cancer survivors over the next few decades, 
understanding the epidemiology of depression and anxiety and other 
psychological disturbances and their adverse impacts on quality of life during the 
survival period, has high clinical and public health significance (Reyes-Gibby et al., 
2012).   
1.8  BREAST CANCER AND SEXUAL FUNCTIONING 
Sex is an important component of most women’s lives and the breast cancer 
survivor is no exception (American Cancer Society, 2013; Kuo, Layden-Wiggens & 
Dizon, 2008). 
1.8.1  Definition of sexual distress 
Apart from the possibility of developing a mood disorder, sexual distress and 
dysfunctions affects a large percentage of women of all ages treated for breast 
cancer. All current breast cancer treatments can cause changes in the female 
body that can abruptly affect sexual desire, sexual functioning and changes in 
intimate relationships (Fobair & Spiegel, 2009; Kaplan, 1992; Sbitti et al., 2011). 
Sexual dysfunction, during or following cancer therapy is a very complex disorder 
due to its bio-psycho-social elements and can compound an already stressful life 
event if not attend to properly (Krychman & Katz, 2011; Speer et al., 2005).  
In the context of breast cancer treatment, many women experience sexual 
problems, yet sexual impairments and challenges have been largely neglected 
and found to be rarely discussed in oncology due to barriers in sexual health 
communication between the oncology team and the breast cancer patient. This 
lack of communication from the side of the oncology team often leads to 
insufficient information regarding important side-effects of cancer treatment, with 
the biggest complaint from the breast cancer patient, being that of premature 
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menopause, and specific sexual dysfunctions, leaving the patient unprepared for 
the changes (Deeks, Gibson-Helm, Teede, & Vincent, 2011; Derogatis & 
Kourlesis, 1981; Park, Zlateva, & Blank, 2009).  This lack of communication was 
confirmed in studies showing many participants reporting that they were not 
properly prepared for sexual changes or equipped to cope with it, leaving the 
couple feeling negative and unprepared for the unexpected and often long-term 
sexual side-effects of breast cancer (Gilbert, Perz, & Ussher, 2016; Flynn et al., 
2012; Hill et al., 2010). It is important for health care professionals to be conscious 
of problems related to sexual intimacy and sexual functioning during cancer and 
cancer treatment and to be prepared to offer information about these aspects and 
also reflect on their patient’s expectations versus the reality (Fallbjork, 
Rasmussen, Karlsson, & Salander, 2013; Kaplan, 1992). Among the major issues 
in addressing sexual problems and dysfunctions regarding breast cancer patients, 
are the lack of recognition that it is a problem and the lack of knowledge about the 
availability and the effectiveness of interventions for sexual problems (Kuo, 
Layden Wiggins, & Dizon, 2008). There are few intervention studies addressing 
sexual adjustment following a cancer diagnosis, with even fewer studies that are 
entirely focused on addressing sexuality in breast cancer women (Reese, Keefe, 
Somers & Abernethy, 2010). Krychman and Katz (2011) reported that while sexual 
problems are an important issue, there are few accepted treatments that have 
been evaluated for efficacy and safety for these sexual challenges in the breast 
cancer population and according to these authors, sexuality and intimacy are 
paramount issues in survivorship care.   
 1.9  PSYCHO-ONCOLOGY  
Historically, the management and treatment of cancer was seated within the 
framework of the bio-medical model and was predominately focussed on survival 
and curing, largely overlooking the psychological experience of the cancer patient 
(Borrel-Carrio, Suchman, & Epstein, 2004; Coleman, Hession & Connolly, 2011; 
Holland, 2003). Developed from the bio-medical model was the bio-psycho-social 
model which offered a holistic alternative and provided the platform for psycho-
oncology to develop. To comprehend the paradigm of psycho-oncology, a 
theoretical framework was attained from Engel’s humanistic or psychological 
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model (caring) and Pasteur’s bio-medical model (curing), forming the basis and 
approach of this study (Borrel-Carrio, Suchman, & Epstein, 2004). 
During the 14th World Congress of the International Psycho Oncology Society 
(IPOS) in Brisbane, 2012, it was underlined that cancer services and care should 
encompass both mental and physical health with the driving principle that there is 
no health without mental health (Breitbart, Bultz, Dunn, Grassi, & Watson, 2013). 
In psycho-oncology, the concept of holism was the guiding framework for recent 
recognition of the significance of comprehensive cancer care. This 
multidisciplinary field acknowledges and addresses the emotional responses of 
patients, their families and caretakers as well as the psychological, social and 
behavioural factors that may influence cancer morbidity and mortality (Haber et al., 
1995; Nicolas, 2013; Spiegel, 2012). According to these authors the task for the 
psycho-oncology experts, now, is to enhance clinical care and practice by 
nurturing closer connections between psycho-oncologists and health practitioners 
and to psycho educate them to see the patient and not just the disease.      
Being diagnosed with cancer is always shocking for a person and causes a lot of 
psychosocial distress during their illness and treatment. Due to advances in 
oncology, cancer treatment has come to be an extremely technical undertaking 
involving laborious efforts of highly specialised professions, each taking their 
responsibility for a share of the patient’s problem, but often working at a rather 
impersonal distance from the patient as an individual. This might leave the patient 
vulnerable and susceptible to psychological distress and in need of specialised 
services to assist them with decision making and survival in this new and 
unfamiliar situation (Haber et al., 1995; Kovac et al., 2006). Psycho-oncology 
classifies the cancer patient as a chronic patient with a continuing threat of 
recurrence of the disease, long-lasting side-effects due to the treatments and who 
needs on-going sympathetic contact, even during long intervals between 
treatments. Integrating the cure and the care as inseparable parts of the medical 
approach to cancer, both physical and mental health must be meticulously linked 
(Jones, 2010; Grassi, 2013).   
Although the prevalence of distress among cancer patients and the serious 
adverse impact of it on patient well-being and quality of life have been well 
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documented, it is as yet not given the warranted attention by both medical 
physicians and advocates for advancements in cancer clinical practice (Breibart et 
al., 2013). Of the 28 million cancer patients worldwide (as well as their family 
members), only a minority of those in need receive appropriate psychosocial 
cancer care by trained professionals, resulting in widespread unnecessary and 
preventable suffering (Breibart et al., 2013). To illustrate this point, Nekolaichuk 
and colleagues (2011) said that although many cancer patients access formal 
psycho-social services, less than 10% are referred for psychosocial evaluation 
and counselling.  
In South Africa the bio-psycho-social perspective is largely accepted as an 
effective way to treat cancer patients, however the implementation of this 
approach is still largely absent, both in the private sector and government funded 
hospitals (Pillay, 2001; Venter, 2014). Some of the reasons for this are the lack of 
interest in and availability of mental health care in cancer treatment (Manicom, 
2010) and the limited studies and literature focussing on  the psycho-social factors 
of cancer (Venter, 2014).  It is possible, according to Manicom (2010) that even 
with limited resources, the oncology teams in South Africa can begin to offer 
holistic health care to the cancer patient through assisting them (and their families) 
with psycho-social issues throughout their cancer journey.  This can be done by 
acknowledging and accommodating their psychological responses. Better 
psychological care can be achieved by more effective employment of mental 
health and support professionals in multidisciplinary teams and by improved 
awareness and education of medical professionals in basic patient focused 
communication. Despite the significance and need for a bio-psycho-social 
approach when treating cancer patients there is still very little literature available 
on the psychological interventions in South Africa (Venter, 2010). Research in 
Africa mainly focuses on bio-medical aspects of cancer, such as physical 
symptoms and medicine, often overlooking the psychosocial aspects and holistic 
care of the patient (Selman et al., 2011).  
It is the vision of the International Psycho-Oncology Society (IPOS) that all cancer 
patients and their families throughout the world should receive optimal psycho-
social care at all stages of the disease and survivorship, pleading urgency with the 
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behavioural and social scientists to initiate and develop a psycho-social 
intervention plan as part of a holistic multidisciplinary quality care for cancer 
patients (Breibart et al., 2013).   Psycho-oncology is important not only from the 
standpoint of being humane and improving the quality of the lives of people 
suffering from a malignant disease, but also from the scientific research aspect 
because the findings in these areas are still relatively uncommon (Grassi, 2013). 
Miles (2009) feels very strongly that in this bio-psycho-social era of cancer 
treatment, it is the task of the oncology team, especially the psychological 
services, to incorporate and treat the human side of the tumour by making the 
cancer patient always feel understood and valued as a human being and being 
treated throughout the whole trajectory of the cancer experience with empathy and 
dignity.  
1.9.1  The role of the clinical psychologist in psycho-oncology   
Clinical psychology is the application of psychology to health and community care 
which involves assessment, improvement and prevention of psychological 
distress, disability and dysfunctional behaviour (British Psychological Society, 
2001; Huey & Britton, 2002). Clinical psychology entered the 21st century with an 
involvement in most medical specialities and across the range of settings in which 
health care is provided from community to hospital settings. Specific medical 
specialities, such as oncology, now routinely assume and receive psychological 
input to patient care (Huey & Britton, 2002). There is a substantial role for the 
clinical psychologist in health care which will hopefully continue to expand with the 
continuation of the development and understanding of human behaviour (Huey & 
Britton, 2002).   
Working in the oncology field, the (clinical) psychologist should have a working 
knowledge of the medical issues the cancer patient will face to be enabled to 
understand and support the patient emotionally, facilitate decision making during 
the course of treatment and function as a liaison between the patient and her 
physician. Familiarity with medical issues makes it simpler for the psychologist to 
dispel fears, anxieties and myths and to stay focused on the individual’s 
psychological reaction without becoming distracted or overwhelmed by the 
medical element (Haber et al., 1995).  
14 
 
Rieger and colleagues (1998) suggest a model of service provision where the 
clinical psychologist is an integral member of the cancer team who routinely sees 
all cancer patients. The advantage of such a model is a greater facilitation in 
normalising psychological difficulties in the context of cancer. There is the 
possibility of preventing or minimising psychological morbidity by early diagnosis 
and intervention early in the course of cancer and also an opportunity to educate 
team members regarding psychological issues of cancer. Another model of 
service provision can also be where the psychologist acts in a liaison capacity on 
the basis of referrals made by other health professionals and see the cancer 
patient outside the oncology team. Rieger and colleagues (1998) also feel that a 
clinical psychologist may contribute to the training and professional development 
of students and staff operating from various disciplines including psychology, 
medicine and nursing regarding the psychological elements of cancer and their 
treatments. This training can include the teaching of communication skills involving 
empathetic communication and listening and techniques for effective information 
gathering and emotion management. Sutherland (1958) had already motivated 
specific education in communication skills for doctors working in the oncology field 
in the 1950’s. Addressing cancer patients’ overall needs and sharing complex and 
often devastating information in an already emotionally charged context and under 
time constraints, is a daily challenge for the oncology clinician (Bredart, Bouleuc, & 
Dolbeault, 2005; Sutherland, 1958).   
1.9.2.  Multi-disciplinary teams in oncology 
Because treating breast cancer is considered to be based on a multidimensional 
concept which comprises biological, psychological, social and spiritual life 
domains, multidisciplinary teams which integrate these elements, are becoming 
the model of care for cancer patients worldwide (Carver, 2005; Golden-Kreutz et 
al., 2005; Jalil, Lamb, Russ, Sevdalis, & Green, 2012; Turner, 2015). 
Implementing multidimensional treatment of cancer requires specialised 
professionals and services with interdisciplinary cooperation focusing on patient-
centred care through continuous multi-professional collaboration in order to 
assess and address patient’s individual needs (Mathews, West, & Buehler, 2009; 
Venter, 2014).   
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The National Health and Medical Research Council (NHMRC) recommend that 
breast cancer patients should have access to the full range of multidisciplinary 
treatment options for the successful integration of psycho-social care into routine 
clinical practice (Nicolas, 2013; Zorbas, Barraclough, Rainbird, Luxford, & 
Redman, 2003). The principles of multidisciplinary care for cancer include active 
multidisciplinary engagement, good communication between team members, the 
availability of psychological services and having access to the full range of 
therapies. In psycho-oncology, the concept of holism has been the driving force for 
recent recognition of the importance of comprehensive cancer care, where quality 
of life is considered an important endpoint in cancer clinical trials (Jalil, Lamb, 
Russ, Sevdalis, & Green,  2012; Nicolas, 2013; Turner, 2015).     
1.10  PSYHO-ONCOLOGIC INTERVENTIONS 
1.10.1  Psychotherapy: Aims and benefits of cancer-related therapeutic 
interventions 
The primary aim in cancer intervening psychotherapy is to enhance the quality of 
life of the cancer patients and survivors through assisting them to achieve 
optimum functioning within the limits imposed by their cancer (Blake-Mortimer, 
Gore-Felton, Kimerling, Turner-Cobb, & Spiegel, 1999; Hopko et al., 2011; 
McQuellon & Danhauer, 2006; Salonen, 2011).  
Apart from the evidence that a sufficient percentage of breast cancer patients 
suffer from psychological hardship, the barriers that keep many patients from 
benefitting from psychological care services include under-recognition of the need 
for psychosocial care by the primary oncology team and even when recognized, 
there is a lack of professional available in many communities to provide psycho-
social care to cancer patients (Jacobsen & Jim, 2008, Venter, 2014). Studies 
confirm that psychological support and psychotherapeutic interventions are clearly 
unavoidable parts of the complete treatment plan for cancer patients and that 
psychological interventions have a positive impact on the quality of life of cancer 
patients (Jacobson & Jim, 2008; McQuellon & Danhauer, 2006; Mens, Helgeson, 
Lembersky, Baum, & Scheier, 2015; Rehse & Pukrop, 2003). According to Kovac 
and colleagues (2014) and Nekolaichuk and colleagues (2012) there is still a need 
for further formal research on the benefits of individual psychotherapy in treating 
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cancer patients. This study will attempt to demonstrate that individual 
psychotherapy has an important place in psycho-oncology for it provides an 
empathetic environment for the exceptional needs of the breast cancer patient.    
Apart from providing psychotherapeutic interventions for the breast cancer patient 
(and family), another responsibility for the psychologist as part of the oncology 
framework, is to educate the medical staff upfront about what psychological 
intervention means and the availability and accessibility of psychological services 
and appropriate referral methods to these services.  
1.10.1.1  Cognitive behavioural therapy (CBT) 
Cognitive behavioural therapy (CBT) is defined as psychotherapies that include 
both cognitive restructuring and behavioural activation.  CBT is well researched as 
a successful therapeutic intervention technique working with breast cancer 
patients during the trajectory of their cancer journey (Beltman, Voshaar, & 
Speckens, 2010; Butler, Chapman, Forman & Beck, 2006; Dolbeault et al., 2009; 
Hale, Treharne, & Kitas, 2007; Montel, 2010; Osborn, Demoncada, & Feuerstein, 
2006). A number of studies have reviewed the effectiveness of cognitive 
behavioural techniques in breast cancer patients, resulting in significant positive 
outcomes for anxiety, depression, fatigue and general cancer distress (Berger et 
al., 2015; Carver, 2005; Dolbeault et al., 2009; Golden-Kreutz et al., 2005; Hopko 
et al., 2008; McQuellon & Danhauer, 2006; Montel, 2010; Osborne et al., 2006; 
Savard, Simard, Ivers, & Morin, 2005). Components within the structure of CBT 
such as psycho-education, cognitive restructuring, behavioural activation, problem 
solving and goal setting, communication strategies and emotional support have all 
been shown to be effective for a variety of cancer patients because of their ease of 
administration as well as face validity (Carver, 2005; Golden-Kreutz et al., 2005; 
Hopko et al., 2008; McQuellon & Danhauer, 2006; Savard et al., 2005). CBT is my 
therapeutic preference working with cancer patients.  I have applied CBT during 
the psycho-therapeutic sessions with the study participants because it is a 
dynamic, practical and an applicable method which can be applied short-term and 
which is easily understood by most people (Hopko et al., 2003; Hopko et al., 2008; 
Spiegel & Rodrigues, 2008).  
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Unlike traditional psychotherapy, working in a cancer setting can necessitate 
consultations in demanding locations such as in a chemotherapy room, or in a 
hospital room or ward with little privacy for the patient and therapist (Deshields & 
Nanna, 2010). In spite of the surroundings, it stays the responsibility of the 
therapist to make the patient feel comfortable and confident enough to participate 
in a therapeutic conversation. While working predominantly within the framework 
of individual therapy, I have learned that the cancer patient often asks to bring a 
family member or her partner with to a session so that “the significant other” can 
understand the cancer and cancer treatment better from a professional point of 
view.    
1.10.2  Sex therapy  
Sex therapy in the oncology framework can be defined as psychotherapy which 
addresses the breast cancer patient’s psychological and physical sexual problems 
resulting from breast cancer and breast cancer treatment (Emilee, Ussher, & Perz, 
2010; Günzler & Berner, 2012; Speer et al., 2005; Taylor, Harley, Ziegler, Brown, 
& Velikova, 2011; Ussher, Perz, & Gilbert, 2013). Working with cancer patients sex 
therapy includes techniques developed by Masters and Johnson such as psycho-
education about sexuality and sexual dysfunctions relating to breast cancer and 
treatments, sensate exercises, cognitive restructuring of inflexible sexual thoughts 
and pharmacology (Hummel, et al., 2015; Masters & Johnson, 1970; Park et al., 
2009). Sex therapy teaches the patients to acknowledge their sexual changes and 
challenges and to develop new skills to enhance their sex lives and intimate 
relationships and to accept their “new” sexual status quo (Jun, Kim, Chang, Oh, 
Kang, & Kang, 2011). Sex therapy can be delivered individually, but can also be 
couple-focussed, educating both partners about the effects of the cancer on the 
patient’s sexuality and their sexual relationship (Hummel et al., 2015). Because it 
is important to maximise sexual wellness during and after cancer treatment, an 
important aim in sex therapy will be to help the patient to normalize her concerns 
about her sexuality and sexual functioning. This will prevent sexual pathology from 
developing and provide a foundation for sex therapy if it is necessary at a later 
stage (American Cancer Society, 2015; Krychman, & Katz, 2012; Park, et al., 
2009).   
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In spite of confirmation that breast cancer patients have a wide variety of sexual 
issues and could experience distress, evidence shows that healthcare 
professionals may not be doing all they can to ensure patients feel able to raise 
their concerns about sexual problems (Dean, 2008; Derogatis and Kourlesis, 
1981; Fobair & Spiegel, 2009; Park et al., 2009). Regarding sex therapy with 
breast cancer patients, few studies have been done about the availability and the 
effectiveness of specific psycho-interventions for sexual problems in this 
population, leaving a gap for further formal studies in this area (Reese, Keefe, 
Somers, & Abernethy, 2010; Taylor, Harley, Ziegler, Brown, & Velikova, 2011).   
1.11  AIMS AND RATIONALE OF THIS STUDY  
In the light of the shocking statistics and ever rising number of cancer diagnoses 
worldwide, especially breast cancer, the time is right for further research in the 
domain of psycho-oncology and has motivated me as the researcher, due to my 
interest and involvement in breast cancer, to make this my field of research. The 
primary aim of this study was to examine and understand the personal 
experiences and perceptions of breast cancer patients concerning their cancer 
journey and unique needs for psycho-oncological interventions through their own 
“voices”. The study further aimed to use this deep and unique knowledge of the 
breast cancer patients and survivors to fill the gap between clinical knowledge and 
the practice. It is my hope that this study will make a valuable contribution to 
research in the field of psycho-oncology in South Africa. This implies increased 
understanding of the new realities of the chronicity of breast cancer and treatment 
complications that demand psychotherapeutic interventions in cancer care and 
initiate new ways of understanding the role of psychology and the psychologist in 
the medical world of cancer.   
1.12  METHODOLOGY 
1.12.1  Ontology and epistemology  
Constructivism-interpretivism is the chosen epistemological paradigm used in this 
case study design that will guide the researcher within the framework of 
postmodernism/idealism (Stake, 2005; Yin, 2003). The constructivism-
interpretivism paradigm is a methodological approach that is typical of qualitative 
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research methods which have the goal to rely as much as possible on the 
participants’ lived experiences. Both constructivists’ and interpretivists’ 
approaches believed that the truth is relative and that reality should be interpreted 
through the meaning that a person gives to his/her lived experiences in order to 
provide a rich insight into their worlds (Bezuidenhoud, 2014; Creswell, 2007; 
Ponterotto, 2005; Schwandt, 2000; Schurink & Schurink, 2012;). The 
constructivist-interpretivist paradigm encourages the researcher to develop a close 
and prolonged interpersonal relationship with the participants to gain their trust 
and insights regarding their lived experiences (Ponterotto, 2005).   
The researcher’s intention with this study, against the background of an 
interpretative framework, was an attempt to develop a clearer understanding of the 
lived experiences of the breast cancer patient through exploring her experience of 
her illness and need for further interventions through her own personal and unique 
interpretation and voice. In conducting this study, I have adopted two 
interconnected roles, namely that of an investigator and that of a professional 
psychologist. In the capacity of an investigator I have explored the breast cancer 
patients’ and survivors’ experience of their cancer journey and need for psycho-
oncologic interventions through a qualitative research lens.  As a professional 
psychologist I was engaged with the study participants in a psycho-therapeutic 
relationship providing them psychological support and interventions. The goal of 
this paradigm which also shares the goal of this study is to rely as much as 
possible on the participants’ lived experiences (Ponterotto, 2005; Schwandt, 
2000). 
1.12.2  Literature review 
The primary use of a literature review in qualitative research is to provide the 
rationale for a research problem and to assist the researcher in his/her research 
approach (Creswell, 2007). This includes establishing which ideas to include in the 
report based on how others have defined and measured these ideas in the past 
and which questions remain unanswered. Literature studies also help researchers 
to become familiar with the limitations and challenges of the type of research they 
intend to execute. The aim is to provide the contextualisation of the arguments of 
the study and expose the researcher to new ideas and methods by opening 
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his/her mind regarding the phenomenon studied (Bezuidenhoud, 2014; Henning, 
van Rensburg, & Smit, 2004; Jaccard & Jacoby, 2010; Maxwell, 2013; Ormston, 
Spencer, Barnard, & Snape, 2014; Shantall, 1996). Shantall (1996) stated that the 
more extensive and thorough the literature study is the more accurate and valid 
the investigation of the phenomenon under research becomes possible.  
Before beginning the study, I have completed an extensive literature study on both 
the biological and psychological aspects of breast cancer and breast cancer 
treatment. This included aspects like the sensitivity of the oncology medical team 
regarding the psychological and sexual elements of breast cancer and the 
availability of psycho-oncologic interventions in this population. I have come to the 
conclusion that in spite of sufficient statistical proof of the rising numbers of breast 
cancer worldwide and the devastating and overwhelming biological and 
psychological side-effects on the patients as well as the occurrence of cancer 
related psychopathology, there is still little known in the way of the actual voices of 
the breast cancer patients and survivors regarding their own unique experience of 
their breast cancer and specific psycho-oncologic needs. I have found very little 
suggestions in recent literature for specific psychotherapeutic interventions for this 
population, including sex therapy. To ensure credibility, I have, as the researcher 
and psychotherapist, made use of thorough research methods, which has included 
conducting a literature review on breast cancer, both internationally and in South 
Africa.   
1.12.3  Case study research design   
1.12.3.1  Qualitative research  
Qualitative research methods are valuable for studying the complexities of the 
healthcare system and in particular patient experiences (Smith & Firth, 2011). 
Because this study explicitly aims to understanding the breast cancer patient’s 
unique experiences and specific needs regarding her cancer and relationships 
with the cancer professionals, the qualitative approach will be appropriate for 
exploring and describing the complexities of health issues. It will facilitate, through 
this type of data gathering and analysis methods, a deep understanding of the 
patient’s experience (Smith & Firth, 2011).  
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The strongest academic rationale for using a qualitative research method is to fill, 
or add to, a gap in the literature by offering a voice for individuals or a specific 
population not otherwise heard. Qualitative researchers study phenomena in their 
natural surroundings and interpret it in terms of the meanings people bring to them 
(Creswell, 2007; Denzin & Lincoln, 2000; Ormston, Spencer, Barnard, & Snape, 
2014). Because of the sensitivity of this study and the needed in-depth 
understanding of the subject, the justification of this study will be explained against 
the background of a multiple case study design as part of a mixed method 
approach.  
Because qualitative research is the researcher’s chosen paradigm, it is important 
to give the key features of qualitative research (Creswell & Muller, 2000; Denzin, 
1989; Denzin & Lincoln, 2002; Morgan, 2000; Ritchie & Lewis, 2003) which the 
researcher has followed in this study from the perspective of a postmodernist:  
 Qualitative research aims at providing an in-depth understanding of the 
experiences and perspectives of the phenomena. 
 Samples are small and selected according to specific criteria. 
 Research is conducted in the participant’s normal environment, rather than 
removing it from personal context for research study. 
 Data is collected during a close relationship between the researcher and 
the research participant.  
 Emphasis is placed on rich, thick descriptions of the phenomena being 
studied. 
 Data is detailed and revealing. 
 Meaning is given to the data, not by measurement, but by interpretation. 
Within this framework, the aim of the study was to provide an in-depth 
understanding of the experiences and perspectives of the breast cancer patient 
during and after cancer treatment, using a small and selected sample of five 
breast cancer patients and survivors. Revealing and detailed data were collected 
over a period of a year through close relationships between the researcher and 
the research participants.  Information was obtained in the form of written and 
spoken language and observations. Open-ended data analysis was used to 
identify and categorise themes which included using the words of the participants. 
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This offered evidence of patients’ different perspectives, patterns of associations, 
typologies and explanations (Creswell, 2015). The writing of the results has 
allowed for a thick description of the setting, the participants and the themes in 
such detail, that readers might be able to feel that they have first-hand experience 
of the events being described in the study (Denzin, 1989; Ritchie & Lewis, 2003).   
Although this study applied both qualitative and quantitative methods, the 
researcher relied more on qualitative methods, for it suited the aims of this study 
better. Qualitative methods allow for openness and flexibility in studying complex 
psychological phenomena in depth through the lived experiences of the people 
living it (Bezuidenhoud, 2014; Thomas & Magilvy, 2011). Another reason for using 
qualitative methods in this study is because the researcher believes that it is more 
beneficial for the phenomenon under study to be explored and understood in 
depth. It makes the phenomenon more “visible”, than the generalising of 
information to other subjects or settings (Thomas & Magilvy, 2011).  
1.12.3.2  Multiple case studies 
Case studies are common research strategies in the field of psychology assisting 
the researcher to understand complex and sensitive issues and inter-relationships 
(Hodkinson & Hodkinson, 2001). Case studies, which aim to explore real life 
experiences and situations in their natural context from multiple angles, are 
descriptive in nature and provides rich, in-depth and longitudinal information about 
the phenomena under study (Colman, 2000; Lindegger, 2006; Salminen, Harra, & 
Lautamo, 2006; Simons, 2009; Yin, 2003 & 2014). Because case studies are 
grounded in ‘lived reality’, it has allowed me to obtain rich and in-depth information 
of the real-life experiences of the breast cancer patient and survivor through 
lengthy interactions over a time span of one year. I decided to use multiply cases 
in the study to provide for different stages of cancer treatment and survivorship 
and to include a wider age range. Multiple cases are considered stronger than 
single case designs and add more reliability to the study’s findings and a deeper 
understanding of the phenomenon through providing more substantial and 
powerful analytic benefits (Salminen et al., 2006; Yin, 2003). A case study’s 
unique strength, according to Yin (2014) is its ability to deal with a full variety of 
evidence – documents, interviews and observations which the researcher has 
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used in this study. The use of multiple sources of evidence in case study research 
allow a researcher to address a broader range of historical and behavioural 
issues, thus the findings and conclusions are likely to be more convincing and 
accurate (Yin, 2014).    
 Case selection 
The most important criterion in case selection is to ensure that the selection allows 
for the maximum amount of information to be learned from the cases in question. 
Each individual case study consists of a “whole” study in which convergent 
evidence is sought (Salminen et al., 2006). Five breast cancer patients and 
survivors were selected from both the private sector and a government hospital 
where the interviews or therapeutic sessions have stretched over one year. The 
breast cancer patients represented the whole trajectory of breast cancer, from 
diagnosis to survivorship (up to 2 years), with ages varying from 34 to 62 years. 
After interviewing and working with the five patients I have felt that a saturation 
point had been reached and that enough information had been gathered and the 
phenomenon had been thoroughly disclosed. Saturation is described in the 
literature as the point in the study where no additional data is found so to develop 
new elements of the given category, or where the interviewer no longer hears 
anything new (Lincoln & Guba, 1985; Schurink, 1988). Cosser (2005) feels that 
with a phenomenon that is complex, the sense of saturation is often intuitive 
whereas Seideman (1991) feels that criteria for saturation and sufficiency are 
useful, but practical demands regarding time, money and other resources also 
play a role.   
Inclusion criteria for the study patients included: 
(a)  A breast cancer diagnosis – any time from diagnosis through all the 
stages of the treatment: the patient could also be in remission, but not for 
longer than 5 years.   
(b)  Aged between 30 and 65 years. 
(c)  Their understanding and willingness to participate in the study. 
(d)  Patients had to live in or around Cape Town. 
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(e)  Patients must be English or Afrikaans speaking (which are the languages 
of the therapist).   
1.12.4  Data collection 
1.12.4.1  Pilot study  
A pilot study is a preliminary study conducted before implementing the final 
research design to identify potential problems within the design, especially the 
research instruments, and to assist the researcher in developing relevant lines of 
questions (Kanjee, 2006; van der Riet & Durrheim, 2006). A pilot study was done 
with one breast cancer patient in an attempt to ensure that the questions selected 
from the literature to be included in the interviews, were clear and adequately 
covering the field of breast cancer and breast cancer treatment (Venter, 2014; Yin, 
2014). It was also implemented to determine practicalities such as the therapeutic 
environment, the length of the sessions, the susceptibility for psychotherapy and 
to ask for the patient’s input for a more applicable line of inquiry or goals for 
psycho-therapy.     
One of the most crucial changes that was made in this study after conducting the 
pilot study was to change the (much more) formal and lengthy interview questions 
to more free range questions, combining the questions with the therapeutic 
process. This meant that instead of having different interview sessions and 
therapeutic sessions, I have integrated the questions into the therapeutic process.   
This was essentially because of time limits (6 to 10 sessions) and because the 
participants needed to talk more freely about their cancer experiences and 
therapeutic needs. Another reason was that the type of open-ended questions that 
were asked almost always triggered a lengthy description of patients’ experiences, 
giving valuable insight into the cancer patient’s life, but also served as an 
emotional catharsis, which was part of the therapeutic process. The information 
that was accumulated from the pilot study patient was of such significance to the 
study that the researcher has decided to include her in the number of the case 
studies.    
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1.12.4.2  Interviews  
Interviews and observations are essential sources of case study information 
because most case studies are about human experiences. Qualitative researchers 
collect data in the form of written or spoken language or in the form of 
observations that are recorded in language (Durrheim, 2006; Yin, 2003; 2014). 
Face to face interacting between participant and researcher, as was the case in 
this study, is regarded a core method of qualitative data collection. This gives the 
researcher the opportunity to get to know the study participant quite intimately and 
allows for understanding the depth of the emotions and needs of complicated 
constructs or experiences (Lewis & McNaughton, 2014; Yeo, Legard, Keegan, 
Ward, McNaughton, Nicholls, & Lewis, 2014). According to Yeo and colleagues 
(2014) in-depth interviews are a powerful method for creating description and 
detailed interpretation of people’s social worlds and stress the importance of 
understanding another person’s world through conversation. A qualitative 
researcher must be skilled in conducting effective interviewing in order to ask 
relevant questions, be a good listener and interpret the answers fairly and 
objectively (Schurink, 1988; Yin, 2014).  
The researcher in this study entered the research relationship with the study 
participants as a professional clinical psychologist with years of experience in 
interviewing and interpreting. Throughout the therapeutic sessions the researcher 
followed her own line of inquiry, as was reflected by the case study protocol and 
which was more in the line of fluid conversations than rigid queries. The developed 
questions that were the guidelines during the psychotherapeutic sessions was 
open-ended and the primary questions are be described in Appendix A.   
1.12.4.3  Quantitative methods 
Qualitative- and quantitative methods, according to Durrheim (2006) complement 
each other and can be regarded as equal and capable to answer different 
questions about the same topic. These combined methods can be applied where 
the study requires measurement of some kind (quantitative method), but also 
deeper understanding of the nature of an issue (qualitative method) (Ormston, et 
al., 2014). Although this study has relied more on qualitative research to obtain 
rich and detailed information, the researcher has used a combination of these two 
26 
 
methods by applying two standardised questionnaires together with the qualitative 
information methods.   
This was done before the start of the therapeutic process in order for the 
researcher to evaluate the psychopathological status of the study patient during 
her specific phase of cancer trajectory when intervention starts. It was also to 
compare what the patient genuinely experienced and was willing to verbalise 
during an open interview as opposed to what a “scientific” questionnaire reveals 
about the same topic. The researcher kept in mind that quantitative methods are 
more rigid and more concerned about objective facts, prediction, generalization 
and the establishment of universal law-like findings in tightly controlled research 
environments (Denzin & Lincoln, 2000; Rule & John, 2011; Ormston, et al., 2014; 
Thomas & Magilvy, 2011). The following instruments were used: 
(a)  The Female Sexual Functioning Index (FSFI). Female sexual dysfunction is 
common among women with breast cancer.  The most frequently used 
instrument to assess sexual functioning in this population is the Female 
Sexual Function Index which was found a reliable and valid instrument for 
measuring levels of sexual functioning and cancer-related female sexual 
dysfunction (Baser, & Carter, 2012). The FSFI is a 19 item inventory and is 
divided into 6 elements: desire, arousal, lubrication, orgasm, satisfaction 
and pain (Rosen, Brown, Leiblum, Meston, Shabsigh, 2000; Sheridan, 
2005). The FSFI has shown to have good reliability properties with test-
related reliability.   
(b)  The Hospital Anxiety and Depression Scale (HADS). The HADS has been 
recognised as a much applied and convenient self-rating instrument for 
anxiety and depression with both somatic and mental problems and has 
been validated in cancer populations (Costanini, 1999; Michopoulos et al., 
2008; Montel, 2010; Moorey et al., 1991). The HADS consists of 14 items 
and contains two subscales namely anxiety and depression (Valdaninia, 
Omidvari & Montazeri, 2010).   
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1.12.4.4  Strategies for ensuring trustworthiness in qualitative research 
designs 
Qualitative researchers have developed a unique language that is more suitable to 
qualitative research and increases credibility, transferability, dependability 
(consistency) and confirmability (proof) which is the naturalist equivalents for 
internal validation, external validation, reliability and objectivity that are the 
concepts used in quantitative research (Creswell, 2007; Guba & Lincoln, 1985; 
Koro- Ljungberg, 2010; Morrow, 2005). In the scientific context, trustworthiness 
refers to the replicability of a study’s findings (Lewis, Ritchie, Ormston, & Morell, 
2014).  For the purpose of this study, the proposed criteria, developed by Lincoln 
and Guba (1985) will be used to address the trustworthiness of the qualitative 
research. The four criteria agree with the positivist researcher and include 
credibility, transferability, dependability and confirmability (Guba, 1981; Lincoln & 
Guba, 1985; Shenton, 2004).     
 Credibility   
Credibility, which refers to the trustworthiness and reliability of the research 
findings, demonstrates that the subject was accurately identified and described.    
Credibility can be seen as the alternative to internal validity and is an important 
criterion for the trustworthiness of a study and can be viewed as an in-depth 
explanation of the data within their natural setting, population and theoretical 
framework (Bezuidenhoud, 2014; Shenton, 2004; Tracy, 2010). Detailed 
description through a literature study and methodology help to communicate the 
actual context of the problem being studied (Bezuidenhoud, 2014). During this 
study, I have gained detailed and vivid information from the lived experiences of 
the five breast cancer patients using their voices to describe their experiences and 
needs against the background of a complete literature study. I have also used 
thick, detailed and vivid descriptions of the data with the purpose for credibility and 
enabling the reader to make decisions about the applicability of the findings to 
other settings or similar contexts (Denzin, 1989).   
• Dependability /Reliability    
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Dependability refers to the stability of data over time and under different conditions 
with the main goal to minimise the errors and biases in a study. To address this 
matter, the positivists apply techniques such as thoroughly documenting the 
procedures followed during the study to demonstrate that if the work were 
repeated, in the same context, with the same methods and study participants 
similar results would be attained (Coetzee, 2007; Elo, Kääriäinen, Kanste, Pölkki, 
Utriainen, & Kyngäs,  2014; Shenton, 2004; Thomas & Magilvy, 2011; Yin, 2014). 
To enable readers of the research report to develop a thorough understanding of 
the methods and their effectiveness, the researcher has in this study included the 
next elements as described by Shenton (2004):  
 Describing in detail the research design and its application in terms of what 
was planned and implemented on a strategic level.  
 The operational detail of the data gathering in the field through providing all 
of the information from the five patients gathered during the therapeutic 
sessions (that will be displayed in Appendix A). 
 Meticulous assessment and analysis of the study data and assessing the 
effectiveness of the data gathering.   
 Confirmability 
Confirmability relates to the traditional concept of objectivity and means that the 
data accurately represents the ideas and the experiences of the participants and 
interpretations of those data are not invented by the inquirer (Elo, Kääriäinen, 
Kanste, Pölkki, Utriainen, & Kyngäs, 2014; Polit & Beck, 2012; Shenton, 2014). 
Triangulation, which is a validity procedure that was used in this study, represents 
the search for integration among multiple and different sources, methods and 
theories to provide supporting evidence and form categories or themes in a 
research study (Creswell, 2007; Creswell & Muller, 2000; Lewis et al., 2014). The 
role of triangulation (Creswell, 2007; Creswell & Muller, 2000; Lewis, et al., 2014) 
in enhancing confirmability is to reduce the effect of investigator bias and 
prejudice, as well as detailed methodological description to enable the reader 
through an “audit trail” to determine the credibility of the data and construct of the 
study (Shenton, 2004).   
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 Transferability 
Transferability can be viewed as the alternative to external validity or 
generalizability, and indicates that a study’s findings must be generalisable 
beyond the immediate case, regardless of the research method used.  In 
qualitative studies, the aim is more to provide a rich and contextualised 
understanding of some aspect of lived experience through the intensive study of 
particular cases, than to generalise (Elo et al., 2014; Merriam, 1998; Polit & Beck, 
2010; Yin, 2014). Although most qualitative studies represent a small number of 
cases, and is not possible to prove that the findings and conclusions are 
applicable to other situations and populations (Stake, 1994) it is important for the 
researcher to apply techniques to adhere to the rules of transferability as 
described by Elo and colleagues (2014). This will include: to communicate the 
boundaries of the study to the reader, the number of cases that will be included,  
the principles and criteria used to select participants, the variables, the number of 
field workers, data collection methods, the number and length of the data 
collection sessions and the time period over which the data was collected.    
In an attempt to meet the above mentioned criteria and to ensure trustworthiness, 
various strategies such as suggested by Lincoln and Guba (1985), Schurink and 
Schurink, (2012) and Shenton, (2004) have been employed during this study, 
included the following:  
 As the researcher, I have developed a familiarity with the breast cancer 
population through working in the industry for many years plus an 
understanding of the participating establishments (private sector and 
government hospitals) and went through a process of gaining permission to 
conduct the study before collecting data (Bezuidenhoud, 2014).  
 I have examined previous research studies by conducting a literature study 
on cancer research both internationally and in South Africa to provide a 
framework for the findings (Venter, 2014).  
 I was engaged with prolonged observation in the field through psycho-
therapeutic sessions with the breast cancer patients over a period of a year 
in weekly and monthly sessions.  
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 Triangulation of different methods were used where a systematic process of 
sorting through data to find general themes by eliminating overlapping 
areas, through the interpretation of only the researcher (Creswell & Muller, 
2000).   
 I have given an in-depth and detailed methodological description of the 
phenomenon. 
 I have assuring sufficient and suitable data by conducting in-depth 
interviews with five breast cancer patients and survivors, undergoing 
adequate interpretation through transcribed interviews (Morrow, 2005). 
 I have tried to be as transparent and detailed as possible, which is central 
to interpretive analysis and represent a thorough explanation of the 
characteristics, developments and surroundings that represent the 
experience of the phenomenon being studied (Burr, 2003). Transparency 
was also presented through detailed descriptions of the selection of 
participants, composed interview questions, and steps of data analysis. As 
the researcher, I have used generously quotations from the participants’ 
own words to support interpretations of the data.   
 Ethics 
The fundamental principle of research involving human subjects is to protect the 
well-being and safety of the research participant (Creswell, 2007; Yin, 2014). Prior 
to the study, the Ethics Committee of the Psychology Department of UNISA has 
reviewed and approved the presented proposal to insure the safety and 
appropriateness of the study (see Appendix D). Because of the two participating 
state hospital patients, ethical approval was also obtained from the National and 
Provincial Health Research & Ethics Committees of South Africa (NHRD), who 
serve as the gatekeeper for monitoring and managing health research for the 
National Health Research Committee, Provincial Health Research Committees 
and Research Ethics Committees across South Africa (see Appendix D).   
Proper ethical consideration was given to the study through following the ethical 
requirements described by Creswell, (2007), Koro-Ljungberg, (2010) and Webster 
and colleagues, (2013).   
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 The researcher has clearly explained the purpose of the research to the five 
participants. 
 Written and verbal consent form the participants was attained (see 
Appendix C). 
 The study participants understood that their participation will be voluntary 
and free from any pressure and that they can without any explanation stop 
their participation from the study.  
 Confidentiality and anonymity were guaranteed by the researcher through 
using pseudonyms and which were explained as such to the participants. 
 As the researcher, I believed that the research will be useful and valuable 
and did not make unreasonable demands on the study participants. 
 The commitment of the researcher to accommodate the participant’s 
requests and needs that goes beyond social norms.   
1.12.5  Analyses of data 
Although there are no clear prescriptions for analysing qualitative data, the 
researcher can choose from different possible approaches or methods that are 
applicable to qualitative research. The interpretive analysis method was used in 
this study as the main approach including elements such as thematic content 
analysis, the framework approach and the phenomenological lens (Smith, 2011; 
Smith & Firth, 2011; Ormston et al, 2014; Yin, 2003). A core ingredient, according 
to Terre Blance and colleagues (2006) of a good interpretive analysis, which the 
researcher has comprised, is to stay close to the data and interpret it through 
empathic understanding. According to these authors, the purpose is not to collect 
portions of real life, but to place real-life experiences and phenomena into some 
kind of perspective.  
The aim of interpretive analysis is to provide a thick description of the data which 
can be defined as a thorough explanation or report of the characteristics, 
processes, and circumstances that represent the phenomenon being studied, 
which was done by giving the study participants a “voice” to explain their unique 
experiences and perceptions in their breast cancer environment.  The analysis of 
the data was influenced by the social constructionist data analysis method which 
focused on interpreting the lived experiences of the participants in the breast 
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cancer context and allowed the researcher to find significant themes within the text 
(Ryan & Bernard, 2003; Sprenkle & Piercy, 2005).   
To demonstrate the analysis process of this study through the principles that was 
discussed above has included the next circular process:    
 I have collect detailed, insightful face-to-face explanations and descriptions 
from the five research participants (Smith, et al., 2009).  
 I have transcribed the interviews in detail after every session with the study 
participants. 
 I have, through careful reading and re-rereading, familiarised myself with 
the data from the early stages of the interaction with the breast cancer 
patients, to gain insights of the phenomena being explored, (Creswell, 
2007).   
 I have then provided a transparent and detailed description of the data 
through a thorough explanation of the characteristics, developments and 
surroundings that represent the breast cancer phenomenon (Burr, 2003). 
 I have systematically searched and identified patterns within in the data in 
order to provide an informative description of the studied phenomenon 
leading to the development of meaningful categories and themes (Basit, 
2003; Ormston et al., 2014; Yin, 2003). One of the core elements of 
analysing within the framework approach is developing a series of 
interconnected stages which enables the researcher to move back and 
forth across the data until a clear description emerges which resulting in a 
refinement of themes that can lead to the development of a conceptual 
framework (Ayres, Kavanaugh, & Knafl, 2003; Ritchie & Lewis, 2003).   
 I have made use of “in vivo” concepts through using the breast cancer 
patients own language or “voice” and then interpreted the data to make 
sense of the concepts and themes in terms of the participants’ lives and 
experiences (Spencer et al., 2014). 
 I have tried to remain true to the descriptions of the participants while 
developing more abstract concepts in analysing the data (Smith & Firth, 
2011).   
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In the light of the purpose and urgency of this study, the researcher has aimed to 
give a rich and an in- depth clarification of the true experiences and psychological 
needs of breast cancer patients. I hope that the voices of the study participants will 
offer new understandings and insights into the psychological world of the breast 
cancer population to be able to assist them in the best possible way with their 
psycho-oncologic needs.   
1.13  OVERVIEW OF THE THESIS 
The thesis includes the following chapters: 
The review of the existing literature will be discussed in Chapters II, III, IV and V.   
Chapter II focused on the statistics and prevalence of breast cancer worldwide 
and in South Africa and provides arguments for the benefits of studying breast 
cancer over other cancers. This chapter described the theoretical background of 
the physiology of breast cancer in terms of the stages and current treatments and 
the side-effects.    
Chapter III gave a theoretic overview of the development of psycho-oncology with 
emphasis on the bio-medical-model and the bio-psycho-social-model with focusing 
on holism, multi-disciplinary teams and the role of a psychologist in treating the 
breast cancer patient. This chapter gave a description of the psycho-pathology 
that is relevant to this study, including major depression, general anxiety 
disorders, other mood disorders and sexual dysfunctions.   
Chapter IV described psycho-oncological interventions for breast cancer 
treatment with special emphasis on individual psycho-therapy with the different 
therapeutic techniques applicable for the breast cancer population. These 
techniques include: psycho-education, Cognitive-Behavioural Therapy (CBT), 
mindfulness-based cognitive therapy and emotional expression. Metastatic- and 
advanced breast cancer as well as the influence of breast cancer on the family are 
covered.    
Chapter V focused on sex therapy as a psycho-therapeutic intervention, covering 
both biological and psychological elements, describing in detail: The Five A’s 
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comprehensive model of Park and colleagues; Masters and Johnson’s model of 
sensate focusing and flexibility as a model of sex intervention.   
Chapter VI discusses the research methodology and focuses on the 
philosophical, paradigm and interpretive frameworks and definitions of the case 
study research design and assessment measures.  
Chapter VII contains the discussion of the main themes of each participant’s 
psycho-therapeutic sessions and provides the results of the study.   
Chapter VIII presents the conclusions, implications for research and practise and 
limitations.      
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CHAPTER II 
LITERATURE OVERVIEW OF CANCER AND 
BREAST CANCER 
2.1  CANCER AND BREAST CANCER STATISTICS  
2.1.1  Introduction  
Breast cancer is the most prevalent cancer for women of all ages throughout the 
world and ranks as the second highest cause of death. Breast cancer is a major 
health risk for all women with global statistics showing that the annual occurrence 
of the disease is escalating (Brem & Kumar, 2011; Howlader, Chen, Ries, Loch, 
2014; Reyes-Gibby et al., 2012; Travado & Reis, 2013; Vahdaninia, Omidvari & 
Montazeri, 2010; Wong & Bloom, 2005).  According to the National Cancer 
Registry network, one in every twenty-six South African women will be diagnosed 
with breast cancer with approximately 5% younger than 35 years of age.  This 
makes breast cancer the number one malignancy amid women in South Africa 
(Van Oers & Schlebusch, 2013).  
Early and progressed cancer screening and advances in clinical oncology have 
noticeably led to protracted survival rates in breast cancer patients with 
percentages as high as 95 when discovered early enough (Cielito et al. 2012; 
Hummel et al., 2015; Vorobiof, Sitas & Vorobiof, 2001; Weis, Poppelreuter & 
Bartsch, 2009). According to Fiszer and colleagues (2014) survival after 5 years 
for early localized breast cancer is now above 96%, while 82% of all women 
diagnosed with breast cancer can anticipate surviving 10 years.   
Survivors of breast cancer are officially the leading group of cancer survivors 
amongst women in the Western world (Fiszer, Dolbeault, Sultan & Bredart, 2014). 
For this reason we see the added interest and research on health related quality of 
life and the critical need to find creative strategies to assist this population in 
coming to terms with the cancer reality (Greeff, 2008; Hummel et al., 2015). 
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2.1.2  Cancer as a chronic illness 
The progress and advances in the oncology discipline over the last 15 years have 
led to the reality that cancer is no longer seen as a death sentence since people 
with cancer are living longer (Greeff, 2008; McCorkle, Ercolano & Lazenby, 2011; 
Naus, Ishler, Parrot & Kovacs, 2009). Cancer as a chronic illness not only 
challenges old school theories that an oncologist’s work is completed after 
treatment, but also requires of patients to acknowledge their cancer as a chronic 
illness with accepting their own participation in the management of their illness 
(McCorkie et al., 2011). Cancer care, as a chronic illness, occurs on a scale that 
extends from early detection and diagnosis to the end of life, with treatment, side-
effects and survivorship in between (McCorkle et al., 2011).   
2.1.2.1  Definition of chronic illness 
Chronic illness or disease can be defined as a long-lasting condition or illness that 
can be restricted or controlled but not cured and which affects the population 
worldwide (Arbor, 2011). In the last decades, there have been dramatic shifts in 
the precedent of diseases from infectious diseases to the present leading causes 
of mortality dominated by chronic illness. There has been an explosive rise in the 
incidence of chronic illness in recent years, especially coronary heart disease, 
diabetes and cancer. These chronic illnesses are viewed as the most common, 
costly and deadly medical conditions to society and will impose a large liability in 
the future (Barsky, Friedman & Rosen, 2006; Fortin, Chouinard, Bouhali, Dubois, 
Gagnon, & Bélanger, 2013; Wright & Kirby, 1999). According to Naus and 
colleagues (2009) the Census Bureau has projected that over the span of the next 
50 years the number of cancer survivors will escalate at a bigger ratio than the 
occurrence of cancer itself. This estimation proposes the importance of creating a 
clearly defined model of cancer as a chronic illness in relations to medical 
treatments and quality of life outcomes.   
2.1.2.2  Chronic illness and emotional and sexual outcomes 
Most chronic illnesses like diabetes mellitus, cardiovascular disease and cancer, 
with their associated treatments, carry a high risk for emotional distress and 
sexual dysfunctions (Carpenter, Andersen, Fowler, & Maxwell, 2009; Nusbaum, 
Hamilton & Lenahan, 2003; Richards, Bertolotti, Doss & McCullagh, 2011). A 
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chronic illness can disturb the quality of life of a person through its antagonistic 
consequences on, amongst other things, sexual functioning which are often long-
term and permanent (Barsky et al., 2006). The emotional impression of an initial 
cancer diagnosis, its consequent treatment and chronicity can have an extreme 
and overpowering influence on the patients’ quality of life (Nekolaichuk et al., 
2012). This will be discussed at length later in this chapter.   
2.1.3  Different types of cancer with their emotional and sexual side-
effects 
A study done by Nekolaichuk and colleagues (2012) have shown that in recent 
years survival for all types of cancers has grown noticeably from 56% to 62% 
resulting in patients living longer with prolonged sequelae. According to Katz 
(2005) and Carpenter and co-workers (2009) the diagnosis of any form of cancer 
has a distressing impact on the psychological, emotional and sexual welfare of the 
patient. 
The group of cancers (gynaecologic cancers, prostate- and testicular cancers) that 
are under discussion here are very similar to breast cancer in symptoms, 
treatments and side-effects, as well as the influence on the patient’s quality of life. 
There are also very clear resemblances between these cancers and breast cancer 
in terms of the lack of existing research concerning specific guidelines and open 
communication between patient and treating practitioner that are adequate to 
address the sexual and emotional demands of this specific cancer population.   
2.1.3.1  Gynaecologic cancers   
Endometrial-, ovarian- and cervix cancer, are the three most common 
gynaecologic cancers. Gynaecologic cancer patients, especially survivors of 
ovarian cancer have been found to be a high risk for developing depression, 
anxiety and chronic sexual dysfunction. With the cumulative number of patients 
attaining long term survival following early stage cervical and endometrial cancer, 
emanates the need to expand existing understanding of post-treatment sexual 
adjustment and rehabilitation requirements of this specific population (Juraskova, 
Butow, Bonner, Robertson, & Sharpe, 2013). 
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Gynaecologic cancer patients, much like prostate cancer patients, undergo early 
declines in sexual activity and disturbed responsiveness that can end in a 
permanent sexual dysfunction (Carpenter et al., 2009). Cervix and endometrial 
cancers can be treated with radical or total abdominal hysterectomy as part of the 
surgical treatment plan, which result in the removal or alteration of the sex organs 
that anatomically influences the cancer patients’ sexual functioning (American 
Cancer Society, 2013; Seungtaek & Eifel, 2009). Because of curative treatments, 
85% to 90% of patients with stage 1 cervical cancer will survive their cancer 
ordeal, needing interventions from the oncology team that can improve their 
quality of life (Phaendler, Wenzel, Mechanic, & Penner, 2015).  
A study done by Phaendler, Wenzel, Mechanic and Penner (2015) shown that 
cervical cancer patients have worse quality of life scores, not only when compared 
with the overall population, but also with other gynaecologic cancer patients and 
survivors. These authors noted that patients with invasive cervical cancer who 
undergo radical surgery and radiation therapy, scored lower in physical, 
psychological and sexual domains which ultimately disrupt long-term quality of life. 
Psycho-social problems affecting quality of life in cervical cancer survivors include 
mood and stress disorders, body image, and fear of recurrence. In the intense 
setting among cervical cancer patients treated with high-dose rate brachytherapy, 
30% experience acute stress disorder (intrusive memories, vegetative hyper 
arousal, and avoidance reaction) one week after the end of their treatment (Fossa, 
& Dahl, 2006). The sexual impact is maybe more prominent amongst cervical 
cancer survivors because of the younger age (average of 50 years) at the onset of 
cervical cancer. It is essential to keep finding ways to open the door for survivors 
to continue to talk about their experience, as is necessary for their sense of 
continued healing and social support, whether that be with family, friends, or 
health care providers (Fossa & Dahl, 2006). 
2.1.3.2  Prostate cancer 
According to McCaughan and colleagues (2013) and the American Cancer 
Society (2010) prostate cancer accounts for approximately a quarter of all new 
male cancer diagnoses each year in the UK and North America. In all South Africa 
population groups, prostate cancer was also the most common male cancer 
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excluding basal cell carcinoma (Babb, Urban, Kielkowski, & Kellett, 2014). 
Patients with clinically localized prostate cancer have a positive long-term overall 
and cancer-specific degree of survival regardless of treatment choice (Koyama, 
Kang-Hsien, Albertsen, et al., 2013).  
Since the median life expectancy after treatment for prostate cancer is 13.8 years, 
a thorough assessment of long-term functional outcomes (very much the same as 
in breast cancer) is vital to an understanding of the complete experience of men 
living with a diagnosis of prostate cancer. According to Resnick and colleagues 
(2013), literature only reports outcomes in terms of health-related quality of life in 
patients with prostate cancer that are short-term (1-3 years) or intermediate-term 
(4-5 years), which might not indicate the long term experience of prostate cancer 
patients. Prostate cancer patients who undergo a prostatectomy (a surgical 
operation to remove all or part of the prostate gland) were five times more prone to 
have urinary incontinence and twice as likely to have erectile dysfunction as the 
patients who went through radiotherapy. Men in the prostatectomy group were 
considerably more prone than those in the radiotherapy group to report having 
erections insufficient for intercourse at two and five years post treatment. 
Sometimes the erectile dysfunction also goes with urinary incontinence (Resnick 
et al., 2013). 
According to Chung and Brock (2013) the challenges for prostate cancer survivors 
comprise the probability of prostate cancer recurrence and management of 
physical, cognitive, sexual, and socioeconomic quality of life concerns. Sexual 
dysfunction is one of the most common, distressing and persistent adverse effects 
of prostate cancer treatment, and has a profound effect on the quality of life for the 
patient and his partner (Cormie, Newton, Taaffe, Spry, & Galvao, 2013). Many 
prostate cancer patients report a loss of masculinity which can sometimes be 
caused by effects of androgen deprivation therapy (ADT). Loss of masculinity in 
prostate cancer patients is a multi-layered concept that may be influenced by 
decreased perceptions in their self-confidence, competitiveness, control, mental 
state, vulnerability to stress and the ability to provide for the family. These factors 
are likely to increase anxiety and depression and must be considered as treatment 
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targets whether through antidepressant medication and/or psychotherapy 
(Sharpley, Bitsika & Denham, 2014).   
Sexual function remains an imperative issue in men who often continue to be 
interested and active in sex after prostate cancer treatment. A recent study done 
by Cormie and colleagues (2013) implied that current health-care provisions are 
inadequate to address the demand for the management of sexual dysfunction, 
with approximately half of prostate cancer survivors reporting unmet sexual health-
care needs. The various post-prostate cancer treatment-related sexual 
dysfunctions are:  
a)  Penile deformities and erectile dysfunction.   
b)  Lack of sexual desire and mental health (depression and anxiety).  
c)  Ejaculatory and orgasmic dysfunctions.  
d)  Changes in partner response (Chung & Brock, 2013). 
Yet, despite literature concerning prostate cancer related sexual dysfunctions, 
there are no existing recommendations or guidelines concerning optimal 
rehabilitation or treatment protocol for the above said dysfunctions. Medical, 
surgical and pharmacological interventions are effective in erectile function 
recovery and/or preservation, but psychological and sexual counselling are as 
important in sexual rehabilitation, relationships and dynamics (Cormie et al., 
2013).   
Resnick and colleagues (2013) concluded that prostate cancer patients 
undergoing a prostatectomy or radiotherapy had declines in all functional 
outcomes, including emotional and sexual, throughout early, intermediate, and 
long-term follow-up. Even in the light of possible emotional and sexual 
dysfunctions and changes in the relationship, it is documented that men are low 
consumers of cancer information and support services (McCaughan, Prue, 
McSorley, Northouse, Schafenacker, & Parahoo, 2013; Weber et al., 2004). Men 
also tend not to recognize or acknowledge illness or openly discuss concerns.  
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2.1.3.3. Testicular cancer 
The most frequent cancer in men from 15 to 44 years is testicular cancer which 
mainly affects the white Caucasian population. This cancer is the most common 
malignancy among young adult men ( Le Cornet et al., 2014; Znaor, 2014). The 
needs of this cancer population may vary from enduring the impacts of the 
diagnosis, treatment and its side effects and the patient’s relative youth. Testicular 
cancer can create practical encounters including difficulty in getting life insurance 
and psychological concerns including fear of cancer recurrence and generally 
unexpected phenomena by younger men associated with substantial personal and 
professional implications (Smith et al., 2013).  
The long term physical effects of testicular cancer treatments may impact potential 
infertility, changed neurological and respiratory function and increase the risk of 
secondary malignancy and cardiovascular disorder (Smith et al., 2013). In a recent 
study, these authors confirmed that the psychological requirements of the 
testicular cancer patients often go unmet. Younger age and the chronicity of the 
illness were associated with a higher frequency of unmet needs. Sixty-seven 
percent of the testicular cancer survivors acknowledged a need for help with 
relationship and sexual issues, but only a small percentage will seek help from 
health professionals. Unfortunately, unmet psychological needs lead to lessened 
mental-health related quality of life. Testicular cancer survivors, similar to many 
other (young) men, are concerned about the stigma/shame connected to seeking 
professional (especially psychological) help (Smith et al., 2013).     
2.1.4  Summary 
It is evident that a chronic illness, with the trauma of the diagnosis and life-long 
liability and adjustments, can alter the quality of the lives of these patients. It also 
impacts the quality of the lives of their families and partners in a permanent 
manner. Cancer, especially breast cancer with its large population of survivors, is 
now formally acknowledged as a chronic illness. With the new status of chronic 
illness, more complications arise in terms of life-long side-effects of medications 
and treatments and the condition itself. Knowledge is needed, not only from the 
biological side (the medical team), but especially from the psychological side. It is 
needed to assist these patients in developing new approaches and skills to adapt 
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to and manage these chronic conditions, together with their families, for a better 
quality of life. Because of the many shared characteristics of different chronic 
illnesses, especially cancer, and the general influences of treatments on the 
human body and psyche, it is imperative to understand the long term 
psychological consequences on the quality of life of chronically ill patients. 
Because of the similarity of these conditions, information, newly developed 
theories and models from different chronic disorders can be applied throughout 
the spectrum of chronic illness disease.   
2.2.  THE BIOLOGY OF BREAST CANCER  
According to Haber and colleagues (1995) understanding the specific cancer 
terminology and procedures is crucial for the psychologist working with cancer 
patients. Having a working knowledge of the medical experience of this patient 
population in terms of diagnosis and prognosis, treatment plan, side effects, level 
of pain and possible level of functioning or dysfunctionality during the trajectory of 
her illness and treatment, the psychologist will be able to understand and 
psychologically support the patient. In understanding the medical side of breast 
cancer, the psychologist will be skilled in facilitating decision making during the 
course of treatment. This can be done when the patient feels overwhelmed and 
the psychologist can act as a liaison between the patient and her physician.   
Fallowfield and Jenkins (2015) reported that breast cancer is no longer a simple 
disease to explain to patients. Because of booklets, DVD’s, leaflets and 
technology (e.g. the internet), patients have access to, and improved knowledge of 
the medical world of cancer and will ask appropriated questions that must be met 
and explained with proper knowledge from the cancer team, including the 
psychologist (Fallowfield & Jenkins, 2015). Patients also familiarise themselves 
with, and use specific terminology (as used by their oncologists), in the 
psychotherapeutic sessions, and therefore the psychologist must have the proper 
knowledge of the so-called “cancer language”. According to Fallowfield & Jenkins 
(2015) breast cancer patients not only suffer emotional mayhem, but they also 
enter an abnormal and unexpected new world of unfamiliar language and 
concepts. To ensure that the patient can provide educated and informed consent 
to treatment plans, it asked for excellent communication skills from the healthcare 
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professionals involved with breast cancer treatment. For this reason it is important 
for the psychologist to acquaint himself/herself with the associated cancer care 
knowledge.   
To be able to do this, the psychologist must understand the basic terminology of 
cancer and cancer treatments. Not to be overly medically complex, this study will 
give descriptions and definitions of cancer, stages of cancer, different diagnosis 
and treatment modalities and biological side-effects, which will explain a very 
complex and difficult illness for the psychologist to understand and apply in the 
psychological framework.   
2.2.1  Cancer terminology and definitions 
The term breast cancer indicates a malignant tumour that develops from cells in 
the breast (Amin, Purdy, Mattingly, Kong, & Termuhlen, 2013). Breast cancer is a 
heterogeneous disease in which abnormal cells grow in an uncontrolled way (Li, 
Uribe & Daling, 2005). A malignant tumour is a cancerous growth that begins in 
the tissues of the breast and is caused by a genetic abnormality as described by 
the breast cancer organization (http://www breastcancer.org/). If left unchecked 
the malignant cells can eventually spread beyond the original tumour to other 
parts of the body (Amin, et al., 2013). 
The most common types of breast cancer are:  
 Ductal Carcinoma in situ (DCIS): starts in the cells which line the breast's 
ducts / tubes beneath the nipple and areola. Between 85% and 90% of all 
breast cancers are ductal. Ductal carcinoma in situ it is well contained and 
not invasive and can be treated successfully through a lumpectomy. If the 
tumour margins are clear of cancer, follow-up treatment may include 
radiation (Solin et al., 2013).  
 
 Lobular Carcinoma in situ (LCIS): starts in the lobes or glands which 
produce milk in the breast. The lobes are located deeper inside the breast, 
under the ducts and account for around 8% of all breast cancers. LCIS 
indicates the cancer is restricted within the lobes and has not spread to 
other areas in the breast. This cancer can be removed during a 
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lumpectomy and if the tumour margins are clear of cancer, follow-up 
treatment could include radiation (Solin et al., 2013). 
 
 Invasive Breast Cancer: When breast cancer is invasive, it started in the 
breast glands or ducts but grows or spread into the breast tissue or nearby 
lymph nodes and beyond. In the case of invasive breast cancer a 
mastectomy and chemotherapy may be needed (Solin et al., 2013). 
 
 Inflammatory Breast Cancer (IBC): This cancer is less common and 
considered an aggressive cancer because it grows quickly, is more likely to 
have spread at the time it is diagnosed and is more likely to recur after 
treatment than most other types of breast cancer. Treatment guidelines for 
inflammatory breast cancer include chemotherapy before surgery to help 
shrink the cancer and reduce the swelling and help the inflamed skin return 
to normal. Most women with IBC usually have a mastectomy after the 
chemotherapy, followed by radiation therapy. When diagnosed early, 
inflammatory breast cancer can be a manageable disease with survival 
rates on the increase. This clinical form of breast cancers typifies1% to 6% 
of all breast cancers with a prognosis which is the worst of all the types of 
breast cancer because of an almost constant metastatic evolution 
(Chevallier, Asselain, Kunlin, Veyret, Bastit, & Graic, 1987; Gonzalez-
Angulo et al., 2007).   
 
 Locally Advanced Breast Cancer: This cancer characterizes a 
heterogeneous class of tumour and represents disease with a rapid growth 
rate particularly for inflammatory breast cancer which is a subcategory of 
locally advanced breast cancer (Buchholz, 2009).   
 Metastatic breast cancer (MBC) is a heterogeneous cancer with a 
diversity of different clinical scenarios, fluctuating from single metastatic 
lesions to multiple organ involvement. Metastasis of breast cancer occurs 
primarily through the lymphatic system, and the extent of lymph node 
involvement is a key prognostic factor for the disease (Skobe et al., 2001). 
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Overall, survival of patients with MBC is gradually improving. The risk of 
death is decreasing by 1%–2% each year (Pagani et al., 2010).   
 Paget’s disease (PD): The least common type of breast cancer is Paget’s 
disease of the breast. It is also known as Paget disease of the nipple and 
mammary Paget disease. It is a rare disorder of the nipple-areola complex that 
is often associated with an underlying in situ or invasive carcinoma (Blanchard, 
Sarr & Farley, 2001; Kollmorgen, Varanasi, Edge, & Carson III, 1998). This 
form of cancer is usually treated with a mastectomy because the cancer has by 
then invaded the nipple, areola and the milk ducts (Kawase et al., 2005, 
Kollmorgen, Varanasi, Edge & Carson, 1989; Sakorafas, Blanchard, Sarr & 
Farley, 2001).   
 
 Recurrent breast cancer: Around 40% of all patients with breast cancer 
suffer a recurrence; most of them die from it. The risk of recurrence is 
highest in the first 2–3 years and then decreases continuously, although it 
never reaches zero (Freund & Reimer, 2010).   
2.2.2  Stages and grading of breast cancer for diagnostic and prognostic 
reasons 
The management of breast cancer relies on the availability of strong clinical and 
pathological prognostic and predictive factors to direct patient decision making and 
the choice of treatment options (Rakha et al., 2010). A range of clinical and 
pathological factors are routinely used to classify patients with breast cancer in 
order to assess prognosis and establish the appropriate therapy. These include 
patient age, axillary lymph node status, tumour size, histological grading and 
hormone receptor status (Schnitt, 2010).   
2.2.2.1  Grading system 
Grading identifies a measure of the probable degree of a tumour and where the 
most malignant growths having spread to and can be carried out on a surgical 
specimen or through histology (blood). The grade of the cancer is representative 
of the aggressive potential of the tumour. Grading also indicates the chance of 
metastases being present in regional lymph nodes and distant organs (Bloom & 
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Richards, 1957; Rakha et al., 2010). Determining the grade is imperative for the 
clinicians to guide them in planning the treatment.   
There are different scoring systems available for determining the grade of the 
breast cancer. One of these systems is the Nottingham Grading System (NGS) 
which is recommended by various international professional bodies and provides a 
simple, inexpensive and regularly applicable indication of the basic biological 
characteristics and clinical behaviour of tumours (Rakha et al ., 2010). The grade 
of a breast cancer is representative of the aggressive potential of the tumour, the 
lower the grade, the less aggressive the tumour.   
Grade 1 (G1): A low grade. If the cells of the tumour and the organization of the 
tumour’s tissue are close to those of normal cells and tissue, the tumour is called 
well differentiated and slow growing and is less likely to spread (divide).  
Grade 2 (G2): Is moderately differentiated or undifferentiated and is an 
intermediate grade and have qualities between grade 1 and grade 3.   
Grade 3 (G3): Is a high grade, poorly differentiated, rapid growing and more likely 
to spread (Bloom & Richardson, 1959; Ivshina et al., 2006).  
Bloom and Richardson (1957) accentuate the importance that grading is indeed 
only a guide and should not be regarded as a method of predicting outcome with 
any degree of mathematical exactness.  Patients should talk to their physicians 
regarding their tumour grading and the influence on their treatment and prognosis 
(Ivshina et al., 2006).     
 2.2.2.2  Stages of breast cancer 
Tumour grade is not the same as the stage of cancer. Cancer stage refers to the 
size and or the extent of the original (primary) tumour and whether or not cancer 
cells have spread in the body. How the physician describes a cancer’s growth or 
spread is called a stage. Cancer staging is based solely on the anatomic extent of 
cancer and remains primarily anatomic (Edge & Compton, 2010). The cancer’s 
stage is one of the most important factors in determining prognosis and treatment 
options. Staging provides a common language for doctors to effectively 
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communicate about a patient’s cancer and collaborate on the best courses of 
treatment (Rakha et al., 2010, American Cancer Society, 2014). 
How does Staging Work? 
Physicians use data they collect from various tests and use it to identify staging in 
breast cancer.  
These tests can include: 
 Physical examinations; may determine the location and size of the 
tumour(s) and offer additional information on whether the cancer has 
spread to the lymph nodes and/or to other organs. 
 Imaging tests; such as x-rays (mammography), CT- and MRI scans, which 
can show the location of the cancer, the size of the tumour, and whether 
the cancer has spread. 
 Laboratory tests; that provide information on blood, urine and other fluids 
and tissues removed from the body and studying under a microscope. 
 Pathology reports; that provide information about the size of the tumour, 
the growth into other tissues and organs, the type of cancer cells and the 
grade of tumour. Pathology reports often confirm the diagnosis of cancer, 
as well as the stage. 
 Surgical reports; tissue samples removed during surgery can determine 
the size and form of a tumour and provide insights about lymph node and 
organ metastases (American Cancer Society, 2014, Bloom &Richardson, 
1957; Edge, & Compton, 2010; Rakha et al., 2010; Singletary & Connolly,  
2006).    
The pathologic stages of breast cancer are based on four characteristics as 
described by Howlader and colleagues (2014).    
 The size of the tumour. 
 If the cancer is invasive or non-invasive. 
 The presence of any lymph nodes metastases. 
 The presence of distant organ metastases  
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The breast cancer organization defines staging as a way of describing where the 
cancer is located, how much the cancer has grown and if or where it has spread.     
STAGE 0 - is non-evasive cancers, such as ductal carcinoma in situ. In stage 0 
there is no evidence of cancer cells or non-cancerous abnormal cells breaking out 
of the segment of the breast in which they started, or invading adjoining normal 
tissue.   
 STAGE I - defines invasive breast cancer where the cancer cells are breaking 
through and invading normal surrounding breast tissue. Stage I is divided into 
subcategories known as IA and IB.   
Stage IA defines invasive breast cancer in which:   
 The tumour measures up to 2 centimetres. 
 The cancer has not spread outside the breast and no lymph nodes are 
involved.   
Stage IB defines invasive breast cancer in which:   
     There is no tumour in the breast but small groups of cancer cells, not larger 
than 2 millimetres are found in the lymph nodes. 
 There is a tumour in the breast that is not larger than 2 centimetres and 
small groups of cancer cells, not larger than 2 millimetres in the lymph 
nodes.   
 
STAGE II - Stage II is divided into subcategories IIA and IIB:   
Stage IIA defines invasive breast cancer in which:   
 
 No tumour is located in the breast but is found in 1 to 3 axillary lymph 
nodes under the arm (but not larger than 2 millimetres) or the lymph nodes 
near the breast bone, OR 
 The tumour in the breast measures 2 centimetres or smaller and has 
spread to the axillary lymph nodes OR  
 The tumour is larger than 2 centimetres but not larger than 5 centimetres 
and has not spread to the axillary lymph nodes.   
49 
 
Stage IIB defines invasive breast cancer in which:   
 The tumour is larger than 2 centimetres but not larger than 5 centimetres; 
or small groups of breast cancer cells, (not larger than 2 millimetres) are 
found in the lymph nodes OR 
 The tumour is larger than 2 centimetres but not larger than 5 centimetres; 
cancer has spread to 1 to 3 axillary lymph nodes or to lymph nodes near 
the breastbone OR 
 The tumour is larger than 5 centimetres but has not spread to the axillary 
lymph nodes.  
STAGE III - Stage III is divided into subcategories known as IIIA, IIIB and IIIC.   
Stage IIIA defines invasive breast cancer in which either:   
 No tumour is found in the breast or the tumour may be any size; but cancer 
is found in 4 – 9 axillary lymph nodes or in the lymph nodes near the 
breastbone OR 
 The tumour is larger than 5 centimetres; small groups of breast cancer cells 
(not larger than 2 millimetres) are found in the lymph nodes OR 
 The tumour is larger than 5 centimetres; cancer has spread to 1 – 3 axillary 
lymph nodes or to the lymph nodes near the breastbone.   
Stage IIIB defines invasive breast cancer in which:   
 The tumour can be any size and has spread to the chest wall and/or skin of 
the breast and caused swelling or an ulcer AND 
 The tumour may have spread to up to 9 axillary lymph nodes OR 
 The tumour may have spread to lymph nodes near the breast bone.   
Inflammatory breast cancer is considered at least stage IIIB. Typical 
characteristics are:   
 Reddening of a large portion of the breast skin. 
 The breast will feel warm and may be swollen. 
 Cancer cells have increased or spread to the lymph nodes and may be 
found in the skin.   
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Stage IIIC defines invasive breast cancer in which:   
 There is no sign of cancer in the breast, or, if there is a tumour, it can be of 
any size and may have extended to the chest wall and /or the skin of the 
breast AND 
 The cancer has spread to 10 or more axillary lymph nodes OR 
 The cancer has spread to lymph nodes above or below the collarbone or 
the breastbone.  
STAGE IV 
This stage defines invasive breast cancer that has spread beyond the breast and 
nearby lymph nodes to other organs of the body, such as the lungs, distant lymph 
nodes, skin, bones, liver or brain. Associated words with stage IV are “advanced” 
and “metastatic”. All of the information about the Stages of breast cancer was 
retracted from Bloom and Richardson (1957), Chevallier and co-workers (1987), 
Haffty (2009), Howlader and co-workers, Ries and colleagues (2014) and the 
breast cancer organization (http://www breastcancer.org/).   
The Tumour-Node-Metastasis (TNM) system is another classification that offers 
more details about the appearance and “actions” of the cancer and is the most 
commonly used tool for doctors to describe the stage of the cancer. This system 
was developed in an attempt to classify cancer based on the major morphological 
characteristics of cancerous tumours which can influence disease prognosis 
(Haber et al., 1995; Haffty, 2009; Howlader et al., 2014, Singletary & Connolly, 
2006). The TNM system is based on three features and the doctors or oncologist 
use the results from diagnostic tests and scans to answer the following questions:  
 Tumour (T): How large is the primary or the original tumour? And where is 
the tumour located? The T classification is about the size of the primary or 
original tumour and the extent of the tumour growth within the breast;  
 Node (N): Has the tumour spread to the lymph nodes? And if so, where are 
they located and how many are there? The N classification has to do with 
the presence and extent of regional lymph node involvement;  
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 Metastasis (M): Has the cancer metastasized to other parts of the body? If 
so, where and how much? (Haber et al., 1995, Haffty, 2009; Howlader et 
al., 2014; Singletary & Connolly, 2006).   
There are 3 other TNM descriptors that oncologists use when applicable, which 
are m (multiple foci of invasive carcinoma), r (recurrent) and y (post treatment).   
Tumour (T):   
Using the TNM system the “T” plus a letter or number (0-4) is used to describe the 
size and location of the primary tumour. Some stages are separated into even 
smaller groups that help describe the tumour in more detail.    
The clinical measurement used for classifying the primary tumour (T) will depend 
on the specific case, e.g. physical examination or imaging such as mammography 
or ultrasound. The size of the primary tumour is measured before any tissue is 
removed for special studies.   
TX: Implies that the primary tumour cannot be evaluated.     
T0: Implies that there is no evidence of the primary tumour in the breast.   
Tis: Refers to carcinoma in situ, which means the tumour has not begun to grow 
into healthy breast tissue and is restricted within the ducts or lobules of the breast 
tissue. There are three types of breast carcinoma in situ:   
Tis (DCIS): Ductal Carcinoma in situ is a non-invasive cancer, where the cancer 
cells have been found in the breast ducts and have not spread past the layer of 
tissue where they began.   
 
Tis (LCIS): Lobular carcinoma in situ defines abnormal cells found in the lobules 
or glands of the breast, although it is not cancer yet, it enlarges the risk of 
developing invasive breast cancer.   
 
Tis (Paget’s): Paget’s disease of the nipple with no tumour is a rare form of early, 
non-invasive cancer that is only in the skin cells of the nipple.     
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T1, T2, T3, and T4: These numbers are based on the size of the tumour, the 
higher the T number and the larger the tumour and/or the more it may have grown 
into the breast tissue. 
T1: The invasive part of the tumour in the breast is 20 millimetres (mm) or smaller. 
T2: The invasive part of the tumour in the breast is larger than 20 mm but not 
larger than 50 mm.    
T3:  The invasive part of the tumour is larger than 50mm.    
T4: The tumour falls into one of the following groups:   
 T4a: The tumour has grown into the chest wall.   
 T4b: The tumour has grown into the skin. 
 T4c: The cancer has grown into the chest wall and the skin.   
 T4d: Represent inflammatory breast cancer.   
 
Lymph Nodes (N): The lymph nodes that are found under the arm, above and 
below the collarbone and under the breastbone are called regional lymph nodes.  
Lymph nodes in other parts of the body are called distant lymph nodes. The N 
category defines if the cancer has reached nearby lymph nodes:  
  
NX: Implies that regional lymph nodes can’t be measured or found.   
N0: No regional lymph node metastasis was found in the lymph nodes.   
N1: The cancer has spread to between 1 and 3 lymph nodes under the arm and is 
at least 2 mm in size. It is also called macro metastasis. 
N2: Cancer within the lymph nodes falls into one of the following categories:   
 N2a: The cancer has spread to 4 to 9 axillary lymph nodes.   
 N2b: When the cancer has spread to internal mammary lymph nodes 
(lymph nodes under the sternum or breastbone) without spread to the 
axillary nodes.   
N3: The cancer falls within one of the following groups:   
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 N3a: The cancer has spread to 10 or more lymph nodes under the arm or 
clavicle or collarbone.   
 N3b: When the cancer has spread to the internal mammary nodes and the 
axillary nodes.   
 N3c: Is when the cancer has spread to the lymph nodes located above the 
clavicle, called the supraclavicular lymph nodes.   
If there is cancer in the lymph nodes, the oncologist can, by knowing how many 
lymph nodes are involved and where they are located, plan the most effective 
treatment plan. If cancer is found in the lymph nodes, treatment other than 
surgery, such as chemotherapy, radiation therapy and hormonal therapy can be 
used. If the doctor assesses the lymph nodes before surgery, based on other tests 
and/or a physical examination, a letter “c” for “clinical” staging is placed in front of 
the “N.” If the lymph nodes are evaluated after surgery, which is a more accurate 
assessment, a letter “p” for “pathologic” staging is placed in front of the “N.”  
Metastasis (M): 
The M in the TNM system specifies whether the cancer has spread to other parts 
of the body. It is also called distant metastasis.    
 MX: indicates that distant metastasis cannot be measured or found.     
 M0: indicates there is no distant metastasis. 
 M1: There is evidence of metastasis to another part of the body, indicating 
that there are cancer cells growing in other organs.   
In addition, a stage may be determined after therapy for the breast cancer patient 
who receive systemic (chemotherapy of hormone) therapy, or radiation therapy 
before surgery, or when no surgery is performed. This is termed neo adjuvant 
therapy staging or post therapy staging (yTNM) (Edge & Compton, 2010).  
The TNM staging procedure includes four classifications: clinical, pathologic, 
recurrence and autopsy.  
 Clinical classification (cTNM): It is based only on evidence gathered 
before initial treatment of the primary tumour and is used to make local 
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treatment suggestions. It can be through physical examination, imaging 
studies (including mammography and ultrasound) and pathologic 
examination of the breast or other tissues obtained from a biopsy as 
appropriate to establish the diagnosis of breast cancer.  
 Pathologic classification (pTNM): It includes the results of clinical staging 
with evidence obtained from surgery and from detailed pathologic 
examination of the primary tumour, lymph nodes and distant metastases (if 
present). It is used to assess prognosis and to make recommendations for 
adjuvant treatment.   
 Recurrent classification (rTNM): This classification is used when the 
cancer has come back after treatment and can be either local or distant or 
both. If the cancer has re-occurred, there will be another round of tests to 
learn about the extent of the recurrence. These tests and scans are often 
similar to those done at the time of the original diagnosis.   
 Autopsy classification (aTNM): is used for cancers discovered after the 
death of a patient, when the cancer was not detected before death. All of 
the above information was from work done by Bloom and Richardson 
(1957); Carter, Allen and Henson (2006); Howlader and colleagues (2014) 
and Singletary (2006).   
Once the pathologist knows the TNM characteristics, it will be used to assign a 
stage to the cancer and then be used by the physician and the rest of the 
oncology team to help guide the treatment options for the patient.  
2.2.3  Procedures in Making the Diagnoses of Breast Cancer 
There are different procedures in making the diagnosis of breast cancer performed 
by different specialties which include the following:   
2.2.3.1  Mammogram   
A mammogram is a specialised medical imaging that uses low dose X-rays of the 
soft tissue in the breast that is taken with a mechanism that compresses and 
flattens the breast. A mammogram can identify small lesions before they can be 
detected by touch and distinguish whether a lump in the breast is a gland, a 
harmless cyst or a tumour (Haber et al., 1995). Mammography can portray 
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calcifications due to malignancy/a tumour, including ductal carcinoma in situ 
(DCIS) (Berg, et al., 2008).   
Mammography is a top-quality method and the gold standard for breast imaging 
and cancer detection (Jalalian, Mashohor, Mahmud, Saripan, Ramli, & Karasfi, 
2013) and reduces mortality from breast cancer (Lee, et al., 2010). However, due 
to some limitations of this modality such as low sensitivity especially in dense 
breasts and women with increased risk for breast cancer, other screening 
modalities like ultrasound and magnetic resonance imaging (MRI) are often 
propose to achieve additional information to enable a more accurate diagnosis of 
breast cancer (Mashohor, 2013; Saslow et al., 2007; Lee et al., 2010).   
2.2.3.2  Sonography  
Ultrasound imaging is one of the most frequently used diagnosis tools to detect 
and classify abnormalities of the breast (Cheng, Shan, Ju, Guo, & Zhang, 2010). 
Sonography is a useful adjunct after mammography for the detection of non-
palpable (not clear) breast cancer, particularly in the dense breast (Leconte et al., 
2003) and using both sonography and mammography increases the sensitivity for 
the detection of cancer from 83% to 91%.   
2.2.3.3  Magnetic resonance imaging (MRI) 
Magnetic resonance imaging uses magnetic fields to produce detailed cross-
sectional images of tissue structures, postulating very good soft tissue contrast 
and has higher sensitivity that the mammogram to find smaller tumours (Saslow et 
al., 2007). The MRI is used widely both for screening women who are at increased 
risk of breast cancer and for treatment selection. Prospective studies (Morrow, 
Waters, & Morris, 2011) confirm that MRI screening of women with known or 
suspected genetic mutation results in a higher sensitivity for cancer detection than 
does mammography on its own.  
2.2.3.4  Biopsy   
A biopsy is the removal of cells or tissues for examination by a pathologist. The 
most common types of biopsies include:  
(1)  Incisional biopsy, in which only a sample of tissue is removed;  
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(2)  Excisional biopsy, in which an entire lump or suspicious area is removed; 
and  
(3)  Needle biopsy, in which a sample of tissue or fluid is removed with a 
needle. When a wide needle is used, the procedure is called a core biopsy. 
When a thin needle is used, the procedure is called a fine-needle aspiration 
biopsy (Haber et al., 1995; NCI Dictionary of Cancer Terms).  
2.2.4  Biological breast cancer treatments   
There have been some exceptional advances the last three decades in breast 
cancer treatments that offer women better prospects of cure or longer good-quality 
survival (Fallowfield & Jenkins, 2014). Biological breast cancer treatments can be 
divided in two categories namely, local treatments and systemic treatments.   
2.2.4.1  Local Treatments 
Local therapy means treating the breast tissue itself and can be achieved by either 
a lumpectomy or mastectomy. Surgical removal of the tumour remains the 
keystone of management with early breast cancer and traditionally it would have 
meant a mastectomy (removal of the whole breast) with or without axillary 
dissection (Veronesi et al., 2002). Currently with all the treatment advancements, 
the first line of treatment now is wide local excision (lumpectomy) followed by 
radiation therapy to the intact breast (Haffty, 2009). 
2.2.4.1.1  Lumpectomy  
A lumpectomy falls in the category of breast conserving therapy which means 
saving the normal breast tissue while removing only the cancer. A lumpectomy per 
definition implies the removal of the lump in the breast and a sample of lymph 
nodes under the arm (Haber et al., 1995).   
The principal advantage of the lumpectomy is that the result is less disfiguring 
than that of a mastectomy. In addition to a lumpectomy, radiation is almost always 
given to increase the effectiveness of surgery (Haber et al., 1995; Meric, 2003). 
According to van Dongen and colleagues (2000) and Meric and co-workers (2003) 
breast conserving therapy plus radiation therapy has been shown to be as 
effective as a mastectomy for most patients with stages I and II breast cancer.  
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 2.2.4.1.2  Mastectomy   
As stated above, the mastectomy (removal of the whole breast) was the treatment 
of choice for breast cancer of any size or type, regardless of the patient’s age 
(Veronesi et al., 2002), and although breast conservation has become more widely 
used in early breast cancer, mastectomy still remains the keystone of treatment 
(Meric et al., 2003). There are two types of a mastectomy: a) Modified radical 
mastectomy, and b) radical mastectomy.   
(a)  Modified radical mastectomy: When treating early stage breast cancer, 
the goal is to remove all or most of the tumour. One of the main surgical 
procedures is called a modified radical mastectomy (MRM), which is the 
most common procedure in treating breast cancer (Meric et al., 2003; 
Veronesi et al., 2002). This procedure involves the removal of the entire 
breast, including the skin, areola and nipple as well as the axillary lymph 
nodes, but not the breast muscles. 
(b)  Radical mastectomy: Is the most extensive type of mastectomy which 
involves the removal of all of the breast tissue along with the nipple, lymph 
nodes under the arm and chest wall muscles under the breast (American 
Cancer Society, 2013; Gregorio, Jimenez, Rodriguez, & Borda-Mas, 2013).   
Because of the severity of this procedure the radical mastectomy comprises more 
alteration and change to the breast cancer patient’s appearance than that of a 
lumpectomy or modified radical mastectomy (Haber et al., 1995).   
2.2.4.1.3  Radiation Therapy 
Radiation, like surgery, is a loco regional therapy for conditions both malignant 
and benign (Haffty, 2009). Radiation can be explained as high energy X-rays that 
are aimed at the breast, chest wall and when necessary, at nearby areas that still 
contain lymph nodes, to destroy cancer cells. Side effects occur because radiation 
can also damage healthy cells and tissues near the treatment area such as 
reddening of the skin, discomfort and swelling of the breast and tiredness (Haber 
et al., 1995). For patients not undertaking chemotherapy directly after surgery, 
radiation treatment should start only after adequate healing of the wound and not 
before three weeks after surgery (Haffty, 2009).   
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2.2.4.2  Systemic Treatments 
Systemic therapy is meant to treat the body and uses medications to target and 
destroy cancer cells that have spread beyond the breast. Chemotherapy and 
hormonal therapy (oestrogen-blocking medications) are examples of systemic 
treatments. Systemic therapy may precede local therapy, then it is called neo 
adjuvant therapy, or it can follow local therapy, and is called adjuvant therapy 
(Runowicz et al., 2016). Most people with breast cancer benefit from both local 
and systemic treatment. Systemic treatments indicate treatments to the whole 
body through the bloodstream and are classified as either chemotherapy or 
hormonal therapy and biological agents (Runowicz et al., 2016).    
2.2.4.2.1  Chemotherapy 
Chemotherapy is a drug treatment that uses powerful chemicals to destroy fast-
growing cells in the body or by stopping the division of cancer cells. 
Chemotherapy is administered to control suspected micro metastatic disease 
(Haber et al., 1995). Early stage breast cancer patients who are at risk for 
systemic metastases are progressively treated with adjuvant chemotherapy (Haffy 
& Wilson, 2009; Recht et al., 1996). Adjuvant means additional or secondary 
treatment given after the primary treatment to enhance or extend the primary 
therapy’s effect (e.g. as in chemotherapy’s addition to a surgical regimen). 
Adjuvant therapy may include chemotherapy, radiation therapy, hormone therapy, 
targeted therapy, or biological therapy. Adjuvant chemotherapy for early stage 
breast cancer is administered before radiation therapy (Haffty & Wilson, 2009).   
The aim of chemotherapy is to decrease the total number of cancer cells, but 
because chemotherapy is not cell selective it will also eradicate all rapidly dividing, 
healthy cells, including hair cells, therefore all the bodily hair will fall out as a side-
effect if chemotherapy. Treatments can be dispensed from 12 weeks to one year 
(Haber et al., 1995) and be administered by mouth, injection or infusion depending 
on the type and stage of the cancer (American Cancer Society).   
Another form of chemotherapy is called palliative chemotherapy. Palliative is a 
type of chemotherapy that is given specifically to address symptom management 
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without expecting to significantly reduce the cancer. The aim of palliative 
chemotherapy is to ease symptoms and prolong life without curing the patient.  
2.2.4.2.2  Hormonal Therapy 
Breast cancer is often hormonally sensitive and tumour cells possess both 
oestrogen and progesterone receptors (Col, Kim, & Chlebowski, 2005). A 
woman's ovaries are the main source of the hormone oestrogen until menopause. 
After menopause, smaller amounts are still made in the body's fat tissue, where a 
hormone made by the adrenal gland is converted into oestrogen. Oestrogen then 
promotes the growth of cancers that are hormone receptor-positive (Kuo et al., 
2008; American Cancer Society, 2013). According to the American Cancer Society 
(2016), two out of three breast cancers are hormone receptor-positive.   
Hormone treatment is another form of systemic therapy and is most often used as 
an adjuvant therapy to help reduce the risk of the cancer coming back after 
surgery for hormonally sensitive breast cancer patients of all ages (Deane, 2008; 
Haber et al., 1995; Haffty, 2009). Hormone therapy also minimises mortality within 
this cancer population (Brem & Kumar, 2011).   
Most types of hormone therapy for breast cancer either lower oestrogen levels or 
stop oestrogen from acting on breast cancer cells. This kind of treatment is helpful 
for hormone receptor-positive breast cancers (American Cancer Society, 2014).   
In spite of all the positive outcomes of hormone therapy there are also negative 
side-effects. Oestrogen is the major hormone in sexual functioning, playing a key 
role in arousal, peripheral sexual response and pelvic sexual response. A 
decrease in oestrogen levels causes early and spontaneous menopause, 
dyspareunia and reduced sexual response (Kuo et al., 2008; Brem & Kumar, 
2011). The two most dominant hormonal therapies are:  
 Tamoxifen 
Tamoxifen is a hormonal treatment that blocks oestrogen receptors in breast 
cancer cells, it stops oestrogen from binding to them and telling the cells to grow 
and divide. For women with hormone receptor-positive invasive breast cancer, 
Tamoxifen can be given in pill form for five to ten years after surgery to lessen 
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changes of the cancer recurring and helping patients live longer. It also reduces 
the risk of a tumour in the other, healthy breast. Tamoxifen acts by stopping cell 
growth (Haber et al., 1995; Davies, McGale, Peto, & Davies, 1998; Powles, 2013).  
Tamoxifen is a drug mainly used for women who have not yet gone through 
menopause (Fisher et al., 1998; Haber et al., 1995). The most common side 
effects of Tamoxifen include fatigue, hot flushes, and vaginal dryness or 
discharge, and mood swings (American Cancer Society, 2014), which result 
ultimately in a reduction in sexual functioning (Krychman, Pereira, Carter, & 
Amsterdam, 2006; Mortimer, Boucher, Baty, Knapp, Ryan, & Rowland, 1999). 
Tamoxifen is a medication that has proven its efficacy in reducing tumour 
recurrence and prolonging survival when administered as postoperative adjuvant 
therapy in breast cancer pre-menopausal patients (Fisher et al., 1998).  
 Adjuvant Aromatase Inhibitor Therapy (AIs) 
Aromatase inhibitors are the preferred hormone treatment for women with breast 
cancer who have already gone through menopause as oppose to the (often 
younger) pre-menopausal breast cancer patients (Mok, Juraskova, & Friedlander, 
2008). This therapy works by blocking an enzyme called aromatase in fat tissue 
that is responsible for making small amounts of oestrogen in post-menopausal 
women. Als cannot stop the ovaries from making oestrogen; therefore this therapy 
is only effective in women whose ovaries aren’t working, either due to menopause, 
or side-effects of treatments. AIs are taken daily as pills (Derzko, Elliott & Lam, 
2007). The presence of postmenopausal gynaecological symptoms such as 
vaginal dryness and dyspareunia has been reported to influence the quality of life 
of women taking AIs. If not managed appropriately, these symptoms may result in 
sexual dysfunction, which can in turn affect a woman's quality of life (Mok et al., 
2008).     
2.2.5  Cancer treatment side-effects 
Breast cancer treatments can result in various physiological and psychological 
side-effects that can have a direct influence on the psychological well-being of this 
population. The most prominent and relevant psychical side-effects with 
psychological impacts will be discussed here.   
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2.2.5.1  Physical side-effects 
Recent years have seen exceptional advances in clinical oncology with an 
explosion of knowledge in breast cancer treatments which offer breast cancer 
patients better possibilities and expectations for cure and longer and healthier 
lives (Fallowfield & Jenkins, 2015; Weis, Poppelreuter & Bartsch, 2009). Apart 
from the positive influence of the treatment modalities for cancer (adjuvant 
chemotherapy, hormone therapy, radiation therapy and surgery) there is also 
growing evidence that these modalities can result in long-term functional deficits 
and reduced health-related quality of life and can even compromise the prognosis 
of the illness (Oers, 2013; Van Oers & Schlebusch, 2013; Weis, Poppelreuter, & 
Bartsch, 2009).    
Lymphedema, fatigue, vasomotor complaints, sexual dysfunction and cognitive 
impairment are the five most common and unpleasant physical complications of 
breast cancer treatment (Mok et al., 2008). Brem and Kumar (2011) add reduced 
cardiac function, nausea and vomiting, alopecia, pain, weight gain, ataxia, (the 
loss of full control of bodily movements), asthenia, (abnormal physical weakness 
or lack of energy), spontaneous menopause and peripheral neuropathy to the list. 
The majority of cancer-related physical side-effects are mostly acute, but some 
symptoms like lymphedema, pain, hormonal changes and cognitive dysfunction 
and sexual dysfunctions can be chronic or even permanent which can incapacitate 
the quality of life of the breast cancer survivor (Brem & Kumar, 2011; Fallowfield & 
Jenkins, 2015). 
2.2.5.1.1  Lymphedema 
Surgical removal of the axillary lymph nodes during a lumpectomy or mastectomy 
can cause lymphedema, which is a chronic side-effect. Lymphedema means 
swelling of the arm, hand or (very rarely) the breast area caused by a build-up of 
lymph fluid in the surface tissues of the body caused by damage to the lymphatic 
system. This damage can occur either through surgery and/or radiotherapy to the 
lymph nodes under the arm (axilla) and surrounding area (Dean, 2008; Gottrup, 
Andersen, Arendt-Nielsen, & Jensen, 2000).    
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Axillary lymph node dissection can generate extensive arm morbidity with 
lymphedema which includes pain, loss of sensation, numbness and loss of 
strength and mobility which did not necessarily lessen over time. The pain can 
also manifest in the shoulder and not just the arm and some breast cancer 
patients report worse results after the axillary surgery in terms of pain and 
discomfort than the surgery of the breast itself (Brem & Kumar, 2011; Fallowfield & 
Jenkins, 2015). A study done by Rosenberg and co-workers (2012) has found 
lymphedema to negatively affect the psycho-social well-being of the breast cancer 
patient, but often only develop at a later stage during the process of treatment.  
Lymphedema, as a cancer treatment side-effect, can also potentially impair sexual 
quality of life because of the influence on the patients’ body image (Dean, 2008; 
Rosenberg et al., 2012) and according to Kuo and co-workers (2008) lymphedema 
can affect comfort during sexual activity and may make sexual intimacy 
challenging or even painful. 
2.2.5.1.2 Cancer-related fatigue 
Fatigue is a common medical complaint amongst a variety of illnesses and one of 
the most common symptoms in breast cancer survivors. It has been estimated that 
this problem can affect up to 70% of cancer patients during chemo- and 
radiotherapy or after surgery (Dimeo, Schwartz, Wesel, Voigt, & Thiel, 2008). 
According to Fallowfield and Jenkins (2015) fatigue has replaced nausea and 
vomiting because of effective anti-nausea medication as the biggest post-
treatment problem in breast cancer patients. Although fatigue is usually acute, up 
to 30% of breast cancer patients report persistent fatigue throughout the first 10 
years post-treatment, even patients in complete remission (Berger et al., 2015; 
Dimeo, 2008; Fallowfield & Jenkins, 2015).   
Fatigue is defined as a feeling of weariness, tiredness or lack of energy and 
influences different dimensions of the patient's life (Fernando, 2001). Chronic 
fatigue syndrome share some features with cancer-related fatigue, but should be 
considered separate entities (Berger et al., 2015; Vahdaninia et al., 2010). In 
comparison with other forms of fatigue, cancer-related fatigue is more rapid in 
onset, more persistent and energy draining, and more severe (Bren & Kumar, 
2011; Dean, 2008; Murray, 2010). Fatigue has been defined as the most 
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distressing and incapacitating symptom of all the cancer treatment related side-
effects and is predominant in patients during and after cancer treatment (Johns, 
Brown, Beck-Coon, Monahan, Tong, & Kroenke, 2015). The degree of fatigue 
varies according to the type of cancer and specific treatment modality. 
Chemotherapy, surgery, radiation therapy and hormone therapy all have the 
capacity to cause fatigue which can persist many years into survivorship (Berger 
et al., 2015; Johns, 2015; Oers, 2013).    
Cancer patients may describe their experience of fatigue in three different ways: 
(a)  Mental fatigue: an absence of concentration and loss of memory.   
(b)  Volitional fatigue: an inability to initiate tasks or a tendency to elude social 
contacts and activities, and 
(c)  Physical fatigue: a tiredness and easy exhaustion from activities demanding 
physical effort.   
While the first two forms of fatigue may primarily indicate psychological 
disturbance and increase mental distress, the physical fatigue experienced by 
cancer patients usually has an organic etiology (Fernando, 2001). Several 
biological, psychological, and social factors have been proposed as explanations 
for the origins of fatigue in this framework for in most cases, fatigue has a 
multifactorial genesis (Fernando, 2001; Johns, Brown, Beck-Coon, Monahan, 
Tong, & Kroenke, 2015).   
 Fatigue as a biological phenomenon 
Recent studies suggest that fatigue may originate from alterations in the muscular 
energetic systems caused by cancer and its treatments (Fernando, 2001; Johns et 
al., 2015). Several etiologic mechanisms have been hypothesised to explain the 
development of fatigue in cancer patients which include the following: pain, 
electrolyte and fluid disturbances, anaemia, changes in nutritional status, weight 
loss, changes in the concentration of metabolically active molecules (as a result of 
the interaction between the tumour and the host defence system), medicines with 
action on the central nervous system and sleep disturbances (Fernando 2001).  
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The most critical factor in the regulation of energy production is the supply of 
oxygen to the mitochondrial crests (Fernando, 2001). Sufficient oxygen delivery to 
the cells requires the reliability of all links in a complex chain of organs and 
functions regulating oxygen absorption, transport, and release. Several functional 
and anatomic changes due to cancer treatment can affect the oxygen supply to 
the cells (Fernando, 2001). Chemotherapy, as a breast cancer treatment, can 
damage bone marrow and consequently impair the production of red blood cells, 
resulting in anaemia which decreases the oxygen transport capacity of the blood 
and therefore the oxygen supply to the cells. Because the maximal oxygen uptake 
is severely impaired as a consequence of the cancer and its treatment, the oxygen 
transport systems can be overwhelmed even by normal daily activities like 
climbing stairs, walking, or housekeeping (Fernando, 2001). Cancer patients then 
not just suffer from fatigue but also from an incapacitation of physical performance 
(Johns et al., 2015). 
Another reason for fatigue can be impaired muscular functioning, which can be 
worsened by the lack of activity during in-hospital treatment. Prolonged bed rest 
results in a substantial loss of muscle mass and plasma volume and a reduction of 
cardiac output that can influence physical capacity. After discharge, patients need 
to make greater efforts to carry out normal activities (Fernando, 2001).   
 Fatigue as a psychological phenomenon  
Regardless of the strong underlying biological element of cancer-related fatigue, 
there is a clear association between fatigue and psychological distress (Fernando, 
2001; Johns et al., 2015). It is not only physical performance that is affected by 
fatigue, but also cognitive functioning. Cancer patients report fatigue as a 
combination of symptoms involving an incapability to carry out physical action, 
tiredness, lack of interest and impairment of short-term memory, attention, or 
concentration. These complaints are commonly related with sleep disturbances, 
as in hypersomnia or insomnia (Dimeo, Schwartz, Wesel, Voigt, & Thiel, 2008). 
Cancer-related fatigue impairs activities of daily living which can contribute to 
anxiety, depression and poor overall health-related quality of life (Dean, 2008; 
Fallowfield & Jenkins, 2015; Johns et al., 2015; Vahdaninia, 2010). This 
restrictions through fatigue on quality of life exist across the whole cancer and 
65 
 
treatment trajectory and has been characterized as overwhelming and persistent 
(Johns et al., 2015). 
On the basis of its different features it has been proposed that fatigue is a 
syndrome rather than an isolated complaint or symptom. For many patients, 
fatigue is a severe and limiting problem that not only impairs the physical and 
mental performance, but can prevent the patient from working or carrying out 
regular daily activities that result in a substantial reduction of quality of life (Dimeo 
et al., 2008; Fallowfield & Jenkins, 2015).     
2.2.5.1.3  Cancer-related pain  
Tumour-related pain syndromes have already been recognized and accepted in 
the past, but currently long-term-treatment-related pain etiology is also being 
acknowledged because of the increasing numbers of cancer survivors suffering 
from pain syndromes. These tumour- and treatment pain syndromes are often 
typified by the type of treatment administered, but as most patients receive 
multiple modalities, the pain syndromes may reflect a combined effect of 
treatments e.g. radiation affects, chemotherapy and surgery (Paice & Ferrell, 
2011).   
 Neuropathic pain 
Neuropathic pain is defined as a complex, chronic pain that is generally 
accompanied by tissue injury (Backonja, 2003). Neuropathic pain can be 
described as a direct consequence of a wound or disease affecting the 
somatosensory system (Geber, et al., 2009).  A change in function, chemistry, and 
structures of neurons (neural plasticity) trigger the production of the altered 
sensitivity characteristics of neuropathic pain (Vranken, 2009). Neuropathic pain or 
nerve pain can last up to three months after surgical and non-surgical treatments 
including radiation- and chemotherapy (Macdonald, Bruce, Scott, Smith, & 
Chamber, 2005). Chronic pain can be defined as pain persisting beyond the 
normal healing time of three months and chronic pain symptoms may be mild and 
not needing treatment or it can be severe and significantly restricting quality of life 
(Blunt, & Schmiedel, 2004; Geber et al., 2009).    
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 Post mastectomy pain syndrome (PMPS)  
Post mastectomy pain, which is classified as a chronic neuropathic pain 
syndrome, can be caused by tissue injury and can affect women permanently after 
a mastectomy or lumpectomy (Brem & Kumar, 2011). Post-mastectomy pain 
syndrome is a recognized complication of breast surgery, although little is known 
about the long-term outcome of this chronic pain condition (Macdonald et al., 
2005). In a study done by Gottrup and co-workers (2000) they have found that as 
many as 75% of women who underwent breast cancer treatment report chronic 
pain.  Although the exact mechanism of development of PMPS is not known, it is 
possibly a neuropathic pain condition which is caused by damage to the nerves in 
the axilla and/or the chest wall during breast surgery (Vilholm, Cold, Rasmussen, 
& Sindrup, 2008). 
Persistent pain after a mastectomy was first described during the 1970s, 
characterized as a typical neuropathic pain consisting of a dull, burning or 
shooting pain evoked by pressure and deep blunt pain. The pain is often sited in 
the frontal chest, shoulder, arm and axilla that worsened by movement of the 
shoulder cord (Blunt et al., 2003; Dean, 2008; Macdonald et al., 2005; Vilholm et 
al., 2008). PMPS can develop shortly after surgery or up to several months after 
surgery and can persist for years. The prevalence of PMPS has been shown to be 
higher after a lumpectomy than after a mastectomy. Axillary lymph node dissection 
can also result in pain and did not necessarily lessen over time which then counts 
as chronic pain (Brem & Kumar, 2011; Sarenmalm, Ohlen, Johnsson, & Gaston-
Joahansson, 2007; Vilholm et al., 2008). High levels of pain after a mastectomy, 
lumpectomy or lymph node dissection can significantly impair the quality of life of 
the breast cancer patient (Gregorio, Jimenez, Rodriguez & Borda-Mas, 2013).   
Risk factors for persistent PMPS include younger age, heavier weight, previous 
breast surgery and tumour located in the upper lateral quarter (Vilholm et al., 
2008). Younger patients tend to have larger tumours which explain the more 
serious postoperative and long-term pain (Macrae, 2008). Macdonald and 
colleagues (2005) suggest that the intensity of PMPS can decrease over time, 
which can be explain in that the breast cancer patient might develop adaptation 
mechanisms or strategies to learn to cope with persistent pain. Constant pain 
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influences all aspects of quality of life and severely influences the patient's ability 
to endure treatment, return to health as a cancer survivor, or achieve a peaceful 
death (Paice & Ferrell, 2011).   
Pain often co-occurs with cancer-related fatigue in a complex relationship and can 
be seen as part of a symptom cluster. In a study done by Lueboonthavatchai 
(2007) pain and fatigue were the two leading symptoms reported by cancer 
patients. Pain itself can be exhausting and can conduct fatigue by interfering with 
sleep and decreasing abilities for physical activity (Berger et al., 2015). Pain is 
often concurrent with psychological distress and pain and fatigue as combination 
can be a risk factor for developing anxiety and depression in breast cancer 
survivors (Brem & Kumar, 2011; Lueboonthavatchai, 2007; Vahdaninia, 2010).   
2.2.5.1.4  Cognitive impairment 
Mild cognitive complaints following chemotherapy is one of the most commonly 
reported post treatment symptoms by breast cancer survivors. This deterioration in 
cognitive function is generally referred to as “chemobrain” or “chemo fog” (Boykoff, 
Moieni, & Subramanian, 2009; Brem & Kumar, 2011; Denlinger et al., 2014). 
According to O’Farrell and colleagues (2013) there is growing evidence that the 
neurotoxicity of chemotherapy contributes to cognitive changes. Chemo-fog or 
chemo-brain reflects the fact that the symptoms of the cognitive dysfunction are 
usually mild to moderate and generally not comprehensive. The specific areas of 
cognition that are affected are: attention, concentration and memory, speed of 
information processing, verbal and visual memory, multitasking and ability to 
organize information (Brem & Kumar, 2011; Brezden, Phillips, Abdolell, Bunston, 
& Tannock, 2000; Fallowfield, 2015; Raffa, 2010). This phenomenon of cognitive 
incapacitation was largely unacknowledged by the medical society until recent 
years (Boykoff et al., 2009). Apart from chemotherapy, evidence suggests that 
other treatment modalities such as endocrine therapy and radiation therapy can 
also be associated with cognitive impairments (Brem & Kumar, 2011; Denlinger et 
al., 2014).   
A recent controlled study (pre- and post-chemotherapy) of neuropsychological 
testing and magnetic resonance imaging (MRI) found changes in the brain’s grey 
matter which they associated with chemotherapy, suggesting a physiological basis 
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for cognitive disturbance. Higher memory complaints were statistically significantly 
associated with the combination of chemotherapy and radiation treatment and not 
chemotherapy alone (Ganz et al., 2013). This cognitive impairment can lasts 
anywhere from six months to ten years following treatment (Brem & Kumar, 2011) 
but Weis and colleagues (2009) claim that there is a significant improvement in the 
cognitive condition and self-assessment as time elapsed after the end of 
treatment. Cognitive dysfunction can be either a side-effect of some of the cancer 
treatments or it can be a symptom of a major depressive disorder in the form of 
diminished ability to pay attention and concentrate and incapacity of short term 
memory (Diagnostic and Statistical Manual of Mental Disorders, 5th edition). In the 
past decade, a growing bulk of evidence has suggested patients suffering from 
major depression present with cognitive disorders such as impairment in attention, 
working memory, and executive function, including cognitive inhibition, problem- 
and task-planning (Marazziti, Consoli, Picchetti, Carlini, & Faravelli, 2010).    
Breast cancer survivors report diminished quality of life and daily functioning as a 
result of chemobrain that affect them emotionally, interpersonally and 
economically and can also increase stress, especially in a professional 
environment. In the light of the above, more research needs to be conducted on 
the psycho-social consequences of post treatment symptoms, especially cognitive 
impairment, in order to understand and support this cancer population better 
(Boykoff et al., 2009).    
2.2.5.1.5  Nausea and vomiting 
Nausea is a protective reflex against the ingestion of toxins and is defined as a 
subjective phenomenon of an unpleasant sensation in the epigastrium and in the 
back of the throat that may or may not culminate in vomiting (Dibble, Israel, 
Nussey, Luce, 2004).  Vomiting is the mechanical result of neuro-physiological 
induced rhythmic, coordinated, diaphragmatic, chest wall and abdominal muscle 
action leading to expulsion of gastric contents through the mouth (Dibble et al, 
2004). The two main treatment modalities that can cause nausea and vomiting are 
chemotherapy and radiotherapy.   
 Chemotherapy induced nausea and vomiting 
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The function of cytotoxic/chemotherapy is to damage cells. Therefore it makes 
perfect sense for the body to eject them as soon after ingestion as possible. From 
the body’s point of view, they should simply be avoided, and it is not surprising 
that the experience of chemotherapy induced nausea and vomiting is powerfully 
aversive (Antonarakis & Hain, 2003). Although the management of nausea and 
vomiting as unpleasant side-effects of chemotherapy has improved, it still remains 
to be amongst the most feared and commonly reported side-effects by cancer 
patients. Because of the improvement of nausea and vomiting through 
antiemetics, concern has shifted now to more subtle and potentially chronic 
problems such as fatigue, menopausal symptoms and cognitive dysfunction, with 
fatigue as the biggest post-treatment problem of cancer (Fallowfield & Jenkins, 
2015; Fan et al., 2005).   
The probability that nausea and vomiting will develop after chemotherapy depends 
on several factors. Two of these factors are sex and age, with female cancer 
patients and younger patients being more likely to develop nausea and vomiting 
(Hesketh, 2008). The occurrence of chemotherapy induced nausea and vomiting 
will further be determined by the dose and type of the chemotherapeutic agents 
administered and by individual patient characteristics, therefor will differ from 
patient to patient (Rapoport et al., 2010; Roscoe et al., 2004; Schnel, 2003).  
Chemotherapy-induced nausea and vomiting can be broadly categorized as 
anticipatory, acute or delayed (Schnell 2003).   
(a)  Anticipatory nausea:  New attention has been dedicated to the occurrence 
of nausea and vomiting in anticipation of chemotherapy (Morrow & Dobkin, 
1988). Anticipatory nausea means it occurs before the start of 
chemotherapy in anticipation of the treatment and develops in 8 – 20% of 
cancer patients (Ryan et al., 2012). In a study done by Morrow and co-
workers (1988) at least 25% of their study population who underwent 
chemotherapy has developed anticipatory nausea and vomiting by the time 
of their fourth treatment. Patients who have a high pre-treatment 
expectation of nausea are more likely to have nausea after chemo. 
Especially patients under the age of 50 years who are treated with 
potentially emetic chemotherapy (emetic meaning a substance causing 
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vomiting) and who experienced upsetting nausea and vomiting after 
previous treatments, appear to be at risk of developing anticipatory nausea 
and vomiting for further treatments (Hesketh, 2008; Morrow  & Dobkin,  
1988).   
(b)  Acute nausea:  Begins within minutes of chemotherapy administration and 
resolves or settles within 24 hours (Antonarakis & Hain, 2004; Ryan et al., 
2012).   
(c)  Delayed nausea:  Occurs from 24 hours up to five days post-chemo and 
can persist for several days (Antonarakis & Hain, 2004; Ryan et al., 2012). 
Chemotherapy-related nausea and vomiting seemed to cause substantial 
physical, psychological and functional distress for cancer patients and there 
for it is important that patients with an increased risk for nausea should be 
identified and treated in advance, e.g. those patients with a history of 
nausea (Enblom, Axelsson, Steineck, Hammar,  & Börjeson, 2009; Foubert 
& Vaessen, 2005; Martin, Rubenstein, Kim, & Osoba, 2003).    
 Radiotherapy induced nausea and vomiting 
Although many studies have focused on chemotherapy induced nausea, less 
attention has been paid to radiotherapy-induced nausea (Enblom et al., 2009; 
Maranzano et al., 2005; Tonini et al., 2003). The incidence of nausea during 
radiotherapy varies depending on the site being treated, for example, total body 
irradiation can cause nausea more often (between 80 - 100% of patients) than 
radiation of specific fields (39%). The size of the radiotherapy field also influence 
the risk for nausea, e.g. if the size of the radiotherapy field are over 400 cm2 the 
risk for nausea is bigger. A single dose treatment more often leads to nausea 
although with shorter duration than fractionated treatments. Radiotherapy targeted 
to the pelvic or abdominal field indicated an increased risk of nausea. Patients 
younger than 40 years were more at risk for radiotherapy related nausea (Enblom, 
et al., 2009). These authors also found that earlier experience of nausea in other 
circumstances e.g. during previous chemotherapy, implied and heightened risk for 
nausea which compares with previous literature (Feyer, Stewart, & Titlbach, 1998; 
Feyer et al., 2005). Although radiotherapy induced nausea is usually considered to 
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be less problematic than chemotherapy induced nausea (Riola, Ciccarese, 
Palladino & De Angelis, 1998) the results of Enblom and colleagues (2009) have 
shown that nausea during radiotherapy may affect the patients’ daily lives in 
several negative ways. Occurrence and severity of nausea and vomiting depend 
(as with chemotherapy-related nausea and vomiting) also on patient-related 
factors as in general health of the patient, age, recent or concurrent 
chemotherapy, psychological state and tumour stage (Roila, et al., 2010).   
2.2.5.1.6  Alopecia 
Alopecia means chemotherapy-induced hair loss which may occur throughout the 
body, including the head, face, arms, legs, underarms, and pubic area (Lemieux, 
et al., 2008). Alopecia, ranging from partial hair loss to total hair loss, is a common 
side effect of most chemotherapy combinations presently used in breast cancer 
treatment (Lemieux, Maunsell, & Provencher, 2008; van den Hurk, Mols, 
Vingerhoets, & Breed, 2010).  The probability of alopecia relates to the type of 
drug used and its schedule of administration. Alopecia ranks amongst the first 
three most important and traumatizing side-effects of cancer treatment.  Cancer 
patients describe hair loss in recent studies as a problem and extremely 
distressing (Kim et al., 2012; Lemieux et al., 2008; Van den Hurk et al., 2010). 
Lemieux and colleagues (2008) also found that a small percentage of their 
patients have even refused chemotherapy because of the risk of alopecia.   
Hair plays an important role in the appearance and uniqueness of an individual 
and is a symbol of identity and personality. Kim and colleagues (2012) found in a 
study that all their participants thought that appearance was important and that 
they had negative perceptions about alopecia. They also reported that they were 
not well prepared for alopecia and experienced substantial physical, psychological 
and social distress. They summarised their results by replying that the lack of 
information regarding alopecia and limited social support combined with negative 
images of cancer made it hard to overcome the trauma of hair loss and prevented 
them from usual daily activities resulting in poor quality of life.  Boehmke and 
colleagues (2005) found that even if hair loss was expected, women still found it a 
traumatic experience and felt it changed their sense of self.  
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There is a link between hair and thoughts of femininity and masculinity, 
attractiveness and sexuality. Alopecia can change a person’s perception of her 
sense of self and sexual self-esteem and some researchers found that this change 
in self-perception can cause a decline in sensuality and sexuality (Kim et al., 2012; 
Lemieux, 2008; Munstedt, Manthey, Sachsse & Vahrson, 1997). This change of 
perception can then result in a change in sexuality and often in sexual functioning.  
Alopecia not only affects a person’s self-image and sexuality, but also 
incapacitates her social activities and interactions, with some patients reporting 
feelings of shame because of their hair loss (Lemieux, 2008; Kim et al., 2012).  
Rossman (2004) said for women in particular, hair loss involves a confrontation 
with the fatal nature of cancer, while for men; it is more of a normal and inevitable 
consequence of treatment. Lemieux and co-workers (2007) however, experience a 
lack of substantial evidence of how alopecia affects male cancer patients and 
regard this as a gap in this research field.    
Alopecia can also stigmatize cancer patients by changing their identity from a 
healthy person into a cancer patient where they often experience a loss of privacy 
because it makes society conscious of their illness and chemotherapy. For cancer 
patients alopecia is furthermore a visible and constant reminder of their illness and 
even in some cases, mortality (Kim et al., 2012; Van den Hurk et al., 2010). 
Consequently, regarding the above information, alopecia causes emotional 
suffering and may lead to personal, social and work related problems which can 
contribute to a reduced quality of life (Kim et al., 2012; Lemieux, 2008; Van der 
Hurk et al., 2010). For some patients, however, the negative effects of hair loss 
can be lessened by the psychological process of adaptation and for many other 
patients, physical characteristics became less important as physical features 
became less important as measures of worth and living itself became more 
important (Wagner & Bye, 1979).   
Although significant advances have been made in controlling the impact of 
chemotherapy-related side-effects, especially in the field of nausea and vomiting 
through anti-nauseous drugs and symptom management, alopecia is still a major 
side-effect with no successful preventive intervention as yet. With regard to 
alopecia, wigs are one strategy to camouflage and hide hair loss (whether it is 
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partially or complete) and over the years the quality of wigs has improved 
drastically. Today the possibilities for head covering are modern and more 
extensive and patients are nowadays often advised about managing alopecia 
before starting their chemotherapy (Rossman, 2004; Van den Hurk et al., 2010). If 
baldness represented being sick, new hair after alopecia represented hope, 
optimism, faith and a new life. In a study done by Kim and colleagues (2012) many 
participants have revealed that they felt that the suffering and difficulty was over 
when they saw newly growing hair and that that looking at new hair made them 
feel alive and happy.  
2.2.5.2  Psychological side-effects  
The last three decades have seen some extraordinary developments in breast 
cancer treatment and an explosion of knowledge regarding the genomics and 
molecular biology which have led to an increased number of chemotherapeutic 
options that is offering women greater expectations and hope of cure or longer, 
good quality survival. But noting comes without a price, and despite these 
creditable therapeutic breakthroughs, substantial psycho-social harmful side-
effects continue to be created by the diagnosis and aggressive treatment 
modalities of breast cancer (Borras et al., 2014; Fallowfield & Jenkins, 2015; 
Spiegel, 2008).   
Psychological distress can be defined as a multifactorial, unpleasant emotional 
experience of a psychological (cognitive, behavioural and emotional), social, 
and/or spiritual nature and is an extensive concern associated with the invasive 
nature of breast cancer and its treatment. According to Nekolaichuk and co-
workers (2011) approximately one in three breast cancer patients will experience 
noteworthy psychological distress at some stage during the course of their breast 
cancer. Breast cancer patients especially are inclined to be psychologically fragile 
because of the stress of the diagnosis, the draining and long treatments, pain, 
unpredictability of the course of the treatment and the chronicity of the disease 
(Brem & Kumar, 2011; Van Oers & Schlebusch, 2013). Beginning with the 
diagnosis of breast cancer, this disease involves a long and upheaval process of 
psychological and social adjustments to this new and unforeseen experience that 
impacts a woman’s life and that of her family (Travado & Reis, 2013). 
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Psychological trauma can be caused by events which are unexpected and sudden 
and in which the individual identifies a dramatic loss of personal control and 
personal safety (DSM-IV). Patients, who are diagnosed with a life-threatening 
illness such as cancer, are confronted with a sense of their own mortality which 
often causes acute psychological stress for them and their families (Brennen, 
2001; Spiegel & Rodrigues, 2008). Unfortunately psychological distress may 
interfere with a person’s ability to cope effectively with the physical symptoms of 
cancer and cancer treatment (Nicolas, 2013). 
According to Livneh (2001) most researchers and clinicians would agree that 
psychosocial adaptation to chronic illness and disability results in a long term 
complex, active and continuously evolving process. Therefore, many patients are 
at risk of developing psychological dysfunctions that might lead to premature 
mortality and morbidity and consequently can compromise their quality of life 
(Brem & Kumar, 2011). This theory was confirmed by a meta-analysis of 31 
prospective studies done by Davis and co-workers (2011) where they found a 25% 
higher mortality rate for patients with cancer suffering from depressive symptoms 
and a 39% higher mortality rate for patients presenting with major depression after 
adjusting for prognostic components. Cancer is regarded as a disease which not 
only disturbs a person’s physique, but also alters his/her self-image, sexuality, 
interpersonal relationships, family dynamics and social roles, even when the 
prognosis is not life threatening (Surbone, Baider, Weitzman, Brames, Rittenberg, 
& Johnson, 2010). 
Studies have shown that the prevalence of psychological distress among breast 
cancer patients is high and that this population is at risk of developing severe 
mood disorders, such as depression and/or anxiety, which are the two most 
common psychiatric disorders in this population (Dolbeault et al., 2009; 
Lueboonthavatchai, 2007; Navari, et al., 2008; Vahdaninia, et al., 2010), as well as 
symptoms of a post-traumatic stress disorder (Ang, 2011; Brennen, 2001; 
Dolbeault et al., 2009). In the light of the above mentioned the psychological 
needs of cancer patients have been, and will carry on being, a subject ripe for 
advocacy by the cancer care professionals and especially that of the psycho-
oncologists (Nicolas, 2013).   
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2.2.5.2.1  Depression 
Taking into consideration that depression in particular has a strong and intricate 
relationship with cancer and that 10% to 25% of breast cancer patients potentially 
are at risk of developing depression, it is important to understand and recognize 
the symptomatology of depression (Nekolaichuk et al., 2011; Reyes-Gibby et al., 
2012).   
 Diagnostic criteria of depression 
The detection of depressive symptoms and syndromes in patients with cancer is of 
value both to the patient, because his/her mental distress may respond to 
treatment, and to the clinician, for some of the clinical difficulties in the diagnosis 
and treatment of the patient may be explained and reduced by the knowledge 
(Endicott, 1984). The diagnostic criteria of a Major Depression and Major 
Depression due to another medical condition according to the DSM-5R are:   
A)  Five or more of the following symptoms have been present during the same 
2 week period and represent a change from previous functioning and at 
least one of the symptoms is either a depressed mood or a loss of interest 
or pleasure.   
(a) Depressed mood most of the day, nearly every day with feelings of sadness 
or hopelessness.   
(b) Markedly diminished interest or pleasure in all or almost all activities.   
(c) Significant weight loss or weight gain.   
(d) Insomnia or hypersomnia nearly every day.   
(e) Psychomotor agitation or retardation.   
(f) Fatigue or loss of energy nearly every day.   
(g) Feelings of worthlessness or excessive or inappropriate guilt nearly every 
day.   
(h) Diminished ability to think or concentrate.   
(i) Recurrent thoughts of death (and not just fear of dying), recurrent suicidal 
ideation without a specific plan, or a suicide attempt or a specific plan of 
committing suicide.   
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B)  There is evidence from the history, physical examination, or laboratory 
findings that the disturbance is the direct pathophysiological consequence 
of another medical condition.   
C)  The disturbance is not better explained by another mental disorder.   
D)  The disturbance does not occur exclusively during the course of a delirium.   
E)  The disturbance causes clinically significant distress or impairment in 
social, occupational, or other important areas of functioning.   
Apart from using the DSM-5R to make the diagnosis of a depressive episode, 
psychologists and clinicians also use the ICD 10 code to strengthen and describe 
a diagnosis. The International Classification of Diseases, Tenth Revision, Clinical 
Modification (ICD 10 – CM) is a system used by physicians and other healthcare 
providers to classify and code all diagnosis, symptoms and procedures recorded 
in conjunction with hospital care which was published by the World Health 
Organisation (WHO). Health care professionals use ICD-10 codes to assist them 
in the storage and retrieval of diagnostic information, e.g. Post-Traumatic Stress 
Disorder (DSM-5R) F43.10 (ICD-10) or an Adjustment Disorder with depressed 
mood (DSM-5R) and ICD-10 of F43.21 (Quan et al., 2005). Apart from the 
diagnosis of a Major Depression, according to the DSM-5R and an ICD-10 code of 
F32, the DSM 5R also refers to depression during an illness as a Major 
Depression due to another medical condition, with an ICD-10 code of F 6.31. In 
making this diagnosis, full criteria for a Major Depression are met, except criterion 
C. Apart from the theoretical use of coding, ICD-10 coding is especially important 
for billing a patient, for medical aids (in South-Africa) only accept ICD-10 codes 
when processing an invoice.   
 The impact of depression on the breast cancer patient 
The prevalence of depression among breast cancer patients is generally much 
higher than the general population. Stressful life events are strongly related to 
depression and a cancer diagnosis have been defined in the literature as one of 
the most stressful and traumatic medical diagnoses that a person can receive 
(Meier, 2010; Reyes-Gibby et al., 2012). Breast cancer diagnosis and treatment 
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have an overwhelming and acute impact on a woman’s physical, psycho-social 
and spiritual welfare consequently compromising her general quality of life.   
The presence of cancer-related symptoms, painful treatments, the number of 
hospital admissions, reduced quality of life, recurrence or progression of the 
disease, uncertain mortality, fear of death, altered body image and sexual 
problems, all contribute to patients’ experience of depression (Lueboonthavatchai, 
2007; Mello et al., 2013; Reich et al., 2007; Vahdaninia et al., 2010). Nausea, 
fatigue, pain, tiredness, weakness and reduced energy are common symptoms 
found in breast cancer patients and can all act as predictors for anxiety and 
depression. Especially pain and fatigue, who are the two leading symptoms, 
reported by breast cancer patients, have a strong connotation with depression 
(Lueboonthavatchai, 2007; Vahdaninia et al., 2010). Cancer patients experience 
depression as feelings of sadness and hopelessness, sleep disturbance and loss 
of appetite, psychomotor retardation, withdrawal from social activities and 
heightened expectancy of pain (Mello et al., 2013; Van Oers, 2013). All of these 
symptoms could be either related to the cancer self, or could be symptoms of 
surgery, chemotherapy, radiotherapy or depression. Because of the overlapping of 
these somatic symptoms it can make the diagnosis of depression difficult which 
then leads to under-diagnosing and treating the depression, which can further 
complicate the treatment and outcome of the cancer (Lueboonthavatchai, 2007). 
Experiencing an episode of depression or anxiety soon after the diagnosis of, or 
during treatment of breast cancer, adds to the pain and suffering of the patients 
and the burden on the family (Meier, 2010).   
Given the anticipated increase in the number of breast cancer survivors over the 
next decades, understanding the epidemiology of depression and its negative 
impact on quality of life during the time of treatment and the survival period, will 
have important clinical and community implications (Reyes-Gibby et al., 2012).  
Recent studies have found that about one in three cancer patients will experience 
significant emotional and psychological distress at some point during the course of 
their cancer and between 16% - 25% of breast cancer patients will develop a 
major depressive disorder (Nekolaichuk et al., 2011; Hopko et al., 2016).  Despite 
the high prevalence of psychological morbidity and major depressive symptoms in 
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breast cancer survivors, it is often misdiagnosed and undertreated in health care 
services. Although cancer patients are known to have high percentages of 
psychological morbidity, they are low consumers of psychiatric care, particularly 
for clinically severe disorders. Gandubert and co-workers (2009) has identified this 
failure to detect breast cancer patients with psychological distress due to time 
constraints and the lack of communication between healthcare professionals and 
their patients. This occurrence is probably based on the common belief amongst 
clinicians that conditions such as anxiety and depression are ‘normal’ reactions to 
the diagnosis and treatment of cancer and the clinical postulation that such 
suffering will diminish over time. In a study done by Gandubert and co-workers 
(2007) 19.4% of the cancer group (different types of cancer were evaluated) 
reported feeling depressed. In the breast cancer group, depression was 
significantly higher comparing with other types of cancer. Poorly managed 
depression can lead to emotional suffering, anxiety and poorer quality of life which 
can cause intensification of physical symptoms, increased functional impairment 
and prevention of returning to a pre-morbid level of functioning (Fann et al., 2008; 
Meier, 2010; Reich, et al., 2007; Wong-Kim & Bloom, 2005). 
Depression and symptoms of depression relates to poor adherence with 
recommended cancer treatment, tumour progression and mortality. All of these 
symptoms can lead to a deterioration of quality of life and an incapacitation of 
social and occupational functioning (Mello et al., 2013; Vahdaninia et al., 2010). It 
is imperative to monitor breast cancer patients for symptoms of depression or a 
depressed mood and provide means for treatment within the clinical oncology 
setting to guarantee a better quality for this cancer population (Reyes-Gibby et al., 
2012). Prevention of depression or anxiety through early diagnoses is therefore a 
worthwhile goal (Hill et al., Meier, 2010).   
Various factors predict depressive disorders in breast cancer patients. These 
factors include demographic aspects such as age, post-menopausal period, 
disease severity, level of patient disability, physical impairment, poor performance 
status and survival (Reyes-Gibby et al., 2012; Wong-Kim & Bloom, 2005). Pre-
morbid psychiatric history is a well-known risk factor in developing depression 
during and after breast cancer and cancer treatment. A study done by Hill and co-
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workers (2010) highlighted the vulnerability of women with previous episodes of 
depression and anxiety to further mental health problems during the year after 
diagnosis of breast cancer. Studies have shown that the frequency of depression 
in breast cancer patients is higher than in most cancers because menopause and 
oestrogen decline are related to (symptoms of) depression (Brem & Kumar, 2011; 
Fann et al., 2008; Navari et al., 2008). Especially women with Stage IV metastatic 
breast cancer, who face the likelihood of a foreshortened future, may be 
particularly at risk of poor mental health and depression (Low & Stanton, 2015).  
There are researchers who claim that risk factors for depression are rather related 
to the patient self and his/her relevant psychodynamics, as to the disease and the 
disease treatment which have implications on treating the symptoms of depression 
and the patient in general (Burgess et al., 2005; Reich et al., 2007). 
 Depression throughout the trajectory of breast cancer  
Although the American Society of Clinical Oncology Cancer Survivorship (ASCO) 
a cancer survivor define as any person who has received a cancer diagnosis from 
the point of diagnosis onward, the committee has chosen to use a more functional 
definition of survivorship, focusing on individuals who have successfully completed 
medicinal treatments or the individuals who have transitioned to maintenance or 
preventative therapy (Raque-Bogdan Hoffman, Ginter, Piontkowski, Schexnayder,  
& White, 2015; Surbone,  Annunziata, Santoro, Tirelli, & Tralongo, 2013). For the 
benefit of this study a cancer survivor or survivorship will refer to a patient in full 
remission. The remission phase means a decrease in or disappearance of signs 
and symptoms of cancer. In partial remission means some, but not all the signs 
and symptoms of cancer have disappeared and complete remission means all the 
signs and symptoms of cancer have disappeared, although the cancer still may be 
in the body (NCI Dictionary of Cancer Terms).  
Two different groups can be identified in terms of time frames and psychological 
distress (Henselmans, Helgeson, Seltman, de Vries, Sanderman, & Ranchor, 
2010).The first group is the patients that experience distress right after the 
diagnosis of breast cancer and which are in the active treatment phase. The 
second group are the patients in the re-entry and remission phase. The re-entry 
phase is defined by different authors as the months from treatment completion 
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through 12 to 18 months (Bloom, Petersen & Kang, 2007; Henselmans et al., 
2010; Stanton, 2012). The same researchers view long-term survivorship as 
beginning at least 5 years after diagnosis and completion of treatment. The 
remission phase can also be in the re-entry phase. According to Henselmans and 
co-workers (2010) there is also a group of breast cancer patients (36%) who 
appear to experience no distress at al.  
 Depression in the diagnostic phase and acute treatment phase 
Although studies have shown that women with breast cancer are highly exposed 
to developing major depression during the course of their illness (16% to 25%), it 
is believed that the level of psychological distress would be higher around the time 
of diagnosis and during active treatment (33%), specifically in the first year 
following the cancer diagnosis (Brem & Kumar, 2011; Burgess et al., 2005; 
Dolbeault et al., 2009; Henselmans et al., 2010; Hopko et al., 2016; Vahdaninia et 
al., 2010). There are a number of challenges that breast cancer patients endure 
during the period of diagnoses and the process of active treatment such as the 
continuous biological and psychological side-effects. These symptoms are 
particularly acute in the first few months after the cancer diagnosis and can affect 
the patients’ lives through changes in their ability to function in daily activities such 
as work, relationships with others, or caring for themselves (Sohl, Levine, Case, 
Danhauer, & Avis, 2014).  Illness invasiveness or how much a chronic illness, 
such as breast cancer, interrupts life domains, is an important concept in 
explaining why the same diagnosis and treatment leads to varied quality of life 
outcomes. There are different psychological reactions at different stages of the 
illness with denial, anger, uncertainty and anxiety often the most prominent 
emotions at the initial stage of diagnosis (Lueboonthavatchai, 2007; Liao, Chen, 
Chen & Chen, 2008; Mello et al., 2013).   Authors like Wong-Kim and Bloom 
(2005) claimed that whether a breast cancer patient is in active treatment or not, 
did not exclusively predict depressive symptoms, instead the treatment side-
effects such as the extent of bodily pain and discomfort is most important when 
assessing woman’s depressive symptoms regardless of the period of treatment or 
remission.        
 Depression in the re-entry- or remission phase  
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There are a substantial number of breast cancer patients reporting a late increase 
in distress and psychological suffering in the re-entry and remission phase (20% - 
30%) (American Cancer Society, 2010; Burgess et al., 2005; Henselmans et al., 
2010). One of the reasons for this occurrence is the sudden end of the visits to the 
oncologist and other clinical specialists which can leave a person with a feeling of 
loss to the ready access of the health care system and the safety net it provides. 
This sense of loss may lead to feelings of vulnerability and of not being in control. 
Another reason for end of treatment distress, is not knowing what to expect after 
the end of treatment, what kind of follow-up is typical and which symptoms are 
important to monitor (Ganz et al., 2004; Golden-Kreutz et al., 2005; Stanton, 
2012).  Symptoms of depression and emotional distress can cause a contradictory 
response for survivors who may feel both relieved at having completed treatment 
and heightened anxiety about the future (Ganz et al., 2004). Evidence from 
various studies have shown that there are prominent problems related with the 
transition from being a cancer patient to being a cancer survivor, or returning from 
a ‘cancer patient’ back to a ‘normal person’ (Dolbeault et al., 2009; Henselmans et 
al., 2010; Stanton et al., 2005). Stanton (2012) states that there are not always 
effective preparation for the re-entry phase by the health care professionals, 
leaving the cancer survivors in a stage of ‘limbo’, therefore it is recommended that 
all cancer patients undergo regular psychological assessment at key points from 
diagnosis throughout the treatment process and have access to psychological 
support (Cook, Salmon, Dunn, Holcombe, Cornford, & Fisher, 2015).   
The re-entry phase brings its own particular challenges for the breast cancer 
patient. The most mentioned problems in this phase are the lingering adverse 
physical and psychological side-effects of the cancer treatments such as; loss of 
physical stamina and fatigue, pain, sleep disturbance, cognitive problems, 
alopecia, urinary/bowel problems, menopausal symptoms and often sexual 
dysfunctions (Ganz et al., 2004; Golden-Kreutz et al., 2005). Breast cancer 
survivors often report that they were unprepared for the complex rehabilitation 
process and persistent symptoms of depression or anxiety after the end of their 
treatment (Brem & Kumar, 2011; Burgess et al., 2005; Dolbeault et al., 2009; 
Reyes-Gibby et al., 2012). In a study done by Ganz and co-workers (2004) 16 of 
their 18 breast cancer patients were astonished and disappointed in themselves to 
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still experience chemotherapy-related and mood problems months after ending 
their treatment, especially when they felt that they have coped well during 
treatment (Brem & Kumar, 2011; Burgess et al., 2005; Dolbeault et al., 2009; 
Reyes-Gibby et al., 2012).   
Apart from the above mentioned problems, other challenges that breast cancer 
survivors face during this transition phase may include worries about the threat of 
death, the risk and fear of recurrence, bodily changes with accompanied feelings 
of decreased femininity, changing psycho-social needs and the uncertainty about 
the future, especially about relationships and occupational difficulties and financial 
stress (Ganz et al., 2004; Haber et al., 1995). Most breast cancer survivors 
experience significant (longer term) fears and even panic about non-cancerous 
symptoms such as pain, fever, headaches and other somatic symptoms (Haber et 
al., 1995). This constant fear and worries has the potential to maintain (at least) a 
low level depression in the post treatment women. Such cognitive and behavioural 
experiences may greatly interrupt established routines and behaviours that 
historically have elicited environmental reward or pleasure, the result being a 
bigger possibility of depression and anxiety (Ganz et al., 2004). Apart from 
experiencing these residual physical and/or psychological consequences of the 
cancer treatment, post treatment cancer survivors or patients may realise now for 
the first time the chronicity of cancer, even when treatment was declared 
successful (Ganz et al., 2004; Haber et al., 1995).  
Added distress in the re-entry phase might be due to a delayed psychological 
response to the hectic and busy period of diagnosis and treatment. Once in a 
calmer period, the cancer experience might finally start to sink in for some 
patients, causing a delayed increase in distress (Henselmans et al., 2010).  
Because of the immediacy created by the cancer diagnosis (the need for surgery 
and/or adjuvant treatments) it may delay the emotional experience surrounding 
other life events. It remains unclear whether the chronic high levels of distress 
were the result of difficulties in adjusting to cancer or of previous psychological 
problems, either triggered by or entirely unrelated to cancer. Future research 
should examine the possible predictors of high distress during the re-entry and 
remission phase in more detail (Golden-Kreutz et al., 2005; Henselmans et al., 
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2010). Studies have suggested that breast cancer survivors are in their highest 
need of interpersonal support after completing their treatment but often find it 
unavailable. Family members and friends may expect that, after completion of the 
cancer treatment, the woman will be able to recommence all of her usual activities 
and responsibilities at her pre-cancer level of functioning. Psycho-social problems 
associated with the end of treatment may be compounded by a withdrawal of and 
changes in the social support system (Ganz et al., 2004; Stanton, 2012; Wurtzen, 
2013). 
To summarise, the occurrence of a substantial number of breast cancer patients 
with elevated depression and anxiety well into their remission phase, indicates that 
breast cancer patients should routinely be screened for psychological distress. 
This should be done even after the completion of treatments so that the problems 
can be targeted for preventive and intervention efforts.  Helping cancer patients 
understand what to expect at the completion of medical treatments and how to 
deal with anticipated problems effectively are critical components of psychological 
care (Reyes-Gibby et al., 2012; Stanton, 2012; Vahdaninia et al., 2010). 
 Depression and young age   
Breast cancer is diagnosed across a broad age group from teen years through to 
old age. According to statistics done by Fiszer and colleagues (2014) the average 
age for breast cancer is 61 years and represents 70% (evenly dispersed) between 
the ages of 45 and 74. Breast cancer patients younger than 40 years represent 
between 6% to 7% of all breast cancer patients, with 2.4% younger than 35 years 
and 0.65% - 1% younger than 30 (Gnerlich, Deshpande, Jeffe, Sweet, White, & 
Margenthaler, 2009; Hussein et al., 2013; Meier, 2010; Raque-Bogdan, Hoffman, 
Ginter, Piontkowski, Schexnayder, & White, 2015).     
Although a diagnosis of breast cancer is distressing at any age, this occurrence in 
young women is laden with several unique challenges. Usually, breast cancer 
occurring in a younger host is differentiated by a more aggressive phenotype and 
has disproportionately high rates of second malignancies. Previous studies have 
shown that breast cancer in a younger population is often presenting more 
aggressively with higher mortality and recurrence rates compared with older 
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women (Anders, Johnson, Litton, Phillips, & Bleyer, 2009; Gnerlich et al., 2009; 
Hussein et al., 2013; Raque-Bogdan et al., 2015). Local recurrence in patients 
younger than 45 years of age was discovered to be four times higher than in 
patients older than 65 years of age. Clinically, younger women are more likely to 
present with a palpable mass, larger tumour sizes, more invasive cancers, and 
more positive lymph nodes than older breast cancer patients which entails more 
aggressive treatment modalities and the need for closer monitoring and follow-up 
after-care. Death rates in the breast cancer population have been steadily 
decreasing, especially in younger women, due to the improved treatment 
modalities and early detection. Although the diagnosis of breast cancer is much 
less common in women under the age of 40 years, it can have a greater impact 
than in older counterparts as it tends to present at a later stage, is more 
aggressive and has a poorer prognosis (Gnerlich et al., 2009; Hussein et al., 
2013).   
Chemotherapy, endocrine- and local therapies have the capacity to meaningfully 
affect young women. This includes physiologic health, future fertility, premature 
menopause, and bone health and psychological health including changes to the 
self-image and femininity as they face a diagnosis of breast cancer (Anders et al., 
2009; Travado & Reis, 2013). Young woman undergoing chemotherapy for breast 
cancer may struggle with fertility and pregnancy issues, where most of them had 
expectations of having more time to be productive (Corney & Swinglehurst, 2014; 
Gabriel & Domchek, 2010).  Although guidelines are available, many women were 
not given sufficient information or even offered treatments or interventions to 
preserve their fertility.  Means of increasing awareness and understanding of 
fertility issues are necessary for both the health professionals and for the young 
breast cancer patient. Different methods of refining the infertility problem need to 
be evaluated and tested so that these needs of young breast cancer patients can 
be met in a more effective way (Corney & Swinglehurst, 2014). Chemo-induced 
amenorrhea also has an impact on bone density (decreasing) compared to women 
who retain their menstrual function after treatment (Gabriel & Domchek, 2010). All 
of these factors can then contribute to the developing of a depressive mood 
disorder in this young population.  Lebel and co-workers (2013) described the fear 
of cancer recurrence as the most frequently cited psychological side-effect of 
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young breast cancer patients. The fear of cancer recurrence has been described 
as “the sword of Damocles” that hangs over young breast cancer patients heads 
for the rest of their lives. Fear of cancer recurrence is defined as fear or worry that 
the cancer will reappear (grow) in the same organ or in another part of the body.  
Compared to older women, young women have more difficulty in adapting to a 
breast cancer diagnosis. They report more symptoms of distress and worry and 
have a lower quality of life. More psychological consequences are evident in 
young breast cancer patients because they tend to have more family and work 
responsibilities and are more likely to report that their illness and treatment 
interfere with important roles and activities than is the case in older women (Lebel, 
Beattie, Ares, & Bielajew, 2013). Due to their roles as mothers, wives and job 
holders and the demands and responsibilities required by their families and 
careers, younger women are more prone to experience unhappiness and greater 
demand for social support when diagnosed with breast cancer. Having young 
children at home is a stressor for a young mother because the role of caregiver 
requires a lot of energy and attention that has to compete with the time consuming 
and energy sapping cancer treatments (Lebel et al., 2013; Wong-Kim & Bloom, 
2005). There is evidence that having dependent children (under the age of 18) 
living at home, increases stress and worries and contributes to fear of recurrence 
and dying and leaving their young children behind. Younger women, under the 
age of 35, have constantly been shown to perform worse on a broad range of 
quality of life domains compared with older women and report greater levels of 
fear of cancer recurrence (Lebel et al., 2013; Rauch and Muriel, 2004).   
A women’s development up to the age of 40 years, which is the age criteria used 
by community cancer organizations to define a patient as a young cancer survivor, 
represents a phase of life in which women begin to see themselves as more 
independent, build their own networks of social support; start their career paths; 
develop new friendships and romantic relationships; and make important decisions 
about their identities, careers, and relationships. Having breast cancer during such 
an important developmental period can impede young women’s ability to adapt to 
critical life events and have significant implications for the rest of their life path 
(Maya & Bauer-Wu, 2009; Raque-Bogdan et al., 2015). Despite early-stage 
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diagnosis and the beginning phases of adulthood, young breast cancer patients 
anticipate their mortality and the potential implications on their loved ones and 
their own careers. Maya and Bauer-Wu (2009) suggest that oncology 
professionals need to be considerate and sensitive to these concerns and provide 
opportunities for discussion and/or referrals for their young patients as they deal 
with such potentially overpowering issues. 
Career and work concerns may be an important element of post treatment quality 
of life for young cancer survivors who may have at least 25 or more years left in 
the workforce. For breast cancer survivors in particular, the decision to work can 
be affected by anxiety about their physical appearance, e.g. hair loss, physical 
restraints such as limited arm or shoulder mobility, chemo-induced cognitive 
impairment and chemo fog and the subsequent impact on their confidence in 
carrying out daily tasks including work tasks (Munir, Burrows, Yarker, Kalawsky, & 
Bains, 2010). There is also the possibility of a potential job loss due to the 
demands of the medical treatment and/or on-going treatment side effects. Raque-
Bogdan and co-workers (2015) state that with women between 25–35 years, their 
career choices are a means of achieving job satisfaction and accomplishment and 
symbolize ways of personal fulfilment and life satisfaction. According to Raque-
Bogdan and co-workers (2015) career troubles take on special importance for 
breast cancer survivors because a career can function as a sign of quality of life. 
Functioning properly in your job represents normality and routine after the illness 
and treatment and symbolises hope for the future and provide access to social 
support, medical insurance and financial resources.   
Young women who had a mastectomy often report feeling incomplete and 
depressed about the loss of their breast and are more at risk for psychological 
distress and reported more sexual problems secondary to the breast cancer 
diagnosis (Wong-Kim & Bloom, 2005). In their study they found that younger 
women who had higher levels of pain, lower levels of self-esteem and emotional 
support and severe treatment side-effects were most at risk for experiencing 
depressive symptoms than older women with breast cancer. A higher percentage 
rate of young women, under the age of 50, as defined by Wong-Kim and Bloom 
(2005) met the criteria for being depressed when diagnosed with late stage 
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cancer. These authors confirm that because of their heightened vulnerability to 
stress and fear of recurrence, young breast cancer patients are most in need of 
screening for psychological stress and fear and interventions to help them manage 
these fears (Lebel et al., 2013; Wong-Kim & Bloom, 2005). The findings of this 
study indicate that age continues to be an important variable in predicting 
depressive symptoms.   
Raque-Bogdan and co-workers (2015) feel that additional research is needed on 
unique aspects of young breast cancer survivors’ psychological functioning given 
that young survivors represent a significant percentage of the breast cancer 
survivor population and that breast cancer in young women remains a great 
challenge to patients, families and health care providers. Since breast cancer is 
normally a disease of older women, the majority of breast cancer studies have 
concentrated on older women and few studies have focused on age as the 
primary exposure (Gnerlich et al., 2009).   
 Depression and end of life 
Diagnosing and treating depression in terminally ill patients implicate unique 
challenges. Feelings of helplessness, worthlessness, guilt and sometimes suicidal 
ideation are better indicators of depression in this population (Block, 2000). The 
results of a study done by this author, found that depressed patients were four 
times more likely to have a desire for a hastened death or a wish to die.  
Hopelessness appears to be an essential element of desire for hastened death. A 
terminal illness like cancer is by definition incurable and many people might 
confuse a “hopeless” prognosis with a “hopeless” cognitive style. According to 
Block (2000) data suggest that patients often maintain hope during the final weeks 
of their life, although what they hope for might change as death nears.   
As death approaches, it is normal for patients with a terminal illness to undergo an 
expansion in the number and severity of their physical and psycho-social 
stressors. These stressors can include severe fatigue and growing weakness with 
incapacitating physical symptoms, loss of independence, decreased social 
interactions, increased existential distress, death-anxiety and anticipatory 
(preparatory) grief (Berger et al., 2015). It is important to understand the 
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epidemiology op psychiatric morbidity among advanced cancer patients to 
minimize the occurrence of clinicians neglecting cases that justify attention. 
Existential distress at the end of life is often regarded as natural which may result 
in clinicians underestimating psychological symptoms, including severe 
depression (Lichtenthal et al., 2009).   
I often found in my practise that, at the end of a patients’ life, there is a natural 
progression of death acceptance (which is supported by authors such as 
Lichtenthal and co-workers (2009) and peaceful awareness as death approached, 
but that the immediate family, especially if they were also the main care takers of 
the patient, often present with depression and can benefit from therapeutic input.   
2.2.5.2.2  General anxiety disorder 
Anxiety is one of the most dominant psychological challenges associated with 
cancer and research conducted in the USA and the UK has shown that anxiety 
prevails throughout the spectrum of treatment and recovery for female patients 
with breast cancer, even among the disease-free breast cancer survivors (Montel, 
2010; Lim et al., 2011). 
 Diagnostic criteria according to DSM-5R 
The diagnostic criteria of a General Anxiety Disorder according to the DSM–5R 
are:   
A)  Excessive anxiety and worry (apprehensive expectation), occurring more 
days than not for at least 6 months about a number of events or activities 
such as work or school performance.   
B)  The individual finds it difficult to control the worry.   
C)  The anxiety and worry are associated with three or more of the following six 
symptoms (with at least some symptoms having been present for more days than 
not for the past 6 months):  
(a) Restlessness or feeling keyed up or on edge.  
(b) Being easily fatigued.   
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(c) Difficulty concentrating or mind going blank.   
(d) Irritability.   
(e) Muscle tension.   
(f) Sleep disturbance.   
D)  The anxiety, worry or physical symptoms cause clinically significant distress 
or impairment in social, occupational or other important areas of 
functioning.   
E)  The disturbance is not attributable to physiological effects of a substance, 
or other medical condition (e.g. hyperthyroidism).   
F)  The disturbance is not better explained by another mental disorder.   
The diagnostic features of a generalized anxiety disorder are excessive anxiety 
and worry about a number of events or activities. The intensity, duration or 
frequency of the anxiety and worry is out of proportion to the actual likelihood or 
impact of the anticipated event. Associated features supporting diagnosis are:  
Muscle tension, trembling, twitching, feeling shaky and muscle aches or soreness.  
Somatic symptoms include sweating, nausea, diarrhoea and an exaggerated 
startle response and hyper-arousal symptoms such as accelerated heart rate, 
shortness of breath and dizziness, but less prominent than in a panic disorder 
(American Psychiatric Association (2001). The International Classification of 
Diseases, Tenth Revision, Clinical Modification (ICD 10 – CM) is used in 
conjunction with the diagnostic criteria of the DSM-5R for General anxiety disorder 
which is F41.1.   
General anxiety disorder is characterized by persistent, excessive and unrealistic 
worry about everyday issues. People with this disorder feel that worrying is 
beyond their control and that they feel powerless to stop it. They often expect the 
worst, even when there is no apparent reason for concern. Exaggerated and 
unrelenting worry often centres on issues of health, family, money or work and it 
can interfere with all aspects of a person’s life. Cancer patients with a general 
anxiety disorder may, during the active phase of cancer, irrationally fear that no 
one will care for them though they have adequate and a willing social support 
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system, or that the outcome of the illness will be fatal, despite optimism of the 
physicians (Montel, 2010).     
The most frequent co-morbid psychological conditions are depression and anxiety 
(Brem & Kumar, 2011; Spiegel & Rodrigues, 2008).  In a study done by Mello and 
colleagues (2013) 44% of the breast cancer survivors reported either depression 
or anxiety, but only 23.8% discussed these symptoms with their physicians. 
Gandubert and colleagues (2009) found that 10.4% of cancer patients present 
with a general anxiety disorder and that re-emerging of the symptoms was as high 
as 67%. According to Van Oers and Schlebusch (2013) anxiety is the more 
common disorder between depression and anxiety in the breast cancer population 
and prolonged anxiety has immunosuppressive effects that can also lead to 
cognitive dysfunction. This was confirmed in a study done by Lueboonthavatchai 
(2007) where the results showed a slightly higher incidence in general anxiety 
(49%) as opposed to depression (46%). Regarding clinical factors associated with 
anxiety and/or depression disorders in the breast cancer population are: a) the 
number of hospital admissions, b) existence of disturbing symptoms, e.g. pain, 
respiratory symptoms and fatigue, and c) the presence of treatment complications. 
The most common somatic symptoms found in cancer patients were; pain, fatigue 
and tiredness, insomnia, lack of appetite, weakness and reduced energy and can 
all be seen as predictors of anxiety and depression.  All of these somatic 
symptoms, which are overlapping each other, complicate the diagnosis of anxiety 
and/or depression which further complicate the treatment and outcome of cancer 
(Lueboonthavatchai, 2007).   
The diagnosis of a life-threatening illness like breast cancer can be overwhelming 
and shocking to patients and their families. Confrontation with a person’s own 
mortality can cause acute psychological stress and feelings of anxiety after a 
cancer diagnosis is not necessarily abnormal, for the threat of cancer is to some 
degree a realistic threat, but without proper management can become 
pathological. A significant percentage of breast cancer patients will suffer sufficient 
emotional stress to qualify for a psychiatric diagnosis, especially depression or 
anxiety.  Apart from the heavy physiological toll on the breast cancer patient, the 
cancer diagnosis can also create a series of psychological stressors disrupting the 
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social, occupational and family functioning. It was also reported that anxiety in 
breast cancer has a detrimental effect on the quality of life of female patients, 
affecting their physical, medical and sexual quality of life (Brem & Kumar, 2011; 
Dolbeault et al., 2009; Lim et al., 2011; Spiegel & Rodrigues, 2008). Both 
chemotherapy and radiation are associated with anxiety and are often the highest 
before the first application, where anticipation fear for follow-up examinations and 
their results are also related to high levels of anxiety (Berger et al., 2015; Travado 
& Reis, 2013; Van Oers & Schlebusch, 2013; Vahdaninia et al., 2010).   
 Health anxiety  
According to Jones and co-workers (2014) there is another (newer) form of anxiety 
called health anxiety. Health anxiety is defined as a persistent fear of illness or 
disease that often includes the misinterpretation of physical symptoms as signs of 
a serious illness. Health anxiety involves contemplating about having or 
developing an illness or having an existing illness worsen, obsessed with bodily 
sensations with accompanied behaviours such as seeking medical reassurance or 
attention. Severe expressions of health anxiety were often classified as 
hypochondriasis in the DSM-IV-TR (Asmundson, Abramowitz, Richter, & Whedon, 
2010; Brennen, 2011).   
Health anxiety affects a considerable percentage of women following the 
diagnosis of breast cancer (Asmundson, et al., 2010; Brennen, 2011). While a 
certain level of health anxiety may be adaptive, (e.g. to alert the patient to watch 
for signs of recurrence), clinically raised health anxiety can lead women to 
continuously monitor their bodies all the time and interpret any symptoms as 
threatening. Severe health anxiety has significant adverse impacts on well-being, 
social and occupational functioning, and health care resource utilization 
(Asmundson et al., 2010; Jones, Hadjistavropoulos, & Gullickson, 2014). It is 
evident that health anxiety is a significant problem for more than 20% of women 
who have been diagnosed with breast cancer and may present challenges over 
and above that of the general anxiety experienced as a result of having breast 
cancer (Jones et al., 2014; Kyranou et al., 2014).   
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The diagnosis of depression or anxiety in isolation can be challenging because the 
symptoms of the two conditions often coincide. According to Van Oers and 
Schlebusch (2013) literature on anxiety as a co-morbid feature is relatively limited 
although there is evidence that anxiety presented itself in a higher percentage as 
depression in the oncology population.  Van Oers and Schlebusch (2013) claim 
that breast cancer patients often experience anxiety before the start of treatment, 
where depression only develops post-treatment. Anxiety also relates more with 
future concerns such as treatment outcomes and recurrence (Kyranou et al., 
2014; Lebel et al., 2013).  
Although anxiety levels vary over the course of the cancer treatment, it tends to be 
the highest during time of diagnoses, before breast surgery and toward the end of 
treatment in anticipation of the results (Van Oers & Schlebusch, 2013). A recent 
study done by Aviado-Langer (2014) emphasises that the pre-operative stage was 
dominated by stressors such as waiting for the surgery and pathology results,  fear 
of the disease and stage.  Results of a recent study done by Aviado-Langer (2014) 
found that patients scheduled for breast-conserving surgery had lower scores for 
anxiety compared to patients scheduled for a mastectomy. The most common 
response to a mastectomy appears to be anxiety, possibly in relation to pain, 
disfigurement and body image (Kyranou et al., 2014; Van Oers and Schlebusch, 
2013). In the light that a breast cancer diagnosis is a stressor, it is important to 
implement preoperative encounters to identify, evaluate, and manage patients’ 
anxieties. Unaddressed, preoperative anxiety may provoke a physiologic stress 
response in the postoperative progression that can comprise heightened anxiety 
and postoperative pain, delayed immune response, increased pulmonary risks and 
thrombus formation (Aviado-Langer, 2014).   
Lim and colleagues (2011) have found evidence that concluded that anxiety is a 
prominent concern enveloping the three main treatment modalities namely, 
surgery, chemotherapy and radiotherapy. Despite similarities, each treatment 
modality contributed to anxiety in different aspects. The evidence that these 
authors gathered disclosed that more than one form of anxiety can co-exist during 
chemotherapy. One example is acute anxiety, with the intensity measured to be 
the highest before the beginning of the first dose of chemotherapy. Anticipation 
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anxiety is another form of anxiety where the patient anticipates the side-effects of 
the chemotherapy.  Cancer patients who anticipate more negative effects from 
chemotherapy consequently experience a higher level of anxiety. When 
measuring the effect of radiotherapy on the anxiety level, Lim and colleagues 
(2011) found that radiotherapy did not seem to affect breast cancer patients’ 
general level of everyday anxiety. In view of the detrimental effects of anxiety and 
the growing number of female patients with breast cancer, the need to address the 
issue of anxiety among these patients is warranted (Lim et al., 2011).  Findings in 
a study done by Hill and co-workers (2010) highlighted the vulnerability of women 
with former episodes of depression and anxiety to develop further mental health 
issues during the year after diagnosis of breast cancer.   
2.2.5.2.3  Post traumatic stress disorder (PTSD)    
According to the DSM-5 (2013) PTSD is categorised as exposure to actual or 
threatened death, serious injury or sexual violence, directly experiencing the 
traumatic events. Symptoms associated with PTSD are recurrent, involuntary and 
intrusive distressing memories, flashbacks and/or dreams of the traumatic event.  
It also includes intense or prolonged psychological distress at exposure to internal 
or external cues that symbolise an aspect of the traumatic event or avoidance of 
stimuli associated with it. The duration of the disturbance must be more than a 
month and must cause clinically significant impairment in social, occupation or 
other important areas of functioning.   
Psychological trauma is caused by occurrences or experiences which are sudden 
and unexpected in which the person perceives a dramatic loss of personal control 
and personal safety. This definition has clear resonance with the experience of 
cancer where the patient is indeed being confronted with the implications of a life-
threatening illness and is included in the DSM-IV as a possible traumatic stressor 
and the cause of posttraumatic stress symptoms (Ang, 2011; Brennen, 2001).  
The cancer experience is adequately traumatic to induce PTSD in a minority of 
cancer survivors. Post-hoc analyses suggest that cancer patients, who are 
younger, diagnosed with more advanced breast cancer and recently completed 
treatment may be at greater risk of PTSD, but more research is needed to 
investigate vulnerability factors for PTSD in cancer survivors (Abbey, Thompson, 
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Hickish, & Heathcote, 2015).  The diagnosis and treatment of cancer may lead to 
a persistence of such symptoms, without leading to the full syndrome of post-
traumatic stress disorder (Brennen, 2001; Dolbeault, 2009). Recently, cancer has 
been regarded as a traumatic event and DSM-IV has conceived life threatening 
illnesses as stressors that could elicit a post-traumatic stress disorder (Ruini & 
Albieri, 2013). Post-traumatic stress disorder has been progressively diagnosed as 
an additional morbidity among cancer patients. A study done by Mehnert and 
Koch (2007) has disclosed that the prevalence of cancer-related PTSD ranged 
from 0% to 32% and literature  indicates that a high number of patients, up to 
80%, are likely to encounter individual PTSD symptoms following cancer 
(Brennen, 2001; Dolbeault, 2009; Mehnert & Koch, 2007; Ruini & Albieri, 2013).   
Breast cancer patients recurrently report future orientated fears, but seldom 
flashbacks and potential arousal symptoms might interfere with cancer- or 
treatment-related somatic symptoms, such as sleep disturbance or irritability 
(Mehnert & Koch, 2007). Post-traumatic stress symptoms were associated with 
depression, anxiety, distress and physical quality of life (Shand, Cowlishaw, 
Brooker, Burney, & Ricciardelli, 2015). In contrast to some literature (Brennen, 
2001; Dolbeault, 2009; Mehnert & Koch, 2007; Ruini & Albieri, 2013) the DSM-5 
states that a life threatening illness of debilitating medical condition is not 
necessarily considered a traumatic event.  
It is sufficient for the benefit of this study to describe and define the three lead 
psychiatric disorders that correlate with breast cancer and breast cancer 
treatment: Major Depression, General Anxiety and Post Traumatic Stress 
Disorder. Although a breast cancer patient can present with other mood disorders 
in different degrees of seriousness, the above mentioned disorders are the most 
challenging in terms of diagnosis and treatment for the patient as well as the 
oncology team.   
2.2.5.2.4  Cancer and sexuality 
All current cancer treatments for breast cancer can cause changes in the female 
body that abruptly affects sexual desire, sexual functioning and emotional 
relationships (Fobair & Spiegel, 2009; Kaplan, 1992; Sbitti et al., 2011). In spite of 
these sexual impairments caused by cancer treatments, it has been largely 
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neglected by oncology teams (Kaplan, 1992).  It is important for health care 
professionals to be conscious of problems related to sexual intimacy and sexual 
functioning during cancer and cancer treatment and to be prepared to offer 
information about these aspects and also reflect on their patient’s expectations 
versus the reality (Fallbjork, Birgit, Rasmusssen, Karlsson & Salander, 2013).    
 Sex and sexuality 
Sex and sexuality is an integral part of normal life for most individuals and is an 
important aspect of quality of life. Sexuality can be defined as a personal 
expression of how a person feels about herself and her body and her relationship 
with her partner and is in essence central to a person’s sense of wellness and self-
concept (Sheppard & Ely, 2008). Sexuality is not a concept that can be regarded 
as separated from that of health and is interrelated with a woman’s need for 
caring, touch, intimacy and communication of sexual needs and the capability to 
engage in satisfying sexual activities. Attitudes about sexuality affect a woman’s 
enthusiasm and passion for living, self-image and relationship with others (Sbitti et 
al., 2011). In contrast with sexuality, sexual functioning (sex) refers to the sexual 
act or activity that is also known as intercourse that implicates functioning such as 
vaginal lubrication, breast sensitivity and penetration (Cancer Society, 2013).   
Research has documented an array of physical changes to a woman’s sexuality 
after breast cancer including disturbances to sexual functioning, disruptions to 
sexual arousal, lubrication, orgasm, sexual desire and sexual pleasure. These can 
all be side-effects of chemotherapy, chemically induced menopause, Tamoxifen 
and breast cancer surgery (Emilee et al., 2010; Hummel et al., 2015; Kuo et al., 
2008; Reese et al., 2010). These research results were confirmed by Sbitti and 
colleagues (2011) where they found that although changes in the breast may not 
necessarily restrict a women’s physical ability to have sexual intercourse, it is 
greatly associated with sexual well-being, body image and feminine identification. 
In their study the participants reported worse sexual functioning during cancer 
treatment, characterized by greater lack of sexual interest, inability to relax and 
enjoy sex, difficulty becoming aroused, and reaching an orgasm. Sexuality can be 
affected either emotionally through related stress, anxiety or depression, or 
through biological changes due to treatment side-effects.   
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 Hormones and sex  
The hormones that contribute to sexual desire are termed oestrogen and 
androgen. Oestrogen is a female steroid hormone that is produced by the ovaries 
and helps control and guide sexual development. Oestrogen is the major hormone 
in sexual functioning, playing a vital role in arousal, peripheral sexual response 
and pelvic sexual response (Kuo et al., 2008). Oestrogen deficiency can lead to 
lack of menstruation (amenorrhea), vaginal dryness, pain during vaginal 
penetration and dyspareunia, menopause and osteoporosis in older age. 
Oestrogen helps keep the vagina moist and flexible and facilitates change when 
sexually aroused.  During the process of arousal the vagina gets longer and wider 
and the cells lining the vagina produce and discharge droplets of fluid that makes 
the vagina moist.  Without oestrogen the vaginal lining thins, its walls lose some of 
their ability to stretch and will stay tight and dry even when sexually excited, which 
is called vaginal atrophy (American Cancer Society, 2013; Derzko, Elliott, & Lam, 
2007). 
Androgens are called "male hormones," and although it is the male sex hormone, 
it is also natural to the female body and is produced in the ovaries, adrenal glands 
and other tissues. Androgens plays a key role in the prevention of bone loss, as 
well as sexual desire and satisfaction and low androgen levels in women are 
linked to decreased sexual desire (low libido), genital sensation and genital 
response that can cause lethargy and loss of sexual interest (American Cancer 
Society, 2013; Derzko et al., 2007).    
 Sexual response cycle for woman 
Nusbaum and colleagues (2003) categorize sexual response into five stages:  
desire, arousal, plateau, orgasm and resolution that are schooled on the stages of 
sexual response of Masters and Johnson (1966) and Kaplan (1979).     
 Desire - The first phase of the sexual response cycle involves generating a 
desire and includes physiologic factors such as neurotransmitters, 
androgens and the sensory system and a wide variety of environmental 
stimuli, such as psychosocial and cultural factors. Desire causes a person 
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to initiate or be receptive to sexual activity (Georgiadis & Kringelbach, 2012; 
Nusbaum et al., 2003).  
  Arousal - involves the parasympathetic nervous system and vascular 
system e.g. breathing becomes heavier, heart rate and blood pressure 
increase and reflective vasocongestion occurs which includes vaginal 
lubrication and enlargement of the clitoris (Nusbaum et al., 2003).   
 Plateau - includes the parasympathetic nervous system and vascular 
system. Vasocongestion phase (vasocongestion refers to the swelling of 
genital tissues with blood) is at its peak where sexual tension increases and 
then levels off immediately before orgasms with carpo-pedal spasms, 
generalized skeletal muscular tension, hyperventilation, tachycardia and 
increased blood pressure (Nusbaum et al., 2003). 
 Orgasm - includes the sympathetic nervous system and muscle tone. It will 
cause heightened excitement to a peaking of subjective pleasure followed 
by release of sexual tension, pelvic response consists of involuntary 
contractions and myotonia (tension may be seen in the neck and face, 
buttocks, thighs), carpopedal spasms, contractions of arms and legs, 
external rectal sphincter contractions, external urethral sphincter 
contractions, hyperventilation, tachycardia and increased blood pressure 
(Georgiadis & Kringelbach, 2012; Nusbaum et al., 2003).   
 Resolution - involves the sympathetic nervous system. The body now 
returns to pre-excitement phase as vasocongestion is relieved and 
hyperventilation and tachycardia decrease. (Nusbaum et al., 2003).  
 
 Female sexual dysfunction 
The Female sexual dysfunction is multi-factorial and refers to a lack of healthy and 
normal sexual response and interest. Contributing factors of this dysfunction can 
be psychological, biological, interpersonal or contextual (Bredart et al., 2011; 
Derzko et al., 2007). Sexual functioning is progressively understood as a truly bio- 
psycho-social phenomenon. A healthy sexual response depends on the 
neurologic, vascular and endocrine systems and is influenced by numerous 
psycho-social factors including certain personal and interpersonal factors. It is 
subject to modifications by illness, disability and the aging process itself. Because 
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of the multifaceted nature of sexual dysfunctions, collaboration and cooperation 
between all health care providers (multi-disciplinary team) is essential to ensure 
that the patient’s quality of life remains as important as her prognosis (Hughes, 
Hertlein, & Hagey, 2011; Kuo et al., 2008; Nusbaum et al., 2003; Speer et al., 
2005). 
Sexual dysfunction is a complex disorder which is a subject that requires thorough 
exploration to understand its etiology. According to Dean (2008) human sexuality 
has both physical and emotional elements which can be difficult to separate.  
Sexual dysfunction can either represent a primary physiological or psychological 
disorder (e.g. depression) or a secondary disturbance associated with the 
presence of a general medical condition (cancer) or the use of a substance or 
medication (psychotropic medications) (Krychman & Katz, 2012; Rivas-Vazquez, 
Blais, Rey, & Rivas-Vazquez, 2000). Dean (2008) used the example of a low libido 
which could be caused both by a physical change in menopausal status and an 
emotional change in mood. Sexual problems caused by the diagnosis and 
treatment of breast cancer can be a complex side effect to manage.    
A breast cancer patient may become disinterested in sex and become sexually 
inactive during her treatment or at least for some time during her treatment.  
Immediately after a cancer diagnosis, anxiety and worry about survival is so 
immense and issues of mortality all consuming, that sex is not necessarily an 
immediate priority. This is a normal reaction and state of mind, but once a woman 
gets back to her normal routines, her interest in sex may return (American Cancer 
Society, 2010; Katz, 2005; Taylor, Harley, Ziegler, Brown, & Velikova, 2011). 
Bearing this in mind, Reece and colleagues (2010) underline the fact that even 
during treatments such as chemotherapy and hormonal therapy, the patient and 
her partner can still have intimacy and sexual needs and that maintaining sexual 
activity can be a sign of overall wellbeing as well as the ability to cope with the 
cancer and its treatment. 
Apart from the possibility to develop a mood disorder it is widely recognised that 
breast cancer has a direct effect on sexual functioning and many women 
experience sexual problems as a result of breast cancer and cancer treatment.  
The impact of these changes can last for many years after successful treatment 
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and can be associated with critical physical and emotional effects (Emilee et al., 
2010; Katz, 2005; Reese et al., 2010; Taylor et al., 2011). In more recent studies a 
relatively large percentage of the breast cancer participants (between 30% and 
100%) have presented with sexual complaints and dysfunction as a consequence 
of their disease and its treatment (Hummel et al., 2015; Kuo et al., 2008; Murray, 
2010; Park et al., 2009). In a study done by Bredart and colleagues (2011) a 
substantial number of breast cancer survivors have experienced sexual problems, 
especially a decrease in libido, dyspareunia and an inability to achieve orgasm in 
the period between six months and five years after completion of treatment.  
Contrary to that finding, Fobair and co-workers (2006) have found that especially 
in the first year after diagnosis, body-image problems and sexuality were at its 
worse. Where levels of emotional distress tend to be higher in the first few months 
after a cancer diagnosis, especially the fear of death, sexual problems on the 
other hand has been shown to worsen beyond the first year after diagnosis and 
breast surgery, indicating that maladaptive patterns concerning body image and 
sexuality are inclined to enhance with time. Because of the seriousness of sexual 
problems in this cancer population, it justifies early detection and intervention.  
Although sexual functioning is an important health issue, there is often a lack of 
recognition that it is a problem. Because cure and management of the disease are 
primarily the main targets in the mind of the oncologist, sexual functioning is often 
neglected and unaddressed. Health care professionals may feel hesitant to ask 
their breast cancer patient about her sexual functioning during medical 
consultations due to time limits, embarrassment or lack of knowledge and 
experience in this area (Kuo et al., 2008; Park et al., 2009; Reece et al., 2010).   
Cancer patients, on the other hand, may also feel reluctant to raise their sexual 
issues with their cancer specialist because of the limited opportunity to do so, yet 
there is evidence that many cancer patients would be keen to discuss issues of 
their sexuality related to their cancer treatment with their health providers 
(American Cancer Society, 2013; Hummel et al., 2015; Kuo et al., 2008; Park et 
al., 2009; Reece et al., 2010). Because of this tendency, Speer and colleagues 
(2005) feel strongly that psychological sexual assessment should be included in 
the oncology physicians’ standard assessment protocol and treatment. There is a 
growing recognition regarding the limitations in which sexual concerns are 
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presently being addressed in the breast cancer population which is now ripe for 
studies of psycho-social interventions as an addition to pharmacologic treatments 
(Krychman & Katz, 2012).   
The four diagnostic groups within female sexual disorders and the most frequent 
sexual problems or dysfunctions related to breast cancer and breast cancer 
treatment are:  
(a) Hypoactive sexual desire disorder,  
(b) Female sexual arousal disorder,  
(c) Sexual pain disorder, and  
(d) Orgasmic disorder (Bredart et al., 2011; Derzko, et al., 2007; Speer et al., 
2005). 
 These disorders can lead to loss of sexual satisfaction, causing disappointment 
and frustration within the couple which then can lead to reduced sexual activity. 
General emotional welfare and the quality of the relationship with the partner can 
be affected by the degree of distress caused within the couple due to a diagnosis 
of breast cancer. According to Bredart and colleagues (2011) younger couples are 
more susceptible to relationship tension which consequently can lead to emotional 
separation (Bredart et al., 2011).   
Factors underlying female sexual dysfunction:   
 Biological factors, such as aging and menopause, endocrine changes, 
illness or disability, surgical interventions and some prescription 
medications can alter a person’s sexual functioning.  Cancer does not have 
to involve sexual organs to affect sexual functioning.   
 Psychological distresses have a profound effect on sexuality, including 
psychiatric conditions (e.g. depression or anxiety), sexual confidence 
influenced by emotions and low self-esteem, performance anxiety, low 
quality of life, irrational thought patterns, interpersonal conflict and lack of 
sexual desire (Laumann, Paik, Raymond & Rosen, 1999; Graziottin & 
Leiblum, 2005).   
1.  Hypoactive sexual desire disorder (HSDD) 
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Sexual desire, also referred to as libido (biologically driven urge) implicates 
fantasies regarding sexual activity and desire to engage in activity (Derzko et al., 
2007; Rivas-Vazquez et al., 2000). Absent or low sexual interest is not intrinsically 
pathological, but may become problematic in the context of inter-partner sexual 
desire discrepancy (ter Kuile, Both, & van Lankveld, 2010). Hypoactive sexual 
desire disorder is characterised by an absence or lack of sexual fantasies and 
desire for sexual activity causing emotional distress or interpersonal difficulties 
and can be caused by the effects of a psychiatric disorder, e.g. major depression 
or anxiety, pathology (as in an illness or disease, such as breast cancer) or 
treatment modalities, including chemotherapy and medication (Kaplan, 1979; 
Mimoun, 2011).    
Symptoms of HSDD are:   
 An absent desire before sexual activity.  
 Desire is not triggered during sexual experiences. 
 Distressed feelings about the problem.   
During cancer treatment a lessened sexual desire or lack of libido is a common 
problem and may be caused by treatment side-effects such as nausea, pain and 
fatigue, or hormone treatments that can interrupt the normal hormone balance.  
Disturbing and anxious thoughts can distract a woman from getting aroused, 
resulting in a tight and dry vagina which can make intercourse painful and difficult. 
Psychological side-effects of cancer treatment such as anxiety and depression 
can also affect sexual desire (American Cancer Society, 2010, Mimoun, 2011; 
Strasser et al., 2006). Low sexual desire can be associated with decreased 
functioning in other aspects of sexual response and can cause physical and 
emotional dissatisfaction, disappointment and frustration in a woman’s sex life and 
relationship (Dennerstein, Koochaki, Barton, & Graziottin, 2006; Fobair et al., 
2006). Menopausal status is important to sexual desire and sexual arousal. 
Studies have shown that cancer patients who had surgical and cancer related 
treatment induced menopause are at a greater risk for decreased sexual desire 
compared with premenopausal or naturally menopausal women (Graziottin & 
Leiblum, Koochaki, Rodenberg, Barton, & Rosen, 2006; Dennerstein et al., 2006). 
Because of the high incidence of depression in breast cancer patients, this is a 
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population which are often high consumers of anti-depressants that have a direct 
influence on sexual desire (Basson & Schultz, 2007; Meier, 2010; Reyes-Gibby et 
al., 2012; Rivas-Vazquez et al., 2000).  
2.  Sexual pain disorders   
Cancer survivors may experience sexual pain disorders that include difficulties 
allowing vaginal entry called dyspareunia and vaginismus. Dyspareunia is a 
persistent or recurrent pain during sexual activity that is associated with attempted 
vaginal entry, or penile vaginal intercourse. Pain is a common result of radiation 
therapy, menopause or adjuvant treatment that affects a woman’s hormones and 
is often related to changes in the vagina’s size or moistness (Murray, 2010; 
Roland et al., 2010, Ter Kuile, et al., 2010). Sexual pain can set of a problem 
called vaginismus which is a persistent or recurrent difficulty to allow vaginal entry 
of a penis, a finger or any object because the muscle around the opening of the 
vagina become tense despite the women’s expressed wish to do so. Vaginismus 
can become a phobic avoidance in anticipation of pain (American Cancer Society, 
2010; Murray, 2010). Pain can lead to avoidance of any form of intimacy and fear 
of intercourse (Murray, 2010).    
3.  Orgasmic dysfunction 
Orgasmic dysfunction characterizes the inability to achieve an orgasm, markedly 
diminished intensity of orgasmic sensations, or an obvious delay of orgasm during 
any kind of sexual stimulation (Lewis et al., 2010; Ter Kuile et al., 2010). Most 
women are normally able to have orgasms after cancer unless the cancer or 
treatment has harmed the spinal cord and caused the genital area to be numb.  
Pain during intercourse, which are often the case with breast cancer patients may 
be a distracting factor from reaching an orgasm (Lewis et al., 2010). Anti-
depressants, especially SSRIs can biologically incapacitate the orgasm stage of 
sexual functioning (Rivas-Vazquez et al., 2000) and it will benefit the patient to be 
informed of this side-effect of anti-depressants.     
4.  Sexual arousal disorders 
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Arousal is defined as the subjective sense of sexual pleasure and accompanying 
physiological changes which means major changes consisting of vasocongestion 
in the pelvis, vaginal lubrication and expansion and swelling of the external 
genitalia (Rivas-Vazquez et al., 2000). Arousal dysfunction implies absence or 
impaired genital sexual arousal, which may include minimum swelling or vaginal 
lubrication from any type of sexual stimulation and reduced sexual sensation from 
direct stimulation of the genitalia (Lewis et al., 2010). Arousal problems may derive 
from inadequate physiological support to allow for appropriate vasocongestion, 
inadequate mental and/or physical sexual stimulation, or disrupting factors such as 
stress, pain and discomfort which can all be part of the breast cancer patients’ 
experience.   
 Menopause 
Menopause is the time in most women's lives when menstrual periods stop 
permanently (twelve consecutive months after the last menstrual period) and it 
also indicates the end of fertility and child bearing years (McKinlay, 1996). The 
end of the menstruation cycle is a universal experience among human females. It 
is not an abrupt occurrence, but a gradual process. The average age of natural 
menopause is 51 years. In Western countries during the past three decades 
menopause between 40 and 45 years is called early menopause and premature 
menopause or ovarian failure is defined as a cessation of menstruation before the 
age of 40. Premature menopause is an occurrence outside the normal life course 
and as such is likely to have a significant impact on the physical and emotional 
well-being of women. Premature and early menopause has an increased risk of 
cardiovascular disease, vasomotor symptoms, vaginal dryness, dyspareunia, 
weight gain, and osteoporosis (Brem & Kumar, 2011; Deeks, Gibson-Helm, 
Teede, & Vincent, 2011; Derzko et al., 2007; Ewertz & Jensen, 2011).   
For younger breast cancer patients, chemotherapy or ovarian ablation, (ovarian 
ablation is the medical term for prevention of the ovaries to produce oestrogen, 
either temporarily or permanently), may cause them to undergo earlier 
menopause. Symptoms of premature menopause, which is the same as 
menopause, are: hot flushes, palpitations, less bone density, urinary urgency, and 
short term memory loss, inability to concentrate, weight gain, mood swings, 
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reduced libido, painful intercourse and vaginal dryness. Younger women who 
experience a treatment-induced menopause may also have to cope with feelings 
around the loss of their fertility, which can affect their relationships both 
emotionally and sexually (Dean, 2008). Chemotherapy related amenorrhea can be 
temporary or permanent (Brem & Kumar, 2011). 
Cancer treatment can affect a woman’s sex life by causing premature and abrupt 
menopause, leading to reduced sexual desire in some women. When a breast 
cancer patient’s ovaries are removed as part of cancer surgery, or when the 
ovaries are affected by chemotherapy or radiation to the pelvis, the loss of 
oestrogen can trigger vaginal changes such as vaginal atrophy (where the vagina 
becomes tight and dry) and hot flushes. The physical symptoms of premature 
menopause are likely to be more severe compared to those of women who 
experience a natural menopause at midlife, and this in turns reduces overall 
quality of life (Deeks et al., 2011; Meier, 2010; Hummel et al., 2015). Women who 
have premature menopause can also have low androgen levels, which can be 
linked to lower sexual desire. As appose to sudden and unexpected menopause, 
healthy woman who experience age related physiological changes due to low 
oestrogen, experience the changes gradually over a period of time with more time 
to adapt to the changes and fewer problems in sexual functioning (Fobair & 
Spiegel, 2009; Meier, 2010). 
Fears and uncertainties that accompany premature menopause are that of weight 
gain, loss of sexuality and decreased sexual function, infertility and loss of 
femininity.  Premature menopause is also associated with a higher incidence of 
depression and anxiety, grief and a negative body image (Deeks et al., 2011). 
Several studies have confirmed that breast cancer patients treated with 
chemotherapy experience vaginal dryness and early menopause resulting in less 
sexual activity with their partners. Vaginal dryness, especially, tends to be a 
physiological disappointment for women suffering from menopause, but is even 
more so for younger woman who is diagnosed with breast cancer during the most 
sexually active years of their lives (Fobair & Spiegel, 2009; Deeks et al., 2011). A 
study done by Fobair and Spiegel (2009) has showed that up to 50% of their study 
patients struggled with sexual problems that did not improve with time. It was also 
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found that breast cancer patients with premature menopause have reported a lack 
of information and support in this area from their oncology team (Deeks et al., 
2011).    
Breast cancer patients of all ages who have hormone-sensitive breast cancer will 
generally be treated by hormone therapy, which can include Tamoxifen and 
aromatase inhibitors. These treatments can cause menopausal-type side effects 
and are largely initiated by oestrogen deficiency (Dean, 2008; Derzko et al., 2007; 
Ewertz & Jensen, 2011; Hummel et al., 2015).  
 Body image 
In addition to the physical effects experienced as a result of breast cancer, there 
are prominent psychological affects in the form of body image concerns that can 
constrain sexual functioning in both partners (Dye, 2008). Body image is defined 
as the mental picture of one’s body, a mind-set about the physical self, 
appearance and health status, wholeness, normal functioning and sexuality. Body 
image is an element of a larger concept of self and that for woman means feeling 
feminine and attractive, enjoying one’s body as a symbol of social and sexual 
expression (Fobair, Steward, Chang, D’Onofrio, Banks, & Bloom, 2006). The way 
in which a woman experiences her body is highly subjective and is a result of her 
own observations, thoughts and feelings about her body size, competence and 
functioning. Fobair and colleagues (2006) have found that a better body image 
and higher levels of self-confidence results in better coping with breast cancer. 
According to these authors, negative perceptions of body image amongst breast 
cancer survivors comprise dissatisfaction and unhappiness with physical 
appearance, perceived loss of femininity and body integrity, reluctance to look at 
one naked, feeling sexually unattractive and self-conscious about surgical scars 
and appearance.   
Loss of a breast, surgical scarring, alopecia, weight changes and lymphedema are 
all sequelae that can impair quality of life in general and body image in particular 
in women with breast cancer, especially younger women (Katz, 2005; Rosenberg 
et al., 2012). Alopecia, which ranks among the most feared effects of 
chemotherapy, is similar to a loss of self or identity (Kuo et al., 2008). 
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Chemotherapy may also cause weight gain as may the use of hormonal therapies 
such as Tamoxifen, which can alter the body image even further, leading to 
negative feelings about their appearance (Dean, 2008).  
Nozawa and co-workers (2013) found in their study that there were as many as 
80% of their study patients concerned about the alterations in their appearance 
rising as a result of cancer therapy. These authors have found that the female 
patients felt greater distress than the male patients with regard to symptoms that 
affected their appearance and they were more aware of their appearance. It was 
evident that physical appearance can influence a persons’ sense of self. 
According to Derzko and colleagues (2007) the cancer patients who are the most 
vulnerable to both body image and sexuality are the patients with advanced breast 
cancer and in those who need adjuvant treatment, patients who have 
lymphedema, are inactive, have poor family and social supports, or are single or in 
an unstable relationship.     
Breasts, apart from having a feeding function, are often thought of as a symbol of 
womanhood and sexual attractiveness and are seen as a source of erotic pleasure 
and stimulation.  The breast is related with a woman’s femininity, maternal role, 
sexuality and intimacy. Breast cancer and cancer treatment, either surgical or 
adjuvant can result in a traumatic experience due to the loss of femininity, a 
healthy body, self-image, sexuality or even intimate relationships, especially for 
younger and sexually active women (Hummel et al., 2015; Kalaitzi, Papadopoulos, 
Vlasis, Skandalakis, & Pilippou, 2007; Katz, 2005; Lueboonthavatchai, 2007; Sbitti 
et al., 2013; Taylor et al., 2011). Although some evidence suggests that sexual 
problems connecting to surgery may improve over time, some patients might still 
need additional psychological support following surgery to help them adjust. While 
self-esteem and body image are already affected by breast surgery, it may be 
further compromised by the development of lymphedema that can occur after 
axillary surgery or radiotherapy (Dean, 2008).   
Some breast cancer patients report a dislike for being touched in the breast area 
after a mastectomy or lumpectomy because of pain or tenderness. Disfigurement 
and pain associated with mastectomy and radiation can cause concern about 
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sexual attractiveness and femininity and affect women’s ability to see themselves 
as sexual beings (Hummel et al., 2015).  
Apart from a lumpectomy and mastectomy, which have been associated with 
changes in sexuality due to significant changes in body image and self-esteem, 
radiotherapy also includes changes that affect sensitivity of the breast. These 
changes can result in thickening and scarring of connective tissue (fibrosis), or 
changes in skin texture and colour, and sometimes even mastalgia (breast pain), 
any of which can affect a women’s perception of herself and desire or ability to 
enjoy sexual functioning (Kuo et al., 2008). Breast cancer patients who had breast 
conserving surgery have fewer body image concerns in comparison with breast 
cancer patients who underwent more radical surgery. It seems that   
reconstructive surgery appears to alleviate the impact on the sexual body image to 
some degree, at least for the short-term.  
2.2.6  Summary 
Interpreting the literature concerning breast cancer, it is conclusive to presume 
that cancer, specifically breast cancer, and breast cancer treatments, have a 
devastating effect on the patient and the patient’s family. In spite of high-quality 
progress in the last decade in detecting breast cancer and cancer treatments, 
especially chemotherapy, the effect of this disease is still traumatic. These 
traumatic effects can be categorised in the physical, emotional and sexual well-
being of the breast cancer patient, with emphasis on mood and sexual 
dysfunctions. While some of the effects can be temporary, many of the signs and 
symptoms can last for many years after successful completion of the treatment.  
Although the diagnosis of breast cancer can occur over a wide variety of age 
groups, the biggest incidence is after 50 years with the most devastating impact 
on the younger population. A younger age group is also the breast cancer 
population where more research is necessary to understand their specific needs. 
In order to assist and support the breast cancer patient and her family throughout 
the duration of her illness and even thereafter, it is crucial to identify and 
understand the psychopathology of breast cancer and its treatment.   
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CHAPTER III 
PSYCHO-ONCOLOGY– A THEORETIC OVERVIEW 
 
“The art of oncology is when the tumour is not the target” (Vickers, et al., 2005. 
p4013).   
 
3.1  INTRODUCTION 
In the past, psychological and social issues in cancer were not the subject of 
scientific inquiry. This lasted until the last two decades where the concept of 
holism has been the guiding framework for recent recognition of the importance of 
complete and inclusive cancer care (Nicolas, 2013). In his paper, Miles (2009) 
wrote that it is often said that, until it is possible for clinicians to always cure or 
ameliorate (to heal or to make something better) completely, it is their “reasonable 
responsibility” to offer comfort of genuine human empathy. Such reasoning seems 
to assume that comforting is a substitute for curing when curing is not possible 
and that in reality, curing should never be separated from comforting and caring. 
Otherwise medicine becomes nothing more than the application of technical 
procedures or the administration of medications outside of the context of the 
necessarily human encounter.  
It is the task of the oncology team, especially the psychological services, to 
incorporate and treat the human side of the tumour and to be able to 
accommodate the biological features together with the psychological aspects of 
the cancer patient. It is imperative that the cancer patient always feel understood 
and valued as a human being and be treated throughout the whole trajectory of 
the cancer experience with empathy and dignity (Miles, 2009).     
Cancer is the first field of medicine where psycho-social factors have been taken 
seriously. One of the reasons for considering psycho-social factors was the 
potency of cytotoxic drugs and the severity and continuity of its adverse effects 
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both emotionally and biologically on the cancer patient. This chronicity and often 
permanency of cancer-related side-effects have led to more interest and research 
in the quality of life of the cancer patient and to balance this with improvements in 
longevity of life.  Cancer, more than any other disease, confronts a person with 
serious existential issues. It challenges the sense of control over life and raises 
questions of worthlessness and futility of life as well as what is seen as a good life 
and a good death (Clarke, 2010). Arising from this, it became impossible to 
maintain only the biological element of cancer, ignoring the psychological and 
social elements.   
Although the occurrence of distress among cancer patients and serious adverse 
impact on patient welfare and quality of life had been well documented, it still has 
not been given the attention it warranted by both medical physicians and 
advocates for advancements in clinical cancer practise (Breibart et al., 2013).  
According to these authors, approximately 40% of cancer patients and family 
members experience levels of psychological distress that require specific 
intervention. But of the 28 million people worldwide with cancer (as well as their 
family members), only a minority of those in need receive suitable psycho-social 
cancer care by trained professionals. This results in widespread and unnecessary 
suffering. Because of this worldwide tendency and the rising numbers of cancer 
survivors, there is an urgent need for further development and implementing of the 
psychological part of cancer care.   
To comprehend the paradigm of psycho-oncology, a theoretical framework was 
attained from Engel’s humanistic or psychological model (caring) and Pasteur’s 
biomedical model (curing). These two models form the basis and approach of this 
study and the reader needs an understanding of the development of these two 
models and where the terminology (psycho-oncology) originates from (Borrell-
Carrió, Suchman, & Epstein, 2004).  
3.2  THE BIO-MEDICAL MODEL 
Up to the 70s the bio-medical model was the only accepted scientific model 
regarding medicine in the world with very little regard for the human side of any 
disease.   
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3.2.1  History and development of the bio-medical model 
The bio-medical model, that has been the dominant force in western medicine, 
was largely schooled on Louis Pasteur’s (1822-1895) germ theory of diseases. 
This model proposed that all diseases are a product of a biological defect, initiated 
by a biologic pathogen. This model is reductionist (reductionism is a procedure or 
theory that reduces complex data and phenomena to simple terms), seeking to 
explain all disease in biological terms. It is also exclusionary, since any symptom 
that cannot be explained in biological terms, are excluded from consideration. This 
theory has led to mind-body dualism in which mental disorders were often 
excluded from the primary concerns of medicine unless they could be explained 
by an underlying somatic defect (Johnson, 2012).   
The western bio-medical paradigm has been effective over many centuries in 
delivering health care because infectious diseases, which were the challenge of 
the 19th and 20th centuries, accounted for most of the deaths. However, by the 
end of the 20th century, infectious diseases have given way to the occurrence of 
chronic disease such as heart disease, diabetes, cancer and strokes and life 
expectancy had grown from 47 years in 1900 to 77 in 2000 (Borrel-Carrio et al., 
2004; McHattie: Cumming & French, 2014). Unfortunately, the bio-medical model 
has limitations within its paradigm for the social, psychological and behavioural 
elements of illness and the predominance of this model were beginning to be 
challenged (McHattie et al., 2014).   
Miles (2012) explained the history and development of the bio-medical model into 
the bio-psycho-social model of health care by concluding that the rapidly 
accumulating psycho-neuro-immunological and genomic (genetics) research are 
generating a growing biological and empirical foundation for the functional 
interrelationship between the somatic, the psyche and the spiritual dimensions of 
man. According to Miles, medicine that remains fixated with the ‘biological body’ 
and which ignores (passively or actively) the status of the non-physical dimensions 
of the patient which impact the biological function, may therefore be considered 
incomplete as a true account of the human and his needs. Medicine has the 
irreversible obligation to care, to comfort and to console as well as to ameliorate, 
lessen, and cure. It is crucial that these two characteristics care and cure be kept 
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together and conserved. This must be done in functional integration rather than 
allowing them to drift apart as if they were polar counterparts or could function in 
any way as alternatives. The ability to successfully integrate these functions will 
improve and enhance medicine as a profession. This will not only facilitate care for 
the patient but also apply technical expertise in attending to the biological 
dysfunction of the illness. Miles (2012) emphasises that such an approach 
reconnects the science, humanism and ethics of medicine. It is in the combination 
of these three components that person-centred medicine is to be found.   
New paradigms like holistic-, humanistic- and narrative-evidence-based medicine 
and medical cosmology has been proposed. This was done continually as a 
manner to fight modern bio-technological reductionism and to put the person in all 
his or her dimensions at the centre of the therapeutic encounter (Miles 2009). For 
this very reason, the bio-psycho-social model of health care practice has been put 
forward as means of connecting the different disciplinary practice models of 
mental and physical health and relationships with service users and carers 
(Ghaemi, 2009; Vetere, 2007). 
Yet, in spite of the on-going struggle to integrate the human side with the pure 
biological side, (cure vs. care), Miles (2012) is quite outspoken in his paper about 
modern medicine. He feels it still places too much emphasis on the study of organ 
systems and the use in practice of objectively measurable biological indicators of 
dysfunction and disease. While, he said, there is no argument against the 
fundamental importance of such an approach, there is a point where such an 
emphasis becomes disproportionate in the sense that this so-called objectification 
of the somatic rejects the human dimension off illness and jeopardies reaching a 
point where the patient is seen as part of the disease, rather than the disease 
being seen as part of the patient. Miles said that Western medicine has ventured 
dangerously close to precisely such a point. He concluded by saying that medical 
knowledge of illness in purely biological terms without an understanding of the 
patient as a person, is ipso facto incomplete.   
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3.3  THE BIO-PSYCHO-SOCIAL MODEL 
In response to this challenge, George Engel (1913 to 1999) an American 
psychiatrist with psychoanalytic training proposed a new medical model during the 
70’s which offered a holistic alternative to the prevailing bio-medical model, 
namely the bio-psycho-social model. Unfortunately the U.S. health care remained 
rooted in the bio-medical model until recently. The aim of this new model was to 
develop and implement patient-centred care provided by interdisciplinary teams 
(Borrel-Carrio et al., 2004; Engel, 1989; Epstein, 2004; Ghaemi, 2009; Johnson, 
2004). Engel formulated this bio-psycho-social model as a dynamic, interactional, 
but dualistic interpretation of human experience in which there is mutual influence 
of body and mind (Borrel-Carrio et al., 2004).   
3.3.1  History and development of the bio-psycho-social model 
George Engel formulated the bio-psycho-social model as a dynamic, interactional 
and dualistic view of human understanding in which there is mutual influence of 
body and mind. He believed that to understand and respond effectively to patients’ 
distress and to give them a sense of being understood, clinicians must attend 
simultaneously to the biological, psychological, and social dimensions of illness. 
He offered a holistic alternative to the prevailing bio-medical model that had 
dominated industrialized societies since the mid-20th century. His new model 
came to be known as the bio-psycho-social model and was formulated at a time 
when science itself was developing from an exclusively analytic, reductionist, and 
specialised enterprise to become more contextual and cross-disciplinary. Engel 
did not deny that the conventional bio-medical research had promoted important 
advances in medicine, but he criticized its extremely narrow bio-medical focus for 
leading clinicians to regard patients as mere objects ignoring the possibility that 
the subjective experience of the patient was amendable to scientific study. In 
developing his bio-psycho-social model, Engel challenged three main components 
in bio-medical thinking that he believed were responsible for dehumanizing care 
(Borrel-Carrio et al., 2004; Engel, 1977).    
First, he criticized the dualistic nature of the bio-medical model which separates 
the body and mind only to focus on the disease to the exclusion of the individual 
who was suffering without connecting the two fields. He indicated a more 
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integrative view, emphasized the appearance of an illness resulting from the 
interaction of diverse causal factors, including those at the molecular, individual, 
and social levels (Borrel-Carrio et al., 2004; Engel, 1977).   
Second, Engel criticized the excessively materialistic and reductionist focus of 
medical thinking. According to these standards, anything that could not be 
objectively verified and explained at the level of cellular and molecular processes 
was ignored or devalued. The main focus of this criticism was that psycho-social 
variables play a more important role in susceptibility, severity and course of illness 
than were previously appreciated by those who maintain a bio-medical view of 
illness, leading to a cold, impersonal, technical and bio-medically-oriented style of 
clinical practice, neglecting the human dimension of suffering (Borrel-Carrio et al., 
2004; Engel, 1977).     
The third element was the influence of the observer on the observed. Unlike 
inanimate subjects of scientific scrutiny, patients are profoundly influenced by the 
way in which they are studied, and the scientists engaged in the study are 
influenced by their subjects. Engel understood that one cannot apprehend a 
system from the inside without disturbing it in some way, in other words, in the 
human dimension, as in the world of particle physics; one cannot accept a stance 
of pure objectivity. To that concern, Engel provided a rationale for including the 
human dimension of the physician and the patient as a legitimate focus for 
scientific study. Engel advocated his ideas not only as a scientific proposal, but as 
a fundamental ideology that tried to reverse the dehumanization of medicine and 
disempowerment of patients. His model brought a meaningful and hopeful element 
to those sectors of the medical profession that wished to bring more empathy and 
compassion into medical practice (Borrel-Carrio et al., 2004; Engel, 1977).     
The bio-psycho-social model is both a philosophy of clinical care and a practical 
clinical guide. Philosophically, it is a way of understanding how illness, disease 
and distress are influenced by multiple levels of organization.  These levels varied 
from the social to the molecular where on the practical side it is a way of 
understanding the patient’s subjective experience as an essential contributor to 
accurate diagnosis, health outcomes, and compassionate care (Borrell-Carrió, et 
al., 2004; Engel, 1977;).  
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In an article written by Borrel-Carrio and colleagues (2004) they defended and 
supported Engel’s bio-psycho-social model as a necessary contribution to a 
scientific clinical method and critically examine and revise three areas in which the 
bio-psycho-social model was offered as a “new medical paradigm”:  
(a) A world view that would include the patient’s subjective experience 
alongside objective bio-medical data. 
(b) A model of connection that would be more comprehensive and naturalistic 
than simple linear reductionist models.  
(c) A perspective on the patient-clinician relationship that would accord more 
power to the patient in the clinical process and transform the patient’s role 
from passive object of investigation to the subject and protagonist of the 
clinical act. This emphasised the need to change the clinician’s stance from 
objective detachment or reflective participation, infusing care with greater 
warmth and caring.   
Patient- and relationship- centred approaches propose that arriving at a correct 
bio-medical diagnosis is only part of the clinician’s task. It insists on interpreting 
illness and health from an intersubjective standpoint by giving the patient the 
freedom to articulate his or her concerns, asking about the patient’s expectations, 
and encouraging the health professional to show the patient some humanity. 
These approaches represent movement toward a more equal relationship in which 
the clinician is aware of and careful with his or her use of power (Borrel-Carrio et 
al., 2004; Steward, 2001). In conclusion, Borrel-Carrio and colleagues (2004) state 
that the value of the bio-psycho-social model has not been in the discovery of new 
scientific laws (as the term “new paradigm” would suggest) but more in guiding 
cautious application of medical knowledge to the needs of each patient. 
3.4  PSYCHO-ONCOLOGY 
3.4.1  Definition and description  
The word oncology comes from the Greek word ‘onkos’, which means a “mass”, 
"tumour" or "volume" (Barraclorgh, 1999). Oncology is the study of cancer and is a 
specialty practise. The field of oncology has three major areas namely medical, 
surgical and radiation. An oncologist is the medical specialist who treats cancer 
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and is the main health care provider for a cancer patient. The oncologist also gives 
supportive care and may coordinate treatment given by other specialists (Spiegel 
& Rodrigues, 2008). The word psycho comes from the Greek word ‘psyche’ which 
means the mind or soul. Psycho-oncology is a relatively new scientific discipline 
which combines the study of the biological- and psychological aspects associated 
with cancer and are involved with relationships between cancer and the mind.  
Psycho-social oncology is a similar term with an even broader implication that 
cancer concerns not just the individual patient, but their families, friends and 
colleagues and the society in which they live (Kidman & Edelman, 1997; 
Barraclorgh, 1999).  
Until the past two decades, psychological and social issues in oncology were 
never the subject of scientific inquest anywhere in the world, but since then, 
psycho-oncology as a new field has started to develop. Psycho-oncology recently 
has achieved subspecialty status with its own body of knowledge contributing to 
cancer care and operating as a multidisciplinary field involved with the 
psychological and social aspects of cancer care (Holland, 2002; Nicolas, 2013). 
Within the professional practice of psychology, psycho-oncology is defined as a 
subspecialty by the Commission for the Recognition of Specialties and 
Proficiencies in the Profession Psychology (2012) as cited in Nicolas (2013). In 
this classification, a subspecialty is a focused and narrow field of study within one 
or more of the recognized specialities. Psycho-oncology operating as a 
subspecialty generates its own set of clinical skills in counselling, behavioural and 
social interventions to oncology and provides training curricula which teach basic 
knowledge and skills in this specific area of oncology and psychology. 
Scientifically, psycho-oncology is creating a body of research and scholarly 
information about clinically relevant issues in the care of patients with cancer. 
Since it is increasingly recognized that psychological, social and behavioural 
variables influence treatment outcomes, attention to psycho-oncology will likely 
continue to increase (Holland 2004).     
Psycho-oncology can best be described as a discipline that helps cancer patients 
mobilize all of their resources to live psychologically healthy with cancer. It 
addresses two dimensions of cancer. First, the emotional responses of patients at 
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all stages of the disease, as well as their families and caretakers (psycho-social) 
and secondly, the psychological, social and behavioural factors that may influence 
cancer morbidity and mortality (psycho-biological) (Haber et al., 1995; Hollard, 
2002; Spiegel, 2012). Rodrigues (2008) sees psycho-oncology in the light of 
“where cure is unlikely, there can always be hope and spiritual support” (p28).   
3.4.2  History and development of psycho-oncology 
A historical perspective is important for understanding current patient-medical 
staff- and society’s responses towards cancer since attitudes, myths and beliefs of 
earlier centuries remain to influences present day perceptions (Holland, 2002, 
2004). Grassi (2013) emphasises the importance to recognize and understand 
these historical underpinnings because of their continuation to influence current 
thoughts and beliefs about cancer and its psychiatric comorbidity and 
psychosocial problems.   
Traditionally the diagnosis of cancer and its prognosis were hold back from 
patients for centuries due to the “stigma” and fears attached to cancer. In the 
1800’s, as in the preceding centuries, a cancer diagnosis was viewed as the 
equivalent of death for there was no cure for the disease. It was considered cruel 
and inhumane to reveal such a diagnosis to the patient because he/she would 
lose all hope and could cope better by not knowing. Since there was also no 
cause identified for the disease, shame and guilt were dominant emotions 
combined with the fear that cancer might be contagious (Holland & Weiss, 2010). 
This custom of keeping the diagnosis quiet prevented communicating with cancer 
patients about their feelings and experiences and how they were coping with the 
disease and the possible threat of death precluding any studies in that field. The 
stigma surrounding cancer was diminished only during the seventies to the point 
where the diagnosis could be revealed to the patient self and the thoughts and 
emotions of the cancer patient and his family could formally be studied. For the 
first time it was also possible to educate the public about cancer, cancer 
prevention and cancer treatment (Holland, 2004; Holland & Weiss, 2010). 
However, a second stigma around cancer has contributed to the delayed 
development of interest in the psychological dimensions of cancer, namely the 
prejudice about mental illness and psychological problems even in the context of a 
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medical illness such as cancer (Holland, 2004). Holland stated that patients still 
fear being labelled as ‘psychiatric’, or ‘psychological’ or ‘weak’ if they seek 
psychological help. To beat this obstacle, cancer patients should be able to 
consume psycho-social services in the oncology clinic and experience it as fully 
integrated into their total oncology care. The cancer patient must see the mental 
health professional as a member of the oncological team, with evaluations and 
clinical services given at the same medical location (if possible) where they 
receive their oncology treatment in order to reduce the barrier that comes from 
experiencing psycho-social services as separate and ‘different’ from their medical 
treatment.  
The formal scientific beginnings of psycho-oncology can be dated back to the work 
of Arthur, M. Sutherland (1910-1971) who was a true pioneer in the field of cancer 
and cancer care. He was an attending physician and psychiatrist and head of 
research psychiatry in the Department of Medicine at the Memorial Hospital in 
New York from 1949 to1961. This was the first formal psychiatric unit established 
in a cancer hospital (Holland, 2004). Sutherlands’ work was an epitome of total 
commitment and dedication to improve psychological care of cancer patients 
(Grassi, 2013; Sutherland, 1957). Sutherland had distanced himself from the 
psycho-somatic etiological hypothesis of cancer, instead advocating the theory 
that the psychology of the cancer patient is the psychology of any person under an 
unusual and severe form of stress during which many basic underlying emotionally 
charged beliefs based on the life history of the patient and his or her experiences, 
are brought to the surface (Grassi, 2013; Sutherland, 1957). Sutherland (1957) 
implied that each cancer patient must be considered as an individual with a 
specific type of cancer and that each patient must be handled in the light of his/her 
unique context, for every person must make her own adjustment to the 
circumstances of his/her particular kind of cancer and its treatment. To Sutherland, 
adjustment to cancer was never independent of concurrent life situations, but on 
the contrary, both life experiences and the patterns of adaptation fundamentally 
influence each other. In terms of family support and the cancer patient, Sutherland 
(1957) considered the importance regarding the background of the relationship 
between the patient and his or her family taking into consideration certain 
variables belonging to the family system, for example, the prior marital relationship 
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or reciprocal support and interrelation. Sutherland also examined the role of 
culture and ethnicity and the different meanings and values as a significant 
variable to assess when dealing with cancer patients who are in need of 
continuous care.   
Sutherland (1957) described the cancer patient as long-lasting, subjected always 
to the threat of recurrence, complications of altered anatomical sequelae, motional 
disturbances in herself and her family and to the prejudices of the ignorant. The 
cancer patient, in his view, needs on-going sympathetic contact even if it is at long 
intervals. Taking into consideration all of the above mentioned elements 
(psychological, family and culture) and the integration of these elements 
developed by Sutherland, it became the foundation for a holistic development and 
understanding of the cancer patient and her family. Sutherland made it very clear 
in his pioneer work that both science and compassion should be part of the same 
integrated approach to cancer and should be the core of psycho-oncology. 
Instrumental (cure) and affective (care) dimensions are complementary part of the 
oncology profession and without any one of the two, the integrity of the profession 
collapses (Grassi, 2013). 
Around the late 1970s, the behavioural medicine movement had begun to develop 
and brought an important group of researchers to the psycho-social aspects of 
cancer, mainly in Germany, the United Kingdom, Australia, Canada and the United 
States. Clinical and health psychologists have contributed new and valuable 
dimensions to this research, presenting theoretical models of coping and 
cognitive-behavioural models of psychological interventions. This development of 
theoretical models has been critically important for building on psycho-social and 
behavioural interventions in cancer care (Barry, Bultz & Johansen, 2011; Holland, 
2004).  
It is important to recognize that the development of psycho-oncology into a sub-
specialty in oncology and psychology has been the result of the efforts of several 
pioneers in the field (Holland, 2004). What makes it remarkable is that these 
pioneers of psycho-oncology came from around the world and represented 
different generations and sub-categories in medicine and psychology. The 
International Psycho-Oncology Society (IPOS) has formed the Sutherland 
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Memorial Award in the early 1980s which has been granted to nine 
developers/pioneers to honour their life-time contributions to psycho-oncology. I 
have summarised from the work of Holland (2004) the works and contributions of 
these nine men and women in order to understand where and how psycho-
oncology has developed. The dates in brackets are the year when they were 
granted the award:   
 Avery Weisman (1982): A professor in psychiatry in Massachusetts General 
Hospital was honoured for his early psycho-social studies in the 1960’s. His 
concepts of existential difficulty and coping mechanisms still remain 
revolutionary and inspirational today. In spite of his training in neurology, 
psychiatry and pathology, he has commented that nothing had prepared 
him for dealing with terminal ill patients. With his interest in the psycho-
social side of death, he embarked on a multifaceted quest of understanding 
how people live with the prospect of death which culminated in his book ‘On 
Dying and Denying: A Psychiatric Study of Terminality’ – 1972 (Holland, 
2004; Kastenbaum, 1993).   
 Bernard Fox (1984): PhD, statistician at the National Cancer Institute in the 
United Kingdom. Fox took a personal interest in the development of 
psycho-social oncology, its initial research and the problems of developing 
valid instruments of high quality. He edited the reports of the first meeting of 
psycho-social oncology researchers in 1975, and he continued to review 
research in this field with a critically constructive eye. He was also a 
founding member of IPOS.   
 Morton Bard (1987): PhD, social psychologist. Dr Bard was a graduate 
student with the Sutherland group at Memorial in the early 1950’s and his 
main interests were in institutional and attitudinal barriers to psycho-social 
care. He set a high standard for research in the psycho-oncology field and 
he later guided the Cancer Control Division of the American Cancer society 
in the 1991 (Holland, 2004).    
 Margit von Kerekjarto (1991): PhD, psychologist from Germany. She was 
one of the earliest researchers in the field of psycho-oncology. Dr 
Kerekjarto directed psycho-social research and clinical care in the 
department of psychological medicine at the University of Hamburg in the 
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1980s.  She was also a Founding Member and president of IPOS and 
played an instrumental part in its early development, especially in Europe. 
 Ned Cassem (1993): MD. Dr. Cassem practised as a psychiatrist and Jesuit 
priest, and has brought a significant contribution to the psychological and 
spiritual domains of palliative care. He founded the first hospital ethics 
committee in the United States which remains up till today a model.  
 Steve Greer (1996): MD. Dr. Greer was one of the early contributors to 
psycho-oncology, defining and measuring ‘fighting spirit’, and its role in 
coping and survival. He developed adjuvant psychotherapy as a cognitive-
behavioural evidence-based intervention. 
 Kawano Hiroomi (1998): MD. Dr. Kawano was a radiotherapist from Kobe in 
Japan. He had a strong and compassionate commitment to psycho-social 
and palliative care. As a Founding Member of IPOS, he continuously 
supported the society’s international works and was an invaluable leader. 
IPOS has honoured him for his early leadership in Japan by establishing 
the Kawano Young Investigator Award. 
 Robert Zittoun (2000): MD. Dr. Zittoun an oncologist in Paris was also a 
founding member of IPOS. He had hosted the first world congress of 
psycho-oncology in Beaune, France, which was the home of the first 
hospice. He had a strong positive influence on the development of psycho-
oncology in Europe and was involved in the first international symposium in 
1999.   
 Jimmy, C. Holland (2003): MD. She received the 9th Sutherland Memorial 
Award. She was at the first meeting on psycho-social issues in 1975 and 
was the founding president of the International Society in 1984 and of the 
American Psychosocial Oncology Society in 1986.    
Grassi (2013) summarises Sutherlands’ contribution to psycho-oncology by saying 
that Sutherland applied to oncology the patients’ personal experience of the 
disease and how this meaning may influence his or her behaviour towards the 
illness and interaction with others. Therefore, human life should be viewed as 
wholeness, demanding and deserving both the tough-mindedness of the scientist 
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and the compassion of the physician, integrating the cure and the care as 
inseparable quantities of the medical methodology.   
3.4.3  Challenges and obstacles in psycho-oncology 
The road of development in psycho-oncology was not without hurdles and 
difficulties. One of the earlier prominent obstacles in the development of psycho-
oncology was the fact that there were only a few assessment- and validated 
instruments and research methods in terms of the psychological and social side of 
cancer that were available to the bio-medical community (Holland, 2004). Over the 
last quarter of the 20th century, outstanding progress was made in developing 
validated, quantitative measurements for pain, anxiety, fatigue, major depression, 
multidimensional quality of life and spiritual beliefs. The international body of 
psycho-oncology encourages researchers to use central instruments so that 
comparison will be possible across studies. I have selected a few of the 
psychometric tests to describe here. These tests were standardised and validated 
specifically for cancer patients and are used worldwide in the psycho-oncology 
setup. Vodemaier and colleagues (2009) stated that brief but validated 
questionnaires would seem to be the tools of choice for routine screening of 
cancer patients’ emotional distress. They said that brief self-reports are easy to 
manage, inexpensive and can help identify patients most in need of professional 
mental health support. Examples of these tests are:   
(a) The BSI-18 is a self-report scale that was designed to assess clinically 
relevant psychological symptoms and demonstrated excellent reliability and 
validity in mixed samples of cancer patients.  
(b) The Zung Self-rating Depression Scale is a 20 item questionnaire that 
evaluates depression in cancer patients.  
(c) Another scale for depression and anxiety is the Hospital and Depression 
Scale (HADS) who was specifically developed for use with physically ill 
patients and is widely used to measure psychological morbidity in cancer 
patients (de Haes, van Knippenberg & Neijt, 1990; Vodermaier, Linden, & 
Siu,  2009).  
(d) The 21-item Psychosocial Screen for Cancer was developed to assess six 
domains: depressive symptoms, anxiety symptoms, quality of life (global), 
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and quality of life (number of days impaired), perceived social support, and 
social support desired (Vodemaier et al., 2009).  
(e) The Fatigue Symptom Inventory (FSI) was established as a valid and 
reliable measure of fatigue in cancer patients (Hann et al., 1998).  
(f) The Rotterdam Symptom Checklist (RSCL) was developed to monitor the 
quality of life of cancer patients and is also applicable for measuring the 
levels of the cancer patients’ anxiety and depression (Trew & Maguire, 
1982).  
(g) The Distress Thermometer (DT) which was validated by the National 
Comprehensive Cancer Network (NCCN) and the psycho-social distress 
practice guidelines panel and is a brief self-reporting screening tool that 
measures sources of distress and distress levels (Zwahlen, Hagenbuch, 
Carley, Recklitis & Buchi, 2008). 
Another research barrier was the fact that there were only a small number of 
clinicians and investigators involved in psycho-oncology world-wide. Because they 
came from different countries, disciplines and back grounds there was not a 
natural and clear shared body of knowledge (Holland, 2004). Because of this gap 
the International Psycho-Oncology Society (IPOS) was founded. Despite these 
obstacles, at the start of the third millennium, psycho-oncology has come of age 
as one of the youngest sub-specialties of oncology and as one of the most clearly 
defined sub-specialties of consultation-liaison psychiatry, representing an example 
of the value of a broad multidisciplinary application of the behavioural and social 
sciences (Dolbeault, Szporn, & Holland, 1999; Holland, 2002; Holland, & Weiss, 
2010; Suls & Rothman, 2004). Holland (2002) claims that over the next 25 years 
there will be a further improvement in the psycho-social care of patients based on 
research that gives a scientific basis for interventions and a reduction in the 
barriers to psycho-social care in cancer. Miles (2012) has asked the question if the 
integration of science and compassion in oncology has been reached after all 
these years. He asked whether there are any scientific data in psycho-oncology 
showing that both cure, in the sense of bio-medical intervention and care, in the 
sense of compassion, respect, and concern for the other, are now part of a whole 
approach to cancer. 
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3.4.4  The development of the international psycho-oncology society 
(IPOS) 
The International Psycho-Oncology Society (IPOS) was founded in 1984 to create 
a network for the small but active teams of multidisciplinary clinicians and 
researchers throughout the world and to assist engaging in clinical, educational 
and research aspects of psycho-oncology. One of the aims of IPOS is to serve as 
an organization for cross-cultural collaboration and international meetings where 
research could be presented. Founding members originated from seventeen 
countries, generating a rich international perspective to the field of psycho-
oncology (Holland, 2004). In parallel with IPOS, the British Psycho-Oncology 
Group (later BPOS) was first formed in 1983, while the American Psycho-
Oncology Society met annually in conjunction with the Academy of Psychosomatic 
Medicine, and eventually the First IPOS World Congress was chaired by Robert 
Zittoun in France in 1992. 
The standards of IPOS were conceived and endorsed at the IPOS World congress 
in Vienna in 2009 (Breibart et al., 2013). These two standards are:   
 Quality cancer care must integrate the psycho-social field into routine care.  
 Distress should be measured as the 6th vital sign after temperature, blood 
pressure, pulse, respiratory rate and pain.  Vital signs are measurements of 
the body’s most basic functions and The International Psycho-Oncology 
Society (IPOS) endorsed distress as the 6th vital sign in June 2009. 
(Breibart et al., 2013; Bultz & Johansen, 2011). 
To ensure universal acceptance and implementation of the IPOS standards, it will 
require training, funding and supporters and advocates at the individual country 
level, and a firm commitment from cancer care professionals and cancer care 
leadership from global authorities (Bultz, Cummings, Grassi, Travado, Hoekstra-
Weebers, & Watson, 2014). According to the very recent article by these authors, 
patients still do not always experience whole patient care due to the fact that 
providers not always embrace new approaches to care delivery because changing 
practice collides with values they hold about their current practise. The IPOS 
federations therefore aims to represent psycho-oncology societies worldwide and 
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create a plan/policy for promoting optimal psycho-social care at all stages of the 
disease and survivorship to all cancer patients and their families.   
A second aspect that guides this commitment of IPOS standards was the 
importance of cross-cultural aspects in psycho-social oncology. The different 
styles in which cultures approach communication and doctor-patient relationships, 
for example, disclosure of information related to diagnosis and prognosis and the 
roles of patients and family in the decision-making process, represents a major 
area related to psycho-oncology and cultural competence in psycho-oncology. It is 
imperative to understand the cultural variables affecting screening and 
assessment of psycho-social distress for unaddressed psychological and social 
needs implicate not just challenges for the patients and their families, but also 
strain the health care system and the community at large (Bultz et al., 2014).   
During the 14th world congress of IPOS in Brisbane, 2012 (Breibart et al., 2013) it 
was again underlined that cancer services and care should include both mental 
and physical health with the driving principle standard (which was borrowed from 
the World Health Organization’s 2001 report) that there is no health without mental 
health interrelated with the patients’ deposition to see them as a person and not 
their illness. The biggest task of IPOS during that time was to motivate the psycho-
oncology experts to enhance clinical care and practice by encouraging closer 
connections between psycho-oncologists and health practitioners, health policy 
makers and health authorities (Breibart et al., 2013). 
One of the major problems that were discussed at the 2013 President’s Plenary 
International Psycho-Oncology Society Meeting (that was held in Rotterdam, in the 
Netherlands) was the funding of psycho-oncology education which was a major 
problem for many members of the federation (Bultz et al., 2014). According to 
them there are inadequate university systems supportive of psycho-oncology, both 
in terms of training offered and opportunities for high level academic research. 
During this meeting their proposed recommendations included:  
 Psycho-social care should be integrated into cancer care.   
 Cancer patients’ distress and quality of life should be routinely screened for 
difficulties and needs.   
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 Communication skills training for health professionals should be 
incorporated into their health education.    
 Multidisciplinary treatment should be patient-centred.  
 Psycho-social care and services should be included in comprehensive 
treatment programmes. (Bultz et al., 2014).   
The IPOS Human Rights Task force was established in 2008 to promote 
awareness and assistance within IPOS and the IPOS Federation for the relevance 
of psycho-social cancer care as a human rights issue. This human rights issue 
could be advocated for internationally, through existing human right laws similar to 
the human rights initiative of the organized palliative care movement (Breitbart et 
al., 2013).   
In November 2014, at the World Congress of Psycho-Oncology in Lisbon, the 
IPOS Board authorized the Lisbon Declaration which states Cancer Care as a 
human right. In 2015, IPOS included this declaration to its international standards 
of quality in cancer care which includes the following:   
 Psycho-social cancer care should be recognized as a universal human 
right.   
 Quality cancer care must integrate the psychosocial field into routine care. 
 Distress should be measured as the sixth vital sign.   
This standard has been endorsed by 75 organizations worldwide and was 
classified in a revision of the World Cancer Declaration. Dr Travado, current head 
of psycho-oncology at Champalimaud cancer centre, Lisbon, said writing and 
approving a declaration is important, but it does not necessarily translate into 
easing the lives of actual patients with cancer, for the vast majority of them still 
suffer without significant help. He said that the majority of the work still lies ahead. 
He said although they have worked hard to influence national cancer policies to 
include psycho-social care and have succeeded in many countries, they need to 
continue to carry out this goal and take further steps to turn this standard into 
international global clinical practice word wide (Grassi et al., 2016).    
For the 17th World Congress of Psycho-Oncology, held in 2015 in Washington, 
DC, IPOS has partnered with the American Psychosocial Oncology Society 
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(APOS). The theme of the Congress was “From National to Global: Implementing 
the standard of psycho-social care in oncology” which defined the awareness that 
psycho-social care has become a recognized subspecialty of cancer in the United 
States and many other Western Countries. Unfortunately, this is not the case in 
many countries in the rest of the world, notably Africa and South America 
(Travado et al 2017). Grassi and colleagues (2016) gave an overview of the areas 
in the world where members of IPOS can be found: Africa (Psycho-oncology 
Society of Nigeria (POSON), North-America, South America, Europe, East Asia, 
Australia, New Zealand, and the Middle East.  According to Grassi and colleagues 
(2016) there are also countries that have societies in a developing phase, 
including the Irish Society of psyho-oncology, The Russian Society of psycho-
oncology, the psycho-oncology Society in Kenya and the Society of psycho-
oncology in South-Africa.    
3.4.5  Psycho-oncology in South Africa  
In spite of the evidence suggesting that bio-psycho-social care is the best way to 
treat cancer patients, in South-Africa the implementation of this strategy is lacking 
(Pillay, 2001; Venter, 2014). This aspect of the management of cancer patients, 
especially in the early stages of the diagnosis, is often either ignored or 
superficially handled (Pillay 2001). Manicom (2010) claims that in South-Africa 
there are only a few mental health professionals with a specific interest in cancer 
care with a few working exclusively in an oncology setting. Research in Africa has 
mainly focused on opioid availability and on the bio-medical aspects of cancer, 
presenting a preference for the assessment of physical symptoms but neglecting 
psycho-social aspects and holistic care of the cancer patient (Selman et al., 2011). 
Venter (2014) described in her work that a bibliometric analysis of research 
publications during 1994-2003 done by CANSA, found that the majority of the 
studies focussed on the bio-medical aspects of cancer with only 16% of studies 
during this timeframe was focused on psycho-social factors. This author feels that 
despite the need for a bio-psycho-social approach, there seems to be limited 
literature available on the psychological adjustment of cancer patients in South 
Africa.   
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For many years South Africa has not had an active National Cancer Registry, but 
according to Grassi and Watson (2012), this will change in the near future.   
Despite difficulties such as lack of access to essential drugs, poor social 
conditions and lack of trained palliative care professionals, it is internationally 
recognised that South-Africa has made sustained gains in the provision of 
palliative care largely through community-based hospices and home-based 
palliative care services (Selman et al., 2011). According to Grassi and Watson 
(2012) the health department in South Africa is working on a national cancer 
control plan where various stake-holders have been contacted regarding such a 
plan in which aspects of palliative care will be included, but it is not apparent when 
it will be implemented.  In a developing country such as South Africa, competing 
healthcare priorities, poor resources, cultural diversity, language barriers and the 
differential standards of treatment in the public and private healthcare sectors, 
challenge a psycho-social approach to cancer (Bateman, 2011; Pfaff, & Couper, 
2009; Pillay, 2002; Venter, 2014). Patient diversity in combination with staff 
shortages and a lack of necessary resources to deal with the demands of the 
oncology environment, results in a cancer care delivery system that does not 
reflect the new realities of cancer survival (Maree & Wright, 2008). 
Traditionally, cancer related psycho-social problems are addressed by 
psychologists, psychiatrists and/or social workers, but these services are not 
always available outside large hospitals and urban areas.  This might lead to the 
possibility of involving other more available professionals such as nurses (Venter, 
2014), and can result in uncertainty about roles and responsibilities and 
challenging well established territory between professionals (Arving & Holmström, 
2011).   
In summary: IPOS has recently advocated an international standard of quality 
cancer care, which declares that all cancer patients should have access to 
psycho-social care and that distress should be assessed as the sixth vital sign. It 
is a worthy goal for all psycho-social oncology societies to try to achieve, but in 
many countries, especially developing nations, psycho-social oncology is either 
not established or not completely established, or not an integral part of cancer 
care where basic care is sometimes not provided to cancer patients (Carlson & 
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Bultz, 2004; Grassi & Watson, 2012). The International Psycho-Oncology Society 
strives to achieve a global perspective, acknowledging that psychosocial issues 
and the potential for implementation vary broadly by culture, economics and health 
care systems (Holland, 2004). 
3.4.6  The development of clinical practise guidelines  
The field of psycho-oncology, over recent years, has seen the development of 
clinical practise guidelines for psycho-social cancer care in several countries 
(Bultz & Johansen, 2011). Clinical practise guidelines are progressively being 
developed in medical settings to provide evidence-based recommendations to 
guide the clinical care of patients. The development of clinical practice guidelines 
for psycho-social care of patients with medical illness is more complex and 
challenging as the target audience includes health care professionals from diverse 
backgrounds. According to Turner and colleagues (2005) clinical practice 
guidelines are in principle a summary of the best available scientific evidence that 
are presented in a format which is effective and practical to guide clinical decision-
making.   
The comprehensive cancer network who established a multidisciplinary panel to 
examine the problem of how to integrate psycho-social care into routine cancer 
care developed the first set of standards and clinical practice guidelines for 
psycho-social care in cancer in 1997 (Barry & Bultz, 2007). The panel included 
representatives from all the major disciplines involved in clinical care namely 
oncology, nursing, psychiatry psychology, chaplaincy, social work and patient 
advocacy (Barry & Bultz, 2007). In Australia, the National Breast Cancer Centre 
and National Cancer Control Initiative have cooperated to develop clinical practice 
guidelines for psycho-social care of adults with cancer (Breibart et al., 2013; 
Turner, Zapart, Pedersen, Rankin, Luxford, & Fletcher, 2005; Zorbas et al., 2003). 
The National Health and Medical Research Council (NHMRC) which is the 
uppermost scientific advisory and research committee in Australia, recommends 
that clinical practice guidelines should be outcome focused, integrate the best 
available evidence and must be developed by a multidisciplinary group which also 
includes the consumers (Turner et al., 2005; Zorbas et al., 2003). Currently the 
National Health and Medical Research Council (NHMRC) recommend that breast 
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cancer patients should have access to the full range of multidisciplinary treatment 
options (Zorbas et al., 2003). The principles of multidisciplinary care for cancer 
include the importance of the team approach, good communication, having access 
to the full range of therapies, maintaining standards of care and involving the 
patient in decision-making (Zorbas et al., 2003). They not only developed these 
practical guidelines, but also attempted to implement them by creating 
demonstration projects, health service delivery and clinician training, educating 
doctors in communication skills, monitoring programs and involving the public, 
mainly by forming partnerships with breast cancer advocacy groups (Redman, 
Turner & Davis, 2003; Turner et al., 2005).  
Broad international confirmation of distress as the ‘6th vital sign’ is considered a 
major step towards improving access to psychosocial care and lowering the 
isolation and stigma experienced by many affected by cancer (Turner, 2015). The 
UK has the National Institute of Health and Clinical Excellence (NICE) guidelines 
for improving supportive and palliative care for cancer patients, which include 
recommendations for implementing psychosocial care. The European Union has 
focused attention on cancer care with psycho-social investigators now involved in 
their discussions (Holland & Watson, 2011). The United States’ Institute of 
Medicine issued a report in 2007, outlining the strong evidence for psychosocial 
intervention in cancer care and suggesting the inclusion of psychosocial care in 
clinical treatment (Breibart et al., 2013).   
3.4.7  The concept of holism and the role of a multi-disciplinary team in 
psycho-oncology      
In psycho-oncology, the concept of holism has been the driving force for recent 
recognition of the importance of comprehensive cancer care as specified in the 
Institute of Medicine’s (IOM, 2008) influential report. This report was called: cancer 
care for the whole patient: meeting psychosocial health needs. This report has 
recommended the following standard of care: All cancer care should guarantee 
the delivery of appropriate psycho-social health services by: 
 Facilitating effective communication between patients and care providers.  
 Identifying each cancer patient’s psychosocial health needs. 
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 Proposing and implementing a plan that links the patient with needed 
psycho-social services and coordinates bio-medical and psycho-social 
care. 
 Systematically following up on, re-evaluating and adjusting plans (Nicolas, 
2013).   
Jalil and co-workers (2012) defined the cancer multidisciplinary team as a group of 
individuals from different healthcare disciplines, who meet together at a given time 
to discuss a particular patient and who are each able to contribute independently 
to the diagnostic and treatment decisions about the patient. As a multidisciplinary 
field, psycho-oncologists come from multiple primary disciplines such as 
psychology, psychiatry, social work, oncology nursing and pastoral care (Jalil et 
al., 2012; Nicolas, 2013). Multidisciplinary teams are becoming the model of care 
for cancer patients worldwide, for the successful integration of psychosocial care 
into routine clinical practice requires active multidisciplinary engagement (Jalil et 
al., 2012; Turner, 2015).  
The contributions from psychiatry, behavioural medicine, health psychology, 
pastoral counselling, social work and nursing, as well as oncologists, ethicists and 
patients themselves have, over the years, created a rich and diverse body of 
information, theoretical models and approaches, both in research and clinical 
interventions. The most successful psycho-oncology programs use this diversity to 
their advantage by evaluating cancer patients and referring them to the most 
appropriate therapeutic resource available drawing on the knowledge of each to 
enrich the others, while remaining fully integrated in the patients’ total medical 
care (Jimmy, 2004).   
According to Vetere (2007) it has long been recognized that multi-disciplinary 
team working in the context of physical and mental health services poses a 
challenge to practitioners, for often they are loyal to their own ideologies and 
occasionally less than accepting of others. Because of this, not referring to other 
disciplines, especially psychology and psychiatry, cancer patients, already known 
to have high rates of psychological morbidity, are low consumers of psychiatric 
care, especially for clinically severe disorders.   
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3.4.8  Patient - doctor communication and referrals    
Communication within oncology is a fundamental clinical skill but also one which 
few oncologists have received much formal training in. Sutherland has motivated 
already in the 1950s for specific education in communication skills for doctors 
working in the oncology field. Addressing cancer patients’ overall needs and 
sharing complex and often devastating information in an already emotionally 
charged context and under time constraints, is a daily challenge for the oncology 
clinician (Bredart, Bouleuc, & Dolbeault, 2005; Sutherland, 1958). The increasing 
amount of information and the complexity of the knowledge about breast cancer 
and the number of therapeutic options now available have made discussions 
between cancer patients and doctors much more challenging. This is even more 
evident when we take into consideration that patients, already experiencing 
emotional confusion, now enters a new and strange world of unknown technical 
language and concepts (Fallowfield & Jenkins, 2013). In order to help patients to 
navigate their way through all this new and intimidating information about their 
diagnosis and to ensure that they can sincerely provide an educated and informed 
consent to treatment plans demands excellent communication skills from the 
healthcare professionals involved with cancer patients.   
Inadequate communication causes distress for cancer patients and their families 
and they often feel that they would have liked to have more information to be 
provided. It consequently affects adjustment to the cancer diagnosis and patient 
decision-making about treatment (Fallowfield & Jenkins, 2015). Because of this, 
many patients leave consultations still uncertain about the diagnosis and 
prognosis. They are often confused about the meaning of and need for further 
diagnostic tests, uncertain about the therapeutic goals and treatment (Fallowfield 
& Jenkins, 1999). Because cancer sufferers have such a high prevalence of 
psychological stress and need of emotional support, it is important, from the start, 
that there is adequate communication about the diagnosis, prognosis and 
treatment alternatives ((Moore, Rivera, Grez & Lawrie, 2013).   
Gandubert and co-workers (2009) claimed the failure to detect psychological 
distress is largely due to lack of communication between healthcare professionals 
and patients. Grassi (2013) referred to this as a specific field regarding the doctor-
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patient communication and the importance of healthcare professional’s use of 
empathy in facilitating cancer patient’s adjustment to the illness. Moore and 
colleagues (2013) suggest that effective communication and support from their 
attending doctor or other healthcare professionals can reduce the psychological 
stress caused by the cancer diagnosis. This can be achieved by using effective 
communication and support. This is the area where both cure and care integrate 
with each other. There is no doubt that good communication between healthcare 
professionals and cancer patients’ correlates well with better quality of health care 
influencing the rate of patient recovery and adherence with treatment procedures 
and overall psychological functioning (Moore et al., 2013).   
According to Gandubert and colleagues (2009) doctors often think that anxiety and 
depression are normal reactions to the diagnosis and treatment of cancer and that 
such suffering will diminish over time. They therefore assume it is not necessary to 
pay attention to possible mood disorders or then refer the patient for further 
psychological help. Another barrier to adequate psycho-social care is doctors’ 
reluctance to ask patients if they are distressed, not wanting to get into an 
emotional interaction because medical doctors often feel inadequate to deal with 
their patients’ emotional turmoil (Gandubert et al., 2009). Nekolaichuk and 
colleagues (2011) found that in spite of the availability of psycho-social services, 
less than 10% of cancer patients are referred by the medical doctor for 
psychological evaluation and counselling and that the most common referral 
sources were the patients self. Kalaitzi and colleagues (2007) have found in a 
study that the active participation of the surgeon through referring the patient pre- 
or post-operative and explaining the importance of seeing a psychologist is helpful 
in reducing the stigma of psychological help.   
As a psycho-oncologist, when working with the medical staff in the oncology 
setup, it is important to educate them upfront about the availability of the psycho-
social services and the appropriate referral methods. Poorly managed referrals 
can result in hostile or reluctant patients (Deshields, & Nanna, 2010).  Miles (2012) 
believed that today’s clinicians are cautious to introduce empathetic and 
compassionate approaches into their care even with adequate time and 
opportunity and that they prefer to distance themselves from an ethical intimacy 
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with the patient in favour of an entirely science-based algorithmic treatment of the 
presenting symptoms. It is important for oncology physicians to understand the 
importance of not only acknowledging their patient’s emotional experience, but 
also discuss it with them, increasing their own awareness of psychological 
symptoms which might enable them to seek psychological help earlier (Mello et 
al., 2013).   
Despite the evidence of a high occurrence of psychological and social distress, 
emotional care for the cancer patient continues to be poorly supported by third 
party payers. Efficient cooperation between the various members of the health 
care team is also recognized to be compromised by poor communication. To 
improve the quality of cancer care delivery, communication in cancer care must be 
seen as the heart of that agenda (Thorne, Bultz & Baile, 2005). Thorne and 
colleagues (2005) summarized the above by stating that there are significant data 
to indicate that effective communication is an asset to an effective cancer system 
and that it is universally recognized that communication exists as a ubiquitous 
object in cancer care delivery.   
3.4.9  The role of the clinical psychologist in psycho-oncology 
The development of clinical psychology started in the 21st century with an 
involvement in most medical specialties and across the range of setting in which 
health care is provided from community to hospital settings. This is contrast to the 
previous years where most psychologists were involved only in activities related to 
patients with mental illnesses, working just within mental health institutions. The 
variety of psychological activities incorporated currently into physical health care 
has also exploded in recent years. Pain is a classical area where initial simplistic 
models (e.g. the medical model) have been illuminated by much more 
sophisticated bio-psycho-social models (Britton, 2002). Specific specialties, such 
as obstetrics and gynaecology, diabetes and oncology now routinely make use of 
psychological input to patient care. It is apparent; according to Huey and Britton 
(2002) that there is a substantial role for the clinical psychologist in health care 
and that this role will continue to expand with the continuation of the development 
and understanding of human behaviour.   
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Clinical psychology, according to the British Psychological Society of 2001, can be 
defined as the application of psychology to health and community care. This 
application includes the assessment, improvement and prevention of 
psychological distress, disability and dysfunctional behaviour (Huey & Britton, 
2002). Clinical psychology is a complex field that resembles the complexity of 
human behaviour and emotion. The field of clinical psychology is an integrative 
attempt to understand the interaction of the biological, psychological and social 
factors that make a person “tick”. Clinical psychology focuses on how the human 
psyche interacts with physical, emotional and social aspect of health and 
dysfunction (Plante, 2011).   
The role of the clinical psychologist is to generate and integrate scientific and 
professional knowledge, opinion and skills to further psychological science, the 
professional practice of psychology and human wellbeing. A clinical psychologist 
can be described as a professional person with a flexible and broad knowledge of 
psychology which facilitates the ability to draw from a range of theories in order to 
devise individually tailored strategies for complex presenting problems. On a more 
practical side, clinical psychologists assesses diagnoses and treats individuals 
suffering from psychological distress and mental illness and performs 
psychotherapy and develops treatment plans (Huey & Britton, 2002; Plante, 2011).  
Most professional psychologists who work as psycho-oncologists are likely to have 
been initially trained as either clinical or counselling psychologists and who have 
most likely received additional training at either a pre-doctoral internship or doing a 
Ph.D. specializing in psycho-oncology (Nicolas, 2013). It seems that in most 
universities (presumably also in South-Africa), cancer care as a sub-speciality in 
psychology is not as yet mandatory and further studies after a psychology degree 
is required to understand and work with cancer patients in the field of psycho-
oncology.   
For a psychologist to work collaboratively with cancer professionals and cancer 
patients, a basic understanding of cancer and its background is necessary (Haber 
et al., 1995; Nicolas, 2013). Understanding the specific cancer procedures, the 
site or bodily location of the cancer, basic information about the cancer staging 
and grading and their relationship to severity and prognosis, as well as an 
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understanding of the types of cancer treatments, such as different types of 
surgery, radiation and chemo- and hormonal therapies will help the psychologist to 
assist the cancer patient better on psychological grounds (Nicolas, 2013). It is also 
important to be knowledgeable about the degree of pain of the cancer patient; the 
side-effects of the various cancer treatments, probable level of functioning and the 
quality of life the patient might be able to expect (Haber et al., 1995; Nicolas, 
2013). Haber and colleagues (1995) stated that by having a working knowledge of 
the medical issues the breast cancer patient will encounter, the psycho-oncologist 
can assist and support the patient (and her family) emotionally, facilitate decision 
making during the trajectory of treatment and function as a liaison between the 
patient and her physician. Understanding the medical issues makes it easier for 
the psychologist to “normalise” fears, anxieties and myths in order to stay focused 
on the psychological reactions without becoming distracted or overwhelmed by the 
medical component. According to Haber and colleagues (1995) the three major 
relationships to consider from the side of the psychologist are: the patient-
physician relationship, the psychologist-physician relationship and patient-
psychologist relationship, with the most significant, the patient-physician 
relationship. There need to be open channels of communication between the 
psychologist and the physician through which necessary information can be 
shared. According to these authors, there must be at least one meaningful 
interchange of information during which they can share relevant information and 
can discuss their particular assessments and treatment plans. 
3.4.10 The bio-psycho-social model in practice 
In my attempt to understand the world of the breast cancer patient, I have done a 
thorough professional literature study of both the physiological side of cancer in 
the framework of the original bio-medical model of Louis Pasteur and the modern 
psychological side based on the psycho-social model from Engel. This knowledge 
that I have acquired from the literature is non-empirical for it is independent of any 
experience. The empirical data will be obtained and tested through a qualitative 
approached where I have studied breast cancer patients in their particular and 
unique social milieu in various stages and time frames in the trajectory of their 
cancer. The aim of my researching attempts was to lessen the distance between 
myself and my research objects cooperating and spending time in the field with 
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them and become an “insider” in their worlds (Creswell, 2007). This fits in with the 
constructionist approach, which was the most suitable epistemological paradigm 
for my qualitative research and agreed with my notion that studying people’s lived 
experiences occur within a particular historical and social context (Ormston, 
Spencer, Barnard, & Snape, 2014; Soini et al., 2011). This fits in with Omar and 
colleagues (2014) proposal that social research should explore lived experiences 
in order to reveal the connections between the social, cultural and historical 
aspects of people’s lives and to see the context in which particular actions take 
place. Constructivism is the understanding of reality as a social construction and 
not as an objective truth and that there exist multiple realities associated with 
different groups and perspectives (Soini et al., 2011).   
The application of the bio-psycho-social model in my therapeutic interventions 
relies on all the core principles of this model with the most important one that of 
integrating body and mind. Combining the knowledge of the biology of the cancer 
and the cancer treatment with the social and psychological impact on the patient 
and her family I have attempted to work within the holistic framework proposed by 
this model. Even in private practise I strive to work within a multi-disciplinary team 
with special effort to effectively communicate with the oncologists, making sure 
that they are informed of my professional services and location and also to be 
aware of other relevant professionals in case I have to refer a patient to another 
speciality. The knowledge generating from the bio-psycho-social model assist me 
in assessing and treating the cancer patient psychotherapeutically in order to 
enhance her quality of life and prevent the development of serious psychiatric 
disorders like depression or anxiety.   
In accepting the “human side” of the cancer patient, it allows her the freedom and 
professional environment to express her experiences without feeling judged or 
ashamed of how she feels and it validates her as a person. Psycho-therapy can 
teach her to take control in a situation with very little control, empowering her to 
take part in the decision- and treatment process with her oncology team and can 
teach her (new) effective skills to cope with this new and challenging journey.  
Because of the whole holistic point of view, the cancer patient is treated not in 
isolation, for her illness is part of her marriage and family and by involving them it 
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improves and develops the whole family and social structure enriching the support 
system.   
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CHAPTER IV 
PSYCHO-ONCOLOGIC INTERVENTIONS FOR THE 
BREAST CANCER PATIENT 
4.1  INTRODUCTION 
The word cancer, due to its continuing ominous threatening symbolic implications, 
still has toxic connotations in all cultures that discourage patients and their families 
from seeing cancer as a disease with varied outcomes, including cure. 
Demystifying the word cancer will require the combined and determined efforts of 
the oncology team, patients, families and media to generate a new culture of care 
in oncology (Surbone et al., 2013).   
McQuellon and Danhauer (2006) use the term “psycho-social rehabilitation in 
cancer” and define it as the process by which physical, mental and social abilities 
are reconditioned or developed for people with disabling conditions. In 1989, the 
Oncology Nursing Society has defined cancer rehabilitation as a process by which 
individuals are assisted, within their circumstances, to achieve optimum 
functioning within the limits imposed by their cancer (McQuellon & Danhauer, 
2006). According to these authors, the growing body of literature supporting the 
effectiveness of psychological- and social interventions in the rehabilitation of 
cancer patients are driven by the increasing number of cancer survivors and the 
fact that there are fewer stigmas attached to employing psycho-social services 
such as counselling.   
Presently, psychological treatment is increasingly acknowledged as an essential 
part of the comprehensive care of the cancer patient. Apart from the importance of 
implementing psychological care, improving the cancer patients’ access to 
psychological care and the availability of this care are just as important and 
remains a critical issue (Jacobson & Jim, 2008). The barriers that keep many 
patients from benefitting from psychological care services include under-
recognition of the need for psycho-social care by the primary oncology team and 
even when recognized, the lack of professions available in many communities to 
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provide psycho-social care to cancer patients (Jacobson & Jim, 2008). Psycho-
social care that is ineffective may be worse than no care at all. With the many 
different types of psychological- and social care available, combined with a 
growing body of research that can serve to guide practice, clinicians have a 
responsibility to provide their patients with the care that is likely to be beneficial for 
their specific type of problem they are undergoing (Jacobson & Jim, 2008). The 
use of research to guide practice is at the centre of evidence-based medicine. This 
is a movement that seeks to integrate individual patient care with the best 
available research evidence. As the practice of oncology attempts to be evidence-
based, so too should the psychological- and social care of the cancer patient be 
evidence based (Jacobson & Jim, 2008; Mens, Helgeson, Lembersky, Baum, & 
Scheier, 2016; Sackett, Rosenberg, Gray, Haynes, & Richardson, 1996). I have 
found in my own practise that in spite of being a qualified clinical psychologist with 
twenty six years’ experience in the field, there is a huge gap in specialised 
knowledge about cancer and cancer related psychiatric conditions and the 
implementation of interventions in this population. Globally, psycho-oncology is not 
a subject that is necessarily comprised in the academic syllabus in psychology 
and must be seen as an extra speciality by doing either a Master’s degree or a 
Doctorate in this sub-speciality in the field of psychology. It is not a given that by 
practicing as a psychologist or clinical psychologist, you have the necessary 
knowledge to treat cancer patients. It is also important for the oncology team to be 
able to distinguish between the different specialities in terms of psychological and 
social care, for example, a clinical psychologist, a counseling psychologist and a 
social worker and what their different roles comprises.     
4.2  AIMS AND BENEFITS OF CANCER-RELATED 
THERAPEUTIC INTERVENTIONS 
Women with breast cancer endure many demanding and anxiety-rousing 
treatments and side-effects of these treatments, along with the unpredictability of 
the disease, uncertainty about the future, unmet expectations about recovery, 
vulnerability to recurrence of disease and changes in relationships and self-image 
(Lee, 2008; Visser, Garssen, & Vingerhoets, 2009).  Although it remains true that 
the central challenge of cancer is to eliminate the disease (bio-medical model), it is 
widely recognized now that the disease per se is not the only source of worry, nor 
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is it the only target for intervention. The subjective quality of the patient’s life is 
important too, whether the amount of life that remains to the patient is long or 
shorter (bio-psycho-social model) (Lechner et al., 2009).  
In a study done by Nekolaichuk and colleagues (2012) they have found that the 
distress and need for psychological interventions of their study participants could 
be divided into four subthemes: 
(a) Difficult and overwhelming impact and emotions they had experienced in 
relation to cancer. 
(b) Concerns about the impact of their cancer on their families. 
(c) Their capacity to cope with the intensity of what they were experiencing. 
(d) The reappearing of emotional difficulties after treatment completion.   
The primary aim in cancer intervening therapies is to enhance the quality of life of 
the breast cancer patient and survivor (Blake-Mortimer, 1995; Hopko et al., 2011; 
Salonen, 2011). Results found in a study by Rehse & Pukrop (2003) clearly 
confirmed the overall hypothesis that psycho-social interventions reveal a positive 
impact on quality of life in adult cancer patients. It can no longer be taken for 
granted that successfully treated cancer patients just take up their lives where they 
had left off before the cancer (Carver, 2005). The concept of quality of life was first 
seen in the form of issues of functionality e.g. whether a patient was free enough 
from pain and fatigue to be able to engage in normal daily activities, if not, it was 
seen as an impairment of quality of life. Recently, the concept of quality of life is 
understood to be broader than these functional issues and is considered a 
multidimensional concept which comprises biological, psychological, social and 
spiritual life domains (Carver, 2005; Golden-Kreutz et al., 2005; Spiegel & 
Rodrigues, 2008).   
Health-related quality of life is considered an important endpoint in clinical cancer 
trials. It has been shown that assessing quality of life in cancer patients could 
contribute to improved treatment and could even be as prognostic as medical 
factors could be prognostic. Among the studies done on quality of life in cancer 
patients, breast cancer has received most attention for several reasons, including 
that the number of women with breast cancer is increasing and because of early 
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detection and improved treatment breast cancer survivors now live longer, 
therefore the studying of quality of life in this context is important (Mehnert & Koch, 
2008; Montazeri, 2008). Montazeri (2008) believed that women play important 
roles as partners, wives and mothers within any family structure, thus when she 
develops breast cancer all members of the family might develop some sort of 
disorder. This author actually feels so strong about this fact, that he considers 
breast cancer as a family disease which has the power to disable the quality of the 
lives of the whole family.   
Another aim of psychological intervention is the proactive management of distress 
levels of a breast cancer patient in order to prevent the development of more 
serious psychiatric problems like depression, anxiety or post-traumatic stress 
disorder. It is already established that breast cancer patients often develop 
psychopathological disturbances during their medical treatment or during their 
remission phase (Berger et al., Brem & Kumar, 2011; Dolbeault et al., 2009; Hill, 
et al., 2010; Nekolaichuk et al., 2011; Reyes-Gibby et al., 2012).The importance of 
early diagnosis and intervention of depression, anxiety and post-traumatic stress 
disorder can never be over emphasized for it is not only beneficial to enhance 
short term quality of life, but would likely decrease the negative impact of stress on 
long-term quality of life which can lead to impaired social and occupational 
functioning (Cielito et al., 2012; Dolbeault et al., 2009; Golden-Kreutz et al., 2005; 
Meier, 2010; van Oers, 2013). One of the goals to improve the quality of life during 
breast cancer is by reducing emotional distress through better coping mechanisms 
and skills with daily difficulties, especially during the treatment phase. Identifying 
and understanding one’s stressors and learning to cope with it successfully 
through learning and applying new skills can cause higher levels of spirituality and 
appreciation for life, all contributing to higher quality of life (Park et al., 2008). 
According to Livneh (2001) good quality of life is often seen as the fundamental 
and ultimate goal for people with a chronic condition and that successful 
acceptance and adaptation will be reflected in the person’s capability to re-
establish and manage the external environment and inner cognitions, feelings and 
behaviours. A longer term goal would be to empower breast cancer patients with 
general life skills and mechanisms beyond their current stint with cancer (Carver, 
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2005). The most frequent and well-studied psychological- and social interventions 
or treatments to enhance quality of life for cancer patients cover a wide range of 
approaches, many comprising multiple components such as education regarding 
cancer and its treatment (psycho-education), emotional support and expression 
(supportive therapy), cognitive- and behavioural therapy, relaxation training, 
problem-solving training and stress management (Fawzy & Fawzy, 2001; Hopko, 
Robertson & Colman, 2008; Livneh, 2001; McQuellon & Danhauer, 2006; Spiegel 
& Rodrigues, 2008). The aim through all of these interventions is to enable the 
breast cancer patient to take control of, and participate in their lives again as it will 
increase their self-efficacy and quality of life and reinstate their self-esteem, 
identity and confidence (Brennan, 2001). Psychological interventions should 
enable the breast cancer patient to face their future with hope alleviated by 
awareness and realistic expectations and arm them with the knowledge that 
lifetime follow-ups and care of potential long-term treatment sequelae will be 
necessary to achieve and maintain good quality of life (Hopko et al., 2011; 
Surbone, Annunziata, Santoro, Tirelli & Tralongo, 2013).   
4.3 INDIVIDUAL PSYCHOTHERAPY AND CANCER-RELATED 
INTERVENTIONS 
Individual psychotherapy can be defined as a formal process of interaction 
between a trained therapist and a patient working in a confidential, safe and caring 
environment for the purpose of improving distress through exploring the patients’ 
beliefs, behaviours, feelings and thoughts (Wedding, 2010).   
Individual treatment sessions, which allow the intervention to be tailored to the 
patients’ unique physical needs, might be more effective than group therapy for all 
breast cancer patients, but especially in metastatic and terminal breast cancer 
patients with psychological disorders (Beltman et al., 2010; Savard et al., 2005). 
This was confirmed by a Meta analyses done by Osborne and colleagues (2006) 
who indicated that cognitive-behavioural therapy is effective for both short- and 
long-term management of quality of life for cancer patients and had better results 
in individual, goal oriented sessions than that of group interventions. Although 
group therapy and the benefits of group therapy for cancer patients have received 
considerable attention in literature, it may not always meet the needs of all cancer 
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patients (Blake-Mortimer et al., 1999; Breitbart et al., 2010; Classen et al., 2001; 
Nekolaichuk et al., 2012). Individual psychotherapy is mostly chosen by patients 
who prefer one-on-one attention and support, or patients with advanced disease 
who need individual sessions that can be flexibly tailored to their own individual 
needs, taking into account their other clinic or hospital appointments as well as 
fluctuations in health status (Lo et al., 2014; Nekolaichuk et al., 2012). Unlike 
traditional therapy, working in a cancer setting can require consultations taking 
place in challenging environments, e.g. due to time, distance or energy constrains, 
the cancer patient may request from the psychologist to be seen while receiving 
chemotherapy or while hospitalised where they are in an area that other patients 
are in close proximity, limiting or making privacy practically impossible (Deshields 
& Nanna, 2010).   
It is important for the psychologist working with cancer patients to understand that 
there is often limited contact with a patient due to the illness, time, distance or 
medical insurance and by necessity assessment and treatment must often be 
done during a single visit. Experts in brief psychotherapy (Deshields and Nanna, 
2010) consider the first appointment also to be an intervention session. In the 
concept of individual psychotherapy, working with cancer patients, the challenge 
that distinguishes this work from most other psychotherapies is the flexible 
identification of “who” the patient is, for cancer patients often bring a family 
member or members with them into their sessions (Deshields & Nanna, 2010). 
The reason for this is that the cancer patient often wants her husband or child (or 
children) or even sometimes parents, to understand the psychological part of their 
cancer and to facilitate communication between them about the cancer experience 
and sensitive topics like death and dying. Although there are studies done on the 
benefits of individual psychotherapy with cancer patients, as mentioned above, 
Nekolaichuk and colleagues (2012) feel that the research focusing on the benefits 
of individual psychological counselling for cancer patients is still limited, 
emphasising the need for further formal evaluations in this area. I will attempt with 
this study to demonstrate that individual psychotherapy can have an important 
place in psycho-oncology for it provides a flexible environment for the exceptional 
needs of the breast cancer patient.   
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4.4  THERAPEUTIC INTERVENTIONS FOR BREAST CANCER 
PATIENTS 
In the ever changing world of cancer care, exploring psychological treatment 
approaches that are holistic and which accentuate the role of the patient in the 
healing process is essential. It is a reasonable hypothesis that if a cancer patient 
feels psychologically better it will contribute to her physical recovery and an overall 
better quality of life (Spiegel & Rodrigues, 2008).    
4.4.1  Patient-active model 
The patient-active approach falls into the category of the bio-psycho-social model 
(Borrel-Carrio et al., 2004; Steward, 2001) and is best described as a goal directed 
and gradual approach that is determined by the patient’s illness profile and 
treatment schedule as well as their performance status, social circumstances and 
personal resources prior to treatment (Greeff, 2008).      
This patient-active approach builds open communication and mutual respect in the 
doctor-patient relationship (the medical relationship) with clear patient-centred 
focus no matter what the treatment outcome. This method counteracts the 
conventional hierarchical medical model, with power entrusted only in the medical 
team, but places the patients at the centre of the care model in a way that will 
facilitate their own healing in a patient-focused holistic care model (Greeff, 2008). 
Patients and their families following a patient-active approach move much earlier 
from victim to survivor. According to Benjamin (1995) combining the will of the 
patient with the skill of the oncology team, will create a powerful combination in the 
fight against the enemy (cancer). People with cancer who participate in this “fight” 
for recovery will improve the quality of their lives, especially by preventing the 
development of serious psychiatric problems such as depression and anxiety 
which then will contribute and promote their physical recovery (Benjamin, 1995; 
Greeff, 2008; Husson, Mols & van de Poll-Franse, 2011).   
The aims and benefits of the patient-active model are as described by Greeff, 
2008):   
 To motivate the breast cancer patient largely through psycho-education to 
become involved in making active choices in her treatment process. 
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Patients who are given relevant information through psycho-education are 
able to ask relevant questions concerning their illness and treatment, which 
will place bigger pressure on the medical team as they have to 
accommodate these questions and provide information that can assist the 
patient in her treatment decisions. Patients with access to the internet will 
often question technical issues relating to treatment such as targeted 
therapies, how it works, the side-effects and the development of new drugs 
and treatment options. This creates space for the more analytical patients 
to ask questions to the oncology team that will ensure greater involvement 
and compliance and a better tolerance of treatment with most probably a 
more effective post-treatment adjustment.   
 This approach necessitates the development and use of a multidisciplinary 
oncology team and for the members of this team to make use of all their 
resources and ensures that the patients are referred to other professions 
such as physiotherapists, nutritionists, biokineticists, psychologists or other 
complementary therapists depending on their needs, guaranteeing the 
development of an individualised rehabilitation plan.   
 Through this model the psychologist encourages and inspires the patient to 
participate in a therapeutic process and to take control of the illness by 
developing a better understanding of their cancer and its treatment through 
knowledge and by learning mentally to live beyond the cancer experience.   
 The emotional load carried by the medical team in terms of the patient’s 
response (especially emotional response) to treatment becomes a shared 
responsibility between the specialist and the patient. Communication might 
be challenging and may require more preparation and input (especially) 
during the initial stages and at the end of treatment, but the shared 
responsibility of this patient-active model will create a new dynamic 
between the patient and the medical team leaving both the multidisciplinary 
team members and patients feeling less overwhelmed by the burden and 
responsibility they are holding (Benjamin, 1995; Greeff, 2008).   
 The patient-active approach to cancer care will encourage patient 
independence and self-sufficiency throughout the cancer journey by taking 
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control of their lives through developing and working toward realistic, 
achievable and new goals and hope.   
 This model proposes educating and encouraging the patient to learn and 
develop new skills in terms of their thought processes and emotions, to 
handle their cancer better and to improve their own quality of life through 
active therapeutic interactions.   
4.4.2  Specific therapeutic techniques in practise 
The specific therapeutic techniques that I predominantly use in my practise 
working with cancer patients are techniques that are well studied and described in 
literature regarding their applicability to the context of cancer. This include an 
emotionally supportive framework to address fears and anxieties about the cancer, 
psycho-education to give information to the patient about the disease and 
treatment, behavioural coping strategies for changing overt behaviour, cognitive 
therapy for restructuring irrational thoughts and learning coping strategies, and 
psychological acceptance and adaptation of the illness (Anderson, 1992;  Fawzy, 
Cousins, Fawzy, Kemeny, Elashoff, & Morton, 1990;  Forst et al., 2010; Golden 
Kreutz et al., 2005; Hopko et al., 2008; Hulbert-Williams, Neal, Morrison, Hood, & 
Wilkinson, 2011; McQuellon & Danhauer, 2006). Studies assessing the usefulness 
and effectiveness of these interventions, provide substantial verification that they 
effectively reduce symptoms of depression, anxiety and pain and improve overall 
quality of life in the breast cancer population (Baum, & Andersen, 2001; Hopko et 
al., 2008; Hulbert-Williams et al., 2011). Using these psychological interventions to 
decrease psychological distress and improve quality of life should be applied 
flexibly to meet the specific type of adjustment difficulties presented by the cancer 
patients throughout the trajectory of their treatment and thereafter (Hulbert-
Williams et al., 2011). A good example of this flexibility is to understand and 
address psychological interventions with cancer patients in a specific time line 
predicted by the illness self and the treatment. Anderson (1992) and Mullan (1985) 
have identified three stages of the disease time line:  
(a) The acute stage: This stage begins with the diagnosis of the cancer where 
the focus is on the trauma of learning one has a potentially life-threatening 
illness, through the active treatment stage. Mullan (1995) describes anxiety, 
147 
 
fear and pain resulting from both the illness and treatment as constant 
elements of this phase.  This stage is defined by both the experience of the 
person diagnosed with cancer and by those of the family members who are 
affected by the diagnosis. 
(b) The extended stage: This stage can be described as immediately post-
treatment and begins when the survivor goes into remission or has 
completed the treatment (or it can be through extended treatment 
(Anderson, 1992). Anderson, who is himself a cancer survivor, said that 
psychologically, this stage is a time of waiting and wondering if any given 
symptoms that you may experience, may be signs of recurrence or just a 
part of everyday life. The ending of the treatment can also cause acute 
anxiety because of the sudden diminished contact with the health care 
team. During this stage, the survivor becomes aware of and learns to live 
with the chronic side effects of the illness and its treatment, even if the 
treatment is finished.   
(c) The permanent stage: This stage can be defined as a time when the 
likelihood of the return of the cancer is sufficiently small and that the cancer 
can be considered “permanently arrested” (Mullan, 1995, p272). Mullan 
acknowledged however, that this stage is more complex than simply the 
status of the disease (in this case, in remission). A cancer survivor in this 
stage may face financial and social challenges, fear of recurrence and 
secondary effects from the cancer treatment (e.g. fatigue, decreased 
memory, etc.). End-of-life concerns can occur during any of the three 
stages. End-of-life care confirms life and regards dying as a normal process 
with the goal of end-of-life care to achieve the best possible quality of life 
for the cancer patient by controlling pain and other symptoms and 
addressing psychological and spiritual needs.   
To summarise the three stages, Mullan (1995) defines the experience of cancer 
survivorship as living “with” cancer, living “through” cancer and living “beyond” 
cancer. Living “with” cancer implies the experience of receiving the cancer 
diagnosis and the treatment that may follow. Living “through” cancer refers to the 
extended stage following treatment and living “beyond” cancer indicates the post 
treatment and long-term survivorship. This process is unique for each cancer 
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patient and the passage from one stage to the next may not always be clearly 
outlined.   
4.4.2.1  Psycho-education 
Psycho-educational as an intervention technique is a therapeutic process where 
information and education are proposed to individuals with psychological- and 
physical disorders. These interventions can fluctuate from the delivery of passive 
materials such as leaflets or any reading material regarding the subject, or 
information websites, or it can be active multi-session interventions with therapist-
guidance (Donker, 2009). Psycho-education is one of the most frequently used 
interventions in treating breast cancer patients through educating them in cancer 
and cancer treatment used in combination with cognitive-behavioural therapy 
(Donker, 2009; Fors et al., 2010; Spiegel & Rodrigues, 2008).   
Psycho-education, as part of psychotherapy, can be defined as a therapeutic 
focus in which patients learn practical and positive emotional and behavioural 
skills through information and knowledge to improve life adjustments and 
management of self-awareness and emotions. A psycho-educational approach 
values the importance of education in changing unhealthy and negative emotional 
and behavioural patterns through information/knowledge and proactive guidance 
(Authier, 1977; Berger et al., 2015; Fors et al., 2010). Psycho-education teaches 
patients personal and interpersonal skills and attitudes which he/she can apply to 
solve present and future psychological problems and enhance quality of life 
(Authier, 1977). The providing of education to cancer patients typically includes 
information regarding the illness or symptoms, symptom management, and 
discussion of treatment options and is one of the most important factors of 
supportive cancer care across the whole cancer continuum. The goal of providing 
appropriate information is to prepare the patient for their treatment in order to 
increase adherence to therapy, to increase their ability to cope with the cancer and 
to promote recovery (Osborn et al., 2006). In the light of the importance of giving 
psycho-education to a cancer patient, a previous systematic review has 
unfortunately showed that between 6-93% of the cancer participants have 
reported adequate information provision as an unmet need throughout their cancer 
experience (Husson et al., 2011). As an oncology psychologist, it is important to 
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understand the new and unknown and threatening world of cancer and cancer 
treatment and (medical) vocabulary of your cancer patient. Especially with a first 
diagnosis, the breast cancer patient and her family’s life change immediately in a 
physical and emotional roller-coaster and by just hearing simple descriptions and 
clarifications about their illness and what to expect, bring a little bit of “safety” and 
security into this unknown time.  
Husson and colleagues (2011) emphasise that giving information to a patient, 
his/her age, gender, cultural background, educational level, cancer type, stage 
and coping style must be taken into consideration, for providing information that is 
consistent with the patients’ needs is an important element for the patient’s 
satisfaction and might contribute to her health-related quality of life. In practise it 
means to give the patient enough time to talk about her (cancer) experience first, 
especially her emotional experience regarding the diagnosis and to give her a 
chance to clarify what she already knows about her disease and treatment and 
what her needs are in terms of the therapeutic process onwards. As a therapist it 
is important to know that “over-information” can also be harmful, therefore it is 
essential to let your patient lead you, especially in the beginning of the therapeutic 
process, as to what and how much information she can accommodate 
emotionally.  
Surbone and colleagues (2013) said that we as cancer therapists need to explain 
to the patient the unpredictable and uncertain nature of cancer and its 
consequently existential uncertainty, but also speak of the favourable prognosis 
and cure rates, long-term sequelae, chronicity and the meaning of survivorship to 
those patients with early-stage or highly curable cancers. On the other hand, 
patients with advanced or untreatable or recurrent cancer need to understand their 
prognosis or relapses, progression and palliative and end-of-life care. This should 
enable the cancer patients to deal with their future with hope, but also allowing for 
realistic expectations (Mack & Smith, 2012; Surbone et al., 2013). Information can 
also make the breast cancer patient aware that from the time of diagnosis some 
cancers can be successfully treated, but that it will require a lifetime of follow-up 
and care of potential long-term treatment sequelae for them to achieve and to 
maintain a good quality of life. This is one of the reasons why early referrals are so 
important, so that the breast cancer patient can, from the beginning, understand 
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the process of cancer treatment and survivorship and what it will require of them 
and their families in terms of chronicity (Osborn et al., 2006; Surbone et al., 2013). 
Because of the high incidence of cancer related fatigue and depression and the 
impact that it has on the cancer patient I will briefly discuss psycho-education in 
relation to this two side-effects of cancer.      
 Psycho-education and fatigue:   
Because fatigue or low-energy levels is one of the most common and 
incapacitating symptoms of breast cancer and can persist for several months or 
years after the end of cancer treatment I have included it in this discussion in 
combination with psycho-education (Brem & Kumar, 2011; Johns et al., 2015) 
Psycho-educational interventions for fatigue integrate proactive guidance about 
possible patterns of fatigue during and after treatment as a side-effect of 
chemotherapy and personalized recommendations for self-management (Berger 
et al., 2015). Patients who have completed their active treatment and still suffer 
from tiredness find information about the longevity of fatigue, especially after 
chemo very helpful and find relief in the fact that there is not necessarily 
something wrong with them (Berger et al., 2015). This emphasises the importance 
that when normalising a condition or emotion for a patient and putting it into the 
right perspective, it lessens their fear and anxiety of not understanding a symptom 
or condition. If a patient is still busy with treatment (especially chemotherapy) it is 
important for her to understand her own unique pattern of tiredness, e.g. which 
day after her chemo session is she the most tired and what time during the day is 
the worst, so that she can time-manage her day around her fatigue and also 
involve her family into her “fatigue time-schedule”. Different patients react 
differently to chemotherapy in terms of their fatigue pattern. The aim of psycho-
education with fatigue is to prepare the patient and her family with knowledge 
about acute and prolonged fatigue and its interference with functioning and 
possible handling mechanisms (Bardwell, & Ancoli-Israel, 2008).    
Berger and colleagues (2015) state that especially progressive muscle relaxation 
and relaxation breathing, exercise, especially walking, and coping skills training 
improve both fatigue severity and fatigue related interference during the day. 
According to Dimeo and colleagues (2008) there are increasing scientific proofs 
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that exercise can markedly reduce cancer-related fatigue. It is important for the 
patient to understand that physical activity also increases levels of beta-
endorphins and serotonin and increase blood flow and circulation which improves 
memory function and provides a feeling of general well-being (Dimeo, 2001; 
Hassan & Amin, 2011). It is important for the cancer patient to always make sure 
from her oncologist or main physician that it is safe for her to start with an exercise 
program, even if it is just walking.    
 Psycho education and Depression:   
Studies regarding depression and cancer which specifically recommended 
psycho-education in combination with any form of behavioural psychotherapy, has 
demonstrated the benefits of brief forms of psycho-education in preparing patients 
for cancer treatment (Jacobsen & Jim, 2008; McQuellon, & Danhauer, 2006; 
Vahdaninia et al., 2010). McQuellon and Danhauer (2006) have developed a very 
brief psycho-educational program designed to reduce anxiety and depression in 
patients starting cancer treatment. The intervention must be delivered at the time 
of the initial consultation with the oncologist (a meeting for 15 to 20 minutes) 
where the patient can ask any questions and has the opportunity to express 
concerns and the therapist can offer suggestions on how to cope. McQuellon and 
Danhauer (2006) found this program very effective due to the reducing of the fear 
of the unknown of the cancer experience at the beginning of the cancer process. 
In my opinion, this can only work if the patient is referred immediately after the 
diagnosis of the breast cancer to give her a change to engage in a 
psychotherapeutic conversation. I do not agree with the time frame (15 to 20 min), 
for I have found that such a short sessions (as proposed by this program) is 
insufficient and unsatisfactory for both the patient and the psychologist. The whole 
oncology experience is already very fast and time oriented for the patient, 
especially the sessions with the medical team, therefore the session(s) with the 
psychologist must be more time friendly (but not longer than an hour) in terms of 
enough time for the patient to express emotions, ask questions and receive proper 
feedback in the form of useful information.  By acknowledging the cancer patient’s 
fears and anxiety and explaining the “normality” of these emotions patients feel 
less threatened by their anxious and depressive thoughts and feel that their 
feelings are validated by being told that their emotional reactions were normal 
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(Nekolaichuk et al., 2012). Normalisation is seen by Nekolaichuk and colleagues 
(2012) as a benefit in its own right. It is also important to explain the possibility to 
the patient that because of the cancer treatment, she can develop depression or 
anxiety and what the symptoms are to look out for (Berger et al., 2015; Cielito et 
al., 2012; Jones, 2010; Wong-Kim & Bloom, 2005).   
4.4.2.2  Cognitive-behavioural therapy (CBT) 
Being a cognitive and cognitive-behavioural therapist, working with cancer patients 
in a hospital setup or in practice, I incorporate a variety of approaches which 
involve multiple components within the structure of CBT such as structured 
psycho-education, cognitive restructuring, behavioural activation, problem solving 
and goal setting, communication strategies and emotional support (Hopko et al., 
2003; Hopko et al., 2008; Spiegel & Rodrigues, 2008). These specific types of 
interventions have all been shown to be effective for a variety of cancer patients 
for reasons of their ease of administration as well as face validity (Armento & 
Hopko, 2009; Carver, 2005; Golden-Kreutz et al., 2005; McQuellon & Danhauer, 
2006; Savard et al., 2005).   
Cognitive-behavioural therapy is a short-term, goal oriented, rational and practical 
type of therapy that can help the patient to change patterns of thinking or 
behaviour that are causing emotional distress and dysfunction (Beck, Rush, Shaw, 
& Emery, 1979; Whitaker, Watson, & 2009). CBT is defined as all psychotherapies 
that include both cognitive restructuring and behavioural activation and is well-
researched as a successful therapeutic intervention technique working with 
patients during the trajectory of the cancer journey (Beltman, Voshaar, & 
Speckens, 2010; Butler et al., 2006; Dolbeault et al., 2009; Hale, Treharne, & 
Kitas, 2007; Montel, 2010; Osborne et al., 2006). The findings of most of these 
researches have supported the effectiveness of CBT and have found positive 
outcomes for cancer patients especially with depression, anxiety, fatigue and 
general cancer distress. Various studies have also indicated the long-term 
effectiveness of CBT and the prevention of relapse (Butler et al., 2006; Espie et 
al., 2008; Park et al., 2008; Simons, Levine, Lustman, & Murphy, 1984).    
Cognitive-behavioural therapy is theoretically based on a cognitive model of 
interactions among cognition, emotion and behaviour and postulates that 
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symptoms and dysfunctional behaviours are often cognitively facilitated. In the 
cognitive model, mood and behaviour are regarded as determined by a person’s 
perception and interpretation of events, which then manifest as a string of 
automatically generated thoughts. These automatic thoughts have their roots in an 
underlying network of beliefs or schema (representation). Automatic thoughts that 
lack validity because they originate from dysfunctional beliefs can cause or 
intensify psychiatric disorders such as depression and anxiety (Beck, 1970; Beck 
et al., 1979; Chand & Grossberg 2013; Hofmann & Smits, 2008). The therapeutic 
process, based on the cognitive theory, consists then of helping the patient 
become aware of the automatic flow of thoughts when distressed and to identify 
and modify these dysfunctional thoughts.   
Behavioural techniques are used to bring about functional changes in behaviour, 
regulate emotions and help the cognitive restructuring process. Current theoretical 
approaches to understand the sources of persistent distress after the diagnosis of 
cancer share a mutual basis within the cognitive paradigm, which is the view that 
distress is maintained by the individual’s negative appraisal of the illness (Cook et 
al., 2015). It is important for the cognitive-behavioural therapist to understand the 
patients’ cognitive representation of their cancer and the role of their illness 
perceptions (including thoughts, ideas and beliefs about their illness) in order to 
teach the patient various coping skills.  
Although disease outcomes might be positively influenced by cognitive-
behavioural interventions it is important to take into account that external 
(environment) and internal (personality) factors may also influence the therapeutic 
process (Hale et al., 2007; Hulbert-Williams et al., 2011; Travado and Reis, 2013). 
An element that a therapist must take into consideration when doing cognitive 
therapy with a cancer patient is the importance of individual differences. People 
view the world differently and they differ in their emotional and behavioural 
responses to hardship. A person’s experience, perceptions and impact of having 
an illness might influence the interpretation and reaction to the illness (Carver, 
2005; Hulbert-Williams et al., 2011). Individual differences play a significant role in 
people’s quality of life during their cancer treatment and in survivorship. It is 
important to keep in mind that the quality of life of a cancer survivor is partially a 
product of the cancer experience self, but also to a degree a product of the 
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individual’s personality. Apart from the role that different personalities play in the 
application of CBT, the time frame within in the treatment trajectory is also 
important as to which technique will be suited best. An example of this is in the 
acute stage, where the patient might still feel traumatized after the cancer 
diagnosis, the aim of the therapy would be to handle the fear and anxiety first 
through emotional supportive strategies. This will be followed by psycho-education 
to explain the procedures to follow, normalizing and accepting of stressful 
emotions and relaxation and breathing exercises to counteract anxiety (Golden-
Kreutz et al., 2005; Mulan, 1985; Hulbert-Williams et al., 2011). After completion of 
the treatment and the re-entry phase, the focus might be more on cognitive 
reconstruction of irrational thoughts, coping strategies, acceptance and adaptation 
to the new status quo and learning to live with the chronicity of cancer (Anderson, 
1992; Mullan, 1985). Early intervention can never be over emphasised, for it not 
only enhance short-term quality of life, but would likely decrease the negative 
impact of stress in the long term.  
 Cognitive-behavioural therapy as treatment modality for depression 
and anxiety in breast cancer patients 
The National Comprehensive Cancer Network (NCCN) has developed several 
clinical practice guidelines for the supportive care of cancer patients and one of 
their guidelines for cancer patients with depression include the initiation of an 
antidepressant combined with psychotherapy with or without the concurrent 
commencement of anxiolytic medication. Psychotherapy is viewed as just as 
effective as medication in treating depression but is more effective than 
medication on its own in preventing relapse. For some patients, the combination of 
psychotherapy and medication will be more beneficial than either treatment on its 
own.   For patients with an anxiety disorder, the initial recommendation is likewise 
for evaluation, diagnostic studies, and modification of factors potentially 
contributing to the presenting symptoms (Montel, 2010).  Individual CBT, such as 
problem solving, appears to be useful when working with cancer survivors treating 
their depression and anxiety (Osborne et al., 2006). 
One of the primary goals of short term cognitive-behavioural therapy in patients 
with an underlying somatic disease (e.g. cancer), is to reduce depressive and 
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anxiety symptoms (Driessen, Cuijpers, de Maat, Abbass, de Jonghe, & Dekker, 
2010). The role of cognitions in the development and maintenance of depressive 
and anxious symptoms has been acknowledged for more than thirty years and 
cognitive-based therapies (e.g. cognitive therapy and cognitive-behavioural 
therapy) are regarded as the gold standard of evidence-based treatment for 
depression and anxiety in adult cancer patients (Osborn et al., 2006; Steiner, 
Wagner, Bigatti, & Storniolo, 2014). Because depression and anxiety often 
coexist, the interventions are similar, with focusing on cognitive-behavioural stress 
management, progressive muscle relaxation, and deep breathing, cognitive 
restructuring and interpersonal training (Brem &Kumar, 2011). CBT interventions 
are based on the supposition that cognitions can be monitored and altered and 
therefore may facilitate change. Effective management of depression and anxiety 
may impact outcomes such as fatigue, cognitive functioning and over-all health in 
adult cancer patients (Osborn et al., 2006).   
Recent studies have confirmed that up to 48% of anxious and depressive cancer 
patients experience frequent, uncontrollable intrusive thoughts (Field, Diego, 
Pelaez, Deeds, & Delgado, 2012; Morris & Shakespeare-Finch, 2011; Steiner et 
al., 2014; Whitaker et al., 2009). If a person thinks perseveratively, which means 
repeating a response after the ending of the original stimulus, about his/her 
negative feelings and problems and losses, it will further contribute to the 
development of depression and anxiety (Morris & Shakespeare-Finch, 2011; 
Osborn et al., 2006). Nolen-Hoeksema and colleagues (2008) use the term 
‘rumination’ to describe persevering thinking about one’s feelings and problems, 
without being able to control the thoughts. It is possible that a thought may start as 
unwanted, negative and intrusive but the process of attending to this thought 
repeatedly is what is defined as rumination and is predictive of the onset or 
maintaining of depressive symptoms. 
In a study done by Montel (2010) regarding breast cancer and associated anxiety, 
they found that the best technique in treating anxiety in this population was 
cognitive reframing. The purpose of cognitive reframing is to help the patient to 
focus away from anticipating the worse and change irrational and dysfunctional 
thoughts to more realistic thoughts. The aim of this technique is to teach the 
patient to view a situation from different angles without denying the reality of the 
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situation. Montel also underlines the importance of relaxation therapy associated 
to the CBT in the improvement of the patient’s anxiety level. The ability to relax 
when symptoms of anxiety occur gives the patient the confidence that she can 
take control over her body and that she is able to cope with stressful situations.   
 Mindfulness-based cognitive therapy (MBCT)  
MBCT is a direct and more modern extension of traditional cognitive-behavioural 
therapy. Mindfulness has been defined as the awareness that emerges through 
consciously concentrating or paying attention in the present moment without being 
judgmental in your own awareness (Johns et al., 2015; Kabat-Zinn, 2003). Such 
present moment awareness lessens worry and rumination of negative and 
disruptive thoughts, allowing for more flexible and adaptive responses to life’s 
present challenges and more openness to experience feedback about the 
effectiveness of problem-solving efforts (Luoma & Villatte, 2012).   
One of the main aims of mindfulness-based treatment is to improve the emotional 
well-being of a patient by increasing awareness of how automatic behaviour and 
cognitive reactions of thoughts, sensations and emotions can cause emotional 
distress. Patients are encouraged to be in the present and to acknowledge and 
accept their thoughts, sensations and emotions with an open mind and flexibility 
(Carlson, Speca, & Segal, 2010; Hofmann, Sawyer, & Fang, 2010). By focusing on 
the present, rather than pondering on the past or worrying about the future, 
patients can more effectively deal with life stressors that frequently lead to feelings 
of anxiety and depression (Hofmann et al., 2010; Kabat-Zinn, 2003). As a 
therapist, it is important to teach the patient to respond thoughtfully (consciously) 
rather than automatically (unconsciously) to stressful situations and negative 
emotions.  
It is important to learn the patient to focus their thoughts and emotions and 
behaviour in the here and now, and not letting their thoughts “wander” off without 
them bringing (controlling) it back to the present (Carlson et al., 2010; Grossman, 
& Van Dam, 2011; Mrazek, Smallwood, & Schooler, 2012; Hayes, Luoma, Bond, 
Masuda, & Lillis, 2006).   
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Part of practising mindfulness is the notion of acceptance which also forms part of 
the Acceptance and Commitment Therapy (ACT). From an ACT perspective 
acceptance is a process of being open to whatever one is experiencing without 
defence (Hayes et al., 2006; Hofmann et al., 2010). ACT encourage patients to 
accept (or embrace) negative thoughts and feelings such as guilt and anxiety, 
rather to eliminate them immediately, learning through that, that acceptance can 
be an important alternative to avoidance (Hayes et al., 2006; Hofmann et al., 
2010). Within traditional cognitive therapy, cognitive restructuring is utilized to 
challenge the validity of dysfunctional thoughts, but in contrast to cognitive 
restructuring, ACT uses cognitive diffusion techniques to change the meaning of 
negative thoughts rather than adjust their content (Deacon, Fawzy, Lickel, & 
Wolitzky-Taylor, 2011). Cognitive diffusion means that no attempt must be made 
by the person to change the content or frequency of his/her negative thoughts, but 
instead, focus on changing how he or she relates to the thoughts, such that 
thoughts are not taken literally as statements of truth or fact, but rather simply 
represents verbal activity (Hayes et al., 2006; Hinton & Gaynor, 2010). Hofmann 
and colleagues (2010) state that instead of changing the negative thoughts 
immediately, the patient must rather focus on new thoughts which make the 
patient feel more in control over her thoughts and feelings. Cognitive diffusion 
empowers patients to develop a more non-judgmental and mindful perspective of 
themselves and of their environments (Deacon et al., 2011).   
It is important for patients to understand that some negative thoughts are realistic 
and normal in severe emotional situations like cancer and is impossible to not 
have negative or scary or unhappy thoughts.  Patients can learn not to feel guilty 
about having negative thoughts, or feeling anxious, but rather to accept these 
thoughts and try to focus on something more acceptable that can make them feel 
better (Manne, Ostroff, Fox, Grana, & Winkel, 2009).     
Another concept of mindfulness-based intervention which forms part of ACT is 
what is called “decentring”. Decentring is described as a mechanism of 
mindfulness-based cognitive therapy in which patients learn to view their thoughts 
as events in their minds rather than necessarily being reflections of reality or 
accurate self-views (Feldman, Greeson, & Senville, 2010). Decentring means 
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present focusing and involves taking a non-judgmental and accepting stance 
regarding thoughts and feelings (Fresco et al., 2007). Working with MBCT, a 
patient can be taught to identify and acknowledge negative and uncomfortable 
thoughts, and accept it, rather than over-identify with it and became entrapped in 
them (Luoma & Villatte, 2012). When you then become so attached or fused to 
these thoughts, it can become very powerful. It is important for the patient to 
understand that thoughts are just thoughts without minimizing the emotional 
impact that thoughts can have or invalidate the factual information often 
associated with thoughts, for both are valid. The point to make for the patient is 
that thoughts are only as powerful as you allow them to become. They are only 
words and pictures that drift through your mind and that you are the one giving 
meaning and energy to it. Just because you “have a thought,” does not mean that 
it is the truth or that any action must be taken. When frightful and powerful 
thoughts pop into your mind, or when you cannot get these thoughts out of your 
mind, then you apply the principles of mindfulness by acknowledging and 
accepting the thought(s) but then focus on new and more rational and pleasant 
thought(s) (Luoma & Villatte, 2012).      
Search for meaning  
The inevitability of death associated with cancer is often one of the first 
confrontations that a person has with his or her own mortality. The recognition of 
one’s imminent death can initiate an existential plight, which is the magnifying of 
thoughts about one’s existence and the potential for non-existence following a 
diagnosis of cancer (Lee, 2008; Weisman, & Worden, 1977). Thoughts about 
one’s mortality and purpose in life following a cancer diagnosis can vary from a 
normal awareness of one’s existence that does not necessarily result in 
psychological distress to a more persistent state of discouragement and 
depression that is characterized by severe and unrelenting feelings of 
helplessness, hopelessness, isolation and pessimism (Lee, 2008). 
With a cancer diagnosis, a person’s belief system that has in the past provided a 
sense of familiarity, stability and security is now questioned and the goals that a 
person has set out for the future may no longer appear realistic or achievable. This 
can then lead to, as current literature calls it, the search for meaning which is a 
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distressing psychological process in which the individual tries to evaluate the 
impact of cancer on his or her life and try to understand the world (Lee, 2008). The 
search for meaning is a process by which cancer patients struggle to retain what is 
personally meaningful for them when nearly all aspects of their life will be 
threatened by changes caused by the cancer and its treatment. In an attempt to 
absorb and understand the reality of cancer, patients then undergo a cognitive 
process that may entail exposure to recurrent and intrusive thoughts about 
aspects of the cancer experience and avoidant behaviours when the distress of 
this exposure becomes overwhelming and relief is needed. Although this cognitive 
process is psychologically and emotionally difficult and tough it is a necessary 
process (Creamer, Burgess, & Pattison, 1992; Lee, 2008). The successful 
completion of the process of searching for meaning occurs when the limitations 
caused by cancer become integrated into a changed and reorganised life schema 
that once again provides a sense of order and purpose (Lee et al., 2004, Lee, 
2008).    
Rapidly emerging empirical evidence is proposing that meaning-making coping is 
a critical mediator between cancer-related distress and psychological well-being 
(Lee, 2008). According to Lee, cancer patients often turn to health care 
professionals to help them make sense of the overwhelming information and 
thoughts and emotions that confront them during their journey from diagnosis to 
death and that clinicians are inherently implicated to help the patient make sense 
of their existential plight or dilemma. Lee (2008) and Taylor (2000) gave practical 
guidelines to use in therapy helping cancer patients to make sense of the meaning 
of their lives. They divide this into three tasks during the therapeutic process:  
 The first task: encourage patients to tell their story from the diagnosis to the 
present, especially their immediate and arising thoughts, emotions and 
actions. Ask what has changed in their lives and what still the same is since 
their diagnosis. Telling their stories gives them time to express all of their 
experiences and emotions from the time of diagnosis. The purpose of this is 
firstly to explain and facilitate emotional expression and the grieving 
process by acknowledging the losses and seriousness of their situation. 
The second purpose is to demonstrate that there are still elements of their 
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lives that they continue to maintain control over and to introduce the idea 
that positive elements can coexist with negative aspects of their lives.    
 The second task: the therapist asks of the patients to carefully think back 
and identify and describe previous critical situations in their lives and to 
identify the coping strategies and strengths that were previously used to 
deal with these challenges. This is to illustrate that they could effectively 
cope with stress and trauma in the past and have survived up to now and 
that by using the same strength and coping skills now they will be able to 
deal with the cancer, or they can either learn new coping skills for the 
present and new situation if their previous techniques doesn’t work.  
 The third task: In the final task patients are encouraged to think about how 
to live life as fully and satisfactory as possible in their current situation. It is 
important during therapy to help them to identify important life goals and 
activities and how to achieve it. It also gives them the opportunity to discuss 
with the therapist their thoughts about their uncertain and unknown future 
and put it against the background of previous strengths and successes that 
has allowed them to master past challenges and now also include survival 
of the cancer experience. If the patient is ready this can be the time for 
more in-depth discussions about confronting the unknown future which may 
include not meeting expectations, anxieties, the fear of recurrence, or even 
plans about death and dying (Lee, 2008). The realization that they may not 
live as long as they had thought, often serves as a motivation to make more 
realistic short-term goals given the uncertainty of their future.   
Visser and colleagues (2009) together with Halstead and Hull (2001) try to explain 
the threat to a cancer patients’ sense of meaning of life through her struggle with a 
number of paradoxes. Examples of some of these paradoxes are: 1) Although 
they still view themselves as healthy, they were diagnosed with a life-threatening 
illness like breast cancer. 2) They are hopeful about being cured and the future, 
but are also scared of recurrence of the disease. 3) They found meaning in their 
belief system, yet it was challenged (and is still being challenged) by the cancer 
diagnosis. 4) They are looking forward to the future, but dreaded the unpleasant 
treatment and possible mortality that lay ahead. Many patients suffer from these 
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fears and uncertainties and they may feel the need for help to deal with these 
fears and to develop a more positive and realistic perspective.   
 Goal Setting  
Much of a person’s sense of identity results from a personal journey which 
presents goals and rewards in the future. Goals are age dependant and range 
from being short-term and clear-cut (e.g. to cook dinner or to go to a movie, or to 
drop the children off at school), to being more long-term and abstract (to become a 
scientist, or to get married, or buy a house or a car). The most prominent and 
important goal in an individual’s life is that of life itself, together with other, as 
important goals, such as the desire to maintain the self-image of a healthy person 
and to continue engaging in a wide range of specific activities and the wish of the 
patient to live out one’s intended future with loved ones (Brennan, 2001; Carver, 
2005). Carver’s approach to cancer survivorship relies on a view in which 
individual lives are seen as organized around goals which support the notion in 
contemporary psychology that human-beings are basically goal-directed by nature 
(Carver, 2005; Stefanic, Caputi, & Iverson, 2013).   
Personal goals are self-defined purposes that provide life with structure, direction, 
rewards and meaning and is recognised that the successful and continued pursuit 
of important personal goals is a key source of psychological well-being throughout 
life. Blocked or disrupted goal pursuit can lead to insufficient motivational structure 
which can induce distress through feelings of hopelessness that life is pointless 
which can lead to the development of clinical depression or anxiety (Brandtstädter 
& Rothermund, 2002; Stefanic et al., 2013; Wrosch, Scheier, Miller, Schulz, & 
Carver, 2003). Within this framework a diagnosis of breast cancer, its treatment 
and accompanying side effects and the knowledge of a shortened life-expectancy 
can represents a threat to the patient’s prolonged ability to reach her goals and 
can lead to a pre-occupation with the loss of goals and aspirations that have 
shaped one’s life (Brandtstädter & Rothermund, 2002; Stefanic et al, 2013; 
Wrosch et al., 2003).  
In the months following a diagnosis of breast cancer, negative cognitions in terms 
of uncertainty about the future, financial uncertainties, time-consuming treatments, 
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disruption or loss of work activities, changing in family roles and challenging 
physical symptoms can all present threats to pursuit and accomplish goals in 
various life domains (Stefanic et al., 2013). Thompson and colleagues (2013) 
confirm that goal re-engagement involves identifying a new goal and then 
committing and pursuing the alternative goal. I found in practise that especially 
after surgery and during chemotherapy, patients struggle with basic day to day 
achievement of goals because of acute side-effects like nausea, pain and fatigue.  
It is often the lack of achieving practical goals (e.g. to go to work every day and to 
be functional at work, or to run the household as before or when there is small 
children, to maintain certain tasks) that can make a patient feel incompetent and 
useless. By explaining the reason(s) why “normal” day to day goals are hard to 
reach (in terms of specific side-effects and symptoms) already make patients feels 
less incompetent and useless. Patients also need to understand that if a goal is 
hard or impossible to achieve, it has to be replaced by a new or altered goal that 
can be achieved and that often after finishing with cancer treatment, some 
previous goals can again be implemented and achieved, but that there will be 
some goals that will be changed in the long run because of permanent changes 
due to the cancer and cancer treatment. This supports the general concept that 
the new life circumstances imposed by a cancer diagnosis and its treatment can 
threaten the pursuit and attainment of an individual’s personal goals (Carver, 
2005; Stefanic et al., 2013; Thompson Stanton, & Bower, 2013; Wrosc et al., 
2003). As a therapist it is imperative to know that women with higher levels of 
symptom burden would also have higher cancer-related goal interference that is 
associated with higher levels of distress (Stefanic et al., 2013). It is of much value 
for the patients to learn to adopt goals that is related to their newly changed life 
context and in response to the demands posed by a serious and chronic health 
condition (Carver, 2005). In the beginning (just after the breast cancer diagnosis) 
new goals are created around the treatments, e.g. to “survive” the surgery, or the 
first chemo, radiation and side-effects like alopecia and other bodily and emotional 
changes and you help the patient to implement this alongside the old existing 
(most often) altered goals.  
The process of goal adjustment in cancer patients plays an important role in the 
reduction of emotional distress and adaptation to a chronic health condition. 
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Losing or changing goals appears to be a challenging process that may contribute 
to a sense of loss and can accompany depressive symptoms, especially in 
patients who are giving up on highly important life goals (Manne et al., 2009; 
Thompson, Stanton, & Bower 2013). Through this process of goal adjustment, 
they learn that together with new and changed goals, they will experience difficult 
emotions that need to be talked about, dealt with and put in proper perspective 
(Low, Stanton, & Bower, 2008). It is important for the therapist to encourage and 
facilitate re-engagement in new goals (motivational structure) to help reinstate a 
sense of purpose for them and to provide opportunities for positive affect that 
accompanies purposeful striving toward attainable goals (Carver, 2005; Brennan, 
2001; Thompson et al., 2013).  
 Coping responses and skills 
Coping is the process of managing internal and external demands which are 
viewed as challenging and exhausting or exceeding the resources of the individual 
(Brennan, 2001). Coping can be defined as constantly changing cognitive 
(thoughts) and behavioural efforts to manage specific internal and/or external 
demands that are comprehended or perceived as a stressor (Drageset, Lindstrom 
& Underlid, 2010; Folkman, 2010). A breast cancer diagnosis activates a variety of 
emotional reactions such as anxiety, uncertainty, hopelessness and despair and 
places extraordinary demands on the breast cancer patient’s coping abilities 
(Drageset et al., 2010; Landmark, Bohler, Loberg & Wahl 2008). Coping strategies 
are classified as problem-focused coping behaviour focussed on solving the 
problem or situations and emotion-focused coping behaviour, focussed at 
changing the emotional reactions to the problem or situations (Folkman, 2010; 
Drageset et al., 2010). Coping can be active, which refers to confronting problems 
and deciding on solutions, or can be passive meaning avoiding the source of the 
distress (van Oers & Schlebusch, 2013). During primary treatments when patients 
are dealing with the immediate and acute impact of the diagnosis, treatment 
decisions and side-effects, the adaptive coping responses are more problem-
focused, dealing actively with the immediate demands or the situation (e.g. who 
will take you to the chemo, what will you do the whole time during the chemo to 
keep yourself busy, who will look after the household when you are at the chemo, 
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etc.). Post treatment, when the patients return to their everyday lives, adaptive 
coping appears to become more introspective and reflective (Park et al., 2008). 
Coping reactions that lead to engagement in the activities of life (e.g. positive and 
realistic reframing of the situation, the use of social resources and acceptance) 
can help to diminish distress later in the process of recovery (Carver, 2005). 
Although personality type plays an important role in the type of coping reactions, I 
find that breast cancer patients are often open for suggestions and information to 
understand their psyche better and to learn new coping skills.  Tools of coping as 
a technique include: identification of irrational or negative thought patterns, 
(dysfunctional thought patterns), normatively effective coping responses, 
emotional expression, adaptation and the use of social support and practical 
activities such as deep muscle relaxation and deep breathing.   
Coping with cancer also includes coping with emotional distress. Emotional 
distress, the sixth vital sign in cancer care, is an important outcome and when 
severe, it has been associated with reduced treatment compliance and elevated 
risk of disease progression and death (Conley, Bishop, & Andersen, 2016; 
Pinquart, & Duberstein, 2010). Adjustment to cancer includes managing emotional 
distress through attempts to reduce and manage the emotional distress that the 
cancer causes (Conley et al., 2016). Conley and colleagues (2016) used the term 
regulating emotional distress. Emotion regulating does not mean that that the 
person replaces negative emotions with positive ones, they still experience 
negative emotions but instead they adjust the dynamics of each emotion and 
produce adaptive responses to the environment (Aldao, 2013; Conley et al., 
2016). Evidence suggest that active efforts to acknowledge, understand, and 
express emotions are associated with improved well-being and diminished 
distress in stressful situations (Austenfeld & Stanton, 2004; Stanton & Low. 2012). 
Patients need to understand that suppressing emotion-related thoughts and 
emotions can impair psychological and interpersonal functioning, especially when 
the suppression is chronic. Hiding emotions is unlikely to help them feel better and 
can interfere with adjustment. Taking into consideration that there are different 
personalities, processing and expressing emotions is not effective for everyone 
under all conditions (Campbell-Sills, Barlow, Brown, & Hoffmann, 2006; Gross & 
Levenson, 1997; Stanton et al., 2000). Findings from a study done by Stanton and 
165 
 
colleagues (2000) reveal that breast cancer patients’ use of coping through 
emotional expression following primary treatment were associated with a 
decreasing in distress, an increasing in healthiness and  an enhanced self-
perceived status.  There is also a correlation with attending les medical 
appointments for morbidities related to cancer and its treatment. In the light of the 
health benefits of sharing emotions, it is important to create a safe and empathetic 
therapeutic environment for patients where they can feel encouraged and 
comfortable sharing their innermost feelings.   
The two most frequent occurrences in terms of coping that I see in my practise are 
coping with uncertainty and coping or dealing with a changing reality, which are 
both fully described by Folkman (2010), and Nelson (1996).   
 Coping with uncertainty:   
Some of the very first questions according to Folkman (2010) that newly 
diagnosed cancer patients usually ask are: “Am I in danger?”, “Will I die?”, “How 
bad is this?” “How will the treatment affect me?” As a psychologist it is important to 
go through their questions and give them time to express their emotions. It is also 
beneficial for patients to understand early in the trajectory of their illness that a big 
part of this cancer journey is the unknown and uncertainty of the illness, but by 
knowing and accepting it, they can at least prepare for it without stressing over it 
the whole time.   
Uncertainty is a common experience for women living with breast cancer 
especially when treatment cannot guarantee disease cure and because of the 
threat of recurrence. There is a prominent connection between uncertainty and 
psychological stress and it is safe to say that every stressful situation involves 
some degree of uncertainty. Learning to live with this uncertainty is part of the 
challenge the cancer survivor has to face (Greeff, 2008; Nelson, 1996; 
Wonghongkul, Dechaprom, Phumivichuvate, & Losawatkul, 2006). Uncertainty 
was found to consist out of three main themes namely, 1) uncertainty because of 
limited or inadequate information, 2) uncertainty regarding the course and 
treatment choices related to the cancer and 3) uncertainty related to everyday life 
and coping with the cancer. It appeared that women with breast cancer experience 
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moderate to high illness uncertainty upon diagnosis, before surgery and at the 
beginning of chemotherapy. This uncertainty has been associated with uncertainty 
of diagnosis, outcome of treatment and the impact of treatment of their life, 
tolerance of physical and mental distresses caused by treatment, survival rate and 
perceived life threats (Folkman, 2010; Liao et al., 2008). The experience of 
uncertainty influences the illness experience, adaptation, quality of life and a 
sense of hope, therefore is an important factor to take into consideration when 
treating a breast cancer patient in psychotherapy (Liao et al., 2008).      
In the period immediately after receiving the cancer diagnosis, the patient 
experiences shock and denial, and feels as if the world becomes overwhelming 
and meaningless and that life makes no sense (Livneh, 2001; Swack, 2008). 
Patients often say that they felt completely numb and couldn’t remember anything 
that the oncologist (or other medical doctor said) after giving the news of the 
cancer. Most often the initial response for most patients is to minimize the 
significance of what they were told or to avoid thinking about it all (denial), but is 
usually only temporary. Technically speaking, this represents the first stage of the 
grieving process and enables the patient to survive the trauma (Kübler-Ross, 
Wessler, & Avioli, 1972; Kübler-Ross & Kessler, 2014). It is important for patients 
to understand that this reaction (denial) can help them to cope on a daily basis 
with the cancer and make survival possible by controlling their feelings of grief in 
dignity. It must be explained to them that denial is nature’s way of giving them time 
to come to terms with a lot of overwhelming emotions in quantities that they can 
handle (Kübler-Ross & Kessler, 2014). Only later, by accepting the reality of the 
breast cancer will the healing process begin and denial will begin to fade (Kübler-
Ross & Kessler, 2014). Some of the most effective coping skills regarding 
uncertainty are: Information-seeking, cognitive and emotional distancing, 
emotional support and expressing emotions: 
 Information-seeking: this must be applied with care, for giving too much 
information too quickly frighten some patients as was found in a study done 
Drageset and colleagues (2010). The preferred method is a step-by-step 
process to enable the patient to face reality gradually and facilitate 
accepting and preparing for what might come. By giving adequate 
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information (actual facts) in their present situation, the patient can be given 
a sense of control over her situation and will allow her to process the 
cancer in a less negative way and avoid dwelling on problems that might 
arise (Loiselle, Lambert, & Cooke,  2006; Rees & Bath, 2000); 
 Cognitive and emotional distancing: Focusing and engaging on something 
positive or activities that require concentration and physical activity is an 
effective coping strategy that will help the patient to cope with uncertainty. 
Physical activity, as a way of coping, produce positive emotions, reduce 
anxiety and offer physical and mental strength (Drageset et al., 2010).  
Patients who are engaged in their work and receive support and positive 
responses from their colleagues, (when it is physically possible for them to 
work) can reduce their anxiety and strengthened their self-confidence by 
diverting their attention away from their cancer and make them feel in 
control of something in their lives (American Cancer Association, 2014).   
Work has the potential to help patients to regain a sense of normalcy, of 
being valued and of re-integration into society. Therefore work comprises a 
range of positive consequences for the recovery and the psychological well-
being of cancer survivors (Mehnert, 2011). Steiner and colleagues (2004) 
found that work after cancer is highly desirable from a social and economic 
perspective but is also associated with enhanced self-esteem and quality of 
life. Taking control over some aspects of their lives and creating order in the 
chaos they are experiencing can be understood as a basic adaptive coping 
strategy (Liao et al., 2008).   
 Expressing emotions: Sharing emotions can give positive relief for some 
women (Hack & Degner, 2004; Stanton et al., 2000). Crying, talking and 
writing could provide a healthy outlet for emotions, helping to keep calm 
and stopping feelings of depersonalization (Hack & Degner, 2004; Stanton 
et al., 2000). It is important for patients in therapy to learn and understand 
that allowing themselves to experience negative emotions and to share it 
with other people can be a healthy mechanism of coping.  
 Coping with a changing reality:   
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When circumstances change with time, previous hopes and expectations may no 
longer be relevant. An example used by Folkman (2010), is where a cancer 
patient learns that her course of chemotherapy was not effective and a new 
treatment with more aversive side effects is required, or that there is no further 
treatments available, or that the cancer has metastasised, or that there is a 
recurrence after a period of remission. The patient and her family are now faced 
with the double challenge of sustaining hope while coping with the changing 
reality. Although recognizing that matters are not going well might mean giving up 
hope with respect to what had been, but hope itself is not necessarily nullified. 
When little can be done to affect a particular outcome, religious faith (for instance) 
can support hope by giving the patient a sense of ultimate control through the 
sacred or through affirming beliefs about the sacred such as “God will be at my 
side”. Individuals who rate high on hope as a trait have the advantage of 
approaching circumstances with a hopeful disposition that is protective, they also 
tend to show diminished stress reactivity and more effective emotional-recovery 
than those low in dispositional hope (Ong, Edwards, & Bergeman, 2006). 
Illness has a way of disturbing goals that organize day-to-day choices and 
behaviour. Because of the illness, patients need to adjust their goals to more 
practical and achievable goals. For example, the mother with young children 
would concentrate on resting more and attending and focusing on her own health 
in order to reinstate her health so that she can resume care of her children (Stein, 
Folkman, Trabasso, & Richards, 1997; Wrosch et al., 2003). This change in reality 
might seem simple and logical to the oncology team but in a world where cancer is 
an unknown phenomenon patients don’t necessarily have the knowledge to 
implement simple interventions. The process of revising goals by letting go of 
goals that is no longer justifiable or achievable and identifying realistic and 
meaningful goals that adaptive for copping in the present situations is an important 
form of meaning-focused coping. This maintains a sense of control creates a new 
sense of purpose and allows hope that is relevant to the new goals (Folkman, 
2010).   
 Hope 
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Hope can be defined as a longing for an improvement of a dreaded outcome, has 
elements of a theological quality along with faith and support and can be seen as 
a positive goal-related motivational state (Eliott & Olver, 2002; Folkman, 2010; 
Hammer, Mogensen & Hall, 2009). Hope has been characterized in the literature 
as having a “being” dimension, an element that is deep inside a person’s self that 
remains positive whatever happens and represent a pragmatic, goal-setting entity 
in response to situations (Hammer et al., 2009). In the medical literature, 
maintaining and restoring hope is seen as an important function of the physician- 
or oncology team (Folkman, 2010). Hope is viewed as a coping strategy that helps 
people to endure uncertainty and is future-orientated (Drageset et al., 2010; 
Stanton, Danoff-Burg, & Huggins, 2002). Folkman (2010) discusses hope from the 
view of a stress and coping theory and is seen as contextual, meaning-based and 
dynamic and is vital for people who are coping with a serious and prolonged 
psychological stress. According to Folkman it is imperative for the cancer patient 
to understand that hope is not static, but has ups and downs and can at times 
even be absent. Theoretically, hope provides a counter-balance to interpersonal- 
and intrapersonal incidents that activates anxiety during periods of uncertainty. In 
this framework hope (as in faith) or hoping (as in actively focusing on reasons for 
feeling hopeful) acts as an emotion-focused coping strategy (Folkman, 2010). 
Hope has a calming effect on a patient (and her family) and can be reinforced by 
other kinds of emotion-focused coping strategies, for example, distracting activities 
such as exercising, work, social activities or crafts, such as handwork or 
gardening.  
According Folkman (2010) hope has a very special quality that is important in 
managing uncertainty over time, for hope allows the patient to hold conflicting 
expectations simultaneously. An example is on the one hand, the patient knows 
she has cancer which means there is unpredictable biological and psychological 
effects, and in worst case scenario, even death, but on the other hand, there is 
also effective treatments and reliable statistics of survivorship that give the patient 
necessary hope to survive. In other words you can feel scared, anxious and 
despair, but also hopeful at the same time. Hope facilitates adaptive problem-
focused and emotion-focused coping. Hope can have many different faces, such 
as “I hope to attend my son’s wedding”, “to maintain my dignity”, “to be at peace 
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with my God”, “that my children/spouse/family will be o.k. without me”, or “not to 
suffer in the end.” These desires give definition to the foundation for hope and 
sustained coping till the very end. Folkman (2010) said it is important to ask 
questions about what patients hope for in cases where reality is changing and a 
grave outcome is inevitable.    
 The Process of accepting and adaptation as a coping response 
according to the cancer survivor adaptation model (CSA)  
According to Livneh (2001) an important goal in therapy, working with a patient 
with a chronic condition, is active acceptance of the condition, accommodation of 
both environmental demands and particular personal needs and desires and the 
integration of these changes (biological and physical) into new and positive 
reconstruction of the self. Through acceptance comes adaptation, which means 
the opposite of feelings of helplessness and hopelessness and denial of the 
condition or its implications. Adaptation refers to the psychological processes that 
occur over time as the patient and their family cope, learn from and adapt to the 
multitude of array of changes which have been precipitated by the illness and its 
treatment. Successful adaptation, according to various authors, is the central 
component of the cancer survivor adaptation model (CSA) and is considered to be 
on-going and dynamic throughout cancer survivorship with cognitive evaluation of 
goals as the specific mechanism of change (Brennan, 2001; Livneh, 2001; Naus et 
al., 2009). The term adjustment or adaptation suggests the completion of change 
form one state to another. In the CSA model quality of life outcomes include 
physical, emotional, spiritual, and cognitive adjustments. These effects constantly 
feed back into the intrapersonal and interpersonal characteristics of the cancer 
survivor, preparing for the on-going adaptation process to continue (Livneh, 2001). 
Brennan (2001) emphasizes that changes and adjustment are not always for the 
worse, they can also precipitate healthy, personal growth, for a life event crisis can 
be an opportunity for positive personal growth.   
The cancer patient’s personal context of intrapersonal and interpersonal 
characteristics creates the background in which a cancer diagnosis is 
experienced. Intrapersonal and interpersonal characteristics include the bio-
psycho-social-spiritual factors that define the individual and impact the cancer 
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experience, containing, but not limited to, specific characteristics of the cancer 
(e.g. type of cancer, prognosis, treatment and late effects), life stage (and 
associated world assumptions and goals), overall mental and physical health, 
personality, social support, coping and spiritual beliefs (Naus et al., 2009). These 
characteristics influence the survivorship experience and play an integral part in 
the adaptation process over time in that they are continually adjusted by changes 
in quality of life outcomes. At each stage of life, the individual’s expectations about 
the world provide a stable lens for perceptions of self, definition of goals and 
predictions about their future. A traumatic occurrence such as a cancer diagnosis 
could be expected to alter basic world expectations of personal health and belief in 
a fair world, influencing both short- and long term goals across many areas and 
quality of life outcomes. According to Naus and colleagues (2009) better quality of 
life outcomes were reported for cancer survivors who detached from unreachable 
goals and moving toward new goal achievement during each chapter of cancer 
survivorship. Naus and colleagues (2009) explain this in a more practical sense: a 
trauma, such as a cancer diagnosis, can disrupt the continuity of the self-concept, 
personal scripts and general belief systems, creating an increased risk of pursuing 
goals that have become either incompatible or unattainable. So when there is a 
threat due to changing conditions such as cancer, the individual must generate 
new goals and modify existing goals in an effort to reduce psychological tension 
and promote coherence of the self-concept.  
In the CSA model adaptation from a cancer patient to a cancer survivor involves 
the creation of new goals and world assumptions applied within the framework of 
the personal context and continually influencing quality of life outcomes (Naus et 
al., 2009). If there is then a reduction in quality of life, because of the cancer or 
cancer treatment, the cancer survivor can then respond by reassigning priority 
allowances to their existing goals and making changes in these goal domains. 
Little and colleagues (2002) said that the best way to accommodate the cancer 
experience is for the cancer survivor to reconstruct plans and expectations for 
their future. Cancer patients can learn, during a therapeutic process, that because 
of all the losses and changes they went through because of their cancer, they can 
never be the same as before the cancer. They cannot look at themselves and the 
world the same way as before the cancer. Understanding this and grieving the 
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losses also helps with healthy adaptation and making peace with your “new” life 
(Livneh 2001; Little, Paul, Jordens, & Sayers, 2002; Naus et al., 2009). The CSA 
model also suggests that in addition to psychological interventions designed to 
promote short-term coping skills and stress relief, that life-long focus must be 
included. This will help the survivor to redefine goals and priorities through 
establishing new goals in marginal domains through new interests, new social 
outlets and new ways to engage in life. Long term interventions designed to 
reorder lives through goal adaptation and identity change might compliment the 
more traditional focus on short-term interventions that reduce symptoms of stress 
during diagnosis and treatment. The CSA model suggests that cancer survivors 
need to be re-assessed for psychological distress over time as adaptation and 
subsequent coping are not static and that the oncology team must be aware of 
this, e.g. a cancer survivor may not experience distress during an earlier stage of 
survivorship, but might require help in coping with stress or emotions in a later 
stage (Naus et al., 2009; Little et al., 2002). Successful adaptation is reflected in 
one’s ability to effectively rebuild and manage both the external and environment, 
and one’s inner experiences (emotions, cognitions and behaviours) and guarantee 
the achievement of improved quality of life (Naus et al., 2009; Little et al., 2002). 
The objective when working in the framework of acceptance is to keep the patient 
engaged in life by maintaining continued goal commitment (Carver, 2005). Greeff 
(2008) accentuates the fact that the process of learning to incorporate the illness 
as part of the “new normal reality” is not an easy task. The CSA model highlights 
the need for longitudinal research in terms of multiple measurements at critical 
periods during the cancer trajectory and suggests future directions for research 
investigations and clinical interventions addressing issues of cancer survivorship 
(Naus et al., 2009).   
 
4.4.2.3  Therapeutic interventions for women with metastatic cancer 
Metastatic cancer is cancer cells that have broken away from where they first 
formed, known as the primary cancer, which then spread through the blood or 
lymph system and form new tumours that are then called metastatic tumours. It 
usually spread to the brain, bone, liver or lungs and have a median survival time of 
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fewer than five years (the American Cancer Society, 2016; Giordano, Buzdar, 
Smith, Kau, Yang, & Hortobagyi, 2004). Metastatic cancer is associated with 
several challenges including multiple physical symptoms and progressive physical 
deterioration that may cause fear and anxiety about the loss of autonomy, death 
anxiety, dependency on others and the loss of a sense of meaning and purpose. 
This psychological and social factors together with disease burden have been 
associated with higher rates of depression and demoralization in this cancer group 
as opposed to women with less advanced disease (Jacobsen, Davis, & Cella, 
2002; Jacobsen & Jim, 2008; Lo et al., 2014). As noted before, psychological 
distress tends to be more critical in cancer patients with advanced disease, hence 
the considerable need for psychosocial interventions that is effective against 
depression in these patients (Jacobson & Jim, 2008; Savard et al., 2005).  
Results of studies suggest that short-term cognitive therapy can effectively treat 
depression in women with metastatic breast cancer in spite of the seriousness of 
the disease (Jacobsen et al., 2008; Savard et al., 2005). Because of this, 
systematic screening of depression should be implemented in this population, 
most probably by the oncologist, who will have the most contact with the patient if 
she was not referred before (Savard et al., 2005). Thompson and colleagues 
(2013) has found that depression in this cancer population is often 
underdiagnosed and insufficiently treated. Savard and co-workers (2005) have 
adapted a form of cognitive therapy developed for treatment of depression in the 
general population to meet the needs of patients with metastatic cancer. The goal 
of this therapy is predominantly to promote a balanced and optimistic but also 
realistic outlook toward their condition as opposed to either an excessively 
negative outlook (only thinking of death), or overly positive attitude (just hoping to 
be cured). The sessions focus largely on helping the patient to modify 
dysfunctional or irrational thoughts about their cancer and other important 
situations in their lives. It is important for the therapist working with this population 
to also acknowledge the fact that in this stage of the illness, there are a lot of 
natural negative and difficult thoughts and emotions, and that it is not unrealistic to 
be fearful of death and anxious for those who will stay behind. Thompson and 
colleagues (2013) feel that it may be more challenging to find alternative goals to 
pursue when confronting shortened life expectancy and physical limitations. The 
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ability to adjust goals is especially important when individuals are confronted by 
prolonged and intense stressors. Understanding the benefits of goal adjustment in 
the context of serious health conditions may encourage the development of 
interventions to promote psychological well-being for chronically ill individuals 
(Wrosch et al., 2003).  
It is important for therapists to encourage direct expression of primary negative 
emotions like fear, anger and sadness in a supportive setting during therapy 
sessions. This will facilitate solutions of on-going difficulties, release unexpressed 
emotions and allow patients to adapt healthier thought processes (Giese-Davis et 
al., 2005). Low and colleagues (2008) found in their study that apart from talking 
about emotions, writing about it can positively affect a patient’s mood. A study 
done by Giese-Davis and colleagues (2005) (although in group therapy for 
metastatic cancer patients), the results have shown that emotional expressions in 
therapy allow patients to be aware of their feelings and cognitions. It gave them 
time to process their feelings and become aware of choices that they can make 
that might lessen some of their distress. In contrast, patients’ expressions of 
positive emotions provide information on their own coping strategies. Happiness, 
for instance could be achieved by choosing circumstances that left patients feeling 
good, e.g. actively changing inevitable situations such as going to treatment by 
connecting it to positive occasions junctures like going out on an outing afterwards 
(Thornton, Levin, Dorfman, Godiwala, Heitzmann, & Andersen, 2014). These 
authors illustrate in the next figure that suppression of emotional expression or 
unwanted thoughts can be maladaptive that put patients at risk of heightened 
emotions and even psychopathology.   
Emotions      Emotion Regulating Strategies 
        Suppression 
    +    Avoidance 
        Rumination 
Depression 
Anxiety 
Anger                           -        
        Acceptance 
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        Problem Solving 
        Reappraisal 
    + 
Happiness 
Love 
Hope 
Illustration of emotional regulation strategies by Thornton and colleagues (2014).   
 
Although group therapy for metastatic cancer patients has received substantial 
attention in the literature with good results, individual psychotherapy is preferred 
by patients with advanced disease. It creates a safe and supportive environment 
and is often more practical to deliver, because the sessions can be flexible and 
can be customised to individual needs (Beacham, Hill,  McDermott, O’Brien, & 
Turner, 2005; Clark, Bostwick, & Rummans, 2003; Giese-Davis et al., 2002; 
Giese-Davis et al., 2006; Goodwin et al., 2001; Kissane, 2009; Lo et al., 2014; 
Savard, et al., 2005; Sherman, Pennington, Latif, Farley, Arent, & Simonton, 
2007). Lo and colleagues (2014) have designed and standardised a brief 
psychotherapeutic intervention technique to lessen distress and to promote 
psychological well-being and growth in patients with metastatic cancer. This 
intervention relates to the seven elements of Spiegel’s therapeutic approach which 
consists of social support, expression of emotions, detoxifying dying, reordering 
life’s priorities, family support, effective communication and symptom management 
(Spiegel & Glafkides, 1983). This psychotherapeutic intervention offers support 
and reflective space for the processing of thoughts and emotions and enables the 
resolution of practical and existential questions that individuals face with 
metastatic cancer. Spiegel urged breast cancer patients to reorder their life’s 
priorities to help them take control and enrich the quality of their lives by living 
beyond the limits that the illness inflicts on them and their families (Spiegel & 
Glafkides, 1983). Lo and colleagues (2014) named this psychotherapy CALM 
which stands for managing cancer and living meaningfully. CALM focuses on four 
main areas that are relevant to patients with advanced disease:   
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(a) Symptom control and communication with health care providers.  
(b) Self-concept and relations with close others. 
(c) Spiritual well-being and the values and beliefs that provide meaning and 
purpose in their lives.  
(d) Preparing for the future, sustaining hope and facing mortality.  
Lo and colleagues (2005) feel that managing cancer and living meaningfully 
(CALM) holds promise as a brief intervention to relieve distress and promote 
psychological well-being and growth in patients with advanced cancer. It is very 
important to let your patient understand that even with a terminally, severe illness, 
that you and others still respect her and that she is worth listening to and that she 
must still have good thoughts about herself. It is imperative for her to hear that she 
is not a burden for her loved ones, but a blessing to be able to look after her.   
4.4.2.4  Therapeutic interventions with woman with advanced cancer 
Patients with advanced, incurable cancer, face complex physical, psychological, 
social and spiritual consequences of the disease and its treatment. Care for this 
population should include an individualised assessment of the patient’s needs, 
goals and inclinations throughout the course of their illness (Peppercorn et al., 
2011). Oncology care providers need to recognize the importance of generating 
an individualised treatment plan for these patients and their families. As a 
psychologist it is important to initiate potentially difficult conversations with these 
patients and their families about prognosis, outcomes, options and end-of-life 
preferences that will fit the patients’ need for information and involvement in 
decision making and establishing a practice model that supports interdisciplinary 
cooperation around care for this patient population (Peppercorn et al., 2011).   
Depressive symptoms that are related to death and dying and other forms of 
distress, especially fatigue, have been found to negatively affect quality of life, 
compliance with medical treatment and appropriate health-care application 
(Berger et al., 2015; Lo et al., 2011; Lo et al., 2014). Although cognitive therapy is 
an empirically supported treatment for depression in the general population, the 
effectiveness remains to be demonstrated in patients with advanced cancer, yet 
according to Savard and colleagues (2005) there are evidence that cognitive 
therapy showed improvements in depression, mood disturbance, and self-esteem 
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in this cancer population. While patients near the end of their lives may be focused 
on life closure and death preparation, those with longer expected survival must be 
equipped to balance the burdens and anxieties of their illness and approaching 
death with goals of living in the present, an occurrence that has been termed 
“double awareness” (Rodin & Zimmermann, 2008). 
It is important for the advanced cancer patient in therapy to feel that they still have 
the capacity to participate in therapy as a worthy person and to be able to learn 
new and helpful skills that will better their quality of lives and also those of the 
family. The therapist and patient must take into consideration the physical 
condition of the patient in order to decide on the types of goals or activities, if it is 
still possible. It is important that the activities lead to a sense of accomplishment 
and satisfaction, for instance, to spend more quality time with friends and family. 
Savard and colleagues (2005) give examples of typical negative and often 
irrational thoughts such as “I am going to die alone and in pain”, “life is no longer 
worth living since I know that I am dying”, “I am no longer useful to my family and 
am just a burden”. The therapist then use cognitive restructuring to modify these 
dysfunctional or negative cognitions, such as “I know that my family will be there 
for me till the end”, “my doctor will ensure that I will get sufficient medication to 
control the pain”, “no one knows how long I am going to live, I might have enough 
time to achieve some of my goals that are important to me”, “my family are happy 
to still have met with them”. Because of the advanced stage that the patient might 
be in, thoughts about fear and death and incapability is not irrational or untrue, and 
it is important for the patient to know that the therapist is also conscious about this, 
but that there are still better, more positive and constructive thoughts that will 
benefit both the patient and her family in terms of their quality of life. Savard and 
colleagues (2005) said that it is better to set life goals that the patient may not 
have time to achieve than to have no life goals at all. Only waiting for death makes 
a patient feel helpless.  
During this stage of cancer, specific needs of the family members may arise and 
may have a major influence on the adjustment of the patient, such that direct 
contact with, and support of family members is often necessary (Beacham et al., 
2005).  During this stage it can be beneficial to engage family members of the 
patient in a therapeutic process to discuss their own emotions and needs 
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regarding the patient and realistic goals concerning their situation. An example of 
this is for instance when a family member is planning a wedding, for them to take 
time (that might be left) and the patient’s physical condition into consideration. 
Family members must be made aware of the impact of certain decisions on them 
and the potential for regret after the patient’s death about things left undone, for 
instance, if the wedding was planned to late and the mother could not attend, how 
the daughter would then feel about that. Only through open communication can 
the family make plans that accommodate the likely course of the disease and 
make the most of the moment (Beacham et al., 2005).  
4.4.2.5  Palliative care in the context of therapeutic interventions 
Palliative means soothing or comforting and palliative care offers specialised 
treatment to patients whose illness is no longer considered curable. The primary 
goals of palliative care is to provide comfort and care for those with life-limiting 
illnesses and their families and to ensure that the patients are able to die 
peacefully in the setting of their choice, often in their own home, while receiving 
necessary nursing, medical, psychological and spiritual care (Chochinov, 2006). 
The world Health Organization (WHO) defines palliative as an approach that 
improves the quality of life of individuals and their families facing difficulties 
associated with a life-threatening illness through the prevention and relief of 
suffering by ways of early identification, assessment and treatment of pain and 
problems concerning physical, psychosocial and spiritual factors. Palliative care is 
helping patients live as actively and comfortable as possible until their death, with 
support being provided to help families cope during their loved ones’ illnesses and 
into their own bereavement (Chochinov, 2006; Singer, Martin, & Kelner, 1999). 
Patients confronting a terminal illness who have pre-existing anxiety disorders are 
at risk for reactivation of their symptoms (Chochinov, 2006; Breitbart, Gibson, & 
Chochinov, 2005). Symptoms such as pain or weakness may reactivate a 
generalized anxiety or panic disorder, while patients with a history of phobias 
especially fear of death, may display anxiety symptoms requiring both medication 
and emotional support. Patients and their families experience such relief when 
they understand this type of near death fears and phobias and that the underlying 
course of these fears are not because the patient is not “ready to die” but because 
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of a psychiatric predisposing (Chochinov, 2006; Breitbart, Gibson, & Chochinov, 
2005).   
Weisman (1972) outlines four criteria for what he referred to as an “appropriate 
death”. 1) Internal conflicts such as fears about loss of control should be reduced 
as much as possible. 2) The patient’s personal sense of identity should be 
sustained. 3) Significant relationships should be improved or at least maintained, 
and if applicable and possible, conflicts resolved. 4) When possible the patient 
should be encouraged to set and attempt to reach meaningful (albeit limited) 
goals.  
4.4.2.6  Interventions with the family and social support system  
Whatever the actual prognosis of the cancer is, it confronts the patients and those 
in their social world with the threat of permanent separation from loved ones which 
is profoundly distressing, not only because of the fear of leaving the world alone, 
but also because people anticipate the grief reactions of their loved ones. In a 
cancer world, assumptions about autonomy and dependency within relationships 
become more obvious. The demands of cancer treatments can also lead to 
changes in social roles (e.g. where the patient was always the care taker but now 
are the one to be taken care of) which may challenge established assumptions 
about self-worth and self-efficacy. Parents with young children in particular, 
experience intense and invasive fears about the fate of their children in the event 
of their death therefore the assumed worlds of both the patient and those attached 
to them require adjustments preferably through psychotherapy (Brennan, 2001).    
According to Nicolas (2013) families facing cancer are conceptualized as second-
order patients, responding to the strain of cancer as interdependent emotional 
beings. The diagnosis of cancer of one member of the family has a rippling effect 
throughout the whole family system; with the primary threat that of separation. 
This threat may obliterate ideas about autonomy and independency or 
dependency within a relationship, and the fear of questioning the unspoken 
dependency needs can lead the couple or family to engage in unhelpful defences 
such as withdrawal and criticism. Relationships will require considerable 
adjustments and accommodation over the course of the cancer illness as both the 
patient and her significant others have to adjust to role changes brought on by the 
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illness and its treatment (Brennan, 2001). Healthcare systems are not always 
aware of the impact that the cancer has within the family milieu. Families are 
launched into an unfamiliar environment where they often have little or no time 
emotionally and psychologically to absorb and integrate the illness within the 
average course of their lives. It can happen that the needs of the family members 
are often neglected because all the attention goes to the patient (Baider, 2008).  
It is a well-known fact that healthy and mature relationships among family 
members offer fundamental social support resources, safeguarding cancer-related 
stressors. However, even when there are healthy inter-family relationships, a 
cancer crisis can challenge patterns of family cohesion and adaptability due to 
concerns, role changes and disruptions to daily routines that come during active 
cancer treatments. Normal family development can be delayed or disrupted in 
response to cancer treatments and even after completion of cancer treatments, 
there might be continues family changes to adapt to a “new normal”. Family rules, 
boundaries and communication patterns are all challenged by the aftermath of 
cancer. The threat that cancer poses to the family can be best understood against 
the background of how different members, individually and as a whole, form and 
share meaning about specific stressful situations, their identity as a family and 
their view of the world (Baider et al., 2008; Surbone et al., 2010). It is important to 
explain to families that neither the patient nor the family can ever return to a pre-
illness status quo and that the only way to reach a successful working family 
functioning is through proper education for everybody about the impact of the 
illness, in the short-term but also for the future (Baider et al., 2000; Surbone et al., 
2010). Providing this emotional contributory support to cancer patients’ families 
during the entire illness is based on a thorough assessment of their cohesiveness, 
empathy and support, flexibility and shared needs (Surbone et al., 2010). Both 
patients and family members can benefit from various forms of psychological 
intervention. It is imperative to explain to the family the importance to listen and 
understand the negative feelings of the cancer patient and that acknowledging 
and expressing negative emotions does not mean that the patient doesn’t feel 
positive or hopeful, but that it is mere human factor. By allowing the patient to feel 
and express negative feelings the family will also then allow themselves to 
acknowledge, accept and work through their own negative feelings (Hack & 
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Degner, 2004; Stanton et al., 2000; Thornton et al., 2014 Giese-Davis et al., 
2005).   
4.4.2.7  Pharmacology and psychotherapeutic interventions 
Although a psychologist cannot prescribe any form of medication, it is essential to 
understand the workings, impacts and benefits that medication can have on your 
patient, especially in terms of her mood and overall functioning. I will very briefly 
discuss some of the pain medication and anti-depressants, for it plays a prominent 
part of the psychological experience of a breast cancer patient.      
The National Cancer Control Initiative’s (NCCI) guidelines for psychological and 
social care of adults with cancer recommends that depression can be managed by 
incorporating a combination of supportive psychotherapy, CBT and 
pharmacotherapy (Jacobson & Wagner, 2012). The superior value of the 
combined treatments of psychotherapy and pharmacotherapy in depression in 
cancer patients over either treatment alone has been confirmed in several meta-
analyses (Cuijpers, Dekker, Hollon, & Andersson, 2009; de Maat, Dekker, 
Schoevers, & de Jonghe, 2006, 2007; Hart et al., 2012). The combination of 
cognitive- and pharmacotherapy for depression is also widely practiced with good 
results (Butler, Chapman, & Beck, 2006.)   Cuijpers and colleagues (2010) found 
psychotherapy and pharmacotherapy are about equally effective in treating 
depression and anxiety within the cancer population, but are more potent in 
combination with each other than on their own. In a meta-analysis, Fann and 
colleagues (2008) found that treatment with SSRIs was somewhat more effective 
than treatment with psychotherapy. One difference that was found between 
psychotherapy and pharmacotherapy was that although both provided similar 
efficacy in the short-term, psychotherapy had superior results in the longer term 
(de Maat et al., 2006; Spielmans et al., 2011).  
In treating depression in patients with breast cancer, antidepressants are effective, 
especially serotonin reuptake inhibitors and norepinephrine reuptake inhibitors 
combined with cognitive and behavioural therapy. Authors like Frann and 
colleagues (2008) and Brem and Kumar (2011) believed that this combination 
might improve the recovery time more than just cognitive treatments alone.   
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To very briefly explain some anti-depressants:   
SSRIs: Selective serotonin reuptake inhibitors (SSRIs) are the most commonly 
prescribed antidepressants because of their relative safety and the fact that they 
have fewer side effects than some of the other anti-depressants. SSRIs can ease 
symptoms of moderate to severe depression and anxiety. Serotonin is one of the 
chemical messengers or neurotransmitters that carry signals between brain cells.  
SSRIs block the re-absorption or reuptake of serotonin in the brain, making more 
serotonin available, which then eases the symptoms of depression. Examples of 
SSRIs that are often used in cancer care are: Citalopram (Celexa), Fluoxetine 
(Prozac), Paroxetine (Paxil) and Sertraline (Zoloft) (Homberg, Schubert & Gaspar, 
2010).   
SNRIs: Serotonin-norepinephrine reuptake inhibitors (SNRIs) is a class of 
antidepressant drugs and is used in the treatment of major depressive disorder 
and other mood disorders, such as anxiety, obsessive-compulsive disorder, 
chronic neuropathic pain and fibromyalgia syndrome, as well as for the relief of 
menopausal symptoms. Examples of SNRIs that are often used with the breast 
cancer population are: Serzone, Cymbalta, Fetzima and Pristiq.   
Venlafaxine (Efexor) is a dual serotonin/norepinephrine reuptake inhibitor that has 
been widely studied in breast cancer patients because of its effects on 
menopausal symptoms (Homberg et al., 2010; Nemeroff, Entsuah, Benattia, 
Demitrack, Sloan, & Thase, 2008; Kligman, & 2010; Paice & Ferrell, 2011). A trial 
done by Loprinzi and colleagues (2000) suggested that Venlafaxine can alleviate 
hot flushes and that the most appropriate dose for this indication is 75 mg daily 
and the effect can occur in a few days. Venlafaxine is one of the few anti-
depressants that would not necessarily decrease the libido as most of the other 
anti-depressants do. The anti-epileptic Gabapentin has also been shown to 
decrease hot flushes to a similar degree and modest improvements in hot flushes 
have also been recounted for other SSRIs and SNRIs, including Fluoxetine and 
Sertraline (Henry, Stearns, Flockhart, Hayes, & Riba, 2008).    
Tricyclic antidepressants: Tricyclic antidepressants (TCAs) act by inhibiting 
reuptake of norepinephrine and serotonin by blocking the transporters responsible 
for reuptake of these neurotransmitters. This inhibition elevates the concentration 
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of neurotransmitters in the synapses and triggers further neurotransmission. 
Tricyclic antidepressants are used to treat depression, bipolar disorder, anxiety, 
obsessive-compulsive disorder and other mood disorders. They are also effective 
as analgesics so are used to treat chronic pain and used for migraine prophylaxis. 
Examples of Tricyclic antidepressant that are used in this population are:  
Doxepin, Clomipramine, Amitriptyline, Imipramine, Nortriptyline, Mianserin 
(Depnon) and doxepin. Tricyclic anti-depressants pose a bigger risk in overdose 
than SSRIs which may not be a good choice for patients with suicidal ideation 
(Rayner, Price, Evans, Valsraj, Hotopf, & Higginson, 2011).   
To conclude the use of anti-depressants with or without psychotherapy in cancer 
care is the evidence from a study done by Rayner and co-workers (2011), that 
depression in patients with a life-threatening illness can be effectively treated with 
anti-depressants which were superior to placebo. 
 
4.4.2.8  Summary   
Cancer is a disease with varied outcomes including cure, but cancer patients and 
their families together with the oncology team need to be educated and motivated 
to move away from the general toxic connotations of cancer to generate a new 
outlook at cancer care which include the human side along with the biological 
element. In treating the breast cancer patient comprehensively, the oncology team 
must acknowledge and incorporate the role of psychological elements and 
enhance the availability of these services. There is a growing body of evidence 
supporting the effectiveness of psychological interventions in the treatment of 
breast cancer patients that can serve as a guide in the practical application of this 
service and although the central challenge of cancer remains to eliminate the 
disease, the primary psychological aim is to enhance the quality of life of the 
breast cancer patient and her family. There is a wide range of approaches to 
successfully treat a breast cancer patient psychologically, with the most studied 
that of psycho-education and various forms of Cognitive-Behavioural Therapy. 
These studies were done in both group settings and individual psycho-therapy 
with the mutual aim to improve and enrich the psychological well-being of the 
patient.    
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Women play essential and influential roles as partners, wives and mothers in the 
family structure and when she develops breast cancer the whole family are 
severely affected by her illness. Intervening psychologically as early as possible 
not only prevents the development of serious psychiatric problems such as 
depression or anxiety in the patient but also keeps the whole family structure 
functional through healthy psychological- and social adaptation to the losses and 
challenges of breast cancer.   
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CHAPTER V 
SEX THERAPY AS A PSYCHO-ONCOLOGIC 
INTERVENTION FOR BREAST CANCER PATIENTS 
5.1  INTRODUCTION 
Sexuality is a deep, enveloping and fundamental part of the total human 
personality, comprising a person’s most intimate feelings of individuality and 
inspires the complete range of the human experience. Sexuality exists in all 
interactions and contexts and correlates directly to an individual’s overall well-
being. It therefore becomes clear that it is not a conception that can be regarded in 
separation from that of health (Sheppard, & Ely, 2008). According to Hordern and 
Currow (2003) individuals encountering a life-limiting illness may welcome the 
opportunity to discuss issues of their intimacy and sexuality with a trusted health 
professional. 
Cancer and cancer treatment, especially chemotherapy can cause changes in the 
female body and although it may not necessarily interfere with the women’s 
physical ability to have sexual intercourse, it often affects sexual functioning and 
intimacy and consequently also emotional relationships (Fobair & Spiegel, 2009; 
Kuo et al., 2008; Sbitti et al., 2011; Taylor et al., 2011). It is widely recognised that 
a woman's sexuality can be affected in a complex manner after being diagnosed 
with breast cancer and sexual changes due to the treatment often becomes a 
problematic aspect in her life. The impact of such changes can last for many years 
after successful treatment, and can be associated with serious physical and 
emotional side-effects (Emilee et al., 2011; Speer et al., 2005; Taylor et al., 2011; 
Usher et al., 2013). In spite of sufficient evidence that many cancer patients would 
like to discuss their sexual functioning regarding their cancer status, many feel 
reluctant to do so, partly because of their own discomfort to talk about sex and 
sexuality, but also because of limited opportunity in the oncology environment 
(Kuo et al., 2008, Park et al., 2009, Reece et al., 2010). It is important for the 
breast cancer patient to understand that staying sexually active is an appropriate 
part of recovery from cancer and its treatment and that there are many effective 
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treatments for sexual problems and dysfunction, ranging from psychological and 
behavioural therapy to pharmacological therapy (Fobair & Spiegel, 2009; Park et 
al., 2009; Schover, 1991). 
5.2  DEFINITION AND DESCRIPTION OF SEX THERAPY 
Sex therapy can be defined as a therapy which addresses patients’ psychological 
and physical sexual problems and include all relevant methods such as 
psychological, pharmacological, educational or surgical methods and techniques 
(Hummel et al., 2015). Sexual dysfunctions can be treated effectively with face-to-
face forms of sex therapy and comprises of a flexible program including a number 
of elements that can be adapted to the needs of the individual patient or couple 
(Günzler & Berner, 2012). Sex therapy usually includes behavioural components 
resulting from techniques developed by Masters and Johnson such as psycho-
education about sexuality and sexual dysfunctions relating to breast cancer and 
treatments.  Other techniques are sensate exercises, cognitive restructuring of 
inflexible sexual thoughts and pharmacology (Hummel et al., 2015; Masters & 
Johnson, 1970; Park et al., 2009). 
Although sex therapy can be delivered individually as described in the literature, 
interventions with stronger outcomes tend to be couple-focused which include 
treatment elements that educate both partners about the women’s breast cancer 
diagnosis and treatments side-effects on her sexuality.   It also promotes couples’ 
mutual coping and support processes and include treatment modalities that make 
use of specific sex therapy methods that address open sexual communication 
skills and sexual and body image concerns (Hummel et al., 2015).   
5.3  AIMS AND BENEFITS OF SEX THERAPY 
In working with breast cancer patients, it is important to initiate conversations 
about sexual functioning whether it is in the medical setting with the oncologist or 
surgeon or with a psychologist (Park et al., 2009). If the conversation about sexual 
functioning is with the medical team, then the ideal would be for the oncologist or 
the surgeon to refer the patient from a very early stage to a psychologist working 
with this type of issues or dysfunctions. It is imperative that conversations 
regarding sexual functioning and cancer become an integral part of cancer care. 
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Discussing sexual functioning with cancer patients can help normalizing their 
concerns about their sexuality and provide a foundation for (brief) sexual therapy if 
it is later necessary (Park et al., 2009). One of benefits of early conversations with 
patients about their sex lives and intimacy is for them to feel comfortable speaking 
about their sexual well-being or problems and to realise that it is acceptable to talk 
about sex and sexuality and that there are applicable interventions for this 
problems. It is important for psycho-therapists to explain to their cancer patients 
that they can expect changes in the way their bodies are going to react and 
respond to sexual encounters during and after chemotherapy and that these 
changes could affect their sexual and intimate relationship with their partners 
(Fobair et al., 2006; Fobair & Spiegel, 2009). In a study done by Park and 
colleagues (2009) they have found that most of their participants wanted basic 
information about their sexual functioning and assurance that their sexual changes 
are normal in their specific situation and that other patients also experience the 
same challenges. Many of these participants reported back that they were not 
properly prepared for sexual changes or equipped to cope with it.  
An important aim with sex therapy in the oncology framework is to remove the 
barriers in sexual health communication between the oncology team and the 
breast cancer patient. According to several authors sexual issues are not yet 
sufficiently integrated into routine cancer care and that health professionals must 
aim to integrate patient sexuality and intimacy into routine palliative assessments 
so that every patient is given the opportunity to discover these matters (Hordern & 
Currow, 2003; Hummel et al., 2015; Park, et al., 2009). Park and colleagues 
(2009) found that breast cancer patients showed a desire to have open 
communication and frank discussions about their sexual issues with the medical 
professionals and they wanted “permission” to discuss their sexual concerns with 
their medical team. Communication about sexuality can be tough and challenging 
for the oncologists because they often lack time and knowledge to attend to the 
sexual matters of their patients despite the patients’ needs and requests to talk 
about their sexual functioning during the course of their cancer treatment (Hordern 
& Currow, 2003; Park et al., 2009).   
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If patients are referred to a psychologist early in their breast cancer treatment, 
discussions about their sexual well-being can start early on in the therapeutic 
process to prepare them for potential changes in their sexual functioning and 
prevent the development of unnecessary and serious sexual pathology. It is 
helpful for the cancer patient to hear from the oncologist or psychologist that there 
are not just sexual side effects due to the cancer treatment, like low libido, vaginal 
dryness and menopausal symptoms, but also available interventions to treat these 
sexual symptoms. It is important to counsel patients when appropriate, that sexual 
activity is not harmful, but can be an integral part of the recovery process (Fobair 
& Spiegel, 2009; Taylor et al., 2011). Prior knowledge of treatment-related sexual 
side effects could help patients to make better informed decisions about treatment 
options and the practical information can help patients with their sexual 
expectations in the future (Park et al., 2009) This information should also be 
repeated at various times during the therapeutic process to make sure that the 
patient stays in contact with her sexual functioning throughout the trajectory of her 
cancer journey. Sex therapy teaches patients to acknowledge their sexual 
changes and challenges and to develop new skills to enhance their sex lives and 
intimate relationships (Jun et al., 2011).   
5.4  SPECIFIC INTERVENTIONS IN SEX THERAPY PRACTICE 
For Schover and colleagues (1984) sexual rehabilitation should begin at a very 
early stage of the breast cancer treatment plan for although the patients might still 
be concerned with life-and-death issues, they will also start thinking about the 
quality of their life during the treatment process. By participating in sex therapy 
from an early start, the breast cancer patient can continue to feel sexually 
attractive and functional and will be able to sustain and conserve better courage 
and self-esteem throughout this process. Schover and colleagues (1984) feel very 
strongly that withholding information about sexuality is never justifiable and that, 
because of the lack of information, patients spend hours needlessly wondering 
whether they will still be able to feel sexual pleasure or whether their partner will 
be forced to look elsewhere for sexual satisfaction. It is important to communicate 
to the patient that sexual pleasure and activity can continue (if the patient wishes) 
throughout the treatment and thereafter.   
189 
 
It has been suggested in the literature that many breast cancer patients and their 
partners can benefit from brief sex therapy. Such sex therapy can include 
components such as cognitive and behavioural coping skills, psycho-education on 
how the cancer treatment can impact their sexual functioning, proposals on how to 
resume sex without anxiety and performance-anxiety and facilitating skills to 
improve sexual communication. Sex therapy can also include the handling of 
specific sexual problems such as loss of sexual self-esteem, pain, loss of desire, 
fatigue and menopause (Derogatis & Kourlesis, 1981; Fobair & Spiegel, 2009; 
Hughes, 2008; Masters & Johnson, 1970; Schover, 1991). Hughes (2008) agrees 
with authors like Derogatis & Kourlesis (1981) and Park and colleagues (2009) 
that sometimes sympathetic understanding of the patient’s problem and careful 
evaluation of her concerns may already be in themselves therapeutic. They all 
agree that for any sexual dysfunction it is important to treat both the physical- and 
psychological conditions and that anxiety and depression as well as physiologic 
symptoms can be treated with medications and or psychotherapy which can 
include cognitive-, behavioural-, marital- or sexual therapy. A theoretical 
framework for sexual interventions for this study was derived from three different 
sexual intervention models which al falls into the bio-psycho-social framework for 
therapeutic interventions and will be discussed separately. The three models 
include the Five A’s comprehensive model, the Masters and Johnson’s model of 
sensate focusing and flexibility as a model of sexual intervention for patients with 
chronic illness:       
5.4.1  The five A’s comprehensive model  
Park and colleagues (2009) has developed a comprehensive model working with 
sexual problems in the cancer population. This model relies on a multidisciplinary 
approach where different clinicians may take on different components of the 5 A’s.  
It offers a very basic and practical framework to use especially at the beginning of 
therapy to initiate either sexual “conversation” or sex therapy. This model consists 
of the next components: 
(a) ASK: The first task in this model is to “ask” by simply bringing up the topic 
of sexuality. It is important for the oncologist or psychologist to understand 
that the patient sometimes need to receive information about their sexual, 
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anatomical and physiological functioning to help them understand how 
sexual side effects are connected to their cancer treatment. A conversation 
about sexuality from the oncologist or psychologist will give the patient the 
opportunity and confidence to discuss any questions regarding their sexual 
functioning and their illness. All adult patients, regardless of their age, 
marital status or whether they are receiving palliative care, should be asked 
about their sexual issues throughout the whole trajectory of their illness and 
treatment (Park et al., 2009). The goals of such a discussion are to provide 
accurate information in practical terms for the patients to understand their 
situation and to help them to come to terms with their feelings about 
sexuality and cancer (Schover et al., 1984). Depending on the 
multidisciplinary team’s composition, this will be asked either by the 
oncologist just to open the subject or from the beginning by the 
psychologist for it will ultimately be part of their therapeutic route. If a breast 
cancer patient is referred for psychotherapy, regardless of the reason, it is 
important to mention the influence of cancer treatment on sexuality and that 
speaking about it can be part of the therapeutic process. The comfort 
displayed by the therapist in addressing sexual functioning with confidence 
and authority and without using excessive medical terminology, can create 
an atmosphere of comfort and safety where the patient or couple can 
express their sexual concerns without feeling embarrassed (Fobair & 
Spiegel, 2009; Nusbaum et al., 2003; Park et al., 2009).  
  
(b) ADVICE: This step provides an opportunity to deliver a brief, dynamic 
message about the importance of sexual problems in the cancer treatment 
regime such as low libido, decreased sexual self-image, vaginal dryness, 
dyspareunia and menopausal symptoms and the role it can play in the 
overall quality of life. This is also the time to normalize sexual and intimacy 
experiences and symptoms for the patient through acknowledging the fact 
that many cancer patients struggle with sexual problems and even 
dysfunctions during and after their cancer treatment. During this time the 
therapist can reinforce the fact that sexual functioning is an important 
quality of life issue and to reassure patients that they can get help if they 
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suffer from sexual problems in the form of marital therapy, individual- or sex 
therapies (Fobair & Spiegel, 2009).    
   
(c) ASSESS: According to Park and colleagues (2009) professionals may find 
it easier to begin the process of sexual interventions by asking their patients 
about their sexual symptoms to initiate dialogue about sexual problems and 
treatment recommendations. Sexual rehabilitation, according to Schover 
and colleagues (1984) begins with the least anxiety-provoking questions, 
e.g. “Are you still sexually active together?” “How often do you have sexual 
activity?” The assessment should then progress to questions about each 
aspect of the patient’s sexual functioning including desire (libido), arousal 
(vaginal lubrication, subjective pleasure), orgasm (quality of sensation, type 
of stimulation needed), pain during sexual activity (including non-genital 
and genital discomfort) and satisfaction of each partner with the frequency 
and variety of sex. Sexual communication and information about how the 
patient feels about herself as a sexual person (sexual-esteem) is also an 
important aspect to assess. It is important to ask when the problems have 
begun, in what context did they first experience the problem or problems 
and how long have they lasted (Derogatis & Kourlesis, 1981). Seeing the 
patient and partner together will allow the therapist to assess the 
effectiveness of the couple’s general communication, especially their ability 
to discuss sexual concerns and often the therapist gets a different picture of 
the quality of sexual performance after speaking to the patients’ partner 
(Derogatis & Kourlesis, 1981; Nusbaum et al., 2003).  Nusbaum and 
colleagues (2003) suggest that in taking the sexual history, although the 
inquiry should be sensitive, it must also be direct enough to clarify the 
issues at hand. Obtaining a detailed sexual history is not only important in 
addressing appropriate sexual matters, but the catharsis is therapeutic in 
itself (Derzko et al., 2007).  
 
What is important in asking for the sexual history is to establish a sexual 
frequency baseline and estimation of the patient’s previous sexual interest, 
it is also important to verify whether the patient has ever (before the cancer) 
experienced sexual dysfunction and if so, what was the nature of the 
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problem and if she underwent any kind of treatment. If there is a current 
sexual problem then more time should be spent asking about the patient’s 
sexual attitudes and experiences and if possible, in a developmental 
framework for it is already established that the younger the patient, the 
bigger the probability of sexual problems (Burwell, Case, Kaelin, & Avis, 
2006; Fobair et al, 2006; Fobair & Spiegel, 2009). Furthermore, the sexual 
history should also be taken in the context of the current medication and 
stage of the cancer treatment, for certain cancer treatments and reduced 
hormone levels may result in lowered mood, fatigue and loss of sexual 
interest, not just because of biological impacts but also because of a 
possible reduction in sexual satisfaction as a result of dyspareunia or other 
gynaecological effects of cancer treatment (Derzko et al., 2007). With the 
information of the sexual history, the clinician should have an 
understanding of the patient’s typical levels of sexual performance and her 
perception of her own sexuality, for example whether she is sexually 
conservative or liberal. These issues can become important when the 
cancer or treatment either temporarily or permanently precludes sexual 
intercourse in the usual manner and alternatives must be created and 
implemented, e.g. alternatives that would be perfectly acceptable to a more 
liberal patient, but might be viewed as perverse and totally unacceptable to 
a more conservative individual. In assessing the nature of a sexual problem 
it is critical to determine precisely what physical changes the patient’s body 
has withstood because of the cancer or treatment and the options left open 
by the cancer. The patient’s current psychological status must also be 
contemplated so that dysfunctions associated with clinical levels of 
depression or anxiety is recognized as such and taken into consideration 
when planning for the treatment. One of the more difficult decisions to make 
is to determine if the sexual dysfunction is mostly biological of psychological 
in nature, but often both factors may be working together, for example: 
dyspareunia resulting from a post-surgical stenosis resulting in an 
anorgasmia based on the patient’s belief that she is now scarred and 
mutilated and no longer physically attractive to her partner.   
The patient’s impressions about the cause or etiology of the sexual 
problems are also important, especially to establish whether she feels that 
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in some way she is responsible for the problem and have guilt feelings 
about it. If the patient says that their sexual functioning is unaffected, it is 
still necessary to determine if her interest in sex remains high because 
there might be a problem of desire rather than performance (Derogatis & 
Kourlesis, 1981).   
(d)      ASSIST: On the basis of the assessment of the current sexual functioning 
of the cancer patient a treatment plan can now be formulated and 
implemented that will benefit the patient the most. Patients should be 
informed about available therapeutic options e.g. psycho-education, or 
cognitive-behavioural techniques or even pharmacology to treat their 
problem (Fobair & Spiegel, 2009; Hughes et al., 2011; Hummel et al., 2015; 
Krychman & Katz, 2012). Derogatis and Kourlesis (1981) said that in their 
experience many sexual problems can be solved by just the opportunity to 
discuss it in a safe and professional environment.   According to these 
authors a large percentage of patients only need education and basic 
information about their situation and what they can use safely such as 
lubricants, vaginal moisturizers, dilators, etc. Other patients will benefit from 
short-term therapy by a psychologist working with sexual disorders 
accentuating strategies such as acceptance, education about treatment-
related sexual problems, encouraging open sexual communication between 
partners, encouraging patients to resume sex during and after treatment 
and learning of new skills concerning sexual performance.   
(e)    ARRANGE FOLLOW-UPS: The last step in this 5 Step comprehensive 
model is to make sure that patients receive follow-ups to evaluate their 
progress and how they are doing with their sexual well-being. This will 
reinforce the importance of sexual welfare for the patient and reassure her 
that it is an issue that she can discuss any time the need may arise. 
Therapeutic feedback is always important in a healing process.  
 
Derogatis and Kourlesis (1981) summarised this model by saying that regardless 
of how the sexual problems present themselves or how it get addressed, the most 
fundamental step that the oncology medical team must make is to accept sexuality 
as an integral and natural aspect of being human and that the treating team 
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should work to treat problems arising in this area with the same excellence and 
commitment that they are devoting to other aspects of cancer care.   
5.4.2  Masters and Johnson’s model of sensate focusing 
Sensate focusing was developed by Virginia Johnson and became the centrepiece 
of Masters and Johnson’s therapeutic work. It is a hierarchy of consistent, 
structured touching and discovery through which partners gradually reintroduce 
the continuous phases of sexual contact (Masters & Johnson, 1970; Weiner & 
Avery-Clark, 2014). The exercises are aimed at becoming more comfortable with 
one’s own body and achieving sexual intimacy with one’s partner, both physically 
and emotionally. Other goals are to discover new approaches to sexual 
stimulation, and to encourage communication between partners about sexual 
experiences, sexual desires and sexual boundaries (Hummel et al., 2015). 
Sensate focusing is a tool for identifying psychological and relationship factors that 
contribute to sexual difficulties and for teaching new skills to overcome these 
problems and to promote a more meaningful sexual intimacy (Weiner & Avery-
Clark, 2014).   
Working with patients with sexual dysfunctions, Masters and Johnson (1970) have 
developed and advocated a homework project to change a patient’s mental focus 
from their physical performance back to pleasurable sensations experienced 
during physical intimacy with a partner. Sensate focus is not so much about 
behaviour as it is a focus attention attitude. Weiner & Avery-Clark (2013) found 
that patients with sexual problems were often trying to make sex happen or trying 
to keep it from happening by touching for their partners’ arousal and pleasure and 
not for themselves, therefore creating performance anxieties. An important goal of 
sensate focus therapy is to counteract these invalid pressures that a patient put 
upon herself/himself. The rationale for sensate focus sessions are to regain a 
sense of awareness off what feels good about being touched and nurtured. 
Patients learn to focus on receiving physical pleasure and in the absence of 
expectations of sexual performance, he/she would return to experiencing sexual 
arousal and interest as a natural result (Weiner, 2011; Weiner & Avery-Clark, 
2014; Wiederman, 2001). The two phases of sensate focusing are:   
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 Phase I: Touching for one’s interest is what is referred to as Sensate Focus 
Phase I.  This phase prescribes specific suggestions: To start the exercise 
the couple must set aside enough time to engage in nude, full-body 
massage where each partner take turns pleasuring the other with the 
specification that there were not to be any sexual episodes or any sexual 
activity. The “toucher” begins by touching the partner head to toe, front to 
back, avoiding the breast, chest and genital areas which are off limits for 
the beginning. This touching involves only the use of hands and fingers but 
not full body contact or kissing. This exercise is aimed at reducing any 
expectation of a sexual encounter. The toucher and the touchee (the 
person being touched) touch and feel only for themselves with the intention 
of taking in concrete, tangible and physical sensations such as temperature 
(cool or warm), pressure (hard or soft) and texture (smooth or rough). If 
there are any distractions, the participants must make an effort to refocus 
on the tactile sensations again. If anything is uncomfortable for the touchee, 
he/she must communicate by moving the toucher’s hand away to a place 
that is more comfortable. There are no limits in terms of the length of time in 
this touching exercise but the toucher touch long enough to become skilful 
at focusing (or refocusing) on sensations but not so long that he/she gets 
bored or tired. When the toucher is finished she/he then say “switch” and 
then they exchange positions where the second partner touches and the 
first partner becomes the touchee (Weiner & Avery-Clark, 2014). The 
advantage of this attitude of touch or being touched for themselves is only 
taking in their own sensations, they don’t evaluate, just experience and only 
stay in objectivity and encourage exploration and experimentation. Sensate 
focusing is not about touching for the other person, it is not about touching 
to sexually arouse one’s self or one’s partner, it is intended to be an 
experience in itself. Sensate focusing is not an introduction to sex, neither a 
form of foreplay, but a paradox of pleasure and sexual responsiveness that 
being present to conscious sensory experience rather than trying to make 
these natural emotions happen, is what stimulates them (Masters and 
Johnson, 1970; Weinera & Avery-Clark, 2014). These exercises are a way 
for the couple to explore each other’s bodies using all of their senses (sight, 
touch, taste, smell and sound) without focusing on the genitals. The 
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importance of patience and taking time should be stressed (Hughes, 2008). 
The advantage of this approach is that when patients are having difficulty 
responding sexually, they are presented with something reliable 
(sensations) on which they can focus, as well as an activity over which they 
have control (refocusing of attention), instead of depending on something 
unreliable as in emotions and trying to oblige a response over which they 
don’t have a direct voluntary control (sexual arousal).    
 Sensate Focus Phase 2: This phase concentrate on bigger 
responsiveness to partner feedback and to emotional experience. When the 
couple has successfully completed phase 1 of sensate focus and they want 
to have sex, they can progress to sexual intercourse. Before they go over to 
intercourse the couple has to understand that sexual desire can vary and is 
not necessarily synchronous and that the sexual need and desire do not 
have to be present at the beginning of the sexual activity, for desire can 
emerge as the individual relax and begin to experience pleasure form 
intimate touch (Weeks & Gambescia, 2009). As with phase 1, depending on 
the sexual problems and needs from the couple, they explore. They can 
take their time and explore with penetration until they are comfortable with 
it. There are different degrees of penetration, e.g. penetration without 
thrusting, or penetration with thrusting, penetration with or without orgasm. 
During phase 2, the therapist will instruct the couple to focus on their 
sensations (as was learned in phase 1), positive thoughts and fantasies 
that make the sexual experience pleasurable (Weeks & Gambescia, 2009). 
This phase also emphasizes that partner communication about their 
emotional experiences are critical to the longer-term goals of intimacy and 
optimum sexuality. Masters and Johnson (as cited in Weiner & Avery-Clark, 
2014) said that it must be presumed that if there is a lack of effective non-
verbal communication in the bedroom, there are probably difficulties with 
verbal communication outside of the bedroom as well.  Therefore it is 
important for the sex therapist to teach the arts of non-verbal and verbal 
communication to sexually dysfunctional couples as an essential part of this 
therapeutic format.   
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The most important aims of sensate exercise are that the couple become more 
comfortable with their own bodies and attaining sexual intimacy with their partner, 
both physically and emotionally and gradually reintroduce the consecutive phases 
of sexual contact. The other goals are to discover and learn new techniques of 
sexual stimulation and to teach and encourage communication between partners 
about their sexual experiences, sexual desires and boundaries. These behavioural 
elements of sex therapy are usually combined with cognitive therapy where the 
therapist and the patient aim to detect and change dysfunctional and irrational 
cognitions regarding sexuality that has arisen during the sensate exercises 
(Hummel et al., 2015; Ussher et al., 2013).     
5.4.3  Flexibility as a model of sexual intervention for patients with 
chronic illness 
The flexibility model has predominantly been developed from a bio-psycho-social 
model with the emphasis to change the patient’s cognitive perception of sex and 
sexuality and accompanied behaviour. Up to recent years the dominant model 
used in understanding the aetiology of sexual dysfunction among patients with a 
chronic illness was biological where sexual dysfunction is hypothesized as 
originating from physiological origins of the disease or its treatment.  Based largely 
on biological models, studies of interventions in managing sexual dysfunction 
among patents’ with chronic disease have focused almost exclusively on medical 
or pharmacological treatment.  But because of the limitations of these treatment 
modalities and the added knowledge and acknowledgement of the role that 
psychosocial factors play in the aetiology and maintenance of sexual dysfunction, 
there has been a rising interest in the development of an alternative bio-psycho-
social approach.  
This approach integrates contextual and relationship factors in the treatment of 
sexual dysfunctions in the chronic illness population (Barsky et al., 2006). In the 
view of the complexity of female sexual dysfunctions and the irreversible nature of 
sexual dysfunction among patients with a chronic illness such as cancer, a bio-
psycho-social approach for the assessment and management of sexual 
dysfunctions with interventions ranging from education and lifestyle changes to 
sexual therapy, sexual aids, medications and exercises and dietary supplements 
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is necessary (Barsky et al., 2006; Derzko et al., 2009; Hughes et al., 2011). This 
treatment model aligns with my own use of the principles of Engle’s’ bio-psycho-
social model which is practical and applicable in treating cancer patients’ sexual 
problems. In developing the flexibility model the focus was on the concept of 
flexibility in cognitive and behavioural coping. Prior research supports the proposal 
that flexible coping has beneficial effects for individuals reacting to stressful 
situations, including beneficial effects on sexual contentment in responding to 
cancer-related sexual distress (Barsky et al., 2006; Reece et al., 2010).  Although 
the clinical methodology to further flexible coping is heavily educated by previous 
clinical approaches to sexual dysfunctions in sex- and marital therapy (e.g. 
sensate focus exercises) the concept of flexible coping also adds to prior 
approaches in several ways. First, if focusing on the concept of flexibility in coping 
with sexual matters, it may facilitate a more targeted approach than sex therapy in 
general which is particularly helpful when considering the (often) brief length of 
time allowed for providers to confront side effects of cancer treatments and other 
quality of life issues. Secondly, in the context of sexual counselling or sex therapy, 
the flexible coping model can address sexual matters due to cancer from different 
contexts such as psycho-education, cognitive and behaviour mind shift in terms of 
their sexual functioning, sexual communication skills and emotional understanding 
and support. Thirdly, because of the nature of the flexible coping theory as 
consisting of multiple concepts of sexuality, it may reflect a patient’s own 
developing perceptions of their sexuality through their cancer trajectory (Reece et 
al., 2010). When assessing sexual functioning during the therapeutic process with 
cancer patients, assessment of flexible coping is necessary and can be done by 
asking targeted questions. Sufficient assessment of flexible coping should focus 
on simple questions relating to broader sense of intimacy in addition to sexual 
performance, for instance, by asking questions related to the patients’ sexuality 
and intimacy, rather than about sexual performance, the therapist is validating the 
importance of such concerns. Flexible coping may be applicable to any person 
coping with sexual difficulties as a threat to their sexual lives, irrespective of the 
person’s age, marital status, sexual preference, and level of disease or any other 
relevant demographic and medical characteristics.   
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Flexibility can be defined as the ability to shift cognitive or behavioural focus in 
order to manage acute and chronic sexual dysfunction and is a significant 
determinant of successful coping with long-term dysfunctions (Barsky et al., 2006). 
This flexible coping model classifies two potential areas of response that can be 
altered to be more flexible in response to sexual matters:  Firstly, the definition of 
sexual function and activity and secondly, the significance of sexual function and 
activity (e.g. how important sexual functioning and activity are for the patient and 
her partner’s overall self-concepts). An example of a person with an inflexible 
definition of sexual function and activity may believe that sexual activity is 
synonymous with sexual intercourse and when incapable to engage in sexual 
intercourse due to illness, this person may experience this challenge or stressor 
as being at odds with his/her capacity to be sexual and may approach the problem 
with avoidance of intimacy. Therefore both cognitive changes (e.g. thinking 
differently about his/her sexual function and activity) and behavioural changes 
(e.g. engaging in different sexual activities such as alternative forms of sexual 
activities, including oral sex or mutual caressing) will institute changes in a 
persons’ definition of sexual function and activity (Barsky et al., 2006; Reece et al., 
2010). The flexible model propose that greater flexibility as indicated in broader 
and less rigid thoughts and behaviours (as shown in Table 5.I and 5.2) will reflect 
in a more beneficial judgment of the challenge that will likely lead to more effective 
coping strategies, which will in turn lead to positive psychological outcomes (e.g. 
increased sexual and relationship satisfaction and mood). Within the model of 
flexibility a patient with cancer may best cope by shifting both the cognitive and 
behavioural manifestations of what constitutes sexual functioning. 
Barsky and colleagues (2006) explain flexible and inflexible coping in the definition 
of sexual function and activity in cancer making use of practical examples. As 
shown in Table 5.1 a patient with a flexible definition of sexual function and activity 
interpret sexual intercourse, non-sexual activities and non-sexual intimacy 
activities as part of sexual activity and is likely to see challenges as being more 
easily overcome and is likely to cope more successfully with challenges such as 
the person that limit the inability to engage in intercourse. A treatment method 
applying the flexible coping theory might focus on the patient’s ability to move from 
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an inflexible to a flexible definition of sexual function and activity which involves 
contemplating a wider range of sexual- and non-sexual intimacy activities. 
 Table 5.1: Flexible and inflexible thoughts regarding the definition of sexual 
function (Barsky et al., 2006).   
Stage in coping 
process 
Inflexible thought Flexible thought 
Cognition Intercourse is the only real form 
of sexual activity that counts.”  
 “Cancer has ruined our sex 
life. We won’t be able to have 
sex again. 
Cancer has changed our 
sexual relationship, but we can 
still have a good sex life, just in 
different ways than before”. 
Behaviour Abstention from any sexual 
activity. 
Engaging in mutual non-sexual 
activities, masturbation or oral 
sex. 
Psychological 
outcomes 
Negative or depressed mood, 
poor sexual functioning. 
Impaired relationship 
functioning. 
Positive mood, enhanced 
sexual functioning. Enhanced 
relationship functioning. 
In table 5.2 it is shown that a patient with flexible thoughts in terms of the centrality 
of his/her sexual functioning, may engage in alternative forms of sexual activities 
through different behaviours, including oral sex or “outercourse” (which is rubbing 
of the genital outside the vagina), mutual caressing when intercourse is not 
possible or uncomfortable. Suggesting a change of scenery, for example engaging 
in sexual activity in the bath or shower or any other place but the bedroom, can 
also be erotic and a novelty and the patients can broaden their sexual horizons. 
By shifting cognitive processes in response to sexual dysfunction will have a 
beneficial effect on psychological well-being and mood and can result in an 
enhanced experience of sexual pleasure and satisfaction (Barsky et al., 2006; 
Reece et al., 2010; Schover, 1988; Week & Gambescia, 2009). 
Table 5.2: Practical examples of stages of inflexible and flexible coping in the 
centrality of sexual functioning (Barsky et al., 2006).    
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Stage in coping 
process 
Inflexible thought Flexible thought 
Cognition “Nothing could replace 
Intercourse in our relationship 
anyway”. 
 “If we could go back to having 
sex like we did before the 
cancer and treatment.   
“Intimacy is a better focus for 
us now than sex”.  
“We show our intimacy through 
laughs and enjoying time 
together”. 
Behaviour Avoiding intimacy in 
Relationship. 
Enrolling in dancing lessons 
together and scheduling weekly 
date nights.   
Psychological 
outcomes 
Negative mood and poor 
relationship. 
Positive mood and relationship 
functioning. 
Ussher and colleagues (2013) consider that renegotiation of sex outside the coital 
obligation involves the positioning of intimacy as more important than sex, 
including versions of cuddling, kissing, non-genital touching, massage, spending 
time together and caring or talking. Renegotiating sex and intimacy can also serve 
to maintain normality in the face of cancer, reassuring the patient that there is still 
a life away from cancer and “healthy” activities to participate in. Previous research 
supported the need for sexual information at various stages along the cancer 
route. Having specific conversations regarding flexible coping with patients may be 
important at all stages along this trajectory concerning a comprehensive treatment 
plan (Barsky et al., 2006; Park et al., 2009).   
Early Stage: A discussion of flexibility in coping with sexual matters early in the 
treatment decision-making process, such as “can you imagine having a fulfilling 
sexual relationship without sexual intercourse being a part of it”, can help patients 
to consider their own preferences and values with objective information and facts 
provided by the therapist, relating to the cancer treatment side-effects on sexuality 
(Reece et al., 2010). It is important for the patient to understand that the method of 
treatment can have an effect on their ability to have sexual intercourse and by 
being involved with the decision making process will give them the ability to be 
prepared for their sexual changes and challenges.   
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Active Stage: During the active stage of treatment, assuming that the patient’s 
sexual needs may change to be more centred on intimacy than sexual intercourse, 
the therapist will alter his approach accordingly, for instance approaching the 
patient by saying the following: “I know you told me that in addition to the fatigue, 
you’ve been bothered by a loss of interest in sex. Are you interested in having 
some kind of physical intimacy even while you’re undergoing treatment and have 
you and your spouse discussed ways that you can accomplish this?”  
Survivorship Stage: During the post-treatment survivorship phase, the therapist 
will engage in questions like “Have you been able to enjoy your intimate 
relationship after you surgery?” and “Are there ways you and your partner could 
find to enjoy intimacy with one another other than intercourse?” “Are you 
comfortable with different sexual techniques?” Responses that indicate a 
willingness to consider from different viewpoints such as: “It was hard at first, but 
we have found other ways to be intimate now even with the ostomy” can indicate 
the presence of flexible coping (Reece et al., 2010).  
According to Reece and colleagues (2010) behavioural exercises should proceed 
in stages so that small changes in behaviour like holding hands precede larger 
changes in behaviour such as trying a new and different sexual activity, in 
accordance with the couple’s success at achieving the prior behaviour change.  
Any successful change in a behaviour or thought towards a more flexible coping 
attitude should be acknowledge and validated. For many cancer survivors, sexual 
problems and concerns are common, persistent and often connected with other 
important domains of their functioning such as their relationships, self-esteem, 
emotional status and overall quality of life. In practise, sexual concerns are not 
often acknowledged and addressed in routine cancer care, and even when they 
are, the traditional medical approach often limits the beneficial nature of these 
interactions for the patient. Although Reece and colleagues (2010) proposed this 
alternative and broader model of coping flexibly when dealing with basic sexual 
concerns in breast cancer, they emphasise that future research will be necessary 
to develop methods of assessing flexible coping and finding the most efficient 
ways to implement this concept clinically into routine cancer care. A counselling 
approach, such as the flexibility model, which is backed up by techniques such as 
203 
 
cognitive strategies and behavioural exercises, is a worthy intervention modality 
when treating sexual dysfunctions with breast cancer patients.   
5.4.4  Couples therapy 
 
In addition to medical- and individual factors, there are also relationship influences 
and dynamics that play a role in how breast cancer can affect a woman’s sexual 
functioning and body image. When one partner has a serious illness, both partners 
in an intimate relationship experience distress which can adversely affect their 
sexual relationship (Derzko et al., 2007; Dye, 2008). Manne and Badr (2008) 
highlighted the importance of viewing cancer from a relationship perspective and 
although the diagnosis of cancer in a member of the family can have substantial 
repercussions for the family, partners in particular are critically affected by cancer.  
There is considerable proof that relationships experience substantial stress during 
breast cancer (Nicolas, 2013; Sheppard & Ely, 2008; Walsh et al., 2005). Partners 
of cancer patients have to cope with certain challenges such as anxiety about the 
potential loss of their life partner and providing emotional and practical support 
under difficult circumstances.  Partners can feel uncertain and at a loss about what 
to expect while their significant others undergo treatment and could require 
relevant information and support from a psychologist (Dean, 2008; Harrow, Wells, 
Barbour, & Cable, 2008). Apart from the emotional concerns, there are also 
several practical issues with which both the patient and her partner must cope with 
during the whole process of treatment and even after finishing the treatment. 
Practical stressors amongst other things can include negotiating changes in 
occupational and family roles, managing household and childcare chores and 
responsibilities and changes in future life plans. For many couples one of the main 
tasks during the cancer trajectory includes resuming an intimate and sexual 
relationship.  There are also discussing changed life plans and health behaviour 
changes, dealing with the treatment side-effects especially chronic effects that 
might influence the patient’s functioning, handling anxiety about disease 
recurrence and discussing the meaning of the cancer experience for themselves 
and the relationship. For couples dealing with advanced disease they have to 
negotiate difficult choices concerning end-of-life treatments and care such as how 
care and assistance with daily activities will be provided to the sick partner. They 
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also have to cope with anticipatory grief regarding the loss of one’s partner, 
managing children and family’s reactions and after death bequests. For couples 
who are in the survivorship stage of cancer, their primary challenge is to negotiate 
the transition from being a cancer patient to a “normal” life. One mutual challenge 
that couples often encounter is that each partner might have a different pace with 
their adaptation and acceptance of the cancer experience (Nicolas, 2013; Manne 
& Badr, 2008). Manne and Badr (2008) said that regardless of the stage along the 
cancer continuum, cancer can create unique challenges for the marital 
relationship, so from a couples’ perspective, successful adjustment may not be as 
reliant on the circumstances of the cancer, but rather on how well the couple 
integrates the cancer into their lives.    
The breast cancer patient’s diagnosis, treatment, recovery or death all has an 
impact on the partner’s adaptation and emotional well-being and they can also 
benefit from psychotherapeutic support at critical and difficult times for their coping 
abilities are also being challenged by their wife’s' illness. To be a “passive 
bystander” is as traumatic and demanding as being the cancer patient self. The 
opposite is also true; that the patient’s sense of support and emotional well-being 
are largely influenced by her partner’s adjustment of the cancer and cancer 
experience, therefore it is important to view cancer also from a relationship 
perspective (Manne & Badr, 2008; Nicolas, 2013).   
5.4.4.1  The relationship intimacy model of couple psycho-social 
adaptation to cancer 
Manne and Badr (2008) have quantified the significance of regarding cancer from 
a relationship perspective which considers the marital relationship as a source that 
individual partners draw on in crisis situations.  It also underlines the importance of 
focusing attention onto the relationship and engaging in communication 
behaviours aimed as sustaining and enhancing the relationship during stressful 
times. In the context of the above, it is important to have a proper framework to 
treat couples that are struggling with breast cancer. Manne and Badr (2008) had 
formulated the relationship intimacy model of couple psycho-social adaptation to 
cancer as a first step in building a framework to help clinicians to include this 
above mentioned areas in dealing with couples undergoing a cancer trauma. They 
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have proposed this model which is an all-embracing, exploratory model which they 
believe could help begin to organize the conceptualization of the marital 
relationship after the diagnosis of cancer since it integrates key components in 
relationship processes and outcomes.   
The model focuses specifically on relationship-enhancing-behaviours. Manne and 
Badr (2008) the authors of this model, have selected and included three 
relationship-enhancing processes in their model.  
 The first is disclosure of concerns and feelings regarding the cancer 
experience and is called reciprocal self-disclosure.   
 The second process is partner responsiveness which is defined as feeling 
understood, cared for and accepted by one’s partner. Nicolas (2013) 
describe these two processes together, stating that the most important 
process between the couple in an extreme situation like cancer is the 
process where the individuals expresses self-important feelings and 
information to one another.  As a result of the other’s response, the person 
feels that he/she is understood, validated and cared for. Openly revealing 
one’s feelings and concerns to one another about the experience of cancer 
(reciprocal self-disclosure), feeling understood, validated and cared for in 
the relationship as a result of a partner’s behaviour (partner 
responsiveness) and continuing to engage in behaviours to improve the 
relationship while also coping with cancer, are all examples of relationship 
enhancing behaviours.   
 The third process is relationship engagement, which is an overarching term 
that is defined as viewing cancer in relational terms (e.g. viewing cancer as 
having implications for the relationship as well as for each partner 
individually) and participating in behaviours that are aimed at either 
sustaining or improving the relationship while coping with cancer. 
Relationship engagement is characterized by an understanding of the 
challenges cancer can create in the couples’ relationship and an openness 
to talk about these changes to one another.  It is also characterized by a 
willingness to address parts of the relationship that have either changed or 
need to change after the cancer, e.g. priorities and roles and lastly efforts to 
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maintain elements of the relationship that are important to either partner 
during the illness (e.g. treated each other as a spouse instead of adopting 
the caregiver-patient roles). Relationship-engagement emphasises 
relationship awareness and maintenance which are both relevant in the 
cancer context and can be achieved by focusing on intimacy as a primary 
mechanism for promoting couples adaptation.   
Relationship intimacy is the main element in this model of couples’ adaptation. In 
defining intimacy the creators of this model adopt a situation-specific approach 
whereby intimacy is the experience of feeling close to and being cared for by a 
partner with regards to the cancer experience.     
The two most noteworthy characteristics of the relationship intimacy model of 
couple psycho-social adaptation to cancer are the fact that the model emphasises 
the importance of partners relating to each other as spouses rather as a patient or 
caregiver and the importance of partner’s efforts to maintain a level of stability in 
their relationship in spite of the trauma of cancer. Manne & Badr (2008) feel that 
partners can draw on the intimate connection between them as a source of 
strength and support while building a closer emotional bond which can open the 
door for relationship growth and simultaneously promote psychological adaptation 
and healing.   
Sheppard and Ely (2008) have confirmed the theoretic and clinical statements of 
the Manne and Badr model that a breast cancer diagnosis can bring up pre-
existing marital problems to the fore-ground or it can enhance a greater sense of 
closeness in the relationship. For example, if the couple were already far apart 
from each other, they may even move further apart during the process of cancer 
where a lot of conflict and resentment can develop, especially if the cancer patient 
feels that her partner doesn’t understand her illness and accompanied needs. A 
couple that is already close to each other, will most probably move even closer to 
each other during the cancer journey, with very good mutual interaction and 
support for each other.   
 Teaching sexual communication within the framework of couples 
therapy 
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Couples coping with cancer often experience impaired communication about their 
sexual problems and changes that may have emerged during this time.  This lack 
of communication may aggravate psychological distress and decrease marital 
satisfaction (Hordern & Currow, 2003; Milbury, & Badr, 2013; Murray, 2010). 
During illness and stress most couples find it hard to talk about sexual problems 
and it is common for a person with a life-limiting illness to be less intimate or 
trusting during the crisis phase of the illness (Hordern & Currow, 2003; Murray, 
2010). Often women with breast cancer develop feelings of fear of abandonment 
because they feel undesirable to their partners due to treatment-related changes 
in appearance. It often happens that the partner of the breast cancer patient will 
sexually withdraw for fear of causing pain or discomfort without discussing it with 
his partner and the partner reads it as not finding her sexually attractive anymore 
and might also withdraw her sexually to prevent rejection (Milbury & Badr, 2013). 
Another example is that the cancer patient may feel guilty for her inability to 
engage in sexual activities as before the cancer, where the partner feels anxious 
or responsible for his partner’s problems. The aim here is for the therapist to help 
the couple remove blame and guilt and accept the perceived loss of control and to 
gain a realistic perspective of the illness and its effects on their sexual functioning. 
Adaptability is a key element in the therapy but the couple can only adapt if they 
are able to communicate openly about these issues. Patients must be encouraged 
to explore changes in their sexuality and intimacy and communicate it with their 
partners (Hordern & Currow, 2003). Learning to identify feelings and recognize 
their impact on their sexual relationship allows partners to start an improved level 
of communication with one another.  An example is: if the breast cancer patient is 
able to tell her partner what feels good and how and where to touch her will 
improve their sexual communication (Fobair & Spiegel, 2009; Hughes, 2008; 
Hughes et al., 2011). Communicating feelings about their altered sexual situation 
may be very difficult at first for a couple given the changes and challenges both 
face, but is a good starting point for the communication process (Hordern & 
Currow, 2003). It is important to help couples to redefine their meaning of an 
intimate relationship and encourage them to be creative about the ways that they 
can exhibit sexuality and to communicate these changes in open and constructive 
communication to each other (Hughes et al., 2011). Teaching a couple effective 
open and constructive exchange of thoughts, concerns and feelings with the goal 
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of mutual problem-solving are effective psychological interventions and will 
advance both emotional intimacy and sexual satisfaction (Hordern & Currow, 
2003; Milbury and Badr, 2013).   
5.4.5  Sexual body image and sexual functioning 
Body image is an important predictor of outcome, with measures of body image 
after breast cancer treatment describing up to 59% of the adjustment in the 
psychosocial process. It was found that more positive body image perception 
relates with higher self-efficacy in coping with breast cancer and its treatment, 
whereas heightened concern with body integrity predicts higher distress, social 
disruption, and deterioration in feelings of sexual desirability (Hormes, Lytle, 
Gross, Ahmed, Troxel, & Schmitz, 2008).  A significant correlation have been 
found between body image and age especially for young premenopausal women 
who have been noted to report emotional suffering, a reduced quality of life, a loss 
of femininity due to fertility issues, and various sexual problems related to early 
induced menopause (Dalton et al., 2009; Jun et al., 2011; Nozawa et al., 2013; 
Rosenberg et al., 2011; Wong-Kim et al., 2005).   
Breast cancer patients are exposed to changes in their physical appearance such 
as the loss or disfigurement of one or both breasts, lymphedema, scars from 
surgery and skin changes related to radiotherapy, where systemic treatments 
(chemotherapy or hormones) often lead to alopecia and weight increase (Dean, 
2008; Krychman & Katz, 2012; Kuo et al., 2008; Reece et al., 2010). These 
changes are all related closely to physical appearance and body image and it is 
important to address these issues during psychotherapy (Derzko et al., 2007; Dye, 
2008; Hughes, 2008). For the therapist it is important to remember that a 
mastectomy is an amputation which can disrupt body image and annihilate sexual 
relationships for a significant period of time (Przezdziecki et al., 2012). Some 
woman find it exceedingly difficult to come to terms with the breast scar especially 
if they perceive their partner to be repelled and bothered by the changes in her 
body. This is often more a case of irrational cognitive thoughts as a reality 
(Sheppard & Ely, 2008). An important fact to consider is that a woman’s sexuality 
not only includes the ability to engage in sexual activity, but also her feelings and 
ideas about her body image and femininity and whereas sexuality is so closely 
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related to body image, any disruption concerning body image can lead to 
disturbances in sexual functioning (Dalton et al., 2009; Derzko et al., 2007; 
Przezdziecki et al., 2012; Sbitti et al., 2011).   
Wilmoth (2001) has classified two elements that were related to post-operative 
body image. The first element includes the changed appearance of the patient that 
resulted from surgery through either the removal of the entire breast or alteration 
in the appearance of the breast that can influence both the nude and clothed 
body. In order to accept and adapt to this change, women had to experience the 
loss of their missing body parts and go through a grieving process. The loss or 
alteration of the breast(s) is the initial and most visible adjustment that confronted 
women as they began to accept the fact that they have breast cancer. The second 
element is more psychological and involves the women’s perception that their 
womanhood and sexuality is threatened by the cancer experience. 
Anagnostopoulos and Myrgianni (2009) stated that breast cancer and its treatment 
can change a woman’s definition of herself, making her feel less of a woman. 
These authors differentiate between a mastectomy and reconstructive surgery in 
term of body image in a study that they have done. Patients who had a 
mastectomy felt more self-conscious and less attractive, they did not like their 
overall appearance, were displeased with their scar and tend to avoid contact with 
people. Their findings were consistent with a study done by Baxter and colleagues 
(2006), who confirmed that women who had mastectomies had higher levels of 
body stigma (a need to keep her body hidden) and transparency (concerns about 
the obviousness of cancer-related changes to her appearance). 
Since breast conserving surgery does not really alter the appearance of the 
breast, or cause only a small reduction or dimpling in the shape of the breast 
which are not noticeable to others, the visible disfigurement that can lead to a 
negative self-image is usually minimal. It is important to discuss both the 
psychological and the biological sides of the breast surgery with the patient for 
there can be physical discomfort and pain due to the surgery interfering with 
sexual activity. The therapist can provide the patient with practical alternatives 
such as: lying on the unaffected side to minimize the pressure on the chest areas 
if the incision or muscles are tender. This position will provide the patient with 
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more control over her movements and reducing irritation to the incision. If the 
patient feels any pain or discomfort over the breast area, she can ask her partner 
to stop, hence the importance of sexual communication. This “break” can give the 
patient an opportunity to rest or change position, which will also help her to relax 
and reduce pain (Dean, 2008; Hughes, 2008; Derzko et al., 2007).      
It was established through studies that patients who feel better about their bodies 
also have stronger beliefs in their own ability to reach out to others for support, 
maintain a more positive attitude toward the cancer and remain active, self-
efficient and independent (Anagnostopoulos & Myrgianni, 2009; Baxter, Goodwin, 
Mcleod, Dion, Devins, & Bombardier, 2006; Sheppard & Ely, 2008; Wilmoth, 
2001). An important aim in therapy concerning sexual functioning and self-image 
is to teach the patient self-compassion, which is the ability to accept oneself and 
show self-directed kindness while in a stressful situation. Self-compassion 
comprises three components: self-kindness (vs. self-judgement), conscious 
awareness of emotions and understanding the universality of human suffering (vs. 
isolation of self) (Przezdziecki et al., 2013). Teaching a patient to be kind and non-
judgmental towards her own body and accepting physical imperfections, 
limitations and setbacks can enhance her sexual body image. This can be done in 
the framework of CBT where negative and deconstructive thoughts about self-
image can be identified and be consciously changed to positive and friendlier 
thoughts. A study done on the effect of CBT of breast cancer patient’s body-image 
dissatisfaction found that patients made significant gains on the multiple measures 
of the presenting target complaints (Almas & Landmark, 2010). Treatment can 
enhance a patient’s social self-esteem, improved her sexual interest and feelings, 
and promoted more positive evaluation of physical fitness (Almås, & Landmark, 
2010). It is also important to emphasize practical matters, for instance to go on a 
regular basis (if possible) for body and facial massages to “spoil” the body and 
keep it in good order and to concentrate on the rest of the body that is not affected 
by the cancer (Przezdziecki et al., 2012). Breast cancer patients often want to talk 
about their (altered) appearance and what to do about it and how to accommodate 
it. It is important for the breast cancer patients to hear that therapeutic 
interventions are not always just about the (more difficult) psychological 
processes, but can also be more practical as in to change the way they dress, 
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especially if they have lymphedema or have a breast prosthesis or have gained a 
considerable amount of weight. Przezdziecki and colleagues (2012) feel strongly 
that self-compassion enhancement is one of the most active ingredients in 
effective body image intervention. Therapeutically it is vital for the breast cancer 
patient to come to terms with her “new” sexual self or sexual identity during and 
after the treatment of cancer and to use it for her advantage in sustaining healthy 
and active sexual functioning.    
5.4.6  Specific breast cancer symptoms and treatment related sexual 
functioning 
The most important and relevant sexual components and functions in the context 
of cancer treatment and psychotherapy have been covered in this chapter, but 
because of the frequency and impact of certain specific cancer related symptoms 
and the importance of implementing effective interventions, I will briefly describe 
them in the framework of therapeutic interventions.  
5.4.6.1  Psycho-social menopausal symptoms and Treatment 
Menopausal symptoms are a frequent complaint off breast cancer patients during 
and after the cancer treatment with the main psycho-social menopausal symptom 
that of low self-esteem resulting from a psycho-sexual dysfunction which is often 
caused by a decreased libido and consequent relationship problems (Dean, 2008; 
Hughes, 2008). As a therapist it is important to remember that menopausal 
symptoms resulting from cancer treatments are not always discussed with the 
patient before treatment, so they often experience these symptoms alone and in 
silence and therefore is important to always ask about,  and incorporate it in 
therapy (Dalton et al., 2009; Hughes, 2008).  Menopause can have a huge impact 
on a woman’s sexuality because of changes in her body including vaginal dryness, 
loss of vaginal tissue elasticity, hot flushes, insomnia, irritability and mood swings, 
each of which can affect sexual interest and sexual functioning (Dean, 2008; 
Hughes, 2008). It is important to talk about the effectiveness of taking medication 
for menopausal symptoms, what kind of medication to use, what type of symptoms 
it can relief and who can prescribe it. Pharmacological options that are most 
effective are anti-depressants (that are discussed in 4.4.2.7) specifically 
Venlafaxine 75 mg and Paroxetine that were found to reduce hot flushes and can 
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also attend to the patients’ mood.  The anticonvulsant drug Neurontin can also be 
prescribed.  It has been found that Wellbutrin SR 300mg daily can increase sexual 
arousal and orgasm intensity and overall sexual satisfaction (Fobair & Spiegel, 
2009; Krychman & Katz, 2012; Kuo et al., 2008).  
5.4.6.2  Fatigue 
Many cancer patients experience fatigue and lethargy as a direct side-effect of 
cancer treatment, which affects the way they feel as a person and how they relate 
to others (Berger et al., 2015). It is important to ask how fatigue is affecting the 
patient and her relationship, emphasising the importance of non-penetrative sex 
and encouraging them to explore what makes them feel good about themselves 
and the type of things they once enjoyed sharing with their partner (Dean, 2008; 
Hordern & Currow, 2003). Patients will find it helpful to learn to plan their activities, 
preserving energy on tasks that are less important, to learn to prioritise their 
activities and to know when to rest without feeling guilty. They can then figure out 
what time during the day do they tend to feel least fatigued and plan their sexual 
activity for the time of the day when symptoms tend to be least bothersome 
(Nusbaum et al., 2003). In the context of sexual activity, this might feel a bit 
forced, depriving the patient of some of the spontaneity they would have liked, but 
allow them more scope for a better functioning sexual relationship with her partner 
if fatigue is making her sexual life difficult (Dean, 2008).    
By using their best time of the day (when they have more energy, less pain, or 
fewer problems with other symptoms) and by setting realistic and achievable 
goals, they will feel more in touch with themselves and their partners (Dean, 2008; 
Hordern & Currow, 2003). It is important for the patient to “save” her energy for 
important activities and to learn to listen to her own body, to know when to rest 
and what activities take the most out of their energy “reservoir” and replace it with 
less active activities.   
5.4.6.3  Pain 
Vaginal dryness as a result of chemotherapy and hormonal treatment can cause 
pain and discomfort and in extreme cases vaginismus (Hughes, 2008; Hordern & 
Currow, 2003; Weinera & Avery-Clark, 2014). A woman who experiences pain (a 
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physical response) during intercourse may fear (a psychological response) that 
future sexual encounters will result in pain which can cause avoidance of intimate 
behaviour.   Vaginal dryness during sexual activity can be treated symptomatically 
with commercial lubricants and it is important to explain or reinforce the use of 
vaginal lubricants and moisturizers to your patient who need to understand how 
they work. There are two different types of lubrication, the one is a lubricant 
(glycerine-free water based) which the patient use before and during sexual 
activity, whereas vaginal moisturizers are used several times a week to help 
maintain normal vaginal moisture and comfort.  The patient and her partner should 
be encouraged to try out new products (Derzko et al., 2007; Krychman & Katz, 
2012; Reece et al., 2010).  Giving and explaining the more practical elements of 
sexual functioning goes down very well with cancer patients and although it might 
sound very basic (the using of lubrications for instance) a lot of women, especially 
younger women who are in a new and unexpected menopausal status, have never 
had to use lubrications before and do not always have the confidence to talk it 
through with their oncology team (Derzko et al., 2007; Hughes, 2008).     
The purpose of CBT with sex related pain is to achieve pain control by the patient 
self which will focus on reducing catastrophic fear of pain through conscious mind 
control, re-establishing overall satisfying sexual functioning through different and 
flexible thoughts and sexual activities and non-penetrative sex and the 
enhancement of intimacy. The therapist will also educate the patient on 
dyspareunia, especially how it can affect desire and arousal and the overall sexual 
functioning, progressive muscle relaxation and abdominal breathing, vaginal 
dilation, cognitive distraction techniques focusing on sexual imagery and cognitive 
restructuring (flexible thoughts) and communication skills training (Hughes, 2008; 
Weinera & Avery-Clark, 2014). Sexuality and intimacy can be a time of gentle 
relaxation for patients, when sharing and touching can improve their sense of well-
being. If patients have biological pain, the health professional should specifically 
ensure that they take breakthrough analgesia before times of intimacy or physical 
sexuality (Hordern, & Currow, 2003).   
In the case of vaginismus, the use of gradual exposure and applied relaxation 
(systematic desensitization) are one of the core elements in treating. Gradual 
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exposure exercises (sensate exercises) can be assigned for homework including 
gradual process to vaginal touching, usually by beginning with the woman’s 
fingers and dilators up to penetration. These elements are often part of a broader 
approach involving cognitive restructuring, education and broader, more inclusive 
sex therapy (Masters & Johnson, 1970; Meier, 2010).    
5.4.6.4  Decreased libido and orgasmic problems  
Women should be advised during the therapeutic process that an age-related and 
menopausal lowered spontaneous (biological driven urge) sex drive is not 
abnormal. It is important that breast cancer patients, including those on Al therapy 
and younger patients be made aware of this. Even if the biological sexual urge is 
not always present, they can be motivated to be sexual for other reasons, for 
instance to generate emotional closeness, reassurance of a loving relationship 
and partner satisfaction. It is also important to medically address any potentially 
reversible causes such as dyspareunia, depression, hormonal alterations and 
medications that can have an impact on libido. If this is out of the range of the 
psychologist, then the patient must be referred back to the medical specialist 
(Derzko et al., 2007). A decrease in lack of libido can be improved by watching 
erotica for instance. It is important to know your patient’s stance (conservative vs. 
liberal) about using alternatives like watching erotic movies or looking at erotic 
journalism with her partner to better her libido, but is also important that the patient 
must do what they feel comfortable with (Hughes, 2008). They can be encouraged 
to talk about their sexual fantasies with their partners and regular sexual 
encounters may need to be scheduled to “drive” them to participate in sex and 
intimacy to keep their relationship on a healthy level (Hughes, 2008).   
Another alternative to help your breast cancer patient to enhance a low libido is to 
focus on self-stimulating.   Sensate focus exercises are also helpful in treating a 
low libido. Another technique to enhance arousal and orgasm is increased 
intensity and duration of genital, especially clitoral, stimulation (Derzko et al., 
2007).    
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5.6  PRACTICAL IMPLICATIONS AND SUMMARY 
To summarize sexual functioning and interventions in the cancer framework I have 
used the American Cancer Society’s (2013) practical guidelines for cancer 
patients for their sexual wellness during cancer and cancer treatment.   
 The American Cancer Society’s Practical Guidelines for Sexual Wellness (2013) are: 
1.  As a cancer patient - learn as much as possible about the effects of cancer and 
cancer treatment on your sexuality and talk to your oncologist or oncology team 
about sexual matters.   
2.  Understand that in spite of any kind of cancer treatment you as the patient will still be 
able to feel pleasure from touching, even if it means non-genital touching and 
stroking.   
3.  Try to have an open mind about ways to feel sexual pleasure and if necessary to 
broaden your view of sex and sexual intercourse and learn new ways to give and 
receive sexual pleasure.   
4.  Implement a clear two-way communication about sex with your partner and with your 
doctor (or psychologist) too. Good communication is the key to adjusting sexual 
routine when cancer changes your body and it is important to communicate pain or 
tenderness in some parts of your body and to guide your partner’s touches to create 
the pleasure and to avoid pain.   
5.  Learn to improve your self-esteem (including sexual self-esteem) and focus on your 
good qualities. If your hair falls out, decide what to wear, e.g. a wig or a hat or a 
scarf, whatever makes you feel good and beautiful. Eating right and exercising (after 
consulting with the Doctor) can also help keep the body strong and the spirits up.   
6.  Practice relaxation- and breathing techniques, and  
7.  Request professional help when depressed or anxious.   
Health professionals must incorporate patient sexuality and intimacy into routine 
palliative assessments, so that every patient is given an opportunity to explore 
these issues. Patients and their partners will appreciate health professionals 
providing information, support and practical strategies related to issues of intimacy 
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and sexuality throughout the course of care. In the light of this, there is a growing 
recognition that there are still limitations in the way that sexual concerns are 
currently being addressed in cancer patients. According to Reese and colleagues 
(2010) there are few intervention studies addressing adjustment following cancer 
that target sexuality and even fewer that are entirely focused on addressing 
sexuality especially in woman. Krychman and Katz (2012) believed that this field is 
ripe for studies of psycho-social interventions as an adjunct to or in place of 
pharmacologic treatments in this population and that further research is warranted.   
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CHAPTER VI 
RESEARCH METHOD: CASE STUDY DESIGN 
Case study research, which was the design of this study, is a valuable method for 
health science research. It lends itself to exploring real life experiences and 
situations where the researcher is interested in the occurrence and the context in 
which it occurs. In this particular case, the breast cancer experience through the 
lived experience of the breast cancer patient self. Case studies are typically 
descriptive in nature and provide rich, in-depth and longitudinal information. It aims 
to investigate a particular topic in its natural context from multiple angles (Baxter & 
Jack, 2008; Lindegger, 2006; Salminen et al., 2006; Simons, 2009; Terre Blance 
et al., 2006). Because of the sensitivity of the subject of breast cancer and the in-
depth understanding needed, the justification of this study will be better 
comprehended against the background of a qualitative research paradigm.  
As the researcher, I have used a combination of qualitative research methods and 
quantitative methods, combining these two methods by applying two standardised 
questionnaires together with the qualitative information methods to gather data 
regarding depression and anxiety and sexual functioning in the breast cancer 
population. These combined methods can be applied where the study requires 
measurement of some kind (quantitative method), but also deeper understanding 
of the nature of an issue (qualitative method) (Ormston et al., 2014).    
6.1  AIMS OF THE STUDY 
The researcher’s aim with this study was to develop a clearer understanding of the 
lived experiences and perceptions of the breast cancer patient through exploring 
and analysing her experience of her illness and unique needs for further 
psychological interventions through her own personal interpretation and voice. The 
researcher hopes that this study will make a valuable contribution to research in 
the oncology field in South Africa and initiate new ways of understanding the role 
of psychology and the psychologist in the medical world of cancer. The study 
further aim to use this deep and unique knowledge from the breast cancer patients 
and survivors to fill the gap between clinical knowledge and practice by 
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implementing individual psychotherapy and sex therapy as part of a holistic 
psycho-oncology treatment plan.   
6.2  PHILOSOPHICAL, PARADIGM AND INTERPRETIVE 
FRAMEWORKS AND DEFINITIONS                                       
6.2.1  Paradigm  
A paradigm or worldview is defined as a basic set of assumptions and beliefs that 
are shared by members of the scientific community that guide researchers in their 
inquiry (Bezuidenhoud, 2014; Creswell, 2007). A paradigm consists of the 
following components: a) ontology, b) epistemology, c) methodology and d) 
methods (Scotland, 2012). The aim of a research paradigm is to anchor a study 
and serves as a map directing the researcher in all the stages of the research 
process (Bezuidenhoud, 2014; Guba & Lincoln, 1994; Schurink & Schurink).   
6.2.1.1  Ontology 
Ontology is the study of ‘being’ and is concerned with what reality represents 
(Scotland, 2012). Reality can be described as something that is subjective and 
multiple and when studying individuals, qualitative researchers conduct a study 
with the intent of reporting these multiple realities. According to Scotland (2012) 
there is a distinction between a scientific paradigm and an interpretivist paradigm 
each with its own ontology. The ontology of the scientific paradigm (positivists) is 
realism which is based on the notion that there is an external reality which exists 
independently of a person’s belief about or understanding of it. They argue that 
there is but one true reality that is apprehendable, identifiable and measurable and 
use mainly quantitative methodology. The ontological position of interpretivism 
(post-positivists) is relativism or idealism which proclaims that reality is subjective, 
differs from person to person and is mediated by a person’s senses and is only 
knowable through the human mind and through socially constructed meanings 
(Guba & Lincoln, 1994; Ormston et al., 2014; Scotland, 2012). Reality, according 
to the constructivist position, is influenced by the context of the situation, namely 
the individual’s experience and perceptions, the social environment and the 
interaction between the individual (study participant) and the researcher (Creswell, 
2007, 2015; Ormston et al., 2014; Ponterotto, 2005).  
219 
 
The guiding ontological framework for this study is that of constructivists-
interpretivists against the background of relativism, providing the framework for 
studying the breast cancer patient’s experience and perceptions of her illness, her 
social environment regarding her interactions with the oncology team and her 
family and her social support system and the interaction process between her and 
the researcher.       
6.2.1.2  Epistemology 
Epistemology has to do with the relationship between the research participant and 
the researcher where the researcher attempts to lessen the distance between 
him/her and the participant through cooperating, spending time in the field with the 
participants and becomes an “insider” in their lives (Creswell, 2007; Ponterotto, 
2005). Crotty (1998) offers three primary epistemological influences namely: 
objectivism, constructionism and subjectivism. There are several paradigms used 
to guide research and different authors incorporate different paradigmatic 
schemas to conceptualize and classify their research (Creswell, 2007; Denzin & 
Lincoln, 2000; Guba, & Lincoln, 1994; Ponterotto, 2005; Schurink & Schurink, 
2012). The Constructivist (or interpretivist) paradigm is the chosen epistemological 
paradigm that will guide this study and where the researcher will briefly describe 
this approach through the lens of Guba & Lincoln (1994), which is the most 
suitable classification for this study.   
The Constructivist–Interpretivist Paradigm:  
This paradigm can been seen as an alternative to the positivist paradigm of 
dualism and objectivism and in marked contrast to positivist’s single, inflexible 
objective external reality. Constructivism adheres to a relativist position that 
adopts multiple, apprehendable and equally valid realities, which supports the 
beliefs of this study. Constructivists believe that reality is constructed in the mind 
of the individual rather than it being an externally extraordinary object (Ponterotto, 
2005). Both Stake (1994) and Yin (2003) have based their approach to case study 
on a constructivist paradigm. Constructivists, according to these authors, claim 
that truth is relative and that it is dependent on one’s perspective. Creswell (2007) 
understands that individuals seek understanding of the world in which they live 
and work through personal or subjective meanings of their experiences. As the 
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researcher, I am interested in the understanding of the world of the breast cancer 
patient during active treatment and when in remission. A distinguishing 
characteristic of constructivism is the centrality of the interaction between the 
investigator and the object of investigation (participant) and only through this 
interaction can deeper meaning be uncovered. The goal of this paradigm which 
also shares the goal of this study is to rely as much as possible on the 
participants’ lived experiences with their illness and to be able to evaluate and 
asses these personal experiences through experiencing it first-hand with them in 
their environment, in this case through a lengthy therapeutic process (Ponterotto, 
2005; Schwandt, 2000). 
 Constructivist paradigm: Rather than starting with a theory, researchers 
within the constructivist paradigm generate a theory of meaning and value. 
In practice, the questions are broad and general and open-ended, so that 
the participant can create his/her own meaning of a situation. The 
constructivist researcher listens carefully to what people say or do and 
addresses the processes of interaction among individuals (Creswell, 2007). 
Constructivism is built on the principle of a social structure of reality, with 
one of the advantages of this approach, the close relationship between the 
researcher and the participant, while facilitating and empowering the 
participant to tell her story (Baxter & Jack, 2008; Guba & Lincoln, 1994) 
 Interpretivist paradigm: is a methodological approach more typical to 
qualitative research, advocating an interpretative understanding and 
explanation that enables the researcher to appreciate the subjective 
meaning of social action (Symon & Cassell, 2012). Schurink and Schurink 
(2012) believe that reality should be interpreted through the meaning that 
research participants give to their life world. This approach provides a deep 
insight into the complex world of lived experiences from the view point of 
the individuals who live it and believe in multiple perspectives rather than a 
single reality (Andrade, 2009; Creswell, 2013). The researcher’s intention 
with this study was to attempt to understand the breast cancer patient 
better through the subjective interpretation of those who experience it.  
 Phenomenological methodology: Because the researcher’s intention is to 
understand the breast cancer patient better through subjective 
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interpretation and consciousness within the context of her own unique 
experience, the researcher has also borrowed some principles of the 
phenomenological methodology known to use thick description and close 
analysis of lived experience to understand how meaning is created through 
personified awareness (Groenewald, 2004; Laverty, 2003).  
6.2.1.3  Axiology 
Axiology involves the role of researcher values in the scientific process (Creswell, 
2007). Positivists argue that there is no place for values in the research process 
and the psychology researcher should remain emotionally detached from the 
investigative inquiry. By using standardized, systematic investigative methods 
(quantitative research), the researcher eliminates and controls any influence he or 
she might have on the participant’s or on the research process (Guba, & Lincoln, 
1994; Ponterotto, 2005). Constructivists-interpretivists support the fact that the 
researcher’s values and lived experience cannot be separated or removed from 
the research process and the researcher should then acknowledge, describe and 
categorise his/her values, but not eliminate them (Guba & Lincoln, 1994). It is 
important to keep in mind that the epistemology underlying a constructivist position 
necessitates close and prolonged interpersonal contact with the participant in 
order to facilitate their construction and expression of their lived experience that is 
being studied (Ponterotto, 2005). In conducting this study, the researcher, who 
also participates as a clinical psychologist in a therapeutic role with the study 
participants, has developed a close and lengthy patient–therapist relationship and 
interaction with the participants resulting in being able to have observed and 
gained in-depth material directly from them.   
6.2.1.4  Rhetoric  
This terminology refers to the language used to present the procedures and 
results to the intended audience or reader (Creswell, 2007; Ponterotto, 2005). 
Rhetoric or language arises closely from the researcher’s epistemological and 
axiological viewpoint. In the Positivist positions where objectivity and emotionally 
neutral research role succeeds, the language is precise and scientific and will be 
presented in an objective manner, where in the constructivist-interpretivism 
position, a subjective and interactive researcher role predominates. The language 
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of the research report will be more likely in the first person and is often 
personalized (Creswell, 2007; Ponterotto, 2005). Qualitative researchers make 
use of a more literary informal style of writing using the personal voice of the 
participant and use qualitative terminology such as credibility, transferability, 
dependability and confirmability or validation instead of quantitative language such 
as internal- and external validity, generalisability and objectivity. The qualitative 
vocabulary will use words such as “understanding”, “discover” and “meaning” and 
are important language indicators in writing purposes statements and research 
questions (Creswell, 2007).   
6.2.1.5  Methodology   
Methodology refers to the strategy or plan of action which lies behind the choice 
and use of specific methods (Creswell, 2007; Crotty, 1998; Ponterotto, 2005; 
Scotland, 2014). Methodology is concerned with why, what, when, from where and 
how data is collected and analysed (Scotland, 2014). Against the background of 
this study’s interpretivism paradigm, the interpretive methodology is directed at 
understanding a phenomenon or experience from an individual’s perspective, 
exploring interaction amongst individuals and also the historical and cultural 
contexts which people populate (Creswell, 2009; Scotland, 2012). The four 
examples of methodology include: a) case studies, which are the in-depth studying 
of cases or events over a lengthy period of time; b) phenomenology, the study of 
close experience without allowing for obstruction of current prejudices; c) 
hermeneutics, which draws hidden meaning form language; and d) ethnography, 
the study of cultural groups over a prolonged period of time (Scotland, 2012).   
6.2.1.6  Methods 
Methods are the specific techniques and procedures used to collect the data and 
to analyse it and will either be qualitative or quantitative (Crotty, 1998; Scotland, 
2014). Research method emerges naturally from the researcher’s position on 
ontology, epistemology and axiology (Ponterotto, 2005). Where Positivists attempt 
to replicate strict scientific methods and procedures where variables are carefully 
controlled and the researcher’s emotional perspective on the research subject is 
irrelevant, the constructivists/interpretivist on the other hand, give their outlook on 
the significance of intense researcher-participant interaction and on the need to be 
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absorbed in the participants’ world over longer periods of time. As the researcher 
of this study, I have embraced the naturalistic designs where the researcher is 
established in the specific study population and their day-to-day lives, which could 
lead to qualitative research methods such as in-depth face-to-face interviewing 
and participant observation, which was applicable in this study (Lincoln & Guba, 
1985; Ponterotto, 2005).    
6.3  QUALITATIVE RESEARCH   
Qualitative research methods are unique and valuable for studying the 
complexities of the healthcare system and in particular patient experiences (Smith 
& Firth, 2011). Because this study explicitly relies on understanding the breast 
cancer patient’s unique experiences and specific needs regarding their cancer and 
relationships with the cancer professionals, the qualitative approach will be 
appropriate for exploring and describing the complexities of health issues and can 
facilitate, through this type of data gathering and analysis methods, a deep 
understanding of the patient’s experience (Smith & Firth, 2011) 
6.3.1 The characteristics of qualitative research that has guided this study   
Qualitative methods refer to a broad class of empirical procedures designed to 
study things in their natural surroundings, attempting to make sense of, or interpret 
events in terms of the meanings people bring to them (Creswell, 2007; Denzin & 
Lincoln, 2005). In short, according to Creswell (2007) qualitative methods make 
the world visible. Ormston and colleagues (2014) described qualitative research 
as a naturalistic, interpretative approach, involving exploring phenomena from the 
inside and taking the perspectives and explanations of research participants as a 
starting point. Theories and models don’t explain the reasons why people respond 
the way they do, or the specific context in which they responded or their deeper 
and meaningful thoughts and behaviours that directed this responses, although 
they provide a general picture of tendencies, associations and relationships 
(Denzin & Lincoln, 2000).   
Qualitative research begins with an assumption, a paradigm, the possible use of a 
theoretical lens, and the study of research problems or phenomena, inquiring into 
the meaning individuals assign to a human problem. To study this problem or 
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phenomenon, qualitative researchers use a developing qualitative approach to 
inquiry, the collection of data in a natural setting sensitive to the people under 
study and data analysis that is inductive and establishes patterns of themes 
(Creswell, 2007). Although there are different opinions about the amount of 
literature needed before a study begins, qualitative texts refer to the need to 
review the literature so that the researcher can provide the rationale for the 
problem and position the study within the on-going literature. This study has 
conducted a thorough literature review first, prior to the data collection process, on 
breast cancer research done internationally and in South Africa to have acquired 
an understanding of the topic. The aim with the literature review was to see what 
has already been done on breast cancer, how it was researched and what the key 
issues were, as well as the criticisms and restrictions on the topic (Hart, 1998).    
The final written report or presentation then includes the voices of the participants, 
the interpretation of the researcher and a multiplex description and interpretation 
of the problem. In writing up the findings of the study, the qualitative researcher 
will make use of everyday language and often incorporate the participants’ own 
words to describe an experience or phenomenon (Ponterotto, 2005). By creating 
dialogue and heightening awareness, as described by Creswell (2007) it was 
hoped by the researcher that this research study can lead to a better 
understanding of the psychological pathology and experiences of the breast 
cancer patient and their need for further psychological interventions and through 
that insight lead to improvements in the oncology practice.    
I support the belief of Denzin and Lincoln (2003) that the way people experience 
life is too complex and rich to be reduced to numbers and statistics as is the 
practise of quantitative research methods. Rather than predicting and 
generalising, the practising of qualitative research has placed importance and 
worth on the human interpretation of their lived experiences and on the meaning of 
both the participants’ and investigators’ interpretations and comprehension of the 
phenomenon being studied (Denzin & Lincoln, 2003; Ormston et al., 2014). 
Although this study used elements of both methods, the largest part of the study 
relied on a qualitative research approach because it offers tools for the researcher 
to study selected and complex issues in depth. Osborne (1994) explained that 
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when a researcher decides on a qualitative enquiry and must make a decision as 
to which qualitative methods are best for the study, an important element to take 
into consideration is that the chosen methods should be a function of the research 
question to be answered and not just a mere commitment to the theoretical 
philosophy.     
Table 6.1 presents a summary of the practical characteristics of qualitative 
research that the researcher has used in this study and described by Creswell, 
(2007), Ritchie and Lewis (2003) and Ormston and colleagues (2014).   
Table 6.1: Description of the common characteristics of qualitative research that 
was used in this study:   
CHARACTERISTIC DESCRIPTION THIS STUDY 
Naturalistic  This means studying real-
world situations in a natural, 
non-manipulative and non-
controlling way with an 
openness to anything that 
can emerge with no 
predetermined limits on 
outcomes.   
Qualitative researchers 
collect data in the field and 
gathered information by 
talking directly to people and 
seeing them perform within 
their context.  
The researcher has collected 
data from the study patients 
during individual psycho-
therapeutic sessions to 
explore their unique lived 
experiences with their breast 
cancer diagnosis or 
survivorship in their own 
natural environment.   
Researcher as key 
instrument 
The qualitative researchers 
collect data themselves 
through examining 
documents, observing 
behaviour and interviewing 
participants. Data is collected 
during close relationships 
As the researcher I have 
adapted the role of a clinical 
psychologist who did 
psychotherapy with the breast 
cancer patients, allowing me 
to observe and have personal 
interaction with them in a 
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CHARACTERISTIC DESCRIPTION THIS STUDY 
between the researcher and 
the participant.   
close and confidential 
psychotherapeutic 
relationship.    
This was done either in the 
practise or the hospital during 
and after their cancer 
treatment. 
Interaction between 
researcher and study 
participants and 
participants’ 
meanings 
Qualitative researchers aim to 
understand a deep structure 
of knowledge that only 
develops from personal 
interaction with the 
participants, spending 
extensive time in the field and 
delving to gather detailed 
meanings.   
The researcher has 
developed a therapist – 
patient relationship with the 
five study patients and was 
involved in a therapeutic 
process for more or less a 
year evaluating the breast 
cancer patient’s unique 
meaning of their experience.        
Samples 
Samples are small and 
selected according to specific 
criteria.   
This study included five 
breast cancer patients and 
survivors that were selected 
according to certain criteria.    
Multiple sources of 
data 
Qualitative researchers 
gather multiple forms of data, 
during close relationships 
between the researcher and 
participant, such as  
as interviews, observations 
and documents, rather than 
rely on a single data source.   
This researcher has used the 
close, therapeutic relationship 
between her and the breast 
cancer patient to gather data 
in the form of “interviews” or 
therapeutic interactions and 
direct observations during the 
therapeutic process. Two 
structured questionnaires 
were used, as was a literature 
study.   
Inductive data 
analysis 
Data-analysis are flexible and 
clear, supporting complexity  
and progression and reflects 
As the researcher I have 
started transcribing the “raw” 
notes after every session, I 
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CHARACTERISTIC DESCRIPTION THIS STUDY 
 
 
the uniqueness of each 
participant. Occurrences 
created from in-depth, 
detailed descriptions of the 
phenomena are based on the 
lived experiences and 
perspectives of the 
participants.   
 
Qualitative researchers 
review all of the data; make 
sense of them and organizing 
them into categories or 
themes from a “bottom-up” 
process that cuts across all of 
the data sources.  
Researchers then work back 
and forth between the themes 
and the database until they 
establish a comprehensive 
set of themes.   
have then worked through 
them back and forth and had 
systematically sorted them 
firstly into core categories and 
sub-categories and then into 
an inclusive set of themes.   
 
Interpretive inquiry 
Qualitative research is a form 
of inquiry in which 
researchers make an 
interpretation of what they 
see, hear and understand. 
The researcher’s 
interpretations cannot be 
separated from their own 
background, history, context 
and prior understandings.  
  
I have observed and listened 
to the five participants during 
conversations and 
therapeutic 
sessions/interactions and with 
my experience of working 
with breast cancer patients 
and deep interests in breast 
cancer, made certain 
interpretations which were 
reported in rich and 
comprehensive descriptions.   
Holistic account 
Holism consists of reporting I have taken all the different 
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CHARACTERISTIC DESCRIPTION THIS STUDY 
various perspectives; 
identifying different factors 
involved in a situation and 
sketches in general the larger 
picture that develops.  
Qualitative researchers aim to 
identify complex interactions 
of different factors in any 
situation and don’t rely on 
rigid cause-and-effect 
relationships between factors.    
aspects and stages of a 
breast cancer diagnosis into 
consideration, putting it into 
both a medical- and psycho-
oncologic framework and 
reported a holistic picture of 
the breast cancer patient and 
survivor in terms of her own 
personal and unique 
experiences and needs.   
The practising of qualitative research (Ormston et al., 2014), has placed emphasis 
and worth on human interpretation of the social world and the importance of both 
participants’ and the investigators’ interpretations and understanding of the 
phenomenon being studied. Besides this discussion and understanding of the 
phenomenon, a qualitative study may also fill a void in existing literature, create a 
new line of thinking or evaluate an issue with an understudied group. 
6.3.2  Literature review as part of a qualitative method 
The primary use of a literature review is to provide the rationale for the problem 
and to help the researcher to become familiar with the challenges, limits and 
language of the type of research they aim to conduct and to provide the 
contextualisation for the arguments of the study (Creswell, 2007; Henning et al., 
2004; Ormston et al., 2014). When a preliminary idea for a study has been 
theorized the researcher will then need to examine how other researchers have 
thought about and researched the topic and need to gain perspective on the 
phenomenon or problem and be able to connect the past with the present (Denyer 
& Tranfield, 2006; Jaccard & Jacoby, 2010).  
Through examining the literature, it was clear that breast cancer survivors are 
officially the leading group of cancer survivors amongst women in the Western 
world, indicating the critical need to find creative strategies to assist this population 
in coming to terms with, and live with their cancer reality (Fiszer, Dolbeault, Sultan 
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& Bredart, 2014; Greeff, 2008; Hummel et al., 2015). Psycho-oncology is a 
relatively new field that has started to develop as a sub-specialty in oncology and 
psychology and Holland (2002) claims that over the next years new research will 
give a scientific basis for interventions and a reduction in the barriers to psycho-
social care in cancer. Venter (2014) who found that the majority of studies done in 
South Africa focussed on the bio-medical aspects of cancer where only 16% of 
studies during this timeframe was focused on psychosocial factors. Venter feels 
that despite the need for a bio-psycho-social approach, there seems to be limited 
literature available on the psychological adjustment of cancer patients in South 
Africa.   
6.3.3  Case study research 
There are five qualitative approaches to inquiry, namely: Narrative research, 
Phenomenology research, Grounded theory, Ethnography and Case study 
research. The chosen approach for this study was case study research.   
6.3.3.1  Definition and background 
Case study research is used to explore real life experiences and situations where 
the researcher is interested in the occurrence and the context in which it occurs.  
Case studies are typically descriptive in nature and provide rich, in-depth and 
longitudinal information and aims to investigate a particular topic in its context form 
multiple angles (Lindegger, 2006; Salminen et al., 2006; Simons, 2009). An 
advantage of case studies is that it allows new ideas and hypotheses that emerge 
from careful and detailed observation. What makes the case study research 
applicable in this study is that it can be a useful approach when studying 
professional practice and problems of practical significances in the case of 
psycho-oncology, which can enable practitioners to re-conceptualise a practical 
problem and comprehend it more fully to incorporate theory and practice (Golby, 
1994; Salminen et al., 2006).   
Specific features associated with case studies and which provided the guidelines 
for this study are:  
 It focuses on an individual unit.  
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 It assists the researcher to understand complex issues and inter-
relationships. 
 The study is intensive and detailed and grounded in “lived reality”. 
 The phenomenon is studied in its context. 
 Case studies can present the processes involved in causal relationships. 
 Multiple data-collection methods were used, and data results are able to 
facilitate rich conceptual or theoretical development (Hodkinson & 
Hodkinson, 2001; Lewis, Ritchie, Ormston, & Morell, 2014).   
Stake (1995) and Yin (2003) base their approach to case study on a constructivist 
paradigm which recognises the importance of the subjective human creation of 
meaning, but doesn’t outright reject some notion of objectivity. This study 
supported constructivism/interpretivism as the chosen epistemological paradigm 
embracing the naturalistic and holistic themes to guide the descriptive and 
exploratory multiple case study design. Marshall and Rossman (2014) stated that 
qualitative studies often include both descriptive and exploratory methods for the 
mere fact that they build rich descriptions of complex circumstances that are 
unexplored in the literature. Case studies can be categorised as explanatory, 
exploratory or descriptive and differentiates amongst single-, holistic- and multiple-
case studies (Creswell, 2007; Durrheim, 2006; Stake, 1994; Yin, 2003, 2014). A 
description of exploratory, descriptive and multiple-cases studies will follow in 
Table 6.2 to give the reader a clearer picture of the framework of this study:    
Table 6.2: Definitions of the categories of case studies that were used in this study 
Concept Definition 
Exploratory: This type of study is conducted for preliminary 
investigations into relatively unknown areas of 
research and to explore situations in which the 
intervention being evaluated does not have a clear 
single set of outcomes (Creswell, 2007; Terre Blance 
2006; Yin, 2003).   
Descriptive: This type of case study is to describe an intervention 
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Concept Definition 
or phenomenon in the real life context in which it 
occurred (Durrheim, 2006; Yin, 2003, 2014).  
Multiple-case 
studies:   
This type of study enables the researcher to explore 
differences within and between cases with the goal of 
replicating findings across cases. Because links and 
comparisons will be drawn, the cases were carefully 
chosen for the researcher to predict similar results 
across cases or predict contrasting results based on a 
theory (Durrheim, 2008; Stake, 1995; Yin, 2003).    
In spite of the strong features of case studies that benefited this study, the 
researcher was attentive to accommodate the limitations and to have worked 
around it as to not disadvantage the study because of that. Hodkinson and 
Hodkinson (2001) gave a short description of the six limitations of case studies:   
 Case studies can generate too much data for easy analysis and even with 
detailed reporting it can still be a simplification of the data. 
 If the sample is too big, it can be very expensive and time-consuming to 
collect the data. 
 The findings of most case studies cannot be explained in a linear fashion, 
which can make it difficult to summarise the results. 
 The findings of a case study do not lend themselves to numerical 
representation which makes it not generalizable in the conventional sense.   
 Because the sample sizes are often small and unique and essentially non-
numerical, there is no definite way to establish the possibility that the data 
is representative of some larger population therefore some researchers find 
case study results of little value.     
 6.3.3.2  Multiple case studies  
Single and multiple case study designs are variants within the same 
methodological framework with the defining feature of a multiple case study design 
that the researcher examines more than one case to illustrate the research 
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problem and to show different perspectives of the issue or problem (Creswell, 
2007; Yin, 2003, 2014). Each individual case study consists of a “whole” study 
where the researcher replicates the procedures for each case and in which 
concurrent evidence is pursued. In this study the researcher wanted to examine 
the whole spectrum of the breast cancer experience throughout the active cancer 
treatment and survivorship.  This was done within the framework of different ages 
and stages of the cancer and treatment together with their related and relevant 
needs.  Because of these differences, the researcher has chosen multiple cases.   
Multiple case designs add reliability to the findings of the study and may offer 
deeper understanding of cases than single case designs. The evidence from 
multiple cases is often considered more compelling and the overall study is 
therefore regarded as being more robust and stronger than single case designs 
(Salminen, 2006; Yin, 2003). Although multiple case studies are more expensive 
and time-consuming to conduct, they are preferred over single-case designs 
because their analytic benefits are more substantial and powerful (Baxter & Jack, 
2008; Yin, 2003). Multiple cases, as opposed to a single case can enhance 
external validity and prevent observer bias (Creswell, 2007; Durrheim, 2006).   
6.3.3.3  Case selection 
The most important criterion in case selection is to ensure that the selection allows 
for the maximum amount of information to be learned from the cases in question 
(Salminen et al., 2006). Purposeful sampling, which is a commonly used method 
of case selection in qualitative research, means the researcher selects certain 
individuals for the study because they have the best knowledge of the research 
topic and therefore can purposefully contribute to the research problem and 
central phenomenon (Creswell, 2007, 2013; Elo et al., 2014; Patton, 2002). The 
researcher, within the multiple case study design, will look for a participant to 
include in the study who understands the phenomenon under study, who is 
articulate, reflective and willing to share her feelings and experiences with the 
interviewer/researcher (Coyne, 1997; Elo et al., 2014). The participant will be 
selected according to critical analysis of the specific population being studied and 
with the assumption that the participant will add value to the outcome of the study 
(Silverman, 2001). Although sampling procedures in qualitative research are not 
so rigidly prescribed as in quantitative studies, Seawright and Gerring (2008), 
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gave a relatively narrow definition of sample procedure stating that it is the 
intensive analysis of a single case or a small number of cases where the 
researcher’s goal is to understand a larger class of similar cases (a population of 
cases). These authors believe that the chosen individual is asked to perform a 
“heroic” role to represent a population of cases that is often much bigger than the 
case itself.   
6.3.3.3.1  Number of participants  
The number of cases that should be selected is an important decision in sampling 
strategy in the data collection process (Creswell, 2007; Voss, Tsikriktsis, & 
Frohlich, 2002). A smaller number of cases facilitate greater opportunity for depth 
of observation and because of the labour intensity of qualitative research, a large 
sample can be time consuming, expensive and sometimes just impractical 
(Coyne, 1997; Creswell, 2007; Mason, 2010; Seawright & Gerring, 2008; Terre 
Blance, 2006; Voss et al., 2002). There is no set number of cases, but Creswell 
(2007) states that he would not include more than four or five cases, for this 
amount should provide sufficient opportunity to collect extensive detail about each 
individual and to identify themes of the cases as well as conduct cross-case theme 
analysis. Creswell warns that if there are too many cases, the uniqueness and 
depth of the cases can be lost.  According to Terre Blance (2006) and Richie and 
colleagues (2013) there are a number of issues that can help the researcher to 
determine the sample size, which was implemented in this study:    
 The heterogeneity of the study population; if the population is relatively 
homogeneous, as in this study where all the participants’ were breast 
cancer patients or survivors, a smaller sample will be representative of the 
study population and will include all the internal variety that is needed;   
 For reasons of comparison. 
 Practical constraints such as the budget and resources available, for each 
sample unit will need intensive resources for data collection and analysis.  
Because there was only researcher in this study, a smaller number of cases were 
more practical, manageable and affordable.   
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To lessen concerns regarding small sample size, Patton (2002) stated that 
researchers must be careful not to over-generalise from purposeful samples, but 
rather maximising the advantages of in-depth, purposeful sampling. Sommer and 
Sommer (2002) (as described in Bezuidenhoud, 2014) indicated that the 
researcher must specify the sample size in advance in order to avoid allegations 
that data collection was stopped as soon as study results favoured the hypothesis 
or research problem. In this study, five breast cancer patients were chosen 
because they could all relate to specific experiences, behaviours and roles that the 
researcher was interested in and wanted to explore.  All five patients were either 
busy with breast cancer treatment or finished with the treatment, but still suffering 
from belated side-effects. They were all able and willing to participate and 
contribute to the study, which according to Patton (2002) ensured that a good 
purpose sampling has taken place. Small numbers, as emphasised by Richie and 
colleagues (2014) will ensure that the sample will be rich in terms of the 
populations, characteristics and diversity that it represents.  
6.3.3.3.2  Data saturation 
Data saturation is discussed in the literature as a point in a study at which the 
researcher no longer hears anything new, or when the researcher may be aware 
that he or she is not learning anything new (Lincoln & Guba, 1985; Patton, 2002). 
As the researcher and therapist, I have felt after the interviews and therapeutic 
sessions with the five breast cancer patients, that I have gained sufficient 
information from them regarding the study subject and felt satisfied with the 
outcome of the interviews and therapeutic sessions.   
6.3.3.3.3  Patients selected 
Five breast cancer patients were purposively selected by the researcher of this 
study on the basis of their potential for providing rich and in-depth descriptions of 
their breast cancer journey, their willingness to participate in the study and their 
availability for the duration of the study. Two of the five participants were selected 
from a government-funded or state hospital which was just diagnosed with breast 
cancer and started their treatment.   Three patients were recruited from the private 
sector and were already finished with their treatment and in the remission or re-
entry phase.     
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As described in Chapter I, the study participants were referred to as patients 
because they were, during the research study, actively busy with a 
psychotherapeutic process (and as a clinical psychologist, come from a 
background were psychotherapeutic “participants” are called patients). The term 
patient refers then rather to their psychotherapeutic status as to their cancer 
status. Academically the terminology of ‘patient’ was associated and used with 
patients actively busy with breast cancer treatment and ‘survivor’ when the person 
was finished with her treatment and in remission (Park et al., 2009; Twombly, 
2004).      
6.3.3.4  Recruitments of the study patients  
 Patients 
State Patients: The reason that I have chosen the two patients from a state 
hospital was from a practical viewpoint regarding the availability of them during the 
whole breast cancer treatment. These two patients were acquired at the State 
hospital’s oncologic department. The decision to include state patients was based 
on the availability of patients to engage in therapeutic interactions on the days of 
their cancer treatments in order for the researcher to be able to participate in their 
whole treatment experience from diagnosis through to the end of their treatment. I 
also wished to include breast cancer patients from the community who would not 
be able to see a psychologist out of their own accord either because of a lack of 
finances or because of a lack of availability of psychological services. During the 
recruitment process of the state patients, I had to familiarise myself with the 
working of a state facility and had to obtain ethical clearance from the National and 
Provincial Health Research & Ethics Committees of South Africa (NHRD) (which 
will be discussed fully in 6.3.3.5) to involve state patients. After obtaining ethical 
clearance, permission was granted from the head of oncology to attend a meeting 
at the state hospital’s oncology ward with a group of newly diagnosed breast 
cancer patients to meet with the oncology team and possibly recruit suitable 
candidates for the research study.    
During this group meeting that was held in the hospital’s oncology ward with the 
newly diagnosed breast cancer patients and their families (some of them brought 
their families with), an oncologist explained what a diagnosis of breast cancer 
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means and the process of breast cancer treatment that was lying ahead of them, 
especially concerning surgery and chemotherapy and their probable side-effects.  
General, practical matters such as the location of the chemo room, consultation 
rooms, the sister’s station, and scheduled dates concerning their treatments were 
also explained to them. At the end of the session the oncologist introduced me to 
the group of patients, giving them a brief explanation of the study and asked to 
consider volunteering if they fit the including criteria. After this introduction I have 
also presented a short description of my study and described what would be 
expected of them if they choose to participate in the study and if they fit the 
criteria. At the end of the session three patients immediately came forward to ask 
to participate in the study. I then, individually, explained in short the aims and the 
context of the study and what their roles as study patients would be. An 
information form was given to them to take home and read through and discus, if 
they wanted to, with their families before making a final decision to participate. All 
three patients who have agreed to participate in the study have complied with the 
criteria for the study and upon recruitment I made a formal appointment together 
with their next chemotherapy session which was three weeks hereafter. One week 
before the first session the patients were contacted by phone to confirm their 
scheduled appointments and to give them time to ask any questions they might 
have before our first session. All three of them sounded enthusiastic and were 
looking forward for the psychotherapeutic sessions to start. After the first session, 
one of the patients did not come back without giving any reason as to why and I 
left it at that. The two state patients were called Patient II and III.    
Private Patients: The breast cancer patients that were included in the study as 
cancer survivors were all three from the private sector. Two were referred by 
medical professionals who knew about this study (I have informed a couple of 
oncologists and psychologists about the study for possible candidates) and one 
was recruited by the researcher, originally for the pilot study. Patient I was 
recruited for the pilot study for the main reason that it was believed that she could 
contribute to the study because of her working knowledge in the medical field and 
strong understanding of psychology together with her own cancer status. She was 
also willing and enthusiastic to take part in a study where she could share the 
237 
 
experiences of her breast cancer for the chance of helping other breast cancer 
patients.  
Patient IV is a private patient but did not belong to a medical aid. She wanted to 
participate in psychotherapy but could not afford to see a psychologist and after 
hearing of this study from another clinical psychologist, she requested to 
participate in the study. She was contacted by the researcher and after explaining 
what the study entails she expressed her willingness to participate. She had a 
need to see a therapist but also to contribute to the study and help other breast 
cancer patients through her own experiences.   
Patient V requested her oncologist to see a psychologist for treatment and the 
oncologist, who knew about this study, referred her. The researcher contacted her 
and explained to her what the study and the process would involve. She was 
willing to participate in the study for the therapeutic process and also for a chance 
to share her knowledge of her breast cancer experience. All three patients have 
complied with the criteria for participating in the study. Only patient I and patient V 
was in the financial position to afford the services of a clinical psychologist.   
The private patients were required to come to the therapeutic sessions on their 
own time (which would suit both the patient and the researcher) and with their own 
transport. It was made clear to them that all the therapeutic sessions were for free.  
After getting their details from the referring practitioners, the three patients were 
first contacted by phone, where they were given a brief explanation of the study 
and what the study would entail and what would be expected of them if they 
decided to participate. They were also given time to ask any questions that they 
might have concerning the study or their participation therein. During the first 
telephone contact, their first appointments were scheduled at my practise and at 
the home of one of the patients (for practical reasons) and the day before their first 
appointments, it was confirmed again telephonically. The three patients complied 
with the criteria for the study and understood the purpose of the study and what it 
would entail for them to participate in the study.    
The inclusion criteria were: (a) a diagnoses of breast cancer; (b) the patients could 
be anywhere in the breast cancer trajectory, from newly diagnosed and at the 
beginning of their treatment, through to the remission phase (but not in remission 
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for more than five years); (c) adult women aged between 30 and 65; (d) patients 
included in the study must live in Cape Town or the Cape Town region for 
accessibility for the therapeutic sessions; and (e) the patients must be able to 
speak and read English or Afrikaans to be able to participate in the research 
survey. There were no limitations in cultural background, marital status, or 
religious preferences for the women who participated in the study, but the study 
did not include patients that were terminally ill or were diagnosed with metastatic 
breast cancer. The appraisal of relevant literature of former research in this field 
helped to identify characteristics that are known to have an impact on the subject 
being investigated and should be included as selection criteria or used to define 
the population for the study (Ritchie et al., 2014).   
 6.3.3.5  Interview Environment and Therapeutic Time Frame 
 Interview Environment:    
The term therapeutic environment refers to any environment that has, as its 
purpose, a therapeutic effect on an individual and a psychologist’s office can be 
regarded as therapeutic because it is designed and decorated with the intent of 
making patients feel safe and comfortable (http://www.wisegeek.com/what-is-a-
therapeutic-environment.htm#). According to Pressly and Heesacker (2001) and 
Wedding (2010) the physical surroundings in the counselling workspace can 
influence the relationship between therapist and patient as well as treatment 
outcomes. For the purpose of this study and working with an already traumatized 
population, it was important for the researcher, also working in the role of a clinical 
psychologist, to have provided a safe and comfortable space for the research 
study patients to share their deepest and innermost experiences. 
 Therapeutic Time Frame:   
The amount of therapeutic sessions have varied from six to eight depending on 
motives such as practical elements, saturation of information and reaching the 
psycho-therapeutic goals. With the two state patients, the sessions were booked 
the same day as their treatments because of practical reasons such as distance 
and transport and with the end of their active cancer treatments they did not have 
to travel to the hospital anymore. Because of the traveling aspect, the sessions 
239 
 
could not go on beyond the completion of the cancer treatment and therefore it 
was terminated, but not without reaching the mutual goals. With the completion of 
their cancer treatment, both state patients felt that they would be able to continue 
without the psycho-therapy, feeling better adapted and equipped to handle their 
current breast cancer situation, as well as the chronicity of their illness. With the 
three private patients, the researcher ended the sessions when the therapeutic 
process was satisfactory for both patient and therapist. Patient IV was an 
exception as she requested sessions as a private patient to continue her 
therapeutic process on a longer term, as soon as her medical aid allowed, for she 
needed extensive therapeutic interventions because of her long and complicated 
history of depression. It must also be taken into consideration that there were time 
limitations on the study.    
Time-wise, all off the sessions were between one hour and one hour and thirty 
minutes. The therapist took Young and Beck’s (1980) principals of therapy into 
consideration, namely that pacing and optimising time are crucial components 
where the objective should be to accomplish as much as possible during each 
session, but with considering the capacity of the patient to absorb new information.  
At the beginning and end of each session, there was usually a brief feedback 
phase of the patient’s experiences of the last session and the time in between. 
Most of the time this came spontaneously from the patient, but it was also an aim 
of the therapist to check on the experience of the patient regarding the therapeutic 
interventions  
6.3.3.6  Ethics 
Regardless of the approach or qualitative inquiry, qualitative researchers are 
confronted with a number of ethical issues and considerations throughout the 
research process which must be consciously controlled by the researcher through 
applying prescribed ethical standards (Creswell, 2007; Flick, 2009; Silverman, 
2011). The fundamental principle of research involving human subjects is to 
protect the well-being and safety of the research participant and to make sure that 
the research process is not harmful to the participants (Creswell, 2007; 
Wassenaar, 2006; Yin, 2014). Appropriate ethical thought was given to the study 
to secure that no harm would be done to any participant as a result of the research 
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and the researcher has adhered to and acknowledged the ethical responsibility to 
conduct consequential and reliable research by following the general ethical 
guidelines of Webster and colleagues (2013) and Creswell (2014).   
Permission to conduct the study was granted by the Ethics Committee of the 
Psychology Department of UNISA on the understanding that:   
 Because of the sensitivity of the information being sought and the fact that 
the participants come from a vulnerable population, it is required that ethical 
principles related to informed consent, anonymity, confidentiality and the 
right of participants to withdraw should be strictly enforced. 
 Clearance is to be obtained from the hospitals from where the participants 
are to be drawn, and all conditions and procedures regarding access to 
patients for research purposes that may be required by these institutions 
are to be met. 
 If any further counselling is required in some cases, the participants will be 
referred to appropriate counselling services. 
Regarding the inclusion of the two participating state hospital patients, ethical 
approval was also obtained from the National and Provincial Health Research & 
Ethics Committees of South Africa (NHRD), who serve as the gatekeeper for 
monitoring and managing health research for the National Health Research 
Committee, Provincial Health Research Committees and Research Ethics 
Committees across South Africa.   
After gaining the permission of the Ethics Committee of UNISA and the NHRD, the 
next step in selecting participants was to gain consent from all persons who might 
be part of the study and to provide them with appropriate information about the 
contents of the study (Wassenaar, 2006). The researcher clearly explained the 
objective, purpose and intent of the research study to the five breast cancer 
patients before starting with the study. The researcher also explained that their 
participation is voluntary and that they have the freedom to decline of withdraw 
any time after the study has started without giving any reason or to feel 
pressurised to continue participating. The five patients were provided with clear, 
detailed and factual information about the study, its methods, risks and benefits, 
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as well as the therapeutic interventions, keeping in mind that a participant can only 
make an informed decision if the information about the study is sufficient 
(Wassenaar, 2006). I was careful not to have made unreasonable demands on the 
study patients and there were an agreement between us that they could enunciate 
any questions or concerns at any given time during the research study. The 
practical elements of the study, like the scheduled times and place of the sessions 
and the duration of the interviews, questionnaires and therapy sessions, were 
explained individually to the patients. At the initial meeting, each participant was 
given an informed consent document to review and sign. The researcher has 
obtained both written and verbal consent from all the participants.   
Ethical principles are clear that researchers should do everything possible to 
maintain the confidentiality and anonymity of participants in research (Webster, 
Lewis, & Brown, 2013). As the researcher, I ensured confidentiality and anonymity 
through the use of pseudonyms and that no identifiable information was used 
during the results discussion. The research participants were treated with dignity 
and respect and appointments were honoured. All the files with their personal 
details, interviews and questionnaires with the full range of findings will be kept 
confidential and secure in a locked filing cabinet with access to nobody other than 
the researcher for at least five years post study, as their information are treated as 
a typical psychotherapeutic patient who’s file must be stored for five years after 
termination of therapy. I have explained in detail to the participants who have 
never been in therapy before, what the psychotherapeutic process entails and 
what they can expect of that. It was also explained to all five patients what sex 
therapy involves, as it was part of the study process and whether they would feel 
comfortable engaging in this type of therapy. I have made sure throughout the 
process that the patients felt valued and respected as people at all times and that 
after the research process unbiased and accurate reporting would be attempted 
by the researcher.   
I have adapted the ethics guidelines of Webster and colleagues (2013) throughout 
the research process to protect the study patients and will summarise it in Table 
6.3.   
242 
 
Table 6.3: The ethical framework that was adapted in this study and was applied 
before, during and after the therapeutic process. 
Before the interview: During the interview: After the interview: 
 The study patients 
were not pressured in 
any way into the 
study. They 
understood that their 
participation is 
voluntary.    
 They were provided 
with a consent form to 
sign after being fully 
informed what the 
study is about.     
 The patients were 
informed why they 
were selected for the 
study and their 
possible contribution 
to the study.   
 The patients have 
understood the 
objective, aim and 
expected intention of 
the study, as it was 
explained to them by 
the researcher.   
 The patients knew 
what to expect during 
the therapeutic 
sessions.     
 
 The patients were 
reminded that their 
participation is 
voluntary and that 
they can end their 
participation at any 
given time if they 
which to.     
 I have continuously 
made sure that all five 
patients felt safe and 
comfortable at all 
times.    
 The patients were 
given enough time for 
self-expression and 
emotional catharsis 
during the sessions.   
 The patients were 
given enough support 
and reinforcement 
during the sessions.   
 The research 
participants were 
treated with dignity 
and respect during all 
the sessions and all 
the appointments 
were honoured. 
 To adhere to the 
responsibility to 
store the information 
of the patients at a 
safe place.   
 As the researcher, I 
have tried to be 
unbiased and 
accurate in 
analysing and 
reporting the data.   
 I have made sure 
after the end of the 
therapeutic process 
that all the patients 
were satisfactory 
(through a last 
telephonic contact) 
and that they were 
permitted to contact 
me in case of an 
emotional 
emergency.   
The consideration and implication of the above means the developing of an ethical 
conscience that put participants’ interests at the heart of decision making, 
intervention, data collection, management and analysis and reporting the results 
(Webster, et al., 2013). 
6.3.3.6.1  Informed Consent 
The first step in selecting the participants was to gain consent from all persons 
who may be part of the study and to provide them with appropriate information 
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about the contents of the study (as explained in Table 6.3), (Wassenaar, 2006). It 
was imperative for the participant to understand the nature and the aim of the 
study, that her participation was voluntary and that she had the freedom to decline 
or withdraw any time after the study has started. This all had to be done in a 
language that she would understand. The researcher has provided the patient with 
clear, detailed and factual information about the study, its methods, risks and 
benefits, as well as the therapeutic interventions, keeping in mind that a participant 
can only make an informed decision if the information about the study is sufficient 
(Wassenaar, 2006). The practical elements of the study, like the scheduled times 
and place of the sessions and the duration of the interviews, questionnaires and 
therapy sessions was explained individually to the five participants.   The consent 
had to be formalised in writing (Wassenaar, 2006), and each participant had 
received a letter of consent to sign (see appendix C).   
6.3.3.6.2  Privacy and confidentiality 
Ethical principles are clear that the researcher should do everything possible to 
maintain the confidentiality and anonymity of participants in research. This meant, 
in practical terms, protecting the privacy and confidentiality of my study 
participants so that they would not unwittingly be put in any undesirable position 
(Webster et al., 2013; Yin, 2014).   
The research participants were treated with dignity and respect and appointments 
were honoured. All the files with their personal details, interviews and 
questionnaires with the full range of findings will be kept confidential and secure in 
a locked filing cabinet with access to nobody other than the researcher for at least 
five years post study. I have explained, in detail, to the two participants who have 
never been in therapy before this study what the psychotherapeutic process 
entails and what they could expect of it.   
6.3.3.7  Strategies for ensuring trustworthiness in qualitative research 
projects 
Qualitative researchers have developed unique terms that are more fitting to 
qualitative research such as credibility (reliability), authenticity (validity or 
trustworthiness), transferability, dependability (constancy) and confirmability 
(prove) which are the naturalist equivalents for internal validation, external 
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validation, reliability and objectivity that are the used terms in quantitative research 
(Creswell, 2007; Koro- Ljungberg, 2010; Lincoln & Cuba, 1985; Morrow, 2005). 
The concepts of validity, credibility and reliability were originally developed in the 
natural sciences and then expanded to qualitative science (Lewis, 2015; Richie & 
Lewis, 2013).   Trustworthiness, which include terminology such as credibility, 
validity and reliability of qualitative research, has been often questioned and 
challenged by qualitative researchers (positivists) because their views of validity 
and reliability cannot be dealt with, and applied in the same way in qualitative 
(naturalistic) work (Shenton, 2004). In the scientific context, trustworthiness refers 
to the replicability of a study’s findings, meaning, if the study gets repeated in the 
exact manner by a different investigator, would he get the same results again 
(Richie & Lewis, 2003, 2013). The goal of trustworthiness is to minimise the errors 
and biases in a study, therefore it is important to thoroughly document the 
procedures which is a way of dealing with reliability (Yin, 2014). Trustworthiness is 
a central concept in any discussion of generalisation and is concerned with the 
strength and credibility of the original research evidence and by implication 
whether any wider interpretation or suggestion can be sustained (Richie et al., 
2013).   
Although all research must have truth value, applicability, consistency, and 
neutrality in order to be regarded as worthwhile, the nature of knowledge within 
the quantitative paradigm is different from the knowledge in the qualitative 
paradigm (Guba & Lincoln, 1981; Morse et al., 2002). In dealing with these 
challenges, several qualitative researchers have demonstrated how qualitative 
researchers can integrate measures that deal with these issues (Guba, 1981; 
Koro-Ljungberg, 2010; Morse et al., 2002; Shenton, 2004; Silverman, 2001: 
Winter, 2000). Guba (1981) has proposed four criteria (that was derived from 
similar issues employed by the positivists) that should be considered by qualitative 
researchers in the quest for a trustworthy study.   
 Credibility (in preference to internal validity). 
 Transferability (in preference to external validity/generalisability). 
 Dependability (in preference to reliability). 
 Confirmability (in preference to objectivity). 
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The researcher employed various strategies, as suggested by Shenton (2004) in 
an attempt to fulfil above-mentioned criteria in this study which included the 
following: 
6.3.3.7.1  Credibility  
Credibility deals with the focus of the research and refers to the confidence in how 
well the data address the intended focus (Elo, et al., 2014). To ensure credibility in 
qualitative studies is one of most important factors in determining trustworthiness 
(Lincoln & Guba, 1985) and the following strategies can be implemented by 
researchers to promote credibility and validity by accurately documenting the 
study phenomena (Creswell, 2007; Creswell & Muller, 2000; Shenton, 2004):     
 Prolonged and lengthy engagement with the study participants and 
persistent observation in the field including building trust with the 
participants is a validation strategy (Creswell, 2007; Lewis 2015; Richie et 
al., 2013).   
 Triangulation, which is a validity procedure, is where researchers search for 
integration among multiple and different sources, methods and theories to 
provide supporting evidence and form categories or themes in a research 
study (Creswell, 2007; Creswell & Muller, 2000; Richie et al., 2014). 
Triangulation represents a systematic process of sorting through data to 
find general themes by eliminating overlapping areas through the 
interpretation of only the researcher (Creswell & Muller, 2000).  
 Individual interviews which form the major data collection strategies for 
much qualitative research.  
 Approaches to help ensure honesty in study participants– each participant 
must be given the opportunity to decline to participate in the study and give 
enough information to make an informed decision to participate to ensure 
that all the participants are genuinely willing to take part in the study. 
Participants should clearly understand that they have the right to withdraw 
at any given point from the study without disclosing an explanation to the 
investigator (Shenton, 2004).   
 Repeated interview sessions between the researcher and his or her 
superiors– in this case the study promotor where, through discussion, the 
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researcher’s vision may be widened or changed to alternative approaches 
(Shenton, 2004).   
 According to Shenton (2004) if the researcher uses a reporting system in 
which he/she defines a series of categories within a typology and illustrates 
these categories using real qualitative episodes which  enables the reader 
to evaluate how far the defined categories truly embrace the actual 
situations (Creswell, 2007; Lewis et al., 2014).   
 Examination of previous research findings through literature to assess the 
degree to which the study’s results are congruent with those of past 
studies. The ability of the researcher to relate his or her findings to an 
existing body of knowledge is a key criterion for evaluating works of 
qualitative inquiry (Silverman, 2001).   
A “valid” account in qualitative research refers to the presentation of an 
explanation that is sound and grounded in the research information (Cosser, 
2009). In spite of the fact that qualitative research if often criticised for not being 
objective and although there is no distinct or clear validation approach, Creswell 
(2007) considers validation in qualitative research as an effort to assess the 
accuracy of the findings as best described by the participants and researcher and 
which suggests that any account or description of research is a representation by 
the author. According to Osborne (1994) findings are valid to the extent that they 
reverberate with the experiences of others who have experienced the 
phenomenon in question. In Creswell’s (2007) viewpoint validation is a definite 
strength of qualitative research in that the justification is made through extensive 
time spent in the field and detailed generous description and the closeness of the 
researcher to the participants in the study which all add to the value or accuracy of 
the study.  
There are authors, such as Wolcott (1990) and Winter (2000) that reject the notion 
of validity entirely in any form as inappropriate to their work. Wolcott (1990) who 
has very little use for validation, suggests that validation neither guides nor informs 
his work because he would rather try to understand than convince. In the light of 
this, statistical tests or measures of reliability and validity as used in quantitative 
studies, are wholly inappropriate for qualitative investigation and would cause 
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confusion if applied (Ritchie et al., 2014). Some authors like Guba and Lincoln 
(1994) are of the opinion that qualitative research should rather be judged by its 
authenticity or genuineness which includes whether it has represented a variety of 
different realities, whether it helped people to develop better and more complex 
understandings and perceptions, if it can motivate and encourage actions and if it 
empowers people to change their social circumstances (Ritchie et al., 2014). If the 
qualitative researcher seeks for validity, it would rather lie in the representation of 
the case studies (individuals), the purposes of the research and appropriateness 
of the processes involved (Winters, 2000).   
6.3.3.7.2  Transferability 
External validity in quantitative work means that a study’s findings must be 
generalizable beyond the immediate case study regardless of the research 
method used (e.g. experiments, surveys or case studies) and be applied to a 
wider population (Merriam, 1998; Winter, 2002; Yin, 2014). Qualitative studies on 
the other hand, strive more to provide a rich and contextualized understanding of 
some aspect of the human experience through the intensive study of particular 
cases, more than to generalize (Polit & Beck, 2010). Another procedure for 
establishing transferability in a research study is for the researcher to give a rich 
and detailed description of the participants under study, providing the reader to 
transfer information to other similar situations and to determine whether the 
findings can be transferred because of shared characteristics (Creswell, 2007; 
Lewis, 2015; Ritchie et al., 2014). The process of writing a thick description in 
terms of information about the setting, the participants and the themes of a 
qualitative study in rich detail, creates, according to Creswell and Muller (2000) 
verisimilitude that creates accounts that produce for the readers the feeling that 
they have first-hand experienced, or could experience the events being described 
in the study. Denzin (1989) states that the process of using thick, detailed and 
vivid description is to help the reader understand that the account is credible and 
enables the reader to make decisions about the applicability of the findings to 
other settings or similar contexts. 
Because findings of a qualitative study are specific to a small number of 
environments and individuals, it is not possible to generalize the findings and 
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conclusions to other situations and populations (Shenton, 2014; Stake, 1994).  
Shenton (2014) urges qualitative researchers not develop a preoccupation with 
transferability, for ultimately, the results must be understood within the context of 
the particular characteristics of the group or population, or even the geographical 
area in which the fieldwork was done.   
My hope for this study is that the reader will learn something new and expand their 
awareness and understanding of the breast cancer patient and survivor by reading 
this study. This project should challenge, not only psychotherapists working within 
this population, but also other medical professionals who desire to effectively work 
with cancer patients. This valuable information should inspire others to learn more 
about supporting cancer patients in a psycho-therapeutic manner.   
6.3.3.7.3  Dependability 
Dependability refers to the stability of data over time and under different 
conditions. The dependability of a study is high if another researcher can readily 
follow the decision trail used by the initial researcher, therefore it is important to 
state the principles and criteria used to select participants and detail the 
participants’ main characteristics so that the transferability of the results to other 
contexts can be assessed (Elo et al., 2014; Thomas & Magilvy, 2011). In 
addressing the issue of reliability, the positivist employs techniques to show that, if 
the work were repeated, in the same context, with the same methods and with the 
same participants, similar results would be obtained (Shenton, 2004). To enable 
readers of the research report to develop a thorough understanding of the 
methods and their effectiveness of the study, it should include the next elements 
as described by Shenton (2004) and as implemented in this study:   
 The research design and its application, describing in detail what was 
planned and implemented on a strategic level. 
 The operational detail of the data gathering in the field. 
 Thoughtful assessment of the study and assessing the effectiveness of the 
data gathering.   
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6.3.3.7.4  Confirmability 
Confirmability is the qualitative researcher’s comparable term to objectivity in 
quantitative research. Confirmability of findings means that the data accurately 
represent the information that the participants provided and the interpretations of 
those data are not invented by the inquirer (Elo et al., 2014; Polit & Beck, 2012). 
For the qualitative study to represent confirmability steps must be taken to make 
sure that the findings of the work are the results of the experiences and ideas of 
the participants and not of the characteristics and preferences of the researcher 
(Shenton, 2004). The role of triangulation in enhancing confirmability must again 
be emphasised to reduce the effect of investigator bias, as well as detailed 
methodological description to enable the reader through an “audit trail” to 
determine the credibility of the data and construct of the study (Creswell, 2007; 
Creswell & Muller, 2000; Ritchie et al., 2013; Shenton, 2004).    
Strategies for achieving trustworthiness in this study  
Although the researcher has taken all the prescribed steps to make the study as 
valid and reliable as possible, the aim was predominantly to understand all the 
aspects of the experiences of the breast cancer patients instead of spending 
unnecessary energy to perfect the validity and reliability of this study.  Table 6.3 
gives a description of the practical application of the characteristics of 
trustworthiness in this study.    
Table 6.3: The practical application of the characteristics of trustworthiness 
CHARACTERISTIC APPLICATION 
Credibility A detailed description of the methodology and a 
literature review was conducted including both the 
psychological and medical aspects of breast cancer, 
allowing the researcher to give a detailed description 
of the phenomenon under investigation. This could 
add credibility as it helped to convey the actual 
situation and context of the problem.    
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As the researcher I have developed a familiarity with 
the participating organisations, the private oncology 
institutions, state hospital and breast cancer 
population before conducting the study.     
I spent extensive time in the field during the psycho-
therapeutic sessions and gave detailed and 
generous descriptions of the data. The closeness 
and time spend between me and the patients in the 
study had also added to the value or accuracy of the 
study. 
I adopted approved research methods such as semi-
structured interview questions and observations 
conducted by myself with 26 years of experience in 
interviewing and assessing patients in a clinical 
practise.   
I developed lengthy engagements with the study 
participants through therapeutic sessions over a 
period of a year, building a trustful relationship for 
gaining more sensitive information.    
I used triangulation through using five breast cancer 
patients of different ages and stages of breast 
cancer. Their different viewpoints and experiences 
were confirmed against each other and a rich and 
detailed image was formed. Triangulation was also 
used to have sorting through the data of the 5 case 
studies to find general themes by eliminating 
overlapping areas.  
The different individual viewpoints and experiences 
of the participants were verified against one another 
and against the literature and a full picture of their 
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attitudes, needs and behaviour were constructed.   
Confirmability I gave a clear and detailed description of the 
purpose of the study, a step-by-step illustration of 
how the data was gathered during the interviews and 
therapeutic sessions and how the data was 
processed.  
The aim of the therapist was for the findings to 
resonate with the experience of others who have 
experienced the same phenomenon by giving a very 
detailed and rich description of the experiences of 
the five breast cancer patients by using their own 
voices and generous quotes.   
Triangulation can also be used in an attempt to 
reduce investigator bias.   
Dependability The researcher provided an in-depth methodological 
description of the design of the study, stating the 
principles and criteria used to select the five patients 
with detail of the biographical details of the patients.   
Transferability The boundaries of the study were made clear from 
the onset of the study. As was the number of cases, 
the variables, data collection methods, including the 
number and length of the data information sessions, 
the average length and the time period over which 
the data was collected.   
Transferability was addressed by providing a clear 
goal of the research study, detailed descriptive data, 
including a comprehensive description of the 
patient’s biographical details and the research 
design.  
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Every step of the research process was documented 
for the reader to be able to “see” the process from 
the “inside”.     
 
6.3.4  Data collection 
6.3.4.1  Pilot study  
During the process of data collection in this study, a pilot study was conducted as 
a final preparation to ensure that the questions selected from the literature to be 
included in the questionnaire, were clear and sufficiently representative of the field 
of cancer and cancer treatment (Venter, 2014; Yin, 2003). Kanjee (2006) explains 
that a pilot study is a preliminary study to conduct before implementing the final 
research design to identify potential problems with the design, especially the 
research instruments. Yin (2003) stated that a pilot study will help the researcher 
to hone his data collection plans regarding the content of the data and the 
procedures to be followed. Yin made it clear that it is not a pre-test, but more of an 
influential element to assist the researcher to develop relevant lines of questions. 
After conducting the pilot study, one of the most crucial changes that I have made, 
was to change the (much more) formal and lengthy interview questions to more 
free range questions combining the questions with the therapeutic process, 
meaning that instead of having different interview sessions and therapeutic 
sessions, the researcher integrated them. This was essentially because of the 
time limits of the study and practical considerations (6 to 10 sessions) and the 
patient’s needs to talk more freely about their cancer experiences and therapeutic 
interventions. Another reason was that the type of open ended questions that were 
asked have almost always triggered a lengthy description of their experiences, 
giving valuable insight into the cancer patient’s life, but also served as an 
emotional catharsis, which was part of the therapeutic process.   
6.3.4.2  Interviews and direct observation 
 • Interviews   
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This study used in-depth interviews to explore breast cancer patients’ perceptions 
of their cancer experience and their need for psycho-oncologic interventions. The 
researcher who conducted the in-depth interviews is a practicing clinical 
psychologist who entered the research relationship with the five participants as a 
professional therapist where years of doing psychotherapy had provided her with 
professional skills in conducting effective interviewing and psycho-therapeutic 
skills. Apart from the pilot study, where there were well defined interview sessions 
with the patient, the researcher preferred to use the term “therapeutic sessions” 
instead of interviews or interview sessions. The reason for this preference of 
terminology is that the patients, from the first session, were encouraged to engage 
in a psychotherapeutic process where they could express their unique cancer 
experience by answering questions or volunteer information, but also experience 
psychotherapeutic interventions immediately. The information and the therapeutic 
process of the pilot patient were so insightful that it was decided to include her in 
the study as part of the study participants. Considering the in-depth and rich 
information that this study had generated, I have succeeded in my aim to establish 
a climate which encouraged trust and self-disclosure from the study patients. The 
aim of the research study, which is to explore and understand the breast cancer 
patients experience and needs regarding their cancer and psycho-oncologic 
interventions, has guided me in asking relevant questions and implementing 
therapeutic interventions but was also noticed that there was a natural and 
spontaneous flow of conversations from the very first session regarding sharing 
their experiences and thus little need for the researcher to engage in a formal 
interview mode because the patients were very focused on their breast cancer 
experiences.   
The amount of sessions for each patient depended on where the patient was in 
her cancer trajectory or her need of psychotherapy in terms of her psychological 
wellbeing and it has varied from five sessions to eight sessions. Five months into 
the process of emerging and improving the interview- and therapeutic process I 
started to recruit and interact with four other breast cancer patients which 
extended over a period of thirteen months. As the researcher, I wish to distinguish 
between the two patients who were newly diagnosed and just started with their 
treatment program (chemotherapy) and which were both state hospital patients 
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and the three patients who were already finished with their treatment and in 
remission and which were private patients.   
Yeo and colleagues (2014) define in-depth interviews as a powerful method for 
creating description and detailed interpretation of people’s social worlds and 
stresses the importance of talking to people to understand their point of view.  
Conducting an interview is a natural form of interacting between individuals and is 
based on verbal communication and spoken descriptions which are essential 
sources of case study information and fitting well with the interpretive approach of 
this study (Kelly, 2006; Lewis & McNaughton, 2014; Yin, 2003, 2014). Face to face 
interacting between participant and researcher is regarded as a core method of 
qualitative data collection where it gives the researcher the opportunity to get to 
know his study participant quite intimately and allowing him/her to really 
understand the depth of the feelings and experiences of complicated constructs or 
experiences (Lewis & McNaughton, 2014; Yeo et al., 2014). Some authors even 
see the interview as a guided and purposeful conversation in order to make the 
interview more fluid and open ended rather than controlled and rigid (Yeo et al., 
2014; Yin, 2003, 2014). I supported the view that the value of an interview as a 
data collection method is grounded in the belief that participants are people who 
dynamically create their own social worlds and can, through words, communicate 
insight about this world (Lewis & McNaughton, 2014). Interviews, which are the 
most apparent way to investigate delicate or complex issues, were used in this 
study (as part of a psychotherapeutic process) where the study patients could 
share their perspectives within the context of their personal history and experience 
of their illness. 
Data was gathered in the form of psychotherapeutic sessions which also served 
as interviews with each breast cancer patient. The length of the interviews was 
ranged from one hour to ninety minutes, which are more or less the standard time 
for a psychotherapeutic session. I have found that during therapy sessions, 
patients often wanted to go over their time especially when they got entangled in 
their emotions and experiences regarding their cancer. This has obligated the 
therapist to stay within the scheduled timeframe of the sessions, which were either 
an hour or an hour and a half. I made it a point at the beginning at each session to 
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remind the patient of the time of the session and to warn her plus minus 10 
minutes before the session ended to wind down and concluded their “stories” or 
experiences and also used the time to schedule the next session.   
Throughout the therapeutic process I aimed to establish a relaxed and trusted 
atmosphere for the study patients to open up and share their deepest 
experiences. We engaged in a more conversational style to build rapport than an 
inquisitorial style. The sessions were also conducted in the participant’s language 
of choice. During the first interview the aim and the purpose of the study was 
explained as well as the ethical obligations concerning the study. With all five 
patients the interview- and therapeutic sessions were very spontaneous in terms 
of their participation and interactions. After the initial explaining of the interview- 
and therapeutic process, little encouragement were necessary to have engaged 
the patients in a therapeutic conversation, for they were open and honest about 
their thoughts and emotions regarding their breast cancer experience and very 
willing to talk about this experience. When asking questions during the sessions, 
open-ended questions were asked regarding their cancer experience or to explore 
certain key themes of the research subject, or to obtain more information or 
interpretative experiences regarding a statement that they have made. The 
sessions were all very flexible in terms of the questions being asked and the 
therapeutic goals. There were certain goals in every therapeutic session in terms 
of the themes that the therapist wished to explore. Flexibility allowed the therapist 
to use follow-up questions to explore responses and to react on related issues 
raised freely by the patient. The patient was allowed lead the way in terms of her 
needs of what she wanted to discuss, or express, or needed knowledge about. I 
found during the sessions that the patients had the need to talk freely and openly 
about their emotions and experiences regarding their cancer experience.   
The general interview guide used for the interviews were discussed in Appendix A 
 Boundaries and roles in in-depth interviewing when the researcher 
doubles as the therapist 
According to Dickson-Swift, James, Kippen and Liamputtong (2006) some aspects 
of qualitative research interviews are strikingly similar to aspects of therapeutic 
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interviews.  An example of this is empathy and listening skills are important for 
both research interviews, especially qualitative interviews on sensitive topics, and 
for therapy interviews.  In this research study, the researcher fulfilled both the 
roles of the researcher, in conducting the research process and analysing the 
data, and as a therapist doing the psychotherapy or therapy interviews.   As acting 
in the dual role of both the researcher and therapist, I have kept in mind the 
importance of defining and managing the boundaries between 
researcher/therapist and the patients while conducting the study (Dickson-Swift et 
al., 2006).  Yeo and colleagues (2014) said that a practitioner-researcher needs to 
understand and take into account their own professional codes which will 
differentiate from other researchers.   
One of the advantages in acting in the dual role of the clinical psychologist and 
researcher was that I could develop a close patient–therapist relationship and 
lengthy interaction with the participants resulting in being able to have observed 
and gained in-depth material directly from them. Because therapists hold a very 
special position in the lives of their patients (Bourdeau, 2000) as their therapist 
and researcher I could observe their pain, but simultaneously also gave them 
compassion and hope during their trauma and challenges.  I have shared the 
vision of Bourdeau (2000) that in this postmodern era, both therapy and qualitative 
research are striving to empower the persons who choose to participate in a study 
and that my work will make a difference and benefit the participants above all else.  
I have also aimed, in this dual relationship, to stay in contact with the context of 
the study and how my questions were presented during therapeutic sessions and 
consciously remained empathetic and understanding during the sessions.  As 
acting in both the capacity of the therapist and researcher, I had the opportunity to 
have observed the patient’s behaviour in the ‘real time’ of her current situation.   
6.3.5  Quantitative measures 
6.3.5.1  Combining qualitative and quantitative methods  
Qualitative and quantitative researchers base their conclusions on different kinds 
of data and utilise different techniques of data analysis. Quantitative methods 
focus on the strict quantification of data and on controlling of empirical variables 
(Grieger, 1999; Ponterotto, 2005). Quantitative researchers collect data in the form 
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of numbers and use statistical types of data analysis, where qualitative 
researchers collect data in the form of written or spoken language or observations 
and analyse the data by identifying and categorising themes. Combining 
qualitative- and quantitative methods is to regard them as equal but also separate 
and capable to answer different questions about the same topics. These combined 
methods can be applied where the study requires measurement of some kind 
(quantitative method), but also deeper understanding of the nature of an issue 
(qualitative method) (Ormston et al., 2014).This study relies more on qualitative 
research to obtain rich, detailed information from the cancer patient through face-
to-face interaction between the study participant and the researcher, than on 
psychometrics, which can suppress the spontaneity of the participants’ 
experience. The researcher used a combination of these two methods by applying 
two standardised questionnaires together with the qualitative information methods, 
to gather data regarding depression and anxiety and sexual functioning in the 
breast cancer population. 
Ormston and colleagues (2014) explain that mixing the two methods is to see 
them triangulating each other, which means that they describe social phenomena 
from different perspectives, where each perspective testing and adding to or 
validating the other. These authors say that the “safety” in using multiple methods 
provides a fuller picture of the phenomenon being studied, but not necessarily a 
more definite one.  Two of the primary strengths of quantitative research are that 
the findings are generalizable and that the data are objective (Terre Blance et al., 
2006). When these two approaches are used together they can present a powerful 
resource to inform and provide clarity about the subject of study.   
This study made use of both qualitative and quantitative measures during data 
collection.  This process of triangulation produce a more complete picture as 
measuring something in more than one way increases the likelihood or seeing all 
aspects of it (Ormston et al., 2014). I have used two standardised questionnaires 
as part of the quantitative method.   
• The Hospital Anxiety and Depression Scale (HADS) 
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The HADS was developed by Zigmond and Snaith in 1983 (Zigmond & Snaith, 
1983). The aim of this brief self-rating scale is to provide clinicians with a reliable 
and valid practical tool that is easy to use, for classifying and quantifying 
depression and anxiety (Michopoulos et al., 2008). According to Herrmann (1997) 
the role of the HADS is more dimensional than categorical, using the scale to 
identifying general hospital patients who need further psychiatric evaluation and 
assistance rather than making a diagnosis of psychiatric disorders.   
The scale include two different subscales of seven items each, one for depression 
and one for anxiety and the sum of these tow subscales corresponds to a total 
score (Montel, 2010; Valdaninia et al., 2010). It has been recognised as a much 
applied and convenient self-rating scale instrument for both anxiety and 
depression with both somatic and mental problems and has also been validated in 
cancer populations (Costanini, 1999; Michopoulos et al., 2008; Moorey et al., 
1991).   
• The Female Sexual Functioning Index (FSFI) 
As previously described, female sexual dysfunction (FSD) is common among 
women who have survived cancer, and the most frequently used instrument to 
assess sexual functioning in this population is the female sexual function index 
(FSFI) (Baser, 2012). The FSFI is a 19 item inventory test and is divided into six 
elements: desire, arousal, lubrication, orgasm, satisfaction and pain (Rosen et al., 
2000; Sheridan, 2006). Although the FSFI was originally developed and validated 
in healthy women, results in a study done by Baser in 2012, indicate that this scale 
is a reliable and valid instrument for measuring levels of sexual functioning and 
cancer-related FSD in the cancer population. Baser (2012) found that thorough 
psychometric properties of the FSFI among cancer survivors were clearly evident 
in their study, and however subtly, the results also suggest that emotional intimacy 
with a partner may play a significant role in the sexual functioning of cancer 
survivors that is conceptually distinct form overall satisfaction with sexual life.    
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6.3.6  Creating a case study database 
6.3.6.1  Case study notes 
Data in this study was obtained through deep, detailed, first-person accounts from 
the research patients during therapeutic sessions, where analysis was based on a 
common set of qualitative principles which included the writing down of the’ 
interviews’ during the therapeutic sessions in detail and the process of 
familiarising the data in an attempt for the researcher to have gained insights in 
the experience of breast cancer (Creswell, 2007; Smith & Firth, 2011; Smith et al., 
2013). The purpose according to Terre Blance and colleagues (2006) is not to 
collect portions of real life, but to place real-life experiences and phenomena into 
some kind of perspective which shared the aim of this study.   
Handwritten notes were the original raw data and the core component of this 
research study and were obtained during the interviews and psychotherapeutic 
sessions with the five breast cancer patients. As described earlier (6.3.6.1) the 
sessions with the study patients were combined between “interview” sessions and 
psychotherapeutic sessions. The researcher prefers to call it therapeutic sessions. 
Even when asking questions during the therapeutic sessions regarding the 
research subject, it was still ‘therapeutic’ in the sense that through answering it, it 
‘doubled’ as emotional catharsis for the patient could use it as emotional 
expression. With all five patients the first session was used to introduce the study 
and explained the therapeutic procedure.  The patients were then asked for a 
detailed history of their cancer experience or any information that they felt they 
would like to share whether it was related to the cancer or not. It was explained to, 
and understood by the patients, that although there were psychotherapy involved, 
it was still firstly a research study that needed certain questions and answers 
which had to be written down. After every session the handwritten notes were 
immediately typed by the researcher in very precise detail to allow for true and 
detailed descriptions of the interactions with the patients and to have captured 
observations and detail of the sessions. I used quotations from the breast cancer 
patients to demonstrate important points (Seidman, 1991). The information was 
then stored in computer files.  
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The observations, and questions and therapeutic process were all written down as 
in ‘usual’ therapeutic notes, meaning there was not a different set of notes for 
questions asked and therapeutic interventions. I took the advice of Yin (2014) and 
made sure that the notes (both handwritten and the computer files) were 
organized, complete and available for later access during analysis process, 
especially because it was such a long process and many sessions which meant 
that I had to rely very heavily on my notes for information and detail. This process 
of getting information, writing it down during the therapeutic sessions and 
transcribing it after the sessions and organise the data into paper files or computer 
files is called data management, which count as the first step in the data analysis 
process (Creswell, 2007; Terre Blance et al., 2006).   
6.3.6.2  Tabular material 
Materials such as surveys or structured questionnaires should be organized and 
stored as part of the above mentioned database (Yin, 2003). In this case the 
HADS and the FSFI were completed by the patients after the first session. The 
questionnaires were explained to them during their first official session and it was 
given to them to take home together with the information- and consent form to 
study and discus with their family or partner and to be brought back the next 
session. All five brought it back with the second session. The questionnaires were 
marked immediately upon arrival and were filed and stored with the hand written 
notes.   
6.3.7  Interpretive analysis of case study data 
 
According to Doody and Noonan (2013) and Rabionet (2011) in certain 
circumstances written notes are preferable to audio recordings due to the fact that 
in some cases, especially when asking questions regarding a sensitive or 
traumatic subject, patients tend to be less comfortable and more formal when 
being recorded.  Because it was my aim to gain in-depth information from the 
study patient on a tough and sensitive matter, I have preferred to keep the 
interviews very therapeutic and not engaging in anything that could jeopardise a 
therapeutic environment.   
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The transcription of the information of the five participants were done immediately 
after completion of each individual interview and interaction in an attempt to 
acquire a general understanding of what the patients experienced and expressed 
regarding their breast cancer phenomenon during the particular session. The 
basic and most important information was written down in order to remember the 
details.  According to Patton (2002) it is difficult to respond properly to 
patients/participants’ cues when trying to write down every word they said.  This 
author also caution the interviewer that taking verbatim notes can interfere with 
listening attentively to what the patient says and that the participant then will only 
get secondary attention. Patton said that qualitative researchers during interviews 
listen through a ‘lens’ causing the researcher to be far more present in his or her 
handwritten notes than would be the case in a verbatim transcriptions or audio-
recordings.    
Once all the interviews and therapeutic interactions were fully transcribed, I 
engaged in a process where the data was read and re-read in order to obtain a 
holistic view of the data. During this process I developed a series of 
interconnected stages enabling me to move back and forth across the data until a 
clear description emerged leading to the development and refinement of a set of 
themes that was part of a set of initial- and refined categories. This was 
accomplished by the systematic classification system underlined by the thematic 
analysis method (as described in 6.3.8) and these themes and categories will be 
fully described in 7. 6. 
The interpretation of the data was influenced by the social constructionist data 
analysis method which focused on interpreting the lived experience of the 
participants in the breast cancer context and allowed the researcher to find 
significant themes within the text (Ryan & Bernard, 2003; Sprenkle, & Piercy, 
2005). Central to interpretive analysis is for the researcher to provide a 
transparent and detailed description of the data which can be defined as a 
thorough explanation of the characteristics, developments and surroundings that 
represent the experience of the phenomenon being studied. This will not only 
enhance the trustworthy analysis of the evidence, but also generate alternative 
debates on the phenomena being researched (Burr, 2003). In practise this has 
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demonstrated to be a circular process rather than a fixed linear process (Creswell, 
2007), which involved careful reading and familiarising of the data from the early 
stages of the interaction with the breast cancer patients and locating and 
developing categories and themes to help the researcher make comparisons or 
identify connections between themes (Basit, 2003).   I have often made use of “in 
vivo” concepts as described by using the participants own language or “voice” and 
then interpreted the data to make sense of the concepts and themes in terms of 
the participants’ lives and experiences. I have tried to remain true to the 
descriptions of the participants while developing more abstract concepts in 
analysing the data (Ponteretto, 2010; Smith & Firth, 2011).   
I was committed to responsibly develop and interpreted themes in the study. I 
used theoretical principles as guidance to analyse the data and then present the 
findings in a written report which included the voices of the breast cancer patients. 
Even though I have used the participating patients own voices on their unique 
experiences of their cancer journey, the themes would to some degree be 
influenced by my perception and interpretation of the meaning of them (Dockery, 
2014; Finlay, 2011).   
6.3.7.1  Theoretical background 
Unlike with quantitative analysis, there are no clear definitions for analysing 
qualitative data, but researchers can choose from different approaches or 
methods. The interpretive analysis method, which was used as the foundation for 
this study, included elements of thematic content analysis and the framework, and 
phenomenological approaches (Smith & Firth, 2011; Spencer et al., 2014; Terre 
Blance et al., 2006; Yin, 2003), which will be described briefly here:  
 Thematic content analysis: This is a subjective interpretation process 
where data is systematically searched to identify patterns or themes within the 
data in order to provide an informative description of the studied phenomenon 
leading to the development of meaningful themes without openly developing 
theory (Ormston et al., 2013; Yin, 2003). The aim of thematic content analysis is to 
provide deep and rich knowledge and insights of the phenomenon under study 
(Neuman, 2003; Smith & Firth, 2011) which was applicable in this study.  
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 The framework approach: This approach enables the researcher to 
systematically explore data in depth and is well suited to the analysis of cross 
sectional descriptive data causing different aspects of the phenomena to be 
captured (Ritchie & Lewis, 2003; Smith & Firth, 2011). This approach also allows 
for searching and identifying patterns and themes during the early stages of the 
analysis process to provide informative description of the subject of study. Both 
approaches attempt to make the process of data analysis transparent and 
showing the connexion between the stages of the analysis (Richie & Lewis, 2003; 
Smith & Firth, 2011). One of the core elements of analysing within the framework 
approach is developing a series of interconnected stages which enables the 
researcher to move back and forth across the data until a clear description 
emerges which results in a refinement of themes that can lead to the development 
of a conceptual framework (Ayres et al., 2003; Ritchie & Lewis, 2003). This was a 
very prominent process during the study, because there were voluminous 
information from thirty-two sessions over a period of one year, the researcher had 
to developed different stages and sub-text and categories and themes and 
through reading and re-reading it and moved back and forth across the data, it 
was possible to develop a conceptual framework.     
 
 Interpretative phenomenological analysis: The researcher incorporated 
this approach because of its particular psychological interest in how people make 
sense of major life experiences. From a phenomenological lens, I have aimed to 
examine the lived experience of the breast cancer patients in detail and analysed 
the data to understand the meaning that the breast cancer patients gave to their 
experience of cancer (Smith et al., 2013).   
6.3.7.1  Interpretive analysis of this study  
The choice of using interpretive analysis was influenced by social constructionism 
which was the guiding epistemology of this study. The methods of interpretive 
analysis allowed the researcher to have focused on interpreting the lived 
experience of the study patients in the breast cancer context and to provide a thick 
and detailed description of the complete breast cancer experience during and after 
active treatment (Ryan & Bernard, 2003; Sprenkle, & Piercy, 2005). As the 
researcher I have used the voices of my breast cancer patients to explain their 
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own unique experiences and perceptions with their families throughout their breast 
cancer journey and their psycho-oncologic needs that developed out of this 
journey.    
In interpreting the data, I used Creswell’s (2007) framework of general data 
analysis strategies specific to case studies, including:   
 Sketching ideas: where the researcher must highlight certain core 
information in notes and draft a summary sheet.   
 Developing core categories and sub categories.  
 Reducing codes to themes and identify patterned regularities. 
 Relating categories to analytic framework in literature, meaning 
contextualizing in framework from literature.   
 Displaying the data. Display findings in tables, charts, diagrams and figures 
and compare cases.    
The beginning of the process of analysis has already started early on in the 
research study with the taking down of notes during every therapeutic session and 
transcribing them over afterwards which involved careful reading and re-reading of 
the sessions to get familiarised with the data. The five cases were written up 
separately and independently as explained by Patton (2002). This author 
reminded the qualitative researcher that when studying multiple cases, each case 
in the beginning, must be treated as a unique entity with its own individual 
meaning and patterns developing from and related to the framework within it 
occurs. One of the aims of this study when analysing the data, was to fully 
understand all five individual patients before combining them thematically (Patton, 
2002). Because of the therapeutic relationship between the therapist and the 
patients, there was a deep and personal understanding of every patient regarding 
the meaning and patterns within every case. The process of analysis and 
interpreting has then continued with making notes in the margins of the original 
data and then started to break down the data, first in brackets of large chunks of 
data and then in groups or sub-text (de Vos, Strydom, Fouche & Delport, 2005; 
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Ryan & Bernard, 2003). The sub-text were then explored and developed in 
categories or codes which involved applying labels to chunks of data considered 
to be about the “same thing” and to help that similarly labelled data can be further 
analysed (Basit, 2003; Ormston et al.,  2014). This process was done from moving 
from one psychotherapeutic session to the next. Through this, a general system of 
core categories has developed which was used throughout the documents and the 
identifying of how they related to one another (de Vos et al., 2005).  The 
categories have helped me to search for similar and related parts of data and 
developing themes to help comparisons or identify connections between the 
themes (Basit, 2003).  This early organisation of data was referred to as indexing 
and sorting (Ritchie, & Spencer, 2002; Richie et al, 2013).   The content categories 
were then matched across the different cases to identified common themes that 
occur in the text or matched and contrasted with other opinions or expressions, for 
example, the literature (Ryan & Bernard, 2003). In practise, when engaging in the 
data gathering and analysing process, it is a definite circular process evolving from 
careful reading and re-reading the transcripts in their entirety and trying to get a 
sense of the interviews as a whole before breaking up in parts (Creswell, 2007). 
This is called the abstraction and interpretation stage. In naming the categories 
and themes, I have used concepts and technical terminology from the psychology 
and oncology discipline (Basit, 2003).    
From the data of the psychotherapeutic sessions, the first chunks of data were 
organised in two core categories, namely the biological and psychological side-
effects of breast cancer treatment and the psycho-therapeutic interventions. From 
the biological and psychological side-effects of breast cancer treatment, eight sub-
categories have developed, namely, (1) the diagnosis of breast cancer; (2) 
interaction and relationship with the oncologist and medical team; (3) breast 
cancer treatments: surgery, chemotherapy and radiation; (4) the emotional and 
practical experience of the cancer journey during and after treatment; (5) sexual 
functioning due to breast cancer and breast cancer treatment; chemotherapy, 
surgery and hormonal therapy; (6) work functioning; (7) social support: family 
system; (8) from breast cancer patient to breast cancer survivor. Developing from 
these categories were ten themes describing and explaining these categories 
(which will be fully described in Chapter VII).      
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I have “clustered” all the emotional, biological and practical categories and themes 
together that had to do with the breast cancer experience of the patient. The 
sexual side effects were kept grouped together, for the reader to be able to 
distinguish between the sexual side-effect and the “non-sexual side-effects. This 
was also the method with the intervention categories. The next categories and 
themes have developed resulting from the intervention component of the data 
resulted in seven sub-categories:  
(a) Emotional catharsis;  
(b) Psycho-education;  
(c) Cognitive and behavioural therapy;  
(d) Sex therapy: talking about sex;  
(e) Sex therapy: psycho-education and behaviour and cognitive techniques;  
(f) Couples and sex therapy;  
(g) Patient feedback.  
 
Developing from these categories were eighteen themes describing these 
categories in detail that will be discussed in Chapter VII.      
The final stage of this qualitative research process involved the explanation of the 
data through the presenting categories and themes and the presenting of the 
findings in a written report which has included the voices of the participants 
through the in depth description of the data and the reflexivity of the researcher, 
an account and interpretation of the problem and its contribution to the literature or 
a request for change (Creswell, 2007, 2013). As the therapist and researcher I 
have understood that reporting a qualitative study is a functional illustration of the 
phenomenon that was being explored in this study (Holdford, 2008; White et al., 
2014) therefore I have included a detailed and extensive representation of the 
methodology, as discussed in this chapter and the findings and implications from 
the research. The reporting of the cases and the conclusions will be fully 
discussed in Chapter VII in the form of written accounts with the aim to present the 
findings in an accessible form that will satisfy the research objectives and engage 
the reader (White et al., 2014).    
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6.4  SUMMARY 
The aim of this chapter was a discussion of the research methodology that was 
followed in this study. To better understand the breast cancer patient’s lived 
experiences and their unique need for psycho-oncologic interventions to live a life 
of maximum quality within the constraints of their illness, qualitative research was 
explained as the researcher’s chosen research paradigm. Within the framework of 
a multiple case study design, the five patients were purposefully selected from the 
breast cancer pool where they, upon selection, willingly agreed to have 
participated in the study. Appropriate ethical thought was given to the study to 
secure that no harm would be done to any participant as a result of the research 
and consent from all the appropriate gatekeepers were obtained. Strategies for 
ensuring the trustworthiness in this qualitative research project were next 
discussed under the headings of credibility, confirmability, dependability and 
transferability. The fact that the researcher has also acted as the participating 
psychotherapist has benefitted the study in the sense that the researcher could 
“enter” the emotional world of the breast cancer patient through a close and 
personal relationship over a period of time from where she had the opportunity to 
have observed and captured the breast cancer patient’s experience in the ‘real 
time’ of her current situation.    
The interpretive analysis method was explained in the framework of the social 
constructionism, which was the guiding epistemology of the study. The methods 
that the researcher has covered here were content analysis and the framework- 
and phenomenological approaches which have led to the development of 
categories and themes allowing me to have interpreted the lived experience of the 
study patients in the breast cancer context, providing a detailed description of this 
phenomenon. I hope that the results of the analytic and interpretation process will 
provide the oncology clinicians with a deep and rich description of the experiences 
and needs of the breast cancer patient, including their psychological and sexual 
effects. By offering a richer and deeper understanding of the breast cancer 
patient’s unique experiences of their illness and survivorship, the therapist hopes 
that oncologists and psychologists will gain a deeper insight when working 
therapeutically with this population.   
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CHAPTER VII 
FINDINGS 
7.1  INTRODUCTION 
In this chapter the researcher will illustrate the research findings by bringing 
together the voices of the five breast cancer patients and survivors and the 
literature to explain and compare them for the sake of generating new insights to a 
deeper and better understanding of this unique population in order to, in a holistic 
manner, facilitate support and interventions to better their overall quality of life. 
The results were developed using a combination of qualitative analytical 
procedures and the results of the two quantitative questionnaires filled in by the 
participants as was described in Chapter VI.  Regarding the analytical procedures, 
an attempt was made to stay true to the core ingredient of interpretive analysis, 
which is staying close to the data and interpret it through empathic understanding 
and then providing a rich description and explanation of the phenomenon being 
studied (Terre Blance et al., 2006). In a more practical manner, the researcher has 
given the participants a voice to explain their own unique experiences and 
perceptions and needs during their cancer journey (Robertson, 2009).   
7.2  PARTICIPANT DESCRIPTION  
The participants in this study were five women who were diagnosed with breast 
cancer and were selected on the basis of their first-hand experience of the 
phenomenon in question. Two of the women were newly diagnosed and at the 
very beginning of their treatment and the other three, already finished with their 
treatment and in remission. The remission periods varied from three months to 
eighteen months and were estimated from their last treatment date or upon clear 
test results up to our first session. The two patients that were newly diagnosed 
and still busy with active treatment were both state patients and the other three 
were from different private practises. The three private participants were identified 
and referred or recommended by somebody in the oncology- or psychology circles 
who knew about this study and the two state patients were recruited by the 
researcher through the hospital’s oncology department. The five patients were all 
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voluntary participants, willing to participate in the study and share their 
experiences. At the time of the study, only two of the five women had access to a 
medical aid that made provision for psychology services. The ages of the 
participants ranged from 34 to 63 years. Four of the participants were married with 
children, ranging from young children to adult children and one couple was in a 
long, permanent relationship, they had no children. The researcher will introduce 
the five study patients through a short summary and will then discus and present 
each data category and theme offering examples from the psychotherapeutic 
sessions. To protect the identities of the five participants their names will not be 
used, but were replaced by a number allocated to them from I to V, and they were 
referred to as Patient I to Patient V. 
7.2.1  State patients vs. private patients  
• State patients:   
Two state patients, (they were called Patients II and III) who met the requirements 
of the research study, were accepted and included as participants due to their 
active undergoing of breast cancer treatment and their willingness to participate in 
a psychotherapeutic process and to share their experiences with me. They both 
confirmed that they understood what the study process would entail. For the 
convenience of the patients all the therapeutic sessions was scheduled on the 
same day and in the same building as their current treatment (either chemo or 
radiation or an appointment with their oncologist) and the sessions were for free. A 
short description of them follows:   
Patient II was a 52 year old coloured woman who was diagnosed with stage II 
breast cancer four months earlier. She had been married for 32 years and had two 
grown, married children. Although she stayed at home, she had a tertiary diploma 
in business. At the time of our first appointment she had already undergone a 
lumpectomy and removal of some lymph nodes and had just started with her first 
chemotherapy. She did not have a history of depression or anxiety and seemed a 
content and relaxed person, looking forward to participate in the study.  
Patient III was a 63 year old coloured woman who was in her second marriage.  
She had two grown-up children and had recently resigned from her job because of 
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its physical demands. She was diagnosed with breast cancer four months earlier 
and was busy with her first chemo when she was recruited for the study. She 
presented with problems, emotional and marital, before the breast cancer 
diagnosis and was very open to participate in the study to be “helped” with her 
problems.   
• Private patients:  
The three private patients (they were called Patients I, IV and V) had already 
completed their breast cancer treatment and was in remission. They volunteered 
to participate in the study after they were referred or it was recommended to them. 
The details were explained to them, and their appointments were made at the 
therapists practise and at the home of Patient I. The sessions were scheduled at 
times that were convenient for them. They were fully informed about what the 
study would entail and they were all committed to participate in and contribute to 
the study.     
Patient I was a 47 year old Caucasian woman who was 45 years old when she 
was diagnosed with Stage II breast cancer. She was married and had two young 
children. She had a lumpectomy and breast reconstruction surgery and had been 
in remission for 15 months when we started with the therapeutic sessions. She 
was well known to me and was recruited for the pilot study because of her 
experience with breast cancer and the fact that she was already in remission. The 
main reason for including her was her working knowledge and training in the 
medical field and strong understanding of psychology. She was also willing and 
enthusiastic to take part in a study where she could share her experiences of her 
breast cancer for the chance of helping other breast cancer patients.  
Patient IV was a 49 year old Caucasian woman who was diagnosed 9 months 
earlier with Stage II breast cancer. She was in a long-term relationship and had no 
children. She had a university degree and a higher diploma and was in a full time 
job. She was a private patient but did not belong to a medical aid and wanted to 
participate in psychotherapy even though she could not afford to see a 
psychologist. After hearing of this study from another clinical psychologist, she 
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requested to participate in the study and was referred. She expressed her 
willingness to participate in the study because of her need to see a psychologist.     
Patient V was a 34 year old Caucasian woman, who had been married for five 
years, with one child of four years old. She had been diagnosed with breast 
cancer stage II, two years prior to the study. She had a matric as well as a higher 
diploma and was in a full time job. She had requested her oncologist to refer her to 
a psychologist and the oncologist, who was familiar with the study, had 
recommended that she participate in the study. She was contacted by the 
researcher and after it was explained to her what the study and process involved, 
she was willing to participate in the study for the therapeutic process and also for a 
change to share her knowledge of her breast cancer experience with other women 
in the same situation. All three patients complied with the criteria for participating 
in the study.   
The complete psychotherapeutic sessions of the research participants, plus their 
biographical information are presented in the Addendum. 
A summary of the demographic information and breast cancer stage and 
treatment of each patient is presented in Table 7.1.  
7.3  CATEGORIES AND THEMES: THE VOICES OF THE 
PARTICIPANTS  
7.3.1  Presentation and interpretation of the themes 
Analysis of the data through interpretive- and IPA analytic methods was gathered 
into categories first and then into developing themes disclosing the biological and 
psychological effects of breast cancer and the psycho-oncologic needs of, and 
interventions for the breast cancer patient. The researcher has separated the 
themes and categories in two parts, the biological and psychological effects and 
experiences of breast cancer which will be listed in Table 7.2 and the psycho-
oncological needs and interventions which will be listed in Table 7.3. The contents 
and results of the themes that emerged from the therapeutic sessions with the 
patients will be discussed below the relevant tables and portray the true 
experiences and interpretations of the breast cancer patients. Several of the 
themes overlay and intersect each other because the different elements in 
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experiencing breast cancer are so close together and influence and complement 
each other in such a way that no major adjustments to the themes were made, but 
were rather accommodating of the natural and spontaneous flow of the 
conversations and sharing from the patients. The descriptions of each theme were 
based on the information given by the study participant and interpretation by the 
researcher, integrated with existing literature to form a unit between the patient, 
the researcher and the literature.   
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Table 7.1: Summary of patient’s detail 
Participant Ag
e 
Marital 
status and 
children 
Education Type of breast cancer Treatment  Busy or 
Finished with 
treat- 
ment 
Patient I 
Private Pt.  
Recruited for study by 
researcher. 
47 Married,   
2 children, 
ages 16 and 
12.   
Gr. 12. University 
and master’s  
degree  
Stage II breast cancer. 
Progesterone +  
Lumpectomy, removal of 
all the lymph nodes, 
chemo (8), radiation (32) 
and hormonal therapy. 
Breast reconstruction. 
Finished  
18months 
Full remission  
Patient II 
Recruited from state 
hospital by researcher 
52 Married,  
2 children, 
ages 21 and 
31 
Gr. 12. Post matric  
diploma  
Stage IIB breast 
cancer. 
pT1cN1M0 
Lumpectomy, then radical 
mastectomy of right 
breast, removal of lymph 
nodes, chemo (8) and 
radiation (15 from 23). No 
breast reconstruction 
Busy with 
radiation 
 
Patient III 
Recruit from state hospital 
by researcher   
63 Married,     
2 children, 
ages 35 and 
38 
Gr. 10 and extra 
qualifi- 
cation    
Stage IIB breast 
cancer. T3N0M0 
Lumpectomy, removal of 
lymph nodes, chemo (8) 
and radiation (15 from 23) 
No breast reconstruction 
Busy with 
radiation   
Patient IV 
Private Patient  referred by 
clinical psychologist 
49 Long-term  
relationship 
Gr. 12. Post matric 
university degrees 
(including a 
Honours degree) 
Stage III Invasive Duct 
Carcinoma. 
Lumpectomy and removal 
of lymph nodes, chemo 
(12) and radiation (30)   
Finished  3 
months Full 
remission 
Patient V 
Private Patient asked 
oncologist to be referred to 
a psychologist for therapy 
34 Married, one 
child, age 4 
Gr. 12. Post matric 
diploma.   
Stage IIA Ductal 
Carcinoma. Oestrogen 
+ 
pT2N0N0. 
Double mastectomy and 
complete hysterectomy, 
chemo (6), radiation (15). 
Breast reconstruction 
Finished 6 
months.  Full 
remission 
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To assist the reader in understanding the themes, and to highlight the unique 
experiences of the patients, their words, when used, has been italicised.  
Analysis of the data was gathered into categories and was then refined into 
themes disclosing the biological and psychological effects of breast cancer and 
breast cancer treatment which will be discussed in Table 7.2 and consists of 
themes 1 to10 and the psycho-therapeutic interventions which will be discussed in 
Table 7.3, consisting of themes 11 to 21.        
Table 7.2 The Biological and Psychological Effects of Breast Cancer as 
experienced by the patients 
CATEGORY THEMES 
The diagnosis of breast cancer.  Theme 1: Emotional reactions 
directly after hearing the diagnosis 
and the busy schedule of cancer 
treatment 
Interaction with the oncologist and 
medical team  
Theme 2: Inter-relationship with 
oncologist and medical team: 
Receiving information and 
communication regarding the 
cancer and cancer treatment.   
 Suggestions from the 
oncologist/surgeon to consult with 
a psychologist 
Breast cancer treatments: surgery, 
chemotherapy and radiation 
 
 
Theme 3: Biological side-effects on 
the breast cancer patient: 
 Chemotherapy: 
Fatigue 
Cognitive impairment 
Nausea and vomiting 
Alopecia 
Pain 
 Radiation 
 Surgery 
 Theme 4: Psychological side-effects 
on the breast cancer patient: 
 Chemotherapy and emotions 
 Feelings of depression and the 
diagnosis of depression 
throughout the trajectory of cancer 
treatment 
 Anxiety and anticipation anxiety 
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The emotional and practical 
experience of the cancer journey 
during and after treatment   
Theme 5: The need to talk about 
emotions: 
Specific emotions 
 Guilt feelings 
 Fear of death 
 Losses 
Sexual functioning affecting by 
breast cancer and breast cancer 
treatment: chemotherapy, surgery 
and hormonal therapy.   
Theme 6: Sexuality and Sex 
 Discussing sexual functioning with 
the oncologist/medical team 
 Changes in sexual functioning and 
losses due to the treatment 
 Sexual communication and 
intimacy in the relationship 
 Self-Image 
 
Theme 7: The Menopausal Factor: 
The breast cancer patient’s 
experience of it. 
Work functioning Theme 8: Working or not working 
while receiving chemotherapy 
Social support: family system Theme 9: Effect of breast cancer on 
the family and marriage 
From breast cancer patient to breast 
cancer survivor 
 
Theme 10: Breast cancer as a 
chronic disease: the patients 
understanding of it: 
 The shift from cancer patient to 
“normal” person again.   
 
The researcher has distinguished between Patients II and III, the two state 
patients which were both still busy with their active treatments, (they will be 
described together) and Patients I, IV and V, the private patients which were 
already in remission, and which will be described together. The reason for this is 
that there is a difference in experiencing and describing the cancer and cancer 
treatment when you are actively busy with it and when you describe something 
that has already happened. There are also experiences, such as the chronicity of 
the illness and belated reactions that the active patients do not experience as in 
yet.   
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7.3.1.1  THE DIAGNOSIS OF BREAST CANCER 
Theme 1: Emotional reactions directly after hearing the diagnosis and the 
busy schedule of cancer treatment:   
Literature defines cancer as one of the most stressful and traumatic medical 
diagnoses that a person can receive (Meier, 2010; Reyes-Gibby et al., 2012) and 
all five the patients stated that they were shocked and traumatised the moment 
that they heard about their cancer diagnosis. Although all of them already 
expected a cancer diagnosis or a diagnosis of some sort after feeling the lump or 
underwent procedures to confirm the diagnosis, they were still overwhelmed upon 
hearing that it was breast cancer. They all agreed that their families were also 
shocked and confused and not knowing what to say or how to support them in the 
time immediately after the diagnosis.   
Patient II said that by the time she had her appointment with the oncologist “I was 
so anxious and stressed due to the waiting for the diagnosis and appointment, that 
the oncologist immediately referred me to their social worker for counselling.”   
Patient III said “I felt devastated when I heard the news and my immediate thought 
was that I was going to die, in fact, that was all I was thinking about, dying. I was 
very shocked and scared and not just for that day, but for a couple of days 
afterwards” saying that she will never forget the date that she heard the diagnosis 
“I only took it one day at a time because I didn’t know what else to do or where to 
go to.”   
Patients I, IV and V, through looking back, confirmed that from the moment of 
diagnosis, everything went extremely quickly and that they experienced the cancer 
from the beginning as a busy illness which contributed to their feeling of 
devastation and being overwhelmed.     
Patient I said: “I was so traumatised and shocked that I felt momentarily 
dissociated from myself and dizzy and nauseas”.   
Patient IV said: “everything started so quickly from when I felt the lump in my 
breast, it felt that everything just snow-balled with no stopping in between for 
catching my breath.”   
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She also said that, from the very beginning of the diagnosis, she was scared and 
afraid and had anticipatory anxiety because of her fear of needles and because of 
her history of depression, she said:   
“I knew after the diagnosis that I should see a psychologist but did not have the 
finances to do so and just lived ‘robotically’ on a daily basis with my fears and 
uncertainties.”    
Research has supported this by stating that cancer and cancer treatment are 
chaotic and busy periods in a patient’s life and that from the beginning of the 
diagnosis of breast cancer, this disease involves a long process of psychological- 
and social adjustments (Henselmans et al., 2010; Travado & Reis, 2010).    
Patient V said that the experience of being diagnosed with breast cancer was so 
overwhelming and everything happened so quickly that she couldn’t think about 
anything else. She felt that she was not able to participate enough in the decision 
making process of her treatment. She said:   
“That although my surgeon gave me certain options, I was so rattled and in shock 
that I didn’t know what to do or what decision to make, I felt there was not enough 
time to consider different options.”    
This reactions are in holding with research findings that the diagnosis of a life-
threatening illness such as breast cancer can be overwhelming and shocking to 
patients and their families with a high probability of experiencing distress right after 
the diagnosis (Brem & Kumar, 2011; Dolbeault et al., 2009; Henselmans et al., 
2010; Lim et al., 2011; Spiegel & Rodrigues, 2008).   
Even in early investigations it was felt that because a cancer patient might feel 
overwhelmed at the beginning of the cancer road, a skilled psychologist can 
facilitate decision making and also act as a liaison between the patient and her 
physician (Haber et al., 1995). All five patients shared the experience of feeling 
overwhelmed after they heard the diagnosis of their cancer. 
Both patients I and V who had young children (between two and sixteen) 
immediately thought about dying after hearing their diagnosis.  
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Patient I said “the first thing that was going through my mind was that I am going 
to die and who will be there for my children. From the beginning of my diagnosis, 
my two children were my biggest concern.”  
Patient V said that she decided immediately after her diagnosis that she will have 
to be the strong one for her husband and child and that she will have to take 
control over all the decision making regarding her cancer.  
There are strong evidence in the literature that having young, dependent children 
under the age of 18, still living at home, increases stress levels and anxiety in 
breast cancer patients and contribute to fear of recurrence and dying, leaving their 
young children behind. The confrontation with a person’s own mortality can also 
cause acute psychological stress (Brem & Kumar, 2011; Dolbeault et al., 2009; 
Lim et al., 2011; Spiegel & Rodrigues, 2008).   
7.3.1.2  INTERACTION AND RELATIONSHIP WITH THE ONCOLOGIST AND 
MEDICAL TEAM    
Theme 2: Inter-relationships with oncologist and medical team: 
Communication and receiving information regarding the cancer and cancer 
treatment:    
A number of studies have strengthened the evidence that interaction and 
communication between patients and their medical teams are especially important 
in cases of life threatening diseases such as cancer (Barth & Lannen, 2011; Ong 
et al., 1995; Pollak et al., 2007). Essential and adequate communication between 
the oncologist and cancer patent is not just about diagnostic information, 
prognosis and treatment options, but also about mental state of mind, for the lack 
of this type of communication can cause emotional distress (Barth & Lannen, 
2011; Fallowfield & Jenkins, 2015).    
All five patients agreed that they had limited knowledge and understanding of 
cancer treatment before being diagnosed with breast cancer and before they 
started their treatments. Most of the cancer related information was presented to 
them verbally by their oncologists and oncology teams and in some cases some 
have also received information in written format, as in brochures. The five patients 
consented that the bulk of the information regarding their treatment was mostly 
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biologically orientated and very little was said about emotional and psychological 
issues and challenges.   
Patient II said that even during her third chemo treatment she still didn’t know what 
stage cancer she was in and said: 
“I feel that there isn’t very good communication between me and my doctor and 
because of that I don’t have the confidence to talk to him about anything or ask 
him any questions, even in terms of the reactions of my body to the chemo.” She 
said that she felt that her doctor was always in a hurry when they were in 
consultation and did not interact well with her. She stated further:    
“This is a problem for me and makes me anxious not to be able to talk to the 
doctor. I feel disappointed in the doctor and personnel for not informing and 
preparing me for my second type of chemotherapy. It made me feel that they do 
not look out for me as their patient.”   
She perceived the lack of information regarding the second type of chemotherapy 
as a “setback” for her in terms of her emotions and adaptation to the treatment.   
Patient III stated: 
“That anything you want to know from the doctor, you must ask them specifically, 
they do not explain anything without you asking.” When asked if she felt 
comfortable talking to her oncologist about her emotions and sexual fears she 
said: “no, we don’t speak, the sessions are too short and over very quickly. There 
is no relationship between me and my doctor”.   
She said that the information she had about the cancer treatment she got from 
their group session the first day where the oncologist explained some things about 
breast cancer and the treatment. She said the chemotherapy sisters had also 
explained what was going to happen during the chemotherapy, saying it made her 
feel more worthy as a person if it seemed that people tried to help her and be nice 
to her. 
Patients I, IV and V experienced good relationships with their oncologists with 
relativity good communication, but all three felt that although the communication 
281 
 
and information were relevant it was more biological and technically orientated. It 
lacked the emotional component and impact it would have on them and their 
families.   
Patient I reported that although she was being kept well informed about her 
condition and treatment in the biological sense, she did not fully comprehend the 
emotional and psychological repercussions of the cancer treatment, or thereafter, 
both on her and her family. When asked if she felt comfortable speaking to her 
oncologist about her emotions and possible sexual fears, she said:   
“No, I did not have the confidence to speak to my doctor about my personal 
feelings or my sexuality, although we had a good relationship it was not on a 
personal level. It was more medical than emotional.”   
Patient IV confirmed that she and her oncologist had a very good relationship from 
the beginning with very open communication, but also said:   
“While I was academically well prepared and well informed about the cancer 
treatment, especially the chemotherapy and its side-effects, the emotional impact 
was still a huge shock on my system. I was not prepared for it.”  
She explained that because of her history with depression and previous 
therapeutic sessions, she understood the importance of seeing a psychologist 
throughout the cancer treatment. She understood the role of a psychologist in 
helping a person with psychological problems and didn’t expect the oncologist to 
help with her emotional state.   
Patient V also had a good relationship with her oncologist with good open 
channels of communication. The relationship was such that she felt emotionally 
supported by her oncologist, hence her request to see a psychologist to discuss 
her emotional distress. Her oncologist was very positive about referring her and 
underlined the benefits of psychotherapy to her. 
Ong and colleagues (1995) have emphasised that from the patient’s standpoint, 
two important needs have to be met during interaction between them and their 
doctors, namely the need to know and understand what is wrong with them and 
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the need to feel known and understood by their doctors. Some researchers found 
that breast cancer patients typically disclose only half of their emotional concerns 
to their oncologists and that failure to detect psychological distress is largely due 
to lack of communication between healthcare professionals and patients 
(Gandubert et al., 2009; Pollak et al., 2007).    
 Suggestions from the oncologist/surgeon to consult with a 
psychologist:   
Out of the five patients only one oncologist has asked the patient during the 
course of her treatment whether she wanted to see a psychologist to help with her 
emotional problems and two oncologists had referred their patients to a social 
worker for a standard and compulsory interview without regard of their emotional 
status or specific needs, or without any feedback afterwards.      
Patient II who started out as a private patient (and then because of financial 
matters had to change to the state hospital) said that when she was so anxious in 
the beginning just after her diagnosis, she was referred by her oncologist to a 
social worker which was part of the oncology team, saying: 
“I cannot say that the session had helped me in any way in terms of my emotional 
wellbeing, for the ‘interview’ was more in a technical manner of what to expect 
from the practical side of the treatment, which helped me a lot, but I didn’t 
experience it as a treatment or help for my anxiety and fears”. She said that apart 
from participating in this study, seeing a psychologist was never mentioned during 
her treatment regime as a state patient.  
Patient III said that she never knew what a psychologist does and because of the 
“stigma” she believed was attached to something like depression, she would never 
have spoken to or asked to speak to anybody about her feelings.   
“I never knew that a person could see a psychologist if you have cancer and 
nobody mentioned it during my treatment except when you told us about your 
study.”   
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Patient I said: “Not at any given stage during my treatment has the surgeon or 
oncologist suggested that I see a psychologist, although I was very depressed and 
anxious. I was referred to a social worker in the beginning of the treatment just 
after the diagnosis which I understood is mandatory in the oncology practise. I did 
not understand why I was referred to a social worker, it was never explained to me 
and psychologically I have not benefitted anything from our one session. I was 
never again asked if I need to see the social worker again or somebody to help me 
with my emotional needs.” 
Patient IV said:  
“Yes, my oncologist had asked me whether I would like to see a psychologist, but 
because of my financial situation I could not afford to see one and had to decline, 
although I wanted to be treated by a psychologist.” She said that being part of this 
study made her feel exited, partly because she could help somebody else going 
through this trauma, but also because she knew she could benefit from the 
sessions.   
Patient V asked her oncologist to be referred to a psychologist because she said 
she realised that she needed to talk to a psychologist about her emotions 
regarding her cancer experience and also about her husband and child. She said:  
“I know what a psychologist does and I realise that I desperately need to see one 
in therapy.” This request from the patient was only after she was finished with her 
treatment and in remission and went for a check-up session to the oncologist, 
explaining to the oncologist that she needed to be referred. Her oncologist was 
very positive about referring her to the researcher and had encouraged her to 
make an appointment.   
Although recent literature found that a multidisciplinary team approach are 
becoming more and more central to comprehensive cancer rehabilitation in 
helping cancer patients to meet their needs, some medical practitioners still find it 
a challenge to involve mental health services when treating a biological disease 
(Jalil, Lamb, Russ, Sevdalis, & Green, 2012; Taplin et al., 2015; Turner, 2015). It 
is believed that medical doctors often do not have the proper knowledge regarding 
breast cancer and the development of mood disorders and are therefore not 
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referring their patients when they need psychological help (Gandubert et al., 2009; 
Vetere, 2007).   
7.3.1.3  BREAST CANCER TREATMENT: CHEMOTHERAPY, SURGERY 
AND RADIATION 
There are two themes related to the effects of the cancer treatment on breast 
cancer patients, namely the biological- and the psychological side-effects.  
Theme 3: The impact of the biological side-effects of the cancer treatment:     
 Chemotherapy: 
According to literature, the most common and unpleasant physical complications 
of chemotherapy include nausea and vomiting, fatigue, lymphedema, alopecia, 
cognitive impairment, pain, weight gain and menopause and sexual dysfunctions 
(which will be discussed in Theme 7), (Brem & Kumar, 2011; Fallowfield & 
Jenkins, 2015; van Oers & Schlebusch, 2013; Weis et al., 2009). The biological 
side-effects of chemotherapy that were experienced most and in the most severe 
degree were described by the five patients as follow:   
 Fatigue: 
The most prominent and severe side-effect that all five patients experienced and 
which affected their quality of life and relationships was that of fatigue, which 
according to literature, impairs activities of daily living (Dean, 2008; Fallowfield & 
Jenkins, 2015; Johns et al., 2015; Vahdaninia, 2010). In all five cases fatigue 
started from the very beginning of chemotherapy up to the present where all of 
them were finished or near the end of their treatment. They complained about the 
severity of the tiredness and its persistence and continuity throughout their whole 
treatment trajectory and thereafter. They all felt that tiredness, although a 
biological side-effect, had not just influenced their level of functioning but had 
drastically affected their emotional wellbeing and had also altered their 
personalities, which left them vulnerable and exposed.  
Patient II said the tiredness started immediately after the first chemo and affected 
her emotional health the most:    
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“It changed me as a person. Working in and around the house and garden and 
being active all the time with family activities is what defines me as a person and 
makes me feel useful and worthy.” She felt that changing to a more inactive 
person because of her lack of energy, was a challenge for her.   
Patient III explained her fatigue as the worst of her side-effects as to date, starting 
the same day as the chemo.   
“I am so tired during the day that I fall asleep and then sleeps badly at night and 
then I start to think about bad things over and over and start the day tired”. She 
said that even now, after the chemo, she still felt tired with less energy as before 
the cancer.   
Patient I said: “I had to change my ‘being’, for I am a ‘doer’ and an active person 
with a challenging job and busy household to a more passive life style during the 
time of my chemo.”   
She experienced that the fatigue had interfered with her activities with her 
husband and children, but also with her work functioning and the cortisone 
treatment brought on insomnia which had made the tiredness even worse. 
Dimeo and colleagues (2008) confirmed that fatigue and tiredness are frequently 
related with sleep disturbances, e.g. hypersomnia or insomnia.   
Patient IV said that her tiredness was there from the start of the chemo, all the 
time and it contributed to her negative feelings during the duration of the 
chemotherapy.   
“The tiredness had made me depended on other people, which made me feel 
vulnerable needing the assistance of other people.”   
She said it was very important for her to feel independent and to do things for 
herself. She described herself as somebody who had very high expectations of 
herself and therefore pushed herself very hard to perform at top level. Whether it 
was at home, or social relationships or at work, saying:   
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“The chemo made me feel very listless and lethargic which was very a-typical of 
how I usually perform. Even now I feel tired all the time and have very little energy 
to do anything else.”   
Apart from an acute symptom, fatigue can be a chronic symptom, which can 
incapacitate the quality of life of the breast cancer patient long after the end of 
chemotherapy (Brem & Kumar, 2011; Fallowfield & Jenkins, 2015).   
Patient V expressed her constant tiredness during the chemo: 
“As something that kept me from doing ‘normal’ day to day things with my son and 
husband, making me feel that I was missing out on them”, explaining that even 
now “Keeping up with my child’s activities can make me very tired.”   
This experience of fatigue by the five participants was in line with research 
findings which states that fatigue is a common medical complaint and one of the 
most common symptoms in breast cancer survivors and that the restrictions of 
cancer-related fatigue on quality of life exists across the whole cancer trajectory 
and has been characterized as overwhelming and persistent and has to be 
accommodated by the health care team (Berger et al., 2015; Fallowfield & 
Jenkins, 2015; Johns et al., 2015).    
 Incapacity of short term memory/chemo fog:  
There is growing evidence that the neurotoxicity of chemotherapy contributes to 
cognitive changes in the cancer patient which are responsible for visual and verbal 
memory problems, the inability to pay attention and concentrate and the lack of 
multitasking. Typical terminology concerning chemo-related cognitive changes are 
chemo fog and chemo brain, reflecting on mild to moderate symptoms of cognitive 
dysfunction (Brem & Kumar, 2011; Brezden et al., 2000; Fallowfield, 2015; 
Fallowfield, 2015; O’Farrell et al., 2013; Raffa, 2010; Shilling et al., 2006). As with 
fatigue, short term memory problems can continue well into survivorship which fits 
in with the theory of the chronicity of some of the side-effects of breast cancer 
treatment (Brem & Kumar, 2011; Fallowfield & Jenkins, 2015).   
The three patients, finished with their treatments, experienced loss of short term 
memory in a prominent way, and because all three of them are in full-time careers, 
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they experienced the lack of concentration and memory as problematic and 
incapacitating and threatening to their work functioning. 
Patient I stated that she had a problem with the fact that she could not remember 
as well as before, saying:   
“I am not used to be so forgetful all the time and am confronted now for the first 
time with a dysfunction influencing a lot of my activities, including my work.”    
Patient IV said:   
“I experienced chemo-fog in the worst degree which made me feel stupid and slow 
and not intelligent at all. This was during the time of the chemo and even now, 
three months after the last chemo, I still feel slow.” Also saying:  
“Because I am very career orientated and driven, my work plays a large and 
important part in my life and identity and the prominent lack of concentration and 
memory threatened my ability to function at my usual level.”    
She said her work entails a lot of concentration and focusing and that she was 
constantly scared of not being able to do her work properly.  
This was underlined by a number of studies, emphasising that memory and 
attention problems after chemotherapy are recurrently reported by breast cancer 
patients (Shilling et al., 2005; Shilling et al., 2006; Wefel et al., 2004).    
Patient V said that although most of her side-effects were gone (it was already 16 
months after her last chemo) her short term memory was still bad and that it was 
causing serious problems for her in her marriage and work. She said she kept on 
forgetting to do things that her husband asked of her and she displaces things all 
the time.   
“My husband complains about me not listening to him, but doesn’t understand that 
I do listen. I just cannot remember it afterwards. The lack of short term memory 
also affects my work, I work with figures and have a responsible job and I am 
scared that I will make mistakes and risk losing my job.” 
 Nausea and vomiting:  
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Although the development of antiemetics (anti-nausea medication) have improved 
drastically over recent years, there is still a percentage of cancer patients that 
suffer from mild to severe nausea and vomiting and which still remains one of the 
most dreaded and aversive side-effect of chemotherapy (Antonarakis & Hain, 
2003; Fallowfield & Jenkins, 2015; Fernandez-Ortega et al., 2012). 
Chemotherapy-induced nausea and/or vomiting can severely impair a patients’ 
quality of life, therefore the awareness of heath care providers is important for 
proper diagnosis and management of this complications (Fernandez-Ortega et al., 
2012; Hilarius et al., 2012).   
 
Patient II experienced nausea from day three for a couple of days in spite of the 
anti-nausea medication, but mentioned that she had never vomited from the 
chemotherapy, saying that this is not a ‘big’ side-effect for her.      
 
Patient III and Patient IV have never experienced or complained about nausea or 
vomiting while Patient I had experienced nausea, but not vomiting, together with 
aches and pains in her body and a metal taste in her mouth for at least seven 
days after each chemotherapy session. This is explained in recent literature 
claiming that chemotherapy-induced vomiting can be prevented in nearly 70% to 
80% of the patients with effective antiemetics, but that the management of nausea 
is more limited with only a success rate between 31% and 45% despite the 
administration of optimal antiemetic prophylaxis (Fernandez-Ortega et al., 2012; 
Hesketh, 2008).    
 
Patient V experienced the worst case of nausea and vomiting of all five patients 
saying she experienced severe biological side-effects from the chemotherapy that 
started the very first day with the “Red Devil”. She further stated that she was 
completely unprepared for the side-effects, especially the nausea and the vomiting 
which started a couple of hours after the administration of the chemo. She 
experienced vomiting the most overwhelming of all the side-effects of the 
chemotherapy. It had made her physically ill and kept her from participating in any 
activities with her husband and child. It was so bad, she said:   
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“I was so surprised. I understood from other patients that nausea and vomiting are 
not so big anymore because of the anti-nausea medication, but I had experienced 
it extremely viciously. The vomiting kept on for days after the chemo, no 
medication worked for me, the vomiting was worse at night and I didn’t want my 
husband and child to see me like that.” She said that this was also the time when 
she was most scared of dying and was very anxious.   
 
This type of nausea is called acute nausea and begins within minutes of 
chemotherapy administration (Antonarakis & Hain, 2004; Ryan et al., 2012) and 
literature underwrite her emotional experience by declaring nausea as a “toxicity” 
that has a negative effect on the daily life of the cancer patient (Fernandez-Ortega 
et al., 2012).    
 
 Alopecia:   
Although all five patients lost all their body hair, three of them were severely 
affected and shaken from their hair loss and described it as follows:      
 
Patient II experienced hair loss directly after the very first “Red Devil” chemo 
saying:   
“I was okay with it because it was explained to me by the oncology sister and was 
prepared for it to happen. It did not affect my self-image the way I thought it would 
and I was never ashamed of my hair falling out or even to walk around bare 
headed.” 
She said she had prepared herself by buying a wig and some headbands in 
advance, but because her husband and family were so supportive and positive 
concerning her hair loss, she could cope better with the situation.    
 
Patient III said although she knew about her hair that was going to fall out, she 
was still shocked and unprepared when it happened, saying:   
“With my hair falling out the reality of the breast cancer hit me for the first time. I 
freaked out when I saw my hair falling out in lumps. It was very traumatic for me 
and I feel quite self-conscious and don’t feel like going out in the public even when 
my head is covered. The situation with my hair even caused conflict between me 
290 
 
and my husband, because he felt I should have prepared myself better for this and 
I should not have allowed it to upset me so much.”   
 
Patient I said the total hair loss of her whole body and the changed shape of her 
breast was the worst part of the changes in her body:   
 
“It affected my body image which was already compromised by the surgery and 
the changed shape of my breast”. 
 
Patient IV:  “The falling out of my body hair was quite a weird experience for me, 
especially together with the weight that I gained. It influenced my self-image quite 
a lot.”  
 
Patient V said, when asked about her hair:   
“The loss of my hair was a shock, but I was more worried about the reactions of 
my husband and child. My husband took it very hard and would not allow me to go 
out without a wig or head band, I felt he was ashamed about my cancer and me 
without my hair”.   
She said because of her child’s very young age, she made him part of the process 
of shaving her hair so that it was not a shock for him seeing her without hair.   
 
The negative perceptions regarding alopecia and appearance was supported by 
literature stating that alopecia ranks amongst the first three most feared and 
traumatizing side-effects of cancer treatment and can be extremely distressing 
(Kim et al., 2012; Lemieux et al., 2008; Van den Hurk et al., 2010). Alopecia can 
affect a person’s self-image and sexuality and can incapacitate her social activities 
and relationships, with some patient’s even reporting feelings of shame because 
of their hair loss (Kim et al., 2012; Lemieux, 2008).    
 
 
 Pain:  
Patients II and III were severely affected by pain due to their second type of 
chemo, Taxol, which they got during the time of our sessions, saying that they did 
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not anticipate the severity of their pain because they did not experience any pain 
with their first chemo (“Red Devil’). Taxol is a common anti-cancer drug that 
induces neuropathic pain by an unknown mechanism (Gutiérrez-Gutiérrez et al., 
2010; Warwick, & Hanani, 2013).  
Patient II said “All of a sudden I experienced vast amounts of pain in my whole 
body especially in my fingertips and feet and this interfered with my sleep and 
even made me vomit once. This was very bad and scary for me. I didn’t see it 
coming and I was not prepared for it”.  
The pain worsened her tiredness which was already bad. She said the pain 
medication was only helping to a certain extent. She also developed sores in her 
mouth, had a bad cough and tight chest and her nails had turned blue. This was 
all due to the new chemotherapy which she felt was not explained to her properly 
and because she was not prepared she said the emotional effect was so much 
worse.   
Patient III said with the new chemo (Taxol):   
“Pain was a new side-effect which I did not know would happen and nobody had 
told me about the new and different side-effects of the chemotherapy. The pain 
was now the worst side-effect that I had up till now, with the most pain in my 
fingertips and soles of my feet, I had numbness underneath my feet and my whole 
body was sore”.   
She also said her appetite went down but she forced herself to eat properly, she 
had heartburn and sores in her mouth and her nails had turned blue. She 
experienced that the pain had worsened her emotional status, and especially her 
feelings of anxiety and fear.   
Patient V experienced pain in her arm where they inserted the needle for the 
chemo which was very painful especially at night. She found herself waking up 
because of the pain. Apart from that, pain did not play a big part in her cancer 
treatment regime.    
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Studies supported the notion that pain can be a common symptom found in breast 
cancer patients and that approximately 20% to 40% of cancer patients who 
receive neurotoxic chemotherapy will develop painful peripheral neuropathy 
(Lueboonthavatchai, 2007; Vahdaninia et al., 2010; Smith et al., 2013; Sohl et al., 
2014). Patients I and IV fell in the category where pain were not a factor, although 
they both experienced pain during their surgery, it did not make a noteworthy 
impact on them psychologically.   
 Surgery:   
Three of the five patients had lumpectomies, one patient had a radical 
mastectomy of the right breast and one patient had a double mastectomy and 
complete hysterectomy. All the patients had axillary lymph node removals as part 
of their surgical procedure. Although pain is mentioned as one of the main side-
effects of the various cancer treatments and a biological factor regarding surgery, 
(Brem & Kumar, 2011; Ganz et al.,2004; Golden-Kreutz et al., 2005; 
Lueboonthavatchai, 2007; Vahdaninia, 2010), the five patients in this study did not 
overtly complain about severe pain at their surgical sites. Three of the patients 
developed lymphedema as side-effect of the surgery and consequently 
experienced pain and swelling and discomfort in their arms and shoulders. This is 
in line with findings claiming that some breast cancer patients report worse results 
after the axillary surgery in terms of pain and discomfort that the surgery of the 
breast self (Brem & Kumar, 2011; Fallowfield & Jenkins, 2015).   
 
The one on-going theme in terms of surgery was that of acute fear and 
anticipation anxiety before the surgery which was very dominant with the two 
patients (Patients II and III) who was waiting for their surgery during this study, so 
much so that Patient III had asked to carry on with therapeutic sessions asking:   
 
“Can I continue seeing you before and after the operation, I am too scared to do it 
on my own”.   
Patient II and III both experienced lymphedema and Patient II said that although 
she handled the healing process well both in terms of the operation and emotions:  
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“The worst pain that I had from the beginning was in my arm and not the surgical 
scar, I still experience pain in my arm and go to a physiotherapist for sessions and 
use the exercises that the physio had taught me”.  
Patients I and IV didn’t experience any pain in their arms or shoulders and didn’t 
even feel that pain was a factor where it concerned their surgery, while Patient I 
said that she felt that she handled the operation physically and emotionally better 
as when she heard she had breast cancer.      
Patient V said the practical side of being away from her family for long periods of 
time because of the surgery outscored any physical side-effects. She had a 
double mastectomy and reconstruction of both breasts at the same time, and yet 
the physical side was never a problem for her. She had good pain medication and 
she felt she did well physically. She said that after the complete hysterectomy she 
only experienced mild pain and discomfort.   
Only two of the five patients (Patients I and V) had breast reconstruction surgery. 
They both decided on the procedures because of their younger ages and their 
need to regain some of their body image back and rebuilt their sexual self-esteem. 
Both said that they did not even consider not undergoing breast reconstruction. 
This was in keeping with research findings that women who had undergone breast 
reconstruction after mastectomy were younger in comparison to those who had no 
reconstruction (Albornoz et al., 2013; Anagnostopoulos & Myrgianni, 2009; 
Fallbjörk et al., 2010). The two patients who were still busy with their treatment did 
not see breast reconstruction as an option for a better self-image at that stage.  
Patient IV said that although she had not considered breast reconstruction up till 
the current time, she was seriously considering breast reconstruction now 
because of her deformed breast and low self- and body-image. Albornoz and 
colleagues (2013) confirm that breast reconstruction can have benefits in body 
image, self-esteem, sexuality and quality of life.  
 
 Radiation therapy:   
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Some of the most common side effects of radiation are fatigue and the damaging 
of healthy cells and tissues near the treatment area such as reddening of the skin, 
discomfort and swelling of the breast and tiredness (Berger et al., 2015; Haber et 
al., 1995; Johns, 2015). All five patients underwent radiation therapy after their 
surgery and chemotherapy but it was only Patient I and Patient IV who 
experienced outspoken physical side-effects of radiation therapy, with Patient I 
saying: 
“I again experienced fatigue and pain as well as sensitivity in the breast area 
where they applied the radiation therapy. It was much easier in a way than 
chemotherapy, both in a biological and emotional way. It was just the 
inconvenience of having to travel every day to and from the oncology rooms.”  
Patient III said the only symptom that she experienced from the radiation was light 
headedness while Patient IV confirmed that the radiation “was not bad at all, it was 
more of a practical issue, the effort to go in to the oncology rooms every day”.  
She said her skin was a little bit red but had healed quickly again.   
Theme 4: The impact of the psychological side-effects of the breast cancer 
treatment: 
Recent studies have demonstrated that breast cancer patients especially, are 
inclined to be psychologically fragile because of the stress of the diagnosis and 
the draining of long treatments, pain, unpredictability of the course of the treatment 
and the chronicity of the disease. It further suggests that at least one in three 
breast cancer patients will experience noteworthy psychological distress at some 
stage during the course of their illness. These psycho-socially harmful side-effects 
can manifest at the time of diagnosis and persevere throughout survivorship 
(Borras et al., 2014; Brem & Kumar, 2011; Fallowfield & Jenkins, 2015; 
Lueboonthavatchai, 2007; Mello et al., 2013; Spiegel, 2008), and was well 
documented during the sessions with the patients in this study.  
 Chemotherapy and emotions:   
 
In this study the prevalence of psychological symptoms was found to be higher in 
breast cancer patients undergoing chemotherapy than when receiving 
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radiotherapy. This can be attributed to the severe negative effects of the 
chemotherapy agents, post-treatment uncertainty and the occurrence of 
psychosocial problems (Roa et al., 2009; Saniah & Zainal, 2010; So et al., 2009). 
Depression, together with fatigue and disrupted sleep are some of the most 
common side effects of chemotherapy for cancer and often co-occur with and are 
significantly associated with negative mood (Jim et al., 2011; Badr et al., 2006; 
Palesh et al., 2010). Studies that explored longitudinal changes in various 
symptoms during chemotherapy have reported a “roller coaster” effect, meaning 
that the symptoms are highest in the week following a chemotherapy infusion, and 
then decline prior to the next infusion, just to start all over again (Jim et al., 2011; 
Badr et al., 2006; Palesh et al., 2010). The psychological side-effects of 
chemotherapy are some of the themes that were the most prominent and vividly 
experienced and described by all 5 breast cancer participants. This was the case 
with the patients still busy with their treatment and the three who had been 
finished for quite a while and was in remission.    
Patient II explained her breast cancer as a busy illness, saying:   
“The travel to and from the hospital and waiting for either procedures or results 
kept me very busy and occupied. Me and my family are physically and emotionally 
tired from my cancer and really need a vacation now away from the hospital and 
cancer experience.” She explained that the tiredness due to the chemotherapy 
affected her emotional health and her mind the most.   
Patient III said that the day that she found out about her cancer and the day of her 
first chemotherapy were the worst for her. Saying she felt extremely scared of the 
chemotherapy and didn’t know how to handle or prepare for it.  
Patient I described her chemotherapy as:   
“It was a very busy and demanding time of traveling and sitting in the chemo room 
not being able to do anything else. Even the days after the chemo I felt 
unavailable for my children and husband, especially on the days that I felt so tired 
and hopeless. The tiredness played a big part in my emotional status and 
depression”.  
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Patient IV said that she had a lot of bad biological and emotional side-effects from 
the chemotherapy, calling it “emotional turmoil” and saying:   
“The chemo was relentless, especially when I had to get chemo every week for 
nine weeks”. 
She said that for the entire duration of the chemotherapy she was feeling negative 
and depressed. Saying that she experienced cancer to be an extremely busy 
illness, especially the chemotherapy:  
“You don’t know how to juggle everything with the treatment and the work and 
relationships. It put a lot of stress on me”.   
Patient V said the chemotherapy (which had already stopped 6 months before):   
“Feels literally like yesterday. The pictures in my head of the chemo room are still 
very vivid and bad, and I can still see the red colour of the chemo and smell and 
taste it.”   
Here she experienced some symptoms of a Post-Traumatic Stress Disorder, that 
is also typical of a breast cancer experience (Berger et al., & Kumar, 2011;  
Dolbeault et al., 2009; Holcombe et al., 2010; Nekolaichuk et al., 2011; Reyes-
Gibby et al., 2012). She said she experienced the chemotherapy as traumatic and 
scary and it completely overwhelmed her. During the period when she received 
chemotherapy she felt vulnerable and emotional and was crying a lot, not 
understanding all her emotions, saying:   
“Especially at night when I couldn’t sleep, I felt alone and scared and constantly 
thinking of death and dying, leaving my son behind. When I was so ill and nauseas 
and throwing up the whole time I honesty wasn’t sure if I would make it and 
wondered if this is what dying felt like”.   
 Feelings of depression and the diagnosis of depression throughout 
the trajectory of cancer treatment:   
The breast cancer patient has a strong probability, according to literature, to 
develop depression or symptoms of depression during the course of their 
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treatment (Burgess et al., 2005; Fan et al., 2008; Meier, 2010; Reyes-Gibby et al., 
2012). Because of this high incidence, Burgess and colleagues (2005) underlined 
the need for devoted psychological service provision during this time. This 
occurrence was supported by this study where Patients I, III and IV developed 
outspoken symptoms of depression after the first 12 months of diagnosis 
(although not diagnosed or treated in the case of Patient IV) while Patient V fitted 
more in with studies stating that a substantial number of breast cancer patients 
report a late increase in distress and psychological suffering in the re-entry and 
remission phase (American Cancer Society, 2010; Burgess et al., 2005; 
Henselmans et al., 2010).   
Patient II felt, in the beginning of her treatment, that the cancer was more of a 
challenge for her thought processes and psyche than anything else and didn’t 
want to become negative and made a point of staying focussed on positive 
thoughts. As the treatment went on and the tiredness became worse, she 
experienced much more negative emotions. After starting with her new chemo, 
(our fourth therapeutic session), she experienced emotional distress for the first 
time due to the lack of information regarding the side-effects and consequently 
could not prepare herself properly for the onslaught of the symptoms. She said:   
“Because I didn’t know or expected any of the new side-effects it was such a 
shock. I was very anxious and scared not knowing what was happening to my 
body.”   
She never developed symptoms of depression during her treatment trajectory, 
although she felt down and tearful and emotional because of the tiredness during 
the chemotherapy and not knowing how to deal with it. She said that she could 
relate to the fact that her mood changes were connected to and because of the 
chemotherapy, saying:   
“I am not usually a depressed kind of person”.   
When she filled in the HADS, she scored a 4 on the depression side, which fell 
into the normal scoring of 0 – 7 and fitted in with her mood at the beginning of her 
treatment.   
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Patient III experienced the cancer and cancer treatment from the beginning as 
emotional, and was very tearful for most of the time during the sessions. During 
the second consultation while busy with chemotherapy, she said:    
“I am crying a lot more lately and feel very emotional”.  
When asked about feeling depressed, she said she had always connected 
depression with shame, saying:   
“Knowing that there is a stigma when you feel depressed, I find it difficult to speak 
about my emotions or admit that I feel depressed to anyone.”     
During our last therapeutic session, after her surgery and while she was still busy 
with her radiation therapy, she seemed very depressed. More so than the previous 
sessions and it was decided that she would be assessed according to the DSM-5 
criteria to see whether she presented with the hypothalamic symptoms of 
depression. She met all the criteria for a major depressive episode and an anti-
depressant was prescribed on the researcher’s request by the oncologist.  
Her score on the HADS, which she filled in, in the beginning of the therapeutic 
process, was a 6 on the depression side, which fell into the normal range between 
0 and 7). There was a clear change from only feelings of depression in the 
beginning of the treatment regime, to the end where she presented with a full 
scale major depression due to the cancer and cancer treatment.   
Literature underlines that there is still prejudice about mental illness and 
psychological problems even in the context of a medical illness such as cancer 
(Holland, 2004; Kalaitzi et al., 2007). This kept patients from admitting to 
psychiatric symptoms and getting treatment. It was also evident with these 
patients that experiencing an episode of depression or anxiety soon after the 
diagnosis of, or during treatment of breast cancer, can add to the pain and 
suffering of the patients and the burden on their family (Meier, 2010).   
Patient I said that she felt severely down and depressed at the time of her 
treatment;   
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“I was scared that I would not be able to go back to normal or to what normal was 
for me before the cancer, but to me the anxiety was even worse than the 
depression because you can feel the anxiousness in your body the whole time”.   
She felt that the cancer treatment was actually taking her away from her normal 
life and normal activities and she was concerned about the time away from her 
home and family. She said that she felt most emotional when she was just 
diagnosed, just before the surgery and before her first chemo;  
“Not knowing what to expect at all made me very emotional and scared. I have 
developed both depression and anxiety and although I am working in the medical 
field I did not realise it at that moment and my oncology team did not, at any given 
time, discuss the conditions with me or acknowledged it. I was never given the 
option of seeing a psychologist”.   
Patient I’s depression score on the HADS, which she filled in in the beginning of 
the study, (between the first and second session) was a 7 which was in the normal 
range. It reflected her current state, which was not as depressed as she was 
during and just after the treatment. She was, at the time of this study, on an anti-
depressant.     
Both Patient I and IV were diagnosed with and treated for depression before their 
cancer diagnosis by their treating psychiatrists. Neither of their conditions was 
accommodated during their cancer treatment, which underline a study done by 
Jacobson and Jim (2008), claiming that the need for psychological care is mostly 
under-recognised by the primary oncology team therefore goes unnoticed and 
undertreated.   
Patient IV said:    
“I noticed that while undergoing the cancer treatment that, especially with the 
chemotherapy, my symptoms of depression increased. I was more scared of 
becoming depressed again because of the cancer diagnosis and treatment than I 
was for the cancer itself!”  
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Because of her history of depression she realised that she could become 
depressed again and immediately contacted her psychiatrist to ensure that her 
psychiatric medication (which she was still on) would be effective with the extra 
stress of the cancer treatment. She said:   
“I realised I would need to see a psychologist, but could not afford to see one.  I 
could literally feel how the depression worsened every day. It was the severest 
form of depression I ever had and for the whole four months of my chemotherapy I 
felt physically ill and emotionally upset.”   
She said her sleeping pattern had changed immediately from day one and she 
suffered from insomnia, saying that she was not sure if it was because of her 
mood and depression or if it was the chemo. Her score on the HADS which she 
filled in, in the beginning of our sessions was 13 which was in the abnormal 
category and was a true reflection of her mood status when we started with the 
sessions. Although she presented with symptoms of depression from the 
beginning of our sessions, which was also the reason why she was referred, she 
was already on an anti-depressant and under treatment of a psychiatrist. Her 
therapeutic sessions continued, but by the fourth therapeutic session (five months 
after her last treatment) there was a need to assess her symptoms again for 
depression (according to the DSM-5 criteria) because her mood was spiralling 
down and she became much worse. There was concern about her psychological 
condition. She was referred back to her psychiatrist to look at her medication and 
maybe to make adjustments to meet her current needs. Hill and colleagues (2010) 
confirmed that a pre-morbid psychiatric history is a well-known risk factor in 
developing depression during and after breast cancer and cancer treatment, 
especially in the year after diagnosis. It was also further confirmed that there are 
overlapping somatic symptoms between depression, chemotherapy, radiation and 
hormonal therapy which can make the diagnosis, and treating of depression, 
difficult (Lueboonthavatchai, 2007).   
Patient V said she was feeling depressed (15 months after the diagnosis and 6 
months after the last treatment) about her losses and because of her marital 
problems and that was why she had asked her oncologist to see a psychologist. 
She was evaluated by the researcher in terms of her symptoms and was found 
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presenting with all the DSM-5 symptoms of a Major Depression. It was explained 
to her that treatment for depression can include both medication and 
psychotherapy, and she had opted for the therapy first before going the route of an 
anti-depressant. The patient explained that she never experienced depression or 
anxiety before the cancer or had any treatment for such conditions,  
“But now I am very worried and troubled by my emotions and the relationship with 
my husband, because I thought that I would automatically feel better once I was 
finished with the treatment, but it is not the case”.  
In spite of her clinical diagnosis of depression, her score on the HADS on the 
depression side was only 6, not corresponding with her true symptoms and 
feelings of depression. It is important to note here, that if she was only subjected 
to a questionnaire for measuring depression, she and treating doctor would have 
gotten the wrong impression that there was no sign of depression.  Symptoms of 
depression or emotional distress can cause a contradictory response for survivors 
who may feel both relieved at having completed treatment, but also a heightened 
anxiety for recurrence (Ganz et al., 2004; Saniah & Zainal, 2010).   
 Anxiety and anticipation anxiety during the cause of breast cancer  
There is strong evidence that shows that anxiety is a prominent concern regarding 
the three main treatment modalities of breast cancer namely surgery, 
chemotherapy and radiotherapy (Dolbeault et al., 2009; Lim et al., 2011; 
Lueboonthavatchai, 2007; Navari et al., 2008; Vahdaninia et al., 2010).  
Patient II was so stressed out and anxious after hearing the diagnosis that she 
was referred to a social worker by her oncologist at their first appointment, saying:  
“After the appointment I still felt anxious and I did not know how to handle that at 
all. I am not an anxious or depressed type of person and didn’t know what to do 
with all that anxiety and fear.”    
Both Patients II and III experienced severe anxiety (anticipation anxiety) regarding 
their upcoming surgery that was scheduled for after their last chemotherapy. They 
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confirmed that they were more scared before they knew what the surgery would 
entail. Patient II said:    
“I was in denial of the surgery and so busy with the chemotherapy that I was not 
thinking about the operation at all. Now after hearing the confirmation of the 
surgery date, it is a reality and I am scared now.”  
She said that the oncologist had commented on her anxiety, but after he explained 
what the surgery would involve and what she could expect, she felt more at ease 
about the whole procedure. For the researcher this was another indication of how 
important communication between the oncologist and/or surgeon and the breast 
cancer patient is and the peace of mind that goes with knowledge regarding the 
cancer procedure.   
Patient III also commented on her fear of the upcoming surgery, saying:   
“I was trying to be positive but felt very emotional and anxious most of the time 
before the surgery. I felt so scared and apprehensive of the forthcoming surgery 
that I was not even joyful at the end of my chemo or when I heard the good news 
that the tumour had remarkably shrunk.”  
Recent literature confirmed the experiences of Patients II and III that the pre-
operative stage is dominated by stressors such as waiting for the surgery and the 
pathology results causing high levels of anxiety (Aviado-Langer, 2014; Berger et 
al., 2015). Both Patients II and III tested within the normal range of anxiety on the 
HADS, which was not a completely true reflection of how they felt in terms of 
anxiety. They were both anxious enough to have complained about it and for me 
to feel that it must be addressed in therapy.   
Patient I explained that, to her, the anxiousness was worse than the depression:   
“It was like a physical presence, especially the anxious thoughts of the cancer that 
didn’t seem to go away. It was as if the anxious thoughts were just milling around 
in my head the whole time”.  
She said that, during her stay in the hospital before the surgery, she was very 
anxious but not depressed: 
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“The waiting in between the procedures and the results was hard-core anxiety. 
After the end of the treatment, when I thought I would be glad and happy, the 
anxiety was back again because I was unsure of what the future held for me and if 
and when the cancer would re-occur.”  
She experienced that her fear and anxiety was even worse after the end of the 
treatment when everything was supposed to be back to normal, saying:  
“My biggest disappointment was the realisation that this anxiety and fearful 
thoughts will never end, that there will never be a full stop after the sentence”.   
She was diagnosed with, and treated for a general anxiety disorder by her 
psychiatrist after her cancer treatment was over and she was in remission. The 
anti-depressant Cipralex 20 mg was prescribed by her psychiatrist. Before the 
cancer diagnosis, she had never been treated for an anxiety disorder, although 
she suffered from a major depressive episode previously. Her score on the anxiety 
side of the HADS was 6, in line with how she felt when I started seeing her in 
therapy. She said that although she was still having her anxious moments, it was 
more under control with the medication and sessions with her psychiatrist.   
Patient IV said that, from the beginning of the diagnosis, the biopsy and surgery 
and then the chemo:   
“I was scared and afraid and was anxious because of my fear of needles. The 
whole process of administering the chemo was very intimidating for me because of 
my fears.” Although this patient experienced more feelings of depression, and 
talked more about her depression, she still tested 13 on the anxiety side of the 
HADS, indicating that she also suffered from severe anxiety in the beginning of 
our sessions combined with her feelings of depression.      
Most of Patient V’s fears and anxiety revolved around her child. She was scared of 
dying and leaving him behind. She was also worried because of the high 
responsibility of her job, she was anxious about making mistakes or even losing 
her job. She requested an appointment with a psychologist because she was so 
depressed and anxious all the time. This patient’s anxiety score was 6 on the 
HADS, indicating that although she experienced symptoms of anxiety to such a 
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degree that she felt that she needed therapy, it did not reflect on the HADS. This 
made it very clear for the medical team and the psychologist to ask about anxiety 
(and depression) and not just rely on tests and tests results, for it might not be a 
true indication of a patient’s real experience of her mood.    
Anxiety, according to some authors, should be distinguished from depression 
because the interventions differ depending on the nature and severity of the 
symptoms (Burgess et al., 2005; Dunn et al., 2011; Stark et al., 2002). 
7.3.1.4  THE EMOTIONAL EXPERIENCE OF THE CANCER JOURNEY 
DURING AND AFTER TREATMENT: SPECIFIC PROMINENT 
EMOTIONS 
Theme 5: The need to talk about emotions:   
Breast cancer causes, amongst other things, unpleasant emotional experiences 
leading to psychological distress (Hack & Degner, 2004; Stanton & Low, 2012), 
and evidence suggested that by acknowledging, understanding and sharing 
negative emotions it can give positive relief which can be associated with 
improved well-being (Austenfeld & Stanton, 2004; Hack & Degner, 2004; Stanfort 
et al., 2000). These authors underline the importance of crying, talking and writing 
as a healthy outlet of the breast cancer patient’s emotions.  
Patient II said she had tried to make a point of talking about how she felt to her 
family, especially in terms of her emotions regarding the cancer, but felt a need to 
speak to a professional person about the cancer process and how she felt about 
everything. She felt that talking to her oncology team was more about statistics 
about cancer survival which she was not so interested in. Instead she rather 
needed somebody to talk to about the treatment and her emotions, saying:  
“I would rather want to know what to expect of my treatment and my emotions, 
more than what the cancer statistics are, ‘over sharing’ makes me anxious”. She 
said because of this (her need to talk) she decided to participate in the study after 
understanding what it would entail.  
Patient III had a sincere desire to talk about her emotions, which she experienced 
as overwhelming, not just regarding her cancer, but also about the worries she 
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had before the cancer concerning her family life and marriage and her and her 
husband’s chronic illnesses.  During the first session she asked:    
“Will it be possible to work on that as well during our sessions because of my 
problems with my family? I don’t have anybody to talk to about how I feel about my 
cancer. I have always found it difficult to talk about how I feel.”   
Patient IV said: “If I could see a psychologist from the beginning, working through 
my emotions the whole time, I think I would have been able to control my emotions 
better”.  
She also said “I need to see somebody to talk to about my deepest feelings and to 
help me to put everything in perspective. It was because of this need to talk about 
my emotions and to prevent a relapse of my depression that I wanted to see a 
psychologist from the beginning …” 
Patient V said: “I need to talk about my emotions and the hardship I went through 
during my breast cancer period even although it is finished. I want to talk to 
somebody that will understand my situation and can give me some advice as to 
what to do now, somebody outside my family.”   
 Fear of death   
For most individuals, a cancer diagnosis is often accompanied by fear of death, 
which makes out a large percentage of the overall fear that the breast cancer 
patient experience and tend to be the highest in the first few months after 
diagnosis (Fobair et al., 2006; Waljee et al., 2008; Yoo et al., 2010). Gurm and 
colleagues found in a study done in 2008 that, regardless of culture, nearly all 
breast cancer patients experienced that death was impending upon hearing the 
diagnosis. Four of the five patients in this study experienced high levels of intense 
fear of dying especially at the beginning of their diagnosis.    
Patient II never pertinently experienced or talked about fear of dying, although she 
had other fears, especially regarding the surgery.  
Patient III said: “I thought I was going to die immediately when I heard that I had 
cancer and I am very scared of dying. Dying was the only thing I could think of.”  
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A family member of her had died during the time of her chemotherapy due to 
cancer, which had triggered a lot of fear, especially fear of dying, she said:   
“I have such a need to talk about my fears to somebody.” 
Patient I experienced that her biggest fear, even after she was in remission, was 
the fear of death. 
 “...not so much for me, but for my children, which are still young…my first thought 
after hearing the diagnosis of breast cancer was that of dying.”  
She explained that she was reluctant to talk about her fear of dying with her family 
and friends, feeling that by doing so, she would appear to be ‘unthankful’ of her 
good prognosis. She had a prominent desire to share her fear of death without 
feeling guilty for doing so.   
Although Patient IV was not scared of dying and felt comfortable talking about 
death, her partner did not like to talk about the subject at all. She felt it is important 
that when you are in a relationship, to be able to talk about death and dying, 
especially about the practical matters. During the conversation she asked if we 
could make an appointment with her partner to talk about this subject later on in 
therapy. I agreed that it will be a sensible topic to discuss together in therapy.    
Patient V said that to her, the fear of death was very prominent during her 
chemotherapy because she was physically sick and really thought that she was 
dying especially at night, often wondering “... if this was what dying felt like”. She 
said during the three days after chemo when she was so ill with the nausea and 
vomiting, she constantly thought about death and what will become of her child if 
she was to die. She said:   
“… even now, I am scared of the cancer coming back and that he, being an only 
child, will grow up without his mother and other siblings …I have a lot of sad 
feelings and anxiousness if I think of him growing up without me.”     
 Guilt Feelings   
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Most cancer patients experience feelings of guilt in some form or another. Some 
may feel that it was somehow their fault (the breast cancer) and that because of 
them, feelings of pain and distress are imposed on their loved ones and that they 
are a liability to them (Drageset et al., 2011; Parrish & Adams, 2003). Feelings of 
guilt are often part of a depressed mood which can be a prominent mood disorder 
in the breast cancer population (Jim et al., 2009).     
Patient II stated that she constantly felt, without any reason, that she should prove 
herself to her husband and family. They should see that she could still do 
everything in and around the house in spite of the cancer. Not doing her normal 
house chores, made her feel guilty and not good enough as a mother and wife.   
Patient III experienced feelings of guilt before her surgery, for leaving her husband 
alone and not being able to look after him and his needs (he also suffered from a 
chronic disease). She also had guilt feelings for their financial situation, as she 
was the main breadwinner en couldn’t cope with going back to work during her 
treatment.    
Patient I said she often felt guilty when she was feeling depressed or anxious and 
therefore seldom allowed herself to feel or share these emotions with her family.   
She felt especially guilty for not being able to participate more in family 
interactions during her chemotherapy and that she was not part of the ‘practical on 
goings’ in her children’s lives. 
Patient V experienced guilt feelings towards her mother and husband and 
especially her child, as her most prominent emotion, even more so than her fear of 
death. She felt she had forsaken her child, saying when she was so ill that:     
“…he was missing out on his mother because I was not there to help him with his 
daily care. …I was not even able to help him get ready in the mornings for pre-
school or taking and fetching him”.   
She said she also felt guilty and disappointed in herself for feeling depressed and 
anxious now after she was in remission, saying:   
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 “… I am clean and healthy and yet I feel depressed and anxious, it makes me feel 
even more guilty …I feel so unthankful and ungrateful.” She thought that she 
would feel better and exited after the end of the treatment, but now instead, feeling 
rather “…depressed and out of sorts”.   
 Losses experienced because of the breast cancer   
Cancer can cause multiple losses which include physical and psychological 
elements and can lead to or even re-stimulate depression and by facilitating the 
very important grieving process, it is important for the patient to acknowledge and 
understand what her losses are (Fobair & Spiegel, 2009; Giese-Davis et al., 2010; 
Lee, 2008).   
Patient II experienced her biggest losses in terms of her inability to fulfil her 
“responsibilities” in and around the house as a wife and mother who made her feel 
useless and unworthy. She felt she lost part of her functionality as a woman and a 
mother.   
Patient I experienced it quite a loss to have scaled down on her activities, 
especially with her husband and children, making her feel “distant” from them, 
contributing to her feelings of sadness and guilt. She said that the loss of 
oestrogen and changes in her sexual functioning, as well as the loss of intimacy 
between her and her husband, was some of her biggest losses throughout her 
breast cancer and made a huge impression on her emotional wellbeing and 
overall functioning 
Patient IV experienced the fact that she was dependant on other people during 
her cancer treatment, especially the chemotherapy, as a loss of her autonomy, 
contributing to her depression, saying:    
“My biggest loss was the fact that I could not trust my own body, I felt betrayed by 
my body and that when you have cancer, you don’t have control over your body 
anymore or what is happening to it. All of a sudden other people got to make 
decisions over your body and especially for somebody like me who is extremely 
private and independent the fact that I was so vulnerable and defenceless was a 
major loss for me”.  
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Another loss for this patient was her financial losses due to the cancer treatment 
which is very expensive, she said:    
“I never realised how expensive cancer treatment was and I had to use all of my 
savings to pay for the treatment”. The patient did not at that stage has a medical 
aid and was still recovering financially from the cancer.   
Patient V explained that she experienced their changed marital relationship and 
conflict as a very big and traumatic loss, especially because they had such a good 
and functional marriage before the cancer, saying about her child:     
“...I have lost out on a lot of new ‘developments’ during the year I was not so 
intensely involved in my child’s life, I can never get the time back”. She said that it 
was part of her child’s ‘baby years’. He was only two then and she had missed out 
on it, again making her feel intensely guilty and sad.    
7.3.1.5  Sexual functioning affecting by breast cancer and breast cancer 
treatment: chemotherapy, surgery and hormonal therapy   
Here the researcher distinguished between two themes (theme 6 and 7) 
discussing first sexuality and sex reacting to the cancer treatment regime and then 
menopause and the psychological effect it had on the breast cancer patient.   
Theme 6: Sexuality and sex: 
Cancer is regarded as a disease which not only disturbs a person’s biology and 
emotional status, but can also affect and influence her self-image, sexual 
functioning and sexuality (Surbone et al., 2013; Wong-Kim & Bloom, 2005).  
Psychological distresses, including psychiatric conditions such as depression can 
also have a profound effect on sexuality and sexual confidence and lack of sexual 
desire (Dean, 2008; Graziottin & Leiblum, 2005; Laumann et al., 1999). 
Discussing sexual functioning with the oncologist/medical team 
In spite of evidence that many cancer patients would like to discuss sexual issues 
related to their cancer treatment with their oncologists, recent research has shown 
that they are reluctant to do so because of limited opportunity and because of their 
own discomfort to talk about sex and sexuality with their doctor (American Cancer 
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Society, 2013; Hummel et al., 2015; Kuo et al., 2008; Reece et al., 2010). On the 
other hand it was found that 62% of the oncology physicians have acknowledged 
in a study, that conversations about sexual health usually do not occur during the 
course of the cancer treatment and that they are not at all likely to initiate 
conversations about sexual dysfunction with their cancer patients (Park et al., 
2009). A cancer patient needs an encouraging and confident relationship with her 
physician(s) to voice her sexual concerns and many patients believe that if a 
physician does not bring an issue up, then it is not a valid concern worthy of 
discussion, meaning that if sexual health conversations are not ‘physician 
initiated’, then they will most probably not happen (Butler et al., 1998; Hordern & 
Street, 2007; Park et al., 2009).   
Patient II spoke spontaneously during the first session to me about their sexual 
functioning which stayed “normal” and satisfying during the whole treatment 
regime, but haven’t discussed any sexual subject with her oncology team. She 
said it never came up anyway.     
Patient III, when asked if she felt comfortable to talk to the oncologist about her 
emotions and sexual fears or functioning said:  
“...no, we don’t speak. ...not even about other side-effects of the chemotherapy.”  
Emphasising again that the oncologist doesn’t spent enough time with her during 
their sessions, saying:   
“It helped to speak to you about sex during our sessions and it feels comfortable 
talking about that”.   
Patient I explained: “…that nobody has spoken openly to me about probable 
changes to my sexuality and sexual functioning. I had to struggle through my 
sexual problems and challenges on my own, not having the confidence to ask my 
oncologist about it … although I was told about the side-effects of the treatments it 
was never explained to me in detail of what I could expect of my body and 
emotions or the influence on the quality of my sex life or even what I could do to 
adapt to the situation, nor was I referred to a psychologist to attend to the 
problem.”   
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She emphasised again the lack of communication between her and her oncologist 
in this field, saying  
“I didn’t feel comfortable discussing my sexual status and accompanying 
emotional status quo”.  
Dean, (2008), suggested that although sexual problems, due to cancer treatment, 
may improve over time, some patients might still need additional psychological 
support following treatment to help them adjust to a better level of functioning. 
Patient, III and IV haven’t discussed their sexual functioning with their oncologists, 
but felt comfortable speaking to me in the sessions about their sex lives.  
Patient V said her oncologist had explained the side-effects of the hormone 
treatment to her in terms of the menopause, but said:   
“… I feel I need more information about what the treatment will do to my body 
since menopause is something unfamiliar to me. ...nothing else was said or 
explained about sex during my treatment.” 
Changes in sexual functioning  
All current cancer treatments, especially chemotherapy, cause changes in the 
female body and although it may not necessarily interfere with the women’s 
physical ability to have sexual intercourse, it often affects sexual functioning and 
intimacy and consequently also emotional relationships (Fobair & Spiegel, 2009; 
Kuo et al., 2008; Sbitti et al., 2011; Taylor et al., 2011). Side-effects of 
chemotherapy and hormonal therapy such as nausea, fatigue, weight changes, 
hair loss, premature menopause and lower oestrogen levels may all contribute to 
sexual problems with some of the symptoms acute and short term and some 
lasting long after chemotherapy treatment ends (Emilee et al., 2010; Hummel et 
al., 2015; Kuo et al., 2008; Reese et al., 2010). Surgical scarring and the loss of a 
breast, coupled with lymphedema are further sequelae that can impair a breast 
cancer patient’s body image (Katz, 2005; Rosenberg et al., 2012). 
Patient II said that there was little change in their sexual functioning:   
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“...I think we always had a good sexual understanding even before the cancer and 
our sexual communication was good”. She said that, although she still felt tired at 
times, their intimate relationship was as good as ever and that they had “normal 
sexual activities”, also saying it made her feel ‘normal’ and still wanted by her 
husband.  
Her score on the FSFI (Female Sexual Function Index) was 51.8 which indicated 
that she did not suffer from a female sexual dysfunction (a score ≤ 26.55 is 
classified as FSD), which corresponded with what she said during the sessions 
regarding her sexual functioning.     
Patient III had previous sexual problems (before the breast cancer diagnosis) due 
to marital difficulties and physical conditions. Both her and her husband suffered 
from chronic diseases that were not under control. During the very first session 
she spoke about their sexual problems and lack of intimacy. She asked whether it 
would be possible to talk about it during our sessions and if we could try to work 
something out to make their sex life better.   
This patient has scored 19.6 with the FSFI scale, which fell in the range of female 
sexual dysfunction. This agreed with her sexual functioning at the time and which 
she also experienced.   
Patient I said, regarding her sexual functioning,  
“…survival was foremost in my mind and I was in survival mode, only wanting to 
get well and healthy again. I only concentrated on my treatment and surviving 
every day. ...although sex was not a big priority we still had a good sex life and it 
did me good when it happened”.  
This was verified in literature by Katz (2005) and Taylor and colleagues (2010) 
stating that sex is not necessarily a priority in the period immediately after a 
cancer diagnosis due to overwhelming emotions and concerns regarding mortality.   
She and her husband never had any sexual problems before the cancer, “...but 
after the treatment I experienced severe problems in that area and saw it as a 
huge loss”, saying:   
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“...another loss for me was the lack of oestrogen which made a huge impression 
on my emotional and sexual wellbeing”. She explained that she was completely 
overwhelmed by the unexpected sexual changes during and after the cancer 
treatment with no knowledge of how to handle it. She also presented with a low 
score on the FSFI scale, less van 26.55, which indicated sexual dysfunction in all 
the areas of sexuality.   
Patient IV experienced her weight gain as the biggest effect on her self-image and 
sexual image, as well her tiredness and listlessness and she requested that we 
make self-image a therapeutic goal in a next session. Both she and her partner felt 
that everything during the cancer treatment was “swallowed up” by the depression 
and her extreme experience and fear of depression. The patient only ever talked 
about anything regarding sex, when she was asked. Her emotional turmoil was 
her biggest “reality” and that the symptoms of depression overruled her sexual 
functioning. This was reinforced by authors stating that psychological distresses, 
such as depression as a cancer treatment side-effect, can have a profound effect 
on sexuality, sexual confidence, performance anxiety and lack of sexual desire 
(Laumann, Paik, Raymond & Rosen, 1999; Graziottin & Leiblum, 2005; Sbitti et 
al., 2011). Her score on the FSFI scale was very low, indicating a sexual 
dysfunction in all the areas that was tested, and agreed with her lack of sexual 
interest or activity during the time of the study.   
When Patient V talked about her sex life the first time during our sessions, it had 
been two weeks after her hysterectomy and they had to withhold from sexual 
intercourse. She said that before her breast cancer they had a good and active 
sex life and were sexually very compatible, even after the diagnosis: 
“...we had carried on with our usual sexual functioning after the breast surgery and 
before the hysterectomy. I think that he is currently okay with my body but after the 
breast reconstruction he hasn’t touched my breasts yet because of the pain.” She 
said that they had not discussed her illness or their sexual activities since her 
diagnosis. She said that there were changes in the way her body reacted to sexual 
stimuli and also in the frequency of their sexual activities.  
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Because of her hysterectomy and sexual abstinence, we had agreed that she 
would fill in the questionnaire as how their sexual activities and her sexual 
functioning were before the hysterectomy. She scored a 33.1 which was well 
above any sexual dysfunction and which matched what she said about their 
sexual functioning.   
 (Sexual) Self-image 
Breast cancer patients are exposed to changes in their physical appearance such 
as the loss or disfigurement of one or both breasts, lymphedema, scars from 
surgery, and skin changes related to radiotherapy, where chemotherapy or 
hormonal treatment often lead to alopecia, weight increase and menopause 
(Dean, 2008; Falk et al., 2010; Krychman & Katz, 2012; Kuo et al., 2008; Reece et 
al., 2010; Sbitti et al., 2011). These physical changes can result in altering the 
breast cancer patient’s self-image, sexual identity and efficiency (Hummel et al., 
2015; Krygman & Katz, 2012; Sbitti et al., 2011; Surbone et al., 2013).   
Patient II said the most positive thing concerning their sex life was that her 
husband had told her after the latest surgery that the loss of her breast and hair 
had no negative effect on him and that he feels sexually the same about her and 
that she must please never doubt that. She said because of her husband’s “soft 
approach” regarding their sexual side she does not feel ashamed about the 
absence of her breast or even the scar. She said from the very beginning, when 
her hair started to fall out, he had told her that she is still attractive to him. She 
said even undressing in front of her husband did not make her uneasy:    
“…because I feel more comfortable with my body I even allow him to touch my 
scars or massage my sore arm”.    
Patient III did not have concerns about her body image at the time of this study, 
but their sexual problems were more because of their health problems and general 
marital problems than that of a changing or altered self-image because of the 
cancer treatment.    
Patient I said: “…my whole self-image has changed due to the fact that the form of 
my body and weight have changed drastically…even the way my body reacts 
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sexually has changed,...I don’t reach an orgasm anymore and it is as if my body 
doesn’t want to react in any sexual manner after the treatment. …I don’t 
understand my body in terms of my sexuality anymore.”   
Patient IV has revealed that she never had a good self-image and that because of 
her weight gain and scarred breast, she felt even more self-conscious about her 
body, especially when she was naked and that it also effected their sexual 
interaction. She said that her breast looked different from the other one where they 
did the lumpectomy and that even with clothes you could still see the difference. 
She said it bothered her so much that she was even considering breast 
reconstruction where she never thought about it before. This was supported in 
literature which stated that negative perceptions of body image amongst breast 
cancer survivors comprise dissatisfaction and unhappiness with physical 
appearance, reluctance to look at oneself naked, feeling sexually unattractive and 
self-conscious about surgical scars and appearance (Fobair et al., 2006).   
Patient V said that because of their young age and the fact that they were very 
active sexually;  
“...I was scared in the beginning when I realised that my body were going to 
change and that he might be repulsed by my changed body.”   
This fits in with statements that all current cancer treatments for breast cancer can 
cause changes in the female body that abruptly affects sexual functioning and 
emotional relationships (Fobair & Spiegel, 2009; Kaplan, 1992; Sbitti et al., 2011), 
and because of her fear that her husband might reject her sexually she has 
decided to have reconstruction surgery as soon as it was possible. She said:  
“I didn’t want my husband to see me without breasts, it is important to me that my 
husband sees me as a woman and I would go to any lengths to restore my body 
image”.  
She said she realised that her husband had experienced the idea of her hair falling 
out very negatively and that he didn’t want her to walk around without her wig and 
she felt that he was ashamed and embarrassed of her cancer and looks, saying 
”...it made me feel more vulnerable and alone”.   
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This was accentuated by Klaeson and colleagues (2011) saying that the loss of 
femininity, libido and satisfactory intercourse can cause emotional distress which 
in turn can affect the women’s already vulnerable transition towards redefining 
their sexuality.   
 Sexual communication and intimacy in the relationship 
As couples cope with cancer they often experience a lack of communication about 
changes to their sexual relationship or sexual problems that might emerge due to 
the cancer treatments and which can cause emotional distancing and marital 
dissatisfaction (Manne et al., 2006; Milbury & Badr, 2013). During illness and 
stress most couples find it hard to talk about sexual problems and it is common for 
a person with a life-limiting illness to be less intimate or trusting during the crisis 
phase of her illness (Hordern & Currow, 2003; Murray, 2010). The American 
Cancer Society (2013) stated that it is eminent that clear two-way communication 
about sexual matters is the key in adjusting sexual routine when cancer changes 
the body and adjustments had to be made. It is an important task for couples to 
resume an intimate relationship to help them draw on this connection as a source 
of strength and support (Manne & Badr, 2008; Nicolas, 2013).   
Patient II experienced that their relationship, sexually and otherwise, was close 
before the cancer and is now even closer, which is confirmed by Sheppard and 
Ely (2008), who said that a cancer experience can enhance a greater sense of 
closeness in a relationship.  
Patient III, when asked about her sex life, answered that she is still feeling that her 
husband is not supporting her the way she would have liked and that he does not 
understand her emotions and fears, saying:   
“… our sex life is not that good, but we had problems from before the cancer, we 
both have chronic illnesses and my husband has once even attended a ‘man 
clinic’ but it didn’t help him.” She also said: 
“Me and my husband don’t talk about sex or even intimacy…” Sheppard and Ely 
(2008) have confirmed this by saying that a breast cancer diagnosis can bring up 
pre-existing marital problems to the fore-ground. During a session with her 
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husband he has confirmed that they do have a problem with their sex life and that 
his physical illness, which is not under control, plays a big part in it.   
Patient I experienced the lack of intimacy between her and her husband as yet 
another loss, she felt that she did not have the proper knowledge regarding the 
cancer and her sexual functioning and she did not communicate her lack of sexual 
interest and overall sexual changes, properly. She said:   
“… the lack of communication between me and my husband then led to absence, 
not just in sexual functioning, but also in intimacy.” Ussher and colleagues (2012) 
underlined the fact that a cancer diagnosis can change the relational dynamics 
between a couple which can affect the sexual relationship and that couples living 
with cancer have reported communication problems or increased conflict that can 
contribute to relationship breakdown. 
Patient IV said that she and her partner do not discuss the impact of her cancer 
and premature menopause on their sexuality at all;  
“...but yet, we always make an effort with our sexual and intimate relationship, but 
I would like to hear what he is saying about our sexual relationship.”   
She explained during a joint session that both of them actually experienced a low 
libido that was present before the cancer, but also emphasized that they don’t see 
it as a problem or crisis because they have a very good intimate relationship. They 
were very close to each other and held hands and touched each other often, this 
was noticeable during our session. She said that having said that, she would like 
them to work harder at their sexual relationship and improve it, for she thinks that 
with a more regular and satisfactory sex life,  
“… it can enhance and strengthen our relationship and even my self-image”. Her 
partner said that the changes in her body have no effect on him or the way he 
feels about her sexually or otherwise.   
Patient V said she was angry and disappointed in her husband because of the fact 
that she didn’t experience him as supportive during the time that she needed him 
the most, especially during the chemotherapy. She felt that there wasn’t much 
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intimacy between them which was hard for her to understand and endure because 
before the cancer they had a very good and special sexual bond between them. 
Because of his lack of interest and indifference towards her and her cancer she 
developed feelings of resentfulness towards him, saying:   
“…the cancer is currently standing between us”. This was confirmed by Ussher 
and colleagues (2012) underlining the fact that a cancer diagnosis can change the 
relational dynamics between a couple which consequently can affect their sexual 
relationship. 
Theme 7: The menopausal factor: The breast cancer patient’s experience of 
it: 
Menopause is an occurrence outside the normal life course and chemically 
induced premature menopause is one of the most unexpected and sudden side-
effects of chemo- and hormone therapy which can influence the breast cancer 
patient’s quality of life through biological and psychological changes (Brem & 
Kumar, 2011; Deeks et al., 2011; Ewertz & Jensen, 2011; Hummel et al., 2015; 
Kuo et al., 2008; Mok et al., 2008). 
Patient II did not experience a lower libido during her treatment and when asked 
about menopause, she said that she was not menopausal before the treatment, 
although expecting it to happen at any time:  
“...Nobody had up till now spoken to me about menopause or even the possibility 
of menopause or any symptoms because of the treatment and I am not sure what 
to expect of it or that it might even happen now. …if this is the case, I would like to 
know more about it, because I am still pre-menopausal”.   
She said she realised that she was at the age where the symptoms of menopause 
would start and she did not feel negative about “normal” menopause, she just 
wanted to be ready. Reece and colleagues (2010) underlined this by saying that 
even during treatments, such as chemotherapy, the patient and her partner can 
still have intimacy and sexual needs and that maintaining sexual activity can be a 
sign of overall wellbeing as well as the ability to cope with the cancer and its 
treatment.   
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Patient III was the only patient that was in complete natural menopause and was 
very comfortable about this status. She said that although her sexual issues was 
not just cancer related, some of their sexual problems were also because a lack of 
sexual communication.   
The therapeutic sessions with Patient II and III (who were still busy with their 
treatment) were more focused on their emotional status and experiences, current 
chemotherapy and new information regarding cancer treatment and the upcoming 
surgery and their anticipation anxiety, with less information about treatment related 
sexual functions. This fitted in with literature stating that because of the trauma of 
the diagnosis of cancer and the accompanying survival mode that kicks in as well 
as the busy treatment schedule, sex is not necessarily an immediate priority for 
the patient (American Cancer Society, 2010; Katz, 2005; Taylor et al., 2011).   
Patients I, IV and V have developed chemically induced premature menopause 
due to their cancer treatments with outspoken symptoms such as hot flushes, 
weight gain, negative body image, little or no sexual desire and changes in their 
sexual responsiveness and functioning. This was supported by authors such as 
Derzko and colleagues (2007) and Deeks and colleagues (2011) stating that 
breast cancer patients experience fears and uncertainties and sexual changes that 
accompany the symptoms of premature menopause.   
Patient I reported a complete lack of oestrogen because of her menopausal 
status, saying:    
“...I now have a much ‘older’ body that I must get used to ...I was not prepared for 
the severe symptoms and suddenness of the menopause and it made a huge 
impression on my emotional wellbeing and sexual relationship with my husband 
…it was completely unexpected.”  
Both she and her husband were of the opinion that they were not properly 
informed about the changes due to premature menopause, especially the changes 
in their sexual functioning during and after the treatment. They didn’t understand 
the complete lack of sexual drive and that it was so specifically related to 
menopause and cancer. Both of them agreed that her lack of interest in sex 
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contributed to their feelings of uncertainty about themselves as sexual partners 
and the development of her lower self-image.  
Patient V also felt that although her oncologist had explained the principle of 
menopause to her, she still needed more information regarding the symptoms of 
menopause especially for the next five years when she must use the hormone 
medication, saying: 
“I know it will influence my sex life, but how and to what extend? I need more time 
to talk to somebody about menopause and my perceptions and emotions 
regarding it…. menopause is something completely unfamiliar to me”.  
Patients I, IV and V complained about severe and uncomfortable hot flushes, 
insomnia and lack of vaginal lubrication which were affecting their sexual 
functioning and sexual relationships. Patient V said because of her recent 
hysterectomy they are not currently engaging in sexual activities, but experienced 
a very low libido which developed recently and which is unfamiliar for her, saying:    
“…I am young and sexually active and don’t understand my lack of sexual 
interest”.  
This was supported by a study done by Deeks and co-workers (2011) that breast 
cancer patients with premature menopause has reported a lack of information and 
support in this area from their oncology team 
Patient IV said she was still completely pre-menopausal before the chemotherapy 
and is not sure of what to expect of menopause. She is not on a hormone 
treatment and her menses has started one month after her last chemotherapy 
where she experienced a very bad PMS episode, but was so thankful when she 
realised that it was PMS and that everything “is back to normal and not my 
depression that was going worse.” This was explained by Brem and Kumar (2011) 
saying that chemotherapy related amenorrhea can be temporary in pre-
menopausal breast cancer patients.   
Al three patients have received information regarding treatment-related premature 
menopause from their oncologists, but all three of them specifically requested 
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more time to talk about it and what exactly menopause meant in terms of practical 
and sexual implications.   
7.3.1.6  Work functioning  
Studies have shown that decisions about working during and after cancer 
treatment are influenced by personal choice, the meaning of work for the individual 
and economic considerations (Kennedy et al., 2007; Shewbridge, Wiseman, & 
Richardson, 2012).   
Theme 8: Working or not working (while receiving chemotherapy):   
Working is important for an individual’s identity and sense of feeling valued. It 
provides a re-integration into society and offers a distraction. Returning to work, 
therefore, has the potential to help the cancer patient to regain a sense of 
normality and control and enhance the patient’s quality of life and psychological 
well-being and is seen as a symbol of recovery (Kennedey et al., 2006; Mehnert, 
2011; Peteet, 2000; Raque-Bogdan et al., 2012). For breast cancer patients 
particularly, going back to work can be affected by anxiety about their physical 
appearance, chemo-induced cognitive impairment and chemo fog which can all 
impact their confidence in carrying out their work tasks (Munir et al., 2010). ‘To 
work or not to work’ varies from patient to patient where some choose to take time 
off from work during their treatment, while other patients continue part-time or 
fulltime employment depending on the type of cancer and treatment, the type of 
work and financial necessity (Short et al., 2005; Spelten et al., 2003). When to go 
back to work is an area that needs to be addressed by the oncology team and 
Kennedey and colleagues (2006) felt that an improvement in communication about 
readiness to return to work and issues such as side-effect management would be 
advantageous for the cancer patient.   
Patients I, III, IV and V had full time careers during their cancer treatment.  Patient 
I stayed at home, where both Patients IV and V continued to work throughout their 
cancer treatment. It was noticeable that Patients IV and V put a high value on 
working and participating in work related activities throughout their chemotherapy 
and the benefits that they have felt from that and that Patient I, who had chosen 
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not to work had experienced much more negative effects feeling hopeless and 
with too much time on her hands to think and experience negative thoughts.   
Patient I hasn’t work for the whole time that she was receiving chemo and 
radiation therapy, saying:   
“The treatment was too radical for me and I was too tired to work and my focus 
was not on the work at all... but not going into work every day also made me feel 
aimless and out of contact with reality,… not being able to work was very hard for 
me and made me feel inadequate and depressed because my work plays a big 
part in my life and identity ...I felt aimless and out of contact with reality...” also 
saying: “on the positive side of staying at home was that it helped me to regain my 
strength and energy …I didn’t have any work related stress which was good for 
my body and mind”.  
The fact that she didn’t work made her feel more isolated and she had more time 
on her hands for negative and destructive thoughts. She went back to work a year 
after her diagnosis and treatment was finished and is currently working full-time 
again, saying:   
“...I am managing my working hours better and more user friendly than before the 
cancer.”  
Patient III who worked in a care facility felt that she was not capable of working 
during her treatment, not emotionally nor physically, saying: 
“I have a very physically demanding job and feel just too tired to do my job 
properly.”   
She was in the process with the social worker to arrange for a temporary absence 
of leave from her work because she felt she could not handle work-related stress 
then, yet it also stressed her out because the whole family was financially 
dependent on her income. She did not know whether she would go back to work 
or not, saying that this was not a big priority for her now. She wanted to get well 
first and get the treatment and surgery out of the way. Spelten and colleagues 
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(2003) have supported this by saying that cancer-related fatigue can affect 
employment by increasing absence from working.    
Because of the increased use of more intensive chemotherapy treatments over 
longer periods of time, the need to continue to work whilst receiving treatment, has 
become more pertinent (Shewbridge et al., 2012), and it is estimated that up to 
62% of cancer patients continue or return to work during or after treatment 
(Spelten et al., 2003). This was applicable to Patients IV and V who continued with 
working during their treatment.   
Patient IV only took off from work the day on which she received the chemo and 
the day after that. She saw herself as a very career orientated and driven person 
and her work played a large and important part in her life and identity, she said:   
“...my work entails a lot of concentration and focusing and in the beginning with 
the chemotherapy I was constantly scared that I would not be able to do my work 
properly. ... I rely heavily on my intellect.” She also said:   
“The fact that I could work every day had saved me, it kept me sane and busy and 
I could focus away from my cancer and anxiety. ...Being so involved in my work 
was one of my coping skills.”     
She was dependent on her salary and because she did not have a medical aid 
she needed her salary to cover her medical costs. She was scared of not being 
able to do her job properly because she was depressed and tired all the time and 
struggled with a lack of concentration and memory. Because of this, she could end 
up jeopardising and losing her job. This is not an unrealistic fear. Literature 
confirmed this by saying that there can be the possibility of potential job loss due 
to the demands of the medical treatment and on-going side effects of treatment 
(Spelten et al., 2003). Although she worked the entire time while she received her 
treatment, there were times that it was hard to “juggle” the work and the chemo 
and the side-effects. She said she tried to go in every day, even the days that she 
felt ill, so that she could stay busy and be surrounded by people. Literature 
explained that functioning properly in your job, represents normality and routine 
after your illness and treatment and symbolises hope for the future while providing 
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access to social support, medical insurance and financial resources (Kennedey et 
al., 2007; Maunsell et al., 2007; Shewbridge et al., 2012).   
Patient V worked right through her chemotherapy and always tried to schedule her 
chemotherapy on a Friday so that she didn’t need to take off from work. The 
longest that she took off was the six weeks after the hysterectomy. She said:  
“I was constantly scared that my energy and concentration would fail me. …I could 
see that especially my energy levels and concentration and memory were not the 
same, but have tried to work around it”.   
Three months after the last treatment she reported back during one of our 
therapeutic sessions that her tiredness and concentration was getting better and 
that she could keep up with her demanding job:      
“...this makes me feel worthy as a worker again”, but six months later, with our last 
therapeutic session, she complained that she struggled again with concentration 
and lack of short term memory:    
“…it is a serious problem for me, I cannot remember things and it affects my 
marriage and work. ...I work with figures and have a responsible job and am 
scared that I will make mistakes and can lose my job. …I need the salary and 
cannot afford to lose it”.   
Munir and colleagues (2010) confirmed this statement, indicating that women 
treated for breast cancer reported experiencing cognitive impairments and often 
struggled with short-term memory that affects their working life. In spite of Patients 
I, IV and V’s fear of not being able to do their work properly or losing their work, 
there is evidence that cancer survivors are still productive and perform well in the 
workplace during and after treatment (Bradley & Bednarek, 2002).    
I have observed that the breast cancer patients in this study found it important to 
be able to continue with their careers during their treatments and strive to do their 
jobs properly in spite of treatment side-effects that directly influence their jobs or 
ability to do their jobs. The reasons seem to be on the one hand to ensure them 
that they don’t lose their jobs and with it their financial security, but also to “keep 
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them in the loop of normality” and help them to focus on something else than their 
illness. It seems that more physical job requirements (as with Patient III) are 
harder to adhere to as a more passive “desk” job.  
Another reason I found for wanting to go to work as often as possible was the 
support that they got from their colleagues, which they all found very lenient and 
accommodating, making it possible for them to continue working throughout their  
treatments. The support and acceptance from their colleagues gave them courage 
to carry on with their “normal” lives during their treatments. Literature confirms that 
the support from employers in facilitating the patient to return to the workplace 
after treatment has an overall effect on the cancer survivor (Bouknight et al., 2006; 
Holgrem & Evanoff, 2007; Shewbridge et al., 2012).   
7.3.1.7  Social support: the family system   
Social support refers to help and encouragement which can be practical and/or 
emotional from family or friends that improve and boost the receiver’s self-esteem 
or provide stress-related interpersonal support and is a critical ingredient to 
physical and mental health when facing cancer care (Kim et al., 2011).   
Theme 9:  Effect of breast cancer on the family and marriage:   
According to Sutherland (1957) and Grassi (2013) understanding the cancer 
patient and her family is the foundation for a holistic development in cancer care 
and that both the patient and the family can benefit from psycho-oncology care 
(Haber et al., 1995). Stressful effects of breast cancer extends beyond the patient 
into the lives of their family members, making them second-order patients who 
respond to the strain of cancer as interdependent, emotional beings (Lethborg et 
al., 2003; Nicolas, 2013; Norhouse et al., 2005). With the diagnosis of cancer, as 
was seen in this study, families were launched into an unfamiliar environment 
where they often did not have the knowledge, either emotionally or 
psychologically, to absorb and integrate the illness into their lives and healthcare 
systems. Oncology teams are not always aware of the impact that the cancer has 
on the family milieu (Baider, 2008). Family members play a prominent role in the 
cancer patient’s life, from the acute stage of treatment, to the extended and 
permanent stage (Mullan, 1995).  
326 
 
Apart from the family angle, it is important to view cancer from a relationship 
perspective as well. The partner of the breast cancer patient in particular, will be 
critically affected by the diagnosis and treatment and according to literature, there 
is considerable proof that relationships can experience substantial stress during 
this crisis time (Manne & Badr, 2008; Nicolas, 2013; Sheppard & Ely, 2008; Walsh 
et al., 2005). The partner of a breast cancer patient has to cope with challenges 
such as worries about the potential loss of their life partner and providing 
emotional and practical support and therefore needs relevant information and 
support from the psychologist, as many will feel uncertain and at a loss about what 
to expect while their partner undergoes treatment (Dean, 2008; Harrow et al., 
2008).   
Patient II said: “...what got me through the diagnosis and the chemotherapy was 
the closeness and constant support of my whole family, they made sure that I was 
okay and that I ate properly every day. …I don’t know what I would have done 
without them, their persistent support and my belief and religion literally pulled me 
through the healing process.”   
She experienced good and strong support from her family from the very beginning, 
saying:    
“…this was the pattern we had before the cancer. ... we all spoke openly about my 
cancer; they also encouraged me to keep myself busy and to stay positive.”   
This patient had, during the course of the session, often commented on the 
support of her family, especially her husband and how it had strengthened her. 
She said that from her side she had, in the beginning with the start of the 
chemotherapy, often felt guilty about not being able to do for them what she was 
used to do before the chemo. Savard and colleagues (2005) confirm this by saying 
that cancer patients often feel like a burden to their family, no longer useful to 
them. Research has further demonstrated positive effects of social support on 
physical as well as psychological welfare of people suffering from chronic illness 
such as cancer and lower degrees of depression and other negative moods 
caused by physical illness, which was evident in this patient (Kim et al., 2010).   
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Patient III was the only patient who had experienced a severe lack of support both 
from her husband and children, especially in the beginning after the diagnosis of 
her breast cancer and during the chemotherapy. She strongly felt that her 
husband did not understand her emotions and fears and didn’t support her the 
way she felt he should have, saying:   
“...for a while I resented him for not supporting and trying to understand me 
better.” She was also very disappointed in her children for not making more effort 
to support her and help her with practical matters during her treatment saying:  
“...I lay it at the door of our poor relationships before the cancer. …we as a family 
don’t have good communication skills and haven’t spoken of the cancer yet and I 
feel I need to talk to them about it. ...I am worried about the absence of my 
children in my life. ...I need them”.   
She has asked if it was possible to see her husband and explain to him her 
emotions and what she was going through. It appears that the lack of emotional 
support and communication has increasing negative effects on a person’s health 
and survival and aggravate psychological distress and decrease marital 
satisfaction and that supportive relationships are important for well-being when 
under stress (Hordern, & Currow, 2003; Milbury & Badr, 2013; Murray, 2010). 
Later through the course of her treatment and therapeutic sessions, the 
relationships between her and the children and her husband improved. Her 
feedback was:  
“...with my surgery I was so stressed and my husband has supported me very 
well. ...for the first time me and my husband had a much better relationship with 
each other and we spoke more about our emotions. ...I feel more understood by 
him. ...the one positive thing about the cancer is the better relationship between 
me and my husband.”   
Both Patients I and V, who had young children at home, were worried about the 
effects that their cancer had on their families and especially their children, 
worrying excessively about leaving their children behind and feeling guilty about 
not spending enough time with their children.    
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Patient I said “I was not able to do my everyday tasks for my husband and children 
on the days that I felt sick and tired. ...my children have busy school and sport 
schedules and I was not actively involved with them. Although I was at home 
during the treatment, I felt less available for my children and it made me feel 
hopeless not having enough energy to do anything at all”.  
She realised that the cancer affected the whole family and that they had to work 
together to accommodate the long term effects of the cancer. As a family they 
were very supportive of each other and engaged in a lot of activities together. She 
also said:   
“My husband was very supportive of me during the entire time of the treatment 
and we were both very focused on the practical workings of the household to 
ensure that the effect on the children were minimal”. She experienced that her 
husband often felt hopeless for not being able to help her with her illness and 
emotional struggle, not knowing how to do it. She said:   
“I had an extremely good support system in my husband and mother and close 
friends, they supported me very well during the treatment and now. ...it was the 
one thing that kept me going”.   
Patient IV stated that she was supported from the beginning by her family and life 
partner. She said that because of her severe depression, although the support 
was there from friends and family, she had isolated herself and would rather have 
been by herself than with other people, saying further:   
“Because I am such an independent person, the fact that I was so tired has 
confronted me to be in the position to have needed the assistance of other people. 
… this ‘dependency’ on other people made me feel vulnerable.” In spite of her 
depression and feelings of isolation, she also said that the constant support from 
her partner was what kept her going.   
Psychological research support this by stating that people are often reluctant to 
ask for help even when it’s needed and agrees that people in need of support 
underestimate the willingness of others to help (Flynn& Lake, 2008; Skeels et al.,  
2010).   
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Patient V confirmed that her fear of dying revolved around her child and that every 
decision that she made was with him in mind.   
This extreme fear of young mothers are underlined in the literature where it has 
been proposed that one of the reasons young mothers with breast cancer 
experience more overall fear for recurrence and dying, is that of leaving their 
young children behind (Connell et al., 2006; Lebel et al., 2013). During her 
treatment she had been only a little involved in her child’s day to day caretaking, 
leaving her with a lot of feelings of guilt and sadness. She said even then, after the 
treatment she could not keep up with him because of her on-going tiredness. It 
worried her that he was still not back to where he was before her diagnosis in 
terms of his behaviour and developmental tasks. There was a clear indication that 
his behaviour had regressed during the time that she was ill. She said: 
“Just thinking or talking about my son makes me depressed and sad.”  
Literature states that parents with young children in particular, experience more 
intense and invasive fears and guilt feelings about potentially abandoning their 
children than that of older patients. They also have more family responsibilities 
therefore they are more likely to report that their illness and treatment interfere 
with important roles and activities than might be the case in older women 
(Brennan, 2001; Ganz et al., 2002; Lebel et al., 2013; Rauch & Muriel, 2004).   
Patient V experienced that her and her husband’s perceptions and expectations of 
support was completely different, saying:   
“…my mother was more involved and supportive during the whole treatment 
process than he was.” She felt that he didn’t make an effort to try to understand 
the cancer or her emotions and she felt that the cancer was standing between 
them, stating:   
“...if we fight now he would refer back to that period when I was busy with my 
treatment, blaming me that I was irritable and abrupt toward him and my son 
…during that period and even now we don’t discuss the cancer with each other.”   
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She said that even after the treatment they were not at a good place with each 
other and that she felt resentful towards him. Beecham and colleagues (2005) 
support this in saying that only through open communication can the family make 
plans that accommodate the likely course of the illness and make the most of the 
situation. She said her mother and grand-mother was a big emotional support for 
her during her whole life and especially during the cancer and cancer treatment 
and that she relied heavily on them.   
7.3.1.8 From breast cancer patient to breast cancer survivor:   
Theme 10: Breast cancer as a chronic disease: the patients’ understanding 
of it:  
Cancer, like most chronic illnesses, carries a high risk for emotional- and sexual 
dysfunctions due to chronic symptoms like fatigue, neuropathic pain, cognitive 
impairment and menopause (Backonja, 2003; Carpenter et al., 2009; Nusbaum, 
Hamilton & Lenahan, 2003; Richards, Bertolotti, Doss & McCullagh, 2011). After 
the end of active treatment the survivor becomes aware of and learns to live with 
the chronic side effects of the illness and its treatment and attempts to adapt to the 
long-term changes and demands needed for adjustment to chronic illness 
(Anderson, 1992; Livneh, 2001).  
Patients II and III were both still busy with their treatment (radiation therapy) when 
we ended our sessions, but understood through our conversations that the side-
effects of the surgery and the chemotherapy can continue well into survivorship.  
Both of them were still experiencing prominent side-effects of their chemotherapy 
(pins and needles in their feet and hands) and severe tiredness and chemo fog.   
Patients I, IV and V experienced the chronicity of their breast cancer in the 
prolonged side-effects of their chemotherapy and surgery and the anticipation 
anxiety before follow-up tests and consultations with their oncologists.   
Patient I said:  
“I never thought about breast cancer as a chronic disease. ...I only started to 
understand the treatment’s side-effects better after the cancer treatment, living 
with it on a daily basis. …I think that having understood it better and in a more 
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knowledgeable framework, I could have coped better with the whole journey, I now 
realise that for the rest of my life I will be confronted with the ‘aftermath’ of cancer 
and although the cancer is in remission the ‘cancer file’ in my brain will never be 
deleted...the psychology of the cancer will always stay with me in the form of the 
permanent changes of my body and sexuality.”   
Patient IV felt that after the treatment her anxiety was worse than during the actual 
treatment phase where she suffered both from depression and anxiety, saying: 
“…I am still experiencing side-effects of the cancer treatment. ...I wasn’t prepared 
or expecting it to last so long after the end of the treatment...currently the tiredness 
is the worst.   
Patient V experienced symptoms of depression only after the treatment while in 
the remission phase:  
“…I feel very badly depressed now, because of our marital problems because of 
my cancer.”  
She experienced the tiredness, lack of short term memory and lack of 
concentration and sexual dysfunction as the worst on-going side-effects of her 
cancer. She understood that the chronicity of the illness would carry on. She 
realised that apart from the treatment side-effects using the hormone therapy 
medication for the next 5 years would entail ‘living’ the active side-effects from 
that. She said:  
“…I will have to go for lifelong follow ups and tests that will make me anxious and 
scared.”  
According to literature, breast cancer survivors often report that they were 
unprepared for the complex rehabilitation process and persistent symptoms of 
depression or anxiety after the end of their treatment (Brem & Kumar, 2011; 
Burgess et al., 2005; Dolbeault et al., 2009; Reyes-Gibby et al., 2012). 
7.3.2  The shift from cancer patient to being a “normal” person again  
Although the end of treatment seems like a time for celebration, which it is, it is 
also a stage full of its own distresses and challenges such as not knowing what to 
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expect after the end of treatment, what kind of follow-ups were expected of them 
and which symptoms are important to monitor (American Cancer Society, 2010; 
Ganz et al., 2004; Golden-Kreutz et al., 2005; Henselmans et al., 2010; Stanton, 
2012). The end of cancer treatment can also cause acute anxiety to the breast 
cancer survivor because of diminished contact with their oncologists and clinical 
specialists, which can leave a person with a feeling of loss to the ready access of 
the health care system and the safety net it provides. This often leads to feelings 
of vulnerability and of not feeling in control (Anderson, 1992; Ganz et al., 2004; 
Golden-Kreutz et al., 2005; Stanton, 2012). This end of treatment anxiety was 
clearly seen in the sessions with the three patients who were already finished with 
their treatment for a while.   
Patient I supported this by saying:  
“...after the end of my treatment when I thought I would be glad and happy, the 
anxiety was bad again …the shift from a cancer patient to ‘nothing’ was difficult for 
me … all of a sudden I felt vulnerable and unsure of myself.”   
Patient IV said:    
“…I didn’t know how to proceed from a cancer patient to a ‘normal’ life again, I got 
so used to the cancer schedule and the interaction with the oncology team and the 
co-cancer patients, it made me feel safe and secure ...I don’t know exactly where I 
belong now, I am in remission, yet I still have physical symptoms of the treatment 
and I have to go back for a follow-up session next month. …it feels as if I am still 
busy with cancer.”   
Patient V said it felt as if her cancer experience was something of the past for her 
family and friends,  
“...but I still need to talk about my cancer experience from time to time to 
somebody but I don’t think they would understand this need of me to talk about the 
cancer after everything is finished and I am cancer-free. ...I can understand that 
‘outside’ people cannot understand the change from a cancer patient to a normal 
person again.”   
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This is underlined in literature stating that family and friends can assume at the 
end of the treatment that the cancer experience has been resolved and that their 
involvement and support is less needed resulting in the cancer survivor feeling 
abandoned and lonely (American Cancer Society, 2010; Burgess et al., 2005; 
Dolbeault et al., 2008; Henselmans et al., 2010). Certain authors even suggested 
that breast cancer survivors are in their highest need of interpersonal support after 
completing their treatment but often find it unavailable (Ganz et al., 2004; Stanton, 
2012; Wurtzen, 2013). Ganz and co-workers (2004) summarised this by saying 
that patients are often overwhelmed and disappointed in themselves to still 
experience chemotherapy-related and mood problems months after the end of 
their treatment, especially if they felt that they have coped well during the 
treatment.  
7.4  CATEGORIES AND THEMES: INDIVIDUAL PSYCHO-
ONCOLOGIC INTERVENTIONS  
Individual therapy was already defined in the literature chapter as a formal process 
of interaction between a trained therapist (in this case the researcher) and a 
patient (the selected breast cancer patient and participant) working in a safe and 
confidential environment to enhance the psychological well-being of the patient 
(Wedding, 2010). I have chosen individual treatment sessions because it allows 
for the breast cancer patients’ unique physical and psychological needs and is 
suitable for the cognitive–behavioural techniques that were used in this study 
(Beltman et al., 2010; Savard et al., 2005).    
7.4.1  Presentation and interpretation of the categories and themes 
The analysis of the individual psycho-oncologic interventions will now be 
presented into core categories and then into themes 11 to 21 in Table 7.3.   
The psycho-therapeutic interventions and process of Table 7.3 will be discussed 
below with a distinction between psycho-therapy and sex therapy interventions. 
There will also again be a distinction between Patients II and III who were still 
active with their cancer treatment during the therapeutic sessions and which will 
be discussed together and Patients I, IV and V who were already in remission and 
will also be discussed together.     
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Table 7.3: Categories and Themes of the Psycho-Therapeutic Interventions with 
Breast Cancer Patients: 
CATEGORIES THEMES 
Emotional catharsis Theme 11: Emotional Expression:  allowing, 
acknowledging and understanding their 
negative emotions and thoughts and 
encouragement to talk about it in therapy.    
Psycho-education Theme 12: The power of knowledge: 
Explaining breast cancer treatment related 
phenomena, including depression, anxiety, 
fatigue and pain. 
 Normalizing emotional experiences 
 Changing from ‘cancer patient’ to a ‘post 
cancer status quo’ and coping with 
permanent changes regarding the chronicity 
of breast cancer.     
Cognitive and behavioural 
therapy 
Theme 13: The Acceptance and Adaptation 
process 
Sex therapy:  Theme 14: Different Cognitive and  
Behavioural techniques   
Talking about sex   Theme 15: Talking about sex: Why cancer 
patients don’t talk to their oncologists about 
their sexual issues and where and to whom 
can they talk about it:   
Sex therapy:    
psycho-education and 
behaviour and cognitive 
techniques 
Theme 16: Explaining and educating the 
most prevalent and relevant sexual matters:  
 Menopause and low libido and the impact on 
sexual functioning 
 Sexual self-esteem and body image 
 Behavioural changes and cognitive 
restructuring 
Couples and sex therapy Theme 17: Couple’s Intervention 
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 Sexual and Emotional issues 
 Communication 
 Long term changes 
Patient feedback (general):    
 
END OF THERAPY 
Theme 18: Patient’s feedback from the 
therapeutic sessions.   
 
7.4.1.1  EMOTIONAL CATHARSIS 
It is important for therapists to support and encourage direct expression of 
negative emotions like fear, anger and sadness in a safe and empathetic 
environment. This will not only lead to releasing of unexpressed emotions, but will 
allow patients to adapt healthier thought processes and diminish the risk of 
psychopathology (Giese-Davist et al., 2005; Stanton et al., 2000; Thornton et al., 
2014; Yoo et al., 2014).   
Theme 11: Emotional expression - allowing, acknowledging and 
understanding you’re patient’s negative emotions and thoughts and 
encouragement to talk about it in therapy:    
In the light of the fact that emotional distress has lately been defined as the sixth 
vital sign in cancer care, and that it plays a dynamic role in treatment outcome, 
various authors have verified that emotional expression during therapy can 
positively affect a patient’s psychological well-being.  Emotional expression allow 
the breast cancer patients to be aware of their feelings and cognitions, deal with it 
and become aware of choices they can make to lessen some of their distress 
(Conley et al., 2016; Drageset et al., 2010; Giese-Davis et al., Low, et al., 2006; 
Pinquart & Duberstein, 2010). Thinking, talking and writing about emotions can 
make emotional experience less intensive and invasive and can increase insight 
into why emotions are experienced and how their effects can be reduce (de Ridder 
et al., 2008). Working with breast cancer patients, I supported the importance of 
implementing emotional catharsis as will be described below.   
Patients I, IV and V: who were finished with their oncology treatments, and who 
did not share much of their emotions with their oncologists during their diagnosis 
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and treatment period, confirmed during their sessions a huge relief in sharing their 
emotional experiences.   
Patient I said that she already experienced emotional relief in answering the 
questions during the first two sessions:   
“...remembering all the emotions, I still have a very prominent need to talk about 
my experience and emotions regarding the cancer treatment and how my family 
has experienced it.”   
She said that she did not speak a lot about her emotions during the treatment 
either to her oncologist or family and that she regretted that she was not more 
forthcoming with her emotional experiences:   
“...I think that I would have dealt better with my emotions if I have shared it more. 
...I appreciate this opportunity to talk freely to somebody with knowledge about the 
psychological side of my cancer it already makes me feel better and more normal. 
…I am looking forward to having therapeutic sessions with you regarding my 
issues around the cancer and my functioning now.”  
She said that, especially talking about her fear of death, which she did not talk at 
all about at the time, made her feel much lighter: 
“...talking about death and my fear of dying, without feeling guilty or unthankful, 
gives me huge relief.” Drageset and colleagues (2011) support this by saying that 
even to some degree, allowing you to experience emotions and to share it is a 
very helpful mechanism of coping. This patient said that if she had the opportunity 
to have spoken to a psychologist during her treatment:  
“...it would have saved me a lot of agony if I could learn about the cancer process 
and had the opportunity to vent my emotions.”   
Patient IV was very emotional during the first three sessions and eager to talk 
about how she felt. During our first session she said that she was ready to talk 
about how she felt during her cancer period and with very little prompting she 
shared her emotions and also showed a lot of emotion during the sessions. In the 
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process of emotional catharsis she provided me with deep and rich appropriate 
information. During the first session she said:   
“I feel much more emotional now after the treatment has ended than during the 
treatment and I cannot understand why I am feeling so emotional. ...during the 
treatment I didn’t have much time to dwell on my emotions for there was no time 
between the chemo sessions and the blood draw sessions and appointments with 
the oncologist and going back and forth to work to have focused on my depression 
and anxiety, but I am crying a lot lately and feeling very depressed and anxious.”  
She said because she was feeling so depressed during her treatment she would 
have liked to talked about her emotions, but because of her lack of finances she 
couldn’t afford to see a psychologist. She said:   
“I need to talk about my fears. …I had never been in a similar situation before and 
I felt a lack of specific skills to deal with my cancer.”   
I explained to her that talking freely about her emotions will make her feel more in 
control and less of a victim and that expression of emotions as a coping 
mechanism can decrease her emotional distress and restore her psycho-
physiological balance (de Ridder et al., 2008; Stanton et al., 2000). She 
understood that through the ability of expressing emotions surrounding her cancer 
experience, she would be able to effectively adjust to her new “post-cancer” status 
quo (Stanton et al., 2000).   
Patient V: The first and second sessions with her were predominantly emotional 
catharsis, she said in the beginning:   
“...I really need to talk about how I felt when I was diagnosed with cancer and 
throughout my treatment, especially now after the treatment was successful and I 
am in remission. I really thought that once I would be finished I will automatically 
feel better, but it is not the case.”   
She said after her cancer diagnosis and during her treatment she talked a lot 
about her cancer to the people around her, saying that it was her way of dealing 
with her emotions, but saying that:   
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“I now need to talk to a professional person who will understand my situation and 
my emotions and give me some advice as to what to do now, not just for me but 
also what to do with my child and husband.”  
Barak and colleagues (2008) stated in the literature that sharing negative feelings 
with others has a tremendous relieving effect and can initiate a feeling of personal 
empowerment and improved self-confidence. One of her prominent emotions 
throughout her illness was that of guilt feelings regarding her husband and child, 
and she was now given the time to talk about it and to put it into the perspective of 
her illness. I explained these guilt feelings to her in the framework that mothers 
with cancer often lacked the ability or the strength to maintain parental roles due to 
factors such as severe side-effects, and then feel guilty because they still want to 
meet the needs of their children. They might even feel that there are societal 
demands on them as a woman to continue to take responsibility for child care and 
housekeeping during their illness, which further contributes to guilt feelings 
(Semple & McCance, 2010).   
Patients II and III who were still busy with their treatments, had the opportunity to 
talk about their emotions regarding the cancer and anything else they wanted to 
talk about during the therapeutic sessions. They were both eager to share their 
feelings and thoughts especially regarding their chemotherapy and emerging 
surgery and spoke about it spontaneously. Their fears and anticipation of their 
surgery and their urgency to speak about it was imminent during our sessions. 
They explained in detail how the chemotherapy affected them biologically in terms 
of specific side-effects and emotionally of how it made them feel.  
Patient II spoke extensively about the persistent tiredness from the chemotherapy 
which was her biggest concern and caused a lot of anxiety, saying it affected her 
emotional health and psyche the most. When asked about her current emotions 
during our third session, she said:  
“The mere fact that we speak every three weeks gives me the courage to carry on 
knowing that I can vent my feelings to somebody that understands the process of 
chemotherapy and somebody that is outside of my family. ...Speaking about the 
cancer and getting information about it makes it less unfamiliar and scary for me.”   
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We talked about the importance for her to acknowledge her negative thoughts and 
worries and to allow herself to “live” through it, speak about it and put it into a 
realistic framework, such as her illness and treatment. I have encouraged her to 
speak to her oncologist regarding the cancer and chemotherapy and to ask him 
questions about matters that are unclear to her after she complained about not 
being able to talk to her oncologist and clarify certain things with him. Schlatter 
and Cameron (2010) strongly emphasize that if the breast cancer patient does not 
reveal the true severity of her symptoms to the medical staff and support system, 
they then may not receive sufficient advice or assistance in using symptom control 
measures (e.g. medications, advice and psychotherapy).    
Patient III immediately started by talking about her experience with her cancer 
during the first session, saying:  
“I was so anxious when I heard that I had breast cancer and I feel so depressed at 
the moment.”   
She said that she needed somebody to talk to but she and her husband was not 
on good terms with each other during the time of her diagnosis and neither was 
she and the children. I gave her the opportunity to voice her emotions concerning 
the relationship with her daughter and the hardship that it was causing her. She 
talked freely about her marriage and the lack of emotional support from her 
husband and talked at length about their financial worries. I explained to her that 
by talking about something that is pressing on you for a long time can be a healing 
experience in itself (the patient said that she was not somebody who spoke easily 
about how she felt). She said she was very glad to be able to talk about her 
feelings regarding the cancer and also her other personal issues. Although the 
expression of negative emotions had long been considered important for 
psychological wellbeing, some cancer patients are scared that feeling ‘too deep’ 
and sharing their deepest emotional experiences might lead to weakness and self-
pity and that other people might look at them in that light (Lieberman & Goldstein, 
2006; Linstrom et al., 2010). The patient was encouraged to talk about her past, 
especially her relationship with her daughter because by not dealing with it, it 
could prevent her from dealing effectively with her cancer. I explained the 
importance of talking about her emotions and to acknowledge it and that although 
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she can deal with her “old” issues and emotions now, she should also focus on the 
cancer and current emotions and needs regarding that. She said:   
“The only place that I can talk about my emotions is during our sessions.”   
I noticed during our sessions that the patients found it hard, for various reasons, to 
speak to their oncologists about their personal experiences and emotions. Studies 
have documented that oncologists, like other medical providers, often do not 
respond empathically or even recognised patient distress even when it is 
expressed (Dean & Street, 2014; Fallowfield et al., 2001; Merckaert, Libert, & 
Razavi, 2005; Zimmerman et al., 2007).  
To summarise emotional catharsis, Dean and Street (2014) confirmed in their 
three stage model that acknowledgement and exploring emotions have some 
therapeutic value for the cancer patient. This lessens emotional suffering and 
responding empathetically to negative emotions in therapy can reduce a patient’s 
distress and improve their quality of life. This was also supported by Zachariae 
and co-workers (2003) and Barak and colleagues (2008).   
 
 
 
Figure 7.1:  The three stage model of recognition and exploration of emotions 
(Dean & Street, 2014).   
7.4.1.2  PSYCHO-EDUCATION 
Lim and colleagues (2011) specified that in practise the first step before using 
psycho-education as an intervention technique is to give the patient enough time 
to talk about her cancer experience and to give her a chance to clarify what she 
understood about her disease and treatment. This is also the time for the patient 
to express her emotions regarding her cancer experience (as discussed in 
emotional catharsis) to determine what her needs are in terms of the forward 
therapeutic process. Psycho-education, in combination with emotional expression 
and support and cognitive-behavioural therapy, is one of the most frequently used 
psychotherapeutic interventions in treating breast cancer patients through 
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teaching them about their cancer and cancer treatment (Donker, 2009; Fors et al., 
2010; Spiegel & Rodrigues, 2008).  
As psycho-therapist I put high repute on psycho-education in combination with 
emotional expression and CBT as a therapeutic intervention tool working with 
breast cancer patients and am a sturdy supporter of the concept of ‘knowledge 
gives power’. Barak and colleagues (2008) voiced this theorem by saying that a 
sense of personal empowerment can be achieved by the cancer patient through 
acquiring cancer related information and knowledge through their oncology team, 
which will give them a better understanding of what they are facing and more 
knowledge of how to handle it.   
Theme 12: “The power of knowledge”- normalizing and explaining breast 
cancer treatment related phenomena:  
In practise, psycho-education means giving information to the breast cancer 
patient about her disease and treatment (Donker, 2009; Fors et al., 2010; Spiegel 
& Rodrigues, 2008), which will enable her to become involved in making active 
choices in her treatment process and to understand her own experiences better 
(Barak et al., 2008). Giving your patient adequate information in their present 
situation, can give her a sense of control over her situation and will allow her to 
process the cancer in a less negative way and avoid dwelling on problems that 
might arise (Loiselle et al., 2006; Rees & Bath, 2000). Greeff (2008) and Dorrepaal 
and colleagues (2012) state very clearly that an informed cancer patient is able to 
ask relevant questions concerning her illness and treatment, not just to make 
certain treatment decisions, but also in attaining a sense of cognitive mastery and 
control.  
The mere knowledge that a percentage of all breast cancer patients will develop 
depression and/or anxiety during their cancer journey can bring a certain amount 
of relief to the patient when experiencing these conditions (Brem & Kumar, 2011; 
Spiegel & Rodrigues, 2008). By acknowledging a patient’s fears and anxiety and 
explaining the “normality” of these emotions during the cancer journey, can make 
the patient feel less threatened by her anxious and depressive thoughts and 
contribute to her feeling validated by being told that their emotional reactions were 
normal in her specific situation. Normalization of negative emotions and thoughts 
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are seen as a benefit in its own right and as a therapist, I support this concept and 
make use of it continuously during the therapeutic process when working with 
breast cancer patients (Nekolaichuk et al., 2012).    
I experienced that both Patients II and III benefitted a lot from psycho-education by 
step-by-step learning about their cancer treatment and their emotional and 
biological experiences. I had the opportunity to explain to them what they could 
expect of their chemotherapy and all the relevant side-effects as they went along, 
for instance the difference between the “Red Devil” and Taxol, the two types of 
chemo that they received and their different side-effects. They were given enough 
time during their sessions to express their emotions regarding their experience of 
the chemo first, and then they were provided with relevant information of their 
present experiences and questions. This is one of the aims of psycho-education, 
to be able to give the patient a sense of cognitive mastery by explaining their 
symptoms (Dorrepaal et al, 2012). Both of them confirmed after every session that 
they understood what was happening to them physically and biologically and were 
able to put their current and active chemo-related symptoms immediately in the 
cancer treatment framework with plans of how to accommodate it. By explaining 
the side-effects of the chemotherapy through psycho-education, (as they 
experienced it) prepared them for the treatment and  prevent unnecessary anxiety 
and gave them a better understanding of what they were facing with more 
knowledge of how to handle it (Barak et al., 2008; Jacobsen & Jim, 2008; 
McQuellon & Danhauer et al., 2006; Vahdaninia et al., 2010).   
Patient II experienced severe tiredness as the chemotherapy went on that caused 
her a lot of anxiety and she strongly felt that the tiredness affected her emotional 
wellbeing and level of functioning and was the main topic of our sessions during 
the chemotherapy. The aim of psycho-education in combination with behavioural 
techniques with acute fatigue is to prepare the breast cancer patient with 
knowledge about her current fatigue and its interference with function and possible 
handling mechanisms. It was explained to her that chemo-related fatigue is a very 
common and prominent side-effect of chemotherapy and that it can be relentless 
and persistent and can make physical action difficult and slow, hence her struggle 
to do her house chores. Literature highlighted the notion that fatigue can be 
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particularly acute in the first few months after diagnosis and can affect the 
patients’ life through changes in her ability to function on daily activities such as 
work and relationships (Fernando, 2001; Johns et al., 2015; Sohl et al., 2014). I 
explained to her the importance of understanding her own unique pattern of 
tiredness, e.g. which day after chemo was she most tired and what time during the 
day was the worst. Through explaining chemo-related fatigue, I tried to put the 
patient’s experience of tiredness in context with her treatment and to normalize 
her feelings around it and the importance of accepting the tiredness as a passing 
element in her life, related to the treatment. I explained some practical ideas 
regarding her tiredness, for example that she can time manage her day around the 
fatigue and also involve her family into her “fatigue-schedule” (Bardwell, & Ancoli-
Israel, 2008). Examples are to rest on the bed with a book or watching TV without 
feeling guilty or thinking that she is lazy, but rather as a way of dealing effectively 
with her situation. In answer to that she said:   
“I can take up knitting again, it is passive, so I can rest while doing it. …I am 
already looking forward to it.”   
Another practical alternative that was discussed was to hire help once a week to 
release her from some of the household chores which made a lot of sense to her, 
she said:  
“I have never thought about it before and will discuss it with my husband.”  
It was explained to her that she could still do some of her house- and garden work, 
but at a different pace as before the cancer. She could develop a new way of 
doing her every day chores and if she changed her behaviour to rest more and 
conserve her energy, she could use it for more important activities like looking 
after herself, doing relaxing activities and spending quality time with her husband 
and children. We also discussed prioritising her activities, for instance she had to 
decide which activities were the most important in terms of quality of her life and 
do that first when her energy levels were higher and leave the rest either for 
somebody else, or do it when she felt less tired. As per definition, psycho-
education can be defined as a therapeutic focus in which patients can learn 
practical and positive emotional and behavioural skills through information and 
344 
 
knowledge to improve life adjustments (Authier, 1977; Berger et al., 2015; Fors et 
al., 2010). The patient said after talking about her tiredness:   
“…the information that you gave me about the side-effects makes it less unfamiliar 
and scary and worrying. …I understand it better.” 
By providing the breast cancer patient with knowledge about treatment related 
symptoms and the impact of fatigue, the development of serious psychiatric 
problems can be prevented and it is confirmed in the literature (Jenkins, 2015; 
Greeff, 2008; Husson et al., 2011).  
With the second round of chemotherapy, Patient II experienced pain as a side-
effect and because she was unprepared for it, it was a shock to her and it made 
her anxious and scared, she said:   
“…I did not know what was happening to my body.”   
We discussed that pain correlates positively with negative emotions such as 
anxiety and depression (Rainville, Bao, & Chrétien, 2005) and that pain can be a 
prominent side-effect of chemotherapy and often co-occurs with cancer-related 
fatigue (Brem & Kumar, 2011; Lueboonthavatchai, 2007; Vahdaninia et al., 2010; 
Wong-Kim and Bloom, 2005). It was pointed out that she must talk to her 
oncologist about her pain and her experience of the pain so that he could help her 
manage it through pain medication (Breivik et al., 2009).   
Patient III experienced both types of chemotherapy very negatively, especially the 
alopecia and nausea. I explained to her that the nickname of the chemotherapy 
‘Red Devil’ originated from the beetroot extract which is an ingredient of the 
chemo which is called Doxorubicin or Dox for short, hence the red colour and that 
some of the well-known side-effects are nausea and vomiting, complete alopecia 
and that urine, tears and sweat can turn pinkish red (Kapadia, Azuine, Subba Rao, 
Arai, Akira, & Harunkuni, 2011; Opperman, 2015).  
This patient experienced the same trauma as Patient II in terms of her second 
type of chemo as she was also not prepared for the vicious side-effects that she 
experienced. After giving the patient time to express her emotional experience of 
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the side-effects of the chemotherapy, I explained that the following Taxol side-
effects are common and that she could experience some of it; an increased risk 
for infection, hair loss, pain in the joints and muscles, numbness and tingling of the 
hands and feet, nausea and vomiting (usually mild) diarrhoea and mouth sores 
(http://www.breastcancer.org/treatment/druglist/taxol). This patient also 
experienced tiredness from the beginning saying:   
“…the tiredness is the worst; it is very bad and starts the same day of the chemo.”   
We discussed that fatigue is a very common and prominent side-effect of chemo 
therapy and that it can be very unpleasant and persistent and that she has to work 
around her own unique pattern of fatigue by accepting it and making provision for 
it and to make sure that she rests enough every day. This is supported in literature 
highlighting the notion that fatigue can be particularly acute in the first few months 
after diagnosis and during treatment and can affect the patients’ life through 
changes in her ability to function with daily activities such as work and 
relationships (Fernando, 2001; Johns et al., 2015; Sohl et al., 2014). The patient 
talked about still doing her house chores, but that her husband was helping her 
out with that and that it made a difference for her because then she could rest 
more.   
Patients II and III received their confirmed dates of their breast surgery during their 
last chemo session and both experienced high levels of fear and anxiety regarding 
the scheduled dates and procedures. They both said that they do not even feel 
like celebrating the end of their chemotherapy. I have explained to them that every 
treatment process (chemotherapy, radiation and surgery) generates its own fears 
and expectations and emotional- and physical outcomes and that every time that 
they start with a new treatment there will be new fears and uncertainties, as it is 
now with the surgery. Aviado-Langer (2014) emphasises that the pre-operative 
stage can be dominated by stressors such as waiting for the surgery and the 
pathology results and fear of the disease and the stage of disease, which all cause 
anticipation anxiety and uncertainty. The aim of the therapy here was to handle 
their acute fears and anxiety of the surgery first through emotional support and 
then the application of psycho-education to explain the procedures to follow, 
normalising and accepting of the stressful emotions and relaxation and breathing 
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exercises (Golden-Kreutz et al., 2005; Mulan, 1985; Hulbert-Williams, et al., 2011). 
It was also explained to them what anticipation anxiety is and that although this 
anxiety is for something that must still happen, it is still very real and draining, but 
also very natural (Berger et al., 2015; Lim et al., 2011). It was explained to them 
during therapy that when they were so anxious they should make a conscious 
effort to relax by doing relaxation and breathing exercises. I explained in full how 
deep breathing and muscle relaxation works. I told them to think about things that 
can relax them, or to get involved in activities like taking a walk with their 
husbands to divert their minds from extreme stressful thoughts. This was 
supported in literature that recommended psycho-education in combination with 
any form of behavioural psychotherapy in preparing patients for cancer treatment 
(Jacobsen & Jim, 2008; McQuellon & Danhauer, 2006; Vahdaninia et al., 2010).   
Patient III was also anxious about leaving her husband behind when she went to 
the hospital and the therapeutic input here was to explain that every situation had 
a practical and a bio-psychological side to attend to. The case with her husband 
was more on the practical side and therefore easier to manage and make plans 
for. The alternatives that were looked at were for example, her grown-up children 
or other family members could help him with tasks that he could not physically 
manage on his own. She could prepare and refrigerate his food in advance for the 
time that she would be in hospital and he could just warm it up in the evenings. 
She could also ask him what his expectations were for the period that she was in 
the hospital and they could both make plans for him to cope. The message here 
was, instead of just worrying about something, she could learn to look at it from 
different angles and make plans to either solve the problem or to make it more 
manageable. I experienced the patient more at peace with herself and relaxed 
about the situation at home after discussing the alternative plans for the surgery.  
On the day before the surgery, I gave the patient time to talk about her feelings 
regarding the surgery and although she was more at peace with the surgery she 
said:  
“…It is going to happen at last…”  
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She was also worried about her heart, she explained that the anaesthetist had 
detected a heart murmur and according to him, most probably related to the 
chemo, she had never previously had a heart problem. During the session we 
reinforced the normality of feeling anxious before surgery and instead of fighting 
the emotion, she should rather acknowledge and accommodate it. She was 
advised to focus on her breathing and relaxation during the day and to divert her 
focus on something else like going somewhere with her husband or participating in 
any activity that will take her focus away from thinking about the operation the 
whole time. At the end of the session she said:  
“I already feel better for talking to you and I will do something with my husband 
today not to think about tomorrow.”   
She also gave feedback from the previous session saying that she had prepared 
everything at home for him (as we have discussed) for the days that she would be 
in hospital saying:     
“…you know it makes me feel less guilty for going away and leaving him alone.”  
The patient said that the oncologist had explained that she would undergo 
radiation therapy after the surgery and she asked a lot of questions about how it 
worked. Her main concern regarding the radiation was whether her husband 
would be affected by the radiation rays and if she would be allowed to sleep next 
to him at night. I encouraged her to talk to her oncologist and to ask all her 
questions at her next appointment. I told her that she should not be afraid or 
ashamed to ask questions and that she would feel more in control if she knew 
what to expect. According to literature, inadequate communication causes distress 
for cancer patients. They often feel that they would like to have more information 
regarding their illness and treatment. More than what is provided and that giving 
information would give them a better understanding of what they are facing and 
more knowledge of how to handle it (Barak et al., 2008; Fallowfield & Jenkins, 
2015).   
After the surgery, the patient also complained about experiencing pain in her arm 
and she was waiting for an appointment with the oncologist to ask about the pain 
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and for treatment of it. I explained what lymphedema is and what she can expect 
of that.    
Patient I, who had been finished with her treatment for 15 months, said during the 
first session, that if she had the relevant knowledge about the cancer treatment 
and what she was going through it would have helped her to have been more 
prepared and equipped for the different stages of treatment. She said that the 
different emotions that she went through and didn’t understand, was never 
explained to her. This lack of information that the patient experienced was  
supported by Surbone and colleagues (2013) saying that therapists working with 
cancer patients need to explain the unpredictable and uncertain nature of breast 
cancer and its consequent existential uncertainty so that they can understand the 
picture of cancer and what they might expect of their cancer journey. The patient 
said:   
“…to me, cancer was such a new and completely unfamiliar situation. You need to 
learn new skills form somebody who has the necessary knowledge and know-how 
of how to handle yourself and your family and the situation.”   
This feedback from the patient confirmed the importance of psycho-education from 
the beginning of the cancer diagnosis. Psycho-education should provide 
information regarding specific areas that will give the patient a better 
understanding of what she is facing and prepare her for the treatment (Barak et 
al., 2008; Jacobson & Jim, 2008; Vahdaninia et al., 2010). She said she 
experienced that her fear and anxiety was worse after the end of the treatment 
when she thought that everything was supposed to be “back to normal.” I 
explained the pathogenesis of anxiety and depression in the context of cancer and 
the chemical impact it can have on the brain and body and the discomfort it can 
cause when left unattended. We discussed the importance of acknowledging and 
allowing herself to feel anxious without feeling guilty and to understand that cancer 
related anxiety and fear are not unrealistic, but in par with what literature says that 
a confrontation with a person’s own mortality can and most probably will cause 
acute psychological stress (Brem & Kumar, 2011; Spiegel & Rodrigues, 2008). 
Anticipation fear for follow-up examinations and their results and the uncertainty of 
the future in terms of recurrence, which is a reality in the post-cancer status quo, 
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was also discussed with the patient (Berger et al., 2015; Travado & Reis, 2013; 
2013; Vahdaninia et al., 2010). It was explained to her that a substantial number of 
breast cancer patients in their remission phase report a late increase in distress 
and psychological suffering, even developing depression and/or anxiety.  She 
understood that this occurrence is not an abnormal phenomenon and also fits in 
with her current experience and her presenting with a major depression and 
anxiety, (American Cancer Society, 2010; Brem & Kumar, 2011; Henselmans et 
al., 2010; Hopko et al., 2016). Ganz and co-workers (2004) explained that they 
found that patients are often astonished and disappointed in themselves for 
experiencing chemotherapy-related- and mood problems months after ending their 
treatment. The patient understood that a pre-morbid psychiatric history such as 
hers was a well-known risk factor in developing depression and/or anxiety during 
and after breast cancer and cancer treatment (Hill et al., 2010). Through psycho-
education the therapist had tried to put the patient’s experiences throughout her 
cancer treatment in perspective by explaining that there are a number of 
challenges during the period of diagnosis and the process of active treatment like 
treatment side-effects such as fatigue, pain, depression and insomnia which can 
be particularly acute in the first few months after the cancer diagnosis.  She also 
understood that this can affect a cancer patient’s life through changes in her ability 
to function in daily activities such as work and family- and social functioning, 
where she experienced a lot of changes and difficulties (Sohl et al., 2014). The 
patient voiced her guilt feelings regarding her absence in her children’s day to day 
functioning while she received her treatment.  It was explained to her that women 
with younger children with their accompanied demands and responsibilities, and 
with the extra time and energy it requires together with a busy cancer treatment 
schedule, tend to experience more psychological distress after the diagnosis of 
breast cancer (Lebel et al., 2013; Wong-Kim & Bloom, 2005). The patient 
understood that it was not abnormal to want to minimize disruption to her family 
life, to be strong for them and spend as much time as possible with them in order 
to still feel like a ‘good’ parent (Bilhult & Segesten, 2003; Simple & McCance, 
2010; Walsh & Avis, 2005). Therapists working with cancer need to understand 
that parents with cancer need support and guidance about how best to manage 
their family life during the acute treatment stage and address issues and 
challenges as a parent surviving cancer (Semple & McCance, 2010). Breast 
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cancer patients often struggle between being a good parent and to care for their 
children and their own need for care, especially during the acute phase of 
treatment and treatment side-effects (Semple & McCance, 2010), therapists needs 
to put this in perspective for them and provide them with knowledge on how to 
handle children of different ages and to enhance open communication about the 
cancer and carrying on with their functioning as a family.   
Patient IV had a very long history of depression and said that she tends to become 
easily depressed and anxious and noticed that while she was undergoing her 
treatment, especially chemotherapy, her symptoms of depression increased. The 
therapist explained to her that risk factors for depression during breast cancer can 
be due to the cancer or cancer treatment, but can also be related to her 
personality and relevant psychodynamics (Burgess et al., 2005; Reich et al., 
2007). A pre-morbid psychiatric history, as is the case with her, is also a well-
known risk factor in developing depression during and after breast cancer and 
cancer treatment Hill and co-workers (2010). In the framework of an existing 
propensity of developing depression, it was explained to her that there are a 
number of challenges to endure during the period of diagnosis and the process of 
active treatment, including treatment side-effects such as fatigue and pain, mood 
disorder and insomnia, all of which she experienced and didn’t know how to 
handle at the time (American Cancer Society, 2010; Brem & Kumar, 2011; 
Henselmans et al., 2010; Hopko et al., 2016). She answered by saying that: 
“I think that I would have been able to control my emotions better if I could have 
spoken to somebody regarding the cancer and my fear of developing depression 
again.”  
The fact that she realised that there was an increased possibility that she could 
develop depression and that she had phoned her psychiatrist to make an 
appointment to sort out her medication, showed me that she was capable of taking 
ownership and responsibility for her healing process. Although she would have 
liked to see a psychologist during her treatment, I told her that it was not too late 
now and that she could still learn new skills to handle herself and her “new” 
situation.  
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Because the patient’s depression had escalated throughout the first couple of 
sessions, I made use of psycho-education, constantly explaining her symptoms 
and experiences to her. This dealt with both her major depression and the side-
effects of the chemotherapy. I also explained that these ‘double’ symptoms could 
be quite overwhelming and that suicidal thoughts could also be present. I told her 
that we must be aware of it and deal with it if it exists. I explained to her that if she 
felt that she cannot cope anymore there are other alternatives when managing 
depression, for instance admittance to a hospital or clinic catering for mood 
disorders, changing her medication by the psychiatrist or increase the therapeutic 
sessions.     
Patient V only presented with symptoms of depression after she was finished with 
her treatment. Because she experienced such bad side-effects from the 
chemotherapy (especially the “Red Devil”) and the fact that she still experiences 
vivid pictures in her head, reliving the experiences often, and the influence that it 
has on her marriage and overall functioning, I used psycho-education to explain to 
her why she was experiencing acute emotional and biological symptoms after the 
end of her treatment. 
Therapists must understand that most people are unfamiliar with conditions like 
depression and anxiety and by explaining the different degrees of distress 
experienced at different times during their cancer journey, can give the patient the 
freedom and surety to concentrate on their cancer treatment and recovery instead 
of worrying over unfamiliar symptoms that they don’t understand (Berger et al., 
2015; Lim et al., 2011).   
It was explained to her what impact treatment side-effects such as nausea, 
vomiting, fatigue, depression and insomnia can have on a person’s functioning 
even after the treatment and especially on activities such as work and 
relationships (Sohl et al., 2014). She could relate to this information because she 
felt depressed about her losses and marital problems but admitted that she was 
not familiar with how depression works or why she suffered from it. The patient 
never had any assistance in receiving knowledge regarding the biological or 
emotional side-effects on her functioning during her treatment or the period after 
that.  
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She said it worried her that her energy levels were still very low and that she had 
problems with her short term memory and ability to concentrate. It was important 
that she realised that some symptoms could carry on for some time after treatment 
in different degrees, as in mood disorders and fatigue and by handling it effectively 
through skills she could prevent the development of serious psychiatric problems 
(Benjamin, 1995; Fallowfield & Jenkins, 2015; Greeff, 2008; Husson et al., 2011).  
I also emphasized that she should give herself time to heal and get back to a level 
of functioning that she would be satisfied with, but in the mean time she could use 
techniques to make life easier for her, (with her incapacitations) e.g. to work 
around her fatigue by taking more breaks to help with her concentration and to 
rest more. She could reserve her energy through prioritising her tasks, involving 
other people to help with certain chores and to do light exercises (Bardwell, & 
Ancoli-Israel, 2008).  She can also communicate with her colleagues about her 
work load and her ability to do her work and accept their support.   
In terms of her functioning with her child, where she still had a lot of guilt feelings, 
she should allow herself to look back at the time of treatment and ‘see’ that she 
was still involved in his life during that difficult period, even if it was more passive 
than before the cancer and allow herself to work through those emotions. Practical 
chanages with her child that she could implement were to ‘play’ with him without 
getting too tired, for example, instead of running around and playing with a ball, 
they could participate more in passive games like colouring in, playing hide-and-
seek in the house and reading or watching TV together. Because it was so 
important for her to be involved in her child’s life she could, by altering her actions 
and time with him in a more suitable way for her, prevent her from feeling guilty of 
not spending enough quality time with him. Literature support the struggle that 
young mothers have regarding their cancer treatment and fulfilling their role as 
mothers and the importance of guidance from professionals especially to 
understand and handle their feelings of guilt about not being a good parent 
(Semple & McCance, 2010). I explained to her that when someone is diagnosed 
with cancer it creates several problems for the family which add to the normal day 
to day challenges of family life.  It can be a difficult time for parents while they 
have to cope with a troublesome diagnosis and subsequent treatments, but also 
continuing to meet the needs of their children, or child as in her case (Semple & 
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McCance, 2010). We also talked about the importance of understanding that her 
role as mother was compromised because of the cancer, but it did not mean she 
was any less of a mother because of the cancer.  Having a young child can make 
the cancer experience worse and can be a further stressor for a mother because 
of the energy and time going into being a caregiver (Lebel et al., Wong-Kim & 
Bloom, 2005) and the fear of leaving a young child behind if you die.  The mere 
confrontation with your own mortality can also cause acute psychological stress 
(Brem & Kumar, 2011; Spiegel & Rodrigues, 2008).   
It was explained to her that it would help to accept the fact that there will be a 
difference between how she was before the cancer and her functioning then. That 
the way she was as a person, wife and mother before the cancer did not exist 
anymore and that there was a ‘new’ person, wife and mother at the other side of 
cancer, but that it is not necessarily a negative concept, just different, asking for 
new skills and adaptation (Baider et al., 2000; Surbone et al., 2010).   
It was explained to patients I, IV and V who all three suffered from depression and 
anxiety after the completion of their treatments (as long as two years after 
diagnosis) that distress in the re-entry phase might be a delayed psychological 
response to the chaotic and frenetic period of diagnosis and treatment.  It was 
further explained that once in a calmer period the cancer experience might finally 
start to sink in causing a delayed or belated increase in distress or even a 
diagnosis of depression or anxiety (Henselmans et al., 2010). To normalize this 
specific phenomenon seemed to me as a therapist, as one of the most adequate 
and able interventions helping the breast cancer survivor to cope with the re-entry 
phase of breast cancer (Ranchor, Wardle, Steptoe, Henselmans, Ormel, & 
Sanderman, 2010).  
 Changing from ‘cancer patient’ to a ‘post cancer status quo’ and 
coping with permanent changes and the chronicity of breast cancer  
The re-entry- or survival phase brings its own particular challenges for the breast 
cancer patient and there is evidence from recent studies that there are prominent 
problems related with the transition from being a cancer patient to being a cancer 
survivor (Dolbeault et al., 2009; Henselmans et al., 2010; Stanton et al., 2005). 
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This difficult transition is often the result of a lack of effective preparation for the 
re-entry phase by the health care professionals, leaving the cancer survivors in a 
stage of ‘limbo’, uninformed and underprepared (Stanton, 2012). Cook and 
colleagues (2015) feel that all cancer patients will benefit to undergo regular 
psychological assessment from diagnosis throughout the treatment process and 
into survivorship and to have access to psychological support to assist them not 
just during the treatment period, but also into survivorship. It will be valuable for 
the breast cancer survivor to have knowledge and insight in the fact that at the end 
of their treatment and at the beginning of their survivorship, celebration and fear 
and anticipation anxiety and even depression can all co-exist. Reasons for this 
challenging opposite emotions can be the sudden end of the visits to the 
oncologist and other clinical specialists, leaving the patient without her medical 
support system.  There exist also the continuous fear and anxiety that relates with 
future concerns such as treatment outcomes, recurrence of the cancer and the 
threat of death (Ganz et al., 2004; Golden-Kreutz et al., 2005; Kyranou et al., 
2014; Lebel et al., 2013; Stanton, 2012).  
Patient II and III were nearly finished with their radiotherapy (the last of the 
treatments) when we terminated our sessions and we discussed the fact that 
breast cancer is a chronic illness and that there will be a bridging time to go from 
breast cancer patient to a ‘normal’ person again and that it might take some time 
for them to get used to their ‘new’ status quo as a breast cancer survivor. I 
explained that they can never be the same again as before the cancer experience 
and that they will feel and think differently now and that even as part of a couple 
they will look differently at each other and life. This explanation is supported in the 
literature where authors such as Baider and colleagues (2000) and Surbone and 
colleagues (2010) said that the breast cancer patient and her family will benefit 
from knowledge that they can never return to their pre-illness status quo and that 
the only way to reach a successful overall functioning is through proper education 
about both the short-term and long-term impact of their illness. It was emphasised 
that these changes are not necessarily all negative but can all be part of personal 
growth. I have explained to them that although they are still busy with their 
treatment, it will be good for them to understand that there will also be a process 
to go through once they were finished with their treatment and in the next stage of 
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their cancer journey. This next stage is also known as the re-entry phase and that 
because the rush of the acute and very busy treatment are then over and it is a 
calmer period, the cancer experience might only start to sink in then and can 
cause a delayed shock reaction (Henselmans et al., 2010). I explained that this 
reaction(s) are not abnormal but they will be able to recognise it with the 
advantage of their therapeutic sessions and either use their new skills to handle 
and accommodate it, or they could seek help form a professional person. I also 
prepared them for a possibility that they might find a heightened need for 
continued interpersonal support after the treatment and perhaps find it unavailable 
(especially people outside the family circle), because family members and friends 
often expect that, after completion of the cancer treatment, the woman will be able 
to recommence all of her usual activities and responsibilities at her pre-cancer 
level of functioning, (Ganz et al., 2004; Stanton, 2012; Wurtzen, 2013).     
Patient I said:   
“…I have never thought about cancer or my cancer as a chronic disease…” 
I explained to her that post treatment cancer survivors often experience remaining 
and sometimes even lasting physical and psychological consequences of the 
treatment and may realise only then for the first time the chronicity of cancer, 
even, as in her case, when treatment was declared successful (Ganz et al., 2004; 
Haber et al., 1995). We discussed the concept of chronicity in terms of a lifelong 
process of going for follow up sessions to her oncologist and waiting for test 
results accompanied with anticipation anxiety.  We also discussed living with 
treatment side-effects such as a diminished memory and tiredness and a changed 
body and sexuality that are all daily reminders of her cancer. She understood that 
through relevant information and knowledge and learning new skills in terms of her 
thought processes and behaviour and to adapt and make peace with her new 
status quo she will be able to function on a high but different level again with a 
chronic disease such as breast cancer. The patient said: 
“…because I was so anxious and depressed at the end of my treatment, I have 
decided to go to a psychologist for therapy.”   
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I could give her reassurance that to many breast cancer patients, depression and 
anxiety can develop or become more serious after treatment or when already in 
remission which are supported from the literature saying that breast cancer 
survivors often report that they were unprepared for the complex rehabilitation 
process and persistent symptoms of depression or anxiety after the end of their 
treatment (Brem & Kumar, 2011; Burgess, et al., 2005; Dolbeault et al., 2009; 
Reyes-Gibby et al., 2012). The patient received this information very positively.    
Both Patient IV and Patient V experienced difficulties to adapt in ‘real life’ again 
after their cancer journey.  They experienced high levels of anticipation anxiety for 
their follow up sessions with their oncologists and waiting for their results. Patient 
V also experienced fear of recurrence of her illness and dying. Because of this, I 
have explained again what anticipation anxiety is and that it will be part of the 
chronicity of her illness and something that will need to be dealt with every time it 
surfaces (Berger et al., 2015; Lim et al., 2011). The role of emotional regulation in 
the process of adjustment to chronic illness where they will keep on 
acknowledging and dealing with their negative emotions surrounding chronic 
occurrences of their breast cancer (de Ridder et al., 2009) was explained to 
Patients IV and V.  Both of them, only realised then, after the completion of their 
treatment, the chronicity of their cancer, even in the face of successful treatment 
and remission (Ganz et al., 2004; Haber et al., 1995). They understood through 
the therapeutic sessions that returning from a ‘cancer patient’ back to a ‘normal 
person’ will take some effort and time (Dolbeault, et al., 2009; Henselmans et al., 
2010; Stanton et al., 2005). Patients I, IV and V were unprepared for the 
rehabilitation process and persistent symptoms of their depression and anxiety 
after the end of their treatment and were very thankful and ready to have received 
knowledge about this status quo and skills to handle it (Brem & Kumar, 2011; 
Burgess et al., 2005; Dolbeault et al., 2009; Reyes-Gibby et al., 2012).   
It was explained to the patients that although the end of their cancer treatment is a 
time for celebration, which it is, it is also a phase full of its own distresses and 
challenges.  I explained that the most mentioned problems during this phase could 
be the lingering adverse physical and emotional side-effects of the cancer 
treatments such as loss of physical stamina and fatigue, sleep disturbance, 
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cognitive problems and menopausal symptoms and worries about the risk and fear 
of recurrence, changing of psychosocial needs and the uncertainty of the future 
(American Cancer Society, 2010; Burgess et al., 2005; Dolbeault, et al, 2008; 
Ganz et al., 2004; Golden-Kreutz et al., 2005; Haber et al., 1995; Henselmans et 
al., 2010). Therefore the importance and aim of psycho-education in this stage is 
to clarify all of these symptoms and experiences for the cancer survivor (Greeff, 
2008; Hopko et al., 2008; Hulbert-Williams et al., 2011; McQuellon & Danhauer, 
2006).  
7.4.1.3  COGNITIVE AND BEHAVIOURAL THERAPEUTIC TECHNIQUES 
Cognitive and behavioural therapy with all its different components such as 
emotional expression, structured psycho-education, cognitive restructuring and 
behavioural activation have been shown to be effective for breast cancer patients 
because of their practical and applicable methods, it can be short-termed and is 
easily understood by most people (Armento et al., 2008; Carver, 2005; McQuellon 
& Danhauer, 2006; Hopko et al., 2008; Savard et al., 2005; Spiegel & Rodrigues, 
2008). Cognitive and behavioural techniques were the therapeutic preference of 
this study.   
Theme 13: The acceptance and adaptation process:   
Loss and grieve are experienced by many breast cancer patients as they cope 
with the shock of their diagnosis, deal with the side-effects of the cancer treatment 
and continuously battle with an unpredictable and uncertain future and even 
possible death.   Dealing with multiple losses can be a very prominent task faced 
by a person with a life threatening illness such as cancer (Kissane et al., 1997; 
Tacón, 2011; Mystakidou et al., 2008; van Heeringen et al., 1989). The aim of the 
therapeutic process here will then be to facilitate the patient’s grieving process by 
firstly acknowledging her losses and the seriousness of her situation within a safe 
and non-judgmental context and secondly to explain what a grieving process 
entails (Kübler-Ross, Kessler, & Shriver, 2014; Lee, 2008). I want to clarify here 
that I have not used the traditional grieving process of Kübler-Ross during 
therapeutic interventions, but has rather used emotional expression and 
acknowledgement of emotions, which were put in the framework of losses. In 
facilitating acceptance, it must be seen as part of an active grieving process (or 
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working through emotions). Successful acceptance and adaptation in the cancer 
framework will be reflected in the cancer patient’s capability to re-establish and 
manage her external environment and inner cognitions, feelings and behaviours 
(Kübler-Ross et al., 2014; Livneh, 2001). Successful adaptation is considered to 
be on-going and dynamic throughout cancer survivorship with cognitive 
restructuring of goals as the main mechanism of change (Brennan, 2001; Livneh, 
2001; Naus et al., 2009). 
Patient I explained that her biggest losses were her permanent adaptation to the 
chronicity of her illness, her hormonal changes, menopause, and body image and 
changed sexual functioning. The therapist emphasized here the permanent 
changes that breast cancer can cause but that she could adapt to these changes 
through conscious efforts to work through and acknowledge her losses and 
emotions and to learn new coping mechanisms for a new chronic situation.  
Literature explained this by saying that in the absence of awareness of the 
grieving process, it might end up being repressed which can affect adjustment to 
the illness and survivorship (Sarenmalm et al., 2009; Tacón, 2011). The patient 
said that:  
“…although I am in remission I have never allowed myself to work through any 
losses.”  
I explained to her that to work through losses, the losses must first be 
acknowledged by her and then working through the accompanied emotions 
(emotional expression) before she can let go of the loss or losses to get to the 
acceptance phase and making peace with it. The patient said her biggest 
challenge was to come to terms with the reality that there is no answer or 
explanation for her breast cancer and that she has to accept it and make peace 
with it, although she will never understand it or find an answer. Lee (2008) 
supported this by saying that cancer patients struggle with their illness because of 
the multitude and distressful present and future losses and changes and 
uncertainties and through letting go of their losses, they could ease their distress.   
She also experienced the changes that she had gone through, regarding her work, 
as a big loss. She had decided to scale down a lot on her working hours and 
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stress related elements and incorporate more time for activities that was more 
relaxing and beneficial for her health and relaxation.  She was also more mindful 
of situations that created stress and affected her mind and body and to either 
avoid it or handle it effectively. It was explained to her that accepting and adapting 
to a chronic illness is a long term process which takes time and skills to achieve.   
This was supported by Livneh (2001) stating that adaptation refers to the 
psychological processes that occur over time as the patient learns to cope, learn 
from and adapt to the multitude of changes which has been generated by the 
illness and its treatment.    
Patient IV explained that one of her biggest challenges was that of her constant 
lack of energy and short-term memory and the influence it had on her work. I 
emphasized that by putting too much pressure on herself to do her work perfectly 
all the time can also contribute to her depression and difficulty in adaptation to her 
slower functioning. To be able to adapt to her fatigue, she could learn to prioritise 
her activities and make use of practical behavioural techniques such as taking of 
time every day, even at work, to take a proper brake and rest so that she could 
preserve her energy to do things that she enjoyed and make her feel better and 
more positive which then will contribute to her quality of life (Nusbaum et al., 
2003). Because every patient experiences fatigue differently  recommendations for 
fatigue self-management will be personalized for suiting the patients unique 
personality, age, work- and social circumstances (Bardwell, & Ancoli-Israel, 2008; 
Berger et al., 2015). Because the patient was so emotional during the sessions 
(especially the first three) I have validated the importance for her to acknowledge 
her emotions and talk or write about it and to consciously engage in a grieving 
process or emotional exploration to mourn all her losses. It was explained to her 
that the cancer experience, losses and new adaptations are often only a reality 
after the cancer treatment and need to be recognised and worked through. We 
talked about facing her emotions regarding the loss of her breast and she said that 
she knew that she needed to face it in a proper way through talking about it and 
accepting it. Adaptation and subsequent coping are not static and can change 
during the course of the cancer treatment and therefore the oncology team must 
be aware of this and re-assess the cancer survivor for psychological distress over 
time (Naus et al., Little et al., 2002).  
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Patient V had continuous problems with lack of energy and short term memory 
which had incapacitated her general functioning and also her work functioning and 
caused a lot of anxiety and feelings of depression and uncertainty. Work was an 
important part of her life and she kept on comparing her work functioning then with 
how she had performed before the cancer. I again explained the principle of 
changing from ‘before’ the cancer to ‘after’ the cancer and that to be able to adapt 
to her next level of functioning within in the cancer framework it was important for 
her to accept the fact that there would be a difference between how she was 
before the cancer treatment and her functioning then. I have attempted to ease 
her negative feelings and reassured her that her fears and emotions regarding her 
changes and losses were justifiable in order to help her to let go of her losses and 
adapt to her new reality (Lee, 2008). The patient understood that, because of all 
her losses and multiple changes she went through, she could not be the same 
person again as before the cancer and could not look at life or herself as before 
the cancer (Baider et al., 2000; Surbone et al., 2010). It was also explained to her 
that some of her symptoms were acute and short-term and needed only short-term 
adaptation (e.g. tiredness and short-term memory) and that some symptoms were 
more permanent and needed permanent acceptance and adaptation (e.g. certain 
thought processes, menopause and hormonal changes). The feedback from the 
patient was that she understood that her level of functioning concerning her work 
(memory and energy) was only temporary, saying:   
“…it makes it less scary for me knowing this.”   
Another therapeutic aim was to talk about acceptance of life-long follow ups which 
was quite a stressor for the patient because of her fear for recurrence. I aimed to 
explain that the anxiousness that was linked with ‘for ever’ follow ups and tests 
and waiting for test results were ‘normal’ anxiety and by adapting to it she could 
learn to work with the anxiety instead of against it by allowing herself to be open to 
anxious thoughts and talk about how she felt. The acceptance and commitment 
therapy model actually encourage cancer patients to be open to whatever one is 
experiencing without resistance and to accept negative thoughts and feelings such 
as guilt and anxiety and that acceptance can be an important alternative to 
avoidance (Hayes et al. 2006; Hofmann et al., 2010; Masuda, 2008; Wetherell et 
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al., 2011). Fears and uncertainty about the illness and the future specifically, when 
not managed effectively, can affect the adjustment to the (chronic) illness 
(Sarenmalm et al., 2009).   
Patient II struggled to make peace with, and accept her constant anxiety for her 
scheduled breast surgery. I explained to her that she could accept the fact that 
anxiety will be part of her anticipation for the surgery and that she could adapt to it 
by making peace with the reality that fear and anxiety in a situation like hers, is 
normal and inevitable. It was discussed with her that different treatment processes 
generate different fears and expectations as well as emotional and physical 
outcomes, and that every time she starts a new treatment modality, there would 
be new fears and emotions and losses (Spiegel, 1995). I emphasised that she 
should also allow herself at the end of a treatment stage (e.g. when she was 
finished with chemotherapy) to celebrate it and end it off on a ‘good note’ and to 
allow herself some rest before the next treatment starts (e.g. the surgery). It 
makes it easier to ‘compartmentalize’ her treatments and properly end it of when 
finished and to either ‘celebrate’ the end or to ‘tick it of’ as finished. By doing so it 
will feel like something with a beginning and an end (Dockery, 2014; Pratt, 2015). 
Another aim was to talk about making peace with the realism that she could not, 
while undergoing active cancer treatment, do certain things the way she was used 
to (e.g. her house chores). She could make practical changes and amendments, 
and still function on an acceptable level. She still had eight radiotherapy sessions 
left, and it was explained to her that at the end of her treatment, there would be a 
transition time to shift again from being an active cancer patient for nearly a year, 
to a ‘normal’ person again (Dolbeault et al., 2009; Henselmans et al., 2010; 
Stanton et al., 2005). It would take some time for her to get used to the idea that 
although she was finished with the treatment, there were still lingering side-effects, 
such as tiredness, short-term memory loss, mood changes and some biological 
dysfunctions that would be a constant reminder of her cancer (Brem & Kumar, 
2011; Fallowfield & Jenkins, 2015). It was discussed that she could not go through 
all these losses and changes and challenges and yet be the same as before the 
cancer. Even as a couple, they would function on a different level (Baider et al., 
2000; Surbone et al., 2000). In answer to this, she said: 
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“…I can feel that there are areas in my personality that has changed, for instance, 
I am more relaxed about my emotions, especially negative emotions and can now 
share it. …I also allow myself more things in life without feeling unnecessary 
guilty. …and I don’t think so rigidly about things anymore.”   
This fits in with Carver (2005) who said that a longer term aim would be to 
empower the breast cancer patient with general life skills and mechanisms beyond 
their current spell with cancer.   
Patient III: I explained to her that part of the reality of breast cancer is that after the 
cancer treatment she would experience some short-term and permanent changes.  
She can learn to accept the chronicity of her illness through acknowledging her 
negative and ‘scary’ emotions and not be afraid of negative feelings and that the 
new challenges must be ‘tackled’ as they come. I explained to her that she might 
feel anxious and scared every time that she have to see her oncologist for a 
follow-up session, but that, that ‘type’ of anxiousness is normal and she must allow 
herself to feel that but can then also use her coping-skills to deal with the anxiety. 
It was also emphasised that she must look after her depression (which was 
diagnosed and explained during the previous session) and if the symptoms did not 
get better she should make an appointment with her oncology team and discuss it 
with them, confirming again that depression and anxiety are treatable conditions 
and not abnormal in her situation (Mello et al., 2013).   
To summarise adaptation, I used a diagram to demonstrate that because of all the 
losses and changes that breast cancer patients go through during treatment, they 
can never be the same as before the cancer, or look at themselves and the world 
the same way as before.    
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Figure 7.2:  Diagram to illustrate the “journey” from breast cancer to the “new” 
status quo after the treatment.   
Theme 14: Cognitive and behavioural techniques (CBT):   
The therapeutic process based on the cognitive theory, consists of helping the 
breast cancer patient to become aware of her automatic flow of thoughts when 
distressed and to identify and modify these dysfunctional thoughts (Beck et al., 
1979; Chand & Grossberg, 2013; Cook et al., 2015; Hofmann & Smits, 2008). 
Behavioural techniques are used to bring about functional changes in behaviour, 
regulate emotions and help the cognitive restructuring process (Cook et al., 2015).  
An element that a therapist must take into consideration when doing cognitive 
therapy with a cancer patient is the importance of individual differences. People 
view the world differently and they differ in their emotional and behavioural 
responses to hardship. A person’s experience, perceptions and impact of having 
an illness might influence the interpretation and reaction to the illness (Carver, 
2005; Hulbert-Williams et al., 2011). During the diagnosis and active treatment 
phase when patients are dealing with the immediate acute impact of the diagnosis, 
treatment decisions and side-effects, CBT is more problem-focused and psycho-
educational.   For example, it then concentrates on active coping responses such 
as re-creation of new goals to survive this active phase of breast cancer where in 
the re-entry phase, the focus might be more on cognitive reconstruction of 
irrational thoughts, coping strategies, acceptance and adaptation to the new status 
Breast Cancer 
and Breast 
Cancer 
Treatment  
New and different 
Status Quo after Breast 
Cancer and Breast 
Cancer Treatment 
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quo and learning to live with the chronicity of cancer (Anderson, 1992; Low et al., 
2008; Mullan, 1985).  
Patient II experienced acute negative thoughts and worries during the 
chemotherapy due to unpleasant and unexpected side-affects. The therapist 
explained to her that these negative thoughts and worries should be seen as 
‘normal’ and realistic in this abnormal and stressful situation and that she can 
learn to acknowledge and allow these negative thoughts, speak about it and put in 
to the perspective of her illness and treatment (Cook & Salmon, 2014). Although 
she had to allow herself to acknowledge negative thoughts, she should be careful 
not to invest energy in it and keep it active, but rather focus on making new 
thoughts which will make her feel better and more in control over her thoughts and 
feelings (Hofmann et al., 2010; Manne et al., 2009). It was explained how to 
cognitively manage her thoughts and emotions by taking control over it through 
allowing herself to go through the negative emotions, sharing it and asking herself 
what can she change regarding her circumstances and what must she accept and 
adapt to. She could also learn to distinguish between realistic negative thoughts 
(e.g. she is scared of the cancer treatment and its unfamiliarity) and irrational 
thoughts (e.g. her constant thoughts that she must prove herself to her husband 
and family and that she still has to do everything around the house in spite of the 
cancer). She could learn to identify her most basic dysfunctional beliefs about 
herself (e.g. “I must prove myself to my husband and children” and “I am only 
useful if I do all the housework myself”) and replace it with realistic and true 
thoughts “I do not have to proof myself after thirty years to my husband and 
children” and “we all have a good and solid relationship, they accept me for who I 
am, even now with the cancer.” (Beck & Greenberg, 1984; Beck, Liese & Najavits, 
2005). The patient understood that there is a difference between irrational 
thoughts, which is not true and is modifiable and negative and anxious thoughts 
that has to do with her cancer and uncertain future that is ‘normal’ in the situation 
and can be acknowledge and accepted (Beck et al., 1984; Cook & Salmon, 2014).   
We concentrated on behavioural changes in terms of her fatigue and day to day 
behaviour and on using different behaviour to divert her focus away from her 
negative and anxious thoughts. Behavioural techniques are used to bring about 
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functional changes in behaviour, regulate emotions and help the cognitive 
restructuring process (Cook et al., 2015).). She could learn that, to stay in the 
present moment with behaviour and thoughts, she could lessen worry and 
rumination of negative and disruptive thoughts, allowing for more adaptive 
responses to what was happening in the moment (Luoma & Villatte, 2012). By 
focusing on the present rather than constantly worrying about the future, she could 
deal more effectively with her stressors, such as the side-effects of her chemo, 
which could lead to her feeling anxious and depressed (Hofmann et al., 2003; 
Kabat-Zinn, 2003). In therapy it is important to teach a patient to respond 
thoughtfully (consciously) rather than automatically (unconsciously) to stressful 
situations and negative emotions. 
Patient III, who had longstanding issues with her husband concerning their 
relationship in general and his lack of support during her illness (which was 
contributing to her feelings of depression), was inclined to concentrate a lot on 
how he was in the past and his negative and unsupportive behaviour. It was 
explained to her that by working through her disappointment in her husband’s lack 
of support and ‘watching’ her thoughts and trying to focus away from it, she could 
change how she felt and reacted towards him now (Beck et al., 1979; Chand & 
Grossberg, 2013; Cook et al., 2015). It was explained to her that she could not 
change what had happened in the past between them, but could consciously 
concentrate to change her behaviour and expectations towards him then. Instead 
of dwelling on negative thoughts about her marriage, she could try to focus away 
from that and replace it with more positive and constructive thoughts and 
behaviour. She could also try to involve him more in her treatment process, 
instead of just expecting of him to know what to do and to talk to him about what 
she needed of him. Her feedback was that he was helping her more in and around 
the house and took her for long drives “to forget about her illness” and so she 
could rather concentrate on his supportive behaviour and helpfulness instead of 
only concentrating on the things that he did not do or did not do right.   
She was extremely stressed and anxious before her surgery, and she was 
preoccupied in the sessions with that and also at home where she was constantly 
anxious about the surgery. The importance of breathing- and relaxation exercises 
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were emphasised again to relax her body, but also to serve as a distraction away 
from the anxiety (Golden-Kreutz et al., 2005; Hulbert-Williams et al., 2011; Mulan, 
1985). She could for instance ask her husband to go for a walk or do an activity to 
divert her mind from the extreme stressful thoughts. Focusing on activities that 
require concentration and physical activity are valued to take the mind of 
threatening emotions and anxious thoughts and that by spending time with others 
was also helpful. This was not only as emotional support but also as distraction 
through positive activities (Logan et al. 2006, Lauver et al. 2007, Giske & Artinian 
2008). It was explained to her that she could allow herself to feel anxious and 
scared because of the upcoming surgery for it is not irrational or abnormal and not 
to ignore the negative thoughts or to feel guilty about it but rather accept it and 
then to move on to ‘new’ thoughts that she could create to feel better and more in 
control (Cook & Salmon, 2014; Hofmann et al., 2010). Harris (2009) and Luoma & 
Villatte (2012) support this by saying that a patient must allow negative thoughts to 
come and go, rather than holding onto them. Because the patient was inclined to 
feel overwhelmed in stressful and negative situations she could became quite 
passive (in terms of behaviour and thoughts). She understood the value and 
benefit of taking action when in a situation that affected her in a negative way. 
An important goal that was of much value for both Patient II and III was to learn to 
adopt goals that were related to their newly changed life context (the acute and 
busy treatment phase). This was in response to the demands posed to their health 
condition (Carver, 2005). It was explained to them that in the beginning, after the 
breast cancer diagnosis and during the active treatment, they might struggle with 
basic day to day achieving of their goals because of acute side-effects like 
nausea, pain and fatigue. The lack of achieving their goals (e.g. to go to work 
every day, or to run the household as before and to maintain certain tasks) could 
make them feel incompetent and useless, therefore it is important to engage in 
new, more suitable goals. An example that suited them both was, in terms of their 
alopecia, to find out where they can buy a wig and headbands and to start wearing 
them and experimenting with it, or how to survive a chemo session, what to take 
with them to make the time shorter, or whom to take with them, or how to work 
around their fatigue. The patients also learnt that together with these new and 
changed goals, they would experience new and challenging emotions that needed 
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to be talked about, dealt with and put in proper perspective of the cancer. It was 
important for the therapist to encourage and facilitate re-engagement in new goals 
in order to help reinstate a sense of purpose (Brennan, 2001; Carver, 2005; 
Thompson et al., 2013). By explaining the reason(s) why “normal” day to day 
goals were hard to reach (in terms of specific side-effects and symptoms) already 
made the patient feel more competent and useful. The patient also needed to 
understand that if a goal was hard or impossible to achieve, it had to be replaced 
by a new or altered goal that could be achieved. Often after finishing with cancer 
treatment, some previous goals could again be implemented and achieved, but 
that there were also some goals that would have to be changed in the long run 
because of permanent changes due to the cancer and cancer treatment. This 
supports the general conception that the new life circumstances imposed by a 
cancer diagnosis and its treatment can threaten the pursuit and attainment of an 
individual’s personal goals (Carver, 2005; Stefanic et al., 2013; Thompson et al., 
2013; Wrosch et al., 2003).    
Patient I reported back that she had experienced a lot of negative, destructive and 
fearful thoughts regarding her cancer when she was busy with chemotherapy 
saying:   
“…The thoughts seemed to just mill around in my head all the time.”   
She said when she felt anxious or had anxious thoughts it helped her to get up 
and walk around or to find an activity to distract herself from her negative and 
stressful thoughts. We talked about the negative and anxious thoughts during her 
active cancer treatment, especially the chemotherapy. I reinforced the fact that 
conscious diverting and focusing away from anxious thoughts could enable her to 
gain objectivity (detachment) towards negative and fearful thoughts and make her 
feel more in control of her emotions and behaviour (Beck, 1970; Cook & Salmon, 
2014; Giske & Artinian 2008; Jacobsen & Jim, 2008; Lauver et al. 2007, Logan et 
al., 2006, Vahdaninia et al., 2010). It was explained to her that instead of changing 
negative thoughts she could learn to accept that it is normal in emotional situations 
like her breast cancer and she could rather focus on how she relate to the 
thoughts. Thoughts were not to be taken literally as statements of truth or fact, but 
rather simply represented verbal activity (Cook & Salmon, 2014; Hinton & Gaynor, 
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2010). Therefore, instead of changing the negative thoughts she could rather 
focus on creating new thoughts which made her feel more in control over her 
thoughts and feelings (Hofman et al., 2010). I explained that if she thought 
constantly about her negative feelings and problems and losses, she could begin 
to over-identify with her thoughts and intensify it in such a way that it could 
become the truth and also very powerful (Luoma & Villatte, 2012). It could then 
contribute to her depression and anxiety (Morris & Shakespeare-Finch, 2011; 
Osborn et al., 2006). On the practical side it is better to identify and acknowledge 
negative and destructive thoughts instead of becoming caught up in the thoughts, 
allowing it to come and go rather than holding onto them (Luoma & Villatte, 2012).   
Because of the patient’s high level of anxiety, I have also explained the benefits of 
muscle relaxation and deep breathing exercises, explaining that deep breathing is 
not only a biological method to reduce anxiousness, but a way to focus away from 
stressful thoughts and concentrating on something else. It is concluded that 
progressive muscle relaxation and diaphragmatic breathing together with cognitive 
behavioural and mindfulness stress reduction are all effective treatment methods 
for reducing stress and anxiety that accompanies daily life and chronic illness 
(Berger et al., 2015; Jerath et al., 2006; Liza, 2011; Norton et al., 2014). The 
relaxation- and breathing exercises made a lot of sense to the patient and she fully 
understood how these skills could help her with her anxiety. 
Patient IV – because this patient had a problem with her weight and its continuous 
contribution to her feelings of depression, it was an aim in therapy to talk about 
changing her behaviour to start getting active again which could result in losing 
some weight. It was explained to her that personal goals (such as losing weight 
and to start exercising) would provide her with a purpose, structure, direction, 
rewards and meaning and that the successful and continued pursuit of these goals 
could be a key source for her psychological well-being (Brandtstädter & 
Rothermund, 2002; Stefanic et al., 2013; Wrosch et al., 2003). We have identified 
short term goals and proposed ways to meet it, e.g. to start walking short 
distances which would both restore some of her energy and she could start losing 
weight. She could make an appointment with a dietician and start with a healthy 
eating program. According to Dimeo and colleagues (2008) there are increasing 
369 
 
scientific proof that exercise can markedly reduce cancer-related fatigue and can 
avert the patient’s appearance. It was also established that she could participate in 
hobbies and activities where she could be creative and live herself out instead of 
thinking (ruminating) about how “bad and passive and different” she felt. It was 
emphasised that it is always better to start with ‘baby steps’ so that the new 
behaviour can be sustainable. We worked on the principle that behavioural 
techniques could be used to bring about functional changes in behaviour, regulate 
emotions and help the cognitive restructuring process (Cook et al., 2015). I 
explained that she could learn to accept that negative thoughts and fears 
regarding the future and her cancer and the continuous follow-up appointments 
with the oncologist were realistic and even ‘normal’ in her situation and that it was 
impossible not to have negative or unhappy thoughts (Cook & Salmon, 2014). She 
could learn to become consciously aware of her present thoughts without being 
judgemental in her awareness, e.g. not to feel angry or guilty about certain 
thoughts, but rather accept it and change her attitude towards it and allow herself 
more flexible and adaptive responses to her present challenges (Brem & Kumar, 
2011; Driessen et al., 2010).  
Patient V asked to specifically learn new skills to handle stressful thoughts and 
situations better for she experienced a lot of worries about everything and she 
knew that too much stress was not good for her cancer. I explained to her that 
there are different mechanisms of handling stress in terms of her thoughts, which 
is called the cognitive process and her behaviour (the things she does), which 
include conscious relaxation exercises and deep breathing. Because the patient 
had gained weight during her cancer treatment, we made it a therapeutic aim to 
talk about getting active and losing weight and she had already cleared it with her 
oncologist that she could start exercising again. We talked about short term goals 
regarding her weight and fitness that was realistic and achievable and that would 
fit her current health status and which would give a purpose and direction in her 
life (Brandtstädter & Rothermund, 2002; Stefanic et al., 2013; Wrosch et al., 
2003). She said that before the cancer she was fit and that she was looking 
forward to participate in formal exercises again.  
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Another therapeutic aim was to take control of her thought process by starting to 
identify her negative and irrational thoughts and to accept the fact that negative 
and anxious thoughts are normal in the aftermath of breast cancer and instead of 
fighting against it, to rather accept it without being judgemental for thinking it 
(Cook & Salmon, 2014; Luoma & Villatte, 2012). Instead of trying to change her 
negative thoughts the whole time, she could acknowledge it and then focus on 
new thoughts or behaviour that are more constructive and positive and could 
make her feel more in control over her thoughts and feelings (Hofmann, et al., 
2010). We talked about the importance of focusing on the here and now, to think 
what was happening around her then, what she was experiencing then and what 
she could do then to feel better, for example: if she had distressing thoughts, she 
could phone a friend and talk to her, make a cup of tea, do something in or around 
the house, go for a walk or engage her husband and child in activities to take her 
mind of the anxious thoughts (Beck, 1970; Cook & Salmon, 2014; Lauver et al. 
2007; Logan et al., 2006; Luoma & Villatte, 2010). The therapist described that if 
she thought perseverated about her negative feelings and problems it will further 
contribute to her feelings of depression and anxiety, but by distancing herself from 
these thoughts she could distinguish between thoughts and reality, e.g. that by 
thinking something does not mean that it is true and that thoughts are just 
thoughts and not necessarily a reality (Morris & Shakespeare- Finch, 2011; Nolen-
Hoeksema et al., 2008; Osborn et al., 2006). The point to make for the patient is 
that thoughts are only as powerful as you allow them to become and that by over-
identifying with your thoughts and intensifying them in your mind it can become the 
truth (Luoma & Villatte, 2012). The patient said:   
“I feel excited about the new skills, it makes sense to me and I cannot wait to start 
doing it.”   
7.4.1.4  SEX THERAPY 
Breast cancer patients and their partners can benefit from brief sex therapy with 
techniques including cognitive and behavioural coping skills, psycho-education 
regarding self-esteem, loss of desire, fatigue and menopause and sexual 
communication between partners (Derogatis & Kourlesis, 1981; Fobair & Spiegel, 
2009; Hughes, 2008; Hummel et al., 2015; Masters & Johnson, 1970; Park et al., 
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2009; Schover, 1991). These elements all form part of this study’s intervention 
plan during the psycho-therapeutic sessions. An important aim of sex therapy, 
when working with breast cancer patients, is to remove the barriers in sexual 
health communication between the oncology team and the patient and to initiate 
conversations about sexual functioning (Derogatis & Kourlesis, 1981; Park et al., 
2009). Sex therapy further aim to teach cancer patients to acknowledge their 
sexual changes and challenges and to develop new skills to enhance their sex 
lives and intimate relationship during and after breast cancer (Jun et al., 2011).     
Theme 15: Talking about sex: Why cancer patients don’t talk to their 
oncologists about their sexual issues and where they can talk about it:   
I have found during the psycho-therapeutic sessions with the patients in this study 
that they all had, including patient II, who has experienced very little sexual 
changes and difficulties during her cancer treatment, a need to speak to 
somebody about the changes and challenges of their sexuality and sex lives. They 
have made it clear that they’ve felt relieved and exited to have expressed their 
sexual concerns with a professional person in a safe and trusted environment 
(Eker & Acikgoz, 2011) and they have expressed their eagerness to learn more 
about their sexuality regarding their cancer. There is sufficient evidence in the 
literature that, although breast cancer patients and their partners need information 
about their sexuality during and after cancer treatment with a health professional, 
such information delivery is often inadequate or completely absent (Fallowfield & 
Jenkins, 1999; Flynn et al., 2012; Gilbert et al., 2014; Hautamäki-Lamminen, 
Lipiäinen, Beaver, Lehto & KellokumpuLehtinen, 2013; Hordern & Currow, 2003). I 
have found that regardless of the ages of the patients in this study, they all had an 
interest in their sexual functioning and in addressing their sexual issues or 
concerns (Hautamäki-Lamminen, Lipiäinen, Beaver, Lehto, & 
KellokumpuLehtinen, 2013; Hill et al., 2010; Lindau et al,. 2007).   
Patient II had, during our first consultation, started to talk about her sex life 
spontaneously, explaining that they still had a “normal” sex life which she found 
quite reassuring, saying that:  
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“…Although I am very tired at times, our intimate relationship is as good as ever. 
…we still have normal sexual activities.”   
I have supported this through explaining to her that sexual activity cannot be 
harmful during cancer treatment and can continue throughout the treatment and 
can in actual fact be an integral part of her recovery process, giving her a feeling 
of “normality” (Fobair & Spiegel, 2009; Hill et al., 2010; Schover et al., 1984; 
Taylor et al., 2011). When asked, she said that nobody in her oncology team had 
spoken to her about biological changes such as menopause or sexual changes 
due to the treatment and that the topic of sex had never came up. We talked about 
possible sexual changes later during or after the treatment. The patient said that if 
that is the case, she would like to have more information about the subject. Hill 
and colleagues (2010) have recommended that women who are treated for breast 
cancer, regardless of their marital status, age, cancer type or stage, should be 
informed by their physician of the sexual impact of their cancer and their cancer 
treatment.   
Patient III experienced sexual difficulties before the cancer diagnosis and 
treatment and asked if it would be possible for me to see her husband and talk to 
him about their sex life, saying: 
“…I would like to improve it, I haven’t enjoyed sex for a while and maybe we can 
then feel closer to each other.”  
It is reported in the literature that cancer patients often find it important for their 
partners to be included in discussions about their sexuality with the health care 
professionals and for the professionals to make provision for it during the 
therapeutic process, or to encourage the cancer patient to involve her partner in 
the therapeutic process (Flynn et al., 201; Gilbert et al., 2014). I have encouraged 
her to talk about their sexual difficulties before the cancer diagnosis and now, 
valuing the fact that by giving her a chance to talk about her sexual hardship can 
be therapeutic in itself (Derzko et al. 2007; Nusbaum et al., 2003). I have asked 
her how she felt talking about sex and she said:  
“…I have never before spoken to anybody else about it, not even my husband …it 
makes me feel so relieved to talk about sex and exited to change our sex life.”     
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Both patients II and III seemed relaxed and relieved to talk about their sex lives in 
therapy and without much prompting they have shared details about their sexuality 
and sexual activities, both relevant to the cancer treatment and otherwise. I have 
used the benefits of early conversations with the patients regarding their sex lives 
to get them comfortable and give them the opportunity and confidence to discuss 
any questions regarding their sexual functioning and illness and to realise through 
that, that it is acceptable to talk about sex and sexuality. Derogatis and Kourlesis 
(1981) felt that many sexual problems can be solved by just the opportunity to 
discuss it in a safe and professional environment without in-depth sex therapy.  
The patients regarded the conversations about their sex lives very therapeutic and 
very positive. Neither of them had even once spoken to their oncologists or any 
member of their oncology team about sex or their sexual functioning for there was 
never a “platform” for conversations regarding that and they didn’t know, before it 
was explained to them in psychotherapy, that there could be effects on their sex 
lives. Both reported speaking about sex as very liberating. Flynn and colleagues 
(2012) felt that clinicians may need to take on greater responsibility for informing 
patients about all potential side effects of treatments, including sexual side-effects 
whether or not patients raise specific questions regarding it. Park and colleagues 
(2009) reported that all patients, regardless of their age, marital status or stage of 
cancer, should be asked about their sexual issues throughout the whole trajectory 
of their illness in order to provide practical information so that the patients can 
understand their situation and help them to come to terms with their feelings about 
their sexuality and cancer. 
Patient I said, when asked about her sexuality and sexual functioning:   
“We did have sex during the time of my treatment, although less. …to me 
everything was about survival and while sex was not my priority then, we still had 
a good sex life and it did me good when it happened.”   
But as the treatment went on, she experienced some sexual problems and when 
asked, she said she never felt that she could have had a conversation about her 
sex life with her oncologist,  
374 
 
“We didn’t have that type of relationship or open communication. Sex was never a 
subject of discussion…nobody has spoken openly to me about my sexuality or 
sexual functioning …I had to struggle through that on my own, not having the 
confidence to ask about it.”   
We talked about the fact that sexual issues are not always integrated into routine 
cancer care as yet and that it could cause feelings of neglect from the oncology 
team for not raising the subject of sexuality or providing adequate information 
regarding it. This is very prominently underlined in literature by recent authors 
(Flynn et al., 2012; Gilbert et al., 2014; Krouwel et al., 2015; Reece et al., 2010; 
Sporn et al., 2015). I have explained to her that other breast cancer patients in her 
position experience more or less the same sexual uncertainties and functioning as 
she does and that experiencing difficulties in her sexual functioning is normal, but 
treatable (Derogatis & Kourlesis, 1981; Stead et al., 2003). By giving her the 
opportunity and safe environment to speak about her sexual functioning and 
concerns and through normalizing her fears and issues, she felt much more 
liberated about this “forbidden” subject, saying:   
“…I understand my sexuality and sexual functioning much better and feel more in 
control in this area of my life.”  
Patient IV appeared comfortable speaking about how she felt about her sexuality 
and sexual activities regarding the cancer and her worries. She asked during the 
third therapeutic session, during a conversation regarding sex, if she could bring 
her partner with her the next time to discuss with him their lack of proper sexual 
activities due to her cancer treatment and other issues that they have. This was 
acknowledged and arranged for the next therapeutic session. Cancer patients 
often need to include their partners in their therapeutic process (Flynn et al., 2012; 
Gilbert et al., 2014; Hordern & Currow, 2003; Hordern & Street, 2007).  When 
asked how she feels about talking to the therapist about her sexual functioning 
she said:   
“Being able to talk to you about sex and putting it in the framework of my 
depression and cancer, I understood my lack of sexual functioning better now 
without feeling so guilty and ‘abnormal’ about myself anymore.”  
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She said, when asked, that she and her oncologist, in spite of a good relationship, 
never discussed her sexual functioning.     
Patient V who presented with severe marital problems asked during the second 
therapeutic session if she could bring her husband to a session because she felt 
that he did not understand the influence that the cancer had on her and their 
relationship, especially their sexual relationship. She said that they had a good sex 
life before the cancer without any problems and that even during the course of the 
cancer treatment their sexual functioning was active and good. I positively 
reinforced their sexual activities during the treatment, explaining that she can look 
at it as a good and positive part of her recovery process and that by keeping up an 
active sex life can play an important role in their sexual functioning as a couple 
(Hill et al., 2010; Taylor et al., 2011). When asked about their problems, she said:     
“Our sexual problems only started after the hormonal treatment. …I then realised 
that I didn’t get enough information regarding my sexual functioning, especially 
menopause, or what to expect of my body and sexual functioning.” 
She understood that information regarding sexual issues are often not integrated 
into routine cancer care which can cause the patient to feel uninformed and 
unsure about sexual changes and who to talk to (Hordern & Currow, 2003; 
Hummel et al., 2015; Park et al., 2009). We discussed the importance of talking 
about her sexual issues and the therapeutic opportunity to learn new skills to 
improve their sexual problems and it was emphasized that the sexual difficulties 
and uncertainties that she was experiencing, was normal in her situation.   
 Sex therapy: psycho-education   
Psycho-education, which is the combination of education and information with 
elements of psychological therapy, was found to significantly improve sexual 
knowledge and understanding in the cancer framework (Brotto et al., 2008).  
During the sex therapy interventions of this study I have predominantly made use 
of psycho-education as a technique believing that breast cancer patients often 
only need education and basic practical information about their sexual situation to 
help them understand their cancer related sexual functioning and to assist them 
with their sexual expectations in the future (Derogatis & Kourlesis, 1981; Park et 
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al., 2009; Taylor et al., 2011). I have worked from the believe that this (sexual) 
information should be repeated several times during the psychotherapeutic 
process to make sure that the patient stays in contact with her sexual functioning 
throughout the course of her cancer journey and feel comfortable talking about it 
(Schover et al., 1984).     
Theme 16: Explaining the most important and relevant sexual matters to the 
patients:  
 Menopause and loss of libido:  
 
Menopause and premature menopause was a prominent and well-discussed 
occurrence in this study especially concerning the three patients already finished 
with their treatment. The reason for this long-term side-effect can be due to the 
use of Tamoxifen and Als which are hormonal treatments and are used for up to 
five or more years after active treatment. The implications of this long term 
treatment can cause the rehabilitation process of the breast cancer patients to 
include living and managing the side effects of on-going treatments and must be 
clearly explained to the breast cancer patient (Brem & Kumar, 2011; Ewertz & 
Jensen, 2011; Kuo et al., 2008; Siegel et al., 2012). Apart from menopause, 
chemotherapy and hormonal treatment can also cause low androgen levels, which 
can be linked to lower sexual desire and can consequently result in less sexual 
activity (Fobair & Spiegel, 2009; Meier, 2010).   
 
Patients II and III who were in the middle of their acute treatment side-effects, did 
not yet experience any treatment related sexual side-effects.  
 
Patient II who was still pre-menopausal said that she experienced no symptoms of 
menopause yet or any changes regarding her sexuality:   
 
“…up till now nobody has spoken or mentioned anything about menopause or 
possible menopausal symptoms.”  
 
The absence of communication and information can leave people with cancer 
feeling unprepared for the sexual side effects of cancer and treatments (Stead et 
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al., 2003). I explained to her that menopause could be a side-effect of 
chemotherapy, which is then called a chemically induced menopause and can 
happen rather quickly. The symptoms of chemo-related menopause and ‘normal’ 
age-relevant menopause are the same and include: stopping of menstruation, hot 
flushes, heart palpitations, an inability to concentrate, short term memory loss, 
possible weight gain, mood swings, a decrease in sexual desire and vaginal 
dryness (Dean, 2008). It was explained to her that vaginal dryness can cause pain 
and discomfort during intercourse and it is important to use (when in that situation) 
enough lubrication, which can be bought over the counter in a pharmacy (Derzko 
& Elliot, 2007). By knowing the symptoms of menopause she could at least be 
prepared for it when it happened.   
 
Patient III was the only patient that had already been menopausal for a couple of 
years. She was comfortable and familiar with the symptoms. She was a good 
example of a cancer patient that firstly focused on her treatment and was in 
complete survival mode and was not sexually active during this time, not just due 
to her severe side-effects of the cancer treatment, but also because her sexuality 
and sexual activities was already compromised because of marital and health 
problems. This was confirmed by authors such as Katz (2005) and Taylor and 
colleagues (2011) stating that immediately after a cancer diagnosis, anxiety and 
worry for survival is so immense and issues of mortality all consuming, that sex is 
not necessarily an immediate priority. It was also her experience that their sexual 
problems laid with her husband’s chronic illness and accompanied erectile 
dysfunction, but has declared herself (more than once) ready and open to 
participle in any form of sex therapy or conversations when her cancer treatment 
was over and her husband’s sexual dysfunction was sorted out. She was also 
willing to assist her husband in sorting out his sexual problems and would go to 
whatever lengths it would take from her to help him in order for them to have a 
healthy sex life. When asked about how she felt talking to me about her sex life, 
she said:   
 
“…I have never done it before, not to anybody, I already feel relieved and I realise 
now that we can work on the problems and that there are ways to deal with it.”   
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Patient I, IV and V who were all three pre-menopausal before their breast cancer 
diagnosis and younger than the two state patients, experienced many more 
challenges and uncertainties regarding their abrupt menopausal symptoms and 
lack of libido. I noticed that all three of them, who was treated by different 
oncology teams, had experienced the same lack of information and knowledge 
regarding menopause and relevant sexual functioning regardless of the fact that 
all three of them were in longstanding permanent relationships or marriages. It is 
clear in the literature and was explained as such to the patients that with the 
absence of communication and information regarding menopause and relevant 
symptoms and side-effects, they and their partners could feel “abnormal” and 
unprepared for the sexual side-effects of the cancer treatments (Deeks et al., 
2011; Gilbert et al., 2014; Stead et al., 2003; Vogel et al. 2009).   
 
Patient I said, when asked about sexual problems, that because of her treatment, 
she was on Tamoxifen for the next five years, (she had already been on it for more 
than a year and a half), she has a complete lack of oestrogen:     
 
“…it happened rather suddenly. I was completely surprised and overwhelmed by 
the unexpected sexual changes during and after my treatment…I was not 
prepared for the suddenness of the menopause. …even the way my body reacted 
sexually has changed.”   
 
This patient explained that menopause was only mentioned briefly by the 
oncologist as a side-effect of the chemotherapy and Tamoxifen,  
 
“…but It was never discussed at length or what I could expect of my body and 
emotions, or what I could do to adapt to the situation…I have a lot of questions 
about my menopause and lack of libido, but did not find answers up till now.” She 
also said: 
 
“…the one thing that me and my husband don’t understand is my complete lack of 
libido or any form of sexual contact or conversations because before the cancer 
we had a good and satisfactory sex life.”   
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Because of her lack of knowledge I have explained that the abruptness of the 
onset of her premature menopause and the severe symptoms which she was not 
prepared for, were all due to the lack of oestrogen because of the cancer 
treatment.  By talking about menopause and its symptoms and learning new skills 
to manage it, she could still have a fulfilled and quality sex life. She also 
understood that a ‘chemical induced’ menopause had an immediate effect on the 
body and mind, and what she was experiencing was normal for her situation. We 
also discussed the chronicity of these changes and that accepting and making 
peace with her permanent menopausal status and complete lack of oestrogen 
were imperative and a prerequisite for adapting to this new status quo. The 
‘practicalities’ of sexual functioning in menopause was further explained, for 
example, the lack of vaginal lubrication and accompanying pain and discomfort 
with intercourse, the using of vaginal moisturizers and lubrication to counteract this 
and to learn new practical skills, such as maintaining longer foreplay to be 
biologically ready for intercourse and to reach an orgasm. It was further explained 
that sex had a lot to do with a mind-set and because of the lack of oestrogen and 
androgen there is an accompanying lack of desire or libido or natural drive to have 
sex and that having sex becomes more a process of thought than biology. It was 
explained that in the framework of this, it was important for her (and her husband) 
to understand that the lack of her sex drive was a biologically driven component 
and had nothing to do with their feelings or attraction for each other or that there 
was something wrong with their relationship. This was also described in literature 
by Brem and Kumar (2011) and Kuo and colleagues (2008).   
 
Patient IV said that both she and her partner suffered from a low libido, both due 
to biological reasons and that it worried her,    
 
“…but I didn’t realise that my treatment has also contributed to a further collapse 
in my libido.”  
 
I explained to her that the lack of her natural sex drive was more biologically 
inclined due to her cancer and depression and the treatments for these conditions 
and had nothing to do with how she felt about her partner (American Cancer 
Society, 2010; Mimoun, 2011; Strasser et al., 2006). It was also explained to her 
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that a lowered spontaneous sex drive is not abnormal in her menopausal situation 
(Derzko et al., 2007). We discussed the biological implications of her current 
menopausal state (she has stopped menstruating after the first chemo infusion), in 
terms of mood swings and emotional reactions, hot flushes, insomnia and 
irritability which could worsen her symptoms of depression even further. She 
needed to be aware of this as not to stress because of her ‘double’ depressive 
symptoms, but understand it in the light of her menopause. The literature 
described the relation between menopause and oestrogen decline and depression 
(Brem & Kumar, 2011; Fann et al., 2008; Navari et al., 2008). Because of her 
history with depression and her chronic use of anti-depressants, it could also 
influence her libido and sexual activities, for most anti-depressants are prone to 
decrease the biological drive even further. She was on Wellbutrin which increased 
sexual arousal and orgasm intensity and overall sexual satisfaction (Faller et al., 
2011; Fobair & Spiegel, 2009; Krychman & Katz, 2012).  It was also explained that 
menopause can have a huge impact on a woman’s sexuality because of changes 
in her body including vaginal dryness and loss of vaginal tissue elasticity, which 
can affect her sexual interest and sexual functioning (Dean, 2008; Hughes, 2008). 
These physical changes could inspire her and her partner to adopt new sexual 
behaviour, for instance, to make more effort with foreplay, taking more time to 
stimulate each other, knowing that it might take longer to get ready for sexual 
activity and pleasure. The using of lubrication was also discussed as a tool to 
make sexual intercourse easier and less uncomfortable and painful and she was 
encouraged to acquaint herself with the different lubrications (Derzko et al., 2007; 
Krychman & Katz, 2012; Reece et al., 2010). The patient admitted that she was 
not familiar with cancer treatment induced menopause and was not ready for the 
changes in her body and already compromised sexual functioning. She felt 
relieved that she at least understood why she felt and reacted different sexually 
than before the cancer. This is again evidence that when a breast cancer patient 
has not sufficient information and knowledge regarding the effects of cancer 
treatment on their bodies, they feel unprepared for the sexual side-effects and 
may feel disappointed with their health professionals for their lack of information 
and support (Deeks et al., 2011; Gilbert et al., 2014; Stead et al., 2003; Vogel, et 
al., 2009).   
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Patient V who is the youngest of the five patients was affected the worst by her 
premature menopause and has asked the most questions. She also presented 
with marital problems which developed during her breast cancer treatment due to 
various cancer side-effects, including that of sexual- and body changes. Although 
her oncologist had explained to her that she would go into menopause because of 
the medication, she felt that she needed more information regarding her hormone 
medication and time to talk about it, saying:  
 
“…I understand that this will also affect my sex life and I must drink it for five years 
…I want to know how menopause works and what it will do to my body since it is 
something unfamiliar to me.”  
 
Young women who are diagnosed with breast cancer often suffer sexual side-
effects and challenges during the most sexually active years of their lives. I 
explained that early menopause could be a shocking and overwhelming 
experience for a young woman like herself (Brem & Kumar, 2011; Deeks et al., 
2011; Ewertz & Jensen, 2011). I described premature menopause to the patient 
as something that happens very abruptly comparing with natural age-appropriate 
menopause where the body and mind has time to adapt to the changes because 
they happen over a period of time. I further explained that premature menopause 
is an occurrence outside the normal life course which can have a significant 
impact on the physical and emotional well-being of a person.  Menopausal 
symptoms, especially vaginal dryness, can be a physiological disappointment for 
woman over 50 years of age and even more so for younger women and must be 
explained very clearly with practical skills to counteract it for the young woman to 
still have a good and fulfilled sex life (Deeks et al., 2011; Fobair, & Spiegel, 2009). 
I have worked here on the principle of Derzko and colleagues (2007) that giving 
and explaining the more practical elements of sexual functioning regarding 
menopause will be beneficial for cancer patients, providing them with active and 
constructive skills to deal with lifelong symptoms and sexual changes. Because 
this patient said that she was completely unfamiliar with menopause, I explained 
all the menopausal symptoms and the impact on her body and her sexuality. This 
included: hot flushes, night sweats, sleep problems (insomnia), possible weight 
gain and slowed metabolism, possible thinning hair and dry skin. Menopause 
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could also influence her mood causing mood swings, irritability and even 
depression and a decreased libido, explaining it as a lessened sex drive. There 
can also be a risk of losing bone density, causing early osteoporosis (American 
Cancer Society, 2014; Brem & Kumar, 2011; Ewertz & Jensen, 2011). The use of 
lubrications was explained in detail, acknowledging the fact that younger women 
who are in a new and unexpected menopausal status have most probably never 
had to use lubrications before and do not necessarily have the confidence to talk it 
through with their oncology team (Derzko et al., 2007; Hughes, 2008). The 
therapist explained that together with managing the biological symptoms of 
premature menopause, accepting something unnatural as this occurrence lies in 
the conscious mind and is a psychological process. It is about making a decision 
to make peace with it and accept it through working though her emotions and 
being open to learn new behaviour to adapt successfully to an ‘older’ body with a 
‘young’ mind (and husband). It was emphasised that despite the fact that there is a 
lot of negative side-effects to the hormone treatment, it has the benefit of reducing 
her risk of the cancer coming back.  
 
It was explained to her that a decreased libido goes together with menopause and 
meant that she would not always, in a biological way, feel in the mood for sex the 
way she had before the cancer. Together with the lessening of oestrogen, there is 
also a lessening of androgen, which is the hormone that “orchestrates” the 
biological drive to want sex (Brem & Kumar, 2011; Kuo et al., 2008). To overcome 
this biological lack of a sex drive, she could consciously think and ‘talk’ herself into 
sex and mentally prepare herself. She could still enjoy the act even if she was not 
automatically aroused from the beginning. Communication about the lack of a 
libido or a lower than usual libido is important so that her husband could 
understand that her lower libido was a biological side-effect of her cancer 
treatment and had nothing to do with him or her feelings towards him and that they 
could work around that instead of getting stuck with it.   
 
I have explained to patients I, IV and V that, because of their loss of libido and lack 
of a biological sexual urge, they could also use other motivations for engaging in 
sexual activities, such as to generate emotional closeness to their partner or 
383 
 
reassurance of a loving and intimate relationship and partner satisfaction, which all 
can contribute to her own quality of life (Derzko et al., 2007).   
 
 Breast cancer treatment vs. self-esteem and body image  
Breast cancer patients undergoing cancer treatment are exposed to changes in 
their physical appearance such as the loss or disfigurement of one or both 
breasts, scars from surgery and skin changes related to radiotherapy, 
lymphedema, alopecia and weight increase (Dean, 2008; Falk et al, 2010; 
Krychman & Katz, 2012; Kuo et al., 2008; Reece et al., 2010; Sbitti et al., 2011). 
These changes are all related closely to physical appearance and body image and 
it is important for the therapist working with this patient population, to address 
these issues during psychotherapy.    
 
Patients II and III spoke little about their body-image concerning their active breast 
cancer treatment and the influence on their sexual functioning despite the fact that 
both of them suffered from alopecia. Most of our sessions were consumed by their 
active emotions and grievances and practicalities regarding their cancer treatment.   
 
It was established through studies that patients who feel better about their bodies, 
as in the case of Patient II, because of the support and positive feedback from 
their husbands, have stronger believes in their own ability to reach out to others 
for support, maintain a more positive attitude towards the cancer and remain 
active, self-efficient and independent, which was especially noticeable during the 
sessions with this patient (Anagnostopoulos and Myrgianni, 2009; Baxter et al., 
2006; Sheppard & Ely, 2008; Wilmoth, 2001).  
 
Patient III: experienced initial doubt regarding her looks when her hair fell out after 
the first chemo infusion, especially because she felt her husband didn’t support 
her enough or made her feel better about it, saying:   
 
“I feel self-conscious and don’t feel like going out in public.”    
 
We have talked about practical interventions, such as wearing head bands or her 
wig, but because of her emotional status due to her active cancer treatment, she 
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did not experience changes to her body-image at this stage, or relate it to their 
sexual problems.   
 
The apparent lack of serious cancer related body image problems from the two 
patients still busy with their treatment supported literature which indicates that 
sexual problems worsen beyond the first year after diagnosis and treatment, 
causing abnormal sexual and body image patterns to develop with time (Dean, 
2008; Katz, 2005; Rosenberg et al., 2012). It also supports conclusions that there 
is a significant correlation between body image and age, especially for young 
premenopausal women as is the case with the next three patients, who have been 
noted to have reported a more prominent loss of femininity, infertility and various 
sexual problems related to early induced menopause (Dalton et al., 2009; Jun et 
al., 2011; Nozawa et al., 2013; Rosenberg et al., 2012; Wong-Kim et al., 2005).   
 
Patient I said that her total hair loss together with the changed shape of her breast 
after the surgery affected her self-image seriously;  
 
“…the cortisone that I used has caused insomnia and swelling, I didn’t look the 
way I did before the cancer. …the form of my body and weight has changed 
drastically …I even thought back then that my children were ashamed of me 
looking ill and swollen and with no hair, but realised later that it was my own 
projection and insecurities about my illness and how I looked at myself.”   
 
She said that even then after all that time her self-image was still compromised 
and that she could make a connection between how she looked and felt physically 
and how her body reacted sexually. She felt her changed appearance and 
accompanied sexual functioning was just another thing to worry about together 
with all the other worries regarding the cancer and depression and anxiety. The 
aim of the therapeutic intervention here was to explain the changes in her body 
due to the cancer treatment and the impact it had on her self-esteem and self-
confidence.  I aimed to have taught her self-compassion, which is the ability to 
accept her the way she is now and show self-directed kindness in this “abnormal” 
and stressful situation. It was explained to her that she could develop a more 
positive body image perception of herself through acceptance of her physical 
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changes and losses and develop a new ‘after-cancer’ self-esteem in a very 
conscious and practical way. By doing this, it could help her to feel self-worthier 
and more sexually acceptable for her husband (Anagnostopoulos & Myrgianni, 
2009; Przezdziecki et al., 2012; Wilmoth, 2001). She said that although she had a 
breast reconstruction operation, her breasts did not look the same and the scaring 
reminded her on a daily basis of her cancer and impacted her self-confidence. 
Although reconstructive surgery can alleviate the impact on the sexual body image 
to some degree (Markopoulos et al., 2009), this patient felt that in spite of her 
reconstructive surgery, she was still self-conscious about her breasts and changes 
in her body-shape which was affecting her sexuality. I attempted to teach her to be 
non-judgemental toward her own body and to accept her physical ‘imperfections’ 
and limitations in order for her to improve her sexual body image. Because this 
patient experienced her changed body so prominently and negatively, it was 
discussed that, in a very practical matter, she could for instance change the way 
she dresses to suit her body shape and weight gain and learn to at least like her 
‘new’ body more. These principles were supported in literature through authors 
such as Przezdziecki and colleagues (2012) and Wilmoth (2001). 
 
Patient IV had gained a lot of weight due to the cancer treatment and had 
consequently suffered from a very negative body image and negative feelings 
about her appearance. She said during the first session (without prompting) that 
she wished to talk about her weight and self-image and self-confidence 
somewhere during the therapeutic sessions. Here the aim of psycho-therapy was 
to help her develop a more positive body image through kindly accept herself and 
showing self-directed empathy while in a difficult situation (Anagnostopoulos & 
Myrgianni, 2009; Przezdziecki, Sherman, Baillie, Taylor, Foley, & Stalgis‐Bilinski, 
2013; Przezdziecki & Sherman 2016; Raes, 2011). Through mindfulness she 
could learn to accept her present appearance rather than focus on achievement of 
ideals or perfection and to concentrate on neutral observation or reality instead of 
body avoidance or harsh self-judgement (Alberts et al. 2012). It was also 
discussed that she could engage in a plan of action to lose weight e.g. to start with 
a proper diet plan together with a dietician and to implement an exercise plan. The 
therapist explained to her the benefits of losing weight in terms of her self-esteem 
and sexual self-esteem, but to be realistic about her goals and to take small steps 
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at a time. Apart from her weight problem, the patient also had a problem with her 
breast, saying:   
 
“…where I had the lumpectomy the breast is now different from the other one and 
it makes me feel self-conscious. …and that even with clothes on, it looks 
different…I really feel very self-conscious.”   
 
She said the whole change of her body was also contributing, not just to her body 
image and sexuality, but also to her feelings of depression. I asked about breast 
reconstruction and she said that although she had never in the past thought about 
it, she was now seriously considering it. She also said that it would be much later 
in the future. It was explained that apart from making peace with her ‘different’ 
breast and changed body she could also, through practical behaviour, e.g. 
changing her clothes to hide her breast deformity and emphasizing other body 
parts she felt more comfortable with. She could wear something like a camisole to 
bed to ‘hide’ the scar when participating in sexual activities to make her feel less 
conscious of her scar and to help her focus away from her body and to enjoy sex 
more. These therapeutic principles were supported by authors like Dimeo and co-
workers, (2001), Hassan and Amin (2011), Przezdziecki and co-workers, (2012) 
and Przezdziecki and Sherman, (2016). The patient said that her dissatisfaction 
with herself has also seeped through to her general functioning and social 
interaction;  
 
“…it has influenced my whole job performance, I feel that I don’t perform in my job 
as I used to…”  
 
Where it was explained that she should concentrate to be consciously aware of 
irrational thoughts regarding her self-image, for example “I am not good at my job 
anymore” or “I can’t remember as well as before the cancer” with more rational 
and ‘true’ thoughts such as “the cancer did not change my intellect or ability to do 
my job” or “the cancer did not take away my qualifications” or “even if I struggle 
with my short term memory, there are ways to help me with that.” She could also 
through self-compassion apply greater cognitive flexibility to change her irrational 
thoughts regarding her self-image as well as by focussing on things and activities 
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that would make her feel better e.g. taking up hobbies again instead of just 
thinking about how bad and passive and different she was   (Martin et al., 2011; 
Przezdziecki, 2013).   
 
Patient V. Various authors have written about the hardship of infertility after breast 
cancer treatment in young patients (Corney & Swinglehurst, 2014; Deeks et al., 
2011; Gabriel & Domchek, 2010). However, this patient who had a hysterectomy 
at the age of 34 years, said her family and husband were more concerned about 
the fact that she could not have another child than she was:     
 
“I am satisfied with only one child, but my husband did not necessarily share my 
vision. …I realised that I am the mother of my child and must make a decision 
regarding to see him grow up or have another child and see neither of them 
growing up. …It was more a question of survival than having another child.”   
 
In terms of her body-image she said because they were still young and sexually 
very active;  
“…I was scared that my husband would be repulsed by my body and I immediately 
decided that I will have reconstruction surgery as soon as it was possible. …my 
husband will not see me without breasts” 
 
She said she felt good about her reconstructive procedure and that it contributed 
positively towards her self-image, but the fact that she had gained weight during 
her cancer treatment as well as her persistent tiredness which made her feel 
“unsexy’ and “older” than her actual years, had affected her body-image 
negatively. Literature agrees with this, saying that breast reconstruction following 
total mastectomy has benefits in terms of body image to some degree (Albornoz et 
al., 2013; Emilee et al., 2010; Fallbjörk et al., 2010). She wanted to talk about her 
weight and her body-image, saying that being unfit and weighing more than before 
the breast cancer, was a negative experience for her, influencing her sexual body 
image. Later in the therapeutic process when she was exercising again she said it 
made her feel more social and “in” with the “normal” crowd;   
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“…I really feel normal again; being able to do normal things every day …but know 
there’s a long road ahead to get used to my ‘new’ body.” 
 
We talked about developing a more positive and realistic body image perception 
and to make an effort to accept herself through a softer approach and a non-
judgemental attitude towards herself. We also talked about going to the gym and 
exercising again as it could be very beneficial not just for her body weight, but also 
for her fatigue, improving of her memory functioning and an overall feeling of 
general well-being (Anagnostopoulos & Myrgianni, 2009; Dimeo et al., 2001; 
Hassan & Amin, 2011; Przezdziecki et al., 2012). I emphasised the practical 
elements such as the way she dresses, especially with lymphedema and the 
weight that she had gained and to go (for instance) regularly if possible for body 
and facial massages to “spoil” her body and keep it in good order and by doing 
that to concentrate on the rest of her body that was not affected by the cancer. It 
was also explained to her that negative and deconstructive thoughts about self-
image can be identified by herself and consciously be changed to positive and 
friendlier thoughts (Przezdziecki et al., 2012, 2013; Przezdziecki & Sherman, 
2016).   
 
I have found that all three patients who were already in remission had severe and 
continuous problems with their body image and sexuality right from the start. This 
escalated throughout their treatment and after the treatment. If they could have 
participated in sex therapy from an early start as indicated in literature, they could 
continue to have, to some degree, felt sexually attractive and functional and would 
have been able to sustain and conserve better courage and self-esteem 
throughout this process (Fobair, & Spiegel, 2009; Jun et al. 2011: Schover et al., 
1984). This again emphasises the importance of early referral to a psychologist by 
the oncologist (Park et al., 2006; Surbone et al., 2013).   
 
 Behavioural changes and cognitive restructuring of inflexible 
thoughts   
Because of the nature of the breast cancer patient’s most prominent sexual 
dysfunctions (arousal- and orgasm problems due to menopause, intimate issues 
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and physical- and body-image changes) the therapist has, through years of 
experience, learned to rely on a more behavioural contribution to intervene with 
this already emotionally traumatized population. Sensate focusing, as a 
behavioural technique, focusses on teaching new skills to a patient who suffers 
from any form of sexual or intimate difficulties, and its basic principles are often 
used when conducting sex therapy. One of the advantages of sensate exercises is 
that it can be implemented in stages so that small changes in behaviour like 
holding hands can precede larger changes in behaviour such as trying new and 
different sexual activities, which will be beneficial in the long run for the “new 
identity” of the breast cancer survivor (Reece et al., 2010; Weinera & Avery-Clark, 
2014). Behavioural- and sensate focusing goes very well together with the 
flexibility model which is a cognitive and behavioural approach to changing 
perceptions and thoughts regarding sexual functioning when confronting with 
acute or chronic sexual changes or dysfunction (Barsky et al., 2006, 2010).   
In contrast with the three patients (I, IV and V) that was in remission and had 
experienced and presented with outspoken sexual issues, Patients II and III did 
not merit specific behavioural or cognitive interventions concerning their sexual 
functioning.  
I have rather focused on providing them with relevant information regarding their 
current sex lives in the framework of their acute cancer treatment and aimed to 
include them in open discussions about their sexuality to make them comfortable 
and used to talking about their sexual functioning This eased possible anxiety 
around post-cancer sexual changes, minimize the negative impact on their 
intimate relationship and to motivate them to discuss their sexuality with their 
partner (Rasmusson & Thome, 2008; Perz, Ussher, & Gilbert 2014; Vogel et al., 
2009).   
During her cancer treatment Patient I experienced the inability and a lack of 
confidence to speak to her husband about the absence of her sexual interest and 
bodily and sexual changes due to her cancer treatment. What had made the 
problem worse was that they had no prior sexual problems before the cancer and 
that she did not have the proper knowledge as to what was happening to her in 
terms of her sexual functioning. This lack of communication has led to a total 
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abstinence of their “normal” sexual interactions during her treatment also resulting 
in a decrease in their intimacy. I explained to her that it was not abnormal for a 
person in a sexual crisis to stay away from sexuality, feeling scared that any form 
of touching might lead to sex or ‘misleading’ the partner that they can have sex 
when they are not in the biological or even psychological position to do so. The 
therapeutic aim here was to talk about going back to basic sexual behaviour, e.g. 
touching and caressing each other without actual penetration and learning to look 
at yourself from a new angle, accommodating your body changes due to the 
cancer treatment. I have learnt from experience working with breast cancer 
patients, that they often find it difficult to start with the sexual act, when it is 
biologically possible to have sex again, after a period of sexual abstinence.   
Therefore it is less threatening for them to “go back to the basics” first to regain 
some of the trust and comfort with each other’s bodies. I have explained the 
“practicalities” of sexual functioning within the framework of menopause as the 
patient’s biggest challenge, for example, the use of lubrication, prolonging the 
foreplay stage and implementing new strategies, e.g. massaging, different 
positions and techniques to reach an orgasm. This was also a good time to invest 
in a new book or books to gain more knowledge about different and new sexual 
skills that was applicable in her situation. I have explained the importance of 
sharing the information with her partner. Talking about sex with your partner, 
together with touching and caressing first before sexual intercourse, is also a safe 
way to start implementing your sexual functioning again. I used the principles of 
sensate touching. I did not use the whole sensate exercise program due to time 
constraints on the study. Patients often only need to understand their unique 
situation and basic information of what to do to get back on track. The most 
important aim here was for the patient to become more comfortable with her own 
changed body again. She had to connect with her husband on an intimate level 
again through talking to him about her emotions and sexual issues. She had to 
discuss her uncertainties and explain to him what she felt sexually and talk to him 
about her sexual desires (Masters & Johnson, 1970; Weinera & Avery-Clark, 
2014). At the end of the session it was decided to involve her husband the next 
time for a couple’s session and the patient revealed that this session in particular 
meant a lot to her, saying:   
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“…I really understood my own body better now as well as the permanent impact 
from the breast cancer on my sexuality …because of the new skills and 
knowledge I feel more relaxed about sex and intimacy and instead of it just being 
another loss and stressor in this ‘jungle’ of effects and side-effects of the breast 
cancer, I found it is something that can be treated and resolved.”   
Although there were lengthy therapeutic discussions about her self-esteem and 
body image, as well as about her chemotherapy related menopause, the sex 
therapy with Patient IV was only done with her partner in a couple’s session. This 
will be discusses under the heading ‘Couples’.   
When Patient V, started with the therapeutic process she just had a hysterectomy 
two weeks earlier and couldn’t engage in sex for six weeks. According to her, her 
husband found this quite challenging. We then discussed the importance of 
intimacy and the therapist explained that when the sexual act was not possible (as 
with her situation then) it was important to still stay involved with cuddling, kissing, 
spending time together, caring and talking. When the time was right for sex again, 
it would be much easier to resume one’s sexual activities when there was some 
form of sexual intimacy as opposed to when there was just a complete absence of 
bodily contact or any form of intimacy. Intimacy could help to maintain a form of 
normality in the face of cancer, reassuring the patient that there is still a life away 
from cancer and healthy activities to participate in. Because of all the changes that 
she is going through in her body and mind, she could see this as a learning curve 
to experience with new sexual techniques to help her with her lack of libido and 
difficulty to reach an orgasm e.g. by using liberal quantities of lubrication, invest in 
longer foreplay and try new sexual styles and positions that will work in their 
unique situation. This is when the six weeks of sexual abstinence due to the 
hysterectomy was over. This was also a good time to talk to her husband about 
what she was experiencing sexually and to include him was the most important 
part of this new sexual journey. This fits in with literature which underlines 
teaching and encouraging communication between partners about their sexual 
experiences, sexual desires and boundaries (Masters & Johnson, 1970; Weinera 
& Avery-Clark, 2014). 
 COUPLES AND SEX THERAPY   
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Although the focus of this research study was primarily on the breast cancer 
patient and her own needs and experiences during individual sessions, the 
therapist has tried to see the patient’s partner at least once in a therapeutic 
session.  The aim with a couple’s session was of getting information from the 
partner regarding his experience of his partner’s cancer, but also to educate both 
partners about the  diagnosis and treatments side-effects.  It was also to promote 
their mutual coping and support processes and include treatment modalities that 
make use of specific sex therapy methods that address open sexual 
communication skills and sexual and body image concerns (Hummel et al, 2015; 
Mann & Badr, 2008; Nicolas, 2013).   
Theme 17: Coupes Intervention when Treating Breast Cancer Patients: 
As a therapist working with breast cancer patients, it is important to understand 
that regardless of the cancer- and cancer treatment stage of your patient, the 
cancer self creates unique challenges for the marital relationship.  Successful 
adjustment will be influenced by how well the couple integrates the cancer into 
their lives and relationship, even more than the circumstances of the cancer self 
(Manne & Badr, 2008). Within this framework I have noticed that each partner had 
a different perception and interpretation of the meaning and influence of the breast 
cancer on their lives with completely different expectations of their partners and 
their support. As a couple, they also had a different pace with their own adaptation 
and acceptance of the cancer experience.    
Patient II who had a very well adapted marriage for 39 years has reported, from 
our first psycho-therapeutic session, the good and appreciated support from her 
husband. She has also made her own conclusion regarding her better emotional 
and sexual adaptation during her cancer treatment, saying that it was because of 
his “soft approach” and effective support both sexually and emotionally. Because 
of this on-going support the whole time that she received the treatment and during 
our therapeutic process, she has never requested or mentioned that she would 
like to involve her husband in our therapy sessions. She did report that after each 
of our sessions she told him what we had discussed and that he was always 
interested in our discussions.   
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Patient III on the other hand, has asked from the very first session whether it 
would be possible for the therapist to see her husband:   
“…to explain to him what I am going through with my cancer and what I feel …He 
doesn’t understand my emotions and fears.”  
She has also asked whether I would please speak to him about their sex life, for 
she would like to improve it.   
I saw this patient’s husband after the fifth individual therapeutic session on his own 
although the session was booked for both of them. There was a change in her 
chemo time and the chemo sister came to fetch her in our scheduled time. The 
session was then held with the husband alone, which had turned out to be a good 
session, with good feedback from the patient after the session. The most 
important and positive information from the husband was that he was looking 
forward to this session to understand his wife better, saying:   
“…I know I am far more practical than my wife and do not always understand her 
emotional reactions and what to do about it.”   
Without asking any questions he explained that they had already made some 
practical adjustments along the way and that he was helping with the housework 
and cooking more than previously. He said that he realised that the breast cancer 
diagnosis was very traumatic for his wife, especially her hair falling out and the 
absence of her daughter and that they were both worried about their financial 
situation. I explained to him the side-effects of the chemotherapy (e.g. the 
tiredness and chemo-fog) and her emotional reactions and fears regarding her 
cancer and future and emphasised the chronicity of the cancer and effects in 
terms of their marriage and sexual functioning. I told him that his wife had confided 
in me about their sex life (or the lack thereof) and asked to talk to him regarding 
that. It was explained to him that despite his chronic illness and accompanying 
sexual problems they could still have a healthy sex life, but they will have to make 
an effort to talk to each other about their needs and expectations, taking into 
consideration her cancer and making plans together on how to improve their 
sexual and intimate functioning. They could consider reading books about sex or 
try out new ways of engaging in sexual activities without intercourse. I suggested 
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that he should make an appointment with an urologist to sort out his (chronic) 
sexual problems and because this was out of the range of the psychologist, the 
patient had to be referred to a medical specialist (Derzko et al., 2007).   
I have encouraged him to communicate more freely and openly with his wife about 
his and her emotions, reminding him that different people have different emotional 
needs and that he needed to ask her what she saw as support and what her 
expectations of him were. It was explained to him that a marital relationship is a 
source that a person can “draw on” in a crisis situation (Manne et al., 2008), and 
when there are negative feelings and resentment towards a partner, as was the 
case with his wife, feeling he is not properly supporting her the way he should it 
will negatively influence her treatment outcome and future adaptation. Her 
uncertainty and anxiety regarding the scheduled breast operation was also 
explained in terms of the normal reaction of anxiety in this type of situation and 
that there are ways to manage it, e.g. to relax through deep breathing, to engage 
in “outside” activities like walking or driving around together and for her to plan and 
prepare his meals for when she is in hospital, making her feel more in control. His 
support during this time before the surgery would help her to cope emotionally and 
prepare herself for the operation and I explained to him that feeling close to and 
being cared for by a partner can make this whole cancer experience more 
bearable (Nicolas, 2013).   
One of the aims of the session was to initiate conversation with the patient’s 
partner about their sexual functioning and for him to feel comfortable discussing 
their sexual matters.  Another goal was giving education and basic information 
about their current situation and to look at alternatives to manage and adapt to the 
situation (Derogatis & Kourlesis, 1981; Park et al., 2009; Zhou et al., 2015).   
At the end of the session he said: 
“I never thought that I would talk about sex to a ‘stranger’ and yet it I feel so 
relieved that we have spoken about it …it was bothering me for such a long time.”   
He also said that he was willing to attend to his sexual problems and make an 
effort to better their sex life, also saying:    
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“…I feel that I know more how to help and understand my wife...” 
Patient I - There was a scheduled session booked for the couple with the aim of 
sex therapy. Information from the husband verifying what his wife had experienced 
concerning the lack of proper information from the oncology team about her sexual 
changes before, during or after the cancer treatment. He confirmed that it had put 
unnecessary pressure on them as a couple, not knowing what to expect and what 
was normal and what was not. They also didn’t know what timeframe to put on 
their sexual changes and whether it would change back to how it was before or if it 
was a permanent situation. This lack of communication was confirmed in studies 
showing many participants reporting that they were not properly prepared for 
sexual changes or equipped to cope with it, leading the couple to feel negative 
and unprepared for the unexpected, often long-term sexual side-effects of cancer 
(Flynn et al., 2012; Gilbert et al., 2014; Hill et al., 2010).   
The couple stated that they did not talk about the patient’s lack of sexual interest 
and sexual functioning during the active treatment or survivorship phase. Neither 
did they discuss changes in her body, admitting that it was easier to talk ‘through’ 
a professional person regarding their uncertainties and questions. It was noticed 
with this couple that their impaired communication about their sexual problems 
and changes caused them psychological distress and influenced their marital 
satisfaction in a negative way (Hordern & Currow, 2003; Milbury & Badr, 2013; 
Murray, 2010).     
We agreed that the aim of the session would mainly be to explain specific side-
effects of cancer such as menopause and to improve their sexual and intimate 
communication. During the course of the session the couple started to speak 
freely and comfortably about their emotions and thoughts about sex and sexuality 
throughout the whole cancer excursion. Both were frustrated and uninformed 
regarding the patient’s complete lack of libido due to her menopause, and could 
not understand their lack of sexual activities.  Before the cancer they had a good 
and satisfactory sex life and they haven’t expected this. It was explained to them 
that this is not an abnormal occurrence because cancer is such a traumatic 
disease which affects all forms of functioning, sex life included, and that 
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oncologists do not always discuss sexual matters or prepare the patient for sexual 
side-effects.   
Chemo related premature menopause was explained in terms of the biological 
side-effects and immediate effect on the body and especially the impact on the 
libido, which is a very big loss in their relationship, leaving the husband relieved 
that her absence of a libido had nothing to do with him or her feelings about him. It 
was a “mere” side-effect of the chemotherapy. As a couple they were encouraged 
to explore the changes and losses in their sexuality and intimacy due to the cancer 
and communicate it with each other and share their feelings regarding it.   
The husband said that he now understood the chronicity of his wife’s cancer and 
that they both have to work hard to create a new and exciting status quo that will 
work for both of them. I also mentioned to the husband that he had to 
acknowledge his own losses regarding their changed and challenged sexual 
functioning as well as that of his wife’s. By understanding their “new” sexuality, 
they could use it to grow individually and as a couple. I have experienced both the 
patient and her husband to have exceptionally good insight in this therapeutic 
session and they both expressed their enthusiasm to start implementing the new 
skills.   
Patient IV - This patient requested that her partner had to participate in one 
session so that he could understand what she was going through in terms of her 
emotions and especially her depression. She also wanted him to understand how 
the cancer treatment had affected her self-esteem and sexuality. She wanted to 
hear from her partner himself how he felt about their sexual relationship.   During 
the couple’s session the partner explained that the emotional side of the cancer 
was the worst for him, seeing her suffer like that and:  
“…not always knowing what to do or how to help her…it was hard for me to see 
her enduring so much turmoil.”   
Because the patient was so depressed, the therapist had given her time to talk 
about how she felt and then explained to her partner the relationship between 
depression and cancer treatment, especially chemotherapy which could cause a 
chemical depression (Brem & Kumar, 2011; Fann et al., 2008; Navari et al., 2008). 
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It was also explained that with her history of depression she was more prone to 
develop depression after the cancer treatment, but that there were interventions to 
relieve the symptoms of depression such as medication which they both were 
familiar with and therapeutic techniques.  I also suggested possible alternatives 
such as admittance in a clinic for mood disorders. We discussed the temporary 
changes after her breast cancer treatment such as her tiredness and short term 
memory incapacitation, as well as some of the permanent changes, especially 
body image, which the patient had a big problem with. It was explained to them 
that they should allow themselves to go through an emotional process to make 
peace with and accept their losses and changes due to the breast cancer and 
share their feelings with each other. Communication is a practical way to start, e.g. 
exchanging needs and expectations, instead of expecting your partner “to know” 
what you are feeling or what you need. It is important to talk about emotions and 
not to feel that you have to be strong all the time.  Showing emotions is not a sign 
of weakness, but a commitment to understand and support each other.   
Both partners were comfortable to speak about their sexuality and they both 
agreed that their sex life was not as good as it could be due to their low libidos. In 
both cases it was because of biological reasons. They never felt threatened by it 
because their intimate relationship and functioning was good and well established, 
yet the patient felt they could improve their sexual functioning. Her unexpected 
menopause and relevant symptoms were explained in terms of the psychological 
implications like mood swings and biological implications like the lack of vaginal 
lubrication, with emphasis on the influence it had on her already low libido. It was 
important for the patient and the partner to know that the patient’s low libido had 
nothing to do with their relationship or how she felt about her partner, but 
everything to do with the breast cancer and treatment and also in her case, the 
depression and anti-depressant (Dean, 2008; Deeks et al., 2011; Rivas-Vazquez 
et al., 2000). It was explained that because of the biological nature of premature 
menopause, it would require changes in their sexual behaviour, e.g. to employ 
different behavioural techniques such as extended foreplay and the use of 
generous vaginal lubrication. I experienced this couple more open-minded when it 
came to sexual activities and they had no problems with more flexible thoughts 
and actions concerning their sex life. I could therefore use some principles of 
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Hughes (2008) suggesting more liberal alternatives to help the patient with her low 
libido and lack of sexual functioning, for instance, experiencing with new 
alternatives such as watching erotic movies together or the use of a vibrator for 
extra stimulation. It was important for both of them to understand that it might take 
longer now and more effort for the patient to get physically ready for intercourse. 
They were also encouraged to work around the patient’s severe tiredness by 
setting up a time table for their sexual activities during the time of the day (or 
night) when the patient felt less stressed and tired and to make an effort to 
participate in sexual activities again to keep their relationship on a healthy level. It 
was explained that to develop a new and more active sexual life will take time and 
effort and creativity and the more they talked about their sexual thoughts and 
needs and “plans” to improve their sex life, the more “normal” and part of their 
lives it will become. The patient talked again about her negative body-image, 
especially the scar and weight gain, and although her partner had assured her that 
it made no difference in his feelings about her, I explained that to “side-step” the 
problem, she could wear something like a camisole to bed to “hide” the scar and to 
take the focus away from her scar. They both agreed to commit themselves to 
working towards a better functioning and to use creativity and effort to improve 
their sex life.   
Patient V asked from the first session if her husband could come to hear from a 
professional person what she went through with her cancer and was still going 
through. She was very disappointed when he didn’t want to come to a session in 
the beginning, but she had convinced him and he did participate later in a 
therapeutic session. He accompanied her during the fourth therapeutic session 
and made it very clear that he was only there because his wife had asked him to 
come, he had no questions (when asked) and said that he would listen to what will 
be said in therapy. The patient then requested that I should explain to him what 
were discussed during the previous sessions regarding the changes in her body 
especially due to the menopause and what they could expect in terms of her 
sexually in the future. I started with the menopausal symptoms, because it was so 
unexpected and had such a devastating impact on their sex life. I explained the 
biological side-effects, namely hot flushes (which she experienced a lot), problems 
with her sleep pattern, weight gain and a possible slower metabolism and a 
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decrease in her natural sex drive as well as a lack of vaginal lubrication. I 
explained to him that his wife was in full menopause, because of the cancer 
treatment and that her body would sexually react in a different way and that the 
menopausal symptoms were permanent which would mean permanent changes 
from both of them. I also explained the subsequent sexual side-effects of the 
hormone medication that she would be using for the next five years. She would 
need his support and understanding to make peace and accept her body and still 
be a good sex partner to him. Menopause did not mean that they would not have a 
good and regular sex life, but there would be differences and changes and by 
accepting that they will be able to develop new skills for a new sexual status quo. 
One of the changes due to menopause is the use of vaginal lubrication and 
moisturising during sexual activities because her body won’t produce natural 
lubrication anymore and that they can also consider different techniques or “aids” 
such as dilators and vibrators or erotic reading or movies to enhance their sex life 
again. This was based on the principles of giving basic information about the 
couples sexual situation and challenges and to provide them with new alternatives 
(Derogatis & Kourlesis, 1981; Hughes, 2008). They were encouraged to make a 
conscious effort to explore the changes in their sexuality and intimacy and 
communicate their desires and needs to each other (Fobair & Spiegel, 2009; 
Hordern & Currow, 2003; Hughes et al., 2011).   
I explained to them that by talking to each other about how they felt or what they 
experienced they could develop an emotional closeness which can enhance their 
overall relationship and which they can “draw” from when they are in a crisis (Hill 
et al., 2010; Manne and Badr; 2008; Mann et al., 2014). They both understood that 
neither of them could be the same (sexually or emotionally) as before the cancer, 
and that only through an emotional process of grieving, accepting and making 
peace with the breast cancer, will they be able to “create” a new way of living and 
growing as a couple. It was important for them to look at themselves as a team 
working together towards an end goal and not just an individual on an individual 
journey. The patient explained to her husband that she was scared that he might 
reject her sexually and that she sometimes felt self-conscious about all her 
physical changes and that she needed to hear from him that he still wanted her 
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the way she was. His reply was that he was still very attracted to her sexually. He 
said:   
“…I only understand now the adjustments that we have to make …I never thought 
about any of it in this light…”  
He also said:  
“I will make an effort to accommodate the changes and I understand your 
emotional reactions better.”  
The patient said that by hearing him say this already made her feel more accepted 
by him. They were reminded that breast cancer is a chronic condition that will 
“ask” for life-long adaptions through learning and implementing new skills, that it 
will take time and remains a team effort.   
7.4.1.5  END OF THERAPY: THE FINAL VOICES  
This is an overall feedback given from the five breast cancer patients about their 
therapeutic experiences. Most of the feedback was acquired during our last 
sessions through specifically asking about their experiences during the sessions. 
They were invited to give their opinions and to make comments regarding these 
experiences. I also acknowledged other feedback that was given spontaneously 
by the patients after some of their other sessions. The feedback was divided in 
general feedback and sexual feedback.   
The feedback of Patients II and III:   
Patient II:  
 General Feedback:   
 
She commented during the third session that she felt more in control of her 
emotions and life, saying:   
“…the mere fact that we speak every three weeks gives me the courage to carry 
on, knowing that I can vent my feelings to somebody that understands the process 
of chemotherapy and somebody that is outside of my family …speaking about the 
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cancer treatment and getting information about it, makes it less unfamiliar and 
scary and worrying.”   
During our last session, she said that by the time that she had to go for her second 
surgery (the radical mastectomy), she understood what “normal anticipation” 
anxiety meant and could then handle the anxiety about the surgery and the time 
away from her family more comfortably when in hospital. She said: 
“I went back in my head to all the stress handling skills that you have taught me, 
especially the time management and how to control my thoughts through focusing 
away from my stress and to talk about my emotions.” 
She said that those skills helped her a great deal through her ordeal with the 
surgery and long wait for the radiation therapy. She said that the two months while 
she had to wait for the results of the surgery was also very tense for her, but she 
could put her fears in the framework that it is “normal” to be scared when waiting 
for medical results. She said because of the therapy: 
“…I now talk very easily about my cancer experience and emotions to others… 
and it is not just helping me to cope but I also help other people now with their 
emotional hardship …I have a completely different outlook on life after the cancer 
and I feel that I can make a difference in other people’s lives.”   
The feedback from this patient regarding the therapeutic sessions and her healing 
process was:   
“…because of our sessions I could understand step by step what was happening 
to me and could prepare myself for every phase during the treatment process…I 
cannot even imagine how different it would have been if it was not for the sessions 
because I was so “clueless” about everything …most of the things that we had 
discussed during the sessions and the skills that I have learned, were not 
previously part of my frame of mind or practical world.”  
She said that to her, one of the most important parts of the therapy was the 
“practical” advise that she got, for example the time management skills and “the 
resting” during the times that she was so tired without feeling guilty.  She said 
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knowing that if she didn’t understand something she could ask me the next time 
and it made her feel more relaxed. She mentioned that something she found very 
positive about therapy was that she could talk about anything without feeling guilty 
or ashamed and that by talking to a therapist, she did not have to “burden” her 
family with certain things, saying:   
“…I have also learned to listen to my own body and talk to other people around 
me about how I feel and also allow myself more things in life without feeling 
unnecessary guilt and that I don’t think as rigidly as before.” She ended this off by 
saying:   
“I am extremely thankful for the privilege to have been accepted for this study and 
being part of a process that might help other breast cancer patients …I don’t think 
that I would have known to go and see somebody like a psychologist…”  
 Relationship and Sexual Feedback:   
She said because we talked about their sexual activity right through the 
therapeutic process from the beginning of the sessions,  
“…it made the changes in my body more ‘natural’ and less scary for me and my 
husband.”   
She said she appreciated the fact that I have made the intimate and sexual side 
part of the therapy,  
“I don’t think that I would ever have just talked about that to anybody, knowing now 
how the treatment can affect my sexuality, I can prepare myself for the changes to 
come…”   
Patient III: 
 General Feedback:   
 
At the end of the first session the patient had already said that she was glad that 
she could talk about her feelings regarding her cancer and other personal issues 
and after the third session she said:  
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“…If you haven’t offered your services in the beginning of the treatment, I don’t 
think I would have ever spoken about my problems to anyone…every time that I 
have spoken to you, I felt relieved, especially when I realised that we can work on 
the problems and that there are ways to deal with it.” She also said:   
 
“...for me, the cancer treatment is more ‘complete’ with our sessions because no 
matter what comes up, even at home, I can come and discuss it with you.”   
 
Her feedback after the session before the surgery was that she felt better for just 
talking about her anxiety and that she would do the practical things that was 
discussed during the session like preparing her husband’s food before her surgery 
and to do something to focus away from her anxiety. She understood the anxiety 
and did not have to “fight” it but could let it go and concentrate on the surgery and 
on getting well. She said that she learned that depression is not something to feel 
ashamed of and she was looking forward to start with her anti-depressant to feel 
better, saying:   
 
“…through learning to focus on the ‘now’ and to accept and control my negative 
thoughts and focus on more positive thoughts, I feel that my emotions are more 
manageable and bearable …through talking to you I have learned to understand 
my stress better and that there are always alternatives to handle a stressful 
situation …I feel better and lighter when I speak about my feelings.”  
 
She also said that for the first time she had identified friends and family with whom 
she could talk to and share her emotions without feeling guilty.   
 
About the sessions she said:     
 
“…I have never before seen a psychologist and did not even know what they were 
doing …I feel so blessed to have been able to see you and understand the cancer 
better and my husband and daughter.”   
 
 Relationship and Sexual Feedback:   
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“…for the first time, me and my husband is in a much better relationship with each 
other, we speak more about our emotions and what we feel …one of the positive 
things that had come from my cancer is a better relationship between me and my 
husband …we have started talking about sex and have decided that after the 
cancer treatment is over, he will go to a urologist…” 
She felt that the psychotherapeutic session with her husband had made a big 
impression on him, saying:   
“…he is making an effort to understand me and the cancer and he supported me 
much better than in the beginning …there is a big change in our relationship, even 
our communication about our sex life has improved drastically.”  
She said that the mere fact that they were talking about their sexual relationship, 
made it a much more approachable topic between the two of them: 
“…I feel that at last we are going to do something about our sex life and I am 
looking forward to it. “  
Patient I:   
 General Feedback:   
She said at the end of the session:   
“…just talking to somebody with knowledge about the psychological side of breast 
cancer already makes me feel better and more ’normal’ …I am looking forward to 
have therapeutic sessions with you regarding my issues around the cancer and 
my functioning now.”   
It was two years after her last treatment and she said:  
“I feel that my rhythm is more or less back to where it was before the cancer 
…being back at work and being able to participate in all my ‘normal’ daily activities 
makes me feel more like myself again.” 
She said that the psychotherapeutic sessions helped her understand that she will 
be confronted with the aftermath of cancer for the rest of her life, but that she has 
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learned to accept this through conscious efforts to grieve her losses and new 
coping skills for a new but ‘unwanted’ chronic situation. She said:   
“It was important for me to work through my trauma step by step by talking about it 
and working through all the emotions before making peace with it and accepting 
it.”   
She also stated that by receiving relevant information and knowledge regarding 
the effects of cancer and the treatment, especially on her emotions and sexual 
functioning, was one of the things that she valued most during the therapeutic 
process, saying:   
“…there has opened a lot of doors for me in terms of understanding what I am 
experiencing and why …I have learned to look at my life goals from different 
angles and had to redefine and adjust some of it, especially in terms of my work.”    
In summarising, she described the therapeutic process, saying:   
“It was a lifeline to grab onto when I was drowning in a sea of emotions, which 
dragged me back to the surface again! …By understanding the reality of what the 
cancer was doing to me and to be able to put my own feelings and experiences in 
context was what brought me back to the ‘surface’.” 
 Relationship and Sexual feedback:   
She said that both she and her husband have benefited from the session 
regarding their sexual functioning,   
“…we were both clueless as to what was happening to us sexually 
…understanding the biological and psychological side-effects of early menopause 
on my sexuality and especially my lack of libido, has clarified a lot of my behaviour 
for me and my husband …We now look at our sexuality through the framework of 
the cancer instead of taking it personally and it makes sense to develop a new 
outlook on not only sex, but also intimacy…” 
Patient IV:  
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Because the patient’s depression made out such a large part of her functioning, 
that the most of her feedback revolved around her depression and then about the 
cancer. 
 General Feedback:   
The patient replied, when asked about for feedback, that: 
“…talking to you from the first session did me very good …every time that we 
speak about my depression and the fact that I can do something about it, made 
me feel stronger and less ‘abnormal’ …knowing and understanding the influence 
of depression on my life and relationship also made me feel more positive about 
myself.”    
The patient said about the therapeutic process:   
“…It was helping me so much with myself and I feel much more ’clever’ now in 
how to understand and handle myself in terms of my depression, especially after 
the cancer.” 
To this patient, knowledge had played a big part in her therapeutic process, she 
felt that if she knew and understood things, whether it was the depression or the 
cancer treatment, she could cope better and be more comfortable with it. She 
said:  
“…I understand now that some of my symptoms like the tiredness and lack of 
energy and drive and even lower sex drive can be both part of my depression and 
side-effects of the chemotherapy, and it makes me feel less of a victim of myself 
and circumstances.”    
She also requested further sessions with me, saying that she felt that it would help 
her to talk about her emotions from time to time with somebody outside her 
relationship and friends and that it would benefit the recovery of her depression 
and the reinforcement of her new skills.      
 Relationship and Sexual Feedback:   
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This patient said that she understood that different things were influencing her 
sexuality and sexual activities, such as her depression, the cancer treatment and 
her low and “affected” self- and body-image. She said after the session with her 
partner that they started to improve their intimacy even more,  
“We have started to participate in activities with much more touching and sexual 
closeness without being necessary sexually active …I am feeling better about 
myself already and as a couple we are feeling much closer to each other.”    
Patient V:   
 General Feedback:   
After our first session she said:   
“I still have so much to talk about and to ask …but feel very excited about the 
sessions and I already feel much ‘lighter’ …thank you! …I need to talk about my 
emotions and hardship I went through during my breast cancer.”  
She said:   
“…I felt better after every session with you and just the opportunity to talk about 
the treatment and my experience of it made me feel ‘lighter’ and less abnormal.”   
She said that one skill she used a lot was the principle that she would be 
‘different’. She would be different as a person, a mother and a wife, and when 
something new came up she would react to it differently than before.  
“…I remember this principle and consciously try to replace an old or inappropriate 
thought or behaviour with a ‘new’ behaviour and accepting it and making peace 
with it.”    
She also gave feedback about the time before the last session where she had to 
go through all her tests and scans, and although she was anxious and scared, she 
kept in mind that it was ‘normal’ which helped her to cope with and manage it and 
feeling good afterward when she got the good news that everything was good and 
she was still in remission. She said she felt so ‘proud’ of herself for handling 
herself emotionally better than before. She said that the opportunity to have 
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spoken about her child and ask all her questions about handling him was a very 
positive experience because:    
“…I didn’t know where else to talk about him, I had so many guilt feelings about 
him and me being sick, especially now that I am cancer free, I feel ashamed to still 
feel stressed about dying from cancer and I don’t feel to share this with anybody 
else …but can now accept the reality that it is normal and realistic to be scared of 
our future because of my cancer and also not feel guilty about my feelings 
regarding my child and my cancer …for me one of the biggest perks of going to 
therapy is speaking about everything and anything that you feel you cannot speak 
to anybody else without feeling being judged or being frowned upon.”   
Another feedback from her was the fact that after the sessions:    
“…I felt so ‘normal’ for hearing that other woman in my situation also feels the way 
I do and I am not the only one …receiving information about all the unfamiliar 
things that was happening to me made me more relaxed and have put my mind to 
rest about things like my on-going tiredness and lack of energy and menopause, 
which I understood nothing of before the therapy.” 
She said that when she started with therapy:   
“…I was so depressed and anxious, but understand it much better now, I also feel 
much better, more in control of my own body and of my own thoughts and just all 
together lighter …I feel positive about therapeutic sessions because it helped me 
and my husband and son a lot during the last part of my cancer journey…”   
She said because she felt so positive about therapy, she would like to continue 
with the sessions, 
“…Seeing you makes me feel comfortable and we already have a therapeutic 
relationship …I would like to from time to time feel supported by a professional 
person and would like to express my feelings and possible questions or worries in 
a therapeutic environment …I feel empowered by these sessions.”   
 Relationship and Sexual Feedback:    
409 
 
After the individual sex therapy session she said:   
“I feel very positive about the information about my sexual functioning and much 
‘lighter’ about my whole sexuality as before I came in here today…” 
After the couple’s session she gave very positive feedback regarding her husband, 
who was very unapproachable and curt in the beginning of their mutual session, 
saying:   
“He has experienced the session rather positive and that after the session I could 
see a change in his behaviour …we talk more to each other and he is making an 
effort to spend more time at home with me …I feel more accepted and understood 
by him, although I know that there is still a long road ahead of us …for the first 
time since my cancer, I feel that he is on board…”   
Even with our last session, which was nine months after the couple’s session, she 
said:   
“…We are functioning much better as a couple now, we talk more, do more things 
together and my husband is more attentive to me than before …even sexually, 
and I can see a huge difference.   
She said:  
“…even if it is so long after our session my husband is still committed to his ‘new’ 
behaviour …both of us still use the therapeutic guidelines from our mutual session 
and the fact that he is more understanding and supportive makes me feel much 
better in general.”  
7.5 PRESENTATION AND INTERPRETATION OF THE 
QUANTITATIVE RESULTS 
The results of the standardised questionnaires, the Female Sexual Functioning 
Index (FSFI) and the Hospital Anxiety and Depression Scale (HADS) will be 
discussed.  These two questionnaires were included in the study for gathering and 
measuring data regarding sexual functioning, depression and anxiety from the five 
breast cancer patients.  The questionnaires were given and explained to study 
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participants during their first official session where they took it home to complete.   
Using both qualitative and quantitative methods abled the researcher to compare 
what the patients genuinely experienced and was willing to verbalise during an 
open interview as opposed to what a “scientific” questionnaire reveals about the 
same topic.   
7.5.1. HADS 
7.5.1.1 The depression sub-scale 
From the interviews, Patient I said that she felt severely down and depressed at 
the time of her treatment, but became better after the end of the treatment and in 
her remission state.  Her depression score on the HADS, which she filled in at the 
beginning of the study, (between the first and second session) was a 7 which was 
in the normal range. Her score reflected her current emotional state during the 
psychotherapeutic stage which was not as depressed as she felt during and just 
after her treatment. She was also, at the time of this study, on an anti-depressant.     
Patient II never developed severe symptoms of depression during her treatment 
trajectory although she sometimes felt down and tearful and emotional, especially 
because of the tiredness during her chemotherapy.  Her score on the HADS was a 
4 on the depression side, which fell into the (low) normal scoring of 0 – 7 and fitted 
in with her mood at the beginning of her treatment.   
Patient III experienced her cancer and cancer treatment from the beginning as 
very emotional, and was very tearful for most of the time during the earlier 
sessions. She was diagnosed with a major depression according to the DSM-5 
criteria during our last session.  Her score on the HADS, which she filled in in the 
beginning of the therapeutic process, was a 6 on the depression side, which fell 
into the normal range between 0 and 7. This was a true indication of her emotional 
status in the beginning of the sessions, although tearful and sad, she was not 
clinically depressed.  There was a clear change from only feelings of depression in 
the beginning of the treatment regime, to the end where she presented with a full- 
scale major depression due to the cancer and cancer treatment.   
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Patient IV:  Her score on the HADS which she filled in in the beginning of our 
sessions was 13 which was in the abnormal category and was a true reflection of 
her mood status when we started with the sessions. Although she presented with 
symptoms of depression from the beginning of our sessions, which was also the 
reason why she was referred, she was already on an anti-depressant and under 
treatment of a psychiatrist. During our therapeutic process, there was a need to 
assess her symptoms again for depression (according to the DSM-5 criteria) 
because her mood was spiralling down and mood became much worse.  
Patient V was feeling depressed when she was referred to me by her oncologist.  
She was evaluated by the researcher in terms of her symptoms and was found 
presenting with all the DSM-5 symptoms of a Major Depression.  In spite of her 
clinical diagnosis of depression, her score on the HADS on the depression side 
was only 6, not corresponding with her true symptoms and feelings of depression.  
Out of the five patients, one patient’s results of the HADS questionnaire, regarding 
the depression sub-scale, didn’t correspond with her true clinical symptoms.   
7.5.1.2 Anxiety sub-scale   
Both Patients II and III tested within the normal range of anxiety on the HADS, 
which was not a completely true reflection of how they felt in terms of anxiety. 
They were both anxious enough to have complained about it and for me to feel 
that it must be addressed in therapy.   
Patient I was diagnosed with, and treated for a general anxiety disorder by the 
time that we started with our sessions.  The anti-depressant Cipralex 20 mg was 
prescribed by her psychiatrist. Her score on the anxiety side of the HADS was 6, 
in line with how she felt when I started seeing her in therapy. She said that 
although she was still having her anxious moments, it was more under control with 
the medication and sessions with her psychiatrist.   
Patient IV was from the beginning of our sessions both depressed and anxious 
and tested 13 on the anxiety side of the HADS which is in the abnormal range.   
This was representative of her anxiousness that she felt during the time of the test.   
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Although Patient V experienced high levels of anxiety during the beginning of the 
therapeutic process, her anxiety score was a 6 on the HADS which falls in the 
normal range, not indicating her symptoms of anxiety.    
Three of the five cancer patients did not have representative anxiety scores on the 
HADS that agreed with their true feelings of anxiety.  This made it clear for the 
researcher to ask about anxiety (and depression) and not just rely on tests and 
tests results, for it might not be a true indication of a patient’s real experience of 
her mood.    
7.5.2 The female sexual function index (FSFI) 
Patient II:  Her score on the FSFI was 51.8 which indicated that she did not suffer 
from a female sexual dysfunction (a score ≤ 26.55 is classified as FSD), which 
corresponded with what she said during the sessions regarding her sexual 
functioning.    
 Patient III had previous sexual problems (before the breast cancer diagnosis) due 
to marital difficulties and physical conditions. Both her and her husband suffered 
from chronic diseases that were not under control. This patient has scored 19.6 
with the FSFI scale, which fell in the range of female sexual dysfunction. This 
agreed with her sexual functioning at the time of the test and which she also 
experienced.   
Patient I experienced and expressed overwhelming sexual changes during and 
after her cancer treatment. She attained a low score on the FSFI scale, less van 
26.55, which indicated sexual dysfunction in all the areas of sexuality.   
Patient IV:  Her symptoms of depression overruled her sexual functioning and she 
didn’t give a lot of thought prior to the therapy about her sexual functioning. Her 
score on the FSFI scale was very low, indicating sexual dysfunction in all the 
areas that was tested, and agreed with her lack of sexual interest or activity during 
the time of the study.   
Patient V:  although there were changes in the way her body reacted to sexual 
stimuli and also in the frequency of their sexual activities, she said during the 
413 
 
sessions that they do not experience problems in their sexual functioning.  
Because of her recent hysterectomy and sexual abstinence, we had agreed that 
she would fill in the questionnaire as how their sexual activities and her sexual 
functioning were before the hysterectomy. She scored a 33.1 which was well 
above any sexual dysfunction and which matched what she said about their 
sexual functioning.   
The scores of the five cancer patients on The Female Sexual Function Index 
(FSFI) were in par with what the patients experienced and disclosed during the 
interviews.   
7.6 SUMMARY 
The purpose with this study was to discover and learn more about the personal 
and intimate experiences of the breast cancer patients, not just through their own 
“lived” experiences, but also through their own “uncut’ version of their stories. 
Since I was so closely involved with them because of our therapeutic sessions 
over a long period of time, and even per occasion with their life partners, I was 
able to encapsulate more insight and understanding of their cancer experiences 
and needs, as individuals, but also as part of a couple and family. I have learned 
that although there were mutual themes among their experiences, there was 
uniqueness in every one’s experience of her breast cancer. I feel humbled and 
honoured to have been allowed to be part of such a journey for my research study.  
I have listened and learned from each and every patient of mine and I have again 
experienced the true value of being passionate about my work. I feel I have a 
better understanding of the experiences of the breast cancer patient and even the 
biological side of breast cancer and all the new medical advances.    
I have also compared some of the main themes, such as depression, anxiety and 
sexual functioning with structured questionnaires (quantitative methods) as a 
validity procedure and to be able to integrate, compare and triangulate the results.    
In the following and final chapter I will discuss my findings and conclusions of the 
data and discuss the implications of the study and conclude the evidences of the 
study.   
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CHAPTER VIII 
Discussion and Conclusions 
In this chapter I will discuss the research findings of the study as well as the 
limitations and implications for practice and further research. The discussion will 
be divided in two sections, namely the biological- and psychological experience of 
the breast cancer patient and her need for psychological interventions and the 
implementing of psycho-therapeutic interventions. 
8.1  DISCUSSION  
The primary objective of the study was to explore in depth, the breast cancer 
patient’s lived experience and unique insights of her cancer journey and her 
expectations for psycho-oncologic interventions. The in-depth understanding of 
the findings was developed using qualitative analytical procedures described in 
Chapter VI.    
It was found that fewer qualitative case studies have been found to investigate the 
in-depth phenomena of the breast cancer experience, especially the quest for 
psycho-oncologic interventions (Edwards et al., 2008; Faller et al., 2013; Hersch et 
al., 2009). I have tried to fill this gap by using a methodology which allowed for a 
rich and in-depth perception to be heard through the voices of the five participants 
who had experienced the trauma of a diagnosis of breast cancer and breast 
cancer treatment.    
8.1.1  The biological and the psychological experiences of the breast 
cancer patients 
It was evident during the therapeutic process that the five patients and (per 
occasion) their partners, were willing to share their emotional and sexual 
experiences by speaking openly and without prompting about it. It appeared that 
each of the five breast cancer patients was committed and interested in being part 
of the research study and my impression was that they were looking forward to 
each session and that the sessions were marked by a natural flow in the 
interaction between us.   
415 
 
 The need to talk:   
The results of this research study indicated that regardless of the stage of the 
treatment or survivorship that the patients were in, they all had a prominent need 
to talk to a professional person about their emotional and sexual experiences 
regarding their breast cancer. All five patients experienced the news of their breast 
cancer diagnosis as traumatic and overwhelming.  The three patients already 
finished with their treatment felt that they never had the opportunity to have 
worked through the initial trauma of the diagnosis before they were confronted 
with the “extended” trauma of the different treatment modalities and chronicity of 
the illness.  These three patients disclosed that they did not know how to deal with 
the trauma of their diagnosis from the very beginning up to where they were when 
we started the sessions, leaving them feeling hopeless and out of control. The two 
patients that were undergoing their cancer treatments both expressed that they 
would never have known how to handle the stress of their diagnosis 
simultaneously with their “tough” treatments if it was not for the therapeutic 
sessions. This is evidence how important early on referencing to psychological 
services from the oncology team is (Kessler, 2014; Livneh, 2001; Swack, 2008). 
All five patients have clearly declared how glad they were for the opportunity to 
have spoken to me about everything, even things and experiences outside of the 
cancer regime, but especially over sensitive matters such as their deepest 
emotions, fears, dying and sexual issues.    
 Communication and relationship with the oncology team:   
It is evident from the findings of this study that all five patients confirmed that the 
communication between them and their oncology team (mainly their oncologists 
and surgeons) were unsatisfactory regarding sensitive matters as in their 
emotional- and sexual experiences and side-effects of their breast cancer. They 
perceive this lack of communication as negative, leaving them in a disposition to 
know what is happening to them and what they can expect of their future, leaving 
them unable to prepare for any emotional or sexual side-effects. Three of the five 
patients felt that their oncology team were not looking out for them or supported 
them on an emotional level. Apart from Patient IV, not one of the other patient’s 
oncologists or surgeons have suggested or referred them at any given time to a 
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psychologist or made any reference to conditions such as depression, anxiety or 
any form of sexual functioning regarding their cancer treatment. The two patients 
undergoing active treatment were very surprised that their sexuality would be 
compromised because of the treatment, not suspecting it at all. The other three 
patients “suffered” from sexual changes and challenges, but as one of them said “I 
suffered in silence”, they did not know what was happening and why, or even what 
could be done about it to improve it. All five of the patients were pleasantly 
surprised to have had the opportunity to speak about their sexual reactions, 
especially menopause and its influence on their bodies in a comfortable and 
professional environment. The three patients who were finished with their cancer 
treatment felt very strongly, that if they had better communication with their 
oncologists and received some information regarding their sexual functioning, they 
could have been saved a lot of unnecessary hardship, not just in themselves, but 
also in their relationships. All three felt that their unfamiliar and unexpected sexual 
and bodily changes (e.g. menopause) have contributed negatively to their 
emotional state of mind. According to Hewitt (2006) the oncology team can 
provide psychological resources proactively to cancer patients, including 
appropriate referrals. After completing their medical treatment, the three survivors 
reported that they had to learn about their psychological reactions and chronicity 
of the illness and support services on their own with no or little guidance from the 
medical personnel. It was noticeable during the course of the study that oncology 
teams did not discuss the psychological impact, such as mood disorders, or 
emotions or sexuality with their patients, leaving them completely in the dark 
regarding the bigger picture of cancer.  
Although cancer is the first field of medicine where psycho-social factors have 
been taken seriously, looking at the results regarding the lack of emotional 
communication and support between the breast cancer patient and the medical 
team and the absence of a proper referring system to disciplines such as 
psychology, it is evident that the oncology team still operates predominantly from a 
bio-medical model when treating cancer (Clark, 2010; Venter, 2014). In spite of 
new paradigms, such as holistic- and humanistic-evidence based medicine and 
sufficient evidence that breast cancer has profound psychological and sexual 
effects on the breast cancer patient, it is still evident that the communication skills 
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and approach from the oncology medical team to accommodate these effects, are 
still lacking (Clark, 2010; Fallowfield & Jenkins, 2015; Ghaemi, 2009; Mok et al., 
2008; Nicolas, 2013; Richards et al., 2014; Spiegel, 2008; Vetere, 2007). I have 
learned from the conversations from the study patients, that the medical team 
often does not have the proper knowledge to distinguish between the qualification 
and practises of social services and psychologists or clinical psychologists (that 
was discussed in Chapter I).    
 Depression and anxiety:    
Although there was no indication of a major depression or anxiety disorder when 
the study began, the two patients that was undergoing their cancer treatment had 
the opportunity to, throughout the cancer treatment and psychotherapeutic 
sessions, to talk about their mood and what they were experiencing. They 
received information during our sessions of what depression and anxiety are, 
especially what anticipation anxiety is and what symptoms to look out for, also as 
to what they could do should they develop a mood disorder. Patient III has 
developed depression during the later stage of her cancer treatment and was 
noticed by me and after an evaluation (checking of the DSM-5 criteria) she was 
diagnosed with a major depression and was referred to the oncologist for an anti-
depressant. It is my opinion that if this patient was not part of the study, the 
diagnosis of a major depression would have been neglected and she would not 
have undergone psychological treatment at all. Sadly this was the route of the 
other three participants (Patients I, IV and V) who had developed symptoms of 
depression and anxiety during and after their cancer treatment, but was not 
treated for these conditions, nor was it explained to them or acknowledged in any 
form from the oncology team. This has resulted in an underdiagnosed and 
undertreated condition or conditions which had incapacitated their complete 
functioning level, without any knowledge about how to overcome that or to 
proceed from there on. Because depression and anxiety are both treatable 
conditions, it is an unnecessary stress that the breast cancer patient or survivor 
must endure. These results was highlighted by a study done by Thompson and 
colleagues (2013) where they have found that depression in this cancer population 
is often under diagnosed and insufficiently treated and that prevention of 
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depression and anxiety through early diagnosis is therefore a worthwhile goal (Hill 
et al., 2010; Meier, 2010). Pre-morbid psychiatric history is a well–known risk 
factor in developing depression during and after breast cancer which was 
confirmed through the diagnosis of Patients I and IV. It was evident during the 
study that mood disorders played a big role during the treatment and afterwards in 
the lives of the breast cancer patient.    
Apart from depression and anxiety, all five patients experienced anticipation 
anxiety, without understanding it or knowing how to handle it, especially the two 
patients who were still busy with their treatment. They experienced severe 
anticipation anxiety before their breast surgery with incapacitated results on their 
current functioning and emotional status, influencing to a large extend their quality 
of life. The three patients finished with their treatment, also experienced 
anticipation anxiety regarding the regular blood tests, scans and other tests and 
follow-up appointments with their oncologists or other cancer specialists.  
During the sessions I experienced that the chronicity of the follow-ups and 
continuous angst regarding the results and their fear of recurrence, left them with 
many questions as how to deal with such on-going phenomena. Sadly for these 
three survivors, they had, not up to the sessions, had any relief in answering these 
questions.    
 Other side-effects and emotions worth taking about:  
The current study has found guilt feelings as another prominent emotion that 
breast cancer patients endure during their cancer treatment and are not always 
willing to talk about it with just anybody. The five study patients had all 
experienced guilt feelings to some degree during and after their cancer treatment 
for not being able to full-fill their roles as a mother or wife, causing them to 
experience feelings of hopelessness and worthlessness. The two patients who 
were still busy with their treatment had acute guilt feelings because they were so 
busy with their cancer treatment and side-effects and so were often tired that they 
were not there for their husbands regarding the household chores and care. It was 
also clear from the results of the study that the two mothers with young children 
had more intense guilt feelings regarding their children, especially the fact that 
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they were not as involved in their children’s lives as before the cancer, especially 
during their chemotherapies. Both felt that they had missed out on some aspects 
of their children’s lives during the time of their treatment, making them feel guilty 
even after the treatment had stopped.     
Guilt feelings also played a big part when it came to fear of death, which in this 
study was a central emotion. All five patients went through a period of intense fear 
of dying after they heard the diagnosis of their breast cancer. Patients II, III and IV 
made peace with their diagnosis and death after the initial shock of the diagnosis 
wore off, while Patients I and V kept on having fearful thoughts about dying and 
leaving their young children growing up without a mother. Apart from their fear of 
dying these two patients felt guilty about feeling scared of dying while their 
prognosis of their breast cancer was actually good and they were in remission, 
feeling that they might “temp fate” by being scared of dying. Again, while all five 
patients were scared of recurrence of their cancer, it was the two patients with 
younger children, who had severe anxiety regarding recurrence of the cancer and 
dying, leaving their children behind. Literature confirmed that young woman 
diagnosed with breast cancer are more prone to develop depression (Gnerlich et 
al., 2009; Hussein et al., 2013; Meier, 2010; Raque-Bogdan et al., 2015) and 
experience fear of cancer recurrence more than that of older women, mainly 
because of their children (Lebel et al., 2013). Guilt feelings and fear of dying were 
also a private matter to all of these patients not wanting to talk to anybody about it, 
feeling that people won’t necessarily understand it and also not wanting to 
“burden” their families with such negative and destructive feelings. They were glad 
for the opportunity to have been able to talk to me about it without feeling 
ashamed and understood it better within the cancer framework.     
Apart from outspoken mood experiences, this study highlighted the severe effects 
that chemotherapy has on the patient’s body and emotions especially fatigue. This 
was the one symptom that everyone in the study relentlessly experienced with far-
reaching consequences on every level of their functioning, biologically, 
psychologically and sexually. This was one of the topics that were discussed the 
most and the most intensely by all five patients in almost every session over the 
whole period of the therapeutic process. This is consistent with literature stating 
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that fatigue is one of the biggest post-treatment problems in breast cancer 
patients, and although it is usually acute, a large percentage of patients 
experience persistent fatigue after completion of treatment, even when in 
complete remission (Berger et al., 2015; Dimeo, 2008; Fallowfield & Jenkins, 
2015). Fatigue is a good example of a physical cancer treatment related side 
effect that effects a person’s emotions directly, e.g. all five patients felt guilty 
because of their severe fatigue and the incapacity on their overall functioning and 
the contribution to their feelings of depression and helplessness. It was also 
evident in this study, that when a patient understands a symptom or side-effect 
and is able to put it in a realistic framework, (e.g. fatigue is a common symptom of 
chemotherapy, it can continue after treatment, but there are skills to work around 
it), it becomes less traumatic and more bearable for the patient.     
 Family: marriage and children and social support:  
The importance of support from their family and friends were confirmed by all five 
patients, with emphasis on their partners and grown-up children, for providing 
them with much needed emotional support. Patient III had problems before the 
cancer with family relationships and marital problems and it was very clear to me 
that it had influenced her in a very negative way. It was evident to me that 
relationship problems that was present before a diagnosis, don’t just go away 
because of the cancer diagnosis, but in fact can worsen during the hardship of the 
cancer treatment. I observed that a lack of support from one’s husband and/or 
children can have a negative impact on a patient’s ability to adhere to her 
treatment and adaptation to the treatment process. Through the therapeutic 
process the relationship with this patient’s husband and children had improved 
ending in a much more positive note by the end of our sessions. It is my opinion 
that if this patient did not have the opportunity to have gone through the 
therapeutic process to help her through her cancer, she would not have the time 
or the knowledge to have sorted her relationship problems out on her own 
because of the demands of the cancer treatment. Patients I, II and III had good 
spousal relationships before their diagnosis and it continued to be good 
afterwards. All of them feeling that the cancer had in fact drew them closer to each 
other. Patient V had a very good relationship with her husband before the cancer, 
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but it changed during her treatment and afterwards because of a lack of support 
from him and an inability to understand her cancer and her emotional needs. This 
has left the patient with a lot of resentment towards her husband and was also one 
of the reasons that she developed serious mood symptoms and marital problems 
after the completion of her treatment, asking for a referral to see a psychologist. 
These findings indicate that emotional support and communication from the 
patient’s spouse are important aspects that enrich a breast cancer patient’s ability 
to go through the cancer treatment and adaptation to the illness and survivorship, 
but that they often need help dealing with problematic relationships.    
 Work and financial matters:    
The results of the current study showed the impact that breast cancer can have on 
the financial status of a cancer patient. Two of the three patients who underwent 
cancer treatment as private patients felt a lot of pressure to go to work during their 
treatments, especially the chemotherapy, regardless of how sick they felt, as not 
to jeopardise their jobs and maybe losing their income and then not being able to 
pay for their medical aids or bills. One of the state patients had to resign from her 
job due to the physical pressure of her type of work, losing her income, which was 
another burden on her and her family that they had to endure together with the 
stress of the cancer and cancer treatment. It was evident from the results of the 
study that work and the identity that a career provides plays a very important role 
especially during the treatment phase. The three patients, who were finished with 
their treatment, talked the most about their jobs and job-related challenges. (One 
patient took of one year while busy with her chemo).  One of the biggest 
challenges that they experienced was to be able to get up and go into the offices 
every day during their chemotherapy treatments, for that is when they felt the 
worst biologically, e.g. suffering from symptoms such as fatigue and chemo-fog. 
Apart from the negative experiences regarding chemotherapy and work, all three 
working patients have agreed that their work helped them to have coped during 
their treatment (and after) in providing them with collegial support, which they all 
experienced very positively. Going to work also helped them to have felt “very 
normal” by doing “normal” things, but the biggest advantage was the fact that they 
felt it helped them to focus away from the cancer experience.   
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 The topic of sex:   
The most common complaint amongst the five study patients regarding the 
influence of the cancer treatment on their sexuality was the fact that sex as a topic 
was never raised by their oncology team. The only mention that was made, but not 
necessarily discussed, was that of menopause as a side-effect of the chemo- and 
hormone therapy. The two patients still busy with their treatment didn’t experience 
any sexual changes yet, but were thankful for the opportunity to have talked about 
possible changes and challenges regarding their sexuality that they could expect 
and prepare themselves for it. They both said that they found it extremely 
liberating to have spoken to a neutral and professional person about sex and 
sexuality for they were not used to speak about sex to anybody. The therapist has 
found that by spontaneously talking about sex and using examples of other breast 
cancer patients and their sexual experiences during their treatments, has enabled 
them to engage in comfortable sexual conversations, to the extent that Patient III 
has also revealed her sexual problems from before the cancer diagnosis. The 
results from the study regarding the three patents who were finished with their 
treatments, was in line with recent literature that sexual problems and body-image 
changes are very prominent cancer treatment side-effects and can last for many 
years after successful treatment, but are not often accommodated by the oncology 
team (Emilee et al., 2011; Kuo et al., 2008; Park et al., 2009; Reece et al., 2010; 
Speer et al., 2005; Taylor et al., 2011; Usher et al., 2013).  
It was evident from the study that the three patients in remission experienced 
severe changes in their body image, especially because of the changes in their 
breasts and body weight, and their active sexual functioning, as in their lack of 
libido and menopausal symptoms. Al three patients said explicitly that although 
menopause was explained to them, the suddenness of it and the unexpectedness 
caught them unprepared, leaving them very vulnerable regarding their functioning 
as a sexual being. Results concerning the patient’s need to talk about, and 
actively do something about their sexual challenges, showed the importance of 
engaging your cancer patients in sexual conversations and as the professional 
person to lead the way in this line of conversations. Talking about the symptoms of 
menopause was also a topic that was very prominent during the study and the 
423 
 
effects that it has on self-image and emotional functioning of the breast cancer 
patient. It was evident in the study that breast cancer patients, because of their 
sexual challenges, wanted their partners to be part of their psycho-therapeutic 
process concerning their sexual changes, implicating that the therapist must make 
provision for inviting the partner to a session or some of the sessions. It was 
evident for me, regarding the sexual topic, that age did not play a part in the 
eagerness of the patients to discuss their sex lives and to learn new skills to 
improve the quality of it and that all five wanted to engage in good and healthy 
sexual activities.  
The results of the study with regards to the psychological and sexual side-effects 
from breast cancer treatments suggest that the quality of life of this population can 
be seriously compromised by it. By not recognising and accommodating these 
elements during the treatment by the oncology team can cause this population to 
suffer unnecessary psychologically in addition to an illness that has already 
affected and challenged them in a biological way.  
8.1.2  The psycho-oncologic interventions  
One of the most prominent observations that I have made during the study was 
the willingness and eagerness of the participants to engage in a 
psychotherapeutic process to talk about, and understand and manage the effect of 
their breast cancer treatment better and to “learn” to enhance their overall quality 
of life. It was evident that by engaging the patients in conversations about 
sensitive matters through spontaneously talking about what other breast cancer 
patients experience, even if they did not ask or mention specific topics, made them 
comfortable to discuss anything that they had issues with.   
Results from this study have shown that some people do not know what a 
psychologist or clinical psychologist does or his/her role in the treatment process 
of cancer. This was clear with Patients II and III, the state patients, but also to a 
lesser degree with the private practise patients, but once they have participated in, 
and understood the therapeutic process and experienced their own benefits during 
the psycho-therapeutic sessions with a clinical psychologist, they agreed that a 
psychologist can play an important and necessary role during the cancer 
treatment process. I realised that there is still a long way to go both in government 
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funded hospitals and in the private practice to introduce services like psychology 
when treating medical conditions, such as cancer. Patients I, IV and V, who were 
more familiar with what a psychologist do, were not introduced to or recommended 
the services of a psychologist during their treatment phase or even after their 
treatment, (apart from Patient IV), and was left to their own devices to deal with 
their psychological problems. All three patients revealed during therapy that they 
thought that they would have benefited from this service if they knew about it or 
could afford it, but it was not an option for them during their treatment and they 
didn’t have enough knowledge to realise the significance of participating in therapy 
during their active cancer treatment.    
Another prominent finding during this study regarding psychological intervention 
was the need of the patients to talk about their cancer experience and to share 
their emotions and fears and anxieties with a professional person who understood 
their hardship without feeling judged or feeling guilty talking about certain sensitive 
subjects. The importance of normalizing emotions and thoughts and experiences 
was very evident during the therapeutic sessions as was the patient’s relief when 
they realised that other patients in their situation or condition, have the same 
experiences and concerns and issues. I experienced that a big part of the 
psychological “healing’ process of the breast cancer patients was grounded in 
emotional expressing and the understanding of their own emotional experiences 
and for the therapist to communicate this understanding to them and putting their 
experiences in the framework of cancer and cancer treatment. It is extremely 
important for the patient to feel “normal” and to be perceived by other people as 
“normal” while going through a tough and unfamiliar and overwhelming period.   
Another therapeutic intervention that was received in a very positive light by the 
study patients was psycho-education. The mere giving of information and 
knowledge about concerns and subjects that the patients don’t have previous 
experience of made them feel relieved and knowledgeable about the matters and 
more in control of their bodies and unfamiliar situation. This observation agrees 
with my belief that “knowledge gives power” to any person in any given situation. I 
found that the topics the breast cancer patients most needed knowledge about 
was the specific side-effects of the cancer treatment, especially chemotherapy 
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such as fatigue and memory problems and the psychological and sexual side-
effects. Depression and anxiety were also two topics that needed a lot of 
explanation, as was menopause and premature menopause with their 
accompanied symptoms. In terms of sex therapy and sexual conversations all five 
patients had indicated their gratitude for being allowed to talk about it (the 
forbidden subject), but also learned new skills regarding their sexuality. I have 
observed a lot of relieve from the patients for being able to feel sexually more 
informed and liberated and “normal” in their new breast cancer status quo. It was 
also evident that learning to accept and improve their self-image and body-image 
made a huge difference in their overall sexual functioning and perceptions of 
themselves as sexual beings, despite their breast cancer. Again it was noticed that 
without engaging in formal sex therapy, by just giving the patient room to talk 
about sex and providing necessary and basic information, it can already solve 
some of the problems and improve their sex lives.   
This study highlighted the applicability of short term cognitive- and behavioural 
techniques when working with breast cancer patients, treating both psychological 
and sexual issues. By teaching breast cancer patients to be consciously aware of 
their thoughts and behaviours regarding their cancer experience and the ability to 
change or amend these thoughts and behaviours, can help them to accept and 
cope better with their situation and improve the overall quality of their lives. By 
teaching them coping skills, it provides them with a better change to adapt to and 
make peace with their new and chronic situation on a psychological healthier 
manner. Making use of cognitive and behaviour techniques in applying sex 
therapy was also observed in a positive light. It is my opinion that all five patients 
found cognitive and behavioural techniques easily understandable and practical, 
which could be seen from their feedback regarding interventions which they could 
implemented with success. This is consistent with findings in other studies 
regarding breast cancer and cognitive- and behavioural therapy (Anderson, 1992; 
Hummel et al., 2015; Mullan, 1985; Savard et al., 2005; Ussher et al., 2013).   
After the couple’s session, the feedback from the four patients (which husbands 
participate in one sex therapy session) was very good indicating the need to 
involve the significant other of the breast cancer patient and to acknowledge their 
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need to express their own experience and emotions of their partner’s cancer and 
their need for information regarding emotional support and sexual functioning. The 
response from the partners (through feedback of the patients) was that the sexual 
input during the session was very valuable for them, as was the general 
information regarding breast cancer and the treatment. A big advantage for both 
the partners and the patients was the knowledge of what to expect further in the 
future and the opportunity it was giving them to prepare for it and learn skills to 
handle it.    
It was noticed from the feedback of the patients that they experienced the practical 
“advise” regarding certain matters as very helpful and positive. Specific examples 
given by the patients were the time management skills with their fatigue, the 
changing of their short- and long term goals to more reachable goals, and 
incorporating new sexual behaviour, with specific mention to their self-image and 
over all sexuality.    
8.1.3  Implications of the study: strengths and limitations of the research 
8.1.3.1  Strengths   
The strengths of the research appear to be as follows:   
 Including patients from different ages and different stages of the cancer 
continuum (active treatment and survivorship) can be seen as a strength of 
the study for it provided in-depth information on the experiences of different 
age groups and different stages of breast cancer.  
 Including both private patients and state patients can be seen as possible 
strength of the study, for it enables the reader to experience both worlds of 
the breast cancer patient.    
 The qualitative approach of this study has enabled the voices of the breast 
cancer patients and survivors in terms of their experiences of the cancer 
and needs from the oncology team regarding psychological interventions, to 
be heard from a perspective of real “lived” experience.  
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 Because there is so little qualitative research done on psycho-oncologic 
interventions with breast cancer patients, especially on the sexual subject, 
this research enables formulation of new insights in a field that is ripe for 
studies of psychological interventions.  
 The fact that the researcher was also the therapist can be seen as an 
advantage of the study since I had first-hand experienced the real “lived” 
worlds of the patients (and partners) but also their reactions to and 
implementation of the therapeutic interventions.     
 The feedback session (the last therapeutic session) that was held with the 
five patients and which has provided the reader with rich in-depth 
information in their own words regarding the therapeutic process, has 
confirmed the trustworthiness and dependability of the study.  
 The combination between the quantitative questionnaires and qualitative 
methods had complimented each other in the sense that the questionnaires 
had provided the confirmation that depression, anxiety and sexual 
pathologies are real in the cancer world, and it can be measured and 
compared with the information from the patients self.    
8.1.3.2  Limitations   
This study was designed to address the gap in literature concerning the 
psychological and sexual experience and psycho-intervention needs of the breast 
cancer patient and breast cancer survivor, but there were several limitations that 
should be considered when examining the research findings.   
 One of the limitations of this study was the small sample size, which can be 
criticized for not being able to generalize, however small samples are 
typical of qualitative research and the aim of this study was not to 
statistically generalise results, but to provide a rich and comprehensive 
presentation of the experiences and perceptions of the breast cancer 
patient.  
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 Another possible limitation of this study is that the participants and the 
researcher shared a cultural context which makes the results not applicable 
to persons from different cultures and languages.    
 I have tried to be aware of my own suppositions because of my 
longstanding and enthusiastic interest in breast cancer and have tried to 
avoid bias in my interpretation of the information and experiences of the 
breast cancer patient. I also understand that it is impossible that these 
components do not influence the interpretation to some extent. Although 
this limitation is part of qualitative studies, I have made an effort to minimize 
this through honesty and transparency regarding the ideas and beliefs that 
was brought to the interpretation of the data.   
8.1.4  Implications and recommendations for research and practice 
8.1.4.1  Further Research   
 Being diagnosed with breast cancer causes major psychological distress, 
but recent findings indicate that there is, to date, a lack of convincing 
evidence of the implementation and benefit of specific psycho-oncologic 
interventions to improve the quality of life of the breast cancer patient 
during and after treatment (Faller et al., 2013; Galway et al., 2012; Hersch, 
2009).   
 The uniqueness of the one-on-one interaction with the five breast cancer 
patients and the in-depth feedback regarding their cancer experience and 
therapy suggested that the best way of further research in this field may be 
in a qualitative direction.   
 It is my suggestion that a larger sample size and a more diverse group of 
breast cancer patients might increase the data of the breast cancer 
patients’ experiences and needs for further psychological interventions. It 
might be useful to work with the major cancer research hospitals as a 
referral system for potential participants.     
 Clark (2010) claimed that although there is sufficient evidence for the 
effectiveness of psychological interventions in lessening distress and 
assisting psychosocial adjustment for breast cancer patients, there remains 
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much work to be done in this area. According to Clark there is a need for 
advocates in this field to “sell” the idea of psycho-oncology and participating 
in research and sharing their experiences to policy-makers and health 
providers to implement evidence-based and compassionate care beyond 
the trial phase.   
 The researcher suggested more research to be conducted on the matter of 
communication patterns and relationships between the oncology staff and 
the cancer patient to accommodate and incorporate the more sensitive 
subjects of breast cancer and to support the cancer patient accordingly.     
Clinical Practise:   
Regarding the results of the study, I suggest a number of practical implications for 
improving the quality of lives of breast cancer patients and survivors and 
improving overall cancer care: I will distinguish in Table 8.1 between the practical 
implications and guidelines for the oncology medical team and for the 
psychologists working with the cancer population.   
Table 8.1: Clinical implications for both the oncology team and once-
psychologists. 
ONCOLOGIC- AND MEDICAL TEAMS PSYCHOLOGISTS AND 
PSYCHOLOGIC SERVICES 
Oncology healthcare professionals need 
to provide more than just a biologically 
based  treatment plan through 
understanding and incorporating the 
breast cancer patients unique 
perceptions and needs regarding 
healthcare if treatment outcomes and 
quality of life are to be improved in the 
future for a rapid growing cancer 
population.   
Tertiary education institutions who are 
responsible for the education of 
psychologists in South Africa, must 
integrate, at a post degree level, extra 
training to include the knowledge and 
treatment of cancer patients.  Because 
cancer care is a highly specialist 
discipline involving the medical, 
psychological and sexual elements of 
cancer, psycho-oncology must be 
regarded as a specialist field and the 
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 In practise it will mean that the 
oncologist and surgeon will have to 
accept the emotional and sexual side of 
breast cancer and address the matters 
with their patients during their 
consultations by providing opportunities 
to talk about sensitive matters.    
This study found a lack of emotional 
relationships and communication 
between the breast cancer patients and 
the oncologists and surgeons.  It is 
important for the medical team to have 
proper communication skills regarding 
sensitive matters to enhance the cancer 
patient’s quality of life and I suggest 
efforts to develop communication skills 
during the studies of medical                                                        
students in order for them to deal with 
emotional and sensitive situations in an 
emphatic manner.     
The oncology–medical team must give 
recognition to and provide for a multi-
disciplinary team to involve all the 
biological and psychological elements of 
breast cancer treatment. The current 
study showed a need to move towards a 
bio-psychosocial approach in treating 
the breast cancer patient with 
cooperation and communication among 
multi-professional team members.   
Because the psychological aspects of 
education must be on par with that.    
Psychologists, working in the field of 
oncology, should advocate very 
strongly their services and knowledge 
in the field and how they can contribute 
to the treatment of breast cancer 
patients as part of multi-disciplinary 
team.  They can also engage the 
medical and oncology specialists in a 
training capacity to acknowledge and 
integrate the psychological elements of 
breast cancer in their practise and 
develop communication skills to 
understand their patient better.    
In terms of sex therapy, specific 
individual interventions should be 
developed and implemented by onco-
psychologists who specialize in sex 
therapy to help breast cancer patients 
to understand and adjust to their 
altered sexual needs and sexual (body) 
self-esteem. Programs like this should 
include specific sexual communication 
skills with their partners, and elements 
like the Five A Comprehensive Model 
(as discussed I 5.4.1) and Masters and 
Johnson’s Model of Sensate Focusing, 
and cognitive-behavioural techniques.   
Health professionals, both the 
oncologist and the psychologist, must 
integrate patient sexuality and intimacy 
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cancer and cancer treatment can be so 
overwhelming as seen in this study and 
being supported in both older and more 
recent literature, it is time for the 
healthcare professionals to suggest to 
and encourage their cancer patients to 
involve in psychotherapy during cancer 
treatment and thereafter. It is saddened 
to see that in spite of the traumatic 
experience of breast cancer and the 
time consuming and overwhelming 
treatments and side-effects, 
psychological interventions are still not a 
priority for most of the medical team.   
 I further suggest that oncology-medial 
teams familiarise themselves with the 
different psycho-social services that are 
available, such as clinical psychologists, 
counselling psychologists and social 
workers.     
 
 
into routine palliative assessments so 
that every patient is given the 
opportunity to discover these matters 
and talk about it freely (Hordern & 
Currow, 2003; Hummel, et al., 2015; 
Park, et al., 2009).  By participating in 
sex therapy from an early start, the 
breast cancer patient can continue to 
feel sexually attractive and functional 
and will be able to sustain and 
conserve better courage and self-
esteem throughout this process.   
Because depression and anxiety are 
the most common psychiatric disorders 
in the breast cancer population, the 
onco- psychologists working with 
breast cancer patients should make 
provision for evaluating and treating 
these conditions with specific 
techniques such as cognitive- 
behavioural therapy in combination with 
pharmacology.   
It is important for the onco-psychologist 
when developing individual 
interventions, to make sure that it 
designed to accommodate personal 
characteristics and age, as well as the 
type of cancer and treatment stage to 
enhance the overall quality of life of the 
cancer patient (Taylor, et al., 2011). 
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Private Practises and State funded 
hospitals: 
There is a large need and opportunity 
for the oncology team to provide the 
breast cancer patient with psychological 
resources, such as either the services of 
a psychologist or appropriate referrals to 
a psychologist, both during the active 
treatment and at the point of treatment 
completion (Hewitt, et al. 2006; Stanton, 
2012).  But because of financial 
restraint, the development and 
implementation of accessible 
psychological interventions are crucial, 
both in government stated hospitals and 
private practises to enable the breast 
cancer patients to acquire psychological 
assistance to contribute to their overall 
mental health and adherence to their 
medical treatment.   
The oncology medical team must be 
aware of the big possibility of depression 
and anxiety being part of the side-effects 
of cancer and cancer treatment and 
should make provision for evaluating 
and treating these conditions.  If they 
are not equipped to do so, acknowledge 
it and then referred the patient for 
psychiatric/psychological support and 
intervention.    
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Improving cancer patients' access to psychosocial care remains a critical issue. 
Many patients who could benefit from psychosocial care do not receive the help 
they need. Barriers for this lack of service providing include under-recognition of 
the need for psychosocial care by the primary oncology team and, even when 
recognized, the lack of professionals available in many communities to provide 
psychosocial care to cancer patients (Jacobsen, & Jim, 2008).   
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APPENDIX A: Participant Interview Questions 
Participant Interview Questions 
The principal interview questions:   
 Tell me how you felt when you heard that you have breast cancer.  
 What was your emotional reaction just after the diagnosis?     
 How did you feel about the surgery? 
 Did you feel the need to speak to a psychologist about the cancer diagnosis and 
the proposed surgery while in hospital? Was it suggested by the surgeon?  
 Tell me about your experience during the chemotherapy.  
 How was your emotional reaction(s) to the chemo?  Did you at any stage feel 
depressed or anxious?  
 Were the emotional side effects like depression and anxiety well explained to you 
by the oncologist?    
 Did the oncology team attend to your depression and/or anxiety and was there 
open communication about this?   
 Did you at any time of your life (before the diagnoses of cancer) suffered from 
Depression or Anxiety and where you ever treated for that?  
 How did the chemo affect your family life and your work?  
 Tell me about the Radiation therapy.   
 Where in the trajectory (in what stage) of the treatment did you feel the most 
emotional?  
 Do you experience any sexual problems because of the cancer? Have you ever 
had sexual problems before?  (If the interview is before treatment – just after the 
diagnoses – the question would be – do think the cancer and treatment will affect 
you sexual life?) 
 How did the chemo affect your sex life?   
 How did the cancer/treatment affect you self-image and sexuality?   
 Do you (and your partner) understand the side-effects of the hormone treatment (if 
you received any) and the effect on of that your body and sex life.  
 Do you think it is necessary for a professional psychologist to explain the changes 
to you and your partner?  
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 Did you feel comfortable to have spoken to your oncology team about your sexual 
functioning?  And did they volunteer any information about the changes in you sex 
life?   
 (If the patient is in remission/finished with treatment). How do you handle cancer 
as a chronic illness?   
 Looking back now would it have helped if you and/or your family could have 
spoken to a psychologist immediately after the diagnosis and before the surgery or 
chemo?  
 Do you think it would have helped to have spoken to a psychologist about 
understanding your feelings? And to have involved the children and husband in a 
session to understand the whole process of cancer and treatment?  
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APPENDIX B: Informed consent form  
INFORMED CONSENT FORM 
SEX THERAPY AND PSYCHOTHERAPY AS PART OF A HOLISTIC PSYCHO 
ONCOLOGY TREATMENT PLAN FOR BREAST CANCER PATIENTS  
Dear Breast Cancer Survivor/Patient, 
 According to the latest statistics, breast cancer is the number one cancer 
amongst women in South Africa (one in every 31) but who has the highest survival 
rate (95%) when detected early.  Five percent of these cancer survivors are 
younger than 35 years of age and predominantly premenopausal which comprise 
a special subgroup with unique concerns regarding early menopause, sexuality, 
infertility and fertility preservation. Breast cancer is clearly an important women’s 
health issue. 
Most breast cancer patients receive multi-modality therapy including surgery, 
(lumpectomy or mastectomy), chemotherapy, radiology and hormonal therapy, 
which cure the disease or prolong life, but the long term side effects of these 
treatments can significantly impact the quality of a patient’s life, including sexual 
functioning.  
This research forms part of my Doctoral study in psychology at the University of 
South Africa (UNISA). As a breast cancer survivor or patient I invite you to form 
part of the study that will investigate sex therapy and psychotherapy as part of a 
holistic psycho oncology treatment plan for breast cancer patients and to serve as 
a guideline for oncologist to understand the cancer patient better and to know how 
and when to refer his/her patient for onco/psychotherapy.  
The study will involve an in depth interview by myself for an hour or 90 minutes at 
the hospital’s oncology department and two questionnaires (a sexual 
questionnaire and a questionnaire regarding Depression and Anxiety). Depending 
on the outcome of the interview and questionnaires we will plan therapy sessions 
(the number of the sessions will be decided upon the therapeutic goals and 
practical time) and can be individual or as a couple, also at the hospital without 
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any costs.  After the therapy sessions you will again be interviewed by me to 
determine the outcome of the sessions.   
The benefit of the study lies in the information and knowledge that can aid breast 
cancer survivors and their oncologists in the long-term. The risk of your 
participation is limited but you may experience some distress as you answer the 
questionnaires and during the interviews due to the sensitive nature of sex therapy 
and psychotherapy.   
All information will be kept confidential (participant files will be kept in a locked 
filing cabinet with no access to any other party than the researcher). Nothing will 
be made public with any identifiable information and reports will not have 
individual information. Only the researcher will know your identity and will keep 
this in the strictest confidence.  
Your participation is voluntary and you will be free to withdraw from the 
study at any time. Your participation in this research will in no manner influence 
your medical treatment in any negative way. 
Please feel free to contact me on 0829295699 if you have any queries or my study 
promoter Dr Madri Jansen van Rensburg (Tel: 082 403 5758) regarding any 
questions or comments.  
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APPENDIX C: Consent form  
CONSENT FORM  
I (name of patient) . . . . . . . . . . . . . . . . . . . . . .. . . . . . . hereby agree to participate 
in this research regarding emotional functioning (depression and anxiety), sexual 
functioning and psychotherapy after being diagnosed with breast cancer, before, 
during or after the cancer treatment. I also agree that my Oncologist can give my 
name and contact numbers to the researcher and refer me as a patient and I 
agree that my medical information can be given to the researcher/clinical 
psychologist (Vanessa Marais) doing this study.  
I understand that I am participating freely and without being forced in any way to 
do so. I also understand that I can stop this interview or participation in the study 
at any point should I not want to continue and that this decision will not in any way 
affect me negatively.  
The purpose of the study has been explained to me and I understand what is 
expected of my participation. I understand that this is a research project and that 
breast cancer patients, other cancer patients, oncologists and psychologists can 
benefit from this in the future.  
I understand that there is psychotherapy and sex therapy involved and I 
understand the concept of the therapies as explained to me by the researcher. I 
also understand that the therapy will be done by a clinical psychologist without any 
costs.  
I understand that this consent form will not be linked to the questionnaire, and that 
my answers will remain confidential and that the therapist – patient confidentiality 
as well as the doctor-patient confidentiality with my oncologist, will not be 
compromised under any circumstances. I also understand that my identity will be 
confidential.  
 
Signature of Participant                            Date 
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APPENDIX D: Ethical clearance 
 
Ethical Clearance for M/D students: Research on human participants 
The Ethics Committee of the Department of Psychology at Unisa has evaluated 
this research proposal for a Higher Degree in Psychology in light of appropriate 
ethical requirements, with special reference to the requirements of the Code of 
Conduct for Psychologists of the HPCSA and the Unisa Policy on Research 
Ethics. 
Student Name: Vanessa Marais. Student no. 53315049 
Supervisor Dr. Madri Jansen van Rensburg Affiliation: Unisa / external 
Title of project: 
Sex therapy and psychotherapy as part of a holistic psycho-oncology treatment 
plan for breast cancer patients 
The proposal was evaluated for adherence to appropriate ethical standards as 
required by the Psychology Department of Unisa. The application was approved 
by the Ethics Committee of the Department of Psychology on the understanding 
that – 
 Because of the sensitivity of the information being sought and the fact that the 
participants come from a vulnerable population, it is required that ethical principles 
related to informed consent, anonymity, confidentiality and the right of participants 
to withdraw should be strictly enforced; 
 Clearance is to be obtained from the hospitals from where the participants are 
to be drawn, and all conditions and procedures regarding access to patients for 
research purposes that may be required by these institutions are to be met; 
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 If any further counseling is required in some cases, the participants will be 
referred to appropriate counseling services. 
Signed: 
Date: 10 February 2015 
Prof P Kruger 
 
[ For the Ethics Committee ] [ Department of Psychology, Unisa ] 
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APPENDIX F:  Patient interviews 
PATIENT I 
This patient was originally my Pilot Study patient but I decided to include her as 
one of my five sample patients because of her informative and insightful 
information and the whole perceptive therapeutic process that we had had, 
including the sex therapy. I knew about her when I started with the study and 
because of the fact that she was working in the medical field and had a strong 
understanding of psychology I thought she would contribute positively to the study. 
I contacted her telephonically and explained the study in short, asking whether she 
would consider to participate. She was very willing and enthusiastic to take part 
and to share her experiences of her breast cancer for the chance of helping other 
breast cancer patients through their process. Throughout the whole initial process 
of interviewing and therapy with her, I learned a lot about the type of questions 
that I had to ask and when to ask them. I realised that some of the questions that I 
had asked in the interview had already been answered in the demographic form. I 
decided to change from a more formal way of conducting the interviews to a more 
unstructured and therapeutic manner, giving the patient more autonomy to reveal 
appropriate and rich information and sharing her living experiences of the cancer. I 
also learned how to switch from asking (interview) questions to therapeutic inputs 
simultaneously and, given the limited time frame of the study, it worked out very 
well for both the patients and interviewer for it was beneficial to both. This was the 
only patient that I had scheduled interview appointments with. This was apart from 
the therapeutic sessions. With the other four patients I immediately started with 
the therapeutic process which included the interview questions and obtaining 
information.     
DEMOGRAPHIC INFORMATION.  
Age: 47 years     
Marital status: married.   
Children: two children, a daughter of 16 and a boy of 12 years.   
Highest education level: master’s degree in the medical field.  
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Occupation: practise in the medical field, working full time.    
Diagnosis: Stage II Breast Cancer.   
Date of diagnosis: October 2013.   
Surgery: lumpectomy. (October 2013). 
Breast reconstruction: completed.   
Treatment: 
Radiation: thirty two sessions – the last date was June 2014  
Chemotherapy: “Red Devil” – four sessions and other chemotherapy 
– four sessions - eight in total. Chemo over a period of six months - 
the last date was on April 2014.   
Hormonal therapy: Neophedan (Tamoxifen).   
Anti-depressant: Cipralex 20 mg for the last two years.  
Psychiatric treatment history: She was treated for depression before 
the diagnosis of breast cancer. 
Diagnoses 
The patient was diagnosed with Stage II Breast Cancer and had had a 
lumpectomy and removal of all the axillary lymph nodes in October 2013. She had 
had eight sessions of chemotherapy and thirty-two radiation sessions all ending in 
June 2014. Because she had completed her treatment so long ago and she had 
not been referred by an oncologist, I did not have access to her medical file.   All 
the information was given by the patient herself.    
Treatment plan 
After the lumpectomy and removal of the axillary lymph nodes, the patient had 
started with eight session’s chemotherapy over six months and thirty-two sessions 
radiotherapy over two months, which had all been completed. At the time of the 
interview she was on Neophedan (Tamoxifen) for five years and Cipralex 20mg. 
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The patient had finished her cancer treatment 16 months prior and was in full 
remission.  
FIRST CONSULTATION: 30/09/2015 
Because of the distance and convenience for the patient I offered to see her at her 
home which was quiet and very private and comfortable and suitable for our 
sessions. We had two sessions of an hour and a half each that were conducted at 
the patient’s home for asking the interview questions. One month elapsed 
between the first, second and third sessions. The planned questionnaire was 
followed very strictly. 
Before we started with the interview, I again gave her a short, detailed explanation 
of what this study entailed and what would be expected of her as a participant. I 
gave her the demographic-, information- and the consent forms to read through in 
her own time and to discuss it with her family in order to give her more time to 
decide whether she wanted to participate in the study, and to sign the consent 
form. I explained the two questionnaires - the HADS Depression and Anxiety 
Scale and the Female Sexual Functioning Index (FSFI) (see Chapter VI) and 
asked her to complete it when she had time and give it back the next session. The 
fact that her participation was voluntary, that she could stop her participation of the 
study at any time without having to explain herself or stop answering any 
questions that made her feel uncomfortable was stated again. She said that she 
understood everything (especially with her medical background) and that she 
would like to participate in the study and that she had already discussed it with her 
husband. Both of them felt positive about her participation. I assured her of my 
commitment to the study and to her as my patient and gave her my cell number 
and encouraged her to phone me if anything worrying happened in between 
sessions that she would like to discuss with me. After the formalities and all the 
explanations, I started with the interview.  
Interview. 
Question 1. How did you feel the moment that you heard that you had breast 
cancer? 
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Answer: I will never forget that precise moment: the exact day, date and place. I 
experienced total dissociation, dizziness and nausea. It was such a traumatic 
experience for me and I was totally in shock.   
Question 2. Did you go to the doctor on your own, or were you accompanied 
by someone (e.g. husband)?  
Answer: I went alone the first time that I saw the surgeon for the medical 
consultation and tests, I was also alone when the doctor phoned me with the news 
that I had breast cancer and that I needed to go in to see him regarding the next 
step.   
Question 3. Did you talk about how you felt after the doctor’s consultation?      
Answer: The trauma that I experienced was so big; I wanted to be with my family 
immediately: my husband and my mother. Everybody was shocked and was 
crying and nobody knew what to say to me.   
Question 4. What went through your mind after the news that you had breast 
cancer?  
Answer: The first thing that I thought was that I was going to die: that cancer 
means “dying”. That was my first thought. I have two young children and they were 
my biggest concern.   
Question 5. What was the type of surgery that you had and how did you 
emotionally handle the surgery?  
Answer: I had a lumpectomy and removal of all the axillary lymph nodes.  
I asked about pain in her arm and she said that after the surgery she never had 
any discomfort, numbness or pain in her shoulder or arm. She said that she felt 
that she had handled the operation emotionally better than when she had heard 
she had breast cancer because to her it was something more concrete, something 
that she understood (the operation itself), and something visible (the wound), 
something that she could fight against. She felt that, after the surgery, she should 
have spoken more to her husband and her mother and friends about her feelings. 
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She realised now that by talking to them and sharing how she felt, she would have 
dealt better with her emotions.   
The patient was on Nuzak 20 mg before the operation.    
Question 6. Did you feel anxious or depressed during your stay in the 
hospital?   
Answer: Yes, I was very anxious during my stay in the hospital, but not 
particularly depressed.   
Question 7. Did you feel the need to talk to a professional (clinical 
psychologist) during your stay in the hospital before or after the surgery?     
Answer: Looking back now and it is always easier to look back on something and 
know the right answer: the answer is, yes. If the surgeon had suggested it, even if 
I had not realised the significance then, I would have benefited from talking to a 
psychologist about how I felt then, and to put some of my emotions into 
perspective and also maybe what to expect after the surgery. I realise now, how 
inexperienced I was as a new cancer patient and how completely clueless I was of 
what was about to happen.   
Question 8. Did you understand what was happening with your body and 
mind (emotions)?   
Answer: No, in spite of my own knowledge of the medical profession, I did not 
fully understand all the emotions that I was going through or even what lied ahead 
of me and what my emotions would be during the whole treatment process. The 
one thing that I did realise was that life must go on, for I have two young children. I 
just had to go forward.   
Question 9. Do you think it would have helped if you or your family could 
have spoken to a psychologist at that stage about your cancer?  
Answer: Yes definitely. I think speaking to a professional person with relevant 
knowledge about what we were going through would maybe have helped us to be 
more prepared for the different stages of the treatment and also all the different 
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emotions that we had and not always knew what to do with. Cancer is not 
something that you can speak about to anybody.   
Question 10. Was the next step of the treatment chemotherapy and/or 
radiation therapy well explained to you by the Oncologist? 
Answer: Yes, I had chemotherapy first. It was first four sessions of the “Red Devil” 
chemo and then four other chemo’s, I had eight sessions altogether. After that I 
had thirty-two sessions of radiotherapy. I feel that the oncologist had explained 
both treatments in a manner that I could understand. 
I asked her if she felt “knowledgeable” about the treatments – she said that the 
oncologist had explained the treatments to her, but more in a technical manner 
and more about the physical effects, but nothing about emotions. She said nobody 
had mentioned or explained the emotional effects and side effects of the 
treatments.  
Question 11: Did the oncologist at any stage suggest seeing a psychologist 
or clinical psychologist?      
Answer: No, the oncologists never suggested that I could see somebody like a 
psychologist during my treatment. She had only referred me to their social worker, 
which is as far as I know, mandatory to see as part of their oncology team. I could 
not understand why I should see a social worker and it was not clearly explained 
to me. Psychologically I have not benefited anything from our session.   
Our one and a half hour was done and we scheduled another session for the next 
questions. I made sure that the participant was emotionally okay because it was 
an emotional session for her having to go through all that emotions. She assured 
me that she felt fine and that although it was an emotional session, she also felt a 
bit lighter emotionally.    
Second Consultation: 29/10/2015 
This consultation was in the same place as the previous time (the patient’s home) 
and we carried on with the interview questions after I had made sure that she was 
coping well after our previous session and that we could continue with the session. 
She said that she was still very positive about participating in the study and that 
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she hoped it would help somebody else who had or was going through breast 
cancer. 
Question 12. What were your physical side-effects of the chemo-therapy and 
how did you experience it?     
Answer: In terms of the biological side effects, the worst part for me was the total 
hair loss, my whole body was hairless, and how that affected my body image 
which was already compromised by the surgery and the changed shape of my 
breast. The tiredness was also physically and emotionally very bad for me, 
especially the severity of the tiredness and the fact that it was so persistent. I had 
chemotherapy for four months and was tired the whole time. I felt that, in a way, I 
had to change my “being”, for I am a “doer” and an active person with a 
challenging job and busy household to a more passive life style during that time. 
This to me was quite a loss to have scaled down my activities, especially with my 
children because they are also busy children with busy schedules and I felt not 
actively involved with them then. I also experienced a lack of short term memory, 
nausea, aches and pains in my body and a metal taste in my mouth for at least 
seven days after each chemo. The cortisone that I used caused insomnia and 
swelling and made me felt very uncomfortable in my own skin.   
Question 13. How did the chemo therapy affect your family and your 
marriage?   
Answer: I felt a loss for not being able to do my everyday tasks for my husband 
and children on the days of my chemo and the days after chemo that I felt sick and 
tired. I experienced the chemo as a busy and demanding time of traveling and 
sitting in the chemo room not being able to do anything else. Although I was at 
home, I felt less available for both my children and husband at that stage of the 
treatment especially the days that I felt so tired and hopeless, not having enough 
energy to do anything at all. I thought that the children were ashamed of me 
(looking ill and swollen with no hair), but realised afterwards that it was my own 
projection and insecurities about my illness and how I looked at myself. My 
husband felt hopeless for not being able to help me with my illness and struggle 
and my son was angry, without knowing why and how to handle it. 
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Question 14. How did the chemo affect your sex life?  
Answer: We did have sex during that time, but less. To me, everything was about 
survival. I was in a survival mode, only wanting to get well and healthy again. I did 
not want to die and leave my family behind. I only concentrated on my treatment 
and surviving every day. So although sex was not my priority, we still had a good 
sex life and it did me good when it happened. 
Question 15. How did the chemo affect your work functioning?   
Answer: I haven’t worked the whole time that I received chemo and radiation 
therapy. The whole process was to “radical” for me and I was just too tired to work 
and my focus was not at work at all. Although I was in a position to take off from 
work, not being able to work was very hard for me and made me feel inadequate 
and depressed. Work played a big part in my life and identity. The fact that I did 
not work also made me feel more isolated and I had more time on my hands to 
have negative and destructive thoughts. Not going in to work every day can make 
a person feel aimless and out of contact with reality. The positive side about the 
fact that I could stay home helped me a lot to regain my strength and energy. I 
didn’t have any work related stress which was good for my body and mind.  
Question 16. Did you feel depressed or anxious or emotionally distressed 
during your treatment?  
Answer: Yes, I felt severely down and depressed at that time and scared that I 
would not be able to go back to normal, or what was normal for me before the 
cancer. For me the anxiety was worse than the depression. You can feel the 
anxiousness in your body the whole time; it is like a physical presence, especially 
the anxious thoughts of the cancer that didn’t seem to go away. It was as if the 
thoughts were just milling around in my head the whole time. I felt at that stage 
that I was “falling behind” as a person, especially as a mother, wife and career 
wise because of the cancer. Cancer treatment was actually taking you away from 
your “normal” life and “normal” activities and I was very concerned about the time 
away from my home and family, especially with the children. 
Question 17. Did you speak to anybody about these feelings?   
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Answer: Yes I did. I spoke to my mother, my husband and to my close friends. I 
have an extremely good and close support system which supported me very well 
at that time as well as now. The support that I got was the one thing that kept me 
going.    
Question 18. Do you think it would have helped to have spoken to a 
psychologist during the time of treatment?   
Answer: Again, looking back now, I would have liked to have seen a psychologist 
before and after the treatment, but are not sure how it would have fit in during the 
treatment.  Because it was not suggested at any given time during the treatment, I 
never actually thought about it. It was mandatory to speak with the oncology 
department’s social worker, but I would have preferred a psychologist. I think I 
would have been more prepared and equipped for the whole process of treatment 
if I saw a psychologist from time to time. Even just to have known that there was 
such a person to go to if needed. Because it is such a new and completely 
unfamiliar situation, you need to learn new skills from somebody who has the 
necessary knowledge and know-how of how to handle yourself, your family and 
the situation.   
Question 19. What were the side-effects of radiation therapy?   
Answer: Fatigue again, pain and sensitivity in the breast area where they applied 
the radiation therapy.   
Question 20. How did you cope with the radiation therapy?   
Answer: Although I had side-effects, to me radiation was much easier both in a 
biological and emotional way than the chemo. It was however a practical 
inconvenience because we had to travel quite far every day for just a couple of 
minutes.  
Question 21. Were there any emotional effects of the radiation therapy?   
Answer: I didn’t find it emotional as the case was with the chemotherapy.   
Question 22. Where in the trajectory of the illness and treatment did you feel 
the most emotional?   
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Answer: My most emotional time was when I was diagnosed with breast cancer, 
at the very beginning. It was such a shock and the experience was very traumatic 
for me. I was, before and after the breast surgery and before my first chemo, very 
emotional and scared not knowing what to expect at all. After the end of the 
treatment, when I thought I would be glad and happy, the anxiety was bad again. 
The shift from being an active cancer patient, with all the medical support and 
constant contact with the oncology staff, to just being a “normal” person again 
without that support, made me feel vulnerable and unsure of myself. Because I 
was so anxious and depressed, I have decided to go to a psychologist for therapy.   
Question 23. Did you feel comfortable speaking with your oncologist about 
your emotions and sexual fears? Would you have felt comfortable? 
Answer: No, not about my personal feelings and sexuality. I felt our relationship, 
although very good, was not on a personal level. It was more on a very 
professional level, more medical and biological than emotional.    
Question 24. Did you suffer from depression and/or anxiety before the 
diagnosis of breast cancer? And did you receive treatment for it?   
Answer: Yes I was diagnosed with depression and was also treated for the 
condition earlier in my life, both with psychotherapy and an anti-depressant.     
Question 25. Would you say that you developed depression and/or anxiety 
after the diagnosis and treatment of your cancer? 
Answer: Yes I have developed both, especially anxiety, but the oncology team did 
not discuss the conditions with me. Although I am in the medical field, I didn’t 
realise that I was busy developing these conditions. I was not given the option of 
treatment by the team. I realised on my own that I was depressed and stressed 
and made my own appointment, after my cancer treatment was finished, with a 
psychologist.   
Question 26. Do you experience any sexual problems because of the cancer 
or the cancer treatment? Did you have sexual problems before the cancer?   
Answer: We never had any sexual problems before the cancer, but after the 
treatment I experienced severe problems in that area and saw it as a huge loss. 
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Because of the type of treatment, (Tamoxifen), I had a complete lack of oestrogen 
(which happened rather suddenly) and I had to drink an oestrogen suppressor for 
the following 5 years. This took me completely by surprise. I was not prepared for 
the suddenness of the menopause. Although I was told about the treatments, the 
chemotherapy and the radiation and their side-effects, it was never explained to 
me in detail what I could expect of my body and emotions, or what I could do to 
adapt to the situation. Nor was I referred to a psychologist to attend to the 
problem. It was just not a subject of discussion. Nobody had spoken openly to me 
about my sexuality and sexual functioning. I had to struggle through that on my 
own, not having the confidence to ask about it.    
Question 27. How did the cancer and cancer treatment affect your self-image 
and self-esteem?   
Answer: It affected me very seriously. In terms of my self-image; I don’t look the 
way I had before the cancer. The form of my body and weight has changed 
drastically. The way my body used to react sexually has also changed, it is not 
possible for me to reach an orgasm anymore, and it is as if my body doesn’t want 
to react in a sexual manner because of the cancer and treatment. I don’t 
understand my body anymore, especially not in terms of my sexuality. To me it 
was another thing to worry about with all the other worries regarding the cancer 
and my depression and anxiety.  
Question 28. Do you think it is necessary for a psychologist to explain the 
influence of the cancer treatment on your sexuality and the changes it can 
create to you and your partner?  
Answer: Yes! Yes!   
Question 30. How do you handle the cancer as a chronic illness?   
Answer: I haven’t handled it very effectively up till now, especially the effects that 
the hormones have on me. It affects me emotionally and sexuality the whole time. 
I have never thought about cancer or my cancer as a chronic disease. I only now 
start to understand the treatment’s side effects better (after the treatment), living 
with it on a daily basis. I think that having understood it better and in a more 
knowledgeable framework, I could have coped better with the whole journey.     
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In both the interview sessions with the patient there was already a therapeutic 
process which had begun with the emotional catharsis in answering the questions 
and remembering the emotions. The patient had a very prominent need to talk 
about her experience and emotions regarding the cancer and cancer treatment 
and how her family experienced her cancer. She also felt that she never had had 
the opportunity to be seen by a psychologist and felt that it could have saved her a 
lot of agony if she could have learnt about the process and had had the 
opportunity to vent her emotions.  
She said that even just talking to somebody with knowledge about the 
psychological side of breast cancer, already made her feel better and more 
“normal”. She was looking forward to having therapeutic sessions with me 
regarding her issues around her breast cancer and how she was functioning. We 
ended the session after one and a half hours and rescheduled for very early in the 
next year after the holidays.   
Third Session: 29/01/2016 
The patient was ready and eager for a therapeutic session after the previous two 
interview sessions. The venue was the same as the previous two times.     
The patient told me that she had had another cancer scare the previous month, 
with a lump in the other breast. She had to go through the whole proses of a 
mammogram, blood work and biopsy. She had experienced this in a very negative 
way, opening all the “old wounds”. The waiting in between the procedures and the 
results caused hard core anxiety. I gave her time to talk about her emotions and 
how it made her feel. We used it as an emotional expression or catharsis.      
She said that the incident made her unsure of the surgeon’s decision not to do a 
mastectomy. (The patient had previously had a lumpectomy). She felt that she 
was not really part of the decision making process after being diagnosed with 
breast cancer. She said she was too shocked and traumatised after the diagnosis 
and that everything happened so quickly that she felt that she wasn’t “present” at 
that time and that everything just happened “around” her.   
I used her anxiety over this incident (with the second lump) as a platform for the 
therapeutic session. I explained the pathogenesis of anxiety and depression (for 
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the sake of information and knowledge) in the context of cancer and that cancer-
related anxiety was not an unrealistic anxiety or fear. The aim was to normalize 
her fears and anxiety. She said her biggest fear (throughout the cancer treatment 
and up till the present) was the fear of death: not so much for herself, but for her 
children, who were still young. Giving the patient the opportunity to talk about 
death and the fear of dying had a positive impact on her.  She was relieved to 
speak about it without feeling guilty or “ungrateful”. She said that her fear and 
anxiety was worse after the end of the treatment when everything was supposed 
to be “back to normal.” The biggest disappointment to her was the realisation that 
the anxiety and fearful thoughts would never end, that there would never be a “full 
stop after the sentence”.     
At that stage she presented with a General Anxiety Disorder (DSM 5), which had 
been diagnosed by a psychiatrist and she was prescribed Cipralex 20 mg. It 
reduced the anxiety symptoms. She had never, before the breast cancer 
diagnosis, been diagnosed or treated for Anxiety Disorder, but had been 
diagnosed with a major depression previously before the breast cancer. 
I reinforced her knowledge about how the mind worked regarding stress and 
trauma and the chemical impact it could have on the brain and body. We also 
talked about the discomfort it can cause when left unattended (e.g. developing 
depression, anxiety or even post-traumatic stress disorder). We discussed the 
importance of allowing herself to feel anxious without feeling guilty. To be aware of 
the fact that she could take control of her (anxious) thoughts by being consciously 
aware of the thought(s) and to replace them with more positive and realistic 
thoughts or focusing away from thoughts that disturbed and disrupted her mind-set 
and mood.   
She said that when she felt anxious, it helped to get up and walk around and find 
an activity to distract herself from her negative and anxious thoughts. I reinforced 
this behaviour, because diverting thoughts and behaviour also meant focusing 
away from anxious thoughts and taking control over your mind reminding yourself 
that you are not dying.    
Another skill that we worked on was relaxation, especially breathing. Breathing is 
not only a biological method to reduce anxiousness, but also (again) a way to 
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focus away from stressful thoughts and consecrate on something else. When the 
body is relaxed and the breathing is steady the mind is clearer to think rational 
thoughts. It made a lot of sense to the patient and she fully understood how these 
skills could help her with her anxiety. In my experience, even people with the 
appropriate knowledge about psychology and how the body works, still need to 
hear this in a professional setting to internalise the knowledge and use it 
accordingly. 
The session lasted one hour and we ended it by making another appointment for 
one month from that date. I made sure that she was comfortable with ending the 
session.   
FOURTH SESSION: 29/02/2016 
This session consisted of sex therapy in an individual session.   
We decided that we were going to talk about sex in the session because of all her 
questions about her menopause and her lack of libido. The patient began by 
saying she was completely surprised and overwhelmed by the unexpected sexual 
changes during and after the cancer treatment. She said that although it was 
mentioned briefly by the oncologist, especially the menopause, it was never 
discussed in depth or explained in terms of symptoms or the influence on the 
quality of her sex life and life in general. Because of the lack of communication 
between her and her oncologist in this field, she didn’t feel comfortable to discuss 
her sexual status and accompanying emotional status quo.  
We discussed the changes in her body image because of the cancer and 
treatment, she said she looked and felt completely different after her treatment 
and that she had to get used to an “older” body. We talked about how to 
accommodate the changes in her body and breast (the scars) and how to make 
peace with it on a conscious level. We talked about the complete lack of oestrogen 
and androgen because of her menopausal status and how it affected her libido or 
sexual desire. We also discussed what she could expect of her sexuality in the 
future. She said the changes in her sexual functioning and lack of oestrogen was 
one of her biggest losses throughout her breast cancer and made a huge 
impression on her emotional wellbeing. I explained the grieving process to her, 
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although she was familiar with it, and said that she should allow herself to go 
through this process first and make peace with this loss. Although she was in 
remission, she had never given herself the time for grieving her losses. She 
understood that, only after working through the emotions, you could get to the 
acceptance phase and make peace with a different mind and body regarding your 
sexuality. We also touched on self-esteem and self-confidence and embraced a 
new “post cancer” identity in a very conscious and cognitive way. We discussed 
the abruptness of the onset of her menopause and the severe symptoms which 
she was not prepared for. This gave her the power to control, understand and 
implement it in her “new” life: especially the chronicity of the sexual changes. 
Another loss was that of intimacy between her and her husband. Because she did 
not have the knowledge or confidence to have spoken about her lack of sexual 
interest, sexual functioning and changes in her body, they did not communicate 
the problem properly. This lack of communication between her and her husband 
then led to an absence of their sexual functioning and intimacy. I explained to her 
that I often find this in working with cancer patients that because they cannot have 
sexual intercourse, they abstain from any form of sexual expression, feeling 
scared that any form of touching might lead to sex or “misleading” the partner that 
they wanted sex when they were not in the biological or even psychological 
position to do so. By not talking about their feelings, they rather ignored any form 
of intimacy. It is important for her to realise that other patients in her position 
experience more or less the same sexual uncertainties and functioning as she did. 
One of the therapeutic goals here was to go back to basic sexual behaviour, 
(touching and caressing) and learning to look at, and experience you and your 
partner’s bodies from a new angle. We later discussed it again with the husband in 
a couple’s therapeutic session. I found that it was often difficult for patients who 
had had a period of sexual abstinence to just start with the sexual act immediately. 
Therefore “going back to basics” first, is important to regain some of the trust and 
comfort with each other’s bodies. I explained to the patient the “practicalities” of 
sexual functioning in menopause, for example, the using of lubrication (different 
types), implementing new strategies e.g. massaging, and different positions and 
experimenting with new techniques to reach orgasm. This was also a good time to 
invest in a new book (or two) reading and learning new sexual behaviour (and 
skills). The more the couple talked about sex, the more comfortable they would get 
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in performing the act. Sex also has to do with a mind-set and because of the lack 
of androgen and oestrogen, there was an accompanied lack of desire (libido) and 
sex became more a process of thought than biology. I explained to her that it was 
important for her and her husband to understand the lack of sex drive in a 
biological sense, otherwise they might feel that their sexual partner was not 
attractive to them anymore, hence the lack of sexual enthusiasm and the 
likelihood of it affecting their sexual confidence. The lack of sexual drive had 
nothing to do with them as persons, but was biological.     
By giving the patient the opportunity and safe environment to speak about sex, her 
sexuality and sexual functionality, she felt much more liberated about this 
“forbidden” subject. By understanding and normalizing her fears, questions and 
“issues” about her sexuality and her “different sexual image”, she understood it 
better and felt more in control in this area of her life.   
At the end of this session, the patient said she really felt that she understood her 
own body better, as well as the permanent impact of the breast cancer on her 
sexuality. Because of the new skills and knowledge, she felt more relaxed about 
sex and intimacy. Instead of just another loss and stressor in this jungle of effects 
and side-effects of breast cancer, it was something that could be treated and 
resolved. The session lasted an hour and 15 minutes. I made sure that she was 
comfortable to end the session and we schedule another session with her and her 
husband.   
FIFTH SESSION 29/03/2016.   
This session consisted of sex therapy with the couple. 
I explained to the couple what sex therapy entails and what they could expect of 
the session. Both felt that the session was necessary for them and they felt ready 
for the session. The patient’s husband was very positive about the session and 
participated in a constructive manner. The patient’s husband agreed with his wife 
that they did not have proper information about the changes in their sexual 
functioning before, during or after the treatment. I explained to them the 
importance of understanding that the husband of the breast cancer patient still has 
his “normal” libido and sexual needs and that just ignoring them because of his 
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partner’s illness is counterproductive for the couple. Therefore it needed to be 
addressed.   
The main aim of this therapeutic session was, (1) to enhance communication 
between the couple about sex and emotions revolving around sexual functioning 
and, (2) to provide knowledge about the influence of cancer and cancer treatment 
on menopause and sexuality. We agreed to the fact that if a couple was not used 
to talking freely about sex or if communication regarding sex became difficult 
because of an illness, it was easier if they could speak through a professional 
person (as in this case, a psychologist). I took the lead in asking questions 
regarding their sex life and gave them examples of specific, general scenarios 
from literature and other couples concerning sexual problems relating to this given 
scenario. Examples of this are that breast cancer patients often complain about 
their lack of sexual needs and that they don’t feel up to any sexual activity. Their 
sexual activities decrease from a couple of times a week to nothing or very little. 
Even if they do have sex, the women complain about their incapability to reach an 
orgasm. Both the patient and her husband could relate to these examples given. 
During the session the couple started speaking freely and comfortably about their 
emotions and their various thoughts about sex and sexuality throughout the whole 
cancer experience. Both disclosed that they did not know how to handle their 
sexual functioning because of their own anxieties around their feelings about sex 
and the cancer. The one thing they did not understand was the patient’s lack of 
libido, or any form of sexual contact, or conversation, because before the cancer 
they had had a good and satisfactory sex life. I explained that it could have 
happened because cancer is such a traumatic disease which affects all forms of 
functioning, sex life included. I explained to them what a chemical induced 
menopause means and the immediate effect on the body and mind. This 
knowledge set the husband at ease, understanding that the lack of sexual activity 
had nothing to do with him or their sexuality, or even how she felt about him, but 
was a mere side effect of the cancer treatment and something that could be 
worked on. I suggested that a good place to start would be to read some literature 
about sex and to talk more about how they could enhance their sex life by 
engaging in sexual communication and even trying new positions or new places 
where they could have sexual interactions. I explained that if she found it difficult 
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to reach an orgasm, they could experiment with new ways to improve sexual 
satisfaction and the importance of using vaginal moisturisers and lubrications.     
He understood the chronicity of this and that they both had to work hard to create 
a new and exciting dispensation that would work for both of them. I explained to 
the husband the importance of acknowledging his own losses regarding their 
changed and challenging sexual functioning as well as his wife’s losses and 
changes especially to her self-image. They should work through that before they 
could actually build a new and fulfilling sex life together. By understanding their 
“new” sexuality, they could use it to grow individually and as a couple. Both the 
husband and wife had exceptionally good insight in this therapeutic process and 
felt very positive and motivated about implementing the new skills.   
The next session would be about feedback from this session and would be the last 
session. The patient also felt ready to end the therapeutic process, for she was 
feeling more knowledgeable and strong in terms of living her life in the aftermath 
of cancer.   
SIXTH (AND FINAL) SESSION: 11/06/2016 
This was the final session that was scheduled to obtain feedback from the 
previous sessions and also to conclude our therapeutic process. I asked the 
patient how she felt, now, after our sessions and she said she felt that her 
“rhythm” was more or less back to where it was before the cancer. She said being 
back at work and being able to participate in all her “normal” daily activities made 
her feel more like herself again. She said she realised that for the rest of her life 
she will be confronted with the “aftermath” of cancer and that although her cancer 
was in remission the “cancer file” in her brain will never be deleted. She said that, 
through therapy, she accepted the fact that the cancer did not only bring 
permanent biological changes, but also permanent psychological changes. She 
also understood that you could learn to adapt to both, through conscious efforts to 
grieve your losses, and learning new coping mechanisms for a new and 
“unwanted” chronic situation. She said she had learned the importance of working 
through her trauma step by step by talking about it and working through all the 
emotions before making peace with it and accepting it: to learn to “live” with the 
aftermath of cancer instead of “fighting” it. She said that the receiving of relevant 
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information and knowledge regarding the effects of cancer and the treatment, 
especially on her emotions and sexual functioning, was one of the things that she 
valued most during the therapeutic process. She said that it opened a lot of doors 
for her in terms of understanding what she was experiencing and why. She said 
that one of the most difficult issues for her during the whole experience of cancer 
was the fact that she could not understand the reason or purpose of the cancer 
and why it had happened to her and what she would do with the devastating 
impact of it for the rest of her life. She said that it was quite a challenge to be able 
to come to terms with the reality that there was no answer or explanation for this 
and that she had to accept and make peace with the breast cancer and live with it 
even though she didn’t understand it. She said she learned to look at her life goals 
from different angles and had to redefine and adjust some of it, especially 
regarding her work. She changed her whole working structure to allow more time 
for activities that were more relaxing and beneficial for her health and relaxation. 
She said she was also more mindful of situations that create stress and affects her 
mind and body and to either avoid it or handle it effectively. She said she realised 
that the cancer had affected her whole family and that they would have to keep on 
working together to accommodate the long term effects of her cancer. She said as 
a family they were very supportive of each other and engaged in a lot of activities 
together. She further stated that her husband was very supportive of her during 
the entire time of the treatment and they were both very focused on the practical 
workings of the household to ensure that the effect on the children were minimal. 
She said he was often the “voice of reason” when she was irrational or felt 
incapacitated because of her tiredness or stress he made her feel safe and she 
felt very thankful for his good support. She said that both of them benefitted a lot 
from the sessions regarding their sexual functioning since both of them were 
clueless as to what was happening to them sexually. She said that understanding 
the biological and psychological side-effects of menopause on her sexuality and 
especially her lack of libido had clarified a lot of her behaviour for both her and her 
husband. She said they could look at their sexual difficulties through the 
framework of the cancer treatment instead of taking it personally and that it made 
sense to develop a new outlook on, not only sex, but also intimacy and to learn 
new skills regarding their sexual functioning.  
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She said because of her occupation she was able to diagnose her depression and 
anxiety early and that being on an anti-depressant was a huge help in adapting to 
the cancer process and stabilising her mood. She said if she could describe the 
therapeutic process for herself: “it was a life-line to grab onto when I was drowning 
in a sea of emotions, which dragged me back to the surface again”. She said that 
the understanding of the reality of what the cancer was doing to her, and being 
able to put her own feelings and experiences in context was what brought her 
back to the “surface”. 
We ended our session and whole therapeutic process on a positive note with the 
understanding that she could contact me again if she would like to continue with 
the therapeutic process.         
PATIENT II 
Patient II was recruited from a state hospital. After obtaining ethical clearance (see 
Chapter VI) I was granted permission to attend a meeting with a group of newly 
diagnosed breast cancer patients at the hospital. This meeting was held in the 
oncology ward where all the newly diagnosed breast cancer patients met at a 
scheduled date and time to receive information about certain particulars regarding 
their chemotherapy appointment dates and to be familiarised with the place, 
procedures and the oncology personnel for the period of their treatment. During 
this group meeting an oncologist explained to the patients what chemotherapy 
entails and what to expect in terms of general side-effects as well as the way 
forward after they complete the treatment. At the end of the group session, he 
introduced me to the group and the personnel and briefly explained the reason for, 
and aim of my study. After the informal information session was over, I interacted 
with group members individually, recruiting volunteers for my study. I selected 
patients falling within the age interval of my planned sample which was 30 to 65 
years. I again explained to each person in a private conversation what my study 
involved. Initially three patients were recruited but one dropped out of the study 
after the first consultation with me. 
I took each patient’s contact number and made our first appointment which would 
coincide with their following chemotherapy appointment at the hospital. I phoned 
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each patient the day before the scheduled date to confirm our appointment. The 
demographic information of patient 1 is presented below. 
DEMOGRAPHIC INFORMATION:  
Age: 52 years 
Marital status: married 
Children: two adult children 
Highest education level: matric and tertiary diploma in Management 
Occupation: housewife 
Diagnosis: Stage IIB Breast Cancer 
Date of diagnosis: November 2015  
Surgery: lumpectomy of the right breast and lymph nodes under right arm. (7 
December 2015)  
Breast reconstruction: no breast reconstruction 
Treatment:  
Radiation: none 
Chemotherapy: busy with the treatment. Had two of the six chemo 
sessions. Four sessions left – the date of the last chemo was 
09/06/2016.        
Hormonal therapy: none 
Anti-depressants: none 
Pain medication: none 
Psychiatric treatment history: she had never before been treated for 
a psychiatric illness 
Diagnosis 
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The following information I obtained from the patient herself. 
The patient had been diagnosed with breast cancer on 10/11/2015 after she had 
felt a lump in her breast four months previously. She had a mammogram and a 
fine needle biopsy on 17/11/2015. Following this she had a lumpectomy (right 
breast) on 07/12/2015. They removed an 18 mm tumour and some axillary nodes. 
Subsequently two nodes tested positive for cancer.  
The diagnosis that was obtained from her medical file was as follows: Stage IIB 
Breast Cancer of the right breast – pT1c N1 M0.   
Treatment plan 
Chemotherapy: she was scheduled for six chemo therapy sessions every three 
weeks. After finishing the chemotherapy she would be re-evaluated for surgery if 
necessary, with a scheduled date for surgery on 11/07/2016 and the possibility of 
radio-therapy.      
FIRST CONSULTATION: 14/03/2016. 
I met the patient formally for the first time on 4/03/2016 for a therapeutic session. I 
saw the patient at the hospital, as agreed, for an hour session in one of the 
hospital’s consultation rooms in the oncology department. We used one of the 
oncology ward’s consultation rooms, which was small and impersonal, but quiet, 
private and adequate for our needs. We had scheduled all our appointments on 
the same days as her chemotherapy appointments for practical reasons. These 
included her presence at the hospital and the cost effectiveness for her in terms of 
traveling to the hospital.  
Before we started with the session, I gave her a short but detailed explanation of 
my study for the second time regarding what the study entailed and what would be 
expected of her as a participant. I avoided complex medical terminology. I told her 
that one of the aims of the study was for the oncology team, including the 
psychologist, to better understand the psychological needs of the breast cancer 
patient in order to provide a holistic service that would enhance the quality of life of 
all breast cancer patients and their families. Learning by way of her experiences, 
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as related to me, the medical team could support other breast cancer patients in 
the future. 
I emphasised the fact that she could stop her participation at any given time 
without giving a reason. She could leave the interview at any time or refrain from 
answering any questions that made her feel uncomfortable. I gave her the 
demographic form, the information form and the consent form to read through at 
home on her own time and discuss it with her family and husband which would 
give her more time to decide whether she wanted to participate in the study. I 
asked her to explain the study to her husband and to ask him if he was 
comfortable with her participating in this study and if he would later attend a 
session with her. She could sign the consent form and return it at the following 
session. I also gave her the two questionnaires to complete at home explaining 
them to her. The questionnaires were the HADS Depression and Anxiety Scale 
and the Female Sexual Functioning Index (FSFI) (see Chapter VI). I assured her 
of my commitment to the study and to her as my patient and gave her my cell 
number, encouraging her to phone me if anything troubled her in between 
sessions so that we could discuss the matter. 
She had already received her first chemotherapy three weeks previously and was 
scheduled for her second session of chemo therapy (“Red Devil”) after our 
session. She referred to the chemo therapy as the “Red Devil” because that is 
how the oncology sister had explained it to her. I told her that the term was the 
“nickname” for a type of chemotherapy which contains beetroot extract as an 
ingredient and made it red in colour (Kapadia, et al., 2011; Opperman, 2015). She 
told me that she was already experiencing some of the side-effects that the 
oncologist had informed the group about. These were immediate hair loss, mouth 
sores and changes to her finger and toenails.    
After the formalities and the explanations I gave the patient the opportunity to talk. 
Without any prompting she began to talk about her experience of breast cancer 
from the very beginning. The patient had found a lump in her breast and had had 
tests confirming the cancer. By the time she had seen the oncologist she was 
extremely anxious and stressed and the oncologist immediately referred her to a 
social worker which is part of their oncology practise. She said she could not say 
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whether the session had helped her in any way in terms of her emotional well-
being. The interview had been done more in a “technical manner” relating to her 
what she could expect from the treatment in a practical way. She only saw the 
social worker once and was thankful for the practical information but still felt 
extremely anxious and did not know how to handle her feelings. She said that she 
was not an anxious type of person and therefore did not have the know-how to 
deal with extreme stress such as her cancer. She had started off as a private 
patient, but because of the costs, she was receiving her cancer treatment as a 
state patient.   
The patient said that her family and their closeness and constant support had 
helped her to cope up to that point. Her husband of nearly thirty years and adult 
children were very supportive and spoke openly about her cancer. She had 
immediately bought a book about cancer which helped her with certain questions 
but said that “over information” made her more anxious and she preferred to know 
only the basic information. She did not want to know about the “time frame” 
connected to her cancer. She said that what she wanted and needed is someone 
to talk to about the treatment and emotions and what she could expect, rather than 
more cancer statistics. She said because of this she had immediately decided to 
participate in this study when I had explained the specifics of the study and the 
therapeutic interventions on the very first day at the group discussion.     
She again said her hair had started to fall out immediately after the first chemo 
session, but she felt she was ok with it because it had been explained to her and 
she had been prepared for it to happen. Again the way her family and especially 
her husband had supported her made her feel safe and that she was still wanted 
as a wife and mother. She said spontaneously, that her husband had ensured her 
that she was still attractive to him and regarding sexuality, he still felt the same 
about her as before the surgery. She began to talk about sex spontaneously 
although I had not asked her any questions or prompted her regarding their sex 
life. They still had a “normal” sex life and she found it very reassuring and it had 
had a calming effect on her. She and her husband had always had a good and 
open form of communication, which give her the freedom to talk openly to him 
about her feelings and fears.  
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I asked her to tell me about her experience of the first chemo therapy. She said 
she could feel after the chemo that her energy levels were lower than usual, but 
found she had more energy in the mornings and she had chosen to do all her 
house work, social meetings and other activities at that time. She stayed busy with 
cooking, cleaning and gardening. Her energy levels decreased in the afternoons, 
and she then rested and became more passive. She felt that the cancer was more 
of a challenge for her thought processes than anything else and she was very 
focused on turning her thoughts from negative to positive. She always had had a 
good way of coping with stress and never let negativity overrule her thoughts and 
wanted to start with mild exercising. We discussed the benefits of exercising and 
the positive effect it could have on her body and mind, but I advised that she 
discuss it with her oncologist firstly.  
The side-effects that she had experienced after her first chemo had been nausea 
from day three although she had been given medication for it. She had also 
experienced tiredness more or less three days after the chemo and again 
repeated that her hair had fallen out immediately.  
We ended the session after an hour and booked our next appointment which 
would be three weeks from now and just before her third chemo session.   
SECOND CONSULTATION: 04/04/2016. 
This consultation took place in the same consultation room as the previous 
session and the order of events were the same. The patient went to draw blood 
first; we then had our therapeutic session for an hour and afterwards she went to 
the chemotherapy room down the corridor from where we were. This was the third 
“Red Devil” chemo and the last one before she would begin a new chemotherapy. 
The patient looked less stressed than at our first session and her opening words 
were: “I couldn’t wait for this session.” She began talking immediately about how 
she felt and especially how she had felt after the previous chemotherapy and 
consultation. She had just found out the date of her next surgery from her 
oncologist. It would be on 11 July 2016. 
Without me asking any questions she talked about the side-effects of the second 
chemotherapy which had started on the third day after it:  
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 She had developed a bad cough and tight chest 
 Her nails had turned blue 
 She had become very tired and continued to be very tired. It was much 
worse than with the previous session. She also said that the tiredness was 
more severe and was lasting longer.   
 
I asked about nausea and vomiting and she said that she had not been nauseas 
at all and that they had given her medication to prevent it. The tiredness was 
affecting her emotional health and psyche the most, because it was changing her 
specific level of functioning that she was used to. She had been a very active 
person who liked working in and around the house, especially gardening. These 
activities were what defined her as a person and made her feel useful. She said 
that she constantly felt, without any reason that she should prove to her husband 
and family that she could still do everything in and around the house in spite of the 
cancer and the treatment.     
THERAPEUTIC INPUT 
I explained the dynamics of chemo related tiredness to her – telling her it was 
different from other forms of tiredness regarding its severity and persistence. It 
was a very common side-effect of chemo therapy and that it could be quite a 
prominent and distressing experience. Chemo-related fatigue not only makes 
physical action difficult, but can also cause a lack of interest and an impairment of 
the short-term memory, attention and concentration. It was important for her to 
understand her own unique pattern of tiredness, identifying the specific day after a 
chemo session when she felt most tired and the specific time of day she would 
feel the worst. I tried to put her tiredness within the context of her treatment and to 
normalize her feelings about it. We also talked about accepting the tiredness as a 
passing or interim element in her life as it was part of her treatment. She could 
time-manage her day around her fatigue and involve her family into her “fatigue 
time-schedule”. We looked at specific practical things that she could do, e.g. 
resting on the bed with a book or watching TV, without feeling guilty or thinking 
that she was “lazy” which would be a way of dealing effectively with her situation. 
She said that she could take up knitting again for this was something “passive” 
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and she was actually looking forward to it. Another practical plan she thought 
about was for them to hire help once a week to relief her from some of the 
household chores. She said this made a lot of sense to her but she had not 
thought about it before and that she would discuss it with her husband. I told her 
that because her situation was different from before she was diagnosed with 
breast cancer; she would need to think about alternatives to help her cope.  
I helped the patient understand the tiredness, putting it within a rational framework 
assisting her to work around it instead of becoming stuck with it. This made her 
more relaxed about her fatigue, realising that there was nothing “the matter with 
her”. 
We also talked about her irrational thoughts that she had to “prove herself” to her 
husband and grown-up children after all these years. Did they really expect her to 
prove herself to them? And her answer was “no, never”. The family all had very 
good and solid relationships with one another and good communication. She could 
learn to identify irrational thoughts which were not true or based on facts. She 
could change them to more rational thoughts, e.g. “I do not need to prove myself 
to my family after 30 years and they accept me for who I am, even now with the 
cancer”; “they still love me and I still love them”.      
I asked how she felt about the scheduled surgery and she answered that she did 
not know what they would do, for they had not decided yet. Everything depended 
on the outcome of the results after the chemotherapy. She still did not know what 
stage of cancer she was in and she wanted to know. She felt that there were not 
good communication between her and her doctor and because of that she did not 
have the confidence to talk to him about anything or ask him any questions. She 
felt that he was in a hurry when she was in consultation and did not interact well 
with her. She experienced this as a problem, because it made her anxious and not 
able to talk to the doctor.      
She spontaneously began to talk again about her emotions over the previous two 
weeks because of the tiredness and the feelings of depression (that was her own 
words). She said that she had been extremely moody and “down” during the 
previous two weeks. She said she had made a point of trying to explain how she 
felt to her family. She could relate her mood to the effect of the chemotherapy 
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because she was usually not a depressed type of person. She talked about her 
hair that fell out and I asked her how she felt about that. She said because her 
husband was so positive and nice about it, she felt that she could live with it for the 
time being. She had bought herself a wig and some headbands, but her husband 
encouraged her to walk around at home without her wig or something on her 
head. She said because of that she felt her self-image was still good and that she 
was not ashamed of her hair that had fallen out. She then talked again about the 
good support from her husband and children.   
Before we ended the session she again emphasized how much she looked 
forward to our sessions although she had good communication with and support 
from her family. She felt she needed to talk to a professional person with 
knowledge about the process and how she felt about everything. We ended the 
session which had lasted an hour by making a new appointment dating it within 
three weeks’ time, coinciding with her next chemo session.    
THIRD CONSULTATION: 28/04/2016 
The patient began the session by talking about the previous chemotherapy 
treatment, saying that she was very tired and that the side-effects were getting 
worse. She said that day she was starting with the new chemotherapy named 
Taxol. She was to have three of these treatments and hoped the next three chemo 
sessions would be better than the “Red Devil”. She said (without me asking) that 
the worst side-effect of the chemo was the persistent tiredness, especially from 
the second day and what really helped her to get through it was the support of her 
whole family. They made sure that she was ok and that she eat properly every 
day. She said she did not know what she would have done without them.   
I asked her about her emotions: she said that she still felt fine and in control of her 
emotions and life and that the mere fact that we spoke every three weeks gave 
her the courage to carry on, knowing that she could vent her feelings to somebody 
that understood the process of chemotherapy and was outside of her family. She 
said that speaking about the cancer and treatment and getting information about it, 
made it less unfamiliar and scary and worrying.   
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I asked her about menopause: she said that she had not been menopausal before 
the beginning of the treatment but that up, until then, nobody had spoken to her 
about menopause or menopausal symptoms because of the treatment and that 
she was not sure what to expect. She said that if this was the case, she would like 
to know more about treatment-related menopause. Although she was still pre-
menopausal, she realised that she was at the age where the symptoms of 
menopause might start and she did not feel negative about “normal” menopause.    
THERAPEUTIC INPUT 
Because the patient felt so tired and negative about her treatment I made a 
decision to talk about accommodating and controlling her negative thoughts 
regarding the treatment in order for her to feel more in control of the cancer 
situation, but to first answer her questions about menopause. 
I explained to her that menopause can be a side-effect of chemotherapy, which is 
called a chemically induced menopause. Menopause means that the body 
produces less oestrogen which causes menstruation to stop as well as other 
symptoms. These symptoms include hot flushes, heart palpitations, an inability to 
concentrate and impaired short term memory, weight gain, mood swings, a 
probable decrease in sexual desire and vaginal dryness. I explained that vaginal 
dryness could cause pain and discomfort during intercourse and it was important 
to use enough lubrication and have a longer foreplay before actually engaging in 
sex. If necessary, they could change their sexual patterns to adapt to the “newer” 
status quo. We decided to talk about sexuality at a later stage when the patient 
thought it necessary for their sexual functioning was still good and satisfying. At 
that point she preferred to talk about her negative feelings regarding the 
chemotherapy.  
We agreed that cancer is a traumatic illness and that the cancer treatment which, 
in her case, was the chemotherapy, is stressful and unfamiliar and that negative 
thoughts and worries should be seen as normal in this situation. She should learn 
to allow and acknowledge negative thoughts, speak about them and their 
accompanying emotions and put them into perspective of her illness. She could 
consciously focus away from negative thoughts and force herself to think about 
things that would make her feel better.   
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She could learn to see the side-effects of the chemotherapy from a different angle, 
realising, for instance that they were not side-effects of the cancer, but of the 
cancer treatment. In this manner they could count as “good” side-effects because 
they would most probably make her healthy or better again.   
We spoke about her tiredness extensively, for this was her biggest concern and 
caused much anxiety. We again discussed how to plan her day around the 
tiredness in order for her to rest enough without feeling guilty (she still sometimes 
felt guilty for not doing as much as before the chemo treatment). She gave 
feedback concerning our previous session where she had agreed to consider help 
with the housework and that she and her husband had hired a woman to help her 
with the house chores. She felt very positive about this step and revealed that it 
was actually not as difficult as she had expected it to be. I explained that resting 
enough and conserving her energy meant she could use it for more important 
activities such as looking after herself, doing relaxing activities and spending 
quality time with her husband and children. She could still do some of the 
housework, but at a different pace as before the cancer. She explained the 
importance of doing her “duty” in their household in order for her to feel “normal” 
and womanly and not “sickly”. I gave her the reassurance that it was good to still 
want to continue life in a “normal” fashion. She could do that to a certain degree 
but had to develop new ways of doing everyday chores so as to manage her time 
well. She should time-manage her day and not make her self-worth dependent on 
the amount of chores she was able to do. We talked about prioritizing her 
activities. She should decide which activities were the most important in terms of 
quality of her life and do those first when her energy levels were higher and leave 
the rest either for somebody else to do or for when she felt less tired.    
The patient said that this made perfect sense to her and that she felt more positive 
than before the session. She said that every time she walked out of a session, she 
felt more at ease and knowledgeable about what was happening to her and what 
she could do to make things better for her. We ended the session on a good note 
and made the follow-up appointment for three weeks from then to coincide with 
her next chemo session.    
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FOURTH CONSULTATION: 16/05/2016 
The patient looked tired and emotional. We started the session with her agonising 
over the new chemo that she had started the previous time. She said it was the 
most terrible experience up to date and that she felt that nobody had prepared her 
for the “shock” of this new chemo and its side-effects. Because it was so 
unexpected, the physical and emotional consequences were very traumatic for her 
and although she was not an anxious type of person, she was very anxious and 
tense because of “not knowing” what was happening to her. She thought that she 
would feel the same or even better than with the “Red Devil” treatment. She 
looked angry and said that she felt angry for not been given the chance to prepare 
herself for the new chemo because of the lack of communication between her and 
the oncologist.    
The side-effects as she explained it to me:   
 Her whole body was sore, very much so. She could not sleep because of 
the extreme pain. During the little time she could sleep, she had nightmares 
because of the pain. She said that she had once even vomited because of 
the pain – and she had never vomited as a side-effect of the chemo. This 
was very bad and scary for her. 
 
 The tips of her fingers were “dead”. Her nails had also turned blue. Her leg 
from her knees downward felt “weird”. Especially the soles of her feet felt 
“weird” and very sensitive as well. The soles of her feet were swollen in 
such a manner that it was uncomfortable for her to wear shoes or to walk. 
Because she had not expected any of these side-effects, it was a shock 
and she was very, very anxious and scared not knowing what was 
happening to her body. She said she thought because she is a diabetic her 
hands and feet were worse, but she was not sure.  
She said she had seen her doctor just before our session and that he had 
prescribed Vitamin B and mentioned that her sugar count is too high, but that they 
would attend to it. The doctor also confirmed the date for her next surgery 
(11/07/2016). She said that although she would have liked to, she had not spoken 
frankly with the doctor about her feelings and even about her physical reactions 
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regarding the chemotherapy and her lack of knowledge about the side-effects. I 
again encouraged her to speak to her doctor regarding the cancer and 
chemotherapy and ask him questions about matters that were unclear to her. She 
said that she was disappointed in the hospital personnel and the doctor for not 
informing her about the severe side-effects of the new chemotherapy and what to 
expect from that. She felt that if the oncology personnel had not looked out for her 
as a person because they withheld information from her. She saw this as a 
setback for her in terms of her emotions and adaptation to the treatment.       
She said that for the first time – after hearing when the operation would be – she 
was scared. She said up till then, it was something that had been too far in the 
future. She said that she had been in denial and also too busy with the 
chemotherapy and that she had not thought about the operation at all. After 
hearing the confirmation of the date, it became a reality for her and she felt 
nervous and scared.   
THERAPEUTIC INPUT  
Because the patient was so emotional and unsettled, I let her talk freely about how 
she felt (as an emotional catharsis) and tried to normalize her emotions and fears 
by saying that pain can be a prominent side-effect of chemotherapy and often co-
occurs with cancer-related fatigue. Pain could create negative feelings, as could 
anything that was unfamiliar and unexpected because it could make a person feel 
scared and unsure of what to expect. I explained to her that pain and fatigue are 
two well-known symptoms reported by breast cancer patients due to 
chemotherapy and that it was important to talk to her doctor about pain medication 
or other alternatives to handle the pain.   
We also talked about the side-effects of the new chemotherapy and how to deal 
with it, still remembering that it was not the cancer that was making her ill, but a 
biological reaction to the cancer treatment. The patient said that this information 
(which we had discussed in the previous session) was the one thing she “grabbed’ 
onto the whole time she was feeling so sick and scared and the fact that she 
would see me again to talk about the pain and the fear regarding the pain and 
uncertainty. We talked about the importance of “living” through your emotions and 
talk about it and share it and put it in a realistic framework (like the cancer- and 
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chemo framework). In terms of the surgery, which was two months away, she had 
to accept the anxiety that went with that, but also make a conscious effort to focus 
on the present – because she could control things that were happening at that 
point better than things that were going to happen in the future. I have explained 
to her that everything was about “baby steps”, one thing at a time, and then when 
something is over, a person could “tick” it off and go on with the next thing.    
The session lasted for just over an hour and was a very emotional session. 
Afterwards she said she felt emotionally much “lighter” for being able to talk about 
how she felt and she could get everything of her chest. She knew what to expect 
of the next chemo session which she was on her way to. We made an 
appointment for the last chemo session three weeks from then. I also reminded 
her that she could call or text me if she was in an emotional crises. 
FIFTH CONSULTATION: 09/06/2016 
This was the last chemo session (the sixth one). The patient seemed to be so 
preoccupied with the coming surgery that she felt more anxious than happy. The 
date of the surgery had been confirmed again on that day for the 11 July 2016 and 
the fact that she still didn’t know what they were going to do during the surgery 
made her feel scared and uncomfortable. She had already undergone a 
lumpectomy together with the removal of some of the lymph nodes. She said that 
she had thought that when the chemo was over, she would feel like celebrating, 
but because of her uncertainties around the operation and the “not knowing”, plus 
the bad side-effects of the last chemo, she didn’t even think about celebrating.  
THERAPEUTIC INPUT  
I explained to her that the different treatment processes (chemotherapy, radiation 
and surgery) would generate their own fears as well as expectations and 
emotional- and physical outcomes. Every time she began with a new treatment, 
there would be new fears and uncertain expectations. We talked about how to 
cognitively “manage” her thoughts and emotions by taking control through allowing 
herself to go through the negative emotions, to acknowledge and accommodate it 
and to share her emotions. She could then ask herself what she could change 
regarding her circumstances and what she should accept and adapt to. Because 
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she still felt tired, she had to commit to resting enough during the day, conserve 
her energy and turn her focus away from constantly having negative thoughts. She 
also had to allow herself, at the end of this stage of the treatment (chemotherapy) 
to celebrate it and end it off on a “good” note. She had to rest and relax before the 
next stage of the treatment started. It made it easier to compartmentalize her 
treatments and end it off properly. She could finish it by either “celebrating” the 
end or by ticking it of as finished. By doing that it would feel like it was something 
with a beginning and an end.    
The patient spontaneously started to talk (again) about the very bad negative side 
effects of the previous chemotherapy and how it made her feel. She said because 
she was more prepared for what to expect with the next chemo (after our previous 
session) she felt stronger and could endure the side-effects better. She also 
mentioned the strong support from her husband and children and how they 
encouraged her to stay busy and positive. They took turns to take her out and 
treat her, especially on or before her chemo so that she could focus on something 
pleasant. I confirmed the positives of her family support and that she should “use” 
it without feeling guilty and see it as a kind of a “pay it back”, for she had invested 
many good years in them.    
I asked her about her appetite and sleeping pattern: She said that her appetite 
was relatively good but her sleeping pattern had changed completely now 
because of the pain. She said the pain in her legs and feet was still very bad but 
the doctor had prescribed pain medication and supplements that was helping her 
to a certain extent. Because of the pain and the lack of sleep, she was also more 
tired than usual. She gave feedback from the previous therapeutic session saying 
that she constantly did something like knitting or other crafts or did things in and 
around the house that she liked, like cooking (but not cleaning anymore). She had 
made peace with the fact that she could not do certain things anymore, but also 
knew that she would be able to do some of that again. She referred back to that as 
the “practical guidelines” that we had discussed, and said knowing what to do in 
certain circumstances, made things easier and less frightening for her.   
She then talked again (out of her own) about her emotions and the uncertainty of 
the upcoming surgery.  She said that if she had a choice she would choose a 
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double mastectomy, because she was scared that the cancer can return to the 
other breast and that she would have to go through everything again. I let her talk 
about her emotions regarding the surgery and she wanted to know what would my 
involvement be with her after the chemotherapy ends and would it be possible to 
still have contact. I assured her that I would have a session with her before (if 
possible) and after the surgery and that we would take it from there and decide 
upon the next therapeutic aims and then plan the follow-ups. After the operation, 
the oncologist would also decide about whether she was going to undergo 
radiotherapy or not.    
We ended the session on a positive note but without a next set date, for she would 
have to contact me about the date which she would be admitted for breast 
surgery.    
SIXTH AND FINAL CONSULTATION: 16/11/2016 
The session was scheduled for an hour because she was booked for her next 
radiation therapy just after our therapy session. A period of five months had lapsed 
in between the last two sessions because of some practical reasons. We were 
supposed to see each other before the surgery in the hospital, as in a hospital 
session, but there were last minute changes to her time and we decided to wait for 
her to go back to the hospital for her radiation therapy and schedule an 
appointment then. She underwent a radical mastectomy of the right breast and 
had to wait for two months for the results of the surgery and to recover properly. 
After the final results the oncologist had decided on 23 sessions of radiotherapy, 
which she already had started before this session. Although we did not see each 
other before the surgery, we had two telephonic contacts where we talked about 
her fears and concerns regarding the operation. I tried to encourage her to 
accommodate her fears and anxious thoughts and concentrate on living one day 
at a time until the surgery and during the recovery stage, making use of the 
support of her husband and family and using her “new” skills.     
The patient looked very well and said that she felt strong and was emotionally in a 
good place. She said that she had so many things to tell me and that she wanted 
to start with the surgery because I had not seen her before or directly after it. She 
said that she had had quite high levels of anxiety before the surgery, especially 
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before she knew what exactly they were going to do. She said that on a few 
occasions she had to visit the oncologist because her blood pressure was very 
high and that the oncologist commented on her anxiousness. She said that after 
they explained what the surgery was going to involve and what she could expect, 
she felt more at ease and less anxious about the whole procedure. She said when 
she was hospitalized, she had experienced “normal” anxiety and her blood 
pressure was back to normal. She said that at that time she was glad that she 
understood what “normal” anxiety meant, for she could then handle the anxiety 
about the surgery and also the time away from the family while she was in the 
hospital. The surgery went well and she handled the healing process well too, both 
in terms of the operation itself and her emotions regarding the whole surgery 
process. In the beginning the worst pain was in her arm and not in the surgical 
scar. She was still experiencing pain in her arm. She went to a physiotherapist for 
sessions and did the exercises that the physio had given her. I then explained 
what lymphedema is and what to expect from it and that it could be present for a 
long period after the surgery, but it could differ from patient to patient. She would 
need to consciously accept the current pain and discomfort of the arm and try to 
implement alternatives to cope with it. I emphasized the importance of going to a 
physiotherapist and commit to doing the given exercises.   
She said that she remembered in her head all the stress handling mechanisms 
that I had taught her especially the time-management and cognitive restructuring 
of her thoughts and to express and manage her emotions. She confirmed that it 
helped her a great deal through her ordeal with the surgery and long wait for the 
radiation therapy. She also said that the consistent support from her husband and 
children and her faith and religion literally pulled her through the healing process. 
She said that she never lost her ability to stay positive and optimistic and kept on 
believing that she would heal fully. The period she had to wait for the results of the 
surgery was also tense, but she could put it in the framework of it being normal to 
be scared when waiting for results. The results of the surgery were very positive 
and they had not found any more cancer in her breast or lymph nodes. After the 
final results, they had scheduled 23 sessions of radiotherapy which she already 
had had 15 of with only eight more to go. The oncologist explained to her that she 
should use Herceptin at the end of the treatment and that because of this she and 
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her husband had joined a medical scheme to provide for this treatment. She said 
that she felt very positive about this medication. I asked her if she understood 
what type of drug it was – and she said it was something to block the growth and 
spread of the cancer. The doctor had explained to her that she should visit the 
hospital for this medication twice a week for six months, that the side-effects would 
not be so harsh and that her body will be able to endure it.    
I asked about the radiation: She said that the positive and pleasant attitudes of the 
radiation personnel and the relaxed atmosphere helped her to experience the 
radiotherapy in a positive way. She explained that throughout the whole process of 
treatment, the way the radiation personnel treated her was the most positive 
experience and made her feel that she was an important and valued person. This 
helped her to handle and cope with the radio therapy. She said that apart from the 
practical implication of traveling to the hospital every day to receive the radiation, 
she did not experience it negatively and as of yet she did not have any side effects 
form the radiation. She said she was looking forward to the end of the treatment 
and that her feelings were especially positive because the therapy would be 
finished before Christmas. She said that on 7 December it would be a year that 
she had been diagnosed with breast cancer and that she was really tired and that 
she could feel she needed a break. She said looking back she had experienced 
the year as very busy with the constant treatments and traveling to and from the 
hospital and the waiting periods for either procedures or results. She and her 
family were going on a long vacation and she was looking forward to it. She now 
talked very easily about her cancer experience and her emotions, and she 
believed that this was not only just helping her with her coping process, but also 
helped other people to cope with their emotional hardship, regardless of what it 
was. She said that she had a completely different outlook on life than before the 
cancer and that she felt that she could make a difference in other people’s lives.  
I asked her about her sexual functioning: She said that there was little change in 
their sexual functioning because, she thought, they always had a good sexual 
understanding even before the cancer and that their sexual communication was 
good. She said that the most positive thing concerning their sex life was that her 
husband had just, after the latest surgery, told her that the operation and loss of 
her breast had no negative effect on him and that he felt sexually the same about 
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her and she should please never doubt that. Although she still felt tired at times, 
their intimate relationship was as good as ever and they had “normal” sexual 
activities. Because of her husband’s “soft” approach regarding the sexual side of 
their relationship she did not feel ashamed about the absence of her breast or 
even the scar. She said when they did have sexual intercourse she was aware of 
the hormonal changes in her body and that she made provision for that e.g. 
lubrication. She felt more comfortable undressing in front of her husband now, she 
felt comfortable with her body and even allowed him to touch her scars or 
massage her sore arm. She said because we had talked about their sexual activity 
right through the therapeutic process, it made the changes in her body more 
“natural” and less scary for both of them. She appreciated the fact that I had 
addressed the intimate and sexual side of the therapy. She had not thought that 
she would ever just talk about sex to anybody. Knowing how the cancer 
treatments would affect her sexuality she could prepare herself for the changes. 
She and her husband decided together that for the time she would not have a 
reconstruction operation and that she felt comfortable with just wearing the breast 
prosthesis.   
I asked her about the role of the therapeutic sessions in her treatment and healing 
process. The patient answered that before the cancer diagnosis she had not ever 
known anybody with breast cancer. She had had no previous experience of an 
illness such as cancer. She revealed that she could cope with all the elements of 
cancer after she had been informed of all the aspects of breast cancer, the 
treatments, the side-effects and especially the emotional experiences. She could 
not have imagined how different it would have been for her if she had not had the 
sessions because she was so “clueless” about everything. Most of the aspects we 
talked about during the sessions and the skills that she had learned were not 
previously part of her frame of mind or practical world. Because of our sessions 
she could understand what was happening to her step by step and therefore 
prepared herself for every phase during the treatment process. She said that she 
was extremely thankful for the privilege to have been chosen for this study 
because she would not have known to visit a psychologist as it was never 
specifically mentioned to her during her treatment regime. She explained that the 
practical advice given to her was the most important aspect of the therapy. An 
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example of such advice was how to do time management as well as resting during 
times when she was very tired, without feeling guilty. She also learned to listen to 
her body and knew the importance of talking to the people around her about her 
feelings. She felt that the therapy prepared her for all the different and unfamiliar 
experiences that she would have and that even with the few surprises, such as the 
side-effects of the second type of chemotherapy, she felt that she had the basic 
knowledge and know-how to cope. She said that when there was something that 
she didn’t know, she knew that she could ask me the next time, and that made her 
relaxed. She said another very positive thing for her in terms of the sessions was 
that she could talk to somebody that was not a family member or even a friend, for 
there were things that she would not want to burden her family with and that she 
could share that with me.   
To conclude the therapeutic process I emphasized that breast cancer is a chronic 
illness and that there will be a bridging time to go from being a breast cancer 
patient to becoming a “normal” person again. It would take some time for her to 
get used to her “new” status quo. I discussed the fact that after the cancer 
experience, she as a patient, would feel and think differently than before. As a 
couple, she and her partner would have a changed perception about each other 
and about life in general. These changes were not necessarily all negative and 
could be part of personal growth. She said she could see that there were areas in 
her personality that had changed. She mentioned that she had become more 
relaxed about her emotions, especially her negative emotions. She had been 
sharing these emotions. She had also allowed herself more things in life without 
feeling needless guilt and that she did not think as rigidly about things as before. I 
enhanced the fact that changing and growing is an on-going process where 
applying the needed skills lead to more success in changing and growing. 
After an hour I concluded the session by reassuring her that she could contact me 
any time she felt it necessary to discuss matters concerning her breast cancer or 
breast cancer treatment and thanked her for being willing to take part in the study. 
She said that she felt very grateful and privileged for the sessions and being part 
of a process that might help other breast cancer patients. 
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Appendix 
PATIENT III 
Patient III was recruited from a state hospital. After the necessary ethical 
clearance, as discussed in Chapter VI was obtained, I was granted permission to 
attend a group meeting of newly diagnosed breast cancer patients with the 
oncology team at the hospital. The meeting was held in the oncology ward where 
all the newly diagnosed breast cancer patients would meet at a scheduled date 
and time. At this meeting the patients were to receive information regarding certain 
practicalities concerning their chemotherapy appointments and dates, as well as to 
be familiarised with the place, procedures and the oncology personnel for the 
period of their treatment. The process of chemotherapy was explained by an 
oncologist. Patients learned what they could expect in terms of general side-
effects and the way forward after finishing the treatment. After the group session 
the oncologist introduced me to the group and the personnel and briefly explained 
what my study would be about. I circulated through the group after the information 
session was over, asking for volunteers. The age interval for my intended study 
was between 30 and 65 years. I again explained what my study would entail. 
Three patients immediately agreed to participate in the study. One of the patients 
only came once and did not return. I scheduled our first appointment for the same 
day as the patient’s next chemotherapy appointment at the hospital. The 
appointments had been confirmed telephonically the previous day.  
DEMOGRAPHIC INFORMATION:   
Age: 63 years.   
Marital status: married.   
Children: two adult children.   
Highest education level: grade 10 with extra diploma 
Occupation: on medical sick leave.   
Diagnosis: Stage IIB Breast Cancer 
Date of diagnosis: 13 November 2015.   
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Surgery: none  
Breast reconstruction: none 
Treatment:  
Radiation: none  
Chemotherapy: had begun the treatment. She had had two of the six 
chemo sessions. Four sessions left – the date of the last chemo 
would be on 09/06/2016 
Hormonal therapy: none 
Anti-depressants: none 
Pain medication: Tramadol 50 mg for pain when needed and 
Metoclopramide 10 mg for nausea. 
Psychiatric treatment history: never treated before  
Diagnoses 
The patient was diagnosed with breast cancer on 13/11/2015 after she had felt a 
lump in her breast. She first had a mammogram and a fine needle biopsy without 
any surgery. A date for possible surgery was scheduled on 11/07/2016. This 
information I obtained from the patient herself.   
The diagnosis that was obtained from her medical file: Stage IIB breast cancer, T3 
N0 M0. The diagnosis was made on 13/11/2015. The tumour in the breast was 
3cm x 3cm and the lymph node was 3cm x 4cm.    
Treatment plan 
After the fine needle biopsy and the consequent diagnosis of stage IIB breast 
cancer the patient was started on chemotherapy. She was scheduled for adjuvant 
chemotherapy every three weeks for a total of six times when she would be 
evaluated for the most appropriate type of breast surgery and to determine 
whether she would require radio-therapy.   
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FIRST CONSULTATION: 14/03/2016 
As we agreed, I saw the patient formally for the first time for a therapeutic session 
on the same day as her chemotherapy appointment at the state hospital. The 
session was scheduled for an hour.  The session took place one month after our 
first meeting where I had attended their breast cancer group session with the 
oncology team. We had spoken on the phone only once just to confirm the 
appointment. We were allocated one of the consultation rooms in the oncology 
department and although small and impersonal, it was quiet and private and 
sufficient for our needs. We scheduled our appointments for the same days as her 
chemotherapies for practical reasons. These included the availability of the patient 
and the cost effectiveness for her in terms of traveling to the hospital. The patient 
had already received her first chemotherapy three weeks prior and was scheduled 
for her second session of chemo therapy after our session.   
Before we started with our session, I gave her a short but detailed explanation of 
what the study would entail, and what would be expected of her as a participant. 
No complex medical terminology was used. I explained that one of the aims of the 
study was for the oncology team, including the psychologist, to understand the 
psychological needs of the breast cancer patient better. This would enable the 
team to provide a holistic service to enhance the quality of life of breast cancer 
patients and their families. I explained to her that learning through her experiences 
during the course of her treatment, could help other breast cancer patients going 
through the same ordeal in the future. I explained to her that she could at any 
given time stop her participation without giving a reason or stop answering any 
questions that made her feel uncomfortable. I gave her the demographic 
information and the consent forms to read through at home on her own time and 
discuss it with her family to give her more time to decide whether she wanted to 
participate in the study and to sign the consent form. I asked her to explain the 
study to her husband and to ask him if he was comfortable with her participating in 
this study and if he would later attend a session with her. I gave her the HADS 
Depression and Anxiety Scale and the Female Sexual Functioning Index – FSFI 
(see Chapter VI). The two questionnaires were to be filled in at home and I 
explained to her how to go about to complete it. I assured her of my commitment 
to the study and to her as my patient and gave her my cell number and 
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encouraged her to phone me if anything troubled her between sessions that she 
would like to discuss with me.    
After the formalities and the explanations I asked the patient to tell me about her 
experience with her cancer. She started by telling me how anxious she was when 
she heard that she had breast cancer, saying that she could remember the exact 
date and time of the day that she had heard the news. She said that she had been 
very shocked at that moment and that even for the next couple of days she had 
felt in a “haze”. She said from there on she only took one day at a time because 
she didn’t know what else to do. The first time that the reality of the breast cancer 
really hit her was the day her hair started to fall out after the first chemotherapy. 
She was receiving what they called the “Red Devil” chemotherapy and that she 
understood that it was very strong and that her hair had fallen out immediately 
after the first session. I explained to her that “Red Devil” was the “nickname” for a 
type of chemotherapy where beetroot extract is an ingredient thereof, causing the 
red colour (Kapadia, et al., 2011; Opperman, 2015). She said she had “freaked 
out” when she saw her hair falling out in lumps. She and her husband had decided 
that he should shave her hair and although it was a very traumatic experience for 
her, her husband felt that she had known about the hair falling out and should 
have prepared herself better for it. She said that she felt resentment towards him 
for his reaction and that they had a lot of stress in their marriage. They were 
recently married, both for the second time.   
She said she felt that at that stage, her husband did not understand what she was 
going through with the stress of having cancer and the chemotherapy, although in 
his own way he was supportive of her. She said she had been the main 
breadwinner before the cancer and still felt that the financial responsibility rested 
largely on her shoulders which put a lot of stress on her. Both her adult children 
also relied on her financially. She worked as a health carer and felt that at that 
stage she could not work with patients, neither physically or emotionally. She said 
that her work was physically very demanding and that she felt too tired to do her 
work properly. At the time they were in a financial predicament because she was 
not earning a salary. The financial stress made her extremely anxious. She said 
she felt her children were not supporting her properly during that time, but blamed 
it on their poor relationships before the cancer. She said that they as a family 
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didn’t have good communication skills and hadn’t spoken of the cancer yet. She 
felt the need to talk to them about what she was going through. The patient said 
she had felt very depressed lately and asked if I could see her husband to explain 
to him why she felt so emotional about the cancer and what she was going 
through. She said that she had a lot of problems apart from the cancer and asked 
if it would be possible to work on that as well. She said she was a diabetic and her 
sugar was not always under control because she had not been so committed to 
the diabetic diet and that she would like to learn to control that as well. 
THERAPEUTIC INPUT 
I let the patient talk freely about how she felt about her marriage and the lack of 
emotional support from her husband. I explained to her that sometimes by just 
talking about something that has been on your heart for a long time could be a 
healing experience in itself. I had the feeling that the patient didn’t often speak 
about her emotions and especially about her marriage and that the catharsis was 
doing her good. I explained to her that different people have different ways of 
dealing with pain and that her husband, for example, seemed to be a more 
practical person when dealing with trauma. An example was the shaving of her 
hair (before the chemotherapy) where she was more emotional and had more 
definite and concrete emotional needs, where he had look more at the practical 
side.   
I suggested to her that she should sit down with her husband and try to explain to 
him how she felt and give him examples of how she would like him to support her.     
The patient said that she was very glad to be able to talk about her feelings 
regarding the cancer and her other personal issues and we ended the session 
after an hour. We made an appointment for three weeks later at the time of her 
third chemotherapy.  
SECOND CONSULTATION: 04/04/2016 
This consultation took place in the same consultation room as the previous 
session and the order of events were the same. The patient went to draw blood 
first, and then we had our therapeutic session for an hour. After this the 
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chemotherapy session would take place in the chemotherapy room down the 
corridor from our consultation room.   
This was the patient’s third and last “Red Devil” chemo before she would start with 
a new chemotherapy three weeks later. Without any prompting, she started talking 
immediately about her worries and how she felt. She said that she was far more 
worried about the absence of her children in her life, than the cancer itself. She felt 
that her children were not interested in her cancer and treatment and were not 
involved or supportive. She said that this was a very big loss to her. She needed 
to talk about the relationship between her and the two children, especially her 
daughter and that she found it depressing that she and her daughter didn’t see 
eye to eye, even in a crisis situation like this with the cancer. There was not a lot 
of contact between her and her daughter and she felt she could use her help in 
and around the house as well as her emotional support.   
THERAPEUTIC INPUT  
I encouraged her to talk about how she felt about her past and especially her 
relationship with her daughter, and how, by not dealing with it, it could prevent her 
to deal effectively with her cancer experience in the present. I explained to her the 
importance of talking about emotions and acknowledging them. I explained that 
although she could deal with her “old” issues and emotions during our sessions, 
she should also focus on the cancer and cancer treatment and her emotions and 
needs regarding that. She could not control her daughter’s behaviour, for she was 
an adult, but she could learn to make peace with that and with their relationship. 
Instead of just focusing on the negative aspects of their relationship, she should 
try to involve her daughter in her treatment and illness by explaining to her what 
she was going through and where she would like her to help and support her. By 
doing something about the problem, she could feel more in control of her life. She 
continued to talk about her husband, saying that at the time they were getting 
along better with each other than they had been at the previous session, but that 
she still felt resentful towards him about things that had happened in their past. 
Because of this, she didn’t feel that she could talk freely to him about her cancer 
and how she felt. I explained to her that she could make a conscious decision to 
accept the things that had happened in the past between her and her husband 
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since she could not change it. However she could concentrate on changing things 
now in their relationship. Instead of dwelling on negative thoughts about her 
marriage, she could try to take her focus away from that and replace it with more 
positive and constructive thoughts. She could try to concentrate on the realistic 
and positive things her husband was doing to help her now, such as taking over 
some of her chores and taking her on long drives to take away her focus from the 
cancer, instead of just concentrating on the things that he didn’t do. 
I asked her about her experience of her previous chemotherapy (the third session) 
and she said that all her hair had fallen out and that she could deal better with it. 
She was a little bit more used to herself without her hair. She said she was 
nauseas at the time and had a bad metallic taste in her mouth. She seemed a lot 
more emotional about the cancer during this session and she was very tearful. 
When I asked her, she said that she had been crying a lot more and she had been 
feeling very emotional. She was glad that she would finish her last “Red Devil” that 
day, but did not know what to expect of the next chemo sessions. She said the 
doctor had informed her that her tumour was already smaller after the chemo 
sessions and that it made her feel a little bit more positive. She said she thought 
about the surgery a lot and that it scared her, especially because she didn’t know 
what they were going to do. I let her share her fears and anxieties about the 
upcoming surgery and said we would deal with it in the therapeutic sessions. I told 
her that she should remember that she had an oncology “team” that was 
supporting her and undertaking the journey with her. She said that she felt so 
worthy that people (as the oncology team) were willing to help her. We talked 
about the good news regarding the smaller tumour and that she should allow 
herself to focus on that. At the end of the session the patient said that she felt 
relieved about being able to talk about her negative emotions and fears and being 
able to understand everything better.     
We ended the second session after an hour. We made a new appointment for 
three weeks when she would come for her fourth session of chemo.   
THIRD CONSULTATION: 25/04/2016 
The patient looked more relaxed than with the previous two sessions. She was 
scheduled for her fourth chemotherapy and she said she was quite anxious to 
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start with the new chemo, not knowing what to expect, but hoping that it would be 
better than the previous three.    
She spontaneously started to talk about how she had felt when she heard she had 
breast cancer. She said she had been devastated by the news and that she 
immediately thought she was going to die. “I was very anxious and scared. I was 
scared of the chemo, not knowing what to expect and was very, very scared to 
die.” She said in fact that was all she was thinking about – dying. She was also 
very scared of the operation: maybe even more scared than of the chemo not 
knowing when that would be and what they were going to do.     
I asked her if she felt that she had the necessary information about the treatments 
that she would receive and she said that the sisters in the oncology clinic had 
explained clearly to her, in a nice way, what was going to happen. However if you 
wanted to know something from the doctors, you had to ask them specifically. She 
said that they did not explain anything without you asking.   
I asked her to what extent the cancer and the chemotherapy was affecting her 
marriage and sex life. She said that she still felt that her husband was not 
supporting her the way she would have liked him to and that he did not understand 
her emotions and fears, but she could see that he was making an effort to help her 
in and around the house. She said: “He still doesn’t know how to deal with my 
emotions.” They both suffered from chronic diseases and because of that their sex 
life was not that good and they may have been doing it only once a month. She 
acknowledged that they have a problem with their sex life. Her husband had 
consulted with a doctor once before, but it didn’t help him with his sexual 
problems. She asked me if I would see her husband and talk to him about their 
sex life as well, for she would like to improve it, saying she thought that maybe 
they would feel closer to each other. I agreed to see both her and her husband for 
a couple’s session.   
I asked her if she felt depressed or anxious after the breast cancer diagnosis and 
she said that she definitely does, saying “but there is a stigma if you feel 
depressed or if you go to a doctor for depression so I would not share this with 
anybody.” She found it difficult to speak about how she felt. She said the day she 
heard she had cancer and the day of her first chemotherapy was the worst for her. 
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She was also anxious on that day because of the new chemotherapy. I asked if 
she was ever treated for depression or anxiety before the cancer and she said that 
she had felt depressed a couple of years ago when she had had problems with 
her son, but she had never been diagnosed with depression or had had any form 
of treatment.    
I asked her about her specific side-effects of the chemo at that point. This is what 
she described:   
 she experienced very little nausea and had only once vomited and that the 
tablets for nausea were helping very much 
 She had stomach pain most days and had very bad heart burn 
 She said the tiredness was the worst. It was very, very bad and started the 
same day as the chemo; she was so tired during the day that she fell 
asleep and then slept badly at night. When she could not sleep at night her 
thoughts were going around and around in her head, making her very 
anxious  
 Her appetite was poor and she didn’t eat well or enough  
 Her hair had fallen out after the first chemo session (“Red Devil”) and that 
she felt quite self-conscious and didn’t feel like going out in public 
I asked her how she felt about speaking to the oncologist about her emotions and 
sexual fears or functioning and she said: “No, we don’t speak”. I asked her to 
explain to me why they don’t speak and she said because the sessions were very 
short and over too quickly. She said that she felt that there was no relationship 
between her and her doctor.          
I asked her if it had helped her to have spoken to a psychologist. She said: “Yes 
definitely, especially about my depression and sex with my husband. I haven’t 
spoken to anybody else about it.” She said sex was really not enjoyable anymore 
and that she and her husband didn’t talk about sex or even intimacy. “We don’t 
talk about the cancer either and I would like to talk about it and how it makes me 
feel.” She further said: “If you haven’t offered your services in the beginning of the 
treatment, I don’t think I would have ever spoken about my problems to anyone. 
Every time that I have spoken to you, I have felt relieved especially when I realised 
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that we can work on the problems and that there are ways to deal with it.” She 
said she felt that the treatment was more “complete” with our sessions because 
she knew that it did not matter what occurred, even at home, she could come and 
discuss it in the therapeutic sessions.   
We ended the session after an hour and reschedule for three weeks from then.  
FOURTH CONSULTATION: 16/05/2016 
During this session the patient looked drawn and tired. She said that she had 
started with her new chemo three weeks previously and had slept more or less the 
whole time. She thought it was most probably because of taking Phenergan which 
is the medication that prevents motion sickness, and treats nausea and vomiting.  
She said she had had very bad side-effects from the new chemo (Taxol) and that 
the worst side-effects were her fingertips and her feet that felt numb underneath. 
The soles of her feet were very sensitive and she walked with difficulty.  Although 
she did not vomit, she had a lot of heartburn. She said she was very tired and 
experienced more and much worse side-effects from this chemo than from the 
“Red Devil”. Her whole body had been (and was) very sore from the beginning of 
the new chemo, but it had gotten worse after day three. She said her appetite was 
also less, but she made sure that she ate properly three times a day. She said that 
although she was very tired, she and her husband made time each day to do 
something nice, like going in to town. She said she was so proud of herself 
because she was still doing all her house work on her own even with the new 
chemotherapy. The good news was that her daughter had asked her for the first 
time to take of her wig so that she could see her without her hair. She said that 
although they had not spoken about her cancer, she saw this as a breakthrough in 
their relationship.    
THERAPEUTIC INPUT 
The patient said she wanted to talk about her daughter and their relationship and I 
gave her the opportunity to voice her emotions about their relationship and the 
cancer. This served as an emotional catharsis. We then talked about practical 
ways to engage her daughter in her treatment and to spend more time together. I 
suggested that she should involve her daughter more in the treatment process, 
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such as for instance asking her to come with her to the chemo sessions to 
familiarise herself with the procedure and to understand more of how the 
chemotherapy works. I suggested that by going with her mother, the daughter 
might understand more of what her mother was experiencing. The patient should, 
from her side, talk to her daughter about how she felt and what she was going 
through. I suggested that she could make a conscious decision to make peace 
with how her daughter reacted towards her and her cancer and see it as part of 
their unique type of relationship. I explained that things between them won’t just 
change because of the cancer since it had been a longstanding difficult 
relationship. By engaging her daughter in the practical activities of the cancer 
treatment and talking to her more openly about how she felt, they could begin to 
build a new relationship that both of them would benefit from. The patient seemed 
to understand this and felt more confident to talk to her daughter and not have 
unrealistic expectations of her. She also agreed and understood that she could, 
from her side, make peace with their relationship and not wait for her daughter to 
do so first. Instead of agonising over it the whole time she should rather use the 
time and energy to engage in a quality relationship.   
I asked her about the rest of the treatment and she replied that this chemo session 
was the second last one and after that they would prepare her for her operation. 
The surgery would be scheduled for three weeks after the last chemo, but she was 
still waiting for them to confirm the date. She said that she wanted us to talk about 
the operation during the next session, for she was very scared. She said not 
knowing what they were going to do make her anxious and uncertain and because 
of the diabetes she was scared that the wound wouldn’t heal properly. She said 
she was not always committed to her diet and I discussed with her the possibility  
of taking responsibility for something such as a diet, would make her feel more in 
control of her illness. She could also apply this advice to the cancer treatment by, 
for instance, resting more and using her energy more conservatively and making 
time to engage in activities to enhance her quality of life.     
A family member had died of cancer the previous week and it triggered a lot of 
fear, especially fear of dying. She said that she had such a need to talk about her 
fears and I gave her time to unwind emotionally. I reassured her that feeling 
scared and anxious when you were diagnosed with cancer was very normal and 
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realistic and that she must acknowledge the fear and talk about it. We confirmed 
again that I would see her husband to explain to him how she felt. We ended the 
session after an hour, with a new date for the next session (with her next and last 
chemo).   
FIFTH CONSULTATION: 09/06/2016 
The patient began the session immediately by telling me that the following chemo 
session was her last, but instead of being joyful she was apprehensive about the 
surgery and that she had just heard from her doctor that the intended date was 11 
July. Although the tumour had shrunk remarkably she was still scared of the 
operation. She was unsure of what the surgery would involve and whether it would 
be a lumpectomy or a mastectomy. When her last chemo session was over that 
day, she had an appointment with the surgery department to be evaluated and to 
get all the information. She asked me if she could continue to see me before and 
after the operation for she was too scared to do it on her own. I assured her that 
we would continue with the sessions if it was possible throughout the surgery and 
afterwards. This alleviated some of her anxiety, for she had appeared very 
anxious and stressed and said she didn’t know how she would have coped without 
the sessions. Her focus during the session had been on the surgery the whole 
time and she ever so often returned to the topic. She also had a lot of questions 
about the possibility of radiation, which she would also only have clarity on after 
her session with the surgeon. Her main concern about the radiation was whether it 
would affect her husband in any way. I told her that it was important to ask 
questions and she should ask the surgeon and oncologist everything that she was 
unsure of and that she should not be afraid or ashamed to ask questions. I 
explained to her that knowing what would happen to her and what to expect, 
would allow her to feel safer and in control.  
Apart from her fears about the surgery itself and the uncertainty about that, she 
said she was worried about her husband alone at home, not being healthy. She 
was scared that after the operation she would not be as strong as before in order 
to help him in the way she used to.   
THERAPEUTIC INPUT 
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I let her talk about her fears first and explained to her that what she was 
experiencing is called anticipation anxiety, which means that you are scared of 
something that must yet happen. This fear could be very draining. I explained to 
her that every situation has a practical side and a bio-psycho-logical side to attend 
to. In the case of her husband the problem was more practical in nature and 
therefore easier to manage. We looked at alternatives e.g. that some other family 
members, like his grown-up children, could help him with tasks he could not 
physically manage on his own. She could perhaps prepare food in advance and 
refrigerate it and he could then just warm it up in the evenings. She could also ask 
him about his alternatives when she would be in hospital and they could then both 
make plans for him to cope when she was not there. Instead of just worrying about 
something, she had to learn to look at it from different angles and make plans to 
either solve the problem or make it more manageable. She said that the 
alternative plans had made her feel more at peace with herself and relaxed about 
the situation at home while she was in hospital. Speaking to her husband later 
during the session I actually realised that her fears were irrational, for he was 
capable and willing to look after himself.   
I explained to her that when she felt so anxious she should make a conscious 
effort to relax by for instance doing relaxation breathing. I told her how deep 
breathing works and that she should relax all her muscles and think about things 
that made her more relaxed. She could also talk to her husband, go for a walk or 
do an activity to divert her mind from extremely stressful thoughts.     
I also gave her reassurance that if and when she received radiation, the oncologist 
and radiotherapist would explain all the details to her, but if she felt that there were 
still things that she didn’t understand, she should ask them until she understood.     
It would be four weeks before I would see her again. If circumstances allowed I 
would only get to see her on the day before the operation. I asked her to write 
down her thoughts, emotions and fears about the surgery and how she was 
coping in general. She said she liked the idea of keeping a “journal”. I also 
explained to her that writing about practical matters and feelings can be very 
therapeutic. Again, without enquiring, she spoke about how bad and unexpected 
the last chemo sessions were and how unprepared she was for the side-effects of 
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it. At the time she still struggled with pins and needles and excessive pain in her 
feet and fingers, but she was more prepared for that day’s chemo and that the 
doctor had prescribed pain medication that worked for her. We ended our session 
after 40 minutes, because the chemo nurse had called her for her chemotherapy 
and I still had to see her husband. She was reluctant to go, but with the 
reassurance that I would most properly see her the day before the surgery, she 
agreed to end the session.   
During the previous session we had arranged for me to see her husband and he 
was in the waiting room while we were first having our session. 
SESSION WITH HER HUSBAND:   
Although the husband did not sign a consent form, I explained to him the purpose 
of the research and that his wife had signed a consent form and if he understood 
that the therapy session also formed part of the research study. They had 
discussed her participation in the beginning before we had had our first session 
and he said that he was thankful for the opportunity for her to be part of the study. 
He also said he felt very positive about that session enabling him to understand 
his wife and her cancer better. 
The husband is a pensioner and came across as a relaxed person. I asked him 
how he felt about his wife’s breast cancer and the chemotherapy and he said it 
was very traumatic for him, for she was always the healthy strong one, helping him 
with his chronic disease. He said that after her diagnosis he had done some 
research on his own about breast cancer and chemotherapy and that he had 
some degree of knowledge. He admitted that he was far more practical than his 
wife and did not always understand or acknowledge her emotional reactions.   
He said there were days during the chemo that his wife was “normal” and okay 
where everything went well, but then there were also days when he could see that 
it was not a good day and then she would be very quiet and withdrawn and was 
not up to her usual chores. He confirmed the absence of relationships with the 
children, but said that there were friends that helped with some of the practical 
issues. He said that his own illness had helped him to understand her better and 
he thought that he better support her now than in the beginning.     
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He said that the whole cancer diagnosis and treatment so far was very traumatic 
for his wife, especially the loss of her hair and the absence of her daughter during 
the time while she was receiving treatment. They were both worried about their 
financial situation, but they could work something out at a later stage.   
I used the rest of the session to explain to him the side-effects of the 
chemotherapy and her emotional reactions and fears. I emphasised that breast 
cancer is a chronic illness with continuous adaptations also in terms of their 
marriage and sexual functioning. I told him that his wife had confided in me about 
their sex life and that she has asked me to talk to him regarding that. I explained 
that even with him having a chronic physical condition, they could still have a 
healthy sex life. However they would have to make an effort to talk to each other 
about their sexual needs and desires and make plans together to improve their 
sex life even if it meant reading books about sex or trying new ways of engaging in 
sexual activities. He said he never thought he would talk about sex to a “stranger” 
and yet he felt so relieved that we had spoken about it, because it had been 
bothering him for such a long time. He said that he was willing to sort out and take 
control of his illness and would make an effort to improve their sex life. I 
recommended that he see a specialist (e.g. urologist) to help him with his sexual 
functioning and he undertook to make an appointment.    
I tried to encourage him to communicate more freely and openly with his wife 
about his and her emotions and that he needed to talk to her and ask her what she 
sees as support and what her expectations of him were, reminding him that 
different people have different emotional needs. I also explained to him that the 
uncertainty of the surgery was causing her a lot of anxiety and that the surgery 
would have an impact on her emotions and physical strength, but that we will talk 
about that after the surgery in the next session. I said to him that the focus was on 
her gaining her strength back after the chemo and preparing herself for the 
surgery. She would need all the support that she could get. At the end of the 
session he said that he felt that he knew more and understood better how to help 
his wife and thanked me for my involvement in the whole process. We ended the 
session in good spirits.  
SIXTH CONSULTATION: 17/07/2016 
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The patient had phoned me to schedule an appointment for a pre-surgery 
therapeutic session. It was on such short notice we could only arrange an 
appointment for half an hour. Her surgery would be the next day. She said that 
although she was scared and anxious for the next day, she was also positive and 
ready because the surgery was finally taking place and the long wait for the results 
after the end of the chemo treatment was also over. It had been very scary. She 
said that she had good news after the chemo concerning the test results. The five 
lumps were gone and it was not necessary for a mastectomy. They were going to 
remove some of the auxiliary nodes. However she had a new concern. The 
anaesthetist said that she had a heart murmur and the function of her heart was 
less than good because of the chemotherapy. She said she was extremely worried 
about her heart but her husband supported her very well and she had faith that 
everything would be going well the next day.   
THERAPEUTIC INPUT:   
We talked about her anxiety and fear of the surgery and I reinforced the fact that 
feeling scared and anxious before surgery was normal and that she didn’t have to 
fight the anxiety but rather acknowledge and accommodate it and work with it. She 
could consciously focus on her breathing and relaxation exercises during the rest 
of the day and try to divert her thoughts onto something else like going 
somewhere with her husband or participating in any activity that would make her 
focus on something else than the surgery. She said that she already felt better for 
talking to me and that she and her husband would do something together to divert 
her attention from the surgery. She said that she had prepared everything at home 
for her husband (e.g. his pre-cooked meals) for the days that she would be in the 
hospital and that made her feel less guilty for “going away” and leaving him alone. 
I emphasized the importance of going to hospital with a calm mood, knowing that 
everything at home is order and her husband would be able to look after himself  
She now had to concentrate on having the surgery and the healing process after 
it.  
We ended the session after half an hour. The patient seemed more relaxed and 
content and we agreed that she would phone me when she was strong enough or 
when she started with her radiotherapy in order to book our next session.   
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SEVENTH (AND FINAL) CONSULTATION: 01/11/2016 
This was the first time that I met with the patient after her surgery that had been on 
18/07/2016.  This extended period without contact was due to practical reasons. 
She had had to wait for the results of the surgery as well as wait for a date to start 
with the radiation therapy. She immediately began to explain to me what they had 
done during the surgery: they had removed twelve of her lymph nodes and found 
small cancer glands. She said that she had coped relatively well with the operation 
in spite of the news of the cancerous glands. She was very disappointed about the 
news of the cancer that they had found because she had thought after the chemo 
and the good news that the breast lumps had shrunk, she would be cancer free. 
She said her husband was more stressed than she was, but they had supported 
each other very well. She had experienced the most pain in her arm and not 
where the surgery had been done. Her arm was also a bit swollen. She said she 
had developed severe pain in her one leg and it was making her scared because 
she didn’t know what the pain meant and she was still in the process of making an 
appointment with the oncologist so that he could explain her leg pain. The 
uncertainty made it worse and she wanted to know what the pain was.   
I asked her about the radiation therapy. She said she was scheduled for 20 
sessions and she already had had six. The only side-effect she was currently 
experiencing was dizziness, but she had no emotional effects such as she had 
experienced with the chemotherapy. She wanted to forget about the chemo 
because it had been very difficult for her, especially the “Red Devil”. She was still 
suffering side-effects from the chemo, especially tiredness, and her toes and 
fingertips were still without feeling. Her sleeping pattern had changed completely 
and she woke up at 3 o’clock every morning. When she was very tired she took a 
prescribed sleeping tablet.   
THERAPEUTIC INTERVENTION 
The patient said although she was trying to be positive, she was very emotional 
and anxious most of the time before the surgery. She was often tearful. I asked 
about specific hypothalamic symptoms and she presented with all of the 
symptoms. I told her that at the end of the session I would ask her doctor to 
prescribe an anti-depressant for her. The doctor later prescribed Nuzac, 20 mg. I 
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further explained to her that it often happens that a person develops depression 
after the cancer treatment because of the treatment itself (the chemical reaction) 
and because of the tremendous amount of stress and trauma. She said that she 
did not think of depression as a shame anymore, as she had done before the 
cancer. She was looking forward to taking an anti-depressant in order to feel 
better. I explained to her that the anti-depressant takes time to work and that she 
should use it for at least six months or longer. I recommended that she discuss 
this with her doctor who would prescribe the anti-depressant. She said that she felt 
more sensitive and scared than before the cancer but controlled her anxiety better. 
By learning to focus on the “now” and accepting and controlling her negative 
thoughts by acknowledging and replacing them with more positive and realistic 
thoughts, she could feel that her emotions were more manageable and bearable. 
By means of our therapy, she had learnt to understand her stress better and that 
there were always alternatives to handle a stressful situation. I let her talk about 
her emotions for the benefit of catharsis and reminded her of the importance of 
talking about feelings and giving yourself the chance to work through your 
emotions. She said that she could feel that when she spoke about her emotions, 
she felt lighter and better and that she had now identified friends and family with 
whom she could talk. Although she had had problems talking about her emotions 
in the past, she now felt much more comfortable in sharing them without feeling 
ashamed.      
She said that for the first time she and her husband were in a much better 
relationship with each other and that they spoke more about their emotions and 
what they were feeling. One of the positive things that had come about as a result 
of the cancer was a better relationship between her and her husband. She felt that 
after the therapeutic session with him, he had made an effort to understand her 
and the cancer better and he supported her much more than in the beginning. 
There was a big change in their relationship, and even their communication 
regarding their sex life had improved drastically. When the treatment of cancer 
was completed he would go to an urologist to help him with his illness-related 
sexual problems. The mere fact that I was willing to talk to him about their sexual 
relationship made it a much more approachable topic between the two of them. 
She said that for the first time they were going to do something about their sex life 
584 
 
and that she was looking forward to it. I advised her to identify positive things in 
her life and relationship with her husband and recognise it and enjoy it and also 
use it as reinforcement when things were difficult for her. It was always important 
to realise that even in difficult times there could be positive and good things 
happening and that you could choose to enjoy it. This would only be possible if 
you lived in the here and the now and concentrate on what was happening, 
accepting your feelings and thoughts without being judgemental or too harsh on 
yourself.    
We talked about taking control over situations that were very stressful, such as the 
extreme pain that she was experiencing at the time by taking some sort of action. 
An example would be to persist in phoning the hospital or going there to make an 
appointment to check it out. By taking action and making plans you would feel less 
of a victim and more in control of yourself and your situation. If there was 
something that you did not have knowledge about, you could ask somebody who 
would know. I advised her that she should use her support system which included 
the oncology team at the hospital. We talked about the importance of her keeping 
busy without tiring herself, choosing her activities wisely and prioritising important 
tasks. I suggested that she and her husband could get involved in activities 
together like taking walks and going on coffee dates to improve their intimacy. 
They should keep on talking and supporting each other. She could also make an 
effort to get involved in doing crafts or maybe join some of their church activities to 
interact with other people.   
I summarised our therapeutic process by emphasizing the reality that after a 
diagnosis of cancer and cancer treatment there would be permanent changes in 
her life such as, for instance, the way she would perceive life and herself as a 
person and a women and her relationships. I explained the losses that she might 
feel and that she should give herself the time to grieve and accept and also to 
embrace that which she still had left. I told her that she should learn to 
acknowledge her emotions when they were negative and not be scared of being 
scared. With the chronicity of the illness, new challenges would come and the she 
would have to “tackle” them too. I told her that every time she needed to go for 
follow-up sessions and tests because of the cancer she could expect to feel 
anxious. She should allow for it and put it in the framework of her cancer and keep 
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on reminding herself that it was normal to feel stressed in such a situation. I 
reminded her that she had learnt new coping skills to handle stress and stressful 
situations and to use and develop then. If she felt depressed and it did not get 
better, she should make an appointment with the hospital to see somebody to 
treat the condition. She should always remember that conditions like depression 
and anxiety are treatable.  
At the end of the session the patient thanked me for the sessions saying that she 
had never before seen a psychologist and did not even know what they did but 
feels so blessed to have been able to see me and had had the opportunity to 
understand not only the cancer better, but also herself, her husband and even her 
daughter.   
PATIENT IV 
This is a private patient who was referred to me by a clinical psychologist who 
knew about my study.  The psychologist contacted me to ask whether I could see 
this person as a study participant because she needed to be seen by a 
psychologist but did not have the available funds to participate in a 
psychotherapeutic process. The psychologist thought that she was a good 
candidate for the study because of her cancer-related emotional distress and 
impairment. The psychologist had first explained my research study to the patient 
asking if she would be willing to participate in such a study and after her 
permission was obtained the psychologist gave me her contact details. I contacted 
her telephonically and gave her a bit of background regarding my study and what 
would be required of her if she wished to participate in a psychotherapeutic 
process. She said that she would like to participate in the study and that she was 
ready for psychotherapy. We scheduled an appointment for her to come and see 
me in my private practise.   
DEMOGRAPHIC INFORMATION: PATIENT IV 
Age: 49 years 
Marital status: in a long term permanent relationship for ten years, no children   
Number of children: none 
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Highest education level: four year degree and higher diploma   
Occupation: full time occupation in higher education   
Diagnosis: Stage III Invasive Duct Carcinoma 
Date of diagnosis: September 2015 
Surgery: Lumpectomy and removal of two lymph nodes on 15/09/2015 
Breast reconstruction: none 
Treatment:  Radiation: thirty sessions in six weeks – ending 24 March 2016 
                     Chemotherapy:   Twelve sessions over three months – ending 
February 2016.   
                     Hormonal therapy: none   
Anti-depressants: Epilizine, Nuzak, Wellbutrin and Pax.    
Pain medication: none 
Psychiatric treatment history: She’s been diagnosed and treated for 
major depression, with the first diagnosis in 1991.   
Diagnosis 
The patient had felt a lump in her left breast nine months prior to her first visit and 
went to her general practitioner. She first had a mammogram and then a fine 
needle biopsy. A diagnosis of breast cancer had been made, after a lumpectomy 
and the removal of two lymph nodes. She was diagnosed with Gr. III Invasive Duct 
Carcinoma (in situ) - 28mm DCIS. Triple negative with clear margins. This 
information was obtained from the patient herself. I did not have access to her 
medical file, nor did I have interaction with her oncologist.   
Treatment Plan 
She had surgery first (very soon after the scanning and diagnosis). She started 
with chemotherapy after lumpectomy and received three sessions of the “Red 
Devil” chemo therapies every three weeks, plus 9 more chemo therapies once a 
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week, every week. She was given one week off in between the chemo and the 
radiation therapies and had had 12 session of radiation therapy. With our first 
consultation she was two months post treatment and in remission.     
FIRST CONSULTATION: 25/06/2016 
I saw the patient for our first consultation session in my private practise which met 
all the criteria for a therapeutic environment as it is comfortable and private. The 
session was booked for an hour and thirty minutes. The patient was from out of 
town and had requested that, if possible, we could schedule longer appointments 
at a time.           
After the formal introduction, I gave her a detailed explanation of this study without 
using complex terminology of what this study entails and what would be expected 
of her as a participant. I explained that one of the aims of the study was for the 
oncology team, including the psychologist, to understand the psychological needs 
of the breast cancer patient better in order to provide a holistic service to enhance 
the quality of life of the breast cancer patient and her family. I gave her the 
demographic, information and the consent forms to read through on her own time 
and to discuss it with her family and partner so as to give her more time to decide 
whether she wanted to participate in the study and then to sign the consent form 
and bring it with the next session. I explained the two questionnaires - the HADS 
Depression and Anxiety Scale and the Female Sexual Functioning Index – FSFI 
(which was explained in Chapter VI) and asked her to complete it when she had 
time and to bring it back the next session.  
After the formalities and explanations I asked the patient why she had requested 
to see a psychologist. She replied that she had had a very long history of 
depression from a young age and that she tended to become easily depressed 
and anxious. She said she had noticed that while she was undergoing the cancer 
treatment, especially chemotherapy, her symptoms of depression had increased 
noticeably. She said in the beginning she was more scared of becoming 
depressed again because of the breast cancer diagnosis and treatment than she 
was for the cancer itself! She explained to me that she had seen psychiatrists and 
psychologists over the years for treatment for her depression, receiving 
medication and therapy. She said she was aware of the fact that she could 
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become depressed because of her history, and that she contacted her psychiatrist 
immediately after she was diagnosed with breast cancer to ensure that her 
psychiatric medication was effective for the extra stress from the cancer. The 
psychiatrist prescribed Epilizene, (an anti-epilepticur), Nuzac and Wellbutrin (both 
are anti-depressants) and she was on this medication throughout her cancer 
treatment until that point. She said that after the cancer diagnosis she felt very 
strongly that she would need to see a psychologist, but as a private patient, she 
could not afford to because of all the expenses the cancer treatment had caused. 
She said that she was very relieved when she heard about this study and that she 
could speak to somebody about her emotions regarding the cancer and her fear of 
developing depression again. She said: “if I could have seen a psychologist from 
the beginning of the cancer, it would have made a huge difference and I would be 
able to have controlled my emotions better”. She said that if she could have seen 
a psychologist her chances of relapsing would have been smaller. She explained 
that apart from the depression she also had high levels of anxiety. During the 
session I experienced that the patient had a great need to talk to somebody about 
how she felt and what she went thought during her cancer treatment which had 
only ended two months prior. She said that everything regarding the treatment 
was still very vivid in her thoughts and she was reliving it every day.   
I asked her how she felt when she was diagnosed with breast cancer and she said 
that it was very traumatic for her although she had expected breast cancer after 
she had felt the lump in her breast. She said everything progressed very quickly 
from the time she had felt the lump and began the treatment and from then on 
everything just snowballed. She said that although she was extremely emotional 
during the treatment, she felt even worse now and in need to see somebody to 
talk to about her “deepest feelings” and to help her to put everything in 
perspective. The patient was very tearful during the session. 
I asked her about the side-effects of the chemo therapy. She said she had a lot of 
bad biological and emotional side-effects and the chemotherapy was “relentless”, 
with the “Red Devil” three times every third week and nine “other” chemo’s every 
week for nine weeks. She described the side-effect of chemo as follows:   
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 The first thing that happened to her due to the chemo therapy – the “Red 
Devil” - was her hair that had all fallen out as well as her body hair, and that 
it was quite a weird experience for her. She was never nauseas and never 
vomited.   
 From the very beginning of the cancer treatment, the biopsy, surgery and 
then the chemotherapy, she had been scared and afraid and had a lot of 
anticipatory anxiety before procedures. She explained that the whole 
process of administering the chemo were very intimidating and freighting to 
her.    
 Her sleeping pattern had changed immediately from day one and she 
suffered from insomnia, but she was not sure if it was because of her mood 
and depression or if it was the cancer treatment.  
 The emotional impact of the breast cancer diagnosis and the chemotherapy 
was the worst for her. She said she felt depressed from the beginning of the 
chemo and could “literally feel how the depression had worsened every 
day”. She described it as the severest form of depression that she had ever 
had. The patient said for the whole four months that she had received 
chemotherapy she felt physically ill and emotionally upset. It was because 
of this that she felt the need to see a psychologist and although her 
oncologist had suggested her seeing a psychologist, she could not afford it 
as a private patient. She said although she was on a combination of anti-
depressants, she also needed to talk about, and understand her emotions 
and fears. She had never before been in a similar situation and felt a lack of 
specific skills to deal with her cancer.   
 She said another side-effect that she experienced a lot was tiredness and it 
contributed to her negative feelings during the duration of the 
chemotherapy. It was very important for her to function at a very 
independent and high level and not be dependent on other people and that 
the tiredness had confronted her with a vulnerability which made her need 
assistance from other people. She said that she had very high expectations 
of herself and therefore pushed herself very hard to perform at top level, 
whether it was at home, or in social relationships or at work. During the 
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chemotherapy, she felt very tired and listless and lethargic which was very 
atypical of how she usually performed.   
 
 She said that she had gained a lot of weight throughout the cancer 
treatment, but that she was not sure if it was because of the treatment itself 
or if it was more because of comfort eating because of her depression. 
Gaining weight also played a role in her depression, “it makes me even 
more depressed if I gain weight”. She said that she tended to be an 
emotional eater when under duress. The weight that she had gained was 
just another stressor that she had had to deal with and would like for us to 
make it a therapeutic goal for the future to talk about her weight and self-
image and self-confidence.   
We ended the session after an hour and thirty minutes. The patient talked very 
easily, eagerly and without any prompting. The session served as an emotional 
catharsis for her, while also providing me with sensible and applicable information. 
We scheduled the next appointment for the following day (because she was in 
town for the two days and it was more practical for her) to continue with the above 
process. We scheduled a one hour and thirty minute session.    
SECOND CONSULTATION: 26/06/2016 
The patient started the session by saying that the session of the previous day had 
done her good because she could talk about all her emotions without keeping 
anything back. She spontaneously started to talk about the negative side-effects of 
the chemo-therapy. She said that apart from the tiredness and emotional turmoil 
that she had experienced during the chemotherapy, the chemo-fog (she used the 
terminology) was a very bad side-effect. She felt very stupid and slow and not 
intelligent at all during the chemo treatments.  She said her work entailed a lot of 
concentration and focusing, and in the beginning of the chemotherapy, she had 
been constantly scared that she would not be able to do her work properly. She 
said she relied heavily on her intellect. She said she saw herself as very career 
orientated and driven and her work played a large and important part in her life 
and identity.  She experienced her employer and colleagues as very 
accommodating and lenient which made it possible for her to have worked 
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throughout her whole treatment and she had only taken off the day on which she 
received the chemo and the day after that. She said the support from her 
colleagues was very positive and encouraging and the fact that she could carry on 
working, made her feel safe and secure. It kept her busy and helped to direct her 
focus away from her cancer and anxiety. The patient said that during the cancer 
treatment her finances were a big concern, because she was a private patient and 
had to pay for the treatment herself. She said she had never realised how 
expensive cancer treatment was and therefore was even more scared of not being 
able to do her job and then ending up losing it.   
I asked her about the radiation therapy to which she replied that it was not bad at 
all, apart for the effort to go in to the oncology rooms every day. She said to her it 
was more of a practical issue than a biological or emotional issue. She said even 
her skin had never been sore or overly red and it had healed quickly again. I 
asked her if she ever experienced any pain and she said in terms of her cancer 
she had little pain but she had “difficult” arteries to insert a needle and that every 
time she had to receive chemotherapy she had intense anticipation anxiety 
because she was scared that it would be painful.   
I asked about her menstrual status before the cancer treatment. She said she was 
still completely pre-menopausal before the cancer and chemotherapy, but her 
menses had stopped after the first chemo. She suspected it was most probably 
more stress related than chemo related because she was so stressed and anxious 
all the time. She said that during that time she also had had hot flushes but 
couldn’t think of any other menopause-related symptoms. She said that she had 
had her period again the previous month (one month after her last treatment) and 
that her PMS was very bad. She thought it was her depression that was returning 
and that she was very relieved when realising that it was (only) PMS. She said she 
was used to severe PMS and she would rather handle it than a full blown 
depression again.   
Therapeutic intervention. I explained to her the psychological impact of a cancer 
diagnosis on a person, even on somebody who never had depression or anxiety 
before and that it was not abnormal to either develop depression or anxiety or be 
scared of developing a mood disorder. I said to her that the fact that she had 
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prepared herself for depression and anxiety by taking extra measurements, e.g. 
phoning the psychiatrist and making an appointment to check her medication was 
very positive to me. I told her that I experienced her as somebody who takes 
responsibility for herself and her treatment. I also told her that, although she felt 
she should have seen a psychologist during her cancer treatment, it was not too 
late now for she can still express her emotions and that she could learn new skills 
to handle herself and her new situation. I said to her that, because she knows the 
symptoms of depression and anxiety, she could manage the symptoms with the 
help of her psychiatrist and psychotherapy. She should remember that depression 
and anxiety are treatable conditions. I explained to her that her negative thoughts 
about developing depression and her constant thoughts roaming around in her 
mind made the depression and anxiety worse and she could try to focus away 
from the roaming thoughts and create more positive and realistic thoughts that 
could make her feel better. I explained to her that putting so much pressure on 
herself in terms of her work could also contribute to her depression and she had to 
accept that she still had less energy than before the cancer and should learn to 
manage her energy and prioritise not just at work, but also at home. I asked her 
about her partner and family in terms of support and she said that she had from 
the beginning gotten very good support from her family and friends and also from 
her partner. We discussed for her to put aside time every day, even at work, to 
take a proper break and rest so that she could preserve her energy and to rest 
more over weekends, and make time for activities that made her feel better and to 
involve her partner in her healing process as well. She asked if it would be 
possible for me to also see her partner to hear what he had to say about her 
cancer.    
I asked her about her relationship with her oncologist and she said that she had a 
very good relationship with her from the very beginning. She explained that she 
and her oncologist had very open communication and she felt that she had 
provided her with enough information about the chemotherapy and side-effects. 
She was also given articles and pamphlets to read on cancer and cancer 
treatment. She said that, although she was “academically” well prepared and well-
informed, the chemo therapy was still a huge shock on her system and was not 
prepared for the emotional impact of that. She said that her oncologist had asked 
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her whether she would like to see a psychologist, but because she did not have a 
medical aid, she could not afford to see both a psychiatrist and a psychologist. 
She said it made sense to her that a cancer patient should see a psychologist 
during the treatment of cancer for the emotional impact is just too big for any 
person to carry on her own, even with good support from friends and family.   
I asked what she perceived as her biggest losses regarding the cancer and cancer 
treatment and she said: “the treason of my body. I have realised that you cannot 
trust your own body which was an eye opener to me, I really felt betrayed by my 
own body.” She said that when you have cancer you don’t have any control over 
your body anymore or what is happening to it, “all of a sudden other people got to 
make decisions over your body” and especially for somebody like her, which was 
extremely private and independent, the fact that she was so vulnerable and 
defenceless, was a major lost for her. She said that, looking back now, she 
thought that if she was given a little more time to think clearly about the treatments 
and their effects and side-effects, or had spoken to a psychologist to settle her 
traumatic reaction, she would have felt more involved in the whole process of 
decision-making. She also found cancer to be an extremely busy illness, saying 
that when you are in the middle of it you don’t know how to juggle everything with 
the treatment, the work and the relationship.  The “busyness” of the treatment had 
put a lot of stress on her, especially because she always wanted to be in control 
and handle everything on her own as well as helping other people. I agreed that 
cancer is indeed a “busy illness” and that a lot of unfamiliar things happen 
simultaneously which can also contribute to a person’s distress. She said another 
big loss was her financial losses because of the lack of a medical aid and that she 
was still recovering financially from the cancer.   
I asked about dying, and she said that she was not afraid of dying at all, but that 
her partner did not like to talk about dying. She thought that they needed to talk 
about it and when we had a session together we should touch the subject of 
death. She said she sees death as a practical component of life which has to be 
talked through with your loved ones. She felt very comfortable about talking about 
death.  
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We ended the session after an hour and a half and made another appointment in 
four weeks’ time. Although I thought that we should see each other sooner 
because of her depressive state, she only came to town every second or third 
weekend because of her financial status. I gave her the reassurance that she 
could phone me, or leave a message any time in between the sessions if she had 
a crisis or needed to discuss something urgently.   
THIRD CONSULTATION: 6/07/2016 
The patient looked very emotional and teary. She started talking immediately 
about the chemotherapy again. She said it had been such a bad experience for 
her and that she had had bad and negative memories of that. She said during the 
chemotherapy she fell apart and that even the medication the doctor had given her 
for the side-effects of the chemo had made her ill. She said that the whole four 
months that she received chemo-therapy she had felt ill and miserable. She had 
had one blood transfusion during the period of the chemotherapy and that the idea 
of receiving blood was very negative to her and she had not coped well with that. 
Looking back on the chemo and the tests and the blood transfusion she said that 
she had experienced it as a very busy, time consuming and stressful process and 
she also realised that she could have coped much better if she had had the help of 
a psychologist. She said that she felt much more emotional after the treatment had 
ended as during the treatment. It had already been three months, and could not 
understand why she was feeling so emotional then. She felt that during the 
treatment, although she felt emotional, she didn’t have the time to dwell on the 
emotions for there was no time between the chemo sessions and the blood 
drawing sessions and appointments with the oncologist and going back and forth 
to work to have focussed on her depression and anxiety. She said recently she felt 
very down and had been crying a lot (she was also crying a lot during the 
session). She was still experiencing side-effects of the cancer treatment and 
wasn’t prepared or expecting it to last such a long time after the end of the 
treatment. She said that at the time the tiredness was the worst. She felt tired all 
the time and had very little energy to do anything else, she said she went home 
and to work and that it was all. She said because she had gained so much weight 
she really wanted to start exercising again, but just didn’t have the energy or the 
595 
 
drive to begin. She said her weight bothered her a lot and that she felt unhealthy 
and uncomfortable. She said that gaining weight contributed to her depression.   
She said that the breast cancer diagnosis and treatment had been an extremely 
radical experience for her and that the most important thing that kept her sane 
during her treatment was going to work.  She said that she had tried to go in every 
day, even on the days that she felt sick, just to stay busy and be surrounded by 
people. Because she was also financially dependent on her salary, she could not 
afford to jeopardise her work. She said that being so involved in her work was one 
of her coping skills.   
THERAPEUTIC INPUT 
Because the patient felt emotional on that day, I gave her time to talk about her 
emotions. I explain to her that often negative and depressive emotions develop or 
intensify after the end of the cancer treatment and that going from a cancer patient 
to being a “normal” person could be challenging, and it would affect her mood. I 
told her that I was concerned about her emotional well-being because she seemed 
more depressed than the previous time I had seen her. I explained to her that 
some of the symptoms of depression could be the same as the side-effects of the 
chemo, especially the tiredness and lack of energy, low libido, problems with 
memory and concentration, disturbed sleeping and eating pattern as well as a 
depressive mood and that these “double” symptoms could be quite overwhelming. 
I asked her if she was having suicidal thoughts and she convinced me that at that 
moment in time she didn’t think about suicide. I explained to her that it was 
important to manage her depression symptoms through her medication and 
coping skills and support from her partner and family. I also assured her that there 
were always alternatives when managing depression, for instance admittance to a 
hospital or a clinic specialising in mood disorders, changing her medication (as 
prescribed by the psychiatrist) or increasing the therapeutic sessions.        
I explained to her the importance of acknowledging her emotions and talking (or 
writing) about it and consciously engaging in a grieving process, working through 
all her losses. The impact of the cancer experience, losses and new adaptations 
was often only a reality after the cancer treatment and could be very overwhelming 
and needed to be recognised and worked through.   
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We talked about how she felt about her weight and eating habits and exercising 
and she said that she needed a session on its own to work on her self-image (we 
made it a goal for the next session to work on this). I explained to her the benefits 
of losing weight in terms of her self-esteem and also sexual self-esteem, but that 
she would have to make a conscious decision to go on a healthy diet.   I 
suggested to her that she might find it helpful to contact a dietician and to start a 
diet plan with professional help. I explained to her that it is always helpful to start 
with baby steps, especially exercising. She could start walking around the block 
once every day and involve her partner in this and as she got fitter, she could walk 
farther. So even if she felt tired, she had to take the first step and start walking and 
if she was too tired during the day she could start over the weekend during the 
time of the day that she felt best. She said that there was a place where she could 
walk at her work place and that she could walk there over her lunch time. I 
explained to her that by talking about things that bothered her and making plans to 
change it would already make her feel more in control and less of a victim. I 
explained the importance of prioritising her activities so that she could have time 
(and energy) to do things that she enjoyed and would contribute to her quality of 
life. I described the importance of focusing on the present and especially focusing 
on her thoughts. She should identify negative and destructive thoughts and try to 
focus on new and more realistic thoughts.   
When asked, the patient said that although she and her partner did not discuss the 
sexual impact of the cancer and menopause they always made an effort with their 
intimate relationship. She said they do not have an active sex life and would like to 
hear what her partner was saying about their sexual relationship.    
We ended the session after the scheduled hour and a half and rescheduled (for 
her and her partner) one month from then for a follow up session with the aim of 
both getting information from the partner and to explain certain matters concerning 
their relationship.  
FOURTH CONSULTATION: 20/08/2016 
The patient and her partner came together for a couple’s session that the patient 
had suggested. (The patient had then been finished with her treatment for five 
months). Her partner had not given written consent, but was fully aware of the 
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research study and that the partner was participating in the study. He felt very 
thankful that there was a place that his partner could talk about her emotions. I 
explained what he could expect from the session and whether he felt comfortable 
about it. I asked him to tell me about his emotions regarding his partner’s cancer 
and the cancer treatment. He said that there were times that were very tough for 
both of them, especially with the tiredness and constant depression. He told me 
that the emotional side was far worse than the medical side, although he thought 
she coped relatively well throughout the treatment. He was not used to seeing her 
enduring so much turmoil and felt sorry for her, not always knowing what to do or 
how to help her.     
The patient then started to talk about how she was feeling, and said that she felt 
very depressed, much more than the previous time that I had seen her. She was 
also very tearful and looked extremely depressed. I used the DSM 5 criteria to 
asses her symptoms for depression and she presented with all the symptoms of 
depression. I suggested that she should make an appointment to go back to her 
psychiatrist and make sure that her medication (Wellbutrin, Epilizene, Pax and 
Nuzac, 20 mg) was still effective.   
THERAPEUTIC INPUT  
I again explained the alternatives in treating depression, for example to be 
hospitalized in a clinic for mood disorders, altering the medication through her 
psychiatrist and more therapeutic sessions. I again emphasized that depression is 
a condition that is treatable and explained to the partner the relationship between 
depression and cancer treatment especially chemotherapy which can cause a 
chemical depression. I also explained to him that somebody like his partner, who 
was predisposed to a mood disorder, was more prone to developing depression 
during cancer treatment or afterwards. I wanted him to understand this and that 
there were interventions to relief the symptoms of depression such as medication 
(which they were familiar with), therapeutic techniques, or as mentioned above, 
even hospitalization. I explained to them that it was important to acknowledge and 
accept a condition (in this case depression) as part of the specific situation and to 
take step-like measures to handle it - always starting with the practical side, such 
as making an appointment with the psychiatrist and sorting out the medication and 
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plan therapeutic goals with the psychologist regarding the symptoms of 
depression. By doing this it would give them the feeling of gaining control of the 
situation. I emphasized the fact that it was not abnormal to develop depression or 
anxiety during or after cancer treatment.   
The partner said that he felt that if she had somebody to help her through the 
process of the cancer treatment she would have coped better, especially because 
of her background of depression, but that he also understood that they could not 
afford both a psychiatrist and a psychologist. The patient (out of her own) said that 
she did not know how to proceed from a cancer patient to a “normal life” again. 
She also said that she had gotten used to the cancer “schedule” and the 
interaction with the oncology team and co-cancer patients. It made her feel safe 
and secure. She didn’t exactly know where she belonged then, although she knew 
she was in remission (she was going for her sixth month check-up the following 
month), but because she still experienced side-effects of the treatment she still felt 
that she was “busy” with cancer. She said her worst symptoms were the persistent 
tiredness and lack of energy, and lack of concentration and memory, which again 
contributed to her feeling of depression.   
THERAPEUTIC INPUT 
I explained to the couple that there could be permanent changes after cancer, not 
only for the individual but also for the couple and that they needed to understand 
these changes and to develop and adapt to, a new post-cancer status quo. The 
changes due to breast cancer could be biological, such as her breast shape and 
scars and the changes in her oestrogen levels, but could also be psychological, 
such as a change in their outlook on life from a different angle and even perceiving 
each other differently. By talking about the changes and challenges, or writing it 
down together, they could then decide how they were going to attend to it and 
incorporate it in their relationship together. It was important for the individual and 
the couple to work through a grieving process through acknowledging and facing 
their emotions and making peace with it and consciously accepting their new 
situation. I also explained to them that all changes were not permanent e.g. the 
tiredness and the reduced short-term memory would get better with time and they 
only had to adapt to such problems temporarily and that all changes were not 
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necessarily negative. I also told them that by using constructive mind control, and 
new behaviour, they could adapt to the new situation in a positive way. 
Communication was a good way to start – to ask your partner what he/she wants 
in a specific situation or how they are experiencing you, instead of expecting your 
partner “to know” what you are feeling or needing. It was also imperative to talk 
about emotions and not to feel that you had to be “strong” all the time for your 
partner’s sake. Showing your emotions is not a sign of weakness, but a 
commitment to understand and support each other. They both said that they felt 
closer to each other after the whole cancer episode and that they were more 
relaxed and at ease with each other and they looked at their relationship and each 
other with different eyes.   
I asked them about their sexual functioning. Both of them were comfortable 
speaking about their sexuality and the patient answered that their sex life was not 
good even before the cancer treatment because both of them suffered from a low 
libido, but that they had never regarded it as a problem for they had a very good 
intimate relationship. She said that, having said that, she would like to talk about 
their sex life when both of them were there because she really thought they could 
improve it and that it would enhance and strengthen their relationship. I explained 
to them the impact that depression and anti-depressive medication and 
menopause could have on their sexual functioning, especially on their libido or 
biological sex drive. It was imperative to understand that the low libido had nothing 
to do with their relationship or feelings for one another, but it had rather to do with 
the biological component of the illness. The biological implications of menopause, 
apart from the mood swings and emotional reactions, were that foreplay might 
take longer and require more effort and using vaginal lubrication or a moisturiser 
was necessary to counteract the lack of vaginal lubrication and discomfort. Some 
of the practical alternatives, especially because the patient felt uncomfortable with 
the surgical scar, were for her to wear something like a camisole to bed to hide the 
scar or to wear the prosthesis bra. They had to talk about what alternatives they 
felt comfortable with and use it (e.g. watching sexual movies together or using a 
vibrator for extra stimulation). We also talked about setting up a time table for 
sexual activities during the time of the day (or night) when the patient felt less 
stressed and tired. They both agreed that more sexual activities would enhance 
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their sexual and overall quality of life and they agreed to commit themselves to 
using creativity to improve their sex life. They were both very liberal regarding 
sexual activities and had no problem with more flexible thoughts and actions 
concerning their sex life. I explained to them that the fact that they were intimate 
the whole time would make it easier for them to regain their sexual activities, but 
that developing a new and more active sex life would take time, effort and 
creativity. The patient mentioned her weight and the scar again and said it inhibits 
her to relax sexually, but her partner said that it does not bother him at all and did 
not affect his sexual attraction toward her.    
We ended the session after an hour and fifteen minutes and the patient asked if 
we could talk about her self-image the next session. We scheduled another hour 
session for one month from then.   
FIFTH (AND FINAL) CONSULTATION: 25/10/2016  
Due to practical reasons, the patient had postponed the session with another 
month, so there was a two month period in between the last two sessions. The 
patient looked distressed and tearful. I asked about a consultation with her 
psychiatrist and medication and she answered that she was in the process of 
making an appointment with the psychiatrist and that she was diligently drinking 
her anti-depressant medication every day. I strengthened the idea that a major 
depression could take time to get better and that a conscious and active 
involvement (medication and therapy and interventions) would bring positive 
results. She said that every time we spoke about her depression and that she 
could do something about it, made her feel stronger and less “abnormal”. She said 
knowing and understanding the influence of depression on her life and relationship 
also made her feel more positive about herself and her relationship and even her 
lack of sexual functioning. She also understood that some of her symptoms like 
tiredness and lack of energy and drive and even lower sex drive and negative 
emotions could be part of both her depression and side-effects of the 
chemotherapy. She felt that she could manage it instead of just feeling like a 
victim of herself and circumstances. Our aim for the session was, by her request, 
to work on her self-image, both in terms of self-confidence and body image as 
related to her sexuality. I asked her what she thought was degrading or influencing 
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her self-image and she said that there were a couple of elements “working 
against” her self-image and confidence. The most important one was her weight 
gain and changed body due to the surgery and cancer. I explained to her the 
importance of firstly making a conscious decision about losing weight and that the 
next step after making a “formal” decision was to start with a commitment to 
changing certain patterns of eating and to use or involve the right professional 
people in this process. Firstly she could schedule an appointment with her 
psychiatrist (as already mentioned above) to (also) discuss her anti-depressant 
medication, because some of the medication could elevate her appetite and 
enhance her chances of gaining even more weight. She could also involve a 
dietician to get a proper diet plan to make sure that she lost weight in a healthy 
way and with the necessary support and encouragement. She explained that the 
breast, where she had the lumpectomy, is now different from the other one and 
that it made her self-conscious and that even her clothes looked different on her. I 
asked her about breast reconstruction and she said that although she had never 
thought about it in the past, she was considering it. She said it would have to wait 
until a much later stage. We talked about a proper grieving process (facing and 
going through her emotions) regarding her breast cancer and accompanied losses 
and she said that she needed to face it in a proper way through talking about it 
and accepting it. We then discussed that in the mean time she had to make peace 
with her “different” breasts and maybe even change her clothes to hide her breast 
deformity and to emphasize other body parts that she felt more comfortable with. 
We talked again about exercising and I referred back to a previous session where 
we had discussed her taking a walk during her lunch hour at work just to start 
getting more active and getting in a habit of exercising and allowing herself to 
invest more in herself without feeling guilty. She should look at the weight she 
gained as part of the whole cancer journey. Her severe depression should serve 
as a reminder that, with the help of other (professional people), she could take 
control of the situation. She also agreed that by losing weight she would feel more 
sexual and confident to participate in sexual activities and that if she lost weight 
she might even have more energy for sex. She said that she wanted to give a bit 
of feedback from our previous shared session with her partner, that they had 
started to improve their intimacy even further and that they had participated in 
activities with much more touching and sexual closeness without necessarily being 
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sexually active. She said that it made her feel better about herself and as a couple 
they felt much closer to each other.  
She said the lack of self-confidence also influenced her job performance. I 
explained that she should concentrate on identifying irrational and untrue thoughts 
regarding her self-image e.g. “I am not good at my job anymore” or “I can’t 
remember as well as before the cancer”, she should then substitute these 
thoughts with more true and realistic thoughts such as “the cancer did not change 
my intellect or ability to do my job” or “the cancer did not take away my 
qualifications” or “even if I struggle with my short term memory, there are ways to 
help me with that”. By keeping on telling herself that she was good and able 
enough and had the ability to grow, would help her “believe” in herself again and 
this way she could “act it out”. Because her self-image and self-confidence had 
decreased over the years because of her weight problem, depression and also 
recently because of the breast cancer, she had to allow for sufficient time to 
improve and develop a “new” self-image and confidence. She also had to accept 
that due to the cancer treatment, her body would be changed biologically and 
factors like menopause would also affect the working of her body. She could focus 
on things, activities and thoughts that would make her feel better about herself. 
She said that she could take up her hobbies again and actualise herself by means 
of this, instead of thinking about how “bad”, passive and different she was. She 
said that by talking it through with me in therapy, her mind already worked in the 
direction of what she could and wanted to do again. She referred specifically to 
those things she had done before the breast cancer that had always enhanced her 
self-confidence. She said that having plans (like making appointments with her 
psychiatrist and dietician) and begin with exercising and new thoughts about 
herself made her feel more positive already. She thought that when she felt 
confident about herself as a whole person, she could maybe even think about 
changing her job or studying further.   
I concluded the session by thanking her for her participation in this study and she 
said that the therapeutic process helped her so much and that she felt much more 
“clever”. She said she understood and could handle herself much better in terms 
of the depression, especially now after the cancer. She asked about extending her 
sessions after the research study, for she was in a process of applying for a 
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medical aid, which I supported, saying that participating in psychotherapy is 
always a beneficial and rewarding process, especially in a chronic situation such 
as breast cancer. 
We ended the session on a good and positive note.    
 
PATIENT V 
This is a private patient who was referred to me by an oncologist working in a 
private practise who knew about my study. The patient asked the oncologist 
during a follow up consultation to be referred to a psychologist to help her with her 
emotions regarding her breast cancer and her relationship with her husband which 
was stressful at the time. The oncologist told her that I was a clinical psychologist 
and that I was busy with a research study regarding breast cancer and whether 
she would be willing to participate in this study. The patient replied that she would 
be willing to participate in a therapeutic process. The oncologist provided me with 
her contact details and I phoned to schedule an appointment. During our 
telephone conversation I explained in short what the study was about and what 
her role as a study participant would entail. An appointment was made for one 
week after the contact.   
DEMOGRAPHIC INFORMATION 
Age: 34 years   
Marital status: married   
Children: one pre-school child 
Highest education level: diploma in financial management   
Occupation: full-time occupation in finances 
Diagnosis: Stage IIA Ductal Carcinoma 
Date of diagnosis: 18 March 2014 
Surgery: double mastectomy (17/11/2014). Complete hysterectomy (June 2015) 
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Breast reconstruction: completed  
Treatment:  
Radiation: fifteen sessions. Ending in April 2015  
  Chemotherapy: six sessions - with three of it “Red Devil”  
Chemo over a period of five months - ending October 2014   
                     Hormonal Therapy:  Tamoplex, still busy.   
Anti-depressants: no anti-depressant, or any treatment for 
depression or anxiety before.   
  Pain medication: none 
Diagnosis   
Patient was diagnosed with Stage IIA Breast Cancer on 18/03/2014 after she had 
felt a lump in her breast. This information was obtained from the patient herself. 
Formal diagnosis that was given to me from the oncologist: pT2N0M0 – Stage II 
Ductal Carcinoma, Oestrogen (+)   
Treatment Plan   
At first, after the diagnosis the patient had had six sessions of chemotherapy, a 
double mastectomy with immediate reconstruction, fifteen radiation sessions and a 
complete hysterectomy. She had completed her treatment and had been in full 
remission for six months. She had been put on a hormone suppressor for the next 
five years. 
FIRST CONSULTATION: 09/06/2015 
I saw her for the first session in a consulting room in the oncologist’s private 
practise which met all the criteria for a therapeutic environment. It was 
comfortable, airy and private. The session was booked for an hour and a half. 
(Because she had requested for the therapeutic sessions, I wanted to have a full 
therapeutic session of an hour, therefore I needed the extra 30 minutes to explain 
the study and forms to be filled in).       
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After the formal introduction, I gave her a detailed explanation of this study without 
using complex terminology of what this study entailed and what would be 
expected of her as a participant. I explained that one of the aims of the study was 
for the oncology team, including the psychologist, to understand the psychological 
experiences and needs of the breast cancer patient better in order to provide a 
holistic service to enhance the quality of life of the breast cancer patient and her 
family. I gave her the demographic information and the consent forms to take 
home to read through on her own time. She could, if she wished, discuss it with 
her husband and it gave her more time to decide whether she wanted to 
participate in the study. I asked her, if she agreed, to bring the signed forms back 
with the next appointment. I explained the two questionnaires - the HADS 
Depression and Anxiety Scale and the Female Sexual Functioning Index – FSFI 
(see Chapter VI) and asked her to complete it when she had time and to return it 
back the next session. 
I further explained to her that her participation was completely voluntary and that 
she could decide to stop her participation at any time without having to give an 
explanation or without any repercussions for her. I assured her of my commitment 
to the study and to her as my patient and gave her my cell number and 
encouraged her to phone me if anything worrying happened in between sessions 
that she would like to discuss with me. The patient said that she understood the 
information and that she would like to participate in the study. She said that she 
had asked her oncologist to see a psychologist and that she could benefit from 
therapeutic sessions. She said she felt that her husband would also benefit from a 
session but it wouldn’t be so easy to convince him to come in for a session. He 
was aware of the fact that she was participating in a psychotherapeutic process. 
After the formalities and all the explanations we started with the session.   
I asked the patient why she had requested to see a psychologist. She explained to 
me that everything regarding her diagnosis was very overwhelming, it had 
happened very quickly and she was so ill that she didn’t have time to deal with 
anything. She said that she really had a need to talk about how she felt and what 
had happened to her. She wanted to talk to somebody that would understand her 
situation and give her some advice as to what to do. It was not just her who 
needed help but her young child and husband as well. I told her that we could 
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begin discussing any of her problems that she felt comfortable speaking about. 
She said she wanted to start with her current situation, specifically her 
hysterectomy, which had been done one week earlier. She said she was still in 
mild pain and discomfort and I should please excuse her if she seemed 
uncomfortable. She explained that her gynaecologist had suggested a full 
hysterectomy just after her breast cancer diagnosis the previous year, before the 
mastectomy or the chemotherapy. The rest of her oncology team had agreed with 
that because of her young age. She was thirty-two when diagnosed and her child 
was still a baby. She said that at that stage she was so overwhelmed by the 
cancer diagnosis and everything that had happened so fast that she had not been 
able to think about anything else or make a proper decision. She said her family 
was concerned about the hysterectomy because they felt that she could have 
another child. She felt satisfied with one child. Her husband did not necessarily 
share her vision. Her feeling was that, after her diagnosis, it was her decision to 
make. She is the mother of her only child and rather wanted him to grow up with 
her than have another child and not see either of them growing up. Although her 
husband was very sad in the beginning about the hysterectomy, he actually made 
peace with that fairly quickly. She said she had also decided to ask if it was 
possible to have a double mastectomy. The surgeon agreed and they had started 
with the breast reconstruction immediately after her mastectomy. She said she 
had taken the decision-making on herself from the beginning because she had 
realised that she would have to be the strong person for her child, her husband 
and her mother and grand-mother. She said she also decided immediately that 
she would survive the breast cancer and that she would go to any lengths to do 
so. Her husband had had a very big scare with her diagnosis because his mother 
died of breast cancer at a young age.   
I asked her about her experience regarding the chemotherapy. She said: “it 
literally feels like yesterday and the pictures in my head are still very vivid, I can 
even still feel and taste and smell the chemo.” For her it had been very traumatic 
and scary. She first had chemotherapy before her double mastectomy. She had 
had the “Red Devil” first, for three times, (she used the term) and became 
extremely ill from that. She said she was completely unprepared for the side-
effects, especially the nausea and the vomiting, for she had understood from 
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‘other people’ that nausea and vomiting were not such big problems anymore 
because of the anti-nausea medication, but in her case it was extremely vicious. 
She explained that the picture in her head of the chemo room was so vivid she 
could still ‘feel’ it. She said that she had a biological reaction to the chemo 
immediately while still sitting there, her tongue felt “weird” and she had a vile taste 
in her mouth. She said the whole experience of her first chemo had been very 
overwhelming for her and yet she desperately felt she had to be strong for her 
whole family. During her first chemotherapy her mother accompanied her and 
waited in the waiting room sitting on a chair where her daughter could see her the 
whole time. She had not expected to be so sick immediately after the chemo and 
said she was completely unprepared for that. She had been nauseas and started 
vomiting a couple of hours after the chemo. She said the red colour and the smell 
of the chemo is still vivid from time to time. She vomited for days before she got 
better and none of the anti-nausea medication worked for her. Because she had 
gotten so violently ill she had not wanted her child to see her like that, and had 
tried as much as possible to keep him away from her when she was so ill. Her 
husband and mother had then taken over his care.  
She said night time had been the worst for her because she was all alone and was 
thinking a lot about dying and her son growing up without her. She felt very 
vulnerable during that time and did not understand all of her emotions. She said 
she was very emotional during that time. She cried a lot and she worried 
constantly over her child and tried for him not see her in the state that she was in. 
The child was foremost in her mind. During the three days that she felt so ill, she 
constantly thought about death, was scared of dying the whole time, thinking 
"what will become of the child if I die, he will not have a mother”. She said when 
she was so ill, nauseas and vomiting the whole time, she honestly wasn’t so sure 
whether she would “make it”. She often wondered if this was what dying felt like. 
She said that, despite of her crying and fear, her most prominent emotions were 
feelings of guilt. The feelings of guilt were especially towards her husband, who 
had already gone through the motions with his mother, and her little child who was 
missing out on her care. She had not been able to perform his daily care such as 
helping him get ready for pre-school in the mornings and taking and fetching him 
there. She said, apart from that, she was very tired. Her short term memory was, 
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and still is, very bad, the food had no taste at all and her left arm, where she had 
had intravenous chemo therapy, was hurting, It had been swollen and burnt. The 
pain was so bad that it woke her up some nights. She said she remembered that, 
the whole time that she got chemotherapy, especially the “Red Devil”; she made a 
conscious decision to focus on other things and not on the chemo. She said by the 
third day after the chemo, she could go back to her work and that she tried to be 
strong and in control and kept on telling herself she would make it. She said it was 
very important for her how people would look at her during the treatment and that 
they had to see how positive and strong she was and if she should die then, at 
least people would remember that she was a fighter and didn’t just sit back without 
even trying to fight. She said that the next three chemo sessions, which she called 
the “transparent” ones, also had severe side-effects on her namely:     
 her throat was extremely sore and raw and she suffered from heartburn   
 she had an elevated appetite and wanted to eat the whole day  
 she slept poorly 
 she was very tired 
 she was swollen  
I asked her about the chemo and her hair: and she replied that the loss of her hair 
did not worry her much personally, but she was very worried about her husband 
and child. She said her husband was very adamant that she should wear a wig 
when they went out in public. They immediately bought a wig. She had had long 
hair before and then decided to cut it shorter before the chemo began so that the 
difference would not be such a shock for her child. After the first chemo her hair 
started to fall out immediately and that was a shock to her. She and her husband 
shaved her hair at home and she let her child touch her head and tried to explain 
to him that her hair felt different because she was sick, but it would grow back 
again. She said he was fine with her bald head and she thinks it was because she 
involved him in the whole process of “shaving her head”. She also made a point to 
talk to her son about what was going on and tried to keep it at his age level.   
We ended the session after an hour and a half and the patient said that she still 
had so much to talk about and that there were so many things that she wanted to 
ask about. She said she felt very excited about the sessions and already felt much 
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“lighter”. She had an urgent need to express her emotions and the hardships she 
had experienced during her breast cancer period. We scheduled a meeting for a 
week later and I said she could phone or message me if she was having a crisis.   
SECOND CONSULTATION: 16/06/2015 
We had booked an hour session. The patient said that she felt better after the 
previous session. Merely the opportunity to have talked about the treatment and 
her experience of it made her feel lighter and less “abnormal”. It had been two 
weeks after the hysterectomy and she felt better than the previous session in 
terms of mobility and pain. She was still on sick leave and would only be going 
back to work in four weeks’ time.  
I asked her about her emotions regarding her husband because that was one of 
the reasons she had asked her oncologist to be referred to a psychologist. She 
said the diagnosis of her breast cancer was a big shock to him because of his 
history with his own mother who had died of breast cancer at a relatively young 
age. She said she thought his reaction was so strong because he knew what lay 
ahead for her and she did not, because she had never before been confronted 
with breast cancer. She had no family history of breast cancer which is why the 
diagnosis came as such a shock to her and her family. She said her husband had 
experienced the idea of her hair falling out very negatively and preferred her with a 
wig. They had only been married for a couple of years and she felt that he had not 
tried to understand or support her enough during her illness and she felt 
abandoned by him. She felt that her perception of support and his perception of 
support were completely different and felt that her mother had been more hands-
on and supportive during the whole cancer process than he had been. She felt 
that the whole cancer experience was embarrassing and shameful to him and it 
made her feel more vulnerable and alone. She said they had had a lot of conflict 
during her cancer treatment especially when she felt irritable or miserable. 
Although her cancer treatment was over, she still felt that their relationship was not 
at a good place. She said she felt a lot of resentment towards him. He didn’t make 
an effort to understand her emotions during her cancer phase and felt that the 
cancer stood between them. She said that now, when they fight about something, 
he would refer to the time of her cancer treatment saying that she had been 
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irritable and abrupt or blunt. He didn’t speak easily, especially about emotional 
matters, while she on the other hand wanted to talk about how she felt and her 
emotional needs. She said that from the beginning, when she heard that she had 
cancer, she talked about it, which was her way of dealing with things. He did not 
agree with her way of dealing with her illness. She said he wanted her to keep it 
more private, which confirmed her point that he was ashamed of her cancer and 
looks. She said because of the conflict in their marriage and her emotions 
regarding her cancer, she had asked her doctor to refer her to a psychologist. She 
said she felt depressed about her losses and because of her marital problems. It 
would therefore be good to begin our consultations by discussing the problems in 
their marriage. I asked her if there is, or was, any change in her mood and she 
said she had been feeling very depressed and emotional for a while now. I 
decided to evaluate her for a major depression using the criteria of the DSM 5. 
She presented with most of the symptoms, including a change of her sleeping and 
eating patterns, lower energy levels, lower drive, and incapacitation of 
concentration, attention and memory, having more negative and irrational thoughts 
than positive thoughts and a low libido. I explained to her that she had symptoms 
of depression and that we could treat the condition with either psychotherapy 
alone or in combination with an anti-depressant. She said that she wanted to give 
the therapy a chance first before we go for the option of medication.   
She also asked if she could bring her husband to the next session and we agreed 
on a joint therapy session and possible couple’s therapy.   
I asked her about her background. She said she grew up in a fairly stable 
household with strong willed women and that she learned from a young age to 
fend for herself, to be strong and to handle stress effectively. She perceived 
herself as somebody who could handle stress in a positive manner and did not 
tend to fall victim to negative situations. She said she had had a strong family 
support system throughout her life and especially during her cancer and cancer 
treatment. She had never experienced depression or anxiety before the cancer, or 
had had any treatment for such conditions, but she was very worried and troubled 
by her emotions and relationship with her husband.   
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As with the first session, this session lead to much emotional catharsis. The 
patient stated that she really needed to talk about how she had felt since her 
breast cancer diagnosis and throughout her treatment. This was especially the 
case after the treatment had been successful and she was in remission. She said 
she thought that once it was all over she expected to (automatically) feel better, 
but it was not the case.   
We ended the session after an hour with a date for the next appointment, which 
was a week from that day.   
THIRD CONSULTATION: 23/06/15  
The patient came to the appointment alone, saying her husband didn’t want to 
come to the session with her. She was very discouraged and disappointed. She 
felt that her husband would understand her illness and her current emotions better 
if he understood the cancer and cancer treatment fully. She felt that maybe if he 
heard the information from a professional person he would understand her and her 
circumstances better and she said she would again try to bring him next time.   
I gave her reassurance that it was sometimes difficult for a partner to participate in 
therapy because of the stigma that it holds for some people to visit a psychologist. 
It was similar to showing some kind of “weakness”. She should continue talking to 
him about how she would appreciate it if he came with her to a session. I also 
explain to her that if she asked him to come with her for a session, she should 
explain to him that it would be for him to understand her cancer and herself better 
and that they would both benefit from a joint session. In other words, she had to 
explain to him that the session would be about her and her problems, and not 
because there was something “wrong” with him. I also explained to her that in my 
experience as a therapist, working with cancer, I often found that a partner could 
feel that they should have therapy because they are “at fault”. Maybe if he 
understood that the session was about her and the cancer, he might feel less 
threatened. She said that made more sense to her and that she would try to 
convince him using this angle.   
She said that even if he was not there she wanted to talk about her feelings 
regarding their marriage.  She felt that currently she stressed a lot because of the 
612 
 
relationship with her husband and was scared that the amount of stress that she 
felt would affect her body and disadvantage her in terms of the cancer. She said 
that currently, because of the hysterectomy two weeks prior, they had to abstain 
from sexual intercourse, which was quite difficult for him.   
I asked her about their sexual functioning. She said that they had always had a 
very good sex life and were sexually very compatible. She thought he was 
presently all right with her body but because of the breast reconstruction surgery, 
her breasts were still sensitive to touch. They had continued their sexual 
functioning after the breast surgery until the hysterectomy. They were still young 
and were sexually very active as a couple. She was very scared in the beginning 
when she realised that her body would look different, that her husband might be 
repulsed by her body and therefore had decided immediately that she would have 
reconstruction surgery as soon as it was possible. She said she didn’t want him to 
see her without breasts and that it was very important to her how her husband saw 
her as a woman. She said: “I will go to any length to restore my body image”. She 
asked if I could tell her about her hormone medication that she would have to drink 
for the next five years, because she understood that the medication would also 
affect her sex life.  
I asked her if her doctor had explained the side-effects of the hormone treatment 
to her, and she said that the doctor had explained it to her regarding menopause, 
but she felt she needed more time and information about it. She wondered what it 
would do to her body since it was something unfamiliar to her.   
Therapeutic input 
Firstly I explained to her that early or premature menopause could be shocking for 
a young women and it was important to understand the ‘mechanics’ of premature 
menopause in order for her to adapt to her new situation. I explained that 
premature menopause happened very abruptly, whereas with natural menopause, 
the body and mind had time to adapt to the changes because they happened over 
a period of time. To accept something as ‘unnatural’ as premature menopause, lay 
in the conscious mind where you could decide to make peace with, and accept it 
through the learning of new skills of adaptation. The processes of making peace 
and acceptance have to do with realising and understanding your losses and 
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working through an active grieving process too. The losses that we discussed 
were; the lack of oestrogen and the influences of this on the body and mind; the 
manner of sexual reaction of her body before menopause and that the fact that 
she would “lose” at least 20 years of having a young body which would have had 
enough oestrogen. I emphasised that the hormone therapy, even with all the 
negative side-effects, would help reduce the risk of the cancer returning, and is 
usually used for at least five years as her doctor had explained to her.   
Secondly I explained what menopause involved in terms of symptoms and the 
impact on her body and her sexuality.  I explained that everybody doesn’t have all 
the symptoms or have them to the same degree but is helpful information for at 
least she would know what to expect. I explained about the hot flushes, night 
sweats, sleeping problems (insomnia), possible weight gain and slowed 
metabolism, possible thinning hair and dry skin. Menopause could also influence 
her mood, causing mood swings, irritability and even depression and a decreased 
libido (which means a lessened sex drive). There was also a risk of losing bone 
mass or density which could lead to osteoporosis. We discussed how to deal with 
the biological symptoms of menopause, such as gathering information about 
menopause by reading, being physically active and including activities such as 
walking or other types of exercise such as yoga. This she could do when her body 
was well again and she had permission from her doctor to exercise. She could 
learn techniques to handle her mood, especially depression. We agreed to make it 
a goal for a future session to discuss depression and for her to discuss symptoms 
such as hot flushes with her doctor.   
We also discussed what she could expect of her and her partner’s sexual 
functioning after the period of absence due to the hysterectomy. I described the 
importance of intimacy when the sexual act was not possible (like then) and that 
resuming one’s sexual activities were much easier when there were still other 
forms of bodily contact like holding hands, kissing, etc. I explained that a 
decreased libido meant that she would not always feel in the mood for sex 
biologically, but that she, by way of her mind, could think and talk herself into sex 
and still enjoy the act even if she was not automatically aroused from the 
beginning. I also said she should discuss with her husband and explain to him her 
lower libido so that he could understand that it had nothing to do with him, but that 
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it was rather a biological side-effect of her cancer treatment. She should inform 
him that they could work around that. It could be a learning curve for her to find out 
and experience what would work for her sexually from then forward. It might be 
different from before the cancer and the menopause. For instance, foreplay might 
take longer because she might need more time to get aroused and that she 
needed to use liberal quantities of lubrication (because of vaginal dryness) to 
avoid painful and uncomfortable sex. This was a good time to try new sexual 
styles and positions that could work in their unique situation, but talking and 
including her husband, was the most important part of this new sexual journey.   
The session came to an end and the patient said that she really wanted her 
husband to come with her to the next session so that I could explain to him the 
changes in her body and sexual functioning in the future. She said she felt very 
positive about the information that she had received and felt much lighter about 
her sexuality than before she had come in that day. We made an appointment for 
a week from then.   
FOURTH CONSULTATION: 01/07/2015                                 
My patient’s husband had accompanied her for the session on her request to 
explain her emotional reactions regarding the breast cancer to him. He did not 
sign a consent form, but I explained the study to him and especially the 
psychotherapeutic element of the study. He was well informed about the study 
before the process begun. I introduced myself and thanked him for joining us in 
this session. I started by asking him if he had any questions for me about the 
course or content of the session or anything else that had to do with his wife and 
their current situation. He said that he had no specific questions and that he was 
there to listen to what I had to say regarding his wife.   
I then asked my patient if there was anything that she wanted me to discuss with 
her husband and if she felt comfortable with me discussing her situation with him. 
She consented, and said that she would like me to explain to him what I had 
explained to her during the previous session regarding all the changes in her body 
especially due to the menopause and what to expect sexually from her in the 
future. 
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I started with the menopausal symptoms by explaining the biological side-effects 
first. The hot flushes (she said then that the hot flushes were very bad, especially 
at night), sleeping problems (insomnia), possible weight gain and slowed 
metabolism and a decreased libido, which meant a diminished sex drive. I also 
explained that her body would react in a different way because of the cancer 
treatment, the hysterectomy and the hormone medication that she would drink for 
the next five years as well as the chemically induced menopause. I explained to 
him that she would have to use ‘aids’ during sex, such as a lubricant, because her 
body would not produce its own vaginal lubrication anymore and that they would 
have to try different (new) things and ways to have a satisfying sex life again. By 
means of intervention, they could start by talking more about sex and their sexual 
desires and needs and what they liked and disliked. They could also try new 
positions or different places, (sex outside the bedroom), to improve their sex life. I 
explained that menopause is a natural occurrence for older women but because of 
the cancer, his wife would now prematurely develop menopausal symptoms and 
that she would not have the longer period of time that comes with natural 
menopause to get used to the symptoms and changes. She would need his 
support and understanding of this premature process to make peace with it and 
accept her body and still be a good sex partner to him. Menopause didn’t mean 
that they would not have a good and regular sex life, but there would be 
differences and changes and by accepting that they would be able to develop new 
skills for a new sexual status quo. He had to be aware of her lower libido and 
understand that the fact that she did not have a natural desire for sex didn’t mean 
that he was at fault, but that it was due to a biological reaction. In order to get her 
stimulated might take “harder work” from his side, especially concerning foreplay 
which might take longer than previously.   
We then went on to the emotional effects and I explained what he could expect of 
her in terms of her emotions and moods. I also clarified some of her previous 
emotions such as her depressive moods and irritability while she had had chemo 
and explained the effect that chemotherapy could have on a person’s mood. I 
emphasised, that it had to do with the chemicals and not the person and he should 
not take it personally. I explained to both of them the process of accepting and 
adapting to this ‘after-breast cancer’ life by understanding that they as individuals 
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and as a couple would never be the same as before the cancer experience and 
that they should be able to make peace with a new way of living. This they could 
achieve through an active grieving process and especially allowing themselves to 
go through their bad and negative emotions, talking to each other about their 
emotions and making plans together on how to develop new ways to adapt in the 
future. It was important for them to look at themselves as a team working towards 
an end goal, and not just as having an individual journey. 
We talked about how he could support her when she felt down or anxious and the 
patient told him that just by understanding her and listening to her when she talked 
about how she felt, would make her feel accepted and supported by him. She also 
asked him to talk to her about how he felt about her cancer and their sex life. 
Communication was very important to her. She told him that she was scared that 
he might reject her, especially sexually. However he said that he felt the same 
about her as before the cancer and that he was still strongly attracted to her 
sexually and that he now understood the adjustments that they had to make. He 
had never seen it in this light and her emotional reactions made more sense to 
him now. The patient said to him that hearing him saying the above, already made 
her feel more accepted by him.   
I asked if he had any more questions about the above and he said he understood 
things better now and he would make an effort to accommodate the changes. I 
reminded both of them of the chronicity of the situation and that it was a lifelong 
process of making peace, adapting and learning new skills for the future. They 
should take into consideration that it would take time and that it remained a team 
effort. 
Before we ended the session, the patient said that she had had good news from 
the gynaecologist and that everything was fine regarding the hysterectomy. In 
seven days she had to go back to the oncologist for her sixth month’s tests but 
although she was a bit nervous, she was also feeling positive about the results.   
We ended the session on a good note, where both of them felt more positive and 
informed than before the session. We made another appointment for one month 
from then, for an individual session.    
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Therapeutic note: This was both a psycho-education session in terms of side-
effects of the chemo therapy, hormonal treatment and menopause and especially 
the effect on their sex life. This session also served as an opportunity for the 
patient and her husband to have an emotional catharsis because they had both 
shared their emotions with each other and experienced the benefits of 
communicating their feelings. They both understood the importance of putting 
certain experiences and emotions in the framework of the breast cancer and 
cancer treatment.   
FIFTH CONSULTATION: 02/08/2015 
The patient looked much more relaxed than the previous sessions. She 
immediately started giving feedback regarding the mutual session with her 
husband the previous time. She said that in spite of the fact that her husband was 
apprehensive about their joint session, he had experienced the session rather 
positive and that after the session she could see a change in his behaviour. I had 
also experienced him as very unapproachable and curt in the beginning of the 
session. She said that they talked more to each other and he was making an effort 
to spend more time at home with her. She said she felt more accepted and 
understood by her husband, although she knew that there was still a long road 
ahead of them to grow and adapt. She felt for the first time that he was on board. 
The patient had very good insight into herself, her condition and her relationship 
with her husband. She was also very committed and positive about the therapeutic 
process. 
She had gone back to work for the first time six weeks after the hysterectomy and 
said that she was actually coping very well. She said working was very important 
to her and even during her chemotherapy she had worked the whole time and had 
always tried to schedule her chemotherapy on a Friday, so that she didn’t need to 
take off from work. She said she found her colleagues very supportive and good to 
her. Before she had gone back to work she had been scared that her energy and 
concentration would fail her, but she could see a difference in her energy levels 
and although her concentration and memory was not up to her usual standard, 
she could work around it.   
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Therapeutic input  
I explained to her that the lack of energy, concentration and memory, which could 
still be side-effects of the chemo, would take a while before it cleared and that she 
had to give herself some time to recuperate from the breast cancer ordeal. She 
could make use of alternatives to handle these problems for instance, making little 
notes to remember things, or to take more breaks to help with her concentration 
and to rest more and reserve her energy through prioritising. I reinforced the 
importance for her to understand the cancer related symptoms and that most 
symptoms usually got better and disappeared over time. We talked about 
accepting the fact that there would be a difference between how she had been 
before the cancer and her current functioning now, after the treatment and that it 
took a process (e.g. working through her emotions and learning new stress 
handling- and coping skills) and some time to adapt to a “new” post-breast cancer 
status quo. The patient said the fact that she understood her level of functioning 
better and that it was only temporary, made it seem less threatening and scary.   
The patient said she was very wary not to stress too much, as she knew stress 
was not good for her or the cancer and that she would like to learn some skills so 
as not to worry so much. I explained to her different mechanisms of handling 
stress in terms of your mind/thoughts. There were cognitive processes and 
behaviour (things wat you do). I would give her examples of how to relax:   
STRESS HANDLING MECHANISMS 
Firstly I explained basic breathing exercises to her by saying that one of the first 
things when stressed or to prevent stress is to concentrate on relaxing the whole 
body and to do relaxing breathing:  
 Firstly I explained how to do it. You can sit or stand, but make sure to 
soften the body a little before you begin. Make sure your hands are relaxed 
(open) and drop your shoulders and let your jaw relax. Take a slow breath 
in through your nose and count to four, keep your shoulders down and 
allow your stomach to expand as you breathe in 
o hold your breath for one or two counts    
o Now release your breath slowly and smoothly as you count to four   
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o Wait a few seconds before taking another breath and repeat the 
exercise for a couple of minutes.    
 
 Secondly I explained a quick way of relaxing her whole body:   
o stand up straight and tall and let your arms hang naturally 
o breathe in slowly through your nose whilst tensing all your muscles   
o hunch your shoulders, make tight fists with your hands, tense your 
stomach and clench your buttocks, push yourself up onto tiptoe 
position and hold and count slowly to five   
o slowly breathe out through your nose while relaxing and return to 
your original standing position 
o repeat the above 3 to 5 times or as time and circumstances allow 
These are relatively easy breathing and muscle exercises that she could do any 
place or time and not just wait for a situation which is stressful. She should 
concentrate during the day to do proper breathing.   
 Thirdly I explained that it is important to exercise after your doctor had 
given you permission to exercise again, such as walking or yoga which is a 
very good and healthy way to get the extra adrenaline out of your body and 
give your body more oxygen and time to think things through. 
 
 Fourthly I explained that she should take control of her thoughts through 
mind control: This entailed the process of focusing away from negative and 
disturbing thoughts by identifying and accepting the negative or irrational 
thoughts without judging them or fighting them and then focussing on other, 
more rational and positive thoughts. I also explained the importance of 
focusing on the here and now, such as what was happening around you at 
that moment, what you were experiencing and what you could do to feel 
better, such as phoning a friend, making a cup of tea, doing something in or 
around the house, or just walking around. This would help her to focus 
away from the disturbing thought(s).     
I summarised the session by asking her to think about all the new information that 
she had received and to begin implementing them one small step at a time. She 
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should give me feedback during the following session. The patient said that she 
felt excited about the new skills. It made sense to her and she could not wait to 
start doing it. We ended the session after one hour and ten minutes with a follow 
up session planned for three months from then. The patient said that she felt much 
better and would like some time to implement the above mentioned skills.    
Sixth consultation:  10/11/2015 
During this feedback session that had been planned three months before, the 
patient seemed in good spirits and looked much more relaxed during this session. 
She seemed fit and healthy. She reported back that since the session with her 
husband, they were functioning much better as a couple. They talked more, did 
more things together and her husband was more attentive to her than previously. 
Even sexually she could see a huge difference. She said what made her exited 
was that it had been three months after the previous session and her husband 
was still committed to his “new” behaviour. She said the mere fact that her 
husband was more understanding and supportive, made her feel much better in 
general.   
She said that her chemo-related symptoms, especially the tiredness and 
concentration, were also less and that she could see that in her functioning at 
work. She said that they were extremely busy at work and that she could keep up 
one hundred percent. She said this made her feel worthy as a “worker” again. 
Keeping up with her child made her very tired and she had to manage her time 
and activities with him very carefully.   
Therapeutic input 
I just emphasized again the principle that who she had been as a person, wife and 
mother before the breast cancer and cancer treatment, did not exist anymore and 
that there was a “new” person, wife and mother this side of cancer. This was not 
necessarily negative, just different, and required new skills and adaptation. She 
said that every time something happened that was different from before the 
cancer, she remembered this principle and consciously applied it by having new 
thoughts or actions and tried to accept and make peace with it. We talked about 
practical ways of playing with her child without getting too tired, for example, 
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instead of running around and playing with a ball she and he could participate 
more in passive games like colouring in, playing hide-and-seek in the house or 
reading or watching TV together. It was very important for her to be involved in her 
child’s life and by altering her actions and time with him in a more suitable way for 
her, would prevent her from feeling guilty of not spending enough and quality time 
with him. She said that during the time that she had had her treatment and had 
been very ill because of the chemotherapy, she could see a difference in his 
behaviour and that his teacher had also commented on his changed behaviour. 
She said it was if he had regressed during that time, especially when she had 
been in hospital. She still experienced feelings of guilt over that. I gave her time to 
talk about her guilt feelings and guided her to put her feelings into perspective of 
her illness and commented that she, in spite of her condition, was still very 
involved in his life during that period of time.      
Although her breast reconstruction surgeries were finished, something had 
happened and she had to undergo a procedure the following month. This meant a 
two day stay in hospital. She said she was not scared, but felt that she had had 
enough of hospitals and wished it was over. She said the only thing that really 
stressed her regarding her stay in hospital, was her son who got tense when she 
went to hospital and she asked me how to approach him. 
My input 
She had to stay as close to the truth as possible and explain to him that she was 
going to the hospital for two days, but not because she was sick again, but to “fix” 
her breast. He knew about the breasts and the operations because “they got sick”. 
She could explain to him that he would stay with his father and that he would still 
go to school. Everything would go on as usual and he could visit her in hospital. 
On a practical side, she could prepare his favourite meal and put it in the freezer 
and he could eat it when she was in hospital, and he would “think” of his Mommy 
still making his favourite meal even if she was in hospital.     
She said another aspect that made her anxious was all the tests that she would 
have to go through again in two months from then. She said she was scared but 
would definitely use the relaxation breathing and exercises. We talked about the 
chronicity of breast cancer and that although she was in remission, she would still 
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have to take the hormone medication for five years. She would need to go for 
lifelong follow ups and tests which would make her anxious and scared. This was 
also a normal reaction to the situation. It was important to accept this anxiousness 
as normal and work with it instead of against it by talking about how she felt, 
focusing away from destructive thoughts and to use relaxing methods to gain 
control. 
I have found as a therapist that the mere fact of normalizing emotions and 
thoughts for a patient, may take away a lot of tension and anxiety and make the 
person feel more in control of herself and her thoughts and emotions. We ended 
the session by scheduling a session three months from then.   
SEVENTH CONSULTATION: 10/02/2016                                        
The patient looked very well and she said that she felt good and healthy. First she 
gave feedback of the previous three months that I had not seen her, saying that 
she had gone for her full blood tests and the other cancer tests and scans and had 
seen the oncologist the previous month. She said she had been anxious, but kept 
it in mind that it was “normal” and that she could manage it and that it was not 
necessary to fight against it. She said that everything was hundred percent normal 
and that she had been in remission at that time for thirteen months. She said that 
she felt extremely happy and good about her health and that she made a point of 
not thinking about the cancer anymore. She said that her and her husband’s 
relationship was still good and at a much better functioning level than before and 
that they still used the therapeutic guidelines from our mutual therapy session. 
She said even the sexual functioning, considering her hormonal therapy, was 
good and enjoyable.   
Her functioning at work was good; she was enjoying her work again and handled 
her work-related stress well. She said that, in general, her health and functioning 
was at a high level and that she enjoyed life to the full again. I asked about her 
depression symptoms and she said that she felt less depressed and anxious and 
that she could feel that because of the therapy her overall level of functioning was 
higher than before. It was only when she thought or talked about her child that she 
felt some degree of depression. She asked whether we could talk about her child 
again, for he was still not at his previous level of functioning and it worried her. 
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She talked about her feelings regarding her child saying she was still scared that 
the cancer might return and that he, being an only child, would grow up without his 
mother and other siblings. She said she had a lot of sad feelings and anxiousness 
when she thought of him growing up without her. I gave her time to express her 
emotions, especially the fear and guilt feelings regarding her child. I also explained 
how important it was for her to allow herself to go through the motions and 
express these feelings, for it was normal to feel that way. We concentrated on 
how, after accepting and accommodating the negative and anxious thoughts, she 
could focus on the reality of their relationship, and participate in present activities. 
She said she felt better for talking about her emotions concerning her child. She 
was feeling guilty and ashamed of herself, because she was actually cancer free 
but yet she was stressing about dying from cancer. She didn’t feel like sharing this 
with anybody else. She said that she felt that this was one of the biggest “perks” of 
going to therapy. You could speak about everything and anything which you 
couldn’t speak about to anybody else without being judged or being frowned upon.       
She said she had received the “green light” from her oncologist and had started to 
exercise again. She said it made a huge difference in how she felt and looked. 
She said she had gained a couple of extra pounds during her cancer treatment, 
but could already see the difference from the exercising. She said that being able 
to exercise again made her also feel more social and “in” with the “normal” crowd. 
She said she felt really “normal” again, being able to do “normal” things. She 
asked whether it was possible to see me every three or sixth months for a 
therapeutic session, for she found that by talking about her emotions and receiving 
the appropriate feedback, and being taught new mechanisms and skills, improved 
her functioning and made her feel in control of her own life. I agreed to such an 
arrangement saying that it was a good way of maintaining her emotional health, 
but for the sake of the study we should make one final session to conclude our 
therapy, also three months from then. From there on we could participate in the 
usual follow up sessions if she still wanted to.     
Eighth and final consultation: 15/05/2016                                             
We made this appointment to conclude the therapeutic process. This session was 
booked and lasted for one hour. I let her to talk freely and lead the session. The 
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patient looked very good and said that apart from a couple of complaints she 
actually felt physically well but needed to talk to me about emotions and certain 
concerns. She asked again if it would be possible for her to keep on scheduling 
appointments with me every couple of months for she felt that seeing me made 
her feel comfortable and that we already had a therapeutic relationship. She said 
that for her family and friends her cancer experience was now something of the 
past, but she felt that she needed, from time to time, to talk about it with somebody 
from the outside. She felt that her family and friends would not understand this 
need to talk about the cancer after everything because it was over and she was 
cancer-free. She also said that she could understand that “outside people” could 
not understand the change from being a cancer patient to a “normal” person.  
The first issue that she wanted to discuss was her short-term memory. She said 
that it was still a serious problem for her. She could not remember things and it 
affected her marriage and her work.  She said her husband complained about it all 
the time, saying that when he asked her to do things for him, she didn’t do it 
although she said she would. She said the lack of memory often instigates conflict 
between them and felt that he did not understand her problem with her memory. 
She said that she was very worried about her work for she worked with figures and 
had a responsible job and was scared that she would make mistakes. She said 
that, never in her past, had she had problems with her work performance and did 
not want to jeopardise her job, for they were dependant on her salary.   
Therapeutic input 
I reminded her about memory loss as a side-effect of chemotherapy and that it 
could be a long term effect which could impact her negatively in certain areas of 
her functioning. The most important thing for her to do was to understand and 
acknowledge it as a cancer treatment related problem and to accept and make 
peace with it. It was not necessary to panic about it as it was “normal” in her 
situation. Her immediate reaction to this was pure relief, saying that although she 
could remember us talking about chemo and memory, she was still unsure why 
she had such a problem with it and it really scared her because the cancer 
treatment had ended so long ago. She said as long as she knew that there was 
not something wrong with her, she would be able to cope and deal with it. I 
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reminded her to be conscious about her thoughts, identify any irrational thoughts 
and replace them with rational and “true” thoughts. On the practical and 
behavioural side, she could make notes (especially at work) and write all the 
important things in her diary to check from time to time to make sure everything 
was done. By doing something about the problem would make her feel more in 
control and lessen the probability of her making unnecessary mistakes at work. In 
her everyday life, as with her interactions with her husband, she could also make 
notes of what he had said and asked her to do and make a daily to do list in terms 
of the household. She shouldn’t feel embarrassed about it; it was part of where 
she was in her “post-cancer” life now.   
The next topic that she wanted to talk about was her weight and lack of hormones. 
She said that although she had not gained weight she weighed more than before 
the cancer but had made peace with it. She said that she exercised regularly and 
was conscious about what she ate. She would like to make another appointment 
to talk about her self-image and sexual self-image. She said she understood the 
impact of the menopause on her sex life and emotions but just wanted to check 
with me again regarding it. I restated the symptoms of menopause again and what 
to do when her libido was low, especially her thoughts regarding her libido and 
plans to enhance a low libido (e.g. think about sex more often, buy books about 
sex and talk about it more with her husband) and she could organise date nights 
with her husband and try different sex scenario’s (e.g. engaging in sex outside the 
bedroom). I reminded her that everything took time and that she should cut herself 
some slack and reward herself when she got something right or when a side-effect 
got better and she should enjoy her better relationship with her husband and 
interactions with her child. She said that she could see that her child’s functioning 
was also better and that he didn’t ask about her going to hospital as often as 
during the cancer treatment. She felt very positive regarding the progress of her 
child and their functioning as a family.   
I asked her to summarise her experience of the therapeutic process so far. She 
said there were so many advantages that she didn’t know where to start, but the 
mere fact that she could talk to me about anything, even her sex life and deepest 
fears and thoughts, made her feel better and more in control of her life again. She 
said what made a big difference to her was that she felt so “normal” again after 
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talking about all her feelings and thoughts and experiences, understanding that 
other woman in her situation also felt that way and that she was not the only one. 
She said she thought it was the receiving of information regarding all the 
unfamiliar things that was happening to her that made her more relaxed and had 
put her mind to rest about her concerns regarding for instance her tiredness and 
lack of memory and menopause. She said when she started with therapy she was 
so depressed and anxious all the time not knowing what was happening to her, 
but felt that she understood her own emotions and reactions much better now 
which made her feel better, saying: “I feel more in control of my own body and my 
own thoughts and feel just all together lighter”. She said she felt very strongly 
about therapy and cancer, because it helped her and her husband and child a lot 
during “their” cancer journey. We ended the session after an hour with the patient 
making an appointment for a next session to work on her self-image.       
 
 
 
 
 
 
 
 
 
 
